Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:lead atom
go back to main search page
Accession:CHEBI:25016 term browser browse the term
Definition:A carbon group element atom that has formula Pb.
Synonyms:related_synonym: 82Pb;   Blei;   Pb;   lead;   plomb;   plomo;   plumbum
 xref: WebElements:Pb;   kegg.compound:C06696
 chemrof_inchi: InChI=1S/Pb
 chemrof_formula: Pb
 chemrof_inchikey: WABPQHHGFIMREM-UHFFFAOYSA-N
 chemrof_smiles: [Pb]


show annotations for term's descendants           Sort by:
elemental lead term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gp6 glycoprotein 6 platelet decreases methylation ISO Lead decreases methylation of the GP6 gene in umbilical cord blood RGD PMID:29492281 RGD:401794439 NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743 		JBrowse link
lead chromate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Xrcc1 X-ray repair complementing defective repair in Chinese hamster cells 1 decreases response to substance ISO XRCC1 protein results in decreased susceptibility to lead chromate CTD PMID:16714390 NCBI chr 7:24,246,124...24,272,863
Ensembl chr 7:24,245,714...24,272,865 		JBrowse link
lead diacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1810055G02Rik RIKEN cDNA 1810055G02 gene increases expression ISO lead acetate results in increased expression of C11ORF24 mRNA CTD PMID:38568856 NCBI chr19:3,758,343...3,767,882
Ensembl chr19:3,758,293...3,767,881 		JBrowse link
G 2010003K11Rik RIKEN cDNA 2010003K11 gene decreases expression ISO lead acetate results in decreased expression of C11ORF86 mRNA CTD PMID:38568856 NCBI chr19:4,546,816...4,548,611
Ensembl chr19:4,546,816...4,548,611 		JBrowse link
G 5430425K12Rik RIKEN cDNA 5430425K12 gene increases expression ISO lead acetate results in increased expression of LUCAT1 mRNA CTD PMID:27562236 PMID:38568856 NCBI chr13:81,088,522...81,096,716
Ensembl chr13:81,088,530...81,096,718 		JBrowse link
G 6820408C15Rik RIKEN cDNA 6820408C15 gene decreases expression ISO lead acetate results in decreased expression of C20ORF96 mRNA CTD PMID:38568856 NCBI chr 2:152,257,507...152,286,256
Ensembl chr 2:152,257,507...152,286,250 		JBrowse link
G A2m alpha-2-macroglobulin affects expression
decreases expression 		ISO lead acetate affects the expression of A2M mRNA
lead acetate results in decreased expression of A2M mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186 		JBrowse link
G Aadat aminoadipate aminotransferase increases expression ISO lead acetate results in increased expression of AADAT mRNA CTD PMID:22641619 NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711 		JBrowse link
G Aars1 alanyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of AARS1 mRNA CTD PMID:11578147 NCBI chr 8:111,759,781...111,784,237
Ensembl chr 8:111,759,776...111,784,296 		JBrowse link
G Abca1 ATP-binding cassette, sub-family A member 1 increases expression ISO lead acetate results in increased expression of ABCA1 mRNA; lead acetate results in increased expression of ABCA1 protein CTD PMID:29908845 NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895 		JBrowse link
G Abca6 ATP-binding cassette, sub-family A member 6 decreases expression ISO lead acetate results in decreased expression of ABCA6 mRNA CTD PMID:38568856 NCBI chr11:110,065,464...110,142,811
Ensembl chr11:110,067,646...110,142,602 		JBrowse link
G Abca9 ATP-binding cassette, sub-family A member 9 decreases expression ISO lead acetate results in decreased expression of ABCA9 mRNA CTD PMID:38568856 NCBI chr11:109,990,919...110,059,532
Ensembl chr11:109,991,575...110,059,022 		JBrowse link
G Abcc1 ATP-binding cassette, sub-family C member 1 increases expression
affects export 		ISO
EXP 		lead acetate results in increased expression of ABCC1 mRNA; lead acetate results in increased expression of ABCC1 protein
ABCC1 protein affects the export of lead acetate 		CTD PMID:23274417 PMID:24598511 PMID:27236077 NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601 		JBrowse link
G Abcc2 ATP-binding cassette, sub-family C member 2 increases expression ISO lead acetate results in increased expression of ABCC2 mRNA CTD PMID:38568856 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179 		JBrowse link
G Abcd4 ATP-binding cassette, sub-family D member 4 decreases expression ISO lead acetate results in decreased expression of ABCD4 mRNA CTD PMID:38568856 NCBI chr12:84,648,634...84,664,259
Ensembl chr12:84,648,238...84,664,187 		JBrowse link
G Abce1 ATP-binding cassette, sub-family E member 1 increases expression ISO lead acetate results in increased expression of ABCE1 mRNA CTD PMID:11578147 NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 (Junior blood group) increases expression ISO lead acetate results in increased expression of ABCG2 mRNA CTD PMID:22641619 NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661 		JBrowse link
G Abhd15 abhydrolase domain containing 15 increases expression EXP lead acetate results in increased expression of ABHD15 mRNA CTD PMID:22609695 NCBI chr11:77,405,943...77,411,454
Ensembl chr11:77,405,947...77,429,433 		JBrowse link
G Ablim3 actin binding LIM protein family, member 3 increases expression ISO lead acetate results in increased expression of ABLIM3 mRNA CTD PMID:38568856 NCBI chr18:61,932,463...62,044,956
Ensembl chr18:61,932,463...62,044,895 		JBrowse link
G Acaca acetyl-Coenzyme A carboxylase alpha decreases expression EXP lead acetate results in decreased expression of ACACA mRNA CTD PMID:33932463 NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477 		JBrowse link
G Acad8 acyl-Coenzyme A dehydrogenase family, member 8 decreases expression ISO lead acetate results in decreased expression of ACAD8 mRNA CTD PMID:38568856 NCBI chr 9:26,885,434...26,910,872
Ensembl chr 9:26,885,431...26,910,862 		JBrowse link
G Acan aggrecan increases expression
multiple interactions 		EXP lead acetate results in increased expression of ACAN mRNA
BMP2 promotes the reaction [lead acetate results in increased expression of ACAN mRNA]; lead acetate promotes the reaction [BMP2 results in increased expression of ACAN mRNA] 		CTD PMID:17805416 NCBI chr 7:78,702,974...78,764,847
Ensembl chr 7:78,703,231...78,764,847 		JBrowse link
G Acat1 acetyl-Coenzyme A acetyltransferase 1 decreases expression EXP lead acetate results in decreased expression of ACAT1 mRNA CTD PMID:21829687 NCBI chr 9:53,491,822...53,521,650
Ensembl chr 9:53,491,822...53,521,682 		JBrowse link
G Acat2 acetyl-Coenzyme A acetyltransferase 2 decreases expression EXP lead acetate results in decreased expression of ACAT2 mRNA CTD PMID:21829687 NCBI chr17:13,161,929...13,179,612
Ensembl chr17:13,161,777...13,179,634 		JBrowse link
G Ace angiotensin I converting enzyme affects expression ISO lead acetate affects the expression of ACE mRNA CTD PMID:21864555 PMID:22641619 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790 		JBrowse link
G Ace2 angiotensin converting enzyme 2 decreases expression EXP lead acetate results in decreased expression of ACE2 mRNA CTD PMID:22613225 NCBI chr  X:162,922,338...162,971,414
Ensembl chr  X:162,922,328...162,971,416 		JBrowse link
G Acer2 alkaline ceramidase 2 increases expression ISO lead acetate results in increased expression of ACER2 mRNA CTD PMID:22641619 NCBI chr 4:86,792,585...86,853,059
Ensembl chr 4:86,792,633...86,853,059 		JBrowse link
G Ache acetylcholinesterase decreases expression
decreases activity
multiple interactions
increases activity 		EXP
ISO 		lead acetate results in decreased expression of ACHE protein
lead acetate results in decreased activity of ACHE protein
[lead acetate results in increased abundance of Lead] which results in decreased activity of ACHE protein; [lead acetate results in increased abundance of Lead] which results in increased activity of ACHE protein; Biological Factors inhibits the reaction [lead acetate results in decreased activity of ACHE protein]; Curcumin inhibits the reaction [lead acetate results in decreased activity of ACHE protein]; ferulic acid inhibits the reaction [lead acetate results in increased activity of ACHE protein]; Plant Preparations inhibits the reaction [lead acetate results in decreased activity of ACHE protein]; Tannic Acid inhibits the reaction [lead acetate results in decreased activity of ACHE protein]
puerarin inhibits the reaction [lead acetate results in decreased expression of ACHE protein] 		CTD PMID:23501611 PMID:25322819 PMID:25496357 PMID:30703413 PMID:35307918 More... NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728 		JBrowse link
G Acin1 apoptotic chromatin condensation inducer 1 decreases expression EXP lead acetate results in decreased expression of ACIN1 mRNA CTD PMID:20542052 NCBI chr14:54,879,618...54,924,422
Ensembl chr14:54,879,618...54,924,388 		JBrowse link
G Acot11 acyl-CoA thioesterase 11 decreases expression ISO lead acetate results in decreased expression of ACOT11 mRNA CTD PMID:38568856 NCBI chr 4:106,601,752...106,662,204
Ensembl chr 4:106,601,752...106,662,195 		JBrowse link
G Acot7 acyl-CoA thioesterase 7 increases expression EXP lead acetate results in increased expression of ACOT7 mRNA CTD PMID:21829687 NCBI chr 4:152,258,872...152,356,312
Ensembl chr 4:152,262,591...152,356,312 		JBrowse link
G Acsf2 acyl-CoA synthetase family member 2 decreases expression ISO lead acetate results in decreased expression of ACSF2 mRNA CTD PMID:38568856 NCBI chr11:94,447,928...94,492,822
Ensembl chr11:94,447,928...94,492,697 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO lead acetate results in decreased expression of ACSL1 mRNA CTD PMID:38568856 NCBI chr 8:46,924,214...46,989,088
Ensembl chr 8:46,924,074...46,989,088 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of ACSL4 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ACSL4 mRNA 		CTD PMID:38568856 PMID:39276841 NCBI chr  X:141,100,989...141,173,792
Ensembl chr  X:141,100,989...141,173,531 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 affects expression ISO lead acetate affects the expression of ACSM3 mRNA CTD PMID:21864555 NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736 		JBrowse link
G Acsm5 acyl-CoA synthetase medium-chain family member 5 decreases expression ISO lead acetate results in decreased expression of ACSM5 mRNA CTD PMID:22641619 NCBI chr 7:119,125,354...119,142,583
Ensembl chr 7:119,118,686...119,144,774 		JBrowse link
G Acta2 actin alpha 2, smooth muscle, aorta multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ACTA2 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ACTA2 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ACTA2 mRNA] CTD PMID:39722890 NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990 		JBrowse link
G Actb actin, beta affects expression EXP lead acetate affects the expression of ACTB protein CTD PMID:20797405 NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509 		JBrowse link
G Actn4 actinin alpha 4 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ACTN4 intron CTD PMID:33445541 NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765 		JBrowse link
G Acvrl1 activin A receptor, type II-like 1 increases expression EXP lead acetate results in increased expression of ACVRL1 mRNA CTD PMID:22609695 NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217 		JBrowse link
G Acyp2 acylphosphatase 2, muscle type decreases expression EXP lead acetate results in decreased expression of ACYP2 mRNA CTD PMID:20542052 NCBI chr11:30,455,991...30,599,778
Ensembl chr11:30,455,991...30,599,587 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 decreases expression EXP lead acetate results in decreased expression of ADAM19 mRNA CTD PMID:22613225 NCBI chr11:45,945,329...46,038,174
Ensembl chr11:45,946,819...46,038,170 		JBrowse link
G Adam1a a disintegrin and metallopeptidase domain 1a increases expression ISO lead acetate results in increased expression of ADAM1A mRNA CTD PMID:22641619 NCBI chr 5:121,656,667...121,659,758
Ensembl chr 5:121,656,639...121,660,134 		JBrowse link
G Adam2 a disintegrin and metallopeptidase domain 2 increases methylation ISO lead acetate results in increased methylation of ADAM2 gene CTD PMID:29571894 NCBI chr14:66,264,778...66,315,300
Ensembl chr14:66,264,778...66,315,182 		JBrowse link
G Adam32 a disintegrin and metallopeptidase domain 32 increases expression ISO lead acetate results in increased expression of ADAM32 mRNA CTD PMID:22641619 NCBI chr 8:25,326,159...25,438,933
Ensembl chr 8:25,326,156...25,438,820 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif 1 decreases expression ISO lead acetate results in decreased expression of ADAMTS1 mRNA CTD PMID:22641619 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001 		JBrowse link
G Adamts15 ADAM metallopeptidase with thrombospondin type 1 motif 15 decreases expression EXP lead acetate results in decreased expression of ADAMTS15 mRNA CTD PMID:22613225 NCBI chr 9:30,810,451...30,833,853
Ensembl chr 9:30,810,451...30,833,748 		JBrowse link
G Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif 20 increases expression ISO lead acetate results in increased expression of ADAMTS20 mRNA CTD PMID:22641619 NCBI chr15:94,166,177...94,329,966
Ensembl chr15:94,168,044...94,363,299 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif 4 increases expression ISO lead acetate results in increased expression of ADAMTS4 mRNA CTD PMID:22641619 NCBI chr 1:171,077,698...171,089,836
Ensembl chr 1:171,077,990...171,088,206 		JBrowse link
G Adamtsl1 ADAMTS-like 1 increases expression EXP lead acetate results in increased expression of ADAMTSL1 mRNA CTD PMID:20542052 PMID:22613225 NCBI chr 4:85,432,242...86,346,627
Ensembl chr 4:85,432,409...86,346,622 		JBrowse link
G Adcy8 adenylate cyclase 8 increases expression EXP
ISO 		lead acetate results in increased expression of ADCY8 mRNA CTD PMID:11578147 PMID:20542052 NCBI chr15:64,570,884...64,794,145
Ensembl chr15:64,568,933...64,794,145 		JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 decreases expression EXP lead acetate results in decreased expression of ADCYAP1 mRNA CTD PMID:22613225 NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965 		JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 affects expression EXP lead acetate affects the expression of ADGRE4 mRNA CTD PMID:21829687 NCBI chr17:56,056,984...56,160,662
Ensembl chr17:56,056,984...56,160,662 		JBrowse link
G Adgrf2 adhesion G protein-coupled receptor F2 increases expression ISO lead acetate results in increased expression of ADGRF2 mRNA CTD PMID:22641619 NCBI chr17:43,004,919...43,054,646
Ensembl chr17:43,007,021...43,053,070 		JBrowse link
G Adgrg6 adhesion G protein-coupled receptor G6 increases expression ISO lead acetate results in increased expression of ADGRG6 mRNA CTD PMID:22641619 NCBI chr10:14,278,327...14,421,467
Ensembl chr10:14,278,327...14,421,403 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression ISO lead acetate results in decreased expression of ADIPOQ mRNA CTD PMID:11578147 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778 		JBrowse link
G Adipor2 adiponectin receptor 2 increases expression EXP lead acetate results in increased expression of ADIPOR2 mRNA CTD PMID:21829687 NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665 		JBrowse link
G Adk adenosine kinase decreases expression EXP lead acetate results in decreased expression of ADK mRNA CTD PMID:20542052 NCBI chr14:21,102,622...21,498,637
Ensembl chr14:21,102,642...21,498,637 		JBrowse link
G Adora1 adenosine A1 receptor multiple interactions
increases expression 		ISO [lead acetate co-treated with Morphine] results in increased expression of ADORA1 mRNA; [lead acetate co-treated with Morphine] results in increased expression of ADORA1 protein; [lead acetate results in increased expression of ADORA1 protein] which results in increased abundance of Adenosine
lead acetate results in increased expression of ADORA1 mRNA; lead acetate results in increased expression of ADORA1 protein 		CTD PMID:20932874 PMID:26478469 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169 		JBrowse link
G Adpgk ADP-dependent glucokinase decreases expression ISO lead acetate results in decreased expression of ADPGK mRNA CTD PMID:22641619 NCBI chr 9:59,198,855...59,223,483
Ensembl chr 9:59,198,841...59,231,335 		JBrowse link
G Adra1d adrenergic receptor, alpha 1d increases expression EXP lead acetate results in increased expression of ADRA1D mRNA CTD PMID:22613225 NCBI chr 2:131,387,277...131,404,417
Ensembl chr 2:131,387,770...131,404,203 		JBrowse link
G Adra2b adrenergic receptor, alpha 2b increases expression EXP lead acetate results in increased expression of ADRA2B mRNA CTD PMID:21829687 NCBI chr 2:127,205,099...127,209,141
Ensembl chr 2:127,205,128...127,209,141 		JBrowse link
G Adss1 adenylosuccinate synthase 1 decreases expression ISO lead acetate results in decreased expression of ADSS1 mRNA CTD PMID:38568856 NCBI chr12:112,586,481...112,607,789
Ensembl chr12:112,586,479...112,607,794 		JBrowse link
G Adtrp androgen dependent TFPI regulating protein increases expression EXP lead acetate results in increased expression of ADTRP mRNA CTD PMID:22609695 NCBI chr13:41,916,621...42,001,092
Ensembl chr13:41,916,624...42,001,160 		JBrowse link
G Aebp1 AE binding protein 1 increases expression ISO lead acetate results in increased expression of AEBP1 mRNA CTD PMID:22641619 NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088 		JBrowse link
G Afg3l2 AFG3-like AAA ATPase 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of AFG3L2 protein CTD PMID:38072110 NCBI chr18:67,537,830...67,582,277
Ensembl chr18:67,537,834...67,582,242 		JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression 		ISO sinapinic acid inhibits the reaction [lead acetate results in increased expression of AGER mRNA] CTD PMID:37471654 NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910 		JBrowse link
G Agtpbp1 ATP/GTP binding protein 1 affects expression ISO lead acetate affects the expression of AGTPBP1 protein CTD PMID:36539177 NCBI chr13:59,597,348...59,705,184
Ensembl chr13:59,593,556...59,733,041 		JBrowse link
G Ahnak AHNAK nucleoprotein increases expression EXP lead acetate results in increased expression of AHNAK mRNA CTD PMID:21829687 NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278 		JBrowse link
G Ahr aryl-hydrocarbon receptor increases expression
multiple interactions 		ISO lead acetate results in increased expression of AHR mRNA; lead acetate results in increased expression of AHR protein
[Cadmium Chloride co-treated with Benzo(a)pyrene co-treated with lead acetate] results in increased activity of AHR protein; [lead acetate co-treated with Benzo(a)pyrene] results in increased activity of AHR protein; [sodium arsenite co-treated with Benzo(a)pyrene co-treated with lead acetate] results in increased activity of AHR protein 		CTD PMID:17576166 PMID:29502740 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037 		JBrowse link
G Ahsp alpha hemoglobin stabilizing protein affects expression ISO lead acetate affects the expression of AHSP mRNA CTD PMID:22641619 NCBI chr 7:127,902,016...127,902,926
Ensembl chr 7:127,901,969...127,902,930 		JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of AIF1 mRNA; lead acetate results in increased expression of AIF1 protein
[lead acetate co-treated with Morphine] results in increased expression of AIF1 mRNA
lead acetate results in decreased expression of AIF1 mRNA 		CTD PMID:21829687 PMID:26478469 PMID:33862172 PMID:38281554 NCBI chr17:35,389,967...35,394,977
Ensembl chr17:35,389,967...35,395,044 		JBrowse link
G Aif1l allograft inflammatory factor 1-like decreases expression ISO lead acetate results in decreased expression of AIF1L mRNA CTD PMID:38568856 NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454 		JBrowse link
G Aifm1 apoptosis-inducing factor, mitochondrion-associated 1 affects expression
decreases expression
multiple interactions 		ISO lead acetate affects the expression of AIFM1 protein
lead acetate results in decreased expression of AIFM1 mRNA
[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein; [sodium arsenite co-treated with lead acetate] results in increased expression of AIFM1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein] 		CTD PMID:18618274 PMID:23146751 PMID:31874198 PMID:35300571 PMID:38072110 NCBI chr  X:47,563,821...47,602,440
Ensembl chr  X:47,563,821...47,602,440 		JBrowse link
G Aifm2 apoptosis-inducing factor, mitochondrion-associated 2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of AIFM2 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA 		CTD PMID:38568856 PMID:39276841 NCBI chr10:61,551,042...61,575,474
Ensembl chr10:61,551,042...61,575,039 		JBrowse link
G Aipl1 aryl hydrocarbon receptor-interacting protein-like 1 decreases expression ISO lead acetate results in decreased expression of AIPL1 mRNA CTD PMID:22641619 NCBI chr11:71,919,527...71,933,184
Ensembl chr11:71,918,789...71,928,335 		JBrowse link
G Akap1 A kinase anchor protein 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of AKAP1 mRNA CTD PMID:33445541 NCBI chr11:88,721,618...88,755,426
Ensembl chr11:88,721,618...88,755,412 		JBrowse link
G Akap12 A kinase anchor protein 12 increases expression ISO lead acetate results in increased expression of AKAP12 mRNA CTD PMID:38568856 NCBI chr10:4,216,329...4,309,471
Ensembl chr10:4,216,380...4,309,470 		JBrowse link
G Akap7 A kinase anchor protein 7 increases expression EXP lead acetate results in increased expression of AKAP7 mRNA CTD PMID:22609695 NCBI chr10:25,044,988...25,175,115
Ensembl chr10:25,044,988...25,183,768 		JBrowse link
G Akap8 A kinase anchor protein 8 increases methylation ISO lead acetate results in increased methylation of AKAP8 gene CTD PMID:29571894 NCBI chr17:32,522,646...32,540,212
Ensembl chr17:32,522,646...32,540,212 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B increases expression ISO lead acetate results in increased expression of AKR1B1 mRNA CTD PMID:38568856 NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413 		JBrowse link
G Akr1b10 aldo-keto reductase family 1, member B10 increases expression ISO lead acetate results in increased expression of AKR1B10 mRNA CTD PMID:37939567 PMID:38568856 NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885 		JBrowse link
G Akr1c18 aldo-keto reductase family 1, member C18 increases expression ISO lead acetate results in increased expression of AKR1C3 mRNA CTD PMID:38568856 NCBI chr13:4,182,614...4,200,645
Ensembl chr13:4,182,614...4,200,653 		JBrowse link
G Akr1c20 aldo-keto reductase family 1, member C20 increases expression ISO lead acetate results in increased expression of AKR1C1 mRNA CTD PMID:22839698 PMID:38568856 NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344 		JBrowse link
G Akr1c21 aldo-keto reductase family 1, member C21 increases expression
multiple interactions 		ISO lead acetate results in increased expression of AKR1C2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of AKR1C2 mRNA 		CTD PMID:22839698 PMID:38568856 PMID:39276841 NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540 		JBrowse link
G Akr1c6 aldo-keto reductase family 1, member C6 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of AKR1C1 mRNA CTD PMID:39276841 NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 decreases expression
decreases phosphorylation
multiple interactions
increases phosphorylation 		ISO
EXP 		lead acetate results in decreased expression of AKT1 protein
lead acetate results in decreased phosphorylation of AKT1 protein
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased phosphorylation of AKT1 protein]
lead acetate results in increased phosphorylation of AKT1 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of AKT1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of AKT1 protein; Genistein inhibits the reaction [lead acetate results in increased phosphorylation of AKT1 protein]; naringenin inhibits the reaction [lead acetate results in decreased expression of AKT1 protein] 		CTD PMID:24530660 PMID:26542248 PMID:26797587 PMID:36652739 PMID:36807407 More... NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Akt2 thymoma viral proto-oncogene 2 increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of AKT2 mRNA
sinapinic acid inhibits the reaction [lead acetate results in decreased expression of AKT2 mRNA] 		CTD PMID:22609695 PMID:30980912 PMID:33932463 PMID:38530053 NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase decreases expression
multiple interactions
decreases activity 		ISO
EXP 		lead acetate results in decreased expression of ALAD protein
Ditiocarb inhibits the reaction [lead acetate results in decreased activity of ALAD protein]; ferulic acid inhibits the reaction [lead acetate results in decreased activity of ALAD protein]; indium trichloride promotes the reaction [lead acetate results in decreased activity of ALAD protein]; lead acetate promotes the reaction [indium trichloride results in decreased activity of ALAD protein]; Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein]
Curcumin inhibits the reaction [lead acetate results in decreased activity of ALAD protein] 		CTD PMID:1032310 PMID:2177232 PMID:2604901 PMID:7084431 PMID:22362014 More... NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Alas1 aminolevulinic acid synthase 1 increases expression ISO lead acetate results in increased expression of ALAS1 mRNA CTD PMID:38568856 NCBI chr 9:106,110,654...106,125,153
Ensembl chr 9:106,110,654...106,125,853 		JBrowse link
G Alas2 aminolevulinic acid synthase 2, erythroid increases expression ISO lead acetate results in increased expression of ALAS2 mRNA CTD PMID:22641619 NCBI chr  X:149,330,443...149,353,614
Ensembl chr  X:149,330,371...149,353,634 		JBrowse link
G Alb albumin increases expression
multiple interactions 		ISO lead acetate results in increased expression of ALB mRNA; lead acetate results in increased expression of ALB protein
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with nickel chloride co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein 		CTD PMID:17657459 PMID:21549428 PMID:22641619 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule increases expression EXP lead acetate results in increased expression of ALCAM mRNA CTD PMID:21829687 NCBI chr16:52,069,359...52,273,444
Ensembl chr16:52,069,359...52,274,437 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 increases expression ISO lead acetate results in increased expression of ALDH1A1 mRNA CTD PMID:22839698 NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829 		JBrowse link
G Aldh1a7 aldehyde dehydrogenase family 1, subfamily A7 decreases expression EXP lead acetate results in decreased expression of ALDH1A7 mRNA CTD PMID:22613225 NCBI chr19:20,670,318...20,704,920
Ensembl chr19:20,670,317...20,704,926 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 increases expression EXP lead acetate results in increased expression of ALDH1L2 mRNA CTD PMID:25270620 NCBI chr10:83,320,386...83,370,008
Ensembl chr10:83,323,314...83,370,004 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial multiple interactions ISO [lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]; [lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]]; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein] CTD PMID:31550440 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887 		JBrowse link
G Aldh3a1 aldehyde dehydrogenase family 3, subfamily A1 increases expression ISO lead acetate results in increased expression of ALDH3A1 mRNA CTD PMID:37939567 NCBI chr11:61,099,336...61,109,244
Ensembl chr11:61,098,363...61,109,247 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase family 3, subfamily A2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of ALDH3A2 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of ALDH3A2 protein 		CTD PMID:37939567 PMID:38072110 NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290 		JBrowse link
G Aldh3b1 aldehyde dehydrogenase 3 family, member B1 decreases expression ISO lead acetate results in decreased expression of ALDH3B1 mRNA CTD PMID:38568856 NCBI chr19:3,963,491...3,980,898
Ensembl chr19:3,963,491...3,979,808 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase family 7, member A1 increases expression EXP lead acetate results in increased expression of ALDH7A1 mRNA CTD PMID:21829687 NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023 		JBrowse link
G Aldoa aldolase A, fructose-bisphosphate increases expression EXP lead acetate results in increased expression of ALDOA protein CTD PMID:20797405 NCBI chr 7:126,394,406...126,399,537
Ensembl chr 7:126,394,406...126,399,923 		JBrowse link
G Aldoc aldolase C, fructose-bisphosphate decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of ALDOC protein
lead acetate results in decreased expression of ALDOC mRNA
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of ALDOC mRNA; [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALDOC mRNA] 		CTD PMID:20797405 PMID:38157908 PMID:38568856 NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607 		JBrowse link
G Alms1 ALMS1, centrosome and basal body associated multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ALMS1 mRNA CTD PMID:22839698 NCBI chr 6:85,564,482...85,698,973
Ensembl chr 6:85,564,513...85,679,735 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of ALOX15 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ALOX15 mRNA 		CTD PMID:22641619 PMID:39276841 NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ALOX5 mRNA CTD PMID:39276841 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139 		JBrowse link
G Alox8 arachidonate 8-lipoxygenase decreases expression ISO lead acetate results in decreased expression of ALOX15B mRNA CTD PMID:38568856 NCBI chr11:69,074,711...69,088,669
Ensembl chr11:69,074,758...69,088,669 		JBrowse link
G Aloxe3 arachidonate lipoxygenase 3 increases expression EXP lead acetate results in increased expression of ALOXE3 mRNA CTD PMID:22613225 NCBI chr11:69,016,243...69,039,941
Ensembl chr11:69,016,722...69,039,941 		JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney decreases expression ISO lead acetate results in decreased expression of ALPL protein CTD PMID:21712424 NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695 		JBrowse link
G Alx3 aristaless-like homeobox 3 decreases methylation ISO lead acetate results in decreased methylation of ALX3 gene CTD PMID:29571894 NCBI chr 3:107,502,347...107,513,191
Ensembl chr 3:107,502,347...107,513,092 		JBrowse link
G Alyref Aly/REF export factor increases expression ISO lead acetate results in increased expression of ALYREF mRNA CTD PMID:38568856 NCBI chr11:120,485,330...120,489,342
Ensembl chr11:120,482,947...120,489,191 		JBrowse link
G Amigo1 adhesion molecule with Ig like domain 1 decreases expression ISO lead acetate results in decreased expression of AMIGO1 mRNA CTD PMID:38568856 NCBI chr 3:108,093,605...108,099,602
Ensembl chr 3:108,093,651...108,099,602 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 increases expression ISO lead acetate results in increased expression of AMIGO2 mRNA CTD PMID:38568856 NCBI chr15:97,141,955...97,145,168
Ensembl chr15:97,142,006...97,145,168 		JBrowse link
G Amy2a5 amylase 2a5 increases expression EXP lead acetate results in increased expression of AMY2A5 mRNA CTD PMID:20542052 NCBI chr 3:113,156,494...113,166,015
Ensembl chr 3:113,154,494...113,166,153 		JBrowse link
G Angptl1 angiopoietin-like 1 decreases expression EXP lead acetate results in decreased expression of ANGPTL1 mRNA CTD PMID:22609695 NCBI chr 1:156,666,495...156,688,648
Ensembl chr 1:156,666,132...156,688,648 		JBrowse link
G Ank2 ankyrin 2, brain multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of ANK2 mRNA CTD PMID:33445541 NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999 		JBrowse link
G Ankrd1 ankyrin repeat domain 1 increases expression ISO lead acetate results in increased expression of ANKRD1 mRNA CTD PMID:37939567 NCBI chr19:36,089,365...36,097,244
Ensembl chr19:36,089,361...36,097,499 		JBrowse link
G Ankrd10 ankyrin repeat domain 10 decreases expression ISO lead acetate results in decreased expression of ANKRD10 mRNA CTD PMID:38568856 NCBI chr 8:11,661,581...11,694,617
Ensembl chr 8:11,661,583...11,685,757 		JBrowse link
G Ankrd2 ankyrin repeat domain 2 decreases expression ISO lead acetate results in decreased expression of ANKRD2 mRNA CTD PMID:38568856 NCBI chr19:42,024,358...42,033,550
Ensembl chr19:42,024,439...42,033,549 		JBrowse link
G Ankrd24 ankyrin repeat domain 24 decreases expression EXP lead acetate results in decreased expression of ANKRD24 mRNA CTD PMID:21829687 NCBI chr10:81,464,352...81,483,446
Ensembl chr10:81,464,374...81,483,444 		JBrowse link
G Ankrd33b ankyrin repeat domain 33B increases expression EXP lead acetate results in increased expression of ANKRD33B mRNA CTD PMID:25270620 NCBI chr15:31,278,328...31,370,446
Ensembl chr15:31,291,624...31,367,872 		JBrowse link
G Ankrd34a ankyrin repeat domain 34A decreases expression EXP lead acetate results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 3:96,503,599...96,507,442
Ensembl chr 3:96,503,952...96,507,091 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 increases expression ISO lead acetate results in increased expression of ANKRD44 mRNA CTD PMID:37939567 NCBI chr 1:54,684,499...54,968,142
Ensembl chr 1:54,684,499...54,965,546 		JBrowse link
G Ankzf1 ankyrin repeat and zinc finger domain containing 1 decreases expression ISO lead acetate results in decreased expression of ANKZF1 mRNA CTD PMID:38568856 NCBI chr 1:75,168,794...75,176,031
Ensembl chr 1:75,168,795...75,176,031 		JBrowse link
G Ano2 anoctamin 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 intron; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 promoter CTD PMID:33445541 NCBI chr 6:125,667,382...126,017,115
Ensembl chr 6:125,667,382...126,017,089 		JBrowse link
G Ano4 anoctamin 4 increases expression ISO lead acetate results in increased expression of ANO4 mRNA CTD PMID:37939567 NCBI chr10:88,784,794...89,181,059
Ensembl chr10:88,784,856...89,180,624 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron CTD PMID:33445541 NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094 		JBrowse link
G Antxr2 anthrax toxin receptor 2 decreases expression EXP lead acetate results in decreased expression of ANTXR2 mRNA CTD PMID:20542052 NCBI chr 5:98,032,547...98,178,876
Ensembl chr 5:98,030,642...98,178,902 		JBrowse link
G Anxa1 annexin A1 decreases expression ISO lead acetate results in decreased expression of ANXA1 mRNA; lead acetate results in decreased expression of ANXA1 protein CTD PMID:11578147 NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308 		JBrowse link
G Anxa10 annexin A10 increases expression ISO lead acetate results in increased expression of ANXA10 mRNA CTD PMID:38568856 NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184 		JBrowse link
G Anxa5 annexin A5 increases expression
multiple interactions 		ISO lead acetate results in increased expression of ANXA5 mRNA; lead acetate results in increased expression of ANXA5 protein
lead acetate binds to and results in increased activity of ANXA5 protein 		CTD PMID:11578147 NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043 		JBrowse link
G Ap2a1 adaptor-related protein complex 2, alpha 1 subunit multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of AP2A1 mRNA CTD PMID:22839698 NCBI chr 7:44,549,797...44,578,914
Ensembl chr 7:44,549,797...44,578,920 		JBrowse link
G Ap3d1 adaptor-related protein complex 3, delta 1 subunit multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of AP3D1 mRNA CTD PMID:22839698 NCBI chr10:80,542,790...80,578,137
Ensembl chr10:80,542,790...80,578,098 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions
increases expression 		ISO
EXP 		sinapinic acid inhibits the reaction [lead acetate results in increased expression of APAF1 mRNA] CTD PMID:20542052 PMID:37471654 PMID:38530053 NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632 		JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of APBA1 mRNA CTD PMID:12634122 NCBI chr19:23,736,170...23,926,961
Ensembl chr19:23,736,251...23,926,960 		JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 multiple interactions
decreases expression
increases expression
decreases response to substance 		ISO [lead acetate results in increased expression of APEX1 protein] which results in increased abundance of Reactive Oxygen Species; APEX1 protein promotes the reaction [lead acetate results in increased expression of CCND1 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK1 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK3 protein]; lead acetate promotes the reaction [MAPK1 protein modified form binds to APEX1 protein]
lead acetate results in decreased expression of APEX1 mRNA
lead acetate results in increased expression of APEX1 mRNA
APEX1 protein results in decreased susceptibility to lead acetate 		CTD PMID:23370007 PMID:33862172 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596 		JBrowse link
G Aph1b aph1 homolog B, gamma secretase subunit decreases expression ISO lead acetate results in decreased expression of APH1B mRNA CTD PMID:22641619 NCBI chr 9:66,682,484...66,704,671
Ensembl chr 9:66,682,484...66,702,772 		JBrowse link
G Api5 apoptosis inhibitor 5 decreases expression ISO lead acetate results in decreased expression of API5P1 mRNA CTD PMID:37939567 NCBI chr 2:94,242,073...94,268,490
Ensembl chr 2:94,242,027...94,268,481 		JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 decreases expression ISO lead acetate results in decreased expression of APOBEC1 mRNA CTD PMID:22641619 NCBI chr 6:122,554,755...122,580,068
Ensembl chr 6:122,554,751...122,579,403 		JBrowse link
G Apoc2 apolipoprotein C2 increases expression EXP lead acetate results in increased expression of APOC2 mRNA CTD PMID:22609695 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866 		JBrowse link
G Apoe apolipoprotein E increases expression
multiple interactions
increases methylation 		EXP
ISO 		lead acetate results in increased expression of APOE mRNA
[APOE alternative form co-treated with lead acetate] results in increased abundance of lead acetate
lead acetate results in increased methylation of APOE gene 		CTD PMID:21829687 PMID:28173832 PMID:29571894 PMID:29746905 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113 		JBrowse link
G App amyloid beta precursor protein decreases methylation
affects expression
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased methylation of APP promoter
lead acetate affects the expression of APP protein
[lead acetate results in increased abundance of Lead] which results in increased expression of APP mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of APP protein
lead acetate results in increased expression of APP mRNA; lead acetate results in increased expression of APP protein; lead acetate results in increased expression of APP protein alternative form; lead acetate results in increased expression of APP protein modified form
lead acetate results in increased expression of APP mRNA; lead acetate results in increased expression of APP protein; lead acetate results in increased expression of APP protein modified form
Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of APP protein modified form]
[[lead acetate results in increased abundance of Lead] which co-treated with APP protein modified form] results in decreased expression of SYP protein; [lead acetate co-treated with tolfenamic acid] results in decreased expression of APP mRNA; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in increased expression of BACE1 protein]; [sodium arsenite co-treated with lead acetate] results in increased expression of APP protein; tolfenamic acid inhibits the reaction [lead acetate results in increased expression of APP protein modified form] 		CTD PMID:21117136 PMID:22279679 PMID:22764079 PMID:23867794 PMID:24462621 More... NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654 		JBrowse link
G Aprt adenine phosphoribosyl transferase decreases activity ISO lead acetate results in decreased activity of APRT protein CTD PMID:19428946 NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648 		JBrowse link
G Aqp3 aquaporin 3 decreases expression ISO lead acetate results in decreased expression of AQP3 mRNA CTD PMID:38568856 NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183 		JBrowse link
G Ar androgen receptor increases expression EXP lead acetate results in increased expression of AR mRNA CTD PMID:21829687 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821 		JBrowse link
G Arc activity regulated cytoskeletal-associated protein decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of ARC mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of ARC mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of ARC protein; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of ARC mRNA]; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of ARC protein] 		CTD PMID:22641619 PMID:27936013 PMID:39947421 NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419 		JBrowse link
G Arfgap2 ARF GTPase activating protein 2 decreases expression EXP lead acetate results in decreased expression of ARFGAP2 mRNA CTD PMID:21829687 NCBI chr 2:91,095,460...91,107,716
Ensembl chr 2:91,095,319...91,107,276 		JBrowse link
G Arfgef2 ARF guanine nucleotide exchange factor 2 decreases expression EXP lead acetate results in decreased expression of ARFGEF2 mRNA CTD PMID:21829687 NCBI chr 2:166,647,371...166,739,972
Ensembl chr 2:166,647,508...166,739,972 		JBrowse link
G Arglu1 arginine and glutamate rich 1 increases expression EXP lead acetate results in increased expression of ARGLU1 mRNA CTD PMID:21829687 NCBI chr 8:8,716,307...8,741,818
Ensembl chr 8:8,715,075...8,740,521 		JBrowse link
G Arhgap17 Rho GTPase activating protein 17 decreases expression EXP lead acetate results in decreased expression of ARHGAP17 mRNA CTD PMID:21829687 NCBI chr 7:122,878,372...122,969,171
Ensembl chr 7:122,878,441...122,969,138 		JBrowse link
G Arhgap24 Rho GTPase activating protein 24 increases expression EXP lead acetate results in increased expression of ARHGAP24 mRNA CTD PMID:20542052 NCBI chr 5:102,355,043...103,053,743
Ensembl chr 5:102,629,257...103,045,803 		JBrowse link
G Arhgap45 Rho GTPase activating protein 45 increases expression ISO lead acetate results in increased expression of ARHGAP45 mRNA CTD PMID:38568856 NCBI chr10:79,852,505...79,867,305
Ensembl chr10:79,852,487...79,867,306 		JBrowse link
G Arid5b AT-rich interaction domain 5B decreases expression ISO lead acetate results in decreased expression of ARID5B mRNA CTD PMID:38568856 NCBI chr10:67,928,353...68,114,596
Ensembl chr10:67,928,350...68,114,570 		JBrowse link
G Arl1 ADP-ribosylation factor-like 1 decreases expression EXP lead acetate results in decreased expression of ARL1 mRNA CTD PMID:21829687 NCBI chr10:88,566,720...88,579,956
Ensembl chr10:88,566,720...88,579,956 		JBrowse link
G Arl8b ADP-ribosylation factor-like 8B increases expression EXP lead acetate results in increased expression of ARL8B mRNA CTD PMID:20542052 NCBI chr 6:108,760,020...108,800,684
Ensembl chr 6:108,760,060...108,802,239 		JBrowse link
G Armc9 armadillo repeat containing 9 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of ARMC9 protein CTD PMID:38072110 NCBI chr 1:86,082,436...86,207,491
Ensembl chr 1:86,082,502...86,206,006 		JBrowse link
G Arpin actin-related protein 2/3 complex inhibitor decreases expression ISO lead acetate results in decreased expression of ARPIN mRNA CTD PMID:22641619 NCBI chr 7:79,575,107...79,585,012
Ensembl chr 7:79,575,109...79,585,107 		JBrowse link
G Arpp21 cyclic AMP-regulated phosphoprotein, 21 decreases expression EXP lead acetate results in decreased expression of ARPP21 mRNA CTD PMID:20542052 NCBI chr 9:111,894,159...112,065,356
Ensembl chr 9:111,894,159...112,065,006 		JBrowse link
G Arrdc4 arrestin domain containing 4 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of ARRDC4 mRNA
lead acetate results in increased expression of ARRDC4 mRNA 		CTD PMID:21829687 PMID:22839698 NCBI chr 7:68,386,742...68,398,986
Ensembl chr 7:68,386,743...68,398,989 		JBrowse link
G Art3 ADP-ribosyltransferase 3 increases expression EXP lead acetate results in increased expression of ART3 mRNA CTD PMID:22609695 NCBI chr 5:92,479,659...92,562,487
Ensembl chr 5:92,479,686...92,562,487 		JBrowse link
G Arvcf armadillo repeat gene deleted in velocardiofacial syndrome decreases expression EXP lead acetate results in decreased expression of ARVCF mRNA CTD PMID:22609695 NCBI chr16:18,166,046...18,225,826
Ensembl chr16:18,166,046...18,225,826 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 increases expression EXP lead acetate results in increased expression of ASAH1 mRNA CTD PMID:21829687 NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810 		JBrowse link
G Asap2 ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 increases expression ISO lead acetate results in increased expression of ASAP2 mRNA CTD PMID:38568856 NCBI chr12:21,161,369...21,320,172
Ensembl chr12:21,040,460...21,320,172 		JBrowse link
G Asb14 ankyrin repeat and SOCS box-containing 14 decreases expression ISO
EXP 		lead acetate results in decreased expression of ASB14 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr14:26,616,547...26,638,393
Ensembl chr14:26,616,514...26,637,215 		JBrowse link
G Asb6 ankyrin repeat and SOCS box-containing 6 increases expression EXP lead acetate results in increased expression of ASB6 mRNA CTD PMID:22609695 NCBI chr 2:30,713,109...30,718,312
Ensembl chr 2:30,713,109...30,720,345 		JBrowse link
G Asb9 ankyrin repeat and SOCS box-containing 9 increases expression EXP lead acetate results in increased expression of ASB9 mRNA CTD PMID:22609695 NCBI chr  X:163,280,899...163,322,748
Ensembl chr  X:163,289,323...163,322,748 		JBrowse link
G Ascc3 activating signal cointegrator 1 complex subunit 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of ASCC3 protein CTD PMID:38072110 NCBI chr10:50,468,756...50,727,300
Ensembl chr10:50,468,765...50,727,581 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of ASF1A mRNA CTD PMID:22839698 NCBI chr10:53,473,057...53,485,321
Ensembl chr10:53,472,853...53,485,321 		JBrowse link
G Asl argininosuccinate lyase increases expression ISO lead acetate results in increased expression of ASL mRNA CTD PMID:11578147 NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088 		JBrowse link
G Asns asparagine synthetase increases expression ISO
EXP 		lead acetate results in increased expression of ASNS mRNA CTD PMID:11578147 PMID:25270620 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254 		JBrowse link
G Aspa aspartoacylase affects expression ISO lead acetate affects the expression of ASPA protein CTD PMID:36539177 NCBI chr11:73,195,813...73,217,677
Ensembl chr11:73,195,818...73,220,422 		JBrowse link
G Aspdh aspartate dehydrogenase domain containing increases expression ISO lead acetate results in increased expression of ASPDH mRNA CTD PMID:22641619 NCBI chr 7:44,114,859...44,117,175
Ensembl chr 7:44,114,815...44,117,182 		JBrowse link
G Asph aspartate-beta-hydroxylase increases expression ISO lead acetate results in increased expression of ASPH mRNA CTD PMID:22839698 PMID:38568856 NCBI chr 4:9,449,085...9,669,344
Ensembl chr 4:9,448,069...9,669,344 		JBrowse link
G Aspn asporin decreases expression ISO lead acetate results in decreased expression of ASPN mRNA CTD PMID:22641619 NCBI chr13:49,697,919...49,721,041
Ensembl chr13:49,697,919...49,721,041 		JBrowse link
G Ass1 argininosuccinate synthetase 1 decreases expression ISO lead acetate results in decreased expression of ASS1 mRNA CTD PMID:11578147 PMID:38568856 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of ATF3 protein CTD PMID:38072110 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of ATF4 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of ATF4 mRNA
lead acetate results in decreased expression of ATF4 mRNA 		CTD PMID:22811615 PMID:24260418 PMID:39547369 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742 		JBrowse link
G Atf5 activating transcription factor 5 increases expression
multiple interactions 		ISO lead acetate results in increased expression of ATF5 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ATF5 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of ATF5 protein; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CLPP mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HSPD1 mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 protein]; ATF5 protein affects the susceptibility to [lead acetate results in increased abundance of Lead]; ATF5 protein results in decreased susceptibility to [lead acetate results in increased abundance of Lead] 		CTD PMID:38568856 PMID:39547369 NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of ATF6 mRNA
sinapinic acid inhibits the reaction [lead acetate results in increased expression of ATF6 mRNA] 		CTD PMID:11578147 PMID:21829687 PMID:38530053 NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340 		JBrowse link
G Atf7 activating transcription factor 7 increases expression EXP lead acetate results in increased expression of ATF7 mRNA CTD PMID:22609695 NCBI chr15:102,434,381...102,533,899
Ensembl chr15:102,434,381...102,533,899 		JBrowse link
G Atg13 autophagy related 13 affects expression ISO lead acetate affects the expression of ATG13 protein CTD PMID:36539177 NCBI chr 2:91,504,957...91,540,947
Ensembl chr 2:91,504,963...91,540,921 		JBrowse link
G Atg5 autophagy related 5 multiple interactions EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein 		CTD PMID:33445541 PMID:36652739 NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287 		JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA CTD PMID:39276841 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575 		JBrowse link
G Atl1 atlastin GTPase 1 increases expression ISO lead acetate results in increased expression of ATL1 mRNA CTD PMID:38568856 NCBI chr12:69,939,879...70,010,859
Ensembl chr12:69,939,388...70,013,191 		JBrowse link
G Atm ataxia telangiectasia mutated multiple interactions
increases phosphorylation 		ISO
EXP 		ATM protein affects the reaction [lead acetate results in decreased expression of COX4 protein]; lead acetate promotes the reaction [PINK1 protein binds to ATM protein]
[lead acetate results in increased abundance of Lead] which results in increased expression of ATM mRNA
lead acetate results in increased phosphorylation of ATM protein 		CTD PMID:29660402 PMID:39276841 NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO lead acetate results in increased expression of ATOX1 mRNA CTD PMID:38568856 NCBI chr11:55,337,463...55,352,034
Ensembl chr11:55,337,467...55,352,065 		JBrowse link
G Atp12a ATPase, H+/K+ transporting, nongastric, alpha polypeptide increases expression EXP lead acetate results in increased expression of ATP12A mRNA CTD PMID:25270620 NCBI chr14:56,602,525...56,626,008
Ensembl chr14:56,602,525...56,626,007 		JBrowse link
G Atp1a1 ATPase, Na+/K+ transporting, alpha 1 polypeptide decreases expression ISO lead acetate results in decreased expression of ATP1A1 mRNA CTD PMID:38568856 NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000 		JBrowse link
G Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide increases expression ISO lead acetate results in increased expression of ATP1B2 mRNA CTD PMID:22160880 NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768 		JBrowse link
G Atp6v1a ATPase, H+ transporting, lysosomal V1 subunit A affects expression EXP lead acetate affects the expression of ATP6V1A protein CTD PMID:20797405 NCBI chr16:43,905,765...43,960,055
Ensembl chr16:43,905,765...43,960,068 		JBrowse link
G Atp6v1b1 ATPase, H+ transporting, lysosomal V1 subunit B1 increases expression EXP lead acetate results in increased expression of ATP6V1B1 mRNA CTD PMID:22609695 NCBI chr 6:83,719,999...83,735,837
Ensembl chr 6:83,719,972...83,735,837 		JBrowse link
G Atp6v1b2 ATPase, H+ transporting, lysosomal V1 subunit B2 increases expression ISO
EXP 		lead acetate results in increased expression of ATP6V1B2 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr 8:69,541,388...69,566,370
Ensembl chr 8:69,541,298...69,566,363 		JBrowse link
G Atp6v1e1 ATPase, H+ transporting, lysosomal V1 subunit E1 increases expression EXP lead acetate results in increased expression of ATP6V1E1 protein CTD PMID:20797405 NCBI chr 6:120,772,205...120,799,659
Ensembl chr 6:120,771,266...120,799,754 		JBrowse link
G Atp6v1g2 ATPase, H+ transporting, lysosomal V1 subunit G2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATP6V1G2 mRNA CTD PMID:36642386 NCBI chr17:35,453,910...35,457,743
Ensembl chr17:35,452,636...35,457,743 		JBrowse link
G Atp6v1h ATPase, H+ transporting, lysosomal V1 subunit H increases expression EXP lead acetate results in increased expression of ATP6V1H mRNA CTD PMID:25270620 NCBI chr 1:5,153,201...5,233,438
Ensembl chr 1:5,140,241...5,232,752 		JBrowse link
G Atp7a ATPase, copper transporting, alpha polypeptide multiple interactions
increases expression
decreases expression 		EXP
ISO 		[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7A protein
ATP7A protein modified form inhibits the reaction [lead acetate binds to HSPA5 protein]
lead acetate results in increased expression of ATP7A mRNA
lead acetate results in decreased expression of ATP7A mRNA; lead acetate results in decreased expression of ATP7A protein 		CTD PMID:10702365 PMID:24316150 PMID:25579025 PMID:40010429 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532 		JBrowse link
G Atp7b ATPase, copper transporting, beta polypeptide multiple interactions EXP [[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7B protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7B protein CTD PMID:40010429 NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 decreases expression ISO lead acetate results in decreased expression of ATP8A1 mRNA CTD PMID:38568856 NCBI chr 5:67,775,482...68,004,822
Ensembl chr 5:67,775,483...68,004,777 		JBrowse link
G Atp8b3 ATPase, class I, type 8B, member 3 decreases expression ISO lead acetate results in decreased expression of ATP8B3 mRNA CTD PMID:38568856 NCBI chr10:80,355,418...80,374,987
Ensembl chr10:80,355,418...80,374,958 		JBrowse link
G Atp9b ATPase, class II, type 9B increases expression EXP lead acetate results in increased expression of ATP9B mRNA CTD PMID:21829687 NCBI chr18:80,777,356...80,977,291
Ensembl chr18:80,777,356...80,977,275 		JBrowse link
G Atxn1 ataxin 1 decreases expression ISO lead acetate results in decreased expression of ATXN1 mRNA CTD PMID:11578147 NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484 		JBrowse link
G Auh AU RNA binding protein/enoyl-coenzyme A hydratase decreases expression ISO lead acetate results in decreased expression of AUH mRNA CTD PMID:38568856 NCBI chr13:52,989,155...53,083,742
Ensembl chr13:52,989,155...53,083,717 		JBrowse link
G Aurka aurora kinase A increases expression EXP lead acetate results in increased expression of AURKA mRNA CTD PMID:20542052 NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455 		JBrowse link
G Aurkc aurora kinase C increases expression EXP lead acetate results in increased expression of AURKC mRNA CTD PMID:22609695 NCBI chr 7:6,998,346...7,006,090
Ensembl chr 7:6,998,299...7,006,090 		JBrowse link
G B3galt2 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 decreases expression ISO lead acetate results in decreased expression of B3GALT2 mRNA CTD PMID:27562236 NCBI chr 1:143,516,435...143,525,675
Ensembl chr 1:143,516,402...143,530,352 		JBrowse link
G B3galt6 UDP-Gal:betaGal beta 1,3-galactosyltransferase, polypeptide 6 decreases methylation ISO lead acetate results in decreased methylation of B3GALT6 gene CTD PMID:29571894 NCBI chr 4:156,073,923...156,077,135
Ensembl chr 4:156,073,923...156,077,106 		JBrowse link
G B3gat2 beta-1,3-glucuronyltransferase 2 decreases expression EXP lead acetate results in decreased expression of B3GAT2 mRNA CTD PMID:21829687 NCBI chr 1:23,801,007...23,886,946
Ensembl chr 1:23,800,834...23,888,239 		JBrowse link
G B3gnt3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 decreases expression ISO lead acetate results in decreased expression of B3GNT3 mRNA CTD PMID:38568856 NCBI chr 8:72,144,017...72,155,270
Ensembl chr 8:72,143,400...72,154,433 		JBrowse link
G B3gnt4 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 increases expression ISO lead acetate results in increased expression of B3GNT4 mRNA CTD PMID:22641619 NCBI chr 5:123,646,519...123,649,945
Ensembl chr 5:123,648,523...123,649,945 		JBrowse link
G B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of B4GALNT1 mRNA
lead acetate results in increased expression of B4GALNT1 mRNA 		CTD PMID:22609695 PMID:37939567 PMID:38568856 NCBI chr10:127,001,025...127,008,209
Ensembl chr10:127,001,094...127,008,199 		JBrowse link
G B4galnt2 beta-1,4-N-acetyl-galactosaminyl transferase 2 increases expression EXP lead acetate results in increased expression of B4GALNT2 mRNA CTD PMID:22609695 NCBI chr11:95,754,385...95,805,786
Ensembl chr11:95,756,769...95,805,717 		JBrowse link
G Baat bile acid-Coenzyme A: amino acid N-acyltransferase decreases expression EXP lead acetate results in decreased expression of BAAT mRNA CTD PMID:22609695 NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557 		JBrowse link
G Bace1 beta-site APP cleaving enzyme 1 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of BACE1 mRNA; lead acetate results in increased expression of BACE1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein
[lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of BACE1 protein 		CTD PMID:23867794 PMID:29908845 PMID:31730887 PMID:31843630 PMID:32058320 NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697 		JBrowse link
G Bach1 BTB and CNC homology 1, basic leucine zipper transcription factor 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of BACH1 protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of DLG1 protein]; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of NDUFB8 protein]; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SDHB protein]; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SYN1 protein]; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of UQCRC2 protein]; BACH1 gene mutant form results in decreased susceptibility to [lead acetate results in increased abundance of Lead]; Hemin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BACH1 protein]
[lead acetate results in increased abundance of Lead] which results in increased expression of BACH1 mRNA 		CTD PMID:36096218 PMID:39276841 NCBI chr16:87,495,842...87,530,234
Ensembl chr16:87,495,833...87,530,234 		JBrowse link
G Bad BCL2-associated agonist of cell death affects expression ISO lead acetate affects the expression of BAD protein CTD PMID:18618274 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267 		JBrowse link
G Bag1 BCL2-associated athanogene 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA CTD PMID:12634122 NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294 		JBrowse link
G Bag3 BCL2-associated athanogene 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of BAG3 protein CTD PMID:38072110 NCBI chr 7:128,125,307...128,148,705
Ensembl chr 7:128,125,340...128,148,705 		JBrowse link
G Baiap2l1 BAI1-associated protein 2-like 1 decreases expression ISO lead acetate results in decreased expression of BAIAP2L1 mRNA CTD PMID:22641619 NCBI chr 5:144,201,335...144,294,922
Ensembl chr 5:144,201,336...144,294,922 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO [[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of BAK1 protein; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (25-35)] results in increased expression of BAK1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of BAK1 protein CTD PMID:35300571 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression ISO lead acetate results in increased expression of BAMBI mRNA CTD PMID:38568856 NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404 		JBrowse link
G Barhl1 BarH like homeobox 1 decreases expression EXP lead acetate results in decreased expression of BARHL1 mRNA CTD PMID:22609695 NCBI chr 2:28,797,692...28,807,996
Ensembl chr 2:28,797,691...28,806,680 		JBrowse link
G Bax BCL2-associated X protein multiple interactions
increases expression
affects expression
decreases expression 		ISO
EXP 		5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of BAX mRNA]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of BAX protein]; [[lead acetate results in increased abundance of Lead] which co-treated with Carbenoxolone] results in increased expression of BAX protein; [Cadmium Chloride co-treated with lead acetate] results in increased expression of BAX protein; [lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of BAX protein; Acetylcysteine affects the reaction [lead acetate results in increased expression of BAX protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of BAX protein]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of BAX mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of BAX protein]; Genistein affects the reaction [lead acetate results in increased expression of BAX protein]; Hemin inhibits the reaction [lead acetate results in increased expression of BAX protein]; lead acetate promotes the reaction [Zinc Oxide results in increased expression of BAX mRNA]; Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of BAX mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein]; Zinc Oxide promotes the reaction [lead acetate results in increased expression of BAX mRNA]
lead acetate results in increased expression of BAX mRNA; lead acetate results in increased expression of BAX protein
NFE2L2 protein inhibits the reaction [lead acetate results in increased expression of BAX protein]
lead acetate affects the expression of BAX protein
lead acetate results in decreased expression of BAX mRNA; lead acetate results in decreased expression of BAX protein
[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein]]; mitoquinone inhibits the reaction [[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BAX protein]] 		CTD PMID:17959157 PMID:23086308 PMID:23146751 PMID:24960054 PMID:25031709 More... NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322 		JBrowse link
G Bbx bobby sox HMG box containing decreases methylation ISO lead acetate results in decreased methylation of BBX gene CTD PMID:29571894 NCBI chr16:50,012,207...50,252,829
Ensembl chr16:50,012,207...50,252,753 		JBrowse link
G BC028528 cDNA sequence BC028528 decreases expression ISO lead acetate results in decreased expression of C1ORF54 mRNA CTD PMID:38568856 NCBI chr 3:95,789,665...95,800,186
Ensembl chr 3:95,791,266...95,799,317 		JBrowse link
G Bcas3 BCAS3 microtubule associated cell migration factor multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of BCAS3 intron CTD PMID:33445541 NCBI chr11:85,243,611...85,716,884
Ensembl chr11:85,243,993...85,716,884 		JBrowse link
G Bcat1 branched chain aminotransferase 1, cytosolic increases expression ISO
EXP 		lead acetate results in increased expression of BCAT1 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr 6:144,939,561...145,021,883
Ensembl chr 6:144,939,561...145,021,910 		JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein decreases expression ISO lead acetate results in decreased expression of BCCIP mRNA CTD PMID:22641619 NCBI chr 7:133,311,045...133,322,874
Ensembl chr 7:133,311,062...133,322,874 		JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases activity 		ISO ferulic acid promotes the reaction [lead acetate results in increased activity of BCHE protein] CTD PMID:25322819 NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748 		JBrowse link
G Bcl10 B cell leukemia/lymphoma 10 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of BCL10 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of BCL10 protein 		CTD PMID:20542052 PMID:38072110 NCBI chr 3:145,630,017...145,640,121
Ensembl chr 3:145,628,559...145,640,111 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions
decreases expression
affects expression
increases expression 		ISO
EXP 		5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of BCL2 mRNA]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]; [[lead acetate results in increased abundance of Lead] which co-treated with Carbenoxolone] results in decreased expression of BCL2 protein; [Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein; Ascorbic Acid promotes the reaction [lead acetate results in increased expression of BCL2 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of BCL2 mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]; Genistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]; Hemin inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]; lead acetate promotes the reaction [Zinc Oxide results in decreased expression of BCL2 mRNA]; Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of BCL2 mRNA]; Tetradecanoylphorbol Acetate inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BCL2 protein]; Zinc Oxide promotes the reaction [lead acetate results in decreased expression of BCL2 mRNA]
[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of BCL2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of BCL2 protein; mitoquinone inhibits the reaction [[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of BCL2 protein]
NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]
lead acetate affects the expression of BCL2 protein
lead acetate results in decreased expression of BCL2 mRNA; lead acetate results in decreased expression of BCL2 protein
lead acetate results in increased expression of BCL2 mRNA
lead acetate affects the expression of BCL2 mRNA 		CTD PMID:17959157 PMID:18618274 PMID:19026729 PMID:22609695 PMID:23086308 More... NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Bcl2l1 BCL2-like 1 affects expression
multiple interactions 		ISO lead acetate affects the expression of BCL2L1 protein
HMOX1 protein affects the reaction [lead acetate affects the expression of BCL2L1 protein] 		CTD PMID:26542248 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648 		JBrowse link
G Bcl2l11 BCL2 like 11 increases expression EXP lead acetate results in increased expression of BCL2L11 mRNA CTD PMID:21829687 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467 		JBrowse link
G Bcl6 B cell leukemia/lymphoma 6 decreases expression ISO lead acetate results in decreased expression of BCL6 mRNA CTD PMID:38568856 NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602 		JBrowse link
G Bcl9l B cell CLL/lymphoma 9-like increases expression ISO lead acetate results in increased expression of BCL9L mRNA CTD PMID:38568856 NCBI chr 9:44,394,103...44,423,203
Ensembl chr 9:44,394,122...44,423,193 		JBrowse link
G Bco2 beta-carotene oxygenase 2 decreases expression EXP lead acetate results in decreased expression of BCO2 mRNA CTD PMID:22609695 NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481 		JBrowse link
G Bdh2 3-hydroxybutyrate dehydrogenase, type 2 increases expression EXP lead acetate results in increased expression of BDH2 mRNA CTD PMID:20542052 NCBI chr 3:134,986,982...135,010,187
Ensembl chr 3:134,986,982...135,010,187 		JBrowse link
G Bdkrb1 bradykinin receptor, beta 1 increases expression ISO lead acetate results in increased expression of BDKRB1 mRNA CTD PMID:38568856 NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687 		JBrowse link
G Bdnf brain derived neurotrophic factor increases expression
multiple interactions
affects expression
decreases expression
decreases secretion
decreases response to substance 		ISO
EXP 		lead acetate results in increased expression of BDNF mRNA
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased expression of BDNF protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of BDNF protein
[lead acetate results in increased abundance of Lead] which results in decreased cleavage of BDNF protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of BDNF mRNA; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of BDNF protein; BDNF protein inhibits the reaction [lead acetate results in decreased expression of SYP protein]; BDNF protein inhibits the reaction [lead acetate results in decreased expression of VAMP2 protein]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased cleavage of BDNF protein]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BDNF mRNA]
lead acetate affects the expression of BDNF mRNA alternative form
lead acetate results in decreased expression of BDNF mRNA alternative form; lead acetate results in decreased expression of BDNF protein
lead acetate results in decreased expression of BDNF mRNA; lead acetate results in decreased expression of BDNF protein
lead acetate results in decreased secretion of BDNF protein
BDNF protein results in decreased susceptibility to lead acetate 		CTD PMID:20375082 PMID:23146751 PMID:23680456 PMID:24260418 PMID:27492863 More... NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352 		JBrowse link
G Becn1 beclin 1, autophagy related increases cleavage
multiple interactions
increases expression 		ISO lead acetate results in increased cleavage of BECN1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of BECN1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of BECN1 protein; bafilomycin A1 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of BECN1 protein]
lead acetate results in increased expression of BECN1 protein 		CTD PMID:22811615 PMID:32879255 PMID:33242459 PMID:36652739 NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112 		JBrowse link
G Best3 bestrophin 3 decreases expression ISO lead acetate results in decreased expression of BEST3 mRNA CTD PMID:22641619 NCBI chr10:116,822,219...116,865,688
Ensembl chr10:116,822,219...116,860,945 		JBrowse link
G Bex4 brain expressed X-linked 4 increases expression ISO lead acetate results in increased expression of BEX4 mRNA CTD PMID:22641619 NCBI chr  X:135,039,745...135,041,192
Ensembl chr  X:135,039,745...135,041,192 		JBrowse link
G Bglap bone gamma carboxyglutamate protein multiple interactions
decreases expression 		ISO Ethanol promotes the reaction [lead acetate results in decreased expression of BGLAP protein] CTD PMID:23376407 NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771 		JBrowse link
G Bhmt betaine-homocysteine methyltransferase decreases expression ISO lead acetate results in decreased expression of BHMT mRNA CTD PMID:22641619 NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469 		JBrowse link
G Bid BH3 interacting domain death agonist affects expression
multiple interactions 		ISO lead acetate affects the expression of BID protein
[lead acetate results in increased abundance of Lead] which results in increased expression of BID mRNA 		CTD PMID:18618274 PMID:36642386 NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 decreases expression EXP
ISO 		lead acetate results in decreased expression of BIRC3 mRNA CTD PMID:21829687 PMID:38568856 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
decreases expression 		ISO RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 mRNA]; RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 protein]
lead acetate results in decreased expression of BIRC5 mRNA; lead acetate results in decreased expression of BIRC5 protein 		CTD PMID:37866543 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569 		JBrowse link
G Bloc1s2 biogenesis of lysosomal organelles complex-1, subunit 2 increases expression ISO lead acetate results in increased expression of BLOC1S2 mRNA CTD PMID:22641619 NCBI chr19:44,127,685...44,134,909
Ensembl chr19:44,127,685...44,134,885 		JBrowse link
G Blvrb biliverdin reductase B increases expression EXP
ISO 		lead acetate results in increased expression of BLVRB mRNA CTD PMID:25270620 PMID:38568856 NCBI chr 7:27,147,403...27,165,406
Ensembl chr 7:27,147,403...27,165,569 		JBrowse link
G Bmal1 basic helix-loop-helix ARNT like 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of BMAL1 mRNA CTD PMID:36642386 NCBI chr 7:112,777,820...112,913,333
Ensembl chr 7:112,806,672...112,913,333 		JBrowse link
G Bmp1 bone morphogenetic protein 1 decreases expression ISO lead acetate results in decreased expression of BMP1 mRNA CTD PMID:38568856 NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674 		JBrowse link
G Bmp10 bone morphogenetic protein 10 increases methylation ISO lead acetate results in increased methylation of BMP10 gene CTD PMID:29571894 NCBI chr 6:87,405,976...87,411,494
Ensembl chr 6:87,405,976...87,414,659 		JBrowse link
G Bmp2 bone morphogenetic protein 2 multiple interactions
decreases expression
increases expression
increases activity 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BMP2 mRNA
lead acetate results in decreased expression of BMP2 mRNA
lead acetate results in increased expression of BMP2 mRNA
lead acetate results in increased activity of BMP2 protein
BMP2 promotes the reaction [lead acetate results in increased expression of ACAN mRNA]; BMP2 promotes the reaction [lead acetate results in increased expression of COL2A1 mRNA]; BMP2 promotes the reaction [lead acetate results in increased expression of SOX9 mRNA]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD1 protein]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD5 protein]; lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD9 protein]; lead acetate promotes the reaction [BMP2 results in increased expression of ACAN mRNA]; lead acetate promotes the reaction [BMP2 results in increased expression of SOX9 mRNA] 		CTD PMID:12634122 PMID:17805416 PMID:21829687 PMID:22641619 NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805 		JBrowse link
G Bmp3 bone morphogenetic protein 3 decreases expression ISO lead acetate results in decreased expression of BMP3 mRNA CTD PMID:22641619 NCBI chr 5:99,002,274...99,031,912
Ensembl chr 5:99,002,274...99,032,255 		JBrowse link
G Bmp4 bone morphogenetic protein 4 multiple interactions
decreases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of BMP4 mRNA
lead acetate results in decreased expression of BMP4 mRNA 		CTD PMID:12634122 PMID:22613225 NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126 		JBrowse link
G Bnc2 basonuclin zinc finger protein 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of BNC2 protein CTD PMID:38072110 NCBI chr 4:84,185,041...84,593,236
Ensembl chr 4:84,193,332...84,593,512 		JBrowse link
G Bnip3 BCL2/adenovirus E1B interacting protein 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of BNIP3 protein CTD PMID:38072110 NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248 		JBrowse link
G Bnip3l BCL2/adenovirus E1B interacting protein 3-like decreases expression ISO lead acetate results in decreased expression of BNIP3L mRNA CTD PMID:38568856 NCBI chr14:67,222,688...67,246,580
Ensembl chr14:67,222,688...67,246,326 		JBrowse link
G Bpifb3 BPI fold containing family B, member 3 increases expression EXP lead acetate results in increased expression of BPIFB3 mRNA CTD PMID:20542052 NCBI chr 2:153,760,118...153,774,916
Ensembl chr 2:153,760,150...153,774,916 		JBrowse link
G Brca1 breast cancer 1, early onset decreases expression EXP lead acetate results in decreased expression of BRCA1 mRNA CTD PMID:22613225 NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781 		JBrowse link
G Brd4 bromodomain containing 4 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of BRD4 mRNA CTD PMID:39276841 NCBI chr17:32,415,246...32,503,717
Ensembl chr17:32,415,248...32,503,696 		JBrowse link
G Bri3 brain protein I3 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of BRI3 mRNA
lead acetate results in increased expression of BRI3 mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr 5:144,181,247...144,383,567
Ensembl chr 5:144,181,247...144,383,567 		JBrowse link
G Bsg basigin affects expression
multiple interactions 		EXP lead acetate affects the expression of BSG mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]; lead acetate results in decreased expression of and affects the localization of BSG protein 		CTD PMID:30615929 PMID:34508822 NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803 		JBrowse link
G Bsx brain specific homeobox decreases expression ISO lead acetate results in decreased expression of BSX mRNA CTD PMID:22641619 NCBI chr 9:40,782,994...40,790,258
Ensembl chr 9:40,785,423...40,791,353 		JBrowse link
G Btbd1 BTB domain containing 1 increases expression EXP lead acetate results in increased expression of BTBD1 mRNA CTD PMID:22609695 NCBI chr 7:81,441,822...81,479,262
Ensembl chr 7:81,441,822...81,479,179 		JBrowse link
G Btbd7 BTB domain containing 7 decreases expression EXP lead acetate results in decreased expression of BTBD7 mRNA CTD PMID:21829687 NCBI chr12:102,747,056...102,844,733
Ensembl chr12:102,747,056...102,844,730 		JBrowse link
G Btbd9 BTB domain containing 9 increases expression EXP lead acetate results in increased expression of BTBD9 mRNA CTD PMID:20542052 NCBI chr17:30,434,498...30,801,595
Ensembl chr17:30,434,498...30,795,462 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 decreases expression ISO lead acetate results in decreased expression of BTG2 mRNA CTD PMID:22641619 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858 		JBrowse link
G Btla B and T lymphocyte associated increases expression EXP lead acetate results in increased expression of BTLA mRNA CTD PMID:20542052 NCBI chr16:45,043,121...45,073,258
Ensembl chr16:45,044,678...45,078,033 		JBrowse link
G Btnl4 butyrophilin-like 4 increases expression ISO lead acetate results in increased expression of BTNL4 mRNA CTD PMID:22641619 NCBI chr17:34,687,320...34,696,402
Ensembl chr17:34,685,536...34,696,292 		JBrowse link
G Bub1 BUB1, mitotic checkpoint serine/threonine kinase decreases expression EXP lead acetate results in decreased expression of BUB1 mRNA CTD PMID:22613225 NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785 		JBrowse link
G C2 complement C2 increases expression EXP lead acetate results in increased expression of C2 mRNA CTD PMID:22609695 NCBI chr17:35,081,578...35,101,076
Ensembl chr17:35,081,580...35,117,241 		JBrowse link
G C3 complement component 3 decreases expression ISO lead acetate results in decreased expression of C3 mRNA CTD PMID:38568856 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136 		JBrowse link
G C4bp complement component 4 binding protein increases expression EXP lead acetate results in increased expression of C4BP mRNA CTD PMID:20542052 NCBI chr 1:130,562,510...130,589,365
Ensembl chr 1:130,562,510...130,589,369 		JBrowse link
G C5ar1 complement component 5a receptor 1 decreases expression ISO lead acetate results in decreased expression of C5AR1 mRNA CTD PMID:38568856 NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465 		JBrowse link
G C77545 expressed sequence C77545 decreases expression EXP lead acetate results in decreased expression of C77545 mRNA CTD PMID:22609695
G C78859 expressed sequence C78859 increases expression EXP lead acetate results in increased expression of C78859 mRNA CTD PMID:22609695 Ensembl chr 8:95,048,786...95,054,728 JBrowse link
G C79242 expressed sequence C79242 increases expression EXP lead acetate results in increased expression of C79242 mRNA CTD PMID:21829687
G C80719 expressed sequence C80719 increases expression EXP lead acetate results in increased expression of C80719 mRNA CTD PMID:22609695
G C86400 expressed sequence C86400 increases expression EXP lead acetate results in increased expression of C86400 mRNA CTD PMID:20542052
G C9 complement component 9 decreases expression EXP lead acetate results in decreased expression of C9 mRNA CTD PMID:22609695 NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232 		JBrowse link
G Cables1 CDK5 and Abl enzyme substrate 1 increases expression ISO lead acetate results in increased expression of CABLES1 mRNA CTD PMID:22641619 NCBI chr18:11,972,600...12,078,681
Ensembl chr18:11,972,277...12,078,687 		JBrowse link
G Cacna1b calcium channel, voltage-dependent, N type, alpha 1B subunit decreases expression EXP lead acetate results in decreased expression of CACNA1B mRNA CTD PMID:33932463 NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164 		JBrowse link
G Cacna1f calcium channel, voltage-dependent, alpha 1F subunit decreases expression ISO lead acetate results in decreased expression of CACNA1F mRNA CTD PMID:22641619 NCBI chr  X:7,473,342...7,501,435
Ensembl chr  X:7,473,322...7,501,435 		JBrowse link
G Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1 decreases expression EXP lead acetate results in decreased expression of CACNA2D1 mRNA CTD PMID:33932463 NCBI chr 5:16,139,390...16,579,509
Ensembl chr 5:16,139,786...16,579,502 		JBrowse link
G Cacna2d4 calcium channel, voltage-dependent, alpha 2/delta subunit 4 decreases expression ISO lead acetate results in decreased expression of CACNA2D4 mRNA CTD PMID:22641619 NCBI chr 6:119,213,435...119,329,368
Ensembl chr 6:119,213,487...119,329,368 		JBrowse link
G Cadm1 cell adhesion molecule 1 affects expression ISO lead acetate affects the expression of CADM1 protein CTD PMID:36539177 NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413 		JBrowse link
G Cadm3 cell adhesion molecule 3 decreases expression ISO lead acetate results in decreased expression of CADM3 mRNA CTD PMID:38568856 NCBI chr 1:173,161,825...173,195,214
Ensembl chr 1:173,160,825...173,195,261 		JBrowse link
G Calb1 calbindin 1 increases expression ISO lead acetate results in increased expression of CALB1 mRNA CTD PMID:33862172 NCBI chr 4:15,881,264...15,906,709
Ensembl chr 4:15,881,264...15,908,064 		JBrowse link
G Calb2 calbindin 2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein] CTD PMID:31708536 NCBI chr 8:110,869,158...110,894,844
Ensembl chr 8:110,864,134...110,894,842 		JBrowse link
G Calca calcitonin/calcitonin-related polypeptide, alpha decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of CALCA mRNA; lead acetate results in decreased expression of CALCA protein
[Ethanol co-treated with lead acetate] results in increased expression of CALCA protein 		CTD PMID:22641619 PMID:23376407 NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592 		JBrowse link
G Cald1 caldesmon 1 decreases expression ISO lead acetate results in decreased expression of CALD1 mRNA CTD PMID:11578147 NCBI chr 6:34,575,433...34,752,404
Ensembl chr 6:34,575,435...34,752,408 		JBrowse link
G Calml3 calmodulin-like 3 increases expression ISO lead acetate results in increased expression of CALML3 mRNA CTD PMID:11578147 NCBI chr13:3,852,893...3,854,318
Ensembl chr13:3,852,896...3,854,316 		JBrowse link
G Calr calreticulin decreases expression EXP lead acetate results in decreased expression of CALR mRNA CTD PMID:21829687 NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563 		JBrowse link
G Calu calumenin increases expression EXP
ISO 		lead acetate results in increased expression of CALU mRNA CTD PMID:20542052 PMID:38568856 NCBI chr 6:29,348,105...29,376,674
Ensembl chr 6:29,348,068...29,377,109 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha decreases expression
multiple interactions
decreases phosphorylation 		ISO
EXP 		lead acetate results in decreased expression of CAMK2A mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of and results in decreased phosphorylation of CAMK2A protein
Quercetin inhibits the reaction [lead acetate results in decreased phosphorylation of CAMK2A protein] 		CTD PMID:22160880 PMID:23855546 PMID:30905827 NCBI chr18:61,058,704...61,121,224
Ensembl chr18:61,058,690...61,121,224 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II, beta decreases expression ISO lead acetate results in decreased expression of CAMK2B mRNA CTD PMID:38568856 NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II, delta decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of CAMK2D mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of CAMK2D mRNA 		CTD PMID:22641619 PMID:33080273 NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975 		JBrowse link
G Camk2n2 calcium/calmodulin-dependent protein kinase II inhibitor 2 decreases expression EXP lead acetate results in decreased expression of CAMK2N2 mRNA CTD PMID:20542052 NCBI chr16:20,437,965...20,440,028
Ensembl chr16:20,437,965...20,440,037 		JBrowse link
G Camkk2 calcium/calmodulin-dependent protein kinase kinase 2, beta multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of CAMKK2 intron CTD PMID:33445541 NCBI chr 5:122,856,064...122,918,295
Ensembl chr 5:122,869,233...122,917,472 		JBrowse link
G Cand1 cullin associated and neddylation disassociated 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CAND1 mRNA CTD PMID:22839698 NCBI chr10:119,034,717...119,075,960
Ensembl chr10:119,035,160...119,075,960 		JBrowse link
G Capsl calcyphosine-like increases expression ISO lead acetate results in increased expression of CAPSL mRNA CTD PMID:22641619 NCBI chr15:9,436,136...9,466,125
Ensembl chr15:9,436,114...9,466,124 		JBrowse link
G Car11 carbonic anhydrase 11 increases expression EXP lead acetate results in increased expression of CAR11 mRNA CTD PMID:20542052 NCBI chr 7:45,348,537...45,354,106
Ensembl chr 7:45,349,267...45,354,106 		JBrowse link
G Car13 carbonic anhydrase 13 affects expression ISO lead acetate affects the expression of CAR13 mRNA CTD PMID:22641619 NCBI chr 3:14,706,787...14,728,062
Ensembl chr 3:14,706,787...14,728,062 		JBrowse link
G Car14 carbonic anhydrase 14 affects expression ISO lead acetate affects the expression of CAR14 mRNA CTD PMID:21864555 NCBI chr 3:95,805,080...95,812,443
Ensembl chr 3:95,805,080...95,812,003 		JBrowse link
G Car2 carbonic anhydrase 2 decreases expression ISO lead acetate results in decreased expression of CA2 mRNA CTD PMID:38568856 NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830 		JBrowse link
G Car8 carbonic anhydrase 8 decreases expression EXP lead acetate results in decreased expression of CAR8 mRNA CTD PMID:22613225 NCBI chr 4:8,141,491...8,239,226
Ensembl chr 4:8,143,362...8,239,041 		JBrowse link
G Car9 carbonic anhydrase 9 decreases expression ISO lead acetate results in decreased expression of CA9 mRNA CTD PMID:38568856 NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729 		JBrowse link
G Card14 caspase recruitment domain family, member 14 decreases expression EXP lead acetate results in decreased expression of CARD14 mRNA CTD PMID:22609695 NCBI chr11:119,197,923...119,236,205
Ensembl chr11:119,198,594...119,236,201 		JBrowse link
G Carhsp1 calcium regulated heat stable protein 1 affects expression ISO lead acetate affects the expression of CARHSP1 protein CTD PMID:36539177 NCBI chr16:8,476,444...8,490,017
Ensembl chr16:8,476,444...8,490,019 		JBrowse link
G Cars1 cysteinyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of CARS1 mRNA CTD PMID:11578147 NCBI chr 7:143,110,967...143,153,827
Ensembl chr 7:143,110,967...143,153,827 		JBrowse link
G Casp1 caspase 1 increases expression
multiple interactions 		EXP lead acetate results in increased expression of CASP1 mRNA
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP1 protein; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP1 protein] 		CTD PMID:22609695 PMID:36308466 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290 		JBrowse link
G Casp3 caspase 3 increases activity
increases expression
increases cleavage
multiple interactions
affects expression
decreases expression 		ISO
EXP 		lead acetate results in increased activity of CASP3 protein
lead acetate results in increased expression of CASP3 mRNA; lead acetate results in increased expression of CASP3 protein
lead acetate results in increased cleavage of CASP3 protein
[[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] co-treated with [lead acetate results in increased abundance of Lead]] results in increased cleavage of CASP3 protein; [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP3 protein; HMOX1 protein affects the reaction [lead acetate affects the expression of CASP3 protein]; NFE2L2 protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]
5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; [Cadmium Chloride co-treated with lead acetate] results in increased expression of CASP3 protein; [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP3 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of CASP3 protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of CASP3 protein modified form; Biological Factors inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; Biological Factors inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; Carbenoxolone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP3 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; Genistein inhibits the reaction [lead acetate results in increased cleavage of CASP3 protein]; lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP3 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP3 mRNA]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP3 mRNA]]; Plant Oils inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; Plant Preparations inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; Plant Preparations inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CASP3 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of CASP3 mRNA]; sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP3 mRNA]; sodium bisulfide inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in increased expression of CASP3 protein]
lead acetate results in increased expression of CASP3 protein; lead acetate results in increased expression of CASP3 protein modified form
[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP3 protein]; [lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP3 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP3 protein; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP3 protein]]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; mitoquinone inhibits the reaction [[cupric chloride results in increased abundance of Copper] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased cleavage of CASP3 protein]]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP3 protein]
lead acetate results in decreased expression of CASP3 mRNA 		CTD PMID:19026729 PMID:21640820 PMID:22033380 PMID:23146751 PMID:23318731 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp8 caspase 8 multiple interactions
increases activity 		EXP 1,3-dimethylthiourea inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] CTD PMID:22033380 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662 		JBrowse link
G Casp9 caspase 9 increases expression
multiple interactions
increases activity 		ISO
EXP 		lead acetate results in increased expression of CASP9 mRNA
lead acetate results in increased expression of CASP9 protein
[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA; MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP9 protein]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP9 protein]
[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein; Carbenoxolone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased cleavage of CASP9 protein]; IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein]; lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in increased expression of CASP9 mRNA]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in increased expression of CASP9 mRNA]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA]]; SB 203580 inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein]; sodium arsenite promotes the reaction [lead acetate results in increased expression of CASP9 mRNA] 		CTD PMID:23906897 PMID:26396915 PMID:27236077 PMID:27604105 PMID:33242459 More... NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287 		JBrowse link
G Cat catalase multiple interactions
decreases expression
increases expression
affects activity
decreases activity
increases activity 		ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CAT mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA]
lead acetate results in decreased expression of CAT protein
lead acetate results in increased expression of CAT mRNA
lead acetate affects the activity of CAT protein
lead acetate results in increased expression of CAT mRNA; lead acetate results in increased expression of CAT protein
lead acetate results in decreased expression of CAT mRNA; lead acetate results in decreased expression of CAT protein
lead acetate results in decreased activity of CAT protein
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of CAT protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] which results in decreased expression of CAT protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of CAT mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of CAT protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CAT protein]; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Clotrimazole inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Fatty Acids, Omega-3 inhibits the reaction [lead acetate results in decreased expression of CAT protein]; S-allylcysteine inhibits the reaction [lead acetate results in decreased activity of CAT protein]
lead acetate results in increased activity of CAT protein
3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; 3-nitropropionic acid affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of CAT mRNA]; [cadmium acetate co-treated with lead acetate] results in increased activity of CAT protein; [lead acetate co-treated with Cadmium Chloride] results in decreased activity of CAT protein; [lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]; [lead acetate results in increased abundance of Lead] which affects the expression of CAT protein; [lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CAT mRNA; [Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of CAT protein]; Amitrole affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of CAT protein]]; Amitrole affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of CAT protein]; Biological Factors inhibits the reaction [lead acetate results in decreased activity of CAT protein]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 protein]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ACTA2 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CDH2 protein]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CHD2 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 protein]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM protein]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]; Cholecalciferol inhibits the reaction [lead acetate results in decreased activity of CAT protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased activity of CAT protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of CAT mRNA]; epigallocatechin gallate inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Genistein inhibits the reaction [lead acetate results in decreased expression of CAT protein]; lead acetate promotes the reaction [sodium arsenite results in decreased activity of CAT protein]; lead acetate results in decreased expression of and results in decreased activity of CAT protein; lead acetate results in increased expression of and results in decreased activity of CAT protein; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in decreased activity of CAT protein]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in decreased activity of CAT protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in decreased activity of CAT protein]]; naringenin inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Plant Oils inhibits the reaction [lead acetate affects the activity of CAT protein]; Plant Preparations inhibits the reaction [lead acetate results in decreased activity of CAT protein]; Silybin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; sinapinic acid inhibits the reaction [lead acetate results in decreased activity of CAT protein]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of CAT protein]; sodium arsenite promotes the reaction [lead acetate results in decreased activity of CAT protein] 		CTD PMID:12634122 PMID:15569323 PMID:16897041 PMID:19347332 PMID:22033380 More... NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Cav1 caveolin 1, caveolae protein decreases expression
increases expression 		ISO lead acetate results in decreased expression of CAV1 mRNA
lead acetate results in increased expression of CAV1 mRNA 		CTD PMID:11578147 PMID:22641619 NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451 		JBrowse link
G Cavin2 caveolae associated 2 decreases expression ISO lead acetate results in decreased expression of CAVIN2 mRNA CTD PMID:38568856 NCBI chr 1:51,328,285...51,342,119
Ensembl chr 1:51,328,285...51,342,119 		JBrowse link
G Cbl Casitas B-lineage lymphoma multiple interactions
increases phosphorylation 		ISO CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]
lead acetate results in increased phosphorylation of CBL protein 		CTD PMID:17298174 NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346 		JBrowse link
G Cblb Casitas B-lineage lymphoma b decreases expression EXP lead acetate results in decreased expression of CBLB mRNA CTD PMID:21829687 NCBI chr16:51,851,593...52,028,410
Ensembl chr16:51,851,588...52,028,411 		JBrowse link
G Cbr1 carbonyl reductase 1 increases expression ISO lead acetate results in increased expression of CBR1 mRNA CTD PMID:38568856 NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393 		JBrowse link
G Cbs cystathionine beta-synthase multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CBS mRNA CTD PMID:39276841 NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212 		JBrowse link
G Cbx1 chromobox 1 decreases expression EXP lead acetate results in decreased expression of CBX1 mRNA CTD PMID:21829687 NCBI chr11:96,679,506...96,699,808
Ensembl chr11:96,679,953...96,699,466 		JBrowse link
G Cbx4 chromobox 4 increases expression ISO lead acetate results in increased expression of CBX4 mRNA CTD PMID:38568856 NCBI chr11:118,968,399...118,977,067
Ensembl chr11:118,968,399...118,977,047 		JBrowse link
G Cbx6 chromobox 6 increases expression ISO lead acetate results in increased expression of CBX6 mRNA CTD PMID:38568856 NCBI chr15:79,708,099...79,718,534
Ensembl chr15:79,708,097...79,718,889 		JBrowse link
G Cbx7 chromobox 7 increases expression EXP lead acetate results in increased expression of CBX7 mRNA CTD PMID:22613225 NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320 		JBrowse link
G Ccdc117 coiled-coil domain containing 117 decreases expression EXP lead acetate results in decreased expression of CCDC117 mRNA CTD PMID:21829687 NCBI chr11:5,478,887...5,492,217
Ensembl chr11:5,478,887...5,492,187 		JBrowse link
G Ccdc18 coiled-coil domain containing 18 increases expression EXP lead acetate results in increased expression of CCDC18 mRNA CTD PMID:22613225 NCBI chr 5:108,280,583...108,388,378
Ensembl chr 5:108,280,741...108,381,494 		JBrowse link
G Ccdc22 coiled-coil domain containing 22 increases expression ISO lead acetate results in increased expression of CCDC22 mRNA CTD PMID:38568856 NCBI chr  X:7,460,048...7,471,659
Ensembl chr  X:7,460,048...7,471,756 		JBrowse link
G Ccdc6 coiled-coil domain containing 6 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of CCDC6 mRNA CTD PMID:22839698 NCBI chr10:69,932,709...70,029,030
Ensembl chr10:69,932,951...70,029,030 		JBrowse link
G Ccdc69 coiled-coil domain containing 69 decreases expression ISO lead acetate results in decreased expression of CCDC69 mRNA CTD PMID:38568856 NCBI chr11:54,940,559...54,969,608
Ensembl chr11:54,940,557...54,968,957 		JBrowse link
G Ccdc71l coiled-coil domain containing 71 like increases expression ISO lead acetate results in increased expression of CCDC71L mRNA CTD PMID:38568856 NCBI chr12:32,428,788...32,432,942
Ensembl chr12:32,428,703...32,432,942 		JBrowse link
G Ccdc80 coiled-coil domain containing 80 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of CCDC80 mRNA
lead acetate results in increased expression of CCDC80 mRNA 		CTD PMID:20542052 PMID:38568856 NCBI chr16:44,913,770...44,948,287
Ensembl chr16:44,913,765...44,948,440 		JBrowse link
G Cckar cholecystokinin A receptor decreases expression EXP lead acetate results in decreased expression of CCKAR mRNA CTD PMID:22613225 NCBI chr 5:53,855,827...53,865,046
Ensembl chr 5:53,855,118...53,865,047 		JBrowse link
G Ccl1 C-C motif chemokine ligand 1 increases expression EXP lead acetate results in increased expression of CCL1 mRNA CTD PMID:20542052 NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 increases expression EXP lead acetate results in increased expression of CCL12 mRNA CTD PMID:20542052 NCBI chr11:81,992,671...81,994,225
Ensembl chr11:81,992,671...81,994,226 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
increases secretion
multiple interactions 		EXP lead acetate results in decreased expression of CCL2 mRNA
lead acetate results in increased secretion of CCL2 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; Celecoxib inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of CCL2 protein]; U 0126 inhibits the reaction [lead acetate results in increased secretion of CCL2 protein] 		CTD PMID:21829687 PMID:24530660 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression ISO lead acetate results in increased expression of CCL20 mRNA CTD PMID:38568856 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888 		JBrowse link
G Ccl26 C-C motif chemokine ligand 26 increases expression ISO lead acetate results in increased expression of CCL26 mRNA CTD PMID:38568856 NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 increases expression
multiple interactions 		EXP lead acetate results in increased expression of CCL28 mRNA
[lead acetate results in increased abundance of Lead] which results in increased methylation of CCL28 intron 		CTD PMID:22609695 PMID:33445541 NCBI chr13:120,085,355...120,115,895
Ensembl chr13:120,085,355...120,115,895 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO lead acetate promotes the reaction [Hemagglutinins results in increased secretion of CCL3 protein] CTD PMID:22839698 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression EXP lead acetate results in increased expression of CCL5 mRNA CTD PMID:29746905 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344 		JBrowse link
G Ccn1 cellular communication network factor 1 affects expression
increases expression 		ISO lead acetate affects the expression of CCN1 mRNA
lead acetate results in increased expression of CCN1 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736 		JBrowse link
G Ccn2 cellular communication network factor 2 increases expression
decreases expression 		ISO
EXP 		lead acetate results in increased expression of CCN2 mRNA
lead acetate results in decreased expression of CCN2 mRNA 		CTD PMID:25270620 PMID:38568856 NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		APEX1 protein promotes the reaction [lead acetate results in increased expression of CCND1 protein]; E 3330 inhibits the reaction [lead acetate results in increased expression of CCND1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CCND1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of CCND1 protein; Wortmannin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CCND1 protein]
lead acetate results in increased expression of CCND1 mRNA
lead acetate results in decreased expression of CCND1 mRNA
lead acetate results in increased expression of CCND1 mRNA; lead acetate results in increased expression of CCND1 protein 		CTD PMID:18353414 PMID:23370007 PMID:25270620 PMID:33862172 PMID:38568856 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662 		JBrowse link
G Ccne1 cyclin E1 decreases expression EXP lead acetate results in decreased expression of CCNE1 mRNA CTD PMID:25270620 NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959 		JBrowse link
G Ccnl2 cyclin L2 decreases expression ISO lead acetate results in decreased expression of CCNL2 mRNA CTD PMID:38568856 NCBI chr 4:155,894,468...155,909,005
Ensembl chr 4:155,896,946...155,909,000 		JBrowse link
G Ccr2 C-C motif chemokine receptor 2 increases expression EXP
ISO 		lead acetate results in increased expression of CCR2 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594 		JBrowse link
G Ccr4 C-C motif chemokine receptor 4 increases expression EXP lead acetate results in increased expression of CCR4 mRNA CTD PMID:20542052 NCBI chr 9:114,319,384...114,334,544
Ensembl chr 9:114,319,384...114,333,984
Ensembl chr 9:114,319,384...114,333,984 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 decreases expression EXP lead acetate results in decreased expression of CCR7 mRNA CTD PMID:20542052 NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903 		JBrowse link
G Ccr8 C-C motif chemokine receptor 8 increases expression EXP lead acetate results in increased expression of CCR8 mRNA CTD PMID:22609695 NCBI chr 9:119,921,199...119,923,972
Ensembl chr 9:119,921,180...119,923,972 		JBrowse link
G Ccs copper chaperone for superoxide dismutase increases expression EXP lead acetate results in increased expression of CCS mRNA CTD PMID:29746905 NCBI chr19:4,875,394...4,889,326
Ensembl chr19:4,875,394...4,889,360 		JBrowse link
G Cd14 CD14 antigen decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of CD14 mRNA
pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in decreased expression of CD14 mRNA] 		CTD PMID:36539177 NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851 		JBrowse link
G Cd163 CD163 antigen increases expression ISO lead acetate results in increased expression of CD163 mRNA CTD PMID:22641619 NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486 		JBrowse link
G Cd209f CD209f antigen increases expression EXP lead acetate results in increased expression of CD209F mRNA CTD PMID:20542052 NCBI chr 8:4,152,784...4,155,838
Ensembl chr 8:4,152,787...4,155,835 		JBrowse link
G Cd247 CD247 antigen increases expression EXP lead acetate results in increased expression of CD247 mRNA CTD PMID:20542052 NCBI chr 1:165,607,514...165,698,722
Ensembl chr 1:165,616,250...165,704,846 		JBrowse link
G Cd27 CD27 antigen increases expression
decreases expression 		EXP lead acetate results in increased expression of CD27 mRNA
lead acetate results in decreased expression of CD27 mRNA 		CTD PMID:20542052 PMID:21829687 NCBI chr 6:125,209,583...125,214,014
Ensembl chr 6:125,209,585...125,213,973 		JBrowse link
G Cd300c2 CD300C molecule 2 increases expression EXP lead acetate results in increased expression of CD300C2 mRNA CTD PMID:22609695 NCBI chr11:114,887,595...114,892,706
Ensembl chr11:114,887,547...114,895,058 		JBrowse link
G Cd36 CD36 molecule increases expression EXP lead acetate results in increased expression of CD36 mRNA CTD PMID:30623991 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799 		JBrowse link
G Cd3e CD3 antigen, epsilon polypeptide increases expression
increases methylation 		ISO lead acetate results in increased expression of CD3E mRNA
lead acetate results in increased methylation of CD3E gene 		CTD PMID:22641619 PMID:29571894 NCBI chr 9:44,910,033...44,920,961
Ensembl chr 9:44,910,038...44,920,925 		JBrowse link
G Cd40 CD40 antigen multiple interactions EXP [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein CTD PMID:17512567 NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868 		JBrowse link
G Cd44 CD44 antigen multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of CD44 mRNA CTD PMID:36642386 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010 		JBrowse link
G Cd47 CD47 antigen (Rh-related antigen, integrin-associated signal transducer) decreases expression EXP lead acetate results in decreased expression of CD47 mRNA CTD PMID:20542052 NCBI chr16:49,671,691...49,732,799
Ensembl chr16:49,620,896...49,735,373 		JBrowse link
G Cd48 CD48 antigen increases expression ISO lead acetate results in increased expression of CD48 mRNA CTD PMID:22641619 NCBI chr 1:171,508,989...171,532,825
Ensembl chr 1:171,509,577...171,532,826 		JBrowse link
G Cd59b CD59b antigen increases mutagenesis ISO lead acetate results in increased mutagenesis of CD59 protein CTD PMID:17045307 NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534 		JBrowse link
G Cd63 CD63 antigen multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CD63 protein CTD PMID:36840722 NCBI chr10:128,731,577...128,748,691
Ensembl chr10:128,736,858...128,748,691 		JBrowse link
G Cd68 CD68 antigen increases expression EXP lead acetate results in increased expression of CD68 mRNA CTD PMID:21829687 NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979 		JBrowse link
G Cd70 CD70 antigen decreases expression ISO lead acetate results in decreased expression of CD70 mRNA CTD PMID:38568856 NCBI chr17:57,452,997...57,456,777
Ensembl chr17:57,452,997...57,456,777 		JBrowse link
G Cd79a CD79A antigen (immunoglobulin-associated alpha) decreases expression EXP lead acetate results in decreased expression of CD79A mRNA CTD PMID:22609695 NCBI chr 7:24,596,922...24,601,283
Ensembl chr 7:24,596,806...24,601,622 		JBrowse link
G Cd80 CD80 antigen multiple interactions EXP [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein CTD PMID:17512567 NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697 		JBrowse link
G Cd86 CD86 antigen multiple interactions EXP [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein CTD PMID:17512567 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443 		JBrowse link
G Cd93 CD93 antigen decreases expression ISO
EXP 		lead acetate results in decreased expression of CD93 mRNA CTD PMID:22613225 PMID:22641619 NCBI chr 2:148,278,571...148,285,455
Ensembl chr 2:148,278,560...148,285,483 		JBrowse link
G Cd99 CD99 antigen decreases expression EXP lead acetate results in decreased expression of CD99 mRNA CTD PMID:21829687
G Cdc42ep5 CDC42 effector protein 5 decreases expression ISO lead acetate results in decreased expression of CDC42EP5 mRNA CTD PMID:22641619 NCBI chr 7:4,154,259...4,167,830
Ensembl chr 7:4,154,259...4,167,859 		JBrowse link
G Cdc45 cell division cycle 45 increases expression EXP lead acetate results in increased expression of CDC45 mRNA CTD PMID:21829687 NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression EXP lead acetate results in decreased expression of CDC6 mRNA CTD PMID:20542052 NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766 		JBrowse link
G Cdca8 cell division cycle associated 8 increases expression EXP lead acetate results in increased expression of CDCA8 mRNA CTD PMID:21829687 NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104 		JBrowse link
G Cdh1 cadherin 1 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of CDH1 mRNA
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CDH1 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 protein] 		CTD PMID:38568856 PMID:39722890 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878 		JBrowse link
G Cdh11 cadherin 11 decreases expression ISO lead acetate results in decreased expression of CDH11 mRNA CTD PMID:11578147 NCBI chr 8:103,358,727...103,512,125
Ensembl chr 8:103,358,727...103,512,274 		JBrowse link
G Cdh13 cadherin 13 affects expression ISO lead acetate affects the expression of CDH13 protein CTD PMID:36539177 NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660 		JBrowse link
G Cdh17 cadherin 17 increases expression EXP lead acetate results in increased expression of CDH17 mRNA CTD PMID:22609695 NCBI chr 4:11,758,157...11,817,905
Ensembl chr 4:11,758,147...11,817,895 		JBrowse link
G Cdh19 cadherin 19, type 2 decreases expression ISO lead acetate results in decreased expression of CDH19 mRNA CTD PMID:22641619 NCBI chr 1:110,811,802...110,905,331
Ensembl chr 1:110,816,056...110,905,314 		JBrowse link
G Cdh2 cadherin 2 multiple interactions ISO CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CDH2 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CDH2 protein] CTD PMID:39722890 NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303 		JBrowse link
G Cdh3 cadherin 3 affects expression
decreases expression 		ISO lead acetate affects the expression of CDH3 mRNA
lead acetate results in decreased expression of CDH3 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929 		JBrowse link
G Cdh7 cadherin 7, type 2 decreases expression ISO lead acetate results in decreased expression of CDH7 mRNA CTD PMID:22641619 NCBI chr 1:109,909,967...110,073,002
Ensembl chr 1:109,910,161...110,067,887 		JBrowse link
G Cdk1 cyclin dependent kinase 1 increases methylation
decreases expression 		ISO lead acetate results in increased methylation of CDK1 gene
lead acetate results in decreased expression of CDK1 mRNA 		CTD PMID:29571894 PMID:33862172 NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768 		JBrowse link
G Cdk13 cyclin dependent kinase 13 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CDK13 mRNA CTD PMID:22839698 NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682 		JBrowse link
G Cdk18 cyclin dependent kinase 18 decreases expression ISO lead acetate results in decreased expression of CDK18 mRNA CTD PMID:38568856 NCBI chr 1:132,041,285...132,067,433
Ensembl chr 1:132,039,975...132,067,422 		JBrowse link
G Cdk4 cyclin dependent kinase 4 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of CDK4 protein CTD PMID:38072110 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789 		JBrowse link
G Cdk5 cyclin dependent kinase 5 multiple interactions
increases expression
increases cleavage 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of CDK5 protein]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of CDK5 protein; pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of CDK5 protein]
lead acetate results in increased expression of CDK5 mRNA; lead acetate results in increased expression of CDK5 protein
lead acetate results in increased cleavage of CDK5 protein 		CTD PMID:24481447 PMID:24954411 PMID:27012722 PMID:27293183 NCBI chr 5:24,612,595...24,628,737
Ensembl chr 5:24,623,239...24,628,528 		JBrowse link
G Cdk5r1 cyclin dependent kinase 5, regulatory subunit 1 multiple interactions EXP lead acetate affects the reaction [MAPT protein affects the abundance of CDK5R1 protein modified form]; lead acetate results in decreased expression of and results in increased cleavage of CDK5R1 protein CTD PMID:24954411 PMID:29203278 NCBI chr11:80,367,849...80,372,010
Ensembl chr11:80,367,849...80,372,010 		JBrowse link
G Cdk5rap3 CDK5 regulatory subunit associated protein 3 decreases expression ISO lead acetate results in decreased expression of CDK5RAP3 mRNA CTD PMID:38568856 NCBI chr11:96,798,251...96,807,359
Ensembl chr11:96,798,252...96,807,322 		JBrowse link
G Cdkal1 CDK5 regulatory subunit associated protein 1-like 1 increases expression EXP lead acetate results in increased expression of CDKAL1 mRNA CTD PMID:21829687 NCBI chr13:29,375,729...30,039,665
Ensembl chr13:29,375,729...30,039,657 		JBrowse link
G Cdkl4 cyclin dependent kinase like 4 increases expression ISO lead acetate results in increased expression of CDKL4 mRNA CTD PMID:22641619 NCBI chr17:80,830,979...80,885,242
Ensembl chr17:80,830,979...80,885,242 		JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA
lead acetate results in increased expression of CDKN1A mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of CDKN1A protein; [lead acetate results in increased abundance of Lead] which results in increased expression of CDKN1A mRNA 		CTD PMID:12634122 PMID:22641619 PMID:34350654 PMID:38568856 PMID:39276841 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701 		JBrowse link
G Cdkn1c cyclin dependent kinase inhibitor 1C decreases expression ISO lead acetate results in decreased expression of CDKN1C mRNA CTD PMID:38568856 NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787 		JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA CTD PMID:12634122 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890 		JBrowse link
G Cdkn2b cyclin dependent kinase inhibitor 2B increases expression ISO lead acetate results in increased expression of CDKN2B mRNA CTD PMID:33862172 PMID:37939567 NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276 		JBrowse link
G Cdkn2c cyclin dependent kinase inhibitor 2C decreases expression ISO lead acetate results in decreased expression of CDKN2C mRNA CTD PMID:33862172 NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386 		JBrowse link
G Cdkn3 cyclin dependent kinase inhibitor 3 increases expression ISO lead acetate results in increased expression of CDKN3 mRNA CTD PMID:22641619 NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126 		JBrowse link
G Cdon cell adhesion molecule-related/down-regulated by oncogenes increases expression EXP lead acetate results in increased expression of CDON mRNA CTD PMID:22609695 NCBI chr 9:35,332,836...35,418,948
Ensembl chr 9:35,332,424...35,418,948 		JBrowse link
G Cdr2 cerebellar degeneration-related 2 affects expression ISO lead acetate affects the expression of CDR2 mRNA CTD PMID:21864555 NCBI chr 7:120,556,259...120,581,535
Ensembl chr 7:120,556,259...120,581,535 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 increases expression EXP lead acetate results in increased expression of CDS2 mRNA CTD PMID:21829687 NCBI chr 2:132,105,068...132,153,970
Ensembl chr 2:132,105,068...132,153,970 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 increases expression
increases methylation
decreases expression 		EXP
ISO 		lead acetate results in increased expression of CEACAM1 mRNA
lead acetate results in increased methylation of CEACAM1 gene
lead acetate results in decreased expression of CEACAM1 mRNA 		CTD PMID:22609695 PMID:22641619 PMID:29571894 NCBI chr 7:25,161,127...25,177,072
Ensembl chr 7:25,161,132...25,177,028 		JBrowse link
G Ceacam10 CEA cell adhesion molecule 10 increases expression ISO lead acetate results in increased expression of CEACAM10 mRNA CTD PMID:22641619 NCBI chr 7:24,476,592...24,484,081
Ensembl chr 7:24,476,631...24,484,082 		JBrowse link
G Ceacam11 CEA cell adhesion molecule 11 increases expression EXP lead acetate results in increased expression of CEACAM11 mRNA CTD PMID:22609695 NCBI chr 7:17,706,092...17,712,481
Ensembl chr 7:17,706,049...17,712,481 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression
increases methylation
decreases expression 		EXP
ISO 		lead acetate results in increased expression of CEBPA mRNA
lead acetate results in increased methylation of CEBPA gene
lead acetate results in decreased expression of CEBPA mRNA 		CTD PMID:20542052 PMID:21829687 PMID:29571894 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta affects expression
increases expression 		EXP
ISO 		lead acetate affects the expression of CEBPB mRNA
lead acetate results in increased expression of CEBPB mRNA 		CTD PMID:21829687 PMID:25270620 PMID:38568856 NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338 		JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon increases methylation ISO lead acetate results in increased methylation of CEBPE gene CTD PMID:29571894 NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631 		JBrowse link
G Cel carboxyl ester lipase increases expression EXP lead acetate results in increased expression of CEL mRNA CTD PMID:20542052 NCBI chr 2:28,445,831...28,453,415
Ensembl chr 2:28,445,807...28,453,415 		JBrowse link
G Cela3b chymotrypsin-like elastase family, member 3B increases expression EXP lead acetate results in increased expression of CELA3B mRNA CTD PMID:20542052 NCBI chr 4:137,148,319...137,157,831
Ensembl chr 4:137,148,310...137,157,851 		JBrowse link
G Cemip2 cell migration inducing hyaluronidase 2 decreases expression EXP lead acetate results in decreased expression of CEMIP2 mRNA CTD PMID:22613225 NCBI chr19:21,755,704...21,835,724
Ensembl chr19:21,755,706...21,835,724 		JBrowse link
G Cend1 cell cycle exit and neuronal differentiation 1 increases expression EXP lead acetate results in increased expression of CEND1 mRNA CTD PMID:20542052 NCBI chr 7:141,006,359...141,009,475
Ensembl chr 7:141,006,359...141,009,404 		JBrowse link
G Cenpe centromere protein E increases expression ISO lead acetate results in increased expression of CENPE mRNA CTD PMID:11578147 NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372 		JBrowse link
G Cenpk centromere protein K increases expression ISO lead acetate results in increased expression of CENPK mRNA CTD PMID:22641619 NCBI chr13:104,365,474...104,386,130
Ensembl chr13:104,365,119...104,388,900 		JBrowse link
G Cenpo centromere protein O decreases expression EXP lead acetate results in decreased expression of CENPO mRNA CTD PMID:22609695 NCBI chr12:4,243,548...4,284,255
Ensembl chr12:4,246,004...4,284,294 		JBrowse link
G Cenpv centromere protein V decreases expression EXP lead acetate results in decreased expression of CENPV mRNA CTD PMID:20542052 NCBI chr11:62,415,770...62,430,695
Ensembl chr11:62,415,772...62,430,087 		JBrowse link
G Cenpw centromere protein W increases expression ISO lead acetate results in increased expression of CENPW mRNA CTD PMID:38568856 NCBI chr10:30,072,005...30,076,599
Ensembl chr10:30,070,565...30,076,556 		JBrowse link
G Cep162 centrosomal protein 162 increases expression ISO lead acetate results in increased expression of CEP162 mRNA CTD PMID:22641619 NCBI chr 9:87,071,626...87,137,589
Ensembl chr 9:87,071,630...87,137,589 		JBrowse link
G Cept1 choline/ethanolaminephosphotransferase 1 decreases expression EXP lead acetate results in decreased expression of CEPT1 mRNA CTD PMID:21829687 NCBI chr 3:106,409,576...106,455,118
Ensembl chr 3:106,409,576...106,455,118 		JBrowse link
G Cers4 ceramide synthase 4 decreases expression EXP lead acetate results in decreased expression of CERS4 mRNA CTD PMID:25270620 NCBI chr 8:4,542,863...4,579,603
Ensembl chr 8:4,543,026...4,581,680 		JBrowse link
G Ces1d carboxylesterase 1D increases expression ISO lead acetate results in increased expression of CES1 mRNA CTD PMID:38568856 NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466 		JBrowse link
G Ces4a carboxylesterase 4A decreases expression ISO lead acetate results in decreased expression of CES4A mRNA CTD PMID:38568856 NCBI chr 8:105,858,432...105,876,741
Ensembl chr 8:105,858,432...105,876,741 		JBrowse link
G Cfap126 cilia and flagella associated protein 126 affects expression ISO lead acetate affects the expression of CFAP126 mRNA CTD PMID:21864555 NCBI chr 1:170,941,326...170,954,525
Ensembl chr 1:170,941,487...170,954,536 		JBrowse link
G Cfap70 cilia and flagella associated protein 70 increases expression ISO lead acetate results in increased expression of CFAP70 mRNA CTD PMID:22641619 NCBI chr14:20,444,258...20,502,332
Ensembl chr14:20,444,261...20,502,294 		JBrowse link
G Cfap77 cilia and flagella associated protein 77 decreases expression ISO lead acetate results in decreased expression of CFAP77 mRNA CTD PMID:22641619 NCBI chr 2:28,845,493...28,945,078
Ensembl chr 2:28,816,961...28,945,078 		JBrowse link
G Cfhr1 complement factor H-related 1 decreases expression EXP lead acetate results in decreased expression of CFHR1 mRNA CTD PMID:22609695 NCBI chr 1:139,474,802...139,487,960
Ensembl chr 1:139,474,791...139,488,010 		JBrowse link
G Cfp complement factor properdin increases expression EXP lead acetate results in increased expression of CFP mRNA CTD PMID:20542052 NCBI chr  X:20,791,693...20,797,794
Ensembl chr  X:20,791,693...20,797,794 		JBrowse link
G Cga glycoprotein hormones, alpha subunit decreases activity
multiple interactions 		EXP lead acetate results in decreased activity of CGA protein
lead acetate inhibits the reaction [CGA protein results in increased abundance of Progesterone] 		CTD PMID:11213355 PMID:12647776 NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370 		JBrowse link
G Cgref1 cell growth regulator with EF hand domain 1 affects methylation
decreases expression 		ISO lead acetate affects the methylation of CGREF1 gene
lead acetate results in decreased expression of CGREF1 mRNA 		CTD PMID:29571894 NCBI chr 5:31,090,487...31,102,771
Ensembl chr 5:31,090,487...31,102,935 		JBrowse link
G Chac1 ChaC, cation transport regulator 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CHAC1 mRNA CTD PMID:39276841 NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862 		JBrowse link
G Chchd5 coiled-coil-helix-coiled-coil-helix domain containing 5 increases expression ISO lead acetate results in increased expression of CHCHD5 mRNA CTD PMID:22641619 NCBI chr 2:128,971,620...128,976,032
Ensembl chr 2:128,971,620...128,976,054 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CHD2 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CHD2 mRNA] CTD PMID:39722890 NCBI chr 7:73,076,400...73,191,494
Ensembl chr 7:73,076,386...73,191,578 		JBrowse link
G Chd3 chromodomain helicase DNA binding protein 3 decreases expression EXP lead acetate results in decreased expression of CHD3 mRNA CTD PMID:21829687 NCBI chr11:69,234,099...69,260,325
Ensembl chr11:69,234,099...69,260,232 		JBrowse link
G Chd7 chromodomain helicase DNA binding protein 7 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CHD7 mRNA CTD PMID:22839698 NCBI chr 4:8,690,345...8,868,449
Ensembl chr 4:8,690,406...8,867,659 		JBrowse link
G Chd8 chromodomain helicase DNA binding protein 8 increases expression
multiple interactions 		ISO lead acetate results in increased expression of CHD8 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of CHD8 protein 		CTD PMID:38072110 NCBI chr14:52,435,608...52,495,499
Ensembl chr14:52,435,608...52,495,237 		JBrowse link
G Chdh choline dehydrogenase increases expression EXP lead acetate results in increased expression of CHDH mRNA CTD PMID:22613225 NCBI chr14:29,730,957...29,762,423
Ensembl chr14:29,730,980...29,762,484 		JBrowse link
G Chek1 checkpoint kinase 1 increases expression EXP
ISO 		lead acetate results in increased expression of CHEK1 mRNA CTD PMID:22609695 PMID:33862172 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361 		JBrowse link
G Chid1 chitinase domain containing 1 increases expression EXP lead acetate results in increased expression of CHID1 mRNA CTD PMID:21829687 NCBI chr 7:141,073,049...141,119,818
Ensembl chr 7:141,073,049...141,119,770 		JBrowse link
G Chmp5 charged multivesicular body protein 5 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CHMP5 mRNA CTD PMID:39276841 NCBI chr 4:40,948,553...40,965,302
Ensembl chr 4:40,948,407...40,965,303 		JBrowse link
G Chordc1 cysteine and histidine rich domain containing 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of CHORDC1 protein CTD PMID:38072110 NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738 		JBrowse link
G Chpf chondroitin polymerizing factor multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of CHPF protein CTD PMID:38072110 NCBI chr 1:75,451,213...75,456,115
Ensembl chr 1:75,451,213...75,455,951 		JBrowse link
G Chrna7 cholinergic receptor, nicotinic, alpha polypeptide 7 decreases expression
increases expression 		ISO lead acetate results in decreased expression of CHRNA7 mRNA
lead acetate results in increased expression of CHRNA7 mRNA 		CTD PMID:33862172 NCBI chr 7:62,748,440...62,862,274
Ensembl chr 7:62,748,440...62,862,317 		JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit increases expression ISO lead acetate results in increased expression of CHRNB2 mRNA CTD PMID:33862172 NCBI chr 3:89,660,755...89,671,939
Ensembl chr 3:89,653,502...89,671,939 		JBrowse link
G Chrnb4 cholinergic receptor, nicotinic, beta polypeptide 4 decreases expression ISO lead acetate results in decreased expression of CHRNB4 mRNA CTD PMID:22641619 NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063 		JBrowse link
G Chst11 carbohydrate sulfotransferase 11 increases expression ISO lead acetate results in increased expression of CHST11 mRNA CTD PMID:38568856 NCBI chr10:82,820,274...83,031,738
Ensembl chr10:82,821,332...83,031,734 		JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase decreases expression ISO lead acetate results in decreased expression of CHUK protein CTD PMID:16547843 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919 		JBrowse link
G Ciapin1 cytokine induced apoptosis inhibitor 1 increases expression EXP lead acetate results in increased expression of CIAPIN1 mRNA CTD PMID:20542052 NCBI chr 8:95,546,446...95,565,454
Ensembl chr 8:95,546,432...95,564,986 		JBrowse link
G Cimip6 ciliary microtubule inner protein 6 decreases expression ISO lead acetate results in decreased expression of CIMIP6 mRNA CTD PMID:22641619 NCBI chr11:30,376,006...30,421,829
Ensembl chr11:30,376,006...30,421,827 		JBrowse link
G Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 decreases expression ISO lead acetate results in decreased expression of CITED2 mRNA CTD PMID:38568856 NCBI chr10:17,598,452...17,601,422
Ensembl chr10:17,598,966...17,601,422 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 increases expression ISO lead acetate results in increased expression of CKAP4 mRNA CTD PMID:38568856 NCBI chr10:84,362,169...84,369,752
Ensembl chr10:84,362,169...84,369,926 		JBrowse link
G Ckb creatine kinase, brain multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CKB mRNA
Curcumin inhibits the reaction [lead acetate results in increased secretion of [CKM protein binds to CKB protein]]; lead acetate results in increased secretion of [CKM protein binds to CKB protein]
lead acetate results in increased expression of CKB protein 		CTD PMID:12634122 PMID:20797405 PMID:21378372 NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772 		JBrowse link
G Cklf chemokine-like factor affects expression EXP lead acetate affects the expression of CKLF mRNA CTD PMID:21829687 NCBI chr 8:104,977,493...104,992,642
Ensembl chr 8:104,977,493...104,991,570 		JBrowse link
G Ckm creatine kinase, muscle increases expression
decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of CKM mRNA
lead acetate results in decreased expression of CKM mRNA; lead acetate results in decreased expression of CKM protein
HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM protein]
Curcumin inhibits the reaction [lead acetate results in increased secretion of [CKM protein binds to CKB protein]]; lead acetate results in increased secretion of [CKM protein binds to CKB protein]
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CKM mRNA 		CTD PMID:11578147 PMID:12634122 PMID:21378372 PMID:37797690 NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766 		JBrowse link
G Clca2 chloride channel accessory 2 decreases expression ISO lead acetate results in decreased expression of CLCA2 mRNA CTD PMID:38568856 NCBI chr 3:144,776,021...144,805,204
Ensembl chr 3:144,776,024...144,805,204 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 increases expression ISO lead acetate results in increased expression of CLCF1 mRNA CTD PMID:38568856 NCBI chr19:4,264,479...4,273,548
Ensembl chr19:4,264,292...4,273,544 		JBrowse link
G Clcn3 chloride channel, voltage-sensitive 3 increases expression ISO lead acetate results in increased expression of CLCN3 mRNA CTD PMID:11578147 NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334 		JBrowse link
G Clcn7 chloride channel, voltage-sensitive 7 increases expression ISO lead acetate results in increased expression of CLCN7 mRNA CTD PMID:11578147 NCBI chr17:25,352,353...25,381,077
Ensembl chr17:25,352,365...25,381,078 		JBrowse link
G Cldn1 claudin 1 affects expression ISO lead acetate affects the expression of CLDN1 mRNA CTD PMID:21864555 NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591 		JBrowse link
G Cldn11 claudin 11 affects expression ISO lead acetate affects the expression of CLDN11 protein CTD PMID:36539177 NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473 		JBrowse link
G Cldn19 claudin 19 affects expression ISO lead acetate affects the expression of CLDN19 mRNA CTD PMID:21864555 NCBI chr 4:119,112,638...119,119,635
Ensembl chr 4:119,112,611...119,119,635 		JBrowse link
G Cldn23 claudin 23 increases expression EXP lead acetate results in increased expression of CLDN23 mRNA CTD PMID:22609695 NCBI chr 8:36,291,863...36,293,713
Ensembl chr 8:36,291,866...36,293,713 		JBrowse link
G Cldn5 claudin 5 multiple interactions
decreases expression 		EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in decreased expression of CLDN5 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of CLDN5 protein] 		CTD PMID:24200059 PMID:31730887 NCBI chr16:18,595,597...18,597,012
Ensembl chr16:18,595,597...18,597,012 		JBrowse link
G Cldn7 claudin 7 decreases expression ISO lead acetate results in decreased expression of CLDN7 mRNA CTD PMID:38568856 NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711 		JBrowse link
G Clec2g C-type lectin domain family 2, member g decreases expression EXP lead acetate results in decreased expression of CLEC2G mRNA CTD PMID:22609695 NCBI chr 6:128,911,344...128,961,670
Ensembl chr 6:128,911,344...128,961,670 		JBrowse link
G Clec3a C-type lectin domain family 3, member a increases expression ISO lead acetate results in increased expression of CLEC3A mRNA CTD PMID:22641619 NCBI chr 8:115,144,744...115,154,871
Ensembl chr 8:115,144,826...115,152,586 		JBrowse link
G Clec4n C-type lectin domain family 4, member n increases expression EXP lead acetate results in increased expression of CLEC4N mRNA CTD PMID:20542052 NCBI chr 6:123,206,802...123,223,983
Ensembl chr 6:123,206,802...123,223,980 		JBrowse link
G Clgn calmegin decreases expression EXP lead acetate results in decreased expression of CLGN mRNA CTD PMID:22609695 NCBI chr 8:84,116,454...84,155,181
Ensembl chr 8:84,116,496...84,155,181 		JBrowse link
G Clic6 chloride intracellular channel 6 affects expression ISO lead acetate affects the expression of CLIC6 mRNA CTD PMID:21864555 NCBI chr16:92,295,035...92,338,129
Ensembl chr16:92,282,624...92,338,131 		JBrowse link
G Clip3 CAP-GLY domain containing linker protein 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of CLIP3 protein CTD PMID:38072110 NCBI chr 7:29,991,120...30,007,792
Ensembl chr 7:29,991,153...30,007,792 		JBrowse link
G Clpp caseinolytic mitochondrial matrix peptidase proteolytic subunit multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CLPP mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of CLPP protein; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CLPP mRNA] CTD PMID:39547369 NCBI chr17:57,297,264...57,303,371
Ensembl chr17:57,297,305...57,303,188 		JBrowse link
G Clspn claspin increases expression ISO lead acetate results in increased expression of CLSPN mRNA CTD PMID:38568856 NCBI chr 4:126,450,738...126,488,326
Ensembl chr 4:126,450,728...126,487,696 		JBrowse link
G Clstn1 calsyntenin 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of CLSTN1 protein CTD PMID:38072110 NCBI chr 4:149,670,536...149,733,356
Ensembl chr 4:149,670,925...149,733,356 		JBrowse link
G Cltrn collectrin, amino acid transport regulator affects expression ISO lead acetate affects the expression of CLTRN mRNA CTD PMID:22641619 NCBI chr  X:162,873,183...162,901,855
Ensembl chr  X:162,871,826...162,901,856 		JBrowse link
G Clxn calaxin affects expression
decreases expression 		ISO lead acetate affects the expression of CLXN mRNA
lead acetate results in decreased expression of CLXN mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr16:14,724,315...14,786,925
Ensembl chr16:14,724,470...14,799,235 		JBrowse link
G Clybl citrate lyase beta like multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of CLYBL protein CTD PMID:38072110 NCBI chr14:122,408,289...122,639,646
Ensembl chr14:122,419,116...122,639,646 		JBrowse link
G Cmbl carboxymethylenebutenolidase homolog multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of CMBL mRNA CTD PMID:22839698 NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265 		JBrowse link
G Cmc1 C-X9-C motif containing 1 decreases expression EXP lead acetate results in decreased expression of CMC1 mRNA CTD PMID:21829687 NCBI chr 9:117,893,051...117,979,264
Ensembl chr 9:117,893,590...117,979,245 		JBrowse link
G Cndp2 CNDP dipeptidase 2 increases expression EXP lead acetate results in increased expression of CNDP2 mRNA CTD PMID:21829687 NCBI chr18:84,685,590...84,703,827
Ensembl chr18:84,685,590...84,703,827 		JBrowse link
G Cngb3 cyclic nucleotide gated channel beta 3 decreases expression ISO lead acetate results in decreased expression of CNGB3 mRNA CTD PMID:22641619 NCBI chr 4:19,280,850...19,510,623
Ensembl chr 4:19,280,850...19,510,623 		JBrowse link
G Cnmd chondromodulin affects expression ISO lead acetate affects the expression of CNMD mRNA CTD PMID:22641619 NCBI chr14:79,875,126...79,899,596
Ensembl chr14:79,875,130...79,899,610 		JBrowse link
G Cnnm3 cyclin M3 decreases expression EXP lead acetate results in decreased expression of CNNM3 mRNA CTD PMID:21829687 NCBI chr 1:36,550,948...36,567,318
Ensembl chr 1:36,550,948...36,567,318 		JBrowse link
G Cnp 2',3'-cyclic nucleotide 3' phosphodiesterase decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of CNP protein
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of CNP protein 		CTD PMID:20797405 PMID:23680456 NCBI chr11:100,465,765...100,472,565
Ensembl chr11:100,465,730...100,482,555 		JBrowse link
G Cntf ciliary neurotrophic factor decreases expression ISO lead acetate results in decreased expression of CNTF mRNA CTD PMID:33862172 NCBI chr19:12,740,892...12,742,996
Ensembl chr19:12,741,024...12,742,996 		JBrowse link
G Cntnap2 contactin associated protein-like 2 decreases expression EXP lead acetate results in decreased expression of CNTNAP2 mRNA CTD PMID:20542052 NCBI chr 6:45,036,995...47,278,330
Ensembl chr 6:45,036,291...47,281,147 		JBrowse link
G Coa6 cytochrome c oxidase assembly factor 6 increases expression ISO lead acetate results in increased expression of COA6 mRNA CTD PMID:38568856 NCBI chr 8:127,149,267...127,152,174
Ensembl chr 8:127,149,254...127,152,172 		JBrowse link
G Cog8 component of oligomeric golgi complex 8 decreases expression EXP lead acetate results in decreased expression of COG8 mRNA CTD PMID:21829687 NCBI chr 8:107,775,341...107,783,369
Ensembl chr 8:107,772,921...107,783,321 		JBrowse link
G Col11a1 collagen, type XI, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL11A1 mRNA CTD PMID:11578147 NCBI chr 3:113,823,933...114,014,405
Ensembl chr 3:113,824,189...114,014,367 		JBrowse link
G Col13a1 collagen, type XIII, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL13A1 mRNA CTD PMID:11578147 NCBI chr10:61,674,013...61,814,985
Ensembl chr10:61,674,015...61,814,887 		JBrowse link
G Col15a1 collagen, type XV, alpha 1 decreases expression EXP
ISO 		lead acetate results in decreased expression of COL15A1 mRNA CTD PMID:11578147 PMID:22613225 NCBI chr 4:47,207,744...47,313,165
Ensembl chr 4:47,208,161...47,313,167 		JBrowse link
G Col16a1 collagen, type XVI, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL16A1 mRNA CTD PMID:11578147 NCBI chr 4:129,941,638...129,993,070
Ensembl chr 4:129,941,633...129,993,076 		JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL18A1 mRNA CTD PMID:11578147 NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382 		JBrowse link
G Col19a1 collagen, type XIX, alpha 1 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of COL19A1 mRNA
lead acetate results in decreased expression of COL19A1 mRNA 		CTD PMID:11578147 PMID:20542052 NCBI chr 1:24,296,764...24,627,870
Ensembl chr 1:24,300,971...24,626,553 		JBrowse link
G Col1a1 collagen, type I, alpha 1 decreases expression
affects expression
increases expression 		ISO lead acetate results in decreased expression of COL1A1 mRNA
lead acetate affects the expression of COL1A1 protein
lead acetate results in increased expression of COL1A1 mRNA 		CTD PMID:11578147 PMID:22641619 PMID:36539177 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868 		JBrowse link
G Col22a1 collagen, type XXII, alpha 1 decreases expression EXP lead acetate results in decreased expression of COL22A1 mRNA CTD PMID:22609695 NCBI chr15:71,667,644...71,906,087
Ensembl chr15:71,667,644...71,906,076 		JBrowse link
G Col2a1 collagen, type II, alpha 1 multiple interactions
increases expression
decreases expression 		EXP
ISO 		BMP2 promotes the reaction [lead acetate results in increased expression of COL2A1 mRNA]
lead acetate results in decreased expression of COL2A1 mRNA 		CTD PMID:11578147 PMID:17805416 NCBI chr15:97,873,483...97,902,525
Ensembl chr15:97,873,483...97,902,576 		JBrowse link
G Col4a1 collagen, type IV, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL4A1 mRNA CTD PMID:11578147 NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826 		JBrowse link
G Col4a3 collagen, type IV, alpha 3 increases expression ISO lead acetate results in increased expression of COL4A3 mRNA CTD PMID:11578147 NCBI chr 1:82,564,647...82,699,778
Ensembl chr 1:82,564,642...82,699,780 		JBrowse link
G Col4a4 collagen, type IV, alpha 4 decreases expression ISO lead acetate results in decreased expression of COL4A4 mRNA CTD PMID:11578147 NCBI chr 1:82,426,140...82,564,570
Ensembl chr 1:82,426,144...82,564,570 		JBrowse link
G Col4a5 collagen, type IV, alpha 5 decreases expression ISO lead acetate results in decreased expression of COL4A5 mRNA CTD PMID:11578147 NCBI chr  X:140,258,367...140,472,232
Ensembl chr  X:140,258,381...140,472,230 		JBrowse link
G Col4a6 collagen, type IV, alpha 6 decreases expression ISO lead acetate results in decreased expression of COL4A6 mRNA CTD PMID:11578147 NCBI chr  X:139,948,399...140,257,091
Ensembl chr  X:139,948,399...140,257,072 		JBrowse link
G Col5a2 collagen, type V, alpha 2 decreases expression ISO lead acetate results in decreased expression of COL5A2 mRNA CTD PMID:11578147 NCBI chr 1:45,413,491...45,542,442
Ensembl chr 1:45,413,481...45,542,442 		JBrowse link
G Col6a1 collagen, type VI, alpha 1 increases expression ISO lead acetate results in increased expression of COL6A1 mRNA CTD PMID:11578147 NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002 		JBrowse link
G Col6a2 collagen, type VI, alpha 2 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA CTD PMID:12634122 NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464 		JBrowse link
G Col7a1 collagen, type VII, alpha 1 increases expression ISO lead acetate results in increased expression of COL7A1 mRNA CTD PMID:11578147 NCBI chr 9:108,782,654...108,813,943
Ensembl chr 9:108,782,654...108,813,943 		JBrowse link
G Col8a1 collagen, type VIII, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL8A1 mRNA CTD PMID:11578147 PMID:22641619 NCBI chr16:57,444,619...57,575,100
Ensembl chr16:57,444,621...57,575,100 		JBrowse link
G Col9a1 collagen, type IX, alpha 1 decreases expression ISO lead acetate results in decreased expression of COL9A1 mRNA CTD PMID:11578147 NCBI chr 1:24,216,670...24,291,819
Ensembl chr 1:24,216,691...24,291,765 		JBrowse link
G Col9a3 collagen, type IX, alpha 3 decreases expression ISO lead acetate results in decreased expression of COL9A3 mRNA CTD PMID:11578147 NCBI chr 2:180,239,895...180,263,985
Ensembl chr 2:180,239,583...180,263,982 		JBrowse link
G Colgalt1 collagen beta(1-O)galactosyltransferase 1 increases expression EXP lead acetate results in increased expression of COLGALT1 mRNA CTD PMID:21829687 NCBI chr 8:72,063,631...72,077,555
Ensembl chr 8:72,063,642...72,077,555 		JBrowse link
G Commd6 COMM domain containing 6 increases expression ISO lead acetate results in increased expression of COMMD6 mRNA CTD PMID:22641619 NCBI chr14:101,871,202...101,877,907
Ensembl chr14:101,870,417...101,878,122 		JBrowse link
G Coprs coordinator of PRMT5, differentiation stimulator increases expression EXP lead acetate results in increased expression of COPRS mRNA CTD PMID:22609695 NCBI chr 8:13,934,787...13,940,501
Ensembl chr 8:13,934,794...13,940,281 		JBrowse link
G Coq5 coenzyme Q5 methyltransferase decreases expression ISO lead acetate results in decreased expression of COQ5 mRNA CTD PMID:38568856 NCBI chr 5:115,417,752...115,435,029
Ensembl chr 5:115,417,725...115,435,031 		JBrowse link
G Cox17 cytochrome c oxidase assembly protein 17, copper chaperone increases expression ISO lead acetate results in increased expression of COX17 mRNA CTD PMID:38568856 NCBI chr16:38,167,332...38,173,125
Ensembl chr16:38,167,353...38,182,659 		JBrowse link
G Cp ceruloplasmin multiple interactions
decreases expression 		ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CP mRNA; [Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of CP protein] CTD PMID:22534743 PMID:39276841 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309 		JBrowse link
G Cpa1 carboxypeptidase A1, pancreatic increases expression EXP lead acetate results in increased expression of CPA1 mRNA CTD PMID:20542052 NCBI chr 6:30,639,217...30,645,360
Ensembl chr 6:30,639,217...30,645,362 		JBrowse link
G Cpa2 carboxypeptidase A2, pancreatic increases expression EXP lead acetate results in increased expression of CPA2 mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 6:30,541,641...30,564,475
Ensembl chr 6:30,541,581...30,564,475 		JBrowse link
G Cpa5 carboxypeptidase A5 increases expression EXP lead acetate results in increased expression of CPA5 mRNA CTD PMID:22609695 NCBI chr 6:30,611,009...30,631,744
Ensembl chr 6:30,611,009...30,631,744 		JBrowse link
G Cpb1 carboxypeptidase B1 increases expression EXP lead acetate results in increased expression of CPB1 mRNA CTD PMID:20542052 NCBI chr 3:20,303,643...20,339,681
Ensembl chr 3:20,302,428...20,329,897 		JBrowse link
G Cpb2 carboxypeptidase B2 increases expression EXP lead acetate results in increased expression of CPB2 mRNA CTD PMID:22609695 NCBI chr14:75,479,727...75,520,995
Ensembl chr14:75,479,727...75,520,995 		JBrowse link
G Cplx4 complexin 4 decreases expression ISO lead acetate results in decreased expression of CPLX4 mRNA CTD PMID:22641619 NCBI chr18:66,088,793...66,103,249
Ensembl chr18:66,088,793...66,103,308 		JBrowse link
G Cpne1 copine I increases expression EXP lead acetate results in increased expression of CPNE1 mRNA CTD PMID:21829687 NCBI chr 2:155,913,765...155,953,847
Ensembl chr 2:155,913,762...155,953,885 		JBrowse link
G Cpne2 copine II decreases expression ISO lead acetate results in decreased expression of CPNE2 mRNA CTD PMID:38568856 NCBI chr 8:95,259,299...95,297,157
Ensembl chr 8:95,259,618...95,297,159 		JBrowse link
G Cpne7 copine VII affects expression ISO lead acetate affects the expression of CPNE7 protein CTD PMID:36539177 NCBI chr 8:123,844,054...123,861,924
Ensembl chr 8:123,844,113...123,861,921 		JBrowse link
G Cpsf3 cleavage and polyadenylation specificity factor 3 decreases expression EXP lead acetate results in decreased expression of CPSF3 mRNA CTD PMID:20542052 NCBI chr12:21,336,298...21,365,057
Ensembl chr12:21,335,392...21,365,057 		JBrowse link
G Cpvl carboxypeptidase, vitellogenic-like decreases expression ISO lead acetate results in decreased expression of CPVL mRNA CTD PMID:38568856 NCBI chr 6:53,850,106...53,955,658
Ensembl chr 6:53,850,264...53,955,656 		JBrowse link
G Crabp1 cellular retinoic acid binding protein I decreases expression
increases expression
decreases methylation 		ISO lead acetate results in decreased expression of CRABP1 mRNA
lead acetate results in increased expression of CRABP1 mRNA
lead acetate results in decreased methylation of CRABP1 gene 		CTD PMID:22641619 PMID:29571894 NCBI chr 9:54,672,032...54,680,394
Ensembl chr 9:54,672,032...54,680,394 		JBrowse link
G Cracdl capping protein inhibiting regulator of actin like decreases expression ISO lead acetate results in decreased expression of KIAA1211L mRNA CTD PMID:38568856 NCBI chr 1:37,650,758...37,758,905
Ensembl chr 1:37,650,758...37,759,166 		JBrowse link
G Crb3 crumbs family member 3 decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of CRB3 mRNA
lead acetate results in increased expression of CRB3 mRNA 		CTD PMID:22609695 PMID:22641619 NCBI chr17:57,368,583...57,372,920
Ensembl chr17:57,366,105...57,372,918 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions
decreases phosphorylation
decreases expression 		ISO
EXP 		[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of CREB1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of CREB1 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CREB1 mRNA]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of CREB1 protein]
lead acetate results in decreased phosphorylation of CREB1 protein
lead acetate results in decreased expression of CREB1 mRNA
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased phosphorylation of CREB1 protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of CREB1 protein; Quercetin inhibits the reaction [lead acetate results in decreased phosphorylation of CREB1 protein] 		CTD PMID:12480136 PMID:23855546 PMID:24260418 PMID:30905827 PMID:32058320 More... NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707 		JBrowse link
G Creb3l2 cAMP responsive element binding protein 3-like 2 increases expression ISO lead acetate results in increased expression of CREB3L2 mRNA CTD PMID:38568856 NCBI chr 6:37,307,956...37,419,083
Ensembl chr 6:37,304,190...37,419,081 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression EXP lead acetate results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr10:80,920,163...80,934,706
Ensembl chr10:80,920,158...80,934,708 		JBrowse link
G Creb5 cAMP responsive element binding protein 5 increases expression EXP lead acetate results in increased expression of CREB5 mRNA CTD PMID:24260418 NCBI chr 6:53,264,154...53,677,349
Ensembl chr 6:53,264,255...53,677,361 		JBrowse link
G Crhr2 corticotropin releasing hormone receptor 2 increases expression EXP lead acetate results in increased expression of CRHR2 mRNA CTD PMID:22613225 NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001 		JBrowse link
G Crip2 cysteine rich protein 2 affects expression ISO lead acetate affects the expression of CRIP2 protein CTD PMID:36539177 NCBI chr12:113,103,856...113,109,126
Ensembl chr12:113,103,856...113,109,126 		JBrowse link
G Crispld1 cysteine-rich secretory protein LCCL domain containing 1 increases expression ISO lead acetate results in increased expression of CRISPLD1 mRNA CTD PMID:22641619 NCBI chr 1:17,797,276...17,840,350
Ensembl chr 1:17,797,269...17,836,568 		JBrowse link
G Crispld2 cysteine-rich secretory protein LCCL domain containing 2 affects expression EXP lead acetate affects the expression of CRISPLD2 mRNA CTD PMID:21829687 NCBI chr 8:120,719,177...120,779,533
Ensembl chr 8:120,719,177...120,779,532 		JBrowse link
G Crkl v-crk avian sarcoma virus CT10 oncogene homolog-like decreases expression EXP lead acetate results in decreased expression of CRKL mRNA CTD PMID:22609695 NCBI chr16:17,269,849...17,305,304
Ensembl chr16:17,269,851...17,305,298 		JBrowse link
G Crnkl1 crooked neck pre-mRNA splicing factor 1 decreases expression EXP lead acetate results in decreased expression of CRNKL1 mRNA CTD PMID:21829687 NCBI chr 2:145,759,402...145,776,620
Ensembl chr 2:145,759,399...145,776,934 		JBrowse link
G Crp C-reactive protein, pentraxin-related multiple interactions
increases secretion 		ISO Curcumin inhibits the reaction [lead acetate results in increased secretion of CRP protein] CTD PMID:21378372 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598 		JBrowse link
G Crx cone-rod homeobox decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of CRX mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of CRX mRNA 		CTD PMID:22641619 PMID:28050121 NCBI chr 7:15,599,872...15,613,880
Ensembl chr 7:15,599,872...15,613,893 		JBrowse link
G Crxos cone-rod homeobox, opposite strand decreases expression EXP lead acetate results in decreased expression of CRXOS mRNA CTD PMID:22609695 NCBI chr 7:15,616,542...15,637,945
Ensembl chr 7:15,616,542...15,637,964 		JBrowse link
G Cryab crystallin, alpha B increases expression EXP
ISO 		lead acetate results in increased expression of CRYAB mRNA CTD PMID:22609695 PMID:37939567 NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936 		JBrowse link
G Cryba1 crystallin, beta A1 increases expression EXP lead acetate results in increased expression of CRYBA1 mRNA CTD PMID:22609695 NCBI chr11:77,609,440...77,616,119
Ensembl chr11:77,609,441...77,616,109 		JBrowse link
G Crybg1 crystallin beta-gamma domain containing 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of CRYBG1 intron CTD PMID:33445541 NCBI chr10:43,826,303...44,024,824
Ensembl chr10:43,826,632...44,024,849 		JBrowse link
G Cryl1 crystallin, lambda 1 decreases expression EXP lead acetate results in decreased expression of CRYL1 mRNA CTD PMID:21829687 NCBI chr14:57,512,491...57,635,940
Ensembl chr14:57,512,450...57,635,986 		JBrowse link
G Cryzl1 crystallin zeta like 1 increases expression EXP lead acetate results in increased expression of CRYZL1 mRNA CTD PMID:25270620 NCBI chr16:91,486,210...91,525,690
Ensembl chr16:91,486,210...91,525,863 		JBrowse link
G Csf1r colony stimulating factor 1 receptor affects expression EXP lead acetate affects the expression of CSF1R mRNA CTD PMID:21829687 NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221 		JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) multiple interactions EXP [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD80 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD86 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of H2 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of ICAM1 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL10 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL6 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of TNF protein CTD PMID:17512567 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493 		JBrowse link
G Csf2ra colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) increases expression EXP lead acetate results in increased expression of CSF2RA mRNA CTD PMID:21829687 NCBI chr19:61,205,629...61,221,141
Ensembl chr19:61,212,395...61,216,867 		JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) increases expression ISO lead acetate results in increased expression of CSF3 mRNA CTD PMID:38568856 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455 		JBrowse link
G Csnk2a2 casein kinase 2, alpha prime polypeptide increases expression EXP lead acetate results in increased expression of CSNK2A2 mRNA CTD PMID:22609695 NCBI chr 8:96,172,724...96,215,505
Ensembl chr 8:96,172,724...96,216,667 		JBrowse link
G Csrp1 cysteine and glycine-rich protein 1 increases expression ISO lead acetate results in increased expression of CSRP1 mRNA CTD PMID:38568856 NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970 		JBrowse link
G Csrp2 cysteine and glycine-rich protein 2 increases expression ISO lead acetate results in increased expression of CSRP2 mRNA CTD PMID:38568856 NCBI chr10:110,756,037...110,775,375
Ensembl chr10:110,755,650...110,775,483 		JBrowse link
G Cth cystathionine gamma lyase decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of CTH protein
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of CTH mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of CTH protein
sodium bisulfide inhibits the reaction [lead acetate results in decreased expression of CTH protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in decreased expression of CTH protein] 		CTD PMID:30980911 PMID:38157908 NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714 		JBrowse link
G Ctnna3 catenin alpha 3 increases expression ISO lead acetate results in increased expression of CTNNA3 mRNA CTD PMID:22641619 NCBI chr10:63,265,877...64,841,174
Ensembl chr10:63,265,877...64,839,446 		JBrowse link
G Ctnnb1 catenin beta 1 increases phosphorylation
increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased phosphorylation of CTNNB1 protein
lead acetate results in increased expression of CTNNB1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased localization of CTNNB1 protein
WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein] 		CTD PMID:24999626 PMID:37436718 PMID:38072110 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573 		JBrowse link
G Ctps1 cytidine 5'-triphosphate synthase 1 decreases expression EXP lead acetate results in decreased expression of CTPS1 mRNA CTD PMID:22613225 NCBI chr 4:120,397,065...120,427,473
Ensembl chr 4:120,397,065...120,427,473 		JBrowse link
G Ctr9 CTR9 homolog, Paf1/RNA polymerase II complex component increases expression EXP lead acetate results in increased expression of CTR9 mRNA CTD PMID:21829687 NCBI chr 7:110,628,158...110,655,584
Ensembl chr 7:110,628,158...110,655,584 		JBrowse link
G Ctrc chymotrypsin C increases expression EXP lead acetate results in increased expression of CTRC mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 4:141,565,550...141,573,598
Ensembl chr 4:141,565,550...141,573,670 		JBrowse link
G Ctrl chymotrypsin-like increases expression EXP lead acetate results in increased expression of CTRB1 mRNA; lead acetate results in increased expression of CTRL mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 8:106,658,626...106,660,494
Ensembl chr 8:106,658,635...106,660,494 		JBrowse link
G Ctsa cathepsin A increases expression EXP
ISO 		lead acetate results in increased expression of CTSA mRNA CTD PMID:11578147 PMID:21829687 NCBI chr 2:164,674,792...164,682,952
Ensembl chr 2:164,674,793...164,682,952 		JBrowse link
G Ctsb cathepsin B multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of CTSB mRNA CTD PMID:39276841 NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372 		JBrowse link
G Ctsc cathepsin C decreases expression ISO lead acetate results in decreased expression of CTSC mRNA CTD PMID:22641619 NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096 		JBrowse link
G Ctsd cathepsin D decreases expression ISO lead acetate results in decreased expression of CTSD mRNA CTD PMID:38568856 NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775 		JBrowse link
G Ctsh cathepsin H increases expression EXP lead acetate results in increased expression of CTSH mRNA CTD PMID:21829687 NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142 		JBrowse link
G Ctsl cathepsin L increases expression ISO lead acetate results in increased expression of CTSL mRNA CTD PMID:38568856 NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704 		JBrowse link
G Ctso cathepsin O increases expression EXP lead acetate results in increased expression of CTSO mRNA CTD PMID:21829687 NCBI chr 3:81,839,908...81,864,032
Ensembl chr 3:81,839,908...81,864,032 		JBrowse link
G Ctsq cathepsin Q increases expression EXP lead acetate results in increased expression of CTSQ mRNA CTD PMID:22609695 NCBI chr13:61,182,852...61,188,411
Ensembl chr13:61,182,838...61,188,445 		JBrowse link
G Ctsz cathepsin Z increases expression EXP lead acetate results in increased expression of CTSZ mRNA CTD PMID:22613225 NCBI chr 2:174,269,287...174,280,832
Ensembl chr 2:174,269,286...174,280,832 		JBrowse link
G Cttn cortactin decreases expression EXP lead acetate results in decreased expression of CTTN mRNA CTD PMID:21829687 NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746 		JBrowse link
G Cux1 cut-like homeobox 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of CUX1 mRNA CTD PMID:33445541 NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344 		JBrowse link
G Cuzd1 CUB and zona pellucida-like domains 1 increases expression EXP lead acetate results in increased expression of CUZD1 mRNA CTD PMID:20542052 NCBI chr 7:130,910,283...130,924,021
Ensembl chr 7:130,910,283...130,924,021 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 increases secretion ISO lead acetate results in increased secretion of CX3CL1 protein CTD PMID:17047031 NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055 		JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 increases expression EXP lead acetate results in increased expression of CX3CR1 mRNA CTD PMID:21829687 NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945 		JBrowse link
G Cxadr coxsackie virus and adenovirus receptor decreases expression ISO lead acetate results in decreased expression of CXADR mRNA CTD PMID:38568856 NCBI chr16:78,098,114...78,156,673
Ensembl chr16:78,098,377...78,156,662 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of CXCL10 mRNA
pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of CXCL10 mRNA] 		CTD PMID:36539177 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748 		JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 multiple interactions
increases expression
increases secretion 		EXP
ISO 		[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of CXCL15 protein]
lead acetate results in increased expression of CXCL8 mRNA
lead acetate results in increased secretion of CXCL8 protein
lead acetate promotes the reaction [Hemagglutinins results in increased secretion of CXCL8 protein] 		CTD PMID:22839698 PMID:24530660 PMID:38568856 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926 		JBrowse link
G Cxcl17 C-X-C motif chemokine ligand 17 decreases expression ISO lead acetate results in decreased expression of CXCL17 mRNA CTD PMID:22641619 NCBI chr 7:25,099,478...25,112,311
Ensembl chr 7:25,099,478...25,112,311 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions
decreases expression
affects expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CXCR4 mRNA
lead acetate results in decreased expression of CXCR4 mRNA
lead acetate affects the expression of CXCR4 mRNA 		CTD PMID:12634122 PMID:21829687 PMID:38568856 NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030 		JBrowse link
G Cyb5b cytochrome b5 type B increases expression EXP lead acetate results in increased expression of CYB5B mRNA CTD PMID:21829687 NCBI chr 8:107,877,293...107,914,102
Ensembl chr 8:107,877,272...107,914,103 		JBrowse link
G Cybb cytochrome b-245, beta polypeptide affects expression
increases expression 		EXP
ISO 		lead acetate affects the expression of CYBB mRNA
lead acetate results in increased expression of CYBB mRNA
lead acetate results in increased expression of CYBB protein 		CTD PMID:15569323 PMID:21829687 PMID:22641619 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010 		JBrowse link
G Cycs cytochrome c, somatic multiple interactions
increases expression 		ISO [[amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] co-treated with [lead acetate results in increased abundance of Lead]] affects the expression of CYCS protein; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (1-40)] affects the expression of CYCS protein; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (25-35)] affects the expression of CYCS protein; [lead acetate results in increased abundance of Lead] which affects the expression of CYCS protein
lead acetate results in increased expression of CYCS mRNA
coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of CYCS mRNA] 		CTD PMID:33856607 PMID:35300571 NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 decreases expression ISO lead acetate results in decreased expression of CYFIP2 mRNA CTD PMID:38568856 NCBI chr11:46,084,676...46,203,686
Ensembl chr11:46,084,677...46,203,686 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 multiple interactions
decreases expression
decreases activity 		ISO
EXP 		[cadmium acetate co-treated with lead acetate] results in decreased expression of CYP11A1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of CYP11A1 mRNA; Glycine inhibits the reaction [lead acetate results in decreased expression of CYP11A1 mRNA]; Taurine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CYP11A1 mRNA]
lead acetate results in decreased expression of CYP11A1 protein
lead acetate results in decreased expression of CYP11A1 mRNA; lead acetate results in decreased expression of CYP11A1 protein
lead acetate results in decreased activity of CYP11A1 protein 		CTD PMID:12647776 PMID:21182167 PMID:22806249 PMID:25270620 PMID:25981801 More... NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 increases expression
decreases expression 		EXP lead acetate results in increased expression of CYP17A1 mRNA
lead acetate results in decreased expression of CYP17A1 mRNA; lead acetate results in decreased expression of CYP17A1 protein 		CTD PMID:21335049 PMID:22806249 NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
decreases expression 		ISO epigallocatechin gallate inhibits the reaction [lead acetate results in decreased expression of CYP19A1 mRNA] CTD PMID:31054310 NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression ISO lead acetate results in increased expression of CYP1A1 mRNA CTD PMID:38568856 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 increases expression ISO lead acetate results in increased expression of CYP1B1 mRNA CTD PMID:22641619 PMID:38568856 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490 		JBrowse link
G Cyp26c1 cytochrome P450, family 26, subfamily c, polypeptide 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of CYP26C1 promoter CTD PMID:33445541 NCBI chr19:37,673,560...37,681,774
Ensembl chr19:37,674,029...37,681,846 		JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression EXP lead acetate results in decreased expression of CYP27A1 mRNA CTD PMID:21829687 NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 decreases expression EXP
ISO 		lead acetate results in decreased expression of CYP27B1 mRNA CTD PMID:22609695 PMID:38568856 NCBI chr10:126,884,115...126,891,897
Ensembl chr10:126,884,119...126,888,875 		JBrowse link
G Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5 increases expression
affects expression 		EXP lead acetate results in increased expression of CYP2A5 mRNA
lead acetate affects the expression of CYP2A5 mRNA 		CTD PMID:26229098 PMID:30623991 NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973 		JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 decreases expression EXP lead acetate results in decreased expression of CYP2B10 mRNA CTD PMID:21829687 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049 		JBrowse link
G Cyp2b9 cytochrome P450, family 2, subfamily b, polypeptide 9 increases expression EXP lead acetate results in increased expression of CYP2B9 mRNA CTD PMID:21335049 NCBI chr 7:25,872,775...25,910,086
Ensembl chr 7:25,872,836...25,910,086 		JBrowse link
G Cyp2c37 cytochrome P450, family 2. subfamily c, polypeptide 37 increases expression EXP lead acetate results in increased expression of CYP2C37 mRNA CTD PMID:20542052 NCBI chr19:39,980,868...40,000,687
Ensembl chr19:39,980,868...40,000,687 		JBrowse link
G Cyp2c68 cytochrome P450, family 2, subfamily c, polypeptide 68 decreases expression EXP lead acetate results in decreased expression of CYP2C68 mRNA CTD PMID:22609695 NCBI chr19:39,677,280...39,729,545
Ensembl chr19:39,677,278...39,729,498 		JBrowse link
G Cyp2d12 cytochrome P450, family 2, subfamily d, polypeptide 12 increases expression EXP lead acetate results in increased expression of CYP2D12 mRNA CTD PMID:22609695 NCBI chr15:82,439,244...82,443,614
Ensembl chr15:82,439,273...82,444,604 		JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 increases expression ISO lead acetate results in increased expression of CYP2R1 mRNA CTD PMID:22641619 NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207 		JBrowse link
G Cyp3a13 cytochrome P450, family 3, subfamily a, polypeptide 13 increases expression ISO lead acetate results in increased expression of CYP3A9 mRNA CTD PMID:22641619 NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881 		JBrowse link
G Cyp3a44 cytochrome P450, family 3, subfamily a, polypeptide 44 increases expression EXP lead acetate results in increased expression of CYP3A44 mRNA CTD PMID:20542052 NCBI chr 5:145,710,793...145,742,701
Ensembl chr 5:145,710,793...145,742,684 		JBrowse link
G Cyp4a14 cytochrome P450, family 4, subfamily a, polypeptide 14 increases expression EXP lead acetate results in increased expression of CYP4A14 mRNA CTD PMID:21335049 NCBI chr 4:115,343,397...115,353,355
Ensembl chr 4:115,343,397...115,353,339 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 decreases expression ISO lead acetate results in decreased expression of CYP4B1 mRNA CTD PMID:38568856 NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920 		JBrowse link
G Cyp4f16 cytochrome P450, family 4, subfamily f, polypeptide 16 decreases expression EXP lead acetate results in decreased expression of CYP4F16 mRNA CTD PMID:21829687 NCBI chr17:32,755,517...32,770,772
Ensembl chr17:32,755,532...32,770,772 		JBrowse link
G Cyp4x1 cytochrome P450, family 4, subfamily x, polypeptide 1 decreases expression ISO lead acetate results in decreased expression of CYP4X1 mRNA CTD PMID:38568856 NCBI chr 4:114,963,518...114,991,276
Ensembl chr 4:114,963,520...114,991,478 		JBrowse link
G D16Ertd472e DNA segment, Chr 16, ERATO Doi 472, expressed increases expression EXP lead acetate results in increased expression of D16ERTD472E mRNA CTD PMID:25270620 NCBI chr16:78,337,224...78,373,576
Ensembl chr16:78,337,226...78,373,596 		JBrowse link
G Dab2 disabled 2, mitogen-responsive phosphoprotein multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA CTD PMID:12634122 NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193 		JBrowse link
G Dao D-amino acid oxidase increases expression ISO
EXP 		lead acetate results in increased expression of DAO mRNA
lead acetate results in increased expression of DAO mRNA; lead acetate results in increased expression of DAO protein 		CTD PMID:11578147 PMID:25242007 NCBI chr 5:114,137,696...114,163,736
Ensembl chr 5:114,141,764...114,163,743 		JBrowse link
G Dapk1 death associated protein kinase 1 increases expression EXP lead acetate results in increased expression of DAPK1 mRNA CTD PMID:21829687 NCBI chr13:60,749,506...60,911,005
Ensembl chr13:60,749,761...60,911,005 		JBrowse link
G Dapk2 death-associated protein kinase 2 decreases expression ISO lead acetate results in decreased expression of DAPK2 mRNA CTD PMID:38568856 NCBI chr 9:66,065,364...66,179,524
Ensembl chr 9:66,065,505...66,179,524 		JBrowse link
G Dapk3 death-associated protein kinase 3 increases expression ISO lead acetate results in increased expression of DAPK3 mRNA CTD PMID:38568856 NCBI chr10:81,018,821...81,029,031
Ensembl chr10:81,018,839...81,029,031 		JBrowse link
G Dapl1 death associated protein-like 1 decreases expression EXP lead acetate results in decreased expression of DAPL1 mRNA CTD PMID:21829687 NCBI chr 2:59,314,997...59,335,364
Ensembl chr 2:59,314,997...59,335,364 		JBrowse link
G Dars1 aspartyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of DARS1 mRNA CTD PMID:11578147 NCBI chr 1:128,291,444...128,345,153
Ensembl chr 1:128,291,444...128,345,105 		JBrowse link
G Dazap1 DAZ associated protein 1 increases expression ISO lead acetate results in increased expression of DAZAP1 mRNA CTD PMID:38568856 NCBI chr10:80,097,168...80,124,242
Ensembl chr10:80,097,320...80,124,242 		JBrowse link
G Dbf4 DBF4 zinc finger decreases expression EXP lead acetate results in decreased expression of DBF4 mRNA CTD PMID:21829687 NCBI chr 5:8,446,969...8,472,789
Ensembl chr 5:8,446,973...8,472,716 		JBrowse link
G Dbn1 drebrin 1 increases expression ISO lead acetate results in increased expression of DBN1 mRNA CTD PMID:11578147 NCBI chr13:55,621,241...55,635,874
Ensembl chr13:55,621,242...55,635,924 		JBrowse link
G Dbndd1 dysbindin domain containing 1 decreases expression ISO lead acetate results in decreased expression of DBNDD1 mRNA CTD PMID:38568856 NCBI chr 8:124,231,744...124,245,535
Ensembl chr 8:124,231,457...124,242,202 		JBrowse link
G Dcaf6 DDB1 and CUL4 associated factor 6 decreases expression ISO lead acetate results in decreased expression of DCAF6 mRNA CTD PMID:38568856 NCBI chr 1:165,157,069...165,288,475
Ensembl chr 1:165,156,267...165,288,044 		JBrowse link
G Dcstamp dendrocyte expressed seven transmembrane protein increases expression EXP lead acetate results in increased expression of DCSTAMP mRNA CTD PMID:20542052 NCBI chr15:39,609,326...39,624,334
Ensembl chr15:39,609,326...39,624,334 		JBrowse link
G Dctn3 dynactin 3 increases expression EXP lead acetate results in increased expression of DCTN3 mRNA CTD PMID:21829687 NCBI chr 4:41,714,798...41,723,213
Ensembl chr 4:41,714,798...41,723,170 		JBrowse link
G Dcun1d1 defective in cullin neddylation 1 domain containing 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of DCUN1D1 mRNA CTD PMID:22839698 NCBI chr 3:35,946,254...35,991,626
Ensembl chr 3:35,946,254...35,991,594 		JBrowse link
G Dcx doublecortin multiple interactions ISO [lead acetate co-treated with sodium arsenite] results in decreased expression of DCX protein CTD PMID:38072110 NCBI chr  X:142,638,838...142,716,392
Ensembl chr  X:142,638,838...142,716,307 		JBrowse link
G Dcxr dicarbonyl L-xylulose reductase increases expression EXP lead acetate results in increased expression of DCXR mRNA CTD PMID:21829687 NCBI chr11:120,615,372...120,618,110
Ensembl chr11:120,616,225...120,618,107 		JBrowse link
G Ddah1 dimethylarginine dimethylaminohydrolase 1 increases expression EXP
ISO 		lead acetate results in increased expression of DDAH1 mRNA CTD PMID:11578147 PMID:20680508 NCBI chr 3:145,464,447...145,600,032
Ensembl chr 3:145,464,430...145,600,032 		JBrowse link
G Ddc dopa decarboxylase decreases expression ISO lead acetate results in decreased expression of DDC mRNA CTD PMID:22641619 NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of DDIT3 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of DDIT3 mRNA
lead acetate results in increased expression of DDIT3 protein 		CTD PMID:22811615 PMID:25270620 PMID:39547369 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157 		JBrowse link
G Ddit4 DNA-damage-inducible transcript 4 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of DDIT4 mRNA
lead acetate results in decreased expression of DDIT4 mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr10:59,785,497...59,787,592
Ensembl chr10:59,785,491...59,787,656 		JBrowse link
G Ddr2 discoidin domain receptor family, member 2 increases expression ISO lead acetate results in increased expression of DDR2 mRNA CTD PMID:22641619 NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331 		JBrowse link
G Ddx23 DEAD box helicase 23 increases expression EXP lead acetate results in increased expression of DDX23 mRNA CTD PMID:22613225 NCBI chr15:98,543,012...98,560,808
Ensembl chr15:98,543,015...98,560,775 		JBrowse link
G Ddx39a DEAD box helicase 39a affects expression EXP lead acetate affects the expression of DDX39A mRNA CTD PMID:21829687 NCBI chr 8:84,441,806...84,453,533
Ensembl chr 8:84,441,806...84,453,521 		JBrowse link
G Ddx39b DEAD box helicase 39b decreases expression EXP lead acetate results in decreased expression of DDX39B mRNA CTD PMID:21829687 NCBI chr17:35,460,722...35,472,683
Ensembl chr17:35,460,722...35,472,683 		JBrowse link
G Ddx3y DEAD box helicase 3, Y-linked decreases expression
increases expression 		EXP lead acetate results in decreased expression of DDX3Y mRNA; lead acetate results in decreased expression of DDX3Y protein
lead acetate results in increased expression of DDX3Y mRNA 		CTD PMID:22609695 PMID:24140753 NCBI chr  Y:1,260,715...1,286,630
Ensembl chr  Y:1,260,771...1,286,629 		JBrowse link
G Ddx54 DEAD box helicase 54 increases expression ISO lead acetate results in increased expression of DDX54 mRNA CTD PMID:38568856 NCBI chr 5:120,751,182...120,766,657
Ensembl chr 5:120,750,804...120,766,657 		JBrowse link
G Dedd2 death effector domain-containing DNA binding protein 2 increases expression EXP lead acetate results in increased expression of DEDD2 mRNA CTD PMID:21829687 NCBI chr 7:24,899,337...24,920,035
Ensembl chr 7:24,899,340...24,920,040 		JBrowse link
G Defa-rs2 defensin, alpha, related sequence 2 increases expression EXP lead acetate results in increased expression of DEFA-RS2 mRNA CTD PMID:22609695
G Defb6 defensin beta 6 increases expression EXP lead acetate results in increased expression of DEFB6 mRNA CTD PMID:22609695 NCBI chr 8:19,275,494...19,278,225
Ensembl chr 8:19,275,494...19,278,225 		JBrowse link
G Dennd3 DENN domain containing 3 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of DENND3 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of DENND3 intron CTD PMID:33445541 NCBI chr15:73,384,333...73,444,091
Ensembl chr15:73,384,409...73,444,091 		JBrowse link
G Denr density-regulated protein increases expression EXP lead acetate results in increased expression of DENR mRNA CTD PMID:20542052 NCBI chr 5:124,045,309...124,066,705
Ensembl chr 5:124,045,238...124,066,898 		JBrowse link
G Depp1 DEPP1 autophagy regulator decreases expression ISO lead acetate results in decreased expression of DEPP1 mRNA CTD PMID:38568856 NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755 		JBrowse link
G Dgcr6 DiGeorge syndrome critical region gene 6 increases expression EXP lead acetate results in increased expression of DGCR6 mRNA CTD PMID:22613225 NCBI chr16:17,870,736...17,889,497
Ensembl chr16:17,870,724...17,889,496 		JBrowse link
G Dgcr8 DGCR8, microprocessor complex subunit decreases expression ISO lead acetate results in decreased expression of DGCR8 mRNA CTD PMID:11578147 NCBI chr16:18,071,812...18,107,115
Ensembl chr16:18,071,812...18,107,110 		JBrowse link
G Dgka diacylglycerol kinase, alpha increases expression ISO lead acetate results in increased expression of DGKA mRNA CTD PMID:11578147 NCBI chr10:128,556,000...128,581,002
Ensembl chr10:128,556,003...128,580,724 		JBrowse link
G Dgki diacylglycerol kinase, iota increases expression ISO lead acetate results in increased expression of DGKI mRNA CTD PMID:37939567 NCBI chr 6:36,814,316...37,281,034
Ensembl chr 6:36,822,957...37,277,119 		JBrowse link
G Dgkz diacylglycerol kinase zeta increases expression ISO lead acetate results in increased expression of DGKZ mRNA CTD PMID:38568856 NCBI chr 2:91,763,167...91,806,788
Ensembl chr 2:91,763,169...91,806,209 		JBrowse link
G Dhcr7 7-dehydrocholesterol reductase multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of DHCR7 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of DHCR7 protein CTD PMID:38157908 NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147 		JBrowse link
G Dhrs3 dehydrogenase/reductase 3 decreases expression
increases expression 		ISO lead acetate results in decreased expression of DHRS3 mRNA
lead acetate results in increased expression of DHRS3 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 4:144,618,712...144,654,214
Ensembl chr 4:144,619,397...144,654,779 		JBrowse link
G Dhrs7 dehydrogenase/reductase 7 increases expression ISO lead acetate results in increased expression of DHRS7 mRNA CTD PMID:38568856 NCBI chr12:72,697,127...72,711,678
Ensembl chr12:72,697,127...72,711,683 		JBrowse link
G Dhtkd1 dehydrogenase E1 and transketolase domain containing 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of DHTKD1 protein CTD PMID:38072110 NCBI chr 2:5,901,030...5,947,648
Ensembl chr 2:5,900,926...5,947,603 		JBrowse link
G Dhx29 DExH-box helicase 29 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of DHX29 mRNA CTD PMID:22839698 NCBI chr13:113,063,976...113,105,968
Ensembl chr13:113,063,988...113,105,966 		JBrowse link
G Dhx58 DExH-box helicase 58 increases expression EXP lead acetate results in increased expression of DHX58 mRNA CTD PMID:22609695 NCBI chr11:100,585,710...100,595,165
Ensembl chr11:100,585,710...100,595,097 		JBrowse link
G Diaph2 diaphanous related formin 2 increases expression EXP lead acetate results in increased expression of DIAPH2 mRNA CTD PMID:21829687 NCBI chr  X:128,650,409...129,366,583
Ensembl chr  X:128,650,491...129,366,583 		JBrowse link
G Dio1 deiodinase, iodothyronine, type I decreases expression EXP lead acetate results in decreased expression of DIO1 mRNA CTD PMID:22609695 NCBI chr 4:107,148,662...107,164,365
Ensembl chr 4:107,148,662...107,164,366 		JBrowse link
G Dio2 deiodinase, iodothyronine, type II increases expression ISO lead acetate results in increased expression of DIO2 mRNA CTD PMID:22641619 NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812 		JBrowse link
G Dio3os deiodinase, iodothyronine type III, opposite strand decreases expression ISO lead acetate results in decreased expression of DIO3OS mRNA CTD PMID:27562236 NCBI chr12:110,241,818...110,244,502
Ensembl chr12:110,241,813...110,244,609 		JBrowse link
G Disc1 disrupted in schizophrenia 1 increases expression ISO lead acetate results in increased expression of DISC1 mRNA CTD PMID:11578147 NCBI chr 8:125,773,928...125,991,882
Ensembl chr 8:125,780,934...125,988,597 		JBrowse link
G Disp3 dispatched RND transporter family member 3 increases expression EXP lead acetate results in increased expression of DISP3 mRNA CTD PMID:20542052 NCBI chr 4:148,320,890...148,372,653
Ensembl chr 4:148,324,721...148,372,422 		JBrowse link
G Dld dihydrolipoamide dehydrogenase decreases expression ISO lead acetate results in decreased expression of DLD protein CTD PMID:25981801 NCBI chr12:31,381,561...31,401,470
Ensembl chr12:31,381,276...31,401,452 		JBrowse link
G Dleu7 deleted in lymphocytic leukemia, 7 increases expression EXP lead acetate results in increased expression of DLEU7 mRNA CTD PMID:20542052 NCBI chr14:62,513,678...62,530,428
Ensembl chr14:62,513,680...62,530,496 		JBrowse link
G Dlg1 discs large MAGUK scaffold protein 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of DLG1 protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of DLG1 protein]; Hemin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of DLG1 protein] CTD PMID:36096218 NCBI chr16:31,482,261...31,692,174
Ensembl chr16:31,482,261...31,693,947 		JBrowse link
G Dlg4 discs large MAGUK scaffold protein 4 multiple interactions
increases expression
affects expression
decreases expression 		EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in decreased expression of DLG4 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of DLG4 protein
lead acetate results in increased expression of DLG4 mRNA
lead acetate affects the expression of DLG4 protein
lead acetate results in decreased expression of DLG4 protein 		CTD PMID:26660114 PMID:27492863 PMID:27984133 NCBI chr11:69,908,029...69,938,107
Ensembl chr11:69,907,768...69,938,348 		JBrowse link
G Dlg5 discs large MAGUK scaffold protein 5 decreases expression EXP
ISO 		lead acetate results in decreased expression of DLG5 mRNA CTD PMID:21829687 PMID:38568856 NCBI chr14:24,184,021...24,295,988
Ensembl chr14:24,184,021...24,295,988 		JBrowse link
G Dlgap2 DLG associated protein 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of DLGAP2 intron CTD PMID:33445541 NCBI chr 8:14,145,793...14,903,426
Ensembl chr 8:14,145,865...14,897,680 		JBrowse link
G Dlk2 delta like non-canonical Notch ligand 2 decreases expression ISO lead acetate results in decreased expression of DLK2 mRNA CTD PMID:38568856 NCBI chr17:46,608,342...46,614,197
Ensembl chr17:46,608,347...46,614,197 		JBrowse link
G Dlx2 distal-less homeobox 2 increases expression EXP
ISO 		lead acetate results in increased expression of DLX2 mRNA CTD PMID:22609695 PMID:38568856 NCBI chr 2:71,373,752...71,377,095
Ensembl chr 2:71,373,752...71,377,098 		JBrowse link
G Dmbt1 deleted in malignant brain tumors 1 increases expression
decreases expression 		EXP lead acetate results in increased expression of DMBT1 mRNA
lead acetate results in decreased expression of DMBT1 mRNA 		CTD PMID:20542052 PMID:22609695 NCBI chr 7:130,633,787...130,723,357
Ensembl chr 7:130,633,776...130,723,357 		JBrowse link
G Dmrt2 doublesex and mab-3 related transcription factor 2 decreases expression EXP lead acetate results in decreased expression of DMRT2 mRNA CTD PMID:21829687 NCBI chr19:25,649,758...25,656,355
Ensembl chr19:25,649,775...25,656,355 		JBrowse link
G Dnah10 dynein, axonemal, heavy chain 10 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of DNAH10 exon CTD PMID:33445541 NCBI chr 5:124,802,149...124,911,372
Ensembl chr 5:124,802,149...124,911,372 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of DNAJA1 protein CTD PMID:38072110 NCBI chr 4:40,722,468...40,734,965
Ensembl chr 4:40,722,150...40,737,149 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of DNAJB1 mRNA
[sodium arsenite co-treated with lead acetate] results in increased expression of DNAJB1 protein 		CTD PMID:21829687 PMID:38072110 NCBI chr 8:84,334,804...84,339,282
Ensembl chr 8:84,334,822...84,339,282 		JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 increases expression ISO lead acetate results in increased expression of DNAJB4 mRNA CTD PMID:38568856 NCBI chr 3:151,887,217...151,915,720
Ensembl chr 3:151,884,148...151,915,939 		JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases expression EXP lead acetate results in decreased expression of DNAJB6 mRNA CTD PMID:22609695 NCBI chr 5:29,940,896...29,991,476
Ensembl chr 5:29,940,686...30,023,132 		JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 decreases expression EXP lead acetate results in decreased expression of DNAJC21 mRNA CTD PMID:21829687 NCBI chr15:10,446,849...10,470,685
Ensembl chr15:10,446,842...10,470,602 		JBrowse link
G Dnase2a deoxyribonuclease II alpha decreases expression EXP lead acetate results in decreased expression of DNASE2A mRNA CTD PMID:20542052 NCBI chr 8:85,635,384...85,638,332
Ensembl chr 8:85,635,189...85,649,544 		JBrowse link
G Dnmt1 DNA methyltransferase 1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased expression of DNMT1 mRNA; lead acetate results in decreased expression of DNMT1 protein
[lead acetate results in increased abundance of Lead] which affects the expression of DNMT1 protein
lead acetate results in increased expression of DNMT1 mRNA; lead acetate results in increased expression of DNMT1 protein 		CTD PMID:21117136 PMID:22160880 PMID:22764079 PMID:23246732 PMID:29481626 NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184 		JBrowse link
G Dnmt3a DNA methyltransferase 3A increases expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of DNMT3A protein
[lead acetate results in increased abundance of Lead] which affects the expression of DNMT3A protein
lead acetate results in decreased expression of DNMT3A protein 		CTD PMID:23246732 PMID:29481626 NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443 		JBrowse link
G Dnmt3l DNA methyltransferase 3-like increases methylation ISO lead acetate results in increased methylation of DNMT3L gene CTD PMID:29571894 NCBI chr10:77,878,121...77,899,456
Ensembl chr10:77,877,781...77,899,456 		JBrowse link
G Dnpep aspartyl aminopeptidase increases expression
decreases expression 		EXP lead acetate results in increased expression of DNPEP mRNA
lead acetate results in decreased expression of DNPEP mRNA 		CTD PMID:21829687 PMID:22609695 PMID:25270620 NCBI chr 1:75,285,209...75,294,648
Ensembl chr 1:75,284,540...75,294,634 		JBrowse link
G Dntt deoxynucleotidyltransferase, terminal decreases expression EXP lead acetate results in decreased expression of DNTT mRNA CTD PMID:22609695 NCBI chr19:41,017,701...41,047,964
Ensembl chr19:41,017,714...41,047,964 		JBrowse link
G Dock1 dedicator of cytokinesis 1 increases expression EXP lead acetate results in increased expression of DOCK1 mRNA CTD PMID:20542052 NCBI chr 7:134,272,416...134,775,376
Ensembl chr 7:134,272,383...134,775,368 		JBrowse link
G Dock4 dedicator of cytokinesis 4 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of DOCK4 intron CTD PMID:33445541 NCBI chr12:40,495,956...40,896,873
Ensembl chr12:40,495,951...40,896,873 		JBrowse link
G Dohh deoxyhypusine hydroxylase/monooxygenase increases expression ISO lead acetate results in increased expression of DOHH mRNA CTD PMID:38568856 NCBI chr10:81,220,268...81,224,186
Ensembl chr10:81,220,262...81,224,186 		JBrowse link
G Dok2 docking protein 2 affects expression EXP lead acetate affects the expression of DOK2 mRNA CTD PMID:21829687 NCBI chr14:71,003,336...71,015,934
Ensembl chr14:71,003,476...71,015,935 		JBrowse link
G Dok3 docking protein 3 increases expression EXP lead acetate results in increased expression of DOK3 mRNA CTD PMID:21829687 NCBI chr13:55,671,044...55,678,158
Ensembl chr13:55,671,044...55,677,109 		JBrowse link
G Dok5 docking protein 5 decreases expression ISO lead acetate results in decreased expression of DOK5 mRNA CTD PMID:37939567 NCBI chr 2:170,573,722...170,721,695
Ensembl chr 2:170,573,727...170,721,689 		JBrowse link
G Dpp4 dipeptidylpeptidase 4 decreases expression EXP lead acetate results in decreased expression of DPP4 mRNA CTD PMID:22609695 NCBI chr 2:62,160,417...62,242,635
Ensembl chr 2:62,160,417...62,242,575 		JBrowse link
G Dppa2 developmental pluripotency associated 2 increases expression EXP lead acetate results in increased expression of DPPA2 mRNA CTD PMID:22609695 NCBI chr16:48,130,637...48,139,876
Ensembl chr16:48,124,271...48,140,086 		JBrowse link
G Dpt dermatopontin decreases expression ISO lead acetate results in decreased expression of DPT mRNA CTD PMID:22641619 NCBI chr 1:164,624,232...164,651,843
Ensembl chr 1:164,624,213...164,651,835 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase decreases expression ISO lead acetate results in decreased expression of DPYD mRNA CTD PMID:38568856 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of DPYSL2 protein
lead acetate results in decreased expression of DPYSL2 mRNA 		CTD PMID:20797405 PMID:38568856 NCBI chr14:67,040,313...67,148,490
Ensembl chr14:67,040,313...67,148,410 		JBrowse link
G Drap1 DR1 associated protein 1 increases expression ISO lead acetate results in increased expression of DRAP1 mRNA CTD PMID:38568856 NCBI chr19:5,472,832...5,475,007
Ensembl chr19:5,472,833...5,475,007 		JBrowse link
G Drd2 dopamine receptor D2 multiple interactions
increases expression 		ISO
EXP 		[lead acetate co-treated with Morphine] results in increased expression of DRD2 mRNA; [lead acetate co-treated with Morphine] results in increased expression of DRD2 protein
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of DRD2 protein
lead acetate results in increased expression of DRD2 mRNA; lead acetate results in increased expression of DRD2 protein 		CTD PMID:23702354 PMID:38157908 NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477 		JBrowse link
G Dsc1 desmocollin 1 decreases expression EXP lead acetate results in decreased expression of DSC1 mRNA CTD PMID:22609695 NCBI chr18:20,216,528...20,247,830
Ensembl chr18:20,217,241...20,247,928 		JBrowse link
G Dsc2 desmocollin 2 decreases expression EXP lead acetate results in decreased expression of DSC2 mRNA CTD PMID:22609695 NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611 		JBrowse link
G Dsg3 desmoglein 3 decreases expression ISO lead acetate results in decreased expression of DSG3 mRNA CTD PMID:38568856 NCBI chr18:20,643,331...20,674,367
Ensembl chr18:20,643,331...20,680,516 		JBrowse link
G Dsp desmoplakin decreases expression ISO lead acetate results in decreased expression of DSP mRNA CTD PMID:22641619 PMID:38568856 NCBI chr13:38,335,357...38,382,553
Ensembl chr13:38,335,270...38,382,553 		JBrowse link
G Dstn destrin multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of DSTN protein CTD PMID:38072110 NCBI chr 2:143,757,251...143,785,244
Ensembl chr 2:143,757,240...143,785,244 		JBrowse link
G Dtwd1 DTW domain containing 1 decreases expression ISO lead acetate results in decreased expression of DTWD1 mRNA CTD PMID:38568856 NCBI chr 2:125,993,981...126,007,197
Ensembl chr 2:125,994,061...126,007,199 		JBrowse link
G Dus1l dihydrouridine synthase 1 like increases expression ISO lead acetate results in increased expression of DUS1L mRNA CTD PMID:38568856 NCBI chr11:120,678,385...120,687,254
Ensembl chr11:120,680,027...120,687,229 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions
increases expression
decreases expression 		ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in increased expression of DUSP1 mRNA
lead acetate results in increased expression of DUSP1 mRNA
lead acetate results in decreased expression of DUSP1 mRNA 		CTD PMID:21829687 PMID:22641619 PMID:36642386 NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102 		JBrowse link
G Dusp10 dual specificity phosphatase 10 increases expression EXP lead acetate results in increased expression of DUSP10 mRNA CTD PMID:33932463 NCBI chr 1:183,766,575...183,807,833
Ensembl chr 1:183,745,499...183,807,833 		JBrowse link
G Dusp12 dual specificity phosphatase 12 decreases expression ISO lead acetate results in decreased expression of DUSP12 mRNA CTD PMID:22641619 NCBI chr 1:170,701,756...170,713,109
Ensembl chr 1:170,701,067...170,713,109 		JBrowse link
G Dusp16 dual specificity phosphatase 16 decreases expression EXP lead acetate results in decreased expression of DUSP16 mRNA CTD PMID:21829687 NCBI chr 6:134,692,431...134,769,687
Ensembl chr 6:134,692,431...134,769,588 		JBrowse link
G Dusp23 dual specificity phosphatase 23 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of DUSP23 mRNA
lead acetate results in decreased expression of DUSP23 mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr 1:172,458,336...172,460,504
Ensembl chr 1:172,458,331...172,460,529 		JBrowse link
G Dusp4 dual specificity phosphatase 4 increases expression ISO lead acetate results in increased expression of DUSP4 mRNA CTD PMID:38568856 NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048 		JBrowse link
G Dvl1 dishevelled segment polarity protein 1 increases expression ISO lead acetate results in increased expression of DVL1 mRNA CTD PMID:38568856 NCBI chr 4:155,931,829...155,943,760
Ensembl chr 4:155,931,859...155,943,760 		JBrowse link
G Dync1li1 dynein cytoplasmic 1 light intermediate chain 1 decreases expression
increases methylation 		ISO lead acetate results in decreased expression of DYNC1LI1 mRNA
lead acetate results in increased methylation of DYNC1LI1 gene 		CTD PMID:29571894 NCBI chr 9:114,517,899...114,552,856
Ensembl chr 9:114,517,858...114,553,370 		JBrowse link
G Dynll2 dynein light chain LC8-type 2 increases expression ISO lead acetate results in increased expression of DYNLL2 mRNA CTD PMID:38568856 NCBI chr11:87,870,351...87,892,746
Ensembl chr11:87,870,351...87,878,359 		JBrowse link
G Ear3 eosinophil-associated, ribonuclease A family, member 3 increases expression EXP lead acetate results in increased expression of EAR3 mRNA CTD PMID:21829687
G Ears2 glutamyl-tRNA synthetase 2, mitochondrial increases expression EXP lead acetate results in increased expression of EARS2 mRNA CTD PMID:22609695 NCBI chr 7:121,633,385...121,666,436
Ensembl chr 7:121,636,436...121,666,486 		JBrowse link
G Ebpl emopamil binding protein-like decreases expression ISO lead acetate results in decreased expression of EBPL mRNA CTD PMID:22641619 NCBI chr14:61,577,212...61,597,894
Ensembl chr14:61,569,191...61,597,888 		JBrowse link
G Ecm1 extracellular matrix protein 1 increases expression ISO lead acetate results in increased expression of ECM1 mRNA CTD PMID:38568856 NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881 		JBrowse link
G Edn2 endothelin 2 decreases expression ISO lead acetate results in decreased expression of EDN2 mRNA CTD PMID:38568856 NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557 		JBrowse link
G Ednrb endothelin receptor type B increases expression ISO lead acetate results in increased expression of EDNRB mRNA CTD PMID:22839698 NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838 		JBrowse link
G Eea1 early endosome antigen 1 decreases methylation ISO lead acetate results in decreased methylation of EEA1 gene CTD PMID:29571894 NCBI chr10:95,776,525...95,881,380
Ensembl chr10:95,776,512...95,881,380 		JBrowse link
G Efcab2 EF-hand calcium binding domain 2 increases expression ISO lead acetate results in increased expression of EFCAB2 mRNA CTD PMID:22641619 NCBI chr 1:178,233,583...178,312,078
Ensembl chr 1:178,233,650...178,312,078 		JBrowse link
G Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1 decreases expression ISO lead acetate results in decreased expression of EFEMP1 mRNA CTD PMID:38568856 NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743 		JBrowse link
G Efna1 ephrin A1 decreases expression ISO lead acetate results in decreased expression of EFNA1 mRNA CTD PMID:38568856 NCBI chr 3:89,179,037...89,188,258
Ensembl chr 3:89,179,040...89,188,449 		JBrowse link
G Efnb2 ephrin B2 increases expression ISO lead acetate results in increased expression of EFNB2 mRNA CTD PMID:38568856 NCBI chr 8:8,667,235...8,711,242
Ensembl chr 8:8,667,434...8,711,242 		JBrowse link
G Egf epidermal growth factor increases expression ISO lead acetate results in increased expression of EGF mRNA CTD PMID:27562236 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression
increases phosphorylation
multiple interactions 		ISO lead acetate results in decreased expression of EGFR protein
lead acetate results in increased phosphorylation of EGFR protein
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of EGFR protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased activity of PRKCA protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased phosphorylation of SRC protein]; RTKI cpd inhibits the reaction [lead acetate results in increased phosphorylation of EGFR protein] 		CTD PMID:17298174 PMID:19133285 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158 		JBrowse link
G Egln1 egl-9 family hypoxia-inducible factor 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EGLN1 mRNA] CTD PMID:38157908 NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 decreases expression
multiple interactions 		EXP lead acetate results in decreased expression of EGLN3 mRNA
[lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EGLN3 mRNA] 		CTD PMID:22609695 PMID:38157908 NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646 		JBrowse link
G Egr1 early growth response 1 decreases expression
increases expression 		ISO lead acetate results in decreased expression of EGR1 mRNA
lead acetate results in increased expression of EGR1 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037 		JBrowse link
G Egr2 early growth response 2 decreases expression
increases methylation 		ISO lead acetate results in decreased expression of EGR2 mRNA
lead acetate results in increased methylation of EGR2 gene 		CTD PMID:22641619 PMID:29571894 NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018 		JBrowse link
G Ehd2 EH-domain containing 2 increases expression EXP lead acetate results in increased expression of EHD2 mRNA CTD PMID:29746905 NCBI chr 7:15,680,883...15,701,402
Ensembl chr 7:15,680,883...15,701,492 		JBrowse link
G Ehf ets homologous factor decreases expression ISO lead acetate results in decreased expression of EHF mRNA CTD PMID:38568856 NCBI chr 2:103,093,776...103,133,620
Ensembl chr 2:103,093,778...103,133,623 		JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked decreases expression EXP lead acetate results in decreased expression of EIF1AX mRNA CTD PMID:21829687 NCBI chr  X:158,155,174...158,172,617
Ensembl chr  X:158,155,174...158,172,924 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of EIF2A protein CTD PMID:38072110 NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 increases expression EXP lead acetate results in increased expression of EIF2AK2 mRNA CTD PMID:20542052 NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases phosphorylation
increases expression
multiple interactions 		ISO lead acetate results in increased phosphorylation of EIF2AK3 protein
lead acetate results in increased expression of EIF2AK3 mRNA
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of EIF2AK3 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of EIF2AK3 mRNA] 		CTD PMID:25088297 PMID:38530053 NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229 		JBrowse link
G Eif2ak4 eukaryotic translation initiation factor 2 alpha kinase 4 decreases expression EXP lead acetate results in decreased expression of EIF2AK4 mRNA CTD PMID:22613225 NCBI chr 2:118,219,065...118,305,715
Ensembl chr 2:118,219,099...118,305,715 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha increases phosphorylation
multiple interactions 		ISO lead acetate results in increased phosphorylation of EIF2S1 protein
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of EIF2S1 protein] 		CTD PMID:25088297 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 decreases expression EXP lead acetate results in decreased expression of EIF4A1 mRNA CTD PMID:21829687 NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249 		JBrowse link
G Eif4e3 eukaryotic translation initiation factor 4E member 3 increases expression EXP lead acetate results in increased expression of EIF4E3 mRNA CTD PMID:22613225 NCBI chr 6:99,599,008...99,669,834
Ensembl chr 6:99,602,096...99,643,732 		JBrowse link
G Eif4g2 eukaryotic translation initiation factor 4, gamma 2 increases expression EXP lead acetate results in increased expression of EIF4G2 mRNA CTD PMID:20542052 NCBI chr 7:110,667,192...110,682,237
Ensembl chr 7:110,666,957...110,682,237 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO lead acetate results in decreased expression of EIF5 mRNA CTD PMID:38568856 NCBI chr12:111,504,535...111,513,187
Ensembl chr12:111,504,450...111,513,186 		JBrowse link
G Elavl4 ELAV like RNA binding protein 4 increases expression EXP lead acetate results in increased expression of ELAVL4 mRNA CTD PMID:24260418 NCBI chr 4:110,060,934...110,209,127
Ensembl chr 4:110,060,919...110,209,106 		JBrowse link
G Elf2 E74-like factor 2 increases expression EXP lead acetate results in increased expression of ELF2 mRNA CTD PMID:22609695 NCBI chr 3:51,160,141...51,248,101
Ensembl chr 3:51,160,141...51,248,084 		JBrowse link
G Elf3 E74-like factor 3 decreases expression ISO lead acetate results in decreased expression of ELF3 mRNA CTD PMID:38568856 NCBI chr 1:135,181,312...135,186,210
Ensembl chr 1:135,181,313...135,186,306 		JBrowse link
G Elf5 E74-like factor 5 decreases expression EXP lead acetate results in decreased expression of ELF5 mRNA CTD PMID:22609695 NCBI chr 2:103,242,443...103,281,334
Ensembl chr 2:103,242,033...103,281,334 		JBrowse link
G Elovl1 ELOVL fatty acid elongase 1 increases expression ISO lead acetate results in increased expression of ELOVL1 mRNA CTD PMID:22641619 NCBI chr 4:118,285,321...118,290,150
Ensembl chr 4:118,285,290...118,290,150 		JBrowse link
G Elp6 elongator acetyltransferase complex subunit 6 affects expression ISO lead acetate affects the expression of ELP6 protein CTD PMID:36539177 NCBI chr 9:110,133,321...110,151,170
Ensembl chr 9:110,134,241...110,151,170 		JBrowse link
G Emcn endomucin decreases expression ISO lead acetate results in decreased expression of EMCN mRNA CTD PMID:22641619 NCBI chr 3:137,046,824...137,136,830
Ensembl chr 3:137,046,828...137,137,946 		JBrowse link
G Emg1 EMG1 N1-specific pseudouridine methyltransferase decreases expression EXP lead acetate results in decreased expression of EMG1 mRNA CTD PMID:21829687 NCBI chr 6:124,681,344...124,689,118
Ensembl chr 6:124,681,048...124,689,141 		JBrowse link
G Eml4 echinoderm microtubule associated protein like 4 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of EML4 mRNA CTD PMID:22839698 NCBI chr17:83,658,341...83,787,790
Ensembl chr17:83,658,360...83,787,790 		JBrowse link
G Emp1 epithelial membrane protein 1 increases expression ISO lead acetate results in increased expression of EMP1 mRNA CTD PMID:38568856 NCBI chr 6:135,339,548...135,360,171
Ensembl chr 6:135,339,543...135,360,171 		JBrowse link
G Endog endonuclease G decreases expression ISO lead acetate results in decreased expression of ENDOG mRNA CTD PMID:37939567 NCBI chr 2:30,061,525...30,064,057
Ensembl chr 2:30,061,505...30,064,081 		JBrowse link
G Eno1 enolase 1, alpha non-neuron increases expression EXP lead acetate results in increased expression of ENO1 protein CTD PMID:20797405 NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336
Ensembl chr18:150,321,178...150,333,336 		JBrowse link
G Eno2 enolase 2, gamma neuronal multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of ENO2 mRNA CTD PMID:38157908 NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636 		JBrowse link
G Eno3 enolase 3, beta muscle increases expression EXP lead acetate results in increased expression of ENO3 mRNA CTD PMID:21829687 NCBI chr11:70,543,973...70,553,339
Ensembl chr11:70,548,028...70,553,339 		JBrowse link
G Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of ENPP1 protein CTD PMID:38157908 NCBI chr10:24,513,812...24,588,057
Ensembl chr10:24,513,812...24,588,057 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 decreases expression ISO lead acetate results in decreased expression of ENPP2 mRNA CTD PMID:21864555 NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288 		JBrowse link
G Enpp6 ectonucleotide pyrophosphatase/phosphodiesterase 6 increases expression ISO lead acetate results in increased expression of ENPP6 mRNA CTD PMID:22641619 NCBI chr 8:47,439,920...47,549,797
Ensembl chr 8:47,439,922...47,549,797 		JBrowse link
G Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 decreases expression ISO lead acetate results in decreased expression of ENTPD2 mRNA CTD PMID:38568856 NCBI chr 2:25,285,886...25,291,335
Ensembl chr 2:25,285,886...25,291,333 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 increases expression EXP lead acetate results in increased expression of ENTPD5 mRNA CTD PMID:21829687 NCBI chr12:84,420,649...84,455,803
Ensembl chr12:84,420,631...84,455,803 		JBrowse link
G Entpd8 ectonucleoside triphosphate diphosphohydrolase 8 increases expression EXP lead acetate results in increased expression of ENTPD8 mRNA CTD PMID:20542052 NCBI chr 2:24,969,308...24,975,731
Ensembl chr 2:24,970,316...24,975,728 		JBrowse link
G Epb41l3 erythrocyte membrane protein band 4.1 like 3 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPB41L3 mRNA CTD PMID:12634122 NCBI chr17:69,382,642...69,596,986
Ensembl chr17:69,382,678...69,596,984 		JBrowse link
G Epcam epithelial cell adhesion molecule decreases expression ISO lead acetate results in decreased expression of EPCAM mRNA CTD PMID:38568856 NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557 		JBrowse link
G Epgn epithelial mitogen increases expression ISO lead acetate results in increased expression of EPGN mRNA CTD PMID:38568856 NCBI chr 5:91,175,376...91,183,071
Ensembl chr 5:91,175,323...91,183,074 		JBrowse link
G Epha2 Eph receptor A2 increases expression ISO lead acetate results in increased expression of EPHA2 mRNA CTD PMID:11578147 NCBI chr 4:141,028,532...141,056,695
Ensembl chr 4:141,028,551...141,056,695 		JBrowse link
G Epha5 Eph receptor A5 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of EPHA5 mRNA CTD PMID:12634122 NCBI chr 5:84,199,024...84,565,677
Ensembl chr 5:84,202,620...84,565,241 		JBrowse link
G Epha8 Eph receptor A8 increases expression ISO lead acetate results in increased expression of EPHA8 mRNA CTD PMID:22641619 NCBI chr 4:136,656,729...136,684,170
Ensembl chr 4:136,656,730...136,684,127 		JBrowse link
G Ephb1 Eph receptor B1 increases expression EXP lead acetate results in increased expression of EPHB1 mRNA CTD PMID:20542052 NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892 		JBrowse link
G Ephb3 Eph receptor B3 decreases expression ISO lead acetate results in decreased expression of EPHB3 mRNA CTD PMID:11578147 NCBI chr16:21,023,530...21,042,054
Ensembl chr16:21,023,505...21,042,055 		JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal increases expression ISO lead acetate results in increased expression of EPHX1 mRNA CTD PMID:38568856 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469 		JBrowse link
G Ephx2 epoxide hydrolase 2, cytoplasmic affects expression ISO lead acetate affects the expression of EPHX2 mRNA CTD PMID:21864555 PMID:22641619 NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949 		JBrowse link
G Epn1 epsin 1 increases expression ISO lead acetate results in increased expression of EPN1 mRNA CTD PMID:38568856 NCBI chr 7:5,083,207...5,101,178
Ensembl chr 7:5,083,234...5,101,177 		JBrowse link
G Eprs1 glutamyl-prolyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of EPRS1 mRNA CTD PMID:11578147 NCBI chr 1:185,093,614...185,160,557
Ensembl chr 1:185,095,241...185,160,557 		JBrowse link
G Epx eosinophil peroxidase decreases expression EXP lead acetate results in decreased expression of EPX mRNA CTD PMID:22609695 NCBI chr11:87,754,824...87,766,362
Ensembl chr11:87,754,826...87,766,362 		JBrowse link
G Eras ES cell-expressed Ras increases expression
decreases expression 		EXP lead acetate results in increased expression of ERAS mRNA
lead acetate results in decreased expression of ERAS mRNA 		CTD PMID:22609695 PMID:25270620 NCBI chr  X:7,790,515...7,794,846
Ensembl chr  X:7,790,515...7,794,846 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERBB3 mRNA CTD PMID:12634122 NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521 		JBrowse link
G Ercc1 excision repair cross-complementing rodent repair deficiency, complementation group 1 decreases expression ISO lead acetate results in decreased expression of ERCC1 mRNA CTD PMID:33862172 NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449 		JBrowse link
G Ercc2 excision repair cross-complementing rodent repair deficiency, complementation group 2 multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC2 mRNA
lead acetate results in increased expression of ERCC2 mRNA 		CTD PMID:12634122 PMID:29746905 NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619 		JBrowse link
G Ercc5 excision repair cross-complementing rodent repair deficiency, complementation group 5 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ERCC5 mRNA CTD PMID:12634122 NCBI chr 1:44,184,084...44,220,399
Ensembl chr 1:44,186,904...44,220,420 		JBrowse link
G Ereg epiregulin increases expression ISO lead acetate results in increased expression of EREG mRNA CTD PMID:38568856 NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505 		JBrowse link
G Eri2 exoribonuclease 2 increases expression ISO lead acetate results in increased expression of ERI2 mRNA CTD PMID:22641619 NCBI chr 7:119,383,049...119,393,283
Ensembl chr 7:119,367,902...119,393,281 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 increases expression
increases phosphorylation
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of ERN1 mRNA
lead acetate results in increased phosphorylation of ERN1 protein
Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of ERN1 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of ERN1 mRNA] 		CTD PMID:21829687 PMID:25088297 PMID:38530053 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678 		JBrowse link
G Errfi1 ERBB receptor feedback inhibitor 1 decreases expression ISO lead acetate results in decreased expression of ERRFI1 mRNA CTD PMID:38568856 NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349 		JBrowse link
G Erv3 endogenous retroviral sequence 3 decreases expression EXP lead acetate results in decreased expression of ERV3 mRNA CTD PMID:22609695 NCBI chr 2:131,695,598...131,701,667
Ensembl chr 2:131,695,598...131,701,667 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 decreases expression ISO lead acetate results in decreased expression of ESM1 mRNA CTD PMID:22641619 NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632 		JBrowse link
G Esrp2 epithelial splicing regulatory protein 2 increases expression EXP lead acetate results in increased expression of ESRP2 mRNA CTD PMID:22609695 NCBI chr 8:106,856,658...106,863,825
Ensembl chr 8:106,856,951...106,863,606 		JBrowse link
G Etf1 eukaryotic translation termination factor 1 increases expression EXP lead acetate results in increased expression of ETF1 mRNA CTD PMID:22609695 NCBI chr18:35,035,838...35,065,060
Ensembl chr18:35,035,838...35,065,060 		JBrowse link
G Etfa electron transferring flavoprotein, alpha polypeptide multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of ETFA protein CTD PMID:38072110 NCBI chr 9:55,361,720...55,419,528
Ensembl chr 9:55,361,792...55,419,527 		JBrowse link
G Etfb electron transferring flavoprotein, beta polypeptide increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of ETFB mRNA
lead acetate results in decreased expression of ETFB mRNA 		CTD PMID:20542052 PMID:22641619 NCBI chr 7:43,093,496...43,107,224
Ensembl chr 7:43,093,507...43,107,224 		JBrowse link
G Etfbkmt electron transfer flavoprotein beta subunit lysine methyltransferase increases expression ISO lead acetate results in increased expression of ETFBKMT mRNA CTD PMID:22641619 NCBI chr 6:149,042,980...149,052,669
Ensembl chr 6:149,041,347...149,052,669 		JBrowse link
G Etnk2 ethanolamine kinase 2 decreases expression ISO lead acetate results in decreased expression of ETNK2 mRNA CTD PMID:38568856 NCBI chr 1:133,291,308...133,308,056
Ensembl chr 1:133,291,310...133,308,074 		JBrowse link
G Ets2 E26 avian leukemia oncogene 2, 3' domain decreases expression ISO lead acetate results in decreased expression of ETS2 mRNA CTD PMID:38568856 NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095 		JBrowse link
G Etv4 ets variant 4 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ETV4 exon CTD PMID:33445541 NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197 		JBrowse link
G Evl Ena-vasodilator stimulated phosphoprotein increases expression ISO lead acetate results in increased expression of EVL mRNA CTD PMID:11578147 NCBI chr12:108,520,942...108,654,775
Ensembl chr12:108,520,979...108,654,775 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 increases expression ISO lead acetate results in increased expression of EYA4 mRNA CTD PMID:22641619 NCBI chr10:22,978,861...23,226,785
Ensembl chr10:22,978,862...23,226,684 		JBrowse link
G F13a1 coagulation factor XIII, A1 subunit increases expression ISO lead acetate results in increased expression of F13A1 mRNA CTD PMID:27562236 NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220 		JBrowse link
G F2r coagulation factor II thrombin receptor decreases expression EXP
ISO 		lead acetate results in decreased expression of F2R mRNA CTD PMID:22613225 PMID:38568856 NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995 		JBrowse link
G F2rl2 coagulation factor II thrombin receptor like 2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of F2RL2 mRNA; lead acetate results in increased expression of F2RL2 protein
F2RL2 protein inhibits the reaction [lead acetate results in increased expression of GFAP mRNA]; F2RL2 protein inhibits the reaction [lead acetate results in increased expression of NES mRNA]; F2RL2 protein promotes the reaction [lead acetate results in increased expression of OLIG2 mRNA] 		CTD PMID:27562236 PMID:37939567 NCBI chr13:95,833,428...95,839,276
Ensembl chr13:95,833,361...95,839,247 		JBrowse link
G F3 coagulation factor III, tissue factor increases expression ISO lead acetate results in increased expression of F3 mRNA CTD PMID:38568856 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697 		JBrowse link
G F5 coagulation factor V affects expression ISO lead acetate affects the expression of F5 mRNA CTD PMID:22641619 NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846 		JBrowse link
G Fa2h fatty acid 2-hydroxylase increases expression EXP lead acetate results in increased expression of FA2H mRNA CTD PMID:20542052 NCBI chr 8:112,071,770...112,120,453
Ensembl chr 8:112,071,767...112,120,456 		JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte decreases expression
increases expression
affects methylation 		EXP
ISO 		lead acetate results in decreased expression of FABP4 mRNA
lead acetate results in increased expression of FABP4 mRNA
lead acetate affects the methylation of FABP4 gene 		CTD PMID:22609695 PMID:29571894 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636 		JBrowse link
G Fabp9 fatty acid binding protein 9, testis increases expression
multiple interactions 		EXP lead acetate results in increased expression of FABP9 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of FABP9 protein 		CTD PMID:22609695 PMID:32142724 NCBI chr 3:10,258,683...10,262,343
Ensembl chr 3:10,258,681...10,262,343 		JBrowse link
G Fads1 fatty acid desaturase 1 increases expression
multiple interactions 		ISO lead acetate results in increased expression of FADS1 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of FADS1 protein 		CTD PMID:38072110 PMID:38568856 NCBI chr19:10,160,245...10,174,238
Ensembl chr19:10,160,252...10,174,241 		JBrowse link
G Fah fumarylacetoacetate hydrolase increases expression ISO lead acetate results in increased expression of FAH mRNA CTD PMID:22641619 NCBI chr 7:84,234,367...84,255,150
Ensembl chr 7:84,234,367...84,255,930 		JBrowse link
G Fam167a family with sequence similarity 167, member A increases expression ISO lead acetate results in increased expression of FAM167A mRNA CTD PMID:38568856 NCBI chr14:63,673,843...63,702,951
Ensembl chr14:63,673,843...63,702,947 		JBrowse link
G Fam185a family with sequence similarity 185, member A decreases expression ISO lead acetate results in decreased expression of FAM185A mRNA CTD PMID:38568856 NCBI chr 5:21,629,861...21,693,269
Ensembl chr 5:21,629,956...21,687,122 		JBrowse link
G Fam20c FAM20C, golgi associated secretory pathway kinase increases expression ISO lead acetate results in increased expression of FAM20C mRNA CTD PMID:38568856 NCBI chr 5:138,740,836...138,795,818
Ensembl chr 5:138,740,269...138,795,832 		JBrowse link
G Fam219a family with sequence similarity 219, member A increases expression ISO lead acetate results in increased expression of FAM219A mRNA CTD PMID:38568856 NCBI chr 4:41,517,691...41,569,538
Ensembl chr 4:41,517,691...41,569,538 		JBrowse link
G Fam81b family with sequence similarity 81, member B decreases expression ISO lead acetate results in decreased expression of FAM81B mRNA CTD PMID:22641619 NCBI chr13:76,349,827...76,427,034
Ensembl chr13:76,349,827...76,453,191 		JBrowse link
G Fam83d family with sequence similarity 83, member D increases expression ISO lead acetate results in increased expression of FAM83D mRNA CTD PMID:22641619 NCBI chr 2:158,610,011...158,628,557
Ensembl chr 2:158,610,013...158,628,557 		JBrowse link
G Fam83h family with sequence similarity 83, member H increases expression ISO lead acetate results in increased expression of FAM83H mRNA CTD PMID:38568856 NCBI chr15:75,872,941...75,886,185
Ensembl chr15:75,872,942...75,886,185 		JBrowse link
G Fam98c family with sequence similarity 98, member C increases expression ISO lead acetate results in increased expression of FAM98C mRNA CTD PMID:38568856 NCBI chr 7:28,851,935...28,855,653
Ensembl chr 7:28,851,935...28,855,659 		JBrowse link
G Fan1 FANCD2/FANCI-associated nuclease 1 increases expression EXP lead acetate results in increased expression of FAN1 mRNA CTD PMID:20542052 NCBI chr 7:63,994,627...64,023,874
Ensembl chr 7:63,996,506...64,023,843 		JBrowse link
G Fanca Fanconi anemia, complementation group A decreases expression EXP lead acetate results in decreased expression of FANCA mRNA CTD PMID:22609695 NCBI chr 8:123,993,033...124,045,390
Ensembl chr 8:123,995,039...124,045,315 		JBrowse link
G Farsa phenylalanyl-tRNA synthetase, alpha subunit decreases expression ISO lead acetate results in decreased expression of FARSA mRNA CTD PMID:11578147 NCBI chr 8:85,583,597...85,595,886
Ensembl chr 8:85,583,618...85,595,886 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate affects the localization of and results in increased activity of FAS protein]; lead acetate affects the localization of and results in increased activity of FAS protein; S-allylcysteine inhibits the reaction [lead acetate affects the localization of and results in increased activity of FAS protein] CTD PMID:22033380 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172 		JBrowse link
G Fasn fatty acid synthase increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of FASN mRNA
lead acetate results in increased expression of FASN protein
SRT1720 inhibits the reaction [lead acetate results in increased expression of FASN protein] 		CTD PMID:30623991 PMID:34842334 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373 		JBrowse link
G Fat1 FAT atypical cadherin 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of FAT1 mRNA CTD PMID:12634122 NCBI chr 8:45,386,137...45,505,294
Ensembl chr 8:45,388,484...45,505,294 		JBrowse link
G Fbl fibrillarin affects localization ISO lead acetate affects the localization of FBL protein CTD PMID:10942594 NCBI chr 7:27,868,293...27,878,701
Ensembl chr 7:27,869,135...27,878,694 		JBrowse link
G Fblim1 filamin binding LIM protein 1 increases expression ISO lead acetate results in increased expression of FBLIM1 mRNA CTD PMID:38568856 NCBI chr 4:141,303,373...141,333,351
Ensembl chr 4:141,303,373...141,333,407 		JBrowse link
G Fbln2 fibulin 2 decreases expression ISO lead acetate results in decreased expression of FBLN2 mRNA CTD PMID:22641619 NCBI chr 6:91,189,442...91,249,522
Ensembl chr 6:91,189,437...91,249,522 		JBrowse link
G Fbn1 fibrillin 1 increases expression EXP lead acetate results in increased expression of FBN1 mRNA CTD PMID:20542052 NCBI chr 2:125,142,514...125,348,417
Ensembl chr 2:125,142,514...125,349,913 		JBrowse link
G Fbxl3 F-box and leucine-rich repeat protein 3 decreases expression EXP lead acetate results in decreased expression of FBXL3 mRNA CTD PMID:22609695 NCBI chr14:103,318,470...103,337,016
Ensembl chr14:103,317,675...103,337,002 		JBrowse link
G Fbxl6 F-box and leucine-rich repeat protein 6 decreases expression EXP lead acetate results in decreased expression of FBXL6 mRNA CTD PMID:21829687 NCBI chr15:76,419,923...76,422,946
Ensembl chr15:76,419,921...76,422,946 		JBrowse link
G Fbxo32 F-box protein 32 increases expression EXP lead acetate results in increased expression of FBXO32 mRNA CTD PMID:20542052 NCBI chr15:58,039,275...58,078,288
Ensembl chr15:58,039,275...58,078,328 		JBrowse link
G Fbxo33 F-box protein 33 increases expression EXP lead acetate results in increased expression of FBXO33 mRNA CTD PMID:21829687 NCBI chr12:59,247,441...59,268,747
Ensembl chr12:59,247,441...59,266,511 		JBrowse link
G Fbxo39 F-box protein 39 increases expression ISO lead acetate results in increased expression of FBXO39 mRNA CTD PMID:38568856 NCBI chr11:72,205,270...72,210,245
Ensembl chr11:72,205,270...72,210,242 		JBrowse link
G Fbxo45 F-box protein 45 increases expression ISO lead acetate results in increased expression of FBXO45 mRNA CTD PMID:38568856 NCBI chr16:32,048,930...32,065,843
Ensembl chr16:32,048,930...32,065,976 		JBrowse link
G Fbxo6 F-box protein 6 affects expression ISO lead acetate affects the expression of FBXO6 protein CTD PMID:36539177 NCBI chr 4:148,230,173...148,236,592
Ensembl chr 4:148,230,173...148,236,597 		JBrowse link
G Fbxo9 F-box protein 9 decreases expression ISO lead acetate results in decreased expression of FBXO9 mRNA CTD PMID:38568856 NCBI chr 9:77,988,781...78,016,347
Ensembl chr 9:77,988,781...78,016,347 		JBrowse link
G Fbxw13 F-box and WD-40 domain protein 13 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FBXW12 mRNA CTD PMID:22839698 NCBI chr 9:109,008,295...109,025,043
Ensembl chr 9:109,008,295...109,025,043 		JBrowse link
G Fcer2a Fc receptor, IgE, low affinity II, alpha polypeptide increases expression EXP lead acetate results in increased expression of FCER2A mRNA CTD PMID:21829687 NCBI chr 8:3,730,280...3,744,174
Ensembl chr 8:3,731,737...3,744,175 		JBrowse link
G Fcgr4 Fc receptor, IgG, low affinity IV decreases expression EXP lead acetate results in decreased expression of FCGR4 mRNA CTD PMID:21829687 NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330 		JBrowse link
G Fcgrt Fc fragment of IgG receptor and transporter decreases expression EXP lead acetate results in decreased expression of FCGRT mRNA CTD PMID:21829687 NCBI chr 7:44,742,417...44,753,246
Ensembl chr 7:44,742,414...44,753,275 		JBrowse link
G Fcrl2 Fc receptor like 2 decreases expression ISO lead acetate results in decreased expression of FCRL2 mRNA CTD PMID:22641619 NCBI chr 3:87,158,318...87,171,046
Ensembl chr 3:87,158,065...87,171,045 		JBrowse link
G Fermt1 fermitin family member 1 decreases expression ISO lead acetate results in decreased expression of FERMT1 mRNA CTD PMID:22641619 NCBI chr 2:132,746,097...132,787,956
Ensembl chr 2:132,746,309...132,787,826 		JBrowse link
G Fga fibrinogen alpha chain decreases expression EXP lead acetate results in decreased expression of FGA mRNA CTD PMID:25270620 NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934 		JBrowse link
G Fgb fibrinogen beta chain decreases expression EXP lead acetate results in decreased expression of FGB mRNA CTD PMID:25270620 NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170 		JBrowse link
G Fgf1 fibroblast growth factor 1 affects expression ISO lead acetate affects the expression of FGF1 mRNA CTD PMID:21864555 NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525 		JBrowse link
G Fgf18 fibroblast growth factor 18 decreases expression EXP lead acetate results in decreased expression of FGF18 mRNA CTD PMID:22609695 NCBI chr11:33,066,970...33,097,400
Ensembl chr11:33,067,430...33,097,400 		JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression
increases expression 		ISO lead acetate results in decreased expression of FGF2 mRNA
lead acetate results in increased expression of FGF2 mRNA 		CTD PMID:22160880 PMID:38568856 NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257 		JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression EXP lead acetate results in increased expression of FGF21 mRNA CTD PMID:22609695 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914 		JBrowse link
G Fgfbp1 fibroblast growth factor binding protein 1 decreases expression ISO lead acetate results in decreased expression of FGFBP1 mRNA CTD PMID:38568856 NCBI chr 5:44,136,200...44,139,173
Ensembl chr 5:44,136,200...44,139,121 		JBrowse link
G Fgfr1 fibroblast growth factor receptor 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA CTD PMID:22839698 NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734 		JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 decreases expression EXP lead acetate results in decreased expression of FGFR4 mRNA CTD PMID:22609695 NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572 		JBrowse link
G Fgfrl1 fibroblast growth factor receptor-like 1 increases expression ISO lead acetate results in increased expression of FGFRL1 mRNA CTD PMID:38568856 NCBI chr 5:108,842,051...108,854,816
Ensembl chr 5:108,840,248...108,854,790 		JBrowse link
G Fgg fibrinogen gamma chain decreases expression EXP lead acetate results in decreased expression of FGG mRNA CTD PMID:25270620 NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356 		JBrowse link
G Fgl1 fibrinogen-like protein 1 decreases expression ISO lead acetate results in decreased expression of FGL1 mRNA CTD PMID:38568856 NCBI chr 8:41,644,471...41,671,015
Ensembl chr 8:41,644,471...41,668,193 		JBrowse link
G Fhip1a FHF complex subunit HOOK interacting protein 1A decreases expression ISO lead acetate results in decreased expression of FHIP1A mRNA CTD PMID:22641619 NCBI chr 3:85,567,370...85,653,516
Ensembl chr 3:85,567,368...85,724,598 		JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression ISO lead acetate results in increased expression of FHL2 mRNA CTD PMID:38568856 NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144 		JBrowse link
G Fibin fin bud initiation factor homolog (zebrafish) decreases expression ISO lead acetate results in decreased expression of FIBIN mRNA CTD PMID:38568856 NCBI chr 2:110,191,270...110,193,338
Ensembl chr 2:110,191,262...110,193,528 		JBrowse link
G Fkbp5 FK506 binding protein 5 increases expression
increases methylation 		ISO lead acetate results in increased expression of FKBP5 mRNA
lead acetate results in increased methylation of FKBP5 gene 		CTD PMID:22641619 PMID:29571894 NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501 		JBrowse link
G Flg2 filaggrin family member 2 decreases expression ISO lead acetate results in decreased expression of FLG2 mRNA CTD PMID:22641619 NCBI chr 3:93,104,585...93,128,701
Ensembl chr 3:93,104,585...93,128,698 		JBrowse link
G Flna filamin, alpha increases expression ISO lead acetate results in increased expression of FLNA mRNA CTD PMID:38568856 NCBI chr  X:73,267,067...73,293,787
Ensembl chr  X:73,267,067...73,293,426 		JBrowse link
G Flrt2 fibronectin leucine rich transmembrane protein 2 increases expression ISO lead acetate results in increased expression of FLRT2 mRNA CTD PMID:38568856 NCBI chr12:95,658,780...95,751,989
Ensembl chr12:95,659,000...95,751,989 		JBrowse link
G Flt4 FMS-like tyrosine kinase 4 increases expression ISO lead acetate results in increased expression of FLT4 mRNA CTD PMID:11578147 NCBI chr11:49,500,506...49,543,566
Ensembl chr11:49,500,090...49,543,566 		JBrowse link
G Fmnl3 formin-like 3 decreases expression EXP lead acetate results in decreased expression of FMNL3 mRNA CTD PMID:22609695 NCBI chr15:99,215,091...99,268,375
Ensembl chr15:99,215,106...99,268,363 		JBrowse link
G Fmo2 flavin containing monooxygenase 2 decreases expression EXP lead acetate results in decreased expression of FMO2 mRNA CTD PMID:29746905 NCBI chr 1:162,701,886...162,726,327
Ensembl chr 1:162,701,886...162,726,295 		JBrowse link
G Fmo5 flavin containing monooxygenase 5 decreases expression EXP lead acetate results in decreased expression of FMO5 mRNA CTD PMID:25270620 NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598 		JBrowse link
G Fmr1 fragile X messenger ribonucleoprotein 1 increases methylation ISO lead acetate results in increased methylation of FMR1 gene CTD PMID:29571894 NCBI chr  X:67,722,144...67,761,569
Ensembl chr  X:67,722,147...67,761,569 		JBrowse link
G Fn1 fibronectin 1 increases expression ISO lead acetate results in increased expression of FN1 mRNA CTD PMID:22641619 PMID:38568856 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359 		JBrowse link
G Fndc3a fibronectin type III domain containing 3A increases expression EXP lead acetate results in increased expression of FNDC3A mRNA CTD PMID:22609695 NCBI chr14:72,775,388...72,948,141
Ensembl chr14:72,775,386...72,947,443 		JBrowse link
G Folh1 folate hydrolase 1 increases methylation ISO lead acetate results in increased methylation of FOLH1 gene CTD PMID:29571894 NCBI chr 7:86,365,733...86,425,171
Ensembl chr 7:86,368,185...86,425,151 		JBrowse link
G Folr1 folate receptor alpha affects expression ISO lead acetate affects the expression of FOLR1 mRNA CTD PMID:21864555 PMID:22641619 NCBI chr 7:101,507,551...101,519,974
Ensembl chr 7:101,507,538...101,519,995 		JBrowse link
G Fos FBJ osteosarcoma oncogene multiple interactions
decreases expression
increases expression 		ISO
EXP 		lead acetate affects the reaction [Amphetamine results in increased expression of FOS protein]; lead acetate inhibits the reaction [HSPA5 protein binds to FOS enhancer]
lead acetate results in decreased expression of FOS mRNA
lead acetate results in increased expression of FOS protein 		CTD PMID:15111246 PMID:15111640 PMID:21829687 PMID:22641619 PMID:33862172 More... NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047 		JBrowse link
G Fosl1 fos-like antigen 1 multiple interactions
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of FOSL1 mRNA
lead acetate results in increased expression of FOSL1 mRNA 		CTD PMID:12634122 PMID:38568856 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974 		JBrowse link
G Foxd4 forkhead box D4 increases expression EXP lead acetate results in increased expression of FOXD4 mRNA CTD PMID:22609695 NCBI chr19:24,876,307...24,878,380
Ensembl chr19:24,876,600...24,878,561 		JBrowse link
G Foxo1 forkhead box O1 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of FOXO1 mRNA
sinapinic acid affects the reaction [lead acetate results in decreased expression of FOXO1 mRNA] 		CTD PMID:38530053 NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642 		JBrowse link
G Foxp2 forkhead box P2 decreases expression EXP lead acetate results in decreased expression of FOXP2 mRNA CTD PMID:22613225 NCBI chr 6:14,901,348...15,441,976
Ensembl chr 6:14,901,348...15,441,976 		JBrowse link
G Foxp3 forkhead box P3 increases expression EXP
ISO 		lead acetate results in increased expression of FOXP3 mRNA
lead acetate results in increased expression of FOXP3 protein 		CTD PMID:20542052 PMID:23058909 NCBI chr  X:7,445,915...7,461,482
Ensembl chr  X:7,439,883...7,461,484 		JBrowse link
G Foxp4 forkhead box P4 increases expression ISO lead acetate results in increased expression of FOXP4 mRNA CTD PMID:38568856 NCBI chr17:48,178,058...48,235,401
Ensembl chr17:48,178,058...48,235,570 		JBrowse link
G Frem2 Fras1 related extracellular matrix protein 2 increases expression EXP lead acetate results in increased expression of FREM2 mRNA CTD PMID:20542052 NCBI chr 3:53,421,359...53,566,014
Ensembl chr 3:53,421,359...53,564,776 		JBrowse link
G Frk fyn-related kinase increases expression ISO lead acetate results in increased expression of FRK mRNA CTD PMID:11578147 NCBI chr10:34,359,396...34,487,530
Ensembl chr10:34,359,395...34,487,274 		JBrowse link
G Frmd3 FERM domain containing 3 decreases expression EXP lead acetate results in decreased expression of FRMD3 mRNA CTD PMID:22613225 NCBI chr 4:73,931,454...74,120,451
Ensembl chr 4:73,931,679...74,120,451 		JBrowse link
G Frmd4b FERM domain containing 4B decreases expression EXP lead acetate results in decreased expression of FRMD4B mRNA CTD PMID:22609695 NCBI chr 6:97,263,828...97,594,618
Ensembl chr 6:97,263,828...97,594,502 		JBrowse link
G Fry FRY microtubule binding protein increases expression EXP lead acetate results in increased expression of FRY mRNA CTD PMID:21829687 NCBI chr 5:150,042,083...150,421,218
Ensembl chr 5:150,042,110...150,421,218 		JBrowse link
G Fshb follicle stimulating hormone beta decreases secretion
multiple interactions 		ISO lead acetate results in decreased secretion of FSHB protein
Cholecalciferol inhibits the reaction [lead acetate results in decreased secretion of FSHB protein] 		CTD PMID:34051273 NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001 		JBrowse link
G Fstl3 follistatin-like 3 increases expression ISO lead acetate results in increased expression of FSTL3 mRNA CTD PMID:38568856 NCBI chr10:79,613,108...79,618,464
Ensembl chr10:79,613,106...79,618,464 		JBrowse link
G Fth1 ferritin heavy polypeptide 1 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of FTH1 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of FTH1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of FTH1 protein; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of FTH1 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of FTH1 protein]; ferrostatin-1 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of FTH1 mRNA] 		CTD PMID:20542052 PMID:37939567 PMID:38568856 PMID:39276841 NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462 		JBrowse link
G Ftl1 ferritin light polypeptide 1 increases expression ISO lead acetate results in increased expression of FTL mRNA CTD PMID:11578147 PMID:27562236 PMID:37939567 PMID:38568856 NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308 		JBrowse link
G Fut4 fucosyltransferase 4 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of FUT4 mRNA CTD PMID:22839698 NCBI chr 9:14,659,755...14,663,418
Ensembl chr 9:14,659,616...14,663,689 		JBrowse link
G Fxn frataxin multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of FXN mRNA CTD PMID:39276841 NCBI chr19:24,236,909...24,257,954
Ensembl chr19:24,238,817...24,257,969 		JBrowse link
G Fxr2 FMR1 autosomal homolog 2 increases expression ISO lead acetate results in increased expression of FXR2 mRNA CTD PMID:38568856 NCBI chr11:69,523,788...69,544,123
Ensembl chr11:69,523,816...69,544,123 		JBrowse link
G Fyb2 FYN binding protein 2 decreases expression ISO lead acetate results in decreased expression of FYB2 mRNA CTD PMID:22641619 NCBI chr 4:104,692,431...104,874,061
Ensembl chr 4:104,770,653...104,874,060 		JBrowse link
G Fyn Fyn proto-oncogene multiple interactions
increases activity 		ISO FYN protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]
lead acetate results in increased activity of FYN protein 		CTD PMID:17298174 NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377 		JBrowse link
G Fzd10 frizzled class receptor 10 multiple interactions EXP [lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FZD10 mRNA] CTD PMID:38157908 NCBI chr 5:128,678,170...128,681,157
Ensembl chr 5:128,677,908...128,681,157 		JBrowse link
G Fzd2 frizzled class receptor 2 decreases expression ISO lead acetate results in decreased expression of FZD2 mRNA CTD PMID:37939567 NCBI chr11:102,495,257...102,498,884
Ensembl chr11:102,495,222...102,498,884 		JBrowse link
G Fzd8 frizzled class receptor 8 decreases expression ISO lead acetate results in decreased expression of FZD8 mRNA CTD PMID:37939567 NCBI chr18:9,212,856...9,216,201
Ensembl chr18:9,212,163...9,218,136 		JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked increases expression
decreases activity
multiple interactions 		ISO lead acetate results in increased expression of G6PD mRNA
lead acetate results in decreased activity of G6PD protein
[naringenin co-treated with lead acetate] results in decreased activity of G6PD protein 		CTD PMID:25228019 PMID:30980912 PMID:37939567 PMID:38568856 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800 		JBrowse link
G Gaa glucosidase, alpha, acid increases expression ISO lead acetate results in increased expression of GAA mRNA CTD PMID:11578147 NCBI chr11:119,158,789...119,176,284
Ensembl chr11:119,158,713...119,176,280 		JBrowse link
G Gab2 growth factor receptor bound protein 2-associated protein 2 increases expression EXP lead acetate results in increased expression of GAB2 mRNA CTD PMID:20542052 NCBI chr 7:96,730,958...96,958,158
Ensembl chr 7:96,730,793...96,958,153 		JBrowse link
G Gabarapl2 GABA type A receptor associated protein like 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of GABARAPL2 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of GABARAPL2 protein CTD PMID:38072110 NCBI chr 8:112,667,335...112,679,547
Ensembl chr 8:112,667,335...112,680,244 		JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta decreases expression ISO lead acetate results in decreased expression of GABRQ mRNA CTD PMID:22641619 NCBI chr  X:71,868,769...71,886,213
Ensembl chr  X:71,868,784...71,886,208 		JBrowse link
G Gabrr1 gamma-aminobutyric acid type A receptor subunit rho 1 decreases expression ISO lead acetate results in decreased expression of GABRR1 mRNA CTD PMID:22641619 NCBI chr 4:33,132,556...33,163,606
Ensembl chr 4:33,132,521...33,163,588 		JBrowse link
G Gad2 glutamic acid decarboxylase 2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of GAD2 protein CTD PMID:31785328 NCBI chr 2:22,512,262...22,583,889
Ensembl chr 2:22,512,217...22,583,886 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha increases expression ISO lead acetate results in increased expression of GADD45A mRNA CTD PMID:38568856 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible 45 gamma increases methylation ISO lead acetate results in increased methylation of GADD45G gene CTD PMID:29571894 NCBI chr13:52,000,711...52,002,511
Ensembl chr13:52,000,714...52,002,504 		JBrowse link
G Galns galactosamine (N-acetyl)-6-sulfatase decreases expression EXP lead acetate results in decreased expression of GALNS mRNA CTD PMID:21829687 NCBI chr 8:123,304,976...123,338,226
Ensembl chr 8:123,304,981...123,338,202 		JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 decreases expression ISO lead acetate results in decreased expression of GALNT15 mRNA CTD PMID:38568856 NCBI chr14:31,750,739...31,784,161
Ensembl chr14:31,750,946...31,784,154 		JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of GALNT2 mRNA; [lead acetate results in increased abundance of Lead] which results in increased methylation of GALNT2 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of GALNT2 promoter CTD PMID:33445541 NCBI chr 8:124,958,133...125,072,461
Ensembl chr 8:124,958,130...125,072,463 		JBrowse link
G Galnt9 polypeptide N-acetylgalactosaminyltransferase 9 increases methylation ISO lead acetate results in increased methylation of GALNT9 gene CTD PMID:29571894 NCBI chr 5:110,692,217...110,769,244
Ensembl chr 5:110,692,221...110,769,246 		JBrowse link
G Galr1 galanin receptor 1 decreases expression ISO
EXP 		lead acetate results in decreased expression of GALR1 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr18:82,410,621...82,424,902
Ensembl chr18:82,410,505...82,424,902 		JBrowse link
G Galr2 galanin receptor 2 increases expression EXP lead acetate results in increased expression of GALR2 mRNA CTD PMID:22609695 NCBI chr11:116,170,520...116,174,776
Ensembl chr11:116,171,765...116,174,764 		JBrowse link
G Gap43 growth associated protein 43 multiple interactions ISO [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of GAP43 protein CTD PMID:31843630 NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression EXP lead acetate results in increased expression of GAPDH protein CTD PMID:20797405 NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430 		JBrowse link
G Gast gastrin increases expression
multiple interactions 		ISO lead acetate results in increased expression of GAST mRNA; lead acetate results in increased expression of GAST protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of GAST mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased expression of GAST mRNA]; RTKI cpd inhibits the reaction [lead acetate results in increased expression of GAST mRNA] 		CTD PMID:23765435 NCBI chr11:100,225,233...100,227,823
Ensembl chr11:100,225,233...100,227,822 		JBrowse link
G Gata2 GATA binding protein 2 decreases expression EXP lead acetate results in decreased expression of GATA2 mRNA CTD PMID:21829687 NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014 		JBrowse link
G Gata3 GATA binding protein 3 decreases expression EXP lead acetate results in decreased expression of GATA3 mRNA CTD PMID:22613225 NCBI chr 2:9,861,889...9,894,845
Ensembl chr 2:9,861,889...9,894,845 		JBrowse link
G Gata6 GATA binding protein 6 multiple interactions
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GATA6 mRNA
lead acetate results in increased expression of GATA6 mRNA 		CTD PMID:12634122 PMID:38568856 NCBI chr18:11,052,510...11,085,636
Ensembl chr18:11,052,064...11,085,635 		JBrowse link
G Gatm glycine amidinotransferase (L-arginine:glycine amidinotransferase) decreases expression EXP lead acetate results in decreased expression of GATM mRNA CTD PMID:20542052 NCBI chr 2:122,424,954...122,441,758
Ensembl chr 2:122,424,948...122,441,784 		JBrowse link
G Gbp2b guanylate binding protein 2b increases expression ISO lead acetate results in increased expression of GBP1 mRNA CTD PMID:38568856 NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940 		JBrowse link
G Gbp8 guanylate-binding protein 8 increases expression EXP lead acetate results in increased expression of GBP8 mRNA CTD PMID:20542052 NCBI chr 5:105,160,379...105,201,475
Ensembl chr 5:105,162,016...105,287,406 		JBrowse link
G Gbp9 guanylate-binding protein 9 increases expression EXP lead acetate results in increased expression of GBP6 mRNA CTD PMID:22609695 NCBI chr 5:105,224,331...105,258,255
Ensembl chr 5:105,225,496...105,287,405 		JBrowse link
G Gbx2 gastrulation brain homeobox 2 decreases expression EXP lead acetate results in decreased expression of GBX2 mRNA CTD PMID:22613225 PMID:25270620 NCBI chr 1:89,855,684...89,858,898
Ensembl chr 1:89,855,678...89,858,901 		JBrowse link
G Gc vitamin D binding protein increases expression ISO lead acetate results in increased expression of GC mRNA CTD PMID:22641619 NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757 		JBrowse link
G Gch1 GTP cyclohydrolase 1 decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of GCH1 mRNA
lead acetate results in increased expression of GCH1 mRNA 		CTD PMID:22641619 PMID:25270620 NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions
increases expression 		ISO [[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of GCLC mRNA; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLC mRNA]
[lead acetate results in increased abundance of Lead] which results in increased expression of GCLC mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of GCLC mRNA; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of CDH1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ACTA2 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CDH2 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of CHD2 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein] 		CTD PMID:26498409 PMID:37939567 PMID:38568856 PMID:39032614 PMID:39276841 More... NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767 		JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of GCLM mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of GCLM mRNA
NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA] 		CTD PMID:25270620 PMID:26498409 PMID:37939567 PMID:38568856 PMID:39276841 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381 		JBrowse link
G Gcnt1 glucosaminyl (N-acetyl) transferase 1, core 2 increases expression ISO lead acetate results in increased expression of GCNT1 mRNA CTD PMID:38568856 NCBI chr19:17,303,505...17,350,208
Ensembl chr19:17,303,505...17,350,208 		JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression EXP lead acetate results in increased expression of GCNT3 mRNA CTD PMID:21829687 NCBI chr 9:69,938,777...69,947,172
Ensembl chr 9:69,938,778...69,945,370 		JBrowse link
G Gcnt4 glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase) increases expression ISO lead acetate results in increased expression of GCNT4 mRNA CTD PMID:22641619 NCBI chr13:97,060,852...97,087,422
Ensembl chr13:97,061,197...97,087,414 		JBrowse link
G Gdap2 ganglioside-induced differentiation-associated-protein 2 decreases expression EXP lead acetate results in decreased expression of GDAP2 mRNA CTD PMID:21829687 NCBI chr 3:100,069,843...100,117,909
Ensembl chr 3:100,069,697...100,114,297 		JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GDF15 mRNA
lead acetate results in increased expression of GDF15 mRNA 		CTD PMID:12634122 PMID:38568856 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106 		JBrowse link
G Gdf2 growth differentiation factor 2 increases expression EXP lead acetate results in increased expression of GDF2 mRNA CTD PMID:22609695 NCBI chr14:33,662,996...33,669,155
Ensembl chr14:33,662,996...33,669,155 		JBrowse link
G Gdf5 growth differentiation factor 5 increases expression EXP lead acetate results in increased expression of GDF5 mRNA CTD PMID:22609695 NCBI chr 2:155,782,943...155,787,204
Ensembl chr 2:155,782,943...155,787,287 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
increases expression
decreases expression 		ISO
EXP 		[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in decreased expression of GFAP protein; [lead acetate co-treated with Morphine] results in increased expression of GFAP mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of GFAP protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP mRNA; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP protein; CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GFAP protein]
lead acetate results in increased expression of GFAP mRNA; lead acetate results in increased expression of GFAP protein
lead acetate results in decreased expression of GFAP protein
[lead acetate results in increased abundance of Lead] which results in increased expression of GFAP protein; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of GFAP mRNA]
F2RL2 protein inhibits the reaction [lead acetate results in increased expression of GFAP mRNA]; PANX2 protein inhibits the reaction [lead acetate results in increased expression of GFAP mRNA] 		CTD PMID:17047031 PMID:20829427 PMID:21322097 PMID:24481447 PMID:25028260 More... NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738 		JBrowse link
G Ggct gamma-glutamyl cyclotransferase increases expression EXP lead acetate results in increased expression of GGCT mRNA CTD PMID:22609695 NCBI chr 6:54,962,080...54,969,947
Ensembl chr 6:54,959,565...54,969,935 		JBrowse link
G Ggh gamma-glutamyl hydrolase increases expression ISO lead acetate results in increased expression of GGH mRNA CTD PMID:38568856 NCBI chr 4:20,041,963...20,066,111
Ensembl chr 4:20,042,052...20,066,750 		JBrowse link
G Ggt5 gamma-glutamyltransferase 5 decreases expression ISO lead acetate results in decreased expression of GGT5 mRNA CTD PMID:38568856 NCBI chr10:75,425,161...75,453,034
Ensembl chr10:75,425,174...75,453,034 		JBrowse link
G Ghitm growth hormone inducible transmembrane protein increases expression EXP lead acetate results in increased expression of GHITM mRNA CTD PMID:25270620 NCBI chr14:36,842,401...36,857,279
Ensembl chr14:36,842,049...36,857,229 		JBrowse link
G Gimap7 GTPase, IMAP family member 7 increases expression EXP lead acetate results in increased expression of GIMAP7 mRNA CTD PMID:21829687 NCBI chr 6:48,695,555...48,701,570
Ensembl chr 6:48,695,555...48,701,570 		JBrowse link
G Gja1 gap junction protein, alpha 1 increases expression
increases uptake
decreases expression
multiple interactions 		ISO lead acetate results in increased expression of GJA1 protein
GJA1 protein results in increased uptake of lead acetate
lead acetate results in decreased expression of GJA1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of GJA1 protein]; 3-methyladenine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GJA1 protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of and affects the localization of GJA1 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of GJA1 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of GJA1 mRNA; Dasatinib promotes the reaction [lead acetate results in decreased expression of GJA1 protein]; GJA1 protein inhibits the reaction [Carbenoxolone results in decreased uptake of lead acetate]; Nimodipine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of GJA1 protein]; Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of GJA1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of GJA1 protein] 		CTD PMID:20932874 PMID:26926986 PMID:28916327 PMID:29457680 PMID:33242459 More... NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609 		JBrowse link
G Gja8 gap junction protein, alpha 8 increases expression EXP lead acetate results in increased expression of GJA8 mRNA CTD PMID:22609695 NCBI chr 3:96,820,882...96,833,367
Ensembl chr 3:96,820,882...96,833,336 		JBrowse link
G Gjb6 gap junction protein, beta 6 increases expression ISO lead acetate results in increased expression of GJB6 mRNA CTD PMID:22641619 NCBI chr14:57,360,760...57,370,764
Ensembl chr14:57,360,760...57,371,068 		JBrowse link
G Gjc2 gap junction protein, gamma 2 increases expression ISO
EXP 		lead acetate results in increased expression of GJC2 mRNA CTD PMID:22609695 PMID:22641619 NCBI chr11:59,066,390...59,074,039
Ensembl chr11:59,066,394...59,074,039 		JBrowse link
G Gjc3 gap junction protein, gamma 3 increases expression ISO lead acetate results in increased expression of GJC3 mRNA CTD PMID:22641619 NCBI chr 5:137,949,254...137,961,360
Ensembl chr 5:137,951,723...137,961,360 		JBrowse link
G Gk glycerol kinase increases expression ISO lead acetate results in increased expression of GK mRNA CTD PMID:11578147 NCBI chr  X:84,745,543...84,820,425
Ensembl chr  X:84,745,543...84,820,425 		JBrowse link
G Gldn gliomedin increases expression ISO lead acetate results in increased expression of GLDN mRNA CTD PMID:22641619 NCBI chr 9:54,193,770...54,249,061
Ensembl chr 9:54,193,770...54,249,070 		JBrowse link
G Gli1 GLI-Kruppel family member GLI1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of GLI1 mRNA CTD PMID:12634122 NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843 		JBrowse link
G Glipr1 GLI pathogenesis related 1 increases expression ISO lead acetate results in increased expression of GLIPR1 mRNA CTD PMID:38568856 NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536 		JBrowse link
G Glipr2 GLI pathogenesis-related 2 increases expression EXP lead acetate results in increased expression of GLIPR2 mRNA CTD PMID:25270620 NCBI chr 4:43,957,702...43,979,118
Ensembl chr 4:43,957,401...43,979,118 		JBrowse link
G Glod4 glyoxalase domain containing 4 increases expression EXP lead acetate results in increased expression of GLOD4 mRNA CTD PMID:21829687 NCBI chr11:76,111,221...76,134,525
Ensembl chr11:76,011,813...76,134,551 		JBrowse link
G Glra2 glycine receptor, alpha 2 subunit decreases expression ISO
EXP 		lead acetate results in decreased expression of GLRA2 mRNA CTD PMID:22613225 PMID:22641619 NCBI chr  X:163,912,013...164,110,863
Ensembl chr  X:163,912,013...164,110,389 		JBrowse link
G Glra3 glycine receptor, alpha 3 subunit decreases expression ISO lead acetate results in decreased expression of GLRA3 mRNA CTD PMID:22641619 NCBI chr 8:56,393,454...56,583,111
Ensembl chr 8:56,393,495...56,583,105 		JBrowse link
G Glrp1 glutamine repeat protein 1 increases expression EXP lead acetate results in increased expression of GLRP1 mRNA CTD PMID:22609695 NCBI chr 1:88,427,593...88,437,788
Ensembl chr 1:88,427,593...88,437,788 		JBrowse link
G Glt28d2 glycosyltransferase 28 domain containing 2 decreases expression EXP lead acetate results in decreased expression of GLT28D2 mRNA CTD PMID:21829687 NCBI chr 3:85,777,153...85,794,825
Ensembl chr 3:85,777,156...85,794,823 		JBrowse link
G Glud1 glutamate dehydrogenase 1 decreases expression ISO lead acetate results in decreased expression of GLUD1 mRNA CTD PMID:38568856 NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222 		JBrowse link
G Glul glutamate-ammonia ligase decreases expression
increases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of GLUL mRNA
lead acetate results in increased expression of GLUL mRNA
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of GLUL protein 		CTD PMID:20542052 PMID:23680456 PMID:25270620 PMID:38568856 NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469 		JBrowse link
G Gm3764 predicted gene 3764 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MIR9-1HG mRNA CTD PMID:12634122 NCBI chr 3:88,113,980...88,137,266
Ensembl chr 3:88,113,033...88,137,271 		JBrowse link
G Gm4553 predicted gene 4553 decreases expression EXP lead acetate results in decreased expression of KRTAP5-4 mRNA CTD PMID:22609695 NCBI chr 7:141,718,433...141,719,488
Ensembl chr 7:141,718,433...141,719,476 		JBrowse link
G Gm9920 predicted gene 9920 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of FAM106A mRNA CTD PMID:22839698 NCBI chr15:54,963,313...54,976,978
Ensembl chr15:54,963,313...54,977,100 		JBrowse link
G Gmnn geminin decreases expression EXP lead acetate results in decreased expression of GMNN mRNA CTD PMID:25270620 NCBI chr13:24,935,828...24,954,222
Ensembl chr13:24,935,828...24,945,906 		JBrowse link
G Gna13 guanine nucleotide binding protein, alpha 13 increases expression EXP lead acetate results in increased expression of GNA13 mRNA CTD PMID:21829687 NCBI chr11:109,253,620...109,292,195
Ensembl chr11:109,253,657...109,292,195 		JBrowse link
G Gnao1 guanine nucleotide binding protein, alpha O increases expression EXP lead acetate results in increased expression of GNAO1 protein CTD PMID:20797405 NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016 		JBrowse link
G Gnb4 guanine nucleotide binding protein (G protein), beta 4 increases expression EXP lead acetate results in increased expression of GNB4 mRNA CTD PMID:21829687 NCBI chr 3:32,632,736...32,670,813
Ensembl chr 3:32,634,481...32,670,734 		JBrowse link
G Gng11 guanine nucleotide binding protein (G protein), gamma 11 increases expression ISO lead acetate results in increased expression of GNG11 mRNA CTD PMID:38568856 NCBI chr 6:4,003,987...4,008,445
Ensembl chr 6:4,003,904...4,008,445 		JBrowse link
G Gng12 guanine nucleotide binding protein (G protein), gamma 12 decreases expression EXP lead acetate results in decreased expression of GNG12 mRNA CTD PMID:22613225 NCBI chr 6:66,873,381...66,998,345
Ensembl chr 6:66,873,381...66,998,334 		JBrowse link
G Gng5 G protein subunit gamma 5 increases expression ISO lead acetate results in increased expression of GNG5 mRNA CTD PMID:38568856 NCBI chr 3:146,205,591...146,211,298
Ensembl chr 3:146,205,562...146,211,327 		JBrowse link
G Gngt2 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 decreases expression ISO lead acetate results in decreased expression of GNGT2 mRNA CTD PMID:22641619 NCBI chr11:95,733,045...95,736,557
Ensembl chr11:95,728,042...95,736,560 		JBrowse link
G Golph3 golgi phosphoprotein 3 decreases expression
increases methylation 		ISO lead acetate results in decreased expression of GOLPH3 mRNA
lead acetate results in increased methylation of GOLPH3 gene 		CTD PMID:29571894 NCBI chr15:12,319,617...12,351,687
Ensembl chr15:12,321,536...12,351,677 		JBrowse link
G Gosr2 golgi SNAP receptor complex member 2 increases expression ISO lead acetate results in increased expression of GOSR2 mRNA CTD PMID:11578147 NCBI chr11:103,567,675...103,590,139
Ensembl chr11:103,567,675...103,588,724 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions
increases expression 		EXP [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased expression of GOT1 protein] CTD PMID:22033380 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044 		JBrowse link
G Got2 glutamatic-oxaloacetic transaminase 2, mitochondrial increases expression ISO lead acetate results in increased expression of GOT2 mRNA CTD PMID:11578147 NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175 		JBrowse link
G Gpat3 glycerol-3-phosphate acyltransferase 3 increases expression ISO lead acetate results in increased expression of GPAT3 mRNA CTD PMID:38568856 NCBI chr 5:100,994,095...101,046,968
Ensembl chr 5:100,993,579...101,046,968 		JBrowse link
G Gpat4 glycerol-3-phosphate acyltransferase 4 increases expression EXP lead acetate results in increased expression of GPAT4 mRNA CTD PMID:20542052 NCBI chr 8:23,661,281...23,698,469
Ensembl chr 8:23,661,281...23,698,362 		JBrowse link
G Gpatch4 G patch domain containing 4 increases expression ISO lead acetate results in increased expression of GPATCH4 mRNA CTD PMID:22641619 NCBI chr 3:87,950,413...87,963,301
Ensembl chr 3:87,950,415...87,963,300 		JBrowse link
G Gpc1 glypican 1 increases expression ISO lead acetate results in increased expression of GPC1 mRNA CTD PMID:38568856 NCBI chr 1:92,759,367...92,787,933
Ensembl chr 1:92,759,367...92,788,501 		JBrowse link
G Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) increases expression ISO lead acetate results in increased expression of GPD1 mRNA CTD PMID:22641619 NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886 		JBrowse link
G Gpd1l glycerol-3-phosphate dehydrogenase 1-like decreases expression ISO lead acetate results in decreased expression of GPD1L mRNA CTD PMID:38568856 NCBI chr 9:114,728,407...114,763,055
Ensembl chr 9:114,728,409...114,763,055 		JBrowse link
G Gpm6b glycoprotein m6b decreases expression ISO lead acetate results in decreased expression of GPM6B mRNA CTD PMID:38568856 NCBI chr  X:165,021,911...165,172,028
Ensembl chr  X:165,021,907...165,171,984 		JBrowse link
G Gpr132 G protein-coupled receptor 132 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of GPR132 mRNA CTD PMID:22839698 NCBI chr12:112,814,493...112,832,035
Ensembl chr12:112,814,493...112,831,848 		JBrowse link
G Gpr139 G protein-coupled receptor 139 decreases expression ISO lead acetate results in decreased expression of GPR139 mRNA CTD PMID:22641619 NCBI chr 7:118,739,970...118,783,761
Ensembl chr 7:118,739,970...118,783,826 		JBrowse link
G Gpr155 G protein-coupled receptor 155 increases expression EXP lead acetate results in increased expression of GPR155 mRNA CTD PMID:21829687 NCBI chr 2:73,171,850...73,216,842
Ensembl chr 2:73,171,850...73,216,916 		JBrowse link
G Gpr183 G protein-coupled receptor 183 increases expression ISO lead acetate results in increased expression of GPR183 mRNA CTD PMID:22641619 NCBI chr14:122,189,743...122,202,605
Ensembl chr14:122,189,963...122,202,607 		JBrowse link
G Gprasp1 G protein-coupled receptor associated sorting protein 1 increases expression EXP lead acetate results in increased expression of GPRASP1 mRNA CTD PMID:21829687 NCBI chr  X:134,643,441...134,704,217
Ensembl chr  X:134,643,482...134,704,223 		JBrowse link
G Gprc5a G protein-coupled receptor, family C, group 5, member A increases expression ISO lead acetate results in increased expression of GPRC5A mRNA CTD PMID:38568856 NCBI chr 6:135,042,660...135,061,707
Ensembl chr 6:135,042,649...135,061,707 		JBrowse link
G Gprin1 G protein-regulated inducer of neurite outgrowth 1 increases expression ISO lead acetate results in increased expression of GPRIN1 mRNA CTD PMID:38568856 NCBI chr13:54,884,484...54,897,486
Ensembl chr13:54,884,484...54,897,687 		JBrowse link
G Gpt glutamic pyruvic transaminase, soluble increases expression
multiple interactions 		EXP lead acetate results in increased expression of GPT protein
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of GPT protein; [lead acetate results in increased abundance of Lead] which results in increased expression of GPT protein; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased expression of GPT protein] 		CTD PMID:22033380 PMID:38180308 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886 		JBrowse link
G Gpx1 glutathione peroxidase 1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased expression of GPX1 mRNA; lead acetate results in decreased expression of GPX1 protein
5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of GPX1 mRNA]; [Cadmium Chloride co-treated with lead acetate co-treated with manganese chloride] results in increased activity of GPX1 protein; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of GPX1 mRNA]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of GPX1 protein]
lead acetate results in increased expression of GPX1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX1 mRNA] 		CTD PMID:15014207 PMID:22197700 PMID:27599793 PMID:29746905 PMID:30623991 More... NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542 		JBrowse link
G Gpx4 glutathione peroxidase 4 decreases expression
multiple interactions
affects expression 		ISO lead acetate results in decreased expression of GPX4 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 protein; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 mRNA]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GPX4 protein]
lead acetate affects the expression of GPX4 mRNA 		CTD PMID:15014207 PMID:33862172 PMID:36642386 PMID:39276841 NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273 		JBrowse link
G Gramd1b GRAM domain containing 1B decreases expression EXP lead acetate results in decreased expression of GRAMD1B mRNA CTD PMID:36183778 NCBI chr 9:40,204,529...40,443,656
Ensembl chr 9:40,204,529...40,442,679 		JBrowse link
G Gramd2a GRAM domain containing 2A decreases expression ISO lead acetate results in decreased expression of GRAMD2A mRNA CTD PMID:38568856 NCBI chr 9:59,587,116...59,626,156
Ensembl chr 9:59,587,427...59,626,157 		JBrowse link
G Grb10 growth factor receptor bound protein 10 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of GRB10 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of GRB10 protein 		CTD PMID:25270620 PMID:38072110 NCBI chr11:11,880,499...11,987,428
Ensembl chr11:11,880,508...11,988,683 		JBrowse link
G Grb7 growth factor receptor bound protein 7 decreases expression ISO lead acetate results in decreased expression of GRB7 mRNA CTD PMID:38568856 NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199 		JBrowse link
G Greb1 gene regulated by estrogen in breast cancer protein increases expression EXP lead acetate results in increased expression of GREB1 mRNA CTD PMID:20542052 NCBI chr12:16,720,616...16,851,395
Ensembl chr12:16,720,616...16,850,887 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist increases expression ISO lead acetate results in increased expression of GREM1 mRNA CTD PMID:27562236 NCBI chr 2:113,579,020...113,588,993
Ensembl chr 2:113,576,509...113,588,991 		JBrowse link
G Grhl3 grainyhead like transcription factor 3 decreases expression ISO lead acetate results in decreased expression of GRHL3 mRNA CTD PMID:38568856 NCBI chr 4:135,269,199...135,300,943
Ensembl chr 4:135,269,199...135,300,941 		JBrowse link
G Gria1 glutamate receptor, ionotropic, AMPA1 (alpha 1) affects expression EXP lead acetate affects the expression of GRIA1 mRNA CTD PMID:24260418 NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070 		JBrowse link
G Gria2 glutamate receptor, ionotropic, AMPA2 (alpha 2) decreases expression EXP
ISO 		lead acetate results in decreased expression of GRIA2 mRNA CTD PMID:24260418 PMID:33862172 NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142 		JBrowse link
G Gria3 glutamate receptor, ionotropic, AMPA3 (alpha 3) decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of GRIA3 mRNA
lead acetate results in increased expression of GRIA3 mRNA 		CTD PMID:24260418 PMID:33862172 NCBI chr  X:40,489,351...40,767,478
Ensembl chr  X:40,489,731...40,767,478 		JBrowse link
G Gria4 glutamate receptor, ionotropic, AMPA4 (alpha 4) decreases expression EXP lead acetate results in decreased expression of GRIA4 mRNA CTD PMID:24260418 NCBI chr 9:4,417,893...4,796,250
Ensembl chr 9:4,417,896...4,796,234 		JBrowse link
G Grik1 glutamate receptor, ionotropic, kainate 1 decreases expression
increases expression 		EXP lead acetate results in decreased expression of GRIK1 mRNA
lead acetate results in increased expression of GRIK1 mRNA 		CTD PMID:24260418 NCBI chr16:87,692,789...88,087,751
Ensembl chr16:87,692,788...88,087,153 		JBrowse link
G Grik2 glutamate receptor, ionotropic, kainate 2 (beta 2) multiple interactions
increases expression 		EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of GRIK2 intron
lead acetate results in increased expression of GRIK2 mRNA 		CTD PMID:24260418 PMID:33445541 NCBI chr10:48,969,776...49,666,523
Ensembl chr10:48,970,929...49,664,862 		JBrowse link
G Grik3 glutamate receptor, ionotropic, kainate 3 affects expression EXP lead acetate affects the expression of GRIK3 mRNA CTD PMID:24260418 NCBI chr 4:125,384,025...125,607,966
Ensembl chr 4:125,384,493...125,607,966 		JBrowse link
G Grik5 glutamate receptor, ionotropic, kainate 5 (gamma 2) decreases expression EXP lead acetate results in decreased expression of GRIK5 mRNA CTD PMID:24260418 NCBI chr 7:24,709,274...24,775,421
Ensembl chr 7:24,709,274...24,771,771 		JBrowse link
G Grin1 glutamate receptor, ionotropic, NMDA1 (zeta 1) multiple interactions
decreases expression 		ISO
EXP 		[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; Choline analog inhibits the reaction [lead acetate results in decreased expression of GRIN1 mRNA]; Choline analog inhibits the reaction [lead acetate results in decreased expression of GRIN1 protein]; lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]
lead acetate results in decreased expression of GRIN1 mRNA; lead acetate results in decreased expression of GRIN1 protein 		CTD PMID:12480136 PMID:20381573 PMID:22160880 PMID:24260418 PMID:25242007 NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199 		JBrowse link
G Grin2a glutamate receptor, ionotropic, NMDA2A (epsilon 1) multiple interactions
affects expression
decreases expression
increases expression 		ISO
EXP 		Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2A mRNA]
lead acetate affects the expression of GRIN2A mRNA
lead acetate results in decreased expression of GRIN2A mRNA; lead acetate results in decreased expression of GRIN2A protein
lead acetate results in increased expression of GRIN2A mRNA 		CTD PMID:15973774 PMID:20381573 PMID:22160880 PMID:22362014 PMID:24260418 More... NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424 		JBrowse link
G Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) multiple interactions
decreases expression
increases expression 		ISO
EXP 		[lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]] which results in decreased phosphorylation of CREB1 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of GRIN2B protein; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GRIN2B protein]; Choline analog affects the reaction [lead acetate results in decreased expression of GRIN2B mRNA]; lead acetate promotes the reaction [GRIN1 protein binds to GRIN2B protein]
lead acetate results in decreased expression of GRIN2B mRNA; lead acetate results in decreased expression of GRIN2B protein
lead acetate results in increased expression of GRIN2B mRNA 		CTD PMID:12480136 PMID:20381573 PMID:22160880 PMID:22362014 PMID:24260418 More... NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509 		JBrowse link
G Grin2c glutamate receptor, ionotropic, NMDA2C (epsilon 3) increases expression EXP lead acetate results in increased expression of GRIN2C mRNA CTD PMID:24260418 NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069 		JBrowse link
G Grin2d glutamate receptor, ionotropic, NMDA2D (epsilon 4) increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of GRIN2D mRNA
lead acetate results in decreased expression of GRIN2D mRNA 		CTD PMID:24260418 PMID:33862172 NCBI chr 7:45,481,307...45,520,708
Ensembl chr 7:45,481,307...45,527,802 		JBrowse link
G Grin3a glutamate receptor ionotropic, NMDA3A increases expression EXP lead acetate results in increased expression of GRIN3A mRNA CTD PMID:24260418 NCBI chr 4:49,661,611...49,846,023
Ensembl chr 4:49,661,611...49,845,744 		JBrowse link
G Grin3b glutamate receptor, ionotropic, NMDA3B increases expression EXP
ISO 		lead acetate results in increased expression of GRIN3B mRNA CTD PMID:22160880 PMID:24260418 NCBI chr10:79,806,227...79,813,024
Ensembl chr10:79,806,549...79,813,024 		JBrowse link
G Grip1 glutamate receptor interacting protein 1 decreases expression ISO lead acetate results in decreased expression of GRIP1 mRNA CTD PMID:37939567 NCBI chr10:119,289,810...119,923,172
Ensembl chr10:119,289,735...119,923,166 		JBrowse link
G Grk1 G protein-coupled receptor kinase 1 increases methylation ISO lead acetate results in increased methylation of GRK1 gene CTD PMID:29571894 NCBI chr 8:13,455,081...13,471,951
Ensembl chr 8:13,455,081...13,471,951 		JBrowse link
G Grk3 G protein-coupled receptor kinase 3 increases expression EXP lead acetate results in increased expression of GRK3 mRNA CTD PMID:21829687 NCBI chr 5:113,058,344...113,163,518
Ensembl chr 5:113,058,348...113,163,657 		JBrowse link
G Grk5 G protein-coupled receptor kinase 5 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of GRK5 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of GRK5 mRNA 		CTD PMID:11578147 PMID:33445541 NCBI chr19:60,877,995...61,084,406
Ensembl chr19:60,878,187...61,084,406 		JBrowse link
G Grm1 glutamate receptor, metabotropic 1 decreases expression
affects expression 		EXP
ISO 		lead acetate results in decreased expression of GRM1 mRNA
lead acetate affects the expression of GRM1 mRNA 		CTD PMID:22362014 PMID:24260418 NCBI chr10:10,561,803...10,958,126
Ensembl chr10:10,561,803...10,958,100 		JBrowse link
G Grm4 glutamate receptor, metabotropic 4 increases expression
affects expression 		EXP
ISO 		lead acetate results in increased expression of GRM4 mRNA
lead acetate affects the expression of GRM4 mRNA 		CTD PMID:22160880 PMID:24260418 NCBI chr17:27,641,361...27,732,800
Ensembl chr17:27,641,361...27,740,377 		JBrowse link
G Grm5 glutamate receptor, metabotropic 5 affects expression ISO lead acetate affects the expression of GRM5 mRNA CTD PMID:22160880 NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115 		JBrowse link
G Grm6 glutamate receptor, metabotropic 6 decreases expression
increases expression 		EXP lead acetate results in decreased expression of GRM6 mRNA
lead acetate results in increased expression of GRM6 mRNA 		CTD PMID:24260418 NCBI chr11:50,741,205...50,757,035
Ensembl chr11:50,741,512...50,757,035 		JBrowse link
G Grm8 glutamate receptor, metabotropic 8 increases expression EXP lead acetate results in increased expression of GRM8 mRNA CTD PMID:24260418 NCBI chr 6:27,275,120...28,135,094
Ensembl chr 6:27,275,118...28,135,177 		JBrowse link
G Grn granulin increases expression
affects expression 		EXP
ISO 		lead acetate results in increased expression of GRN mRNA
lead acetate affects the expression of GRN protein 		CTD PMID:21829687 PMID:36539177 NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874 		JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha decreases methylation
increases expression 		ISO lead acetate results in decreased methylation of GSK3A gene
lead acetate results in increased expression of GSK3A mRNA 		CTD PMID:29571894 PMID:38568856 NCBI chr 7:24,927,683...24,937,276
Ensembl chr 7:24,927,683...24,937,276 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta increases phosphorylation
increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased phosphorylation of GSK3B protein
lead acetate results in increased expression of GSK3B mRNA
lead acetate results in increased expression of GSK3B protein
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of GSK3B protein]; [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein 		CTD PMID:27012722 PMID:37385299 PMID:37436718 PMID:38568856 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446 		JBrowse link
G Gsr glutathione reductase decreases expression
increases activity
multiple interactions
affects activity
decreases activity
increases expression 		ISO
EXP 		lead acetate results in decreased expression of GSR mRNA; lead acetate results in decreased expression of GSR protein
lead acetate results in increased activity of GSR protein
5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of GSR mRNA]; [lead acetate results in increased abundance of Lead] which results in decreased activity of GSR protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of GSR protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased activity of GSR protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of GSR mRNA]; ferulic acid inhibits the reaction [lead acetate results in increased activity of GSR protein]; lead acetate promotes the reaction [sodium arsenite results in decreased activity of GSR protein]; sodium arsenite promotes the reaction [lead acetate results in decreased activity of GSR protein]
lead acetate affects the activity of GSR protein
lead acetate results in increased expression of GSR mRNA 		CTD PMID:19263481 PMID:22197700 PMID:25322819 PMID:28817314 PMID:30510688 More... NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191 		JBrowse link
G Gss glutathione synthetase increases expression EXP lead acetate results in increased expression of GSS mRNA CTD PMID:25270620 NCBI chr 2:155,405,101...155,434,730
Ensembl chr 2:155,405,101...155,434,730 		JBrowse link
G Gsta1 glutathione S-transferase, alpha 1 (Ya) decreases expression
increases expression 		ISO lead acetate results in decreased expression of GSTA5 mRNA
lead acetate results in increased expression of GSTA5 mRNA 		CTD PMID:33862172 NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966 		JBrowse link
G Gsta2 glutathione S-transferase, alpha 2 (Yc2) increases expression ISO lead acetate results in increased expression of GSTA2 protein CTD PMID:9750042 NCBI chr 9:78,238,300...78,254,474
Ensembl chr 9:78,238,300...78,263,070 		JBrowse link
G Gsta4 glutathione S-transferase, alpha 4 affects expression
increases expression 		ISO lead acetate affects the expression of GSTA4 mRNA
lead acetate results in increased expression of GSTA4 protein 		CTD PMID:7878682 PMID:9750042 PMID:21864555 NCBI chr 9:78,099,248...78,116,631
Ensembl chr 9:78,090,056...78,116,631 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 decreases expression EXP lead acetate results in decreased expression of GSTK1 mRNA CTD PMID:29746905 NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381 		JBrowse link
G Gstm1 glutathione S-transferase, mu 1 affects localization
increases expression 		ISO lead acetate affects the localization of GSTM1 protein
lead acetate results in increased expression of GSTM1 mRNA; lead acetate results in increased expression of GSTM1 protein 		CTD PMID:7878682 PMID:9750042 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289 		JBrowse link
G Gstm2 glutathione S-transferase, mu 2 decreases expression
increases expression 		ISO lead acetate results in decreased expression of GSTM2 protein
lead acetate results in increased expression of GSTM2 protein 		CTD PMID:9750042 NCBI chr 3:107,889,018...107,893,736
Ensembl chr 3:107,889,018...107,893,769 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 increases expression
multiple interactions 		ISO lead acetate results in increased expression of GSTO1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of GSTO1 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GSTO1 mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of GSTO1 mRNA] 		CTD PMID:11578147 PMID:31610155 NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229 		JBrowse link
G Gstp1 glutathione S-transferase, pi 1 affects localization
increases expression 		ISO
EXP 		lead acetate affects the localization of GSTP1 protein
lead acetate results in increased expression of GSTP1 mRNA
lead acetate results in increased expression of GSTP1 mRNA; lead acetate results in increased expression of GSTP1 protein 		CTD PMID:7878682 PMID:9750042 PMID:29746905 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985 		JBrowse link
G Gstt2 glutathione S-transferase, theta 2 increases expression EXP lead acetate results in increased expression of GSTT2 mRNA CTD PMID:21829687 NCBI chr10:75,667,676...75,673,253
Ensembl chr10:75,666,948...75,673,258 		JBrowse link
G Gstz1 glutathione transferase zeta 1 (maleylacetoacetate isomerase) affects expression ISO lead acetate affects the expression of GSTZ1 protein CTD PMID:36539177 NCBI chr12:87,192,102...87,211,497
Ensembl chr12:87,193,939...87,211,497 		JBrowse link
G Gtf2a2 general transcription factor II A, 2 decreases expression ISO lead acetate results in decreased expression of GTF2A2 mRNA CTD PMID:22641619 NCBI chr 9:69,919,830...69,930,148
Ensembl chr 9:69,919,832...69,930,148 		JBrowse link
G Gtf2f1 general transcription factor IIF, polypeptide 1 affects expression ISO lead acetate affects the expression of GTF2F1 protein CTD PMID:36539177 NCBI chr17:57,310,402...57,318,398
Ensembl chr17:57,310,405...57,318,288 		JBrowse link
G Gtf3c5 general transcription factor IIIC, polypeptide 5 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of GTF3C5 protein CTD PMID:38072110 NCBI chr 2:28,456,257...28,473,291
Ensembl chr 2:28,456,323...28,473,763 		JBrowse link
G Guca1a guanylate cyclase activator 1a (retina) decreases expression ISO lead acetate results in decreased expression of GUCA1A mRNA CTD PMID:22641619 NCBI chr17:47,705,482...47,724,439
Ensembl chr17:47,705,483...47,711,509 		JBrowse link
G Guca1b guanylate cyclase activator 1B decreases expression ISO lead acetate results in decreased expression of GUCA1B mRNA CTD PMID:22641619 NCBI chr17:47,692,526...47,703,892
Ensembl chr17:47,696,318...47,703,892 		JBrowse link
G Gucy1a1 guanylate cyclase 1, soluble, alpha 1 decreases expression ISO lead acetate results in decreased expression of GUCY1A1 mRNA CTD PMID:11729227 NCBI chr 3:81,999,734...82,053,253
Ensembl chr 3:81,999,734...82,053,096 		JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions
decreases expression 		ISO Ascorbic Acid inhibits the reaction [lead acetate results in decreased expression of GUCY1B1 protein]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [lead acetate results in decreased expression of GUCY1B1 protein]
lead acetate results in decreased expression of GUCY1B1 mRNA; lead acetate results in decreased expression of GUCY1B1 protein 		CTD PMID:11729227 PMID:16395254 NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996 		JBrowse link
G Gulp1 GULP, engulfment adaptor PTB domain containing 1 decreases expression ISO lead acetate results in decreased expression of GULP1 mRNA CTD PMID:22641619 NCBI chr 1:44,590,540...44,835,998
Ensembl chr 1:44,590,671...44,835,998 		JBrowse link
G Gys1 glycogen synthase 1, muscle increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of GYS1 mRNA
lead acetate results in decreased expression of GYS1 mRNA; lead acetate results in decreased expression of GYS1 protein 		CTD PMID:25270620 PMID:28916327 NCBI chr 7:45,084,263...45,106,041
Ensembl chr 7:45,084,268...45,106,043 		JBrowse link
G Gzmd granzyme D increases expression EXP lead acetate results in increased expression of GZMD mRNA CTD PMID:22609695 NCBI chr14:56,367,013...56,370,060
Ensembl chr14:56,367,013...56,370,065 		JBrowse link
G H1f10 H1.10 linker histone increases expression ISO lead acetate results in increased expression of H1-10 mRNA CTD PMID:38568856 NCBI chr 6:87,957,403...87,958,464
Ensembl chr 6:87,957,403...87,958,619 		JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha increases expression EXP lead acetate results in increased expression of H2-AA mRNA CTD PMID:22609695 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797 		JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 affects expression EXP lead acetate affects the expression of H2-AB1 mRNA CTD PMID:20542052 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393 		JBrowse link
G H2-DMb1 histocompatibility 2, class II, locus Mb1 increases expression EXP lead acetate results in increased expression of H2-DMB1 mRNA CTD PMID:20542052 NCBI chr17:34,372,165...34,379,203
Ensembl chr17:34,372,046...34,379,204 		JBrowse link
G H2-Ea histocompatibility 2, class II antigen E alpha increases expression
decreases expression 		ISO
EXP 		lead acetate results in increased expression of RT1-DA mRNA
lead acetate results in decreased expression of H2-EA mRNA 		CTD PMID:22609695 PMID:22641619 NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618 		JBrowse link
G H2-K1 histocompatibility 2, K1, K region increases expression EXP lead acetate results in increased expression of H2-K1 mRNA CTD PMID:20542052 PMID:22609695 NCBI chr17:34,214,986...34,219,316
Ensembl chr17:34,214,991...34,219,321 		JBrowse link
G H2-Oa histocompatibility 2, O region alpha locus decreases expression EXP lead acetate results in decreased expression of H2-OA mRNA CTD PMID:21829687 NCBI chr17:34,311,353...34,314,286
Ensembl chr17:34,311,314...34,314,208 		JBrowse link
G H2-Q1 histocompatibility 2, Q region locus 1 decreases expression
affects expression 		EXP
ISO 		lead acetate results in decreased expression of H2-Q1 mRNA
lead acetate affects the expression of RT1-CE16 mRNA 		CTD PMID:22613225 PMID:22641619 NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075 		JBrowse link
G H2-Q4 histocompatibility 2, Q region locus 4 increases expression EXP lead acetate results in increased expression of H2-Q4 mRNA CTD PMID:22613225 NCBI chr17:35,598,593...35,603,650
Ensembl chr17:35,598,593...35,604,266 		JBrowse link
G H2ac1 H2A clustered histone 1 decreases expression EXP lead acetate results in decreased expression of H2AC1 mRNA CTD PMID:20542052 NCBI chr13:24,118,420...24,118,896
Ensembl chr13:24,118,445...24,118,834 		JBrowse link
G H2ax H2A.X variant histone multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of H2AX protein; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of H2AX protein] CTD PMID:31874198 NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374 		JBrowse link
G H3f3b H3.3 histone B increases expression EXP lead acetate results in increased expression of H3F3B mRNA CTD PMID:21829687 NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788
Ensembl chr11:115,912,738...115,918,788 		JBrowse link
G H4c14 H4 clustered histone 14 increases expression ISO lead acetate results in increased expression of H4C3 mRNA CTD PMID:38568856 NCBI chr 3:96,170,250...96,170,633
Ensembl chr 3:96,168,998...96,170,627 		JBrowse link
G Hacd4 3-hydroxyacyl-CoA dehydratase 4 decreases expression ISO lead acetate results in decreased expression of HACD4 mRNA CTD PMID:22641619 NCBI chr 4:88,325,924...88,357,175
Ensembl chr 4:88,314,381...88,357,165 		JBrowse link
G Hamp hepcidin antimicrobial peptide multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of HAMP mRNA CTD PMID:39276841 NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457 		JBrowse link
G Hap1 huntingtin-associated protein 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 protein; REST protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 mRNA]; REST protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 protein] CTD PMID:30742882 NCBI chr11:100,238,153...100,247,808
Ensembl chr11:100,238,153...100,246,954 		JBrowse link
G Hapln2 hyaluronan and proteoglycan link protein 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of HAPLN2 mRNA CTD PMID:32458983 NCBI chr 3:87,927,865...87,934,818
Ensembl chr 3:87,929,057...87,934,890 		JBrowse link
G Haus2 HAUS augmin-like complex, subunit 2 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of HAUS2 mRNA CTD PMID:22839698 NCBI chr 2:120,439,863...120,452,041
Ensembl chr 2:120,439,864...120,452,041 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of HAVCR1 protein CTD PMID:34350654 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405 		JBrowse link
G Hbb-b1 hemoglobin, beta adult major chain increases expression
affects expression 		EXP
ISO 		lead acetate results in increased expression of HBB-B1 mRNA
lead acetate affects the expression of HBB-B1 mRNA
lead acetate results in increased expression of HBB mRNA 		CTD PMID:22609695 PMID:22641619
G Hbb-bh1 hemoglobin Z, beta-like embryonic chain increases expression EXP lead acetate results in increased expression of HBB-BH1 mRNA CTD PMID:21829687 PMID:22609695 NCBI chr 7:103,490,845...103,492,369
Ensembl chr 7:103,490,844...103,492,371 		JBrowse link
G Hbb-bs hemoglobin, beta adult s chain multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of HBB-BS mRNA CTD PMID:32458983 NCBI chr 7:103,475,730...103,477,135
Ensembl chr 7:103,475,741...103,477,303 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor increases expression ISO lead acetate results in increased expression of HBEGF mRNA CTD PMID:38568856 NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858 		JBrowse link
G Hcfc1 host cell factor C1 increases expression ISO lead acetate results in increased expression of HCFC1 mRNA CTD PMID:38568856 NCBI chr  X:72,986,400...73,011,430
Ensembl chr  X:72,986,398...73,009,963 		JBrowse link
G Hck hemopoietic cell kinase multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA CTD PMID:12634122 NCBI chr 2:152,950,388...152,993,361
Ensembl chr 2:152,950,388...152,993,361 		JBrowse link
G Hdac2 histone deacetylase 2 multiple interactions
increases expression 		EXP HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG protein]
lead acetate results in increased expression of HDAC2 protein 		CTD PMID:37797690 NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885 		JBrowse link
G Hdac4 histone deacetylase 4 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of and affects the localization of HDAC4 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of HDAC4 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of HDAC4 protein; PPP1R12A protein affects the reaction [[lead acetate results in increased abundance of Lead] which affects the localization of HDAC4 protein] CTD PMID:33080273 NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421 		JBrowse link
G Hdac7 histone deacetylase 7 increases expression
multiple interactions 		EXP lead acetate results in increased expression of HDAC7 mRNA
[lead acetate results in increased abundance of Lead] which results in increased methylation of HDAC7 promoter 		CTD PMID:20542052 PMID:33445541 NCBI chr15:97,690,542...97,742,383
Ensembl chr15:97,690,545...97,742,383 		JBrowse link
G Hdac9 histone deacetylase 9 increases expression EXP lead acetate results in increased expression of HDAC9 mRNA CTD PMID:20542052 NCBI chr12:34,097,579...34,967,094
Ensembl chr12:34,097,579...34,967,094 		JBrowse link
G Hdc histidine decarboxylase increases expression
decreases expression 		ISO
EXP 		lead acetate results in increased expression of HDC mRNA
lead acetate results in decreased expression of HDC mRNA 		CTD PMID:11578147 PMID:22609695 NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219 		JBrowse link
G Hdhd2 haloacid dehalogenase-like hydrolase domain containing 2 increases expression EXP lead acetate results in increased expression of HDHD2 mRNA CTD PMID:20542052 NCBI chr18:77,031,775...77,059,867
Ensembl chr18:77,031,788...77,063,003 		JBrowse link
G Hecw1 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 decreases expression EXP lead acetate results in decreased expression of HECW1 mRNA CTD PMID:21829687 NCBI chr13:14,401,023...14,697,874
Ensembl chr13:14,401,023...14,697,813 		JBrowse link
G Hepacam2 HEPACAM family member 2 increases expression EXP lead acetate results in increased expression of HEPACAM2 mRNA CTD PMID:22609695 NCBI chr 6:3,457,202...3,498,319
Ensembl chr 6:3,457,096...3,498,298 		JBrowse link
G Heph hephaestin increases expression EXP lead acetate results in increased expression of HEPH mRNA CTD PMID:20542052 NCBI chr  X:95,499,042...95,618,091
Ensembl chr  X:95,498,965...95,618,091 		JBrowse link
G Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 affects expression EXP lead acetate affects the expression of HERPUD1 mRNA CTD PMID:25270620 NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005 		JBrowse link
G Hes6 hairy and enhancer of split 6 decreases expression EXP lead acetate results in decreased expression of HES6 mRNA CTD PMID:22609695 NCBI chr 1:91,339,204...91,342,901
Ensembl chr 1:91,339,205...91,341,760 		JBrowse link
G Hexb hexosaminidase B decreases expression EXP lead acetate results in decreased expression of HEXB mRNA CTD PMID:21829687 NCBI chr13:97,312,839...97,334,865
Ensembl chr13:97,312,839...97,334,865 		JBrowse link
G Hey2 hairy/enhancer-of-split related with YRPW motif 2 increases expression EXP lead acetate results in increased expression of HEY2 mRNA CTD PMID:22609695 NCBI chr10:30,708,355...30,718,779
Ensembl chr10:30,708,355...30,718,797 		JBrowse link
G Heyl hairy/enhancer-of-split related with YRPW motif-like decreases expression EXP lead acetate results in decreased expression of HEYL mRNA CTD PMID:22613225 NCBI chr 4:123,127,349...123,143,663
Ensembl chr 4:123,127,349...123,143,668 		JBrowse link
G Hfe homeostatic iron regulator decreases expression EXP lead acetate results in decreased expression of HFE mRNA CTD PMID:21829687 NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837 		JBrowse link
G Hgsnat heparan-alpha-glucosaminide N-acetyltransferase increases expression EXP lead acetate results in increased expression of HGSNAT mRNA CTD PMID:25270620 NCBI chr 8:26,432,495...26,466,704
Ensembl chr 8:26,434,481...26,466,781 		JBrowse link
G Hid1 HID1 domain containing affects expression ISO lead acetate affects the expression of HID1 mRNA CTD PMID:22641619 NCBI chr11:115,238,531...115,261,087
Ensembl chr11:115,238,533...115,258,582 		JBrowse link
G Hif3a hypoxia inducible factor 3, alpha subunit decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of HIF3A mRNA
lead acetate results in increased expression of HIF3A mRNA 		CTD PMID:21829687 PMID:22641619 NCBI chr 7:16,764,918...16,796,352
Ensembl chr 7:16,765,432...16,796,352 		JBrowse link
G Hilpda hypoxia inducible lipid droplet associated increases expression EXP lead acetate results in increased expression of HILPDA mRNA CTD PMID:21829687 NCBI chr 6:29,272,487...29,275,448
Ensembl chr 6:29,272,487...29,275,445 		JBrowse link
G Hkdc1 hexokinase domain containing 1 increases expression ISO lead acetate results in increased expression of HKDC1 mRNA CTD PMID:38568856 NCBI chr10:62,218,916...62,259,490
Ensembl chr10:62,218,916...62,258,270 		JBrowse link
G Hlcs holocarboxylase synthetase (biotin- [propriony-Coenzyme A-carboxylase (ATP-hydrolysing)] ligase) increases expression ISO lead acetate results in increased expression of HLCS mRNA CTD PMID:11578147 NCBI chr16:93,930,054...94,116,098
Ensembl chr16:93,929,741...94,114,430 		JBrowse link
G Hmbs hydroxymethylbilane synthase increases activity ISO lead acetate results in increased activity of HMBS protein CTD PMID:10416826 NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions
increases expression 		ISO copper protoporphyrin IX inhibits the reaction [lead acetate results in increased expression of HMGB1 mRNA]; zinc protoporphyrin promotes the reaction [lead acetate results in increased expression of HMGB1 mRNA]
lead acetate results in increased expression of HMGB1 mRNA; lead acetate results in increased expression of HMGB1 protein 		CTD PMID:29447957 NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of HMGCR mRNA; lead acetate results in decreased expression of HMGCR protein
SRT1720 inhibits the reaction [lead acetate results in increased expression of HMGCR protein] 		CTD PMID:29908845 PMID:34842334 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of HMGCS1 mRNA
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of HMGCS1 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of HMGCS1 protein 		CTD PMID:38157908 PMID:38568856 NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 decreases expression EXP lead acetate results in decreased expression of HMGCS2 mRNA CTD PMID:25270620 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054 		JBrowse link
G Hmmr hyaluronan mediated motility receptor (RHAMM) increases expression EXP lead acetate results in increased expression of HMMR mRNA CTD PMID:22609695 NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
decreases response to substance
decreases expression 		ISO
EXP 		2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of HMOX1 mRNA]; [lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; copper protoporphyrin IX promotes the reaction [lead acetate results in increased expression of HMOX1 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; lead acetate results in increased expression of and results in increased activity of HMOX1 protein; NFE2L2 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of HMOX1 mRNA]; sodium bisulfide inhibits the reaction [lead acetate results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in decreased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA]
lead acetate results in increased expression of HMOX1 mRNA; lead acetate results in increased expression of HMOX1 protein
HMOX1 protein results in decreased susceptibility to lead acetate
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; [[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of HMOX1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; Ascorbic Acid promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA]; HMOX1 protein affects the reaction [lead acetate affects the expression of BCL2L1 protein]; HMOX1 protein affects the reaction [lead acetate affects the expression of CASP3 protein]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA]; Rutin promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 mRNA]; SB 203580 inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; U 0126 inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]
lead acetate results in decreased expression of HMOX1 mRNA; lead acetate results in decreased expression of HMOX1 protein
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of HMOX1 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of HMOX1 protein; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of HMOX1 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HMOX1 protein] 		CTD PMID:12774885 PMID:25270620 PMID:26498409 PMID:26542248 PMID:27562236 More... NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Hmx1 H6 homeobox 1 increases expression EXP lead acetate results in increased expression of HMX1 mRNA CTD PMID:22609695 NCBI chr 5:35,546,124...35,557,629
Ensembl chr 5:35,546,452...35,557,074 		JBrowse link
G Hnf1b HNF1 homeobox B decreases expression EXP lead acetate results in decreased expression of HNF1B mRNA CTD PMID:22609695 NCBI chr11:83,741,035...83,796,743
Ensembl chr11:83,740,889...83,796,645 		JBrowse link
G Hnf4g hepatocyte nuclear factor 4, gamma decreases expression EXP lead acetate results in decreased expression of HNF4G mRNA CTD PMID:22609695 NCBI chr 3:3,573,090...3,724,863
Ensembl chr 3:3,573,084...3,724,860 		JBrowse link
G Hnrnpa0 heterogeneous nuclear ribonucleoprotein A0 increases expression ISO lead acetate results in increased expression of HNRNPA0 mRNA CTD PMID:38568856 NCBI chr13:58,273,693...58,276,370
Ensembl chr13:58,273,693...58,276,370 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 increases expression EXP lead acetate results in increased expression of HNRNPA2B1 mRNA CTD PMID:21829687 NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874 		JBrowse link
G Hnrnpdl heterogeneous nuclear ribonucleoprotein D-like decreases expression ISO lead acetate results in decreased expression of HNRNPDL mRNA CTD PMID:38568856 NCBI chr 5:100,181,436...100,187,769
Ensembl chr 5:100,181,436...100,187,523 		JBrowse link
G Hnrnph2 heterogeneous nuclear ribonucleoprotein H2 increases expression EXP lead acetate results in increased expression of HNRNPH2 mRNA CTD PMID:21829687 NCBI chr  X:133,501,928...133,507,809
Ensembl chr  X:133,501,928...133,507,809 		JBrowse link
G Homer1 homer scaffolding protein 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of HOMER1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of HOMER1 protein CTD PMID:30738087 NCBI chr13:93,440,265...93,549,471
Ensembl chr13:93,436,143...93,541,637 		JBrowse link
G Hopx HOP homeobox increases expression EXP lead acetate results in increased expression of HOPX mRNA CTD PMID:21829687 NCBI chr 5:77,234,831...77,262,970
Ensembl chr 5:77,234,835...77,262,968 		JBrowse link
G Hotair HOX transcript antisense RNA (non-protein coding) increases expression EXP lead acetate results in increased expression of HOTAIR mRNA CTD PMID:20542052 NCBI chr15:102,852,497...102,856,381
Ensembl chr15:102,852,494...102,862,817 		JBrowse link
G Hoxa3 homeobox A3 increases expression ISO lead acetate results in increased expression of HOXA3 mRNA CTD PMID:38568856 NCBI chr 6:52,146,039...52,190,316
Ensembl chr 6:52,146,042...52,190,316 		JBrowse link
G Hoxb9 homeobox B9 decreases expression EXP lead acetate results in decreased expression of HOXB9 mRNA CTD PMID:20542052 NCBI chr11:96,162,156...96,167,421
Ensembl chr11:96,162,283...96,167,421 		JBrowse link
G Hoxc6 homeobox C6 decreases expression EXP lead acetate results in decreased expression of HOXC6 mRNA CTD PMID:22609695 NCBI chr15:102,906,658...102,920,314
Ensembl chr15:102,906,689...102,920,313 		JBrowse link
G Hoxc8 homeobox C8 increases expression ISO lead acetate results in increased expression of HOXC8 mRNA CTD PMID:38568856 NCBI chr15:102,898,971...102,902,707
Ensembl chr15:102,899,039...102,902,543 		JBrowse link
G Hp1bp3 heterochromatin protein 1, binding protein 3 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of HP1BP3 mRNA CTD PMID:22839698 NCBI chr 4:137,943,781...137,971,994
Ensembl chr 4:137,943,607...137,971,994 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 decreases activity
decreases expression 		ISO
EXP 		lead acetate results in decreased activity of HPRT1 protein
lead acetate results in decreased expression of HPRT1 mRNA 		CTD PMID:19428946 PMID:21829687 NCBI chr  X:52,076,955...52,110,537
Ensembl chr  X:52,077,014...52,110,536 		JBrowse link
G Hras Harvey rat sarcoma virus oncogene multiple interactions
increases activity 		ISO lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer]
lead acetate results in increased activity of HRAS protein
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased activity of HRAS protein]; Go 6976 inhibits the reaction [lead acetate results in increased activity of HRAS protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of RAF1 protein]; PRKCA mutant form inhibits the reaction [lead acetate results in increased activity of HRAS protein]; SU 6656 inhibits the reaction [lead acetate results in increased activity of HRAS protein] 		CTD PMID:15111246 PMID:19133285 NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918 		JBrowse link
G Hrh4 histamine receptor H4 decreases methylation
increases expression 		ISO lead acetate results in decreased methylation of HRH4 gene
lead acetate results in increased expression of HRH4 mRNA 		CTD PMID:29571894 NCBI chr18:13,140,039...13,156,758
Ensembl chr18:13,140,047...13,155,939 		JBrowse link
G Hs3st3a1 heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 increases expression ISO lead acetate results in increased expression of HS3ST3A1 mRNA CTD PMID:38568856 NCBI chr11:64,326,158...64,413,667
Ensembl chr11:64,326,158...64,413,667 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 increases expression ISO lead acetate results in increased expression of HSD11B1 mRNA CTD PMID:38568856 NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383 		JBrowse link
G Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 decreases expression EXP lead acetate results in decreased expression of HSD17B1 protein CTD PMID:22806249 NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353 		JBrowse link
G Hsd17b10 hydroxysteroid (17-beta) dehydrogenase 10 decreases expression
multiple interactions 		EXP lead acetate results in decreased expression of HSD17B10 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of HSD17B10 mRNA; Glycine inhibits the reaction [lead acetate results in decreased expression of HSD17B10 mRNA]; Taurine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HSD17B10 mRNA] 		CTD PMID:36088639 PMID:36484981 NCBI chr  X:150,784,892...150,787,438
Ensembl chr  X:150,784,841...150,787,438 		JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 increases expression ISO lead acetate results in increased expression of HSD17B2 mRNA CTD PMID:38568856 NCBI chr 8:118,427,752...118,485,767
Ensembl chr 8:118,428,643...118,485,766 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions
decreases expression 		EXP Glycine inhibits the reaction [lead acetate results in decreased expression of HSD3B1 mRNA] CTD PMID:36088639 NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110 		JBrowse link
G Hsd3b3 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3 decreases expression EXP lead acetate results in decreased expression of HSD3B3 mRNA CTD PMID:22609695 NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443 		JBrowse link
G Hsf1 heat shock factor 1 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of HSF1 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of HSF1 mRNA 		CTD PMID:21829687 PMID:39276841 NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113 		JBrowse link
G Hsp90aa1 heat shock protein 90, alpha (cytosolic), class A member 1 multiple interactions
affects expression 		ISO
EXP 		[sodium arsenite co-treated with lead acetate] results in increased expression of HSP90AA1 protein
lead acetate affects the expression of HSP90AA1 mRNA 		CTD PMID:21829687 PMID:38072110 NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162 		JBrowse link
G Hsp90b1 heat shock protein 90, beta (Grp94), member 1 affects expression EXP lead acetate affects the expression of HSP90B1 mRNA CTD PMID:21829687 NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373 		JBrowse link
G Hspa1a heat shock protein 1A decreases expression
multiple interactions
increases expression 		EXP
ISO 		lead acetate results in decreased expression of HSPA1A mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of HSPA1A mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of HSPA1A protein
lead acetate results in increased expression of HSPA1A mRNA 		CTD PMID:29746905 PMID:38072110 PMID:38568856 PMID:39547369 NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132 		JBrowse link
G Hspa1b heat shock protein 1B affects expression EXP lead acetate affects the expression of HSPA1B mRNA CTD PMID:21829687 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214 		JBrowse link
G Hspa2 heat shock protein 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of HSPA2 protein CTD PMID:38072110 NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712 		JBrowse link
G Hspa4l heat shock protein 4 like multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of HSPA4L protein CTD PMID:38072110 NCBI chr 3:40,698,664...40,750,538
Ensembl chr 3:40,699,814...40,750,538 		JBrowse link
G Hspa5 heat shock protein 5 multiple interactions
affects localization
increases expression
affects binding
affects expression 		ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of HSPA5 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of HSPA5 mRNA; ATP7A protein modified form inhibits the reaction [lead acetate binds to HSPA5 protein]; Cycloheximide inhibits the reaction [lead acetate results in increased expression of HSPA5 protein]; Dactinomycin inhibits the reaction [lead acetate results in increased expression of HSPA5 mRNA]; lead acetate inhibits the reaction [HSPA5 protein binds to FOS enhancer]; lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer]; lead acetate results in increased expression of and results in increased activity of HSPA5 protein; Nickel inhibits the reaction [lead acetate binds to HSPA5 protein]; Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of HSPA5 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of HSPA5 mRNA]; Zinc inhibits the reaction [lead acetate binds to HSPA5 protein]
lead acetate affects the localization of HSPA5 protein
lead acetate results in increased expression of HSPA5 mRNA; lead acetate results in increased expression of HSPA5 protein
lead acetate affects the expression of HSPA5 mRNA 		CTD PMID:10702365 PMID:15111246 PMID:17915553 PMID:21815057 PMID:22811615 More... NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559 		JBrowse link
G Hspa8 heat shock protein 8 affects expression
decreases expression 		EXP lead acetate affects the expression of HSPA8 protein
lead acetate results in decreased expression of HSPA8 mRNA 		CTD PMID:20797405 PMID:21829687 NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383 		JBrowse link
G Hspa9 heat shock protein 9 increases expression ISO lead acetate results in increased expression of HSPA9 mRNA CTD PMID:11578147 NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410 		JBrowse link
G Hspb1 heat shock protein 1 affects expression
multiple interactions 		ISO
EXP 		lead acetate affects the expression of HSPB1 mRNA
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of HSPB1 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of HSPB1 protein
[sodium arsenite co-treated with lead acetate] results in increased expression of HSPB1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of HSPB1 mRNA 		CTD PMID:21864555 PMID:38072110 PMID:38157908 PMID:39276841 NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417 		JBrowse link
G Hspb8 heat shock protein 8 increases expression ISO lead acetate results in increased expression of HSPB8 mRNA CTD PMID:38568856 NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923 		JBrowse link
G Hspd1 heat shock protein 1 (chaperonin) affects expression
multiple interactions
decreases expression
increases expression 		EXP
ISO 		lead acetate affects the expression of HSPD1 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of HSPD1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of HSPD1 protein; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HSPD1 mRNA]
lead acetate results in decreased expression of HSPD1 protein
lead acetate results in increased expression of HSPD1 mRNA 		CTD PMID:20797405 PMID:21829687 PMID:29660402 PMID:38072110 PMID:39547369 NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402 		JBrowse link
G Hspe1 heat shock protein 1 (chaperonin 10) increases expression ISO lead acetate results in increased expression of HSPE1 mRNA CTD PMID:11578147 NCBI chr 1:55,127,307...55,130,476
Ensembl chr 1:55,127,291...55,130,466 		JBrowse link
G Hsph1 heat shock 105kDa/110kDa protein 1 affects expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate affects the expression of HSPH1 mRNA
[sodium arsenite co-treated with lead acetate] results in increased expression of HSPH1 protein
lead acetate results in decreased expression of HSPH1 mRNA 		CTD PMID:21829687 PMID:25270620 PMID:38072110 NCBI chr 5:149,540,308...149,562,594
Ensembl chr 5:149,537,752...149,559,841 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 increases expression ISO lead acetate results in increased expression of HTATIP2 mRNA CTD PMID:38568856 NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723 		JBrowse link
G Htr1b 5-hydroxytryptamine (serotonin) receptor 1B decreases expression ISO lead acetate results in decreased expression of HTR1B mRNA CTD PMID:11578147 NCBI chr 9:81,510,344...81,515,885
Ensembl chr 9:81,510,344...81,515,881 		JBrowse link
G Htr1d 5-hydroxytryptamine (serotonin) receptor 1D decreases expression EXP lead acetate results in decreased expression of HTR1D mRNA CTD PMID:22613225 NCBI chr 4:136,150,835...136,171,716
Ensembl chr 4:136,150,835...136,171,709 		JBrowse link
G Htr2c 5-hydroxytryptamine (serotonin) receptor 2C affects expression
decreases expression 		ISO lead acetate affects the expression of HTR2C mRNA
lead acetate results in decreased expression of HTR2C mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr  X:145,745,509...145,980,273
Ensembl chr  X:145,745,509...145,980,273 		JBrowse link
G Htr3a 5-hydroxytryptamine (serotonin) receptor 3A decreases expression ISO lead acetate results in decreased expression of HTR3A mRNA CTD PMID:22641619 NCBI chr 9:48,810,513...48,822,451
Ensembl chr 9:48,810,513...48,822,399 		JBrowse link
G Htr5a 5-hydroxytryptamine (serotonin) receptor 5A increases expression EXP lead acetate results in increased expression of HTR5A mRNA CTD PMID:20542052 NCBI chr 5:28,046,836...28,059,403
Ensembl chr 5:28,047,147...28,060,086 		JBrowse link
G Htra4 HtrA serine peptidase 4 increases expression EXP lead acetate results in increased expression of HTRA4 mRNA CTD PMID:22613225 NCBI chr 8:25,514,944...25,529,160
Ensembl chr 8:25,514,945...25,528,978 		JBrowse link
G Htt huntingtin increases expression EXP lead acetate results in increased expression of HTT mRNA CTD PMID:24260418 NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878 		JBrowse link
G Huwe1 HECT, UBA and WWE domain containing 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of HUWE1 exon CTD PMID:33445541 NCBI chr  X:150,583,779...150,718,413
Ensembl chr  X:150,583,803...150,718,413 		JBrowse link
G Hymai hydatidiform mole associated and imprinted transcript decreases expression ISO lead acetate results in decreased expression of HYMAI mRNA CTD PMID:38568856 NCBI chr10:12,966,589...12,971,644 JBrowse link
G Hyou1 hypoxia up-regulated 1 decreases expression EXP lead acetate results in decreased expression of HYOU1 mRNA CTD PMID:21829687 NCBI chr 9:44,290,840...44,303,662
Ensembl chr 9:44,290,787...44,303,666 		JBrowse link
G Iars1 isoleucyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of IARS1 mRNA CTD PMID:11578147 NCBI chr13:49,835,606...49,887,743
Ensembl chr13:49,835,576...49,887,743 		JBrowse link
G Ibsp integrin binding sialoprotein decreases expression EXP lead acetate results in decreased expression of IBSP mRNA CTD PMID:22609695 NCBI chr 5:104,447,153...104,459,338
Ensembl chr 5:104,447,037...104,459,335 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
decreases expression 		EXP [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of ICAM1 protein
lead acetate results in decreased expression of ICAM1 mRNA 		CTD PMID:17512567 PMID:21829687 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113 		JBrowse link
G Id1 inhibitor of DNA binding 1, HLH protein multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ID1 mRNA CTD PMID:12634122 NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330 		JBrowse link
G Id2 inhibitor of DNA binding 2 multiple interactions ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of ID2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ID2 protein; baricitinib inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of ID2 protein] 		CTD PMID:12634122 PMID:32428222 NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139 		JBrowse link
G Id3 inhibitor of DNA binding 3 decreases expression EXP lead acetate results in decreased expression of ID3 mRNA CTD PMID:25270620 NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066 		JBrowse link
G Ide insulin degrading enzyme decreases expression EXP lead acetate results in decreased expression of IDE protein CTD PMID:28427492 NCBI chr19:37,246,140...37,341,664
Ensembl chr19:37,246,142...37,340,010 		JBrowse link
G Idh1 isocitrate dehydrogenase 1 (NADP+), soluble decreases expression EXP lead acetate results in decreased expression of IDH1 mRNA CTD PMID:29746905 NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659 		JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 increases expression EXP lead acetate results in increased expression of IDO1 mRNA CTD PMID:20542052 NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025 		JBrowse link
G Ier3 immediate early response 3 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of IER3 mRNA
lead acetate results in increased expression of IER3 mRNA 		CTD PMID:20542052 PMID:38568856 NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815 		JBrowse link
G Ifi202b interferon activated gene 202B affects expression EXP lead acetate affects the expression of IFI202B mRNA CTD PMID:21829687 NCBI chr 1:173,790,135...173,810,410
Ensembl chr 1:173,790,134...173,810,310 		JBrowse link
G Ifi204 interferon activated gene 204 decreases expression ISO lead acetate results in decreased expression of IFI16 mRNA CTD PMID:38568856 NCBI chr 1:173,574,859...173,594,606
Ensembl chr 1:173,574,859...173,594,509 		JBrowse link
G Ifi35 interferon-induced protein 35 decreases expression EXP lead acetate results in decreased expression of IFI35 mRNA CTD PMID:20542052 NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524 		JBrowse link
G Ifi44 interferon-induced protein 44 decreases expression ISO lead acetate results in decreased expression of IFI44 mRNA CTD PMID:22641619 NCBI chr 3:151,436,559...151,455,580
Ensembl chr 3:151,436,559...151,455,597 		JBrowse link
G Ifi44l interferon-induced protein 44 like affects expression
decreases expression 		EXP lead acetate affects the expression of IFI44L mRNA
lead acetate results in decreased expression of IFI44L mRNA 		CTD PMID:21829687 PMID:22609695 NCBI chr 3:151,464,374...151,468,528
Ensembl chr 3:151,464,374...151,468,529 		JBrowse link
G Ifit1 interferon-induced protein with tetratricopeptide repeats 1 decreases expression EXP lead acetate results in decreased expression of IFIT1 mRNA CTD PMID:22609695 NCBI chr19:34,618,289...34,627,409
Ensembl chr19:34,618,271...34,627,409 		JBrowse link
G Ifitm2 interferon induced transmembrane protein 2 increases expression
decreases expression 		ISO lead acetate results in increased expression of IFITM2 mRNA
lead acetate results in decreased expression of IFITM2 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 7:140,534,750...140,539,602
Ensembl chr 7:140,534,750...140,535,900 		JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 decreases expression ISO lead acetate results in decreased expression of IFITM3 mRNA CTD PMID:38568856 NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683 		JBrowse link
G Ifitm6 interferon induced transmembrane protein 6 increases expression EXP lead acetate results in increased expression of IFITM6 mRNA CTD PMID:21829687 NCBI chr 7:140,595,725...140,596,805
Ensembl chr 7:140,595,612...140,597,837 		JBrowse link
G Ifnar2 interferon (alpha and beta) receptor 2 decreases expression EXP lead acetate results in decreased expression of IFNAR2 mRNA CTD PMID:22609695 NCBI chr16:91,166,517...91,202,477
Ensembl chr16:91,169,671...91,202,477 		JBrowse link
G Ifng interferon gamma decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of IFNG protein
[[lead acetate results in increased abundance of Lead] co-treated with [Lipopolysaccharides co-treated with IFNG protein]] results in increased expression of H2 protein; [lead acetate results in increased abundance of Lead] inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased secretion of Nitric Oxide]; [lead acetate results in increased abundance of Lead] promotes the reaction [[IL4 protein co-treated with IFNG protein] results in increased expression of MRC1 protein]
[lead acetate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA 		CTD PMID:15843504 PMID:29594315 PMID:34352350 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797 		JBrowse link
G Ifngr1 interferon gamma receptor 1 decreases expression ISO lead acetate results in decreased expression of IFNGR1 mRNA CTD PMID:38568856 NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977 		JBrowse link
G Ifrd1 interferon-related developmental regulator 1 increases expression ISO lead acetate results in increased expression of IFRD1 mRNA CTD PMID:11578147 NCBI chr12:40,253,128...40,273,184
Ensembl chr12:40,251,566...40,298,503 		JBrowse link
G Ift172 intraflagellar transport 172 increases expression EXP lead acetate results in increased expression of IFT172 mRNA CTD PMID:29746905 NCBI chr 5:31,410,623...31,448,458
Ensembl chr 5:31,410,621...31,448,460 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression
increases methylation
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of IGF1 protein
lead acetate results in increased methylation of IGF1 gene
[lead acetate results in increased abundance of Lead] which results in decreased expression of IGF1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of IGF1 protein 		CTD PMID:24200854 PMID:29571894 PMID:36652739 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904 		JBrowse link
G Igf1r insulin-like growth factor I receptor multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of IGF1R mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of IGF1R protein CTD PMID:36652739 NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416 		JBrowse link
G Igf2 insulin-like growth factor 2 affects expression
decreases methylation
decreases expression 		ISO
EXP 		lead acetate affects the expression of IGF2 mRNA
lead acetate results in decreased methylation of IGF2 gene
lead acetate results in decreased expression of IGF2 mRNA
lead acetate results in decreased expression of IGF2 protein 		CTD PMID:21864555 PMID:24200854 PMID:25596546 NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553 		JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 increases expression EXP lead acetate results in increased expression of IGF2BP3 mRNA CTD PMID:22609695 NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression
decreases expression 		EXP lead acetate results in increased expression of IGFBP1 mRNA
lead acetate results in decreased expression of IGFBP1 mRNA 		CTD PMID:21335049 PMID:25270620 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 increases expression ISO lead acetate results in increased expression of IGFBP3 mRNA CTD PMID:38568856 NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 decreases expression ISO lead acetate results in decreased expression of IGFBP5 mRNA CTD PMID:11578147 NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 increases expression ISO lead acetate results in increased expression of IGFBP6 mRNA CTD PMID:38568856 NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946 		JBrowse link
G Igfbp7 insulin-like growth factor binding protein 7 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA CTD PMID:12634122 NCBI chr 5:77,497,092...77,555,892
Ensembl chr 5:77,497,087...77,555,888 		JBrowse link
G Igfbpl1 insulin-like growth factor binding protein-like 1 affects expression ISO lead acetate affects the expression of IGFBPL1 mRNA CTD PMID:21864555 NCBI chr 4:45,809,507...45,826,827
Ensembl chr 4:45,809,468...45,826,923 		JBrowse link
G Igkv1-135 immunoglobulin kappa variable 1-135 decreases expression EXP lead acetate results in decreased expression of IGKV1-135 mRNA CTD PMID:22609695 NCBI chr 6:67,586,729...67,587,492
Ensembl chr 6:67,586,697...67,587,492 		JBrowse link
G Igsf6 immunoglobulin superfamily, member 6 decreases expression EXP lead acetate results in decreased expression of IGSF6 mRNA CTD PMID:22609695 NCBI chr 7:120,663,290...120,673,753
Ensembl chr 7:120,663,290...120,673,795 		JBrowse link
G Ihh Indian hedgehog multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of IHH protein CTD PMID:23604592 NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831 		JBrowse link
G Iigp1 interferon inducible GTPase 1 increases expression EXP lead acetate results in increased expression of IIGP1 mRNA CTD PMID:20542052 NCBI chr18:60,506,688...60,525,706
Ensembl chr18:60,509,099...60,525,706 		JBrowse link
G Iigp1b interferon inducible GTPase 1B increases expression EXP lead acetate results in increased expression of IIGP1B mRNA CTD PMID:21829687
G Ikbkg inhibitor of kappaB kinase gamma increases expression ISO lead acetate results in increased expression of IKBKG mRNA CTD PMID:38568856 NCBI chr  X:73,436,883...73,498,013
Ensembl chr  X:73,436,896...73,497,460 		JBrowse link
G Il10 interleukin 10 decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of IL10 mRNA; lead acetate results in decreased expression of IL10 protein
[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 mRNA; [[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 protein; NFE2L2 protein affects the reaction [[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 mRNA]; NFE2L2 protein affects the reaction [[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 protein]
Cholecalciferol inhibits the reaction [lead acetate results in decreased expression of IL10 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of IL10 mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of IL10 protein]
[Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL10 protein 		CTD PMID:17512567 PMID:22609695 PMID:32116774 PMID:34051273 PMID:39032614 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711 		JBrowse link
G Il10ra interleukin 10 receptor, alpha increases expression EXP lead acetate results in increased expression of IL10RA mRNA CTD PMID:21829687 NCBI chr 9:45,165,135...45,180,447
Ensembl chr 9:45,165,135...45,180,447 		JBrowse link
G Il11 interleukin 11 increases expression ISO lead acetate results in increased expression of IL11 mRNA CTD PMID:37939567 NCBI chr 7:4,775,372...4,785,877
Ensembl chr 7:4,775,372...4,785,858 		JBrowse link
G Il12a interleukin 12a decreases expression EXP lead acetate results in decreased expression of IL12A mRNA CTD PMID:21829687 NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880 		JBrowse link
G Il13 interleukin 13 multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [IL4 protein co-treated with IL13 protein]] results in increased expression of TGFB1 protein CTD PMID:34352350 NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529 		JBrowse link
G Il18 interleukin 18 affects expression
increases expression 		EXP
ISO 		lead acetate affects the expression of IL18 protein
lead acetate results in increased expression of IL18 mRNA 		CTD PMID:21322097 PMID:33862172 PMID:37939567 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140 		JBrowse link
G Il18bp interleukin 18 binding protein decreases expression EXP lead acetate results in decreased expression of IL18BP mRNA CTD PMID:20542052 NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897 		JBrowse link
G Il18rap interleukin 18 receptor accessory protein increases expression EXP lead acetate results in increased expression of IL18RAP mRNA CTD PMID:21829687 NCBI chr 1:40,554,548...40,590,867
Ensembl chr 1:40,554,522...40,590,865 		JBrowse link
G Il1a interleukin 1 alpha increases expression ISO lead acetate results in increased expression of IL1A mRNA CTD PMID:38568856 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892 		JBrowse link
G Il1b interleukin 1 beta decreases expression
multiple interactions
increases expression
increases secretion 		ISO
EXP 		lead acetate results in decreased expression of IL1B protein
[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of IL1B protein; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B mRNA]]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B protein]]; Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B mRNA]; Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B protein]
lead acetate results in increased expression of IL1B mRNA
lead acetate results in increased expression of IL1B protein
lead acetate results in increased secretion of IL1B protein
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein; [lead acetate results in increased abundance of Lead] which results in increased expression of IL1B protein; MitoTEMPO inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased secretion of IL1B protein]
lead acetate results in decreased expression of IL1B mRNA
lead acetate results in increased expression of IL1B mRNA; lead acetate results in increased expression of IL1B protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead acetate results in increased expression of IL1B protein]; 3-methyladenine inhibits the reaction [lead acetate results in increased expression of IL1B protein]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of IL1B mRNA]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of IL1B protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of IL1B protein]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of IL1B mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of IL1B protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of IL1B protein]; naringenin inhibits the reaction [lead acetate results in increased expression of IL1B protein]; Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of IL1B protein]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of IL1B protein]; Quercetin inhibits the reaction [lead acetate results in increased expression of IL1B protein]; SB 203580 inhibits the reaction [lead acetate results in increased expression of IL1B protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of IL1B mRNA]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of IL1B protein]; sodium bisulfide inhibits the reaction [lead acetate results in increased expression of IL1B protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in increased expression of IL1B protein] 		CTD PMID:15843504 PMID:17047031 PMID:22728154 PMID:22952811 PMID:25028260 More... NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il1r1 interleukin 1 receptor, type I multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of IL1R1 protein CTD PMID:26396915 NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417 		JBrowse link
G Il1r2 interleukin 1 receptor, type II decreases expression ISO lead acetate results in decreased expression of IL1R2 mRNA CTD PMID:38568856 NCBI chr 1:40,123,872...40,164,390
Ensembl chr 1:40,113,239...40,164,391 		JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 decreases expression ISO lead acetate results in decreased expression of IL1RL1 mRNA CTD PMID:38568856 NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575 		JBrowse link
G Il1rl2 interleukin 1 receptor-like 2 increases expression EXP lead acetate results in increased expression of IL1RL2 mRNA CTD PMID:20542052 NCBI chr 1:40,363,697...40,406,722
Ensembl chr 1:40,363,770...40,406,722 		JBrowse link
G Il1rn interleukin 1 receptor antagonist increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of IL1RN mRNA
IL1RN protein inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased cleavage of CASP9 protein] 		CTD PMID:25270620 PMID:26396915 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506 		JBrowse link
G Il2 interleukin 2 multiple interactions ISO [lead acetate co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA CTD PMID:29594315 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108 		JBrowse link
G Il20 interleukin 20 increases expression EXP lead acetate results in increased expression of IL20 mRNA CTD PMID:20542052 NCBI chr 1:130,834,722...130,839,033
Ensembl chr 1:130,834,722...130,839,188 		JBrowse link
G Il21 interleukin 21 increases expression EXP lead acetate results in increased expression of IL21 mRNA CTD PMID:20542052 NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785 		JBrowse link
G Il24 interleukin 24 increases expression ISO lead acetate results in increased expression of IL24 mRNA CTD PMID:38568856 NCBI chr 1:130,809,801...130,815,153
Ensembl chr 1:130,809,811...130,815,191 		JBrowse link
G Il31 interleukin 31 increases expression EXP lead acetate results in increased expression of IL31 mRNA CTD PMID:20542052 NCBI chr 5:123,618,215...123,620,686
Ensembl chr 5:123,618,220...123,627,552 		JBrowse link
G Il4 interleukin 4 increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of IL4 mRNA
Cholecalciferol inhibits the reaction [lead acetate results in decreased expression of IL4 protein]; lead acetate promotes the reaction [Zinc Oxide results in decreased expression of IL4 protein]; Zinc Oxide promotes the reaction [lead acetate results in decreased expression of IL4 protein]
[[lead acetate results in increased abundance of Lead] co-treated with [IL4 protein co-treated with IL13 protein]] results in increased expression of TGFB1 protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[IL4 protein co-treated with IFNG protein] results in increased expression of MRC1 protein] 		CTD PMID:20542052 PMID:34051273 PMID:34352350 PMID:34553816 NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496 		JBrowse link
G Il4ra interleukin 4 receptor, alpha increases expression EXP lead acetate results in increased expression of IL4RA mRNA CTD PMID:22609695 NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646 		JBrowse link
G Il5 interleukin 5 increases expression EXP lead acetate results in increased expression of IL5 mRNA CTD PMID:20542052 NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933 		JBrowse link
G Il6 interleukin 6 affects expression
increases expression
multiple interactions
decreases secretion
increases secretion
decreases expression 		EXP
ISO 		lead acetate affects the expression of IL6 protein
lead acetate results in increased expression of IL6 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead acetate results in increased expression of IL6 protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of IL6 protein]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of IL6 protein]; Quercetin inhibits the reaction [lead acetate results in increased expression of IL6 protein]; SB 203580 inhibits the reaction [lead acetate results in increased expression of IL6 protein]
lead acetate results in decreased secretion of IL6 protein
[lead acetate results in increased abundance of Lead] which results in increased expression of IL6 mRNA; lead acetate promotes the reaction [Hemagglutinins results in increased secretion of IL6 protein]
lead acetate results in increased secretion of IL6 protein
lead acetate results in decreased expression of IL6 mRNA
lead acetate results in increased expression of IL6 mRNA; lead acetate results in increased expression of IL6 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of IL6 protein]; 3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of IL6 protein]; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of IL6 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL6 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of IL6 protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of IL6 protein; Celecoxib inhibits the reaction [lead acetate results in increased secretion of IL6 protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of IL6 protein]; MitoTEMPO inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL6 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL6 protein]; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL6 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased secretion of IL6 protein]; U 0126 inhibits the reaction [lead acetate results in increased secretion of IL6 protein] 		CTD PMID:17047031 PMID:17512567 PMID:21322097 PMID:21815057 PMID:22728154 More... NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979 		JBrowse link
G Il6ra interleukin 6 receptor, alpha decreases expression EXP lead acetate results in decreased expression of IL6RA mRNA CTD PMID:22609695 NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503 		JBrowse link
G Il7 interleukin 7 increases expression EXP lead acetate results in increased expression of IL7 mRNA CTD PMID:20542052 PMID:22609695 NCBI chr 3:7,637,088...7,678,820
Ensembl chr 3:7,635,054...7,678,820 		JBrowse link
G Il7r interleukin 7 receptor increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of IL7R mRNA
lead acetate results in decreased expression of IL7R mRNA 		CTD PMID:20542052 PMID:22609695 PMID:38568856 NCBI chr15:9,505,880...9,530,270
Ensembl chr15:9,505,874...9,530,262 		JBrowse link
G Ilk integrin linked kinase affects expression ISO lead acetate affects the expression of ILK protein CTD PMID:36539177 NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132 		JBrowse link
G Ing1 inhibitor of growth family, member 1 decreases expression EXP lead acetate results in decreased expression of ING1 mRNA CTD PMID:25270620 NCBI chr 8:11,605,762...11,613,251
Ensembl chr 8:11,605,571...11,613,251 		JBrowse link
G Ing4 inhibitor of growth family, member 4 decreases expression ISO lead acetate results in decreased expression of ING4 mRNA CTD PMID:38568856 NCBI chr 6:125,016,811...125,026,228
Ensembl chr 6:125,016,723...125,026,228 		JBrowse link
G Inhba inhibin beta-A increases expression EXP lead acetate results in increased expression of INHBA mRNA CTD PMID:20542052 NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206 		JBrowse link
G Inhbb inhibin beta-B decreases expression EXP lead acetate results in decreased expression of INHBB mRNA CTD PMID:25270620 NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978 		JBrowse link
G Inhbe inhibin beta-E increases expression EXP lead acetate results in increased expression of INHBE mRNA CTD PMID:22609695 NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280 		JBrowse link
G Ino80e INO80 complex subunit E increases expression ISO lead acetate results in increased expression of INO80E mRNA CTD PMID:22641619 PMID:38568856 NCBI chr 7:126,450,756...126,461,544
Ensembl chr 7:126,450,132...126,461,549 		JBrowse link
G Inpp1 inositol polyphosphate-1-phosphatase decreases expression EXP lead acetate results in decreased expression of INPP1 mRNA CTD PMID:21829687 NCBI chr 1:52,824,584...52,856,847
Ensembl chr 1:52,824,586...52,856,847 		JBrowse link
G Ins1 insulin I increases expression EXP lead acetate results in increased expression of INS1 mRNA CTD PMID:20542052 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Insr insulin receptor decreases expression ISO lead acetate results in decreased expression of INSR mRNA CTD PMID:30980912 NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617 		JBrowse link
G Insyn2b inhibitory synaptic factor family member 2B increases expression ISO lead acetate results in increased expression of INSYN2B mRNA CTD PMID:38568856 NCBI chr11:34,264,822...34,372,642
Ensembl chr11:34,264,758...34,372,640 		JBrowse link
G Ipo5 importin 5 decreases expression ISO lead acetate results in decreased expression of IPO5 mRNA CTD PMID:38568856 NCBI chr14:121,134,271...121,185,451
Ensembl chr14:121,148,636...121,185,411 		JBrowse link
G Ipo7 importin 7 decreases expression ISO lead acetate results in decreased expression of IPO7 mRNA CTD PMID:38568856 NCBI chr 7:109,617,522...109,655,816
Ensembl chr 7:109,617,481...109,655,816 		JBrowse link
G Irag2 inositol 1,4,5-triphosphate receptor associated 2 decreases expression EXP lead acetate results in decreased expression of IRAG2 mRNA CTD PMID:21829687 NCBI chr 6:145,061,357...145,120,655
Ensembl chr 6:145,061,379...145,120,660 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 increases expression ISO lead acetate results in increased expression of IRAK1 mRNA CTD PMID:38568856 NCBI chr  X:73,057,520...73,067,527
Ensembl chr  X:73,057,520...73,067,524 		JBrowse link
G Irf2bp1 interferon regulatory factor 2 binding protein 1 increases expression ISO lead acetate results in increased expression of IRF2BP1 mRNA CTD PMID:38568856 NCBI chr 7:18,737,983...18,740,688
Ensembl chr 7:18,737,969...18,740,702 		JBrowse link
G Irf2bp2 interferon regulatory factor 2 binding protein 2 increases expression EXP lead acetate results in increased expression of IRF2BP2 mRNA CTD PMID:20542052 NCBI chr 8:127,315,035...127,320,725
Ensembl chr 8:127,315,035...127,320,725 		JBrowse link
G Irf2bpl interferon regulatory factor 2 binding protein-like increases expression ISO lead acetate results in increased expression of IRF2BPL mRNA CTD PMID:38568856 NCBI chr12:86,927,477...86,931,588
Ensembl chr12:86,927,475...86,931,572 		JBrowse link
G Irf4 interferon regulatory factor 4 decreases expression EXP lead acetate results in decreased expression of IRF4 mRNA CTD PMID:21829687 NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959 		JBrowse link
G Irf6 interferon regulatory factor 6 decreases expression ISO lead acetate results in decreased expression of IRF6 mRNA CTD PMID:38568856 NCBI chr 1:192,835,420...192,854,344
Ensembl chr 1:192,835,419...192,854,331 		JBrowse link
G Irs1 insulin receptor substrate 1 decreases expression ISO lead acetate results in decreased expression of IRS1 mRNA CTD PMID:30980912 NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137 		JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression EXP lead acetate results in decreased expression of IRS2 mRNA CTD PMID:21829687 NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458 		JBrowse link
G Itga3 integrin alpha 3 increases expression ISO lead acetate results in increased expression of ITGA3 mRNA CTD PMID:38568856 NCBI chr11:94,935,301...94,967,637
Ensembl chr11:94,935,300...94,967,627 		JBrowse link
G Itga5 integrin alpha 5 (fibronectin receptor alpha) increases expression ISO lead acetate results in increased expression of ITGA5 mRNA CTD PMID:38568856 NCBI chr15:103,252,713...103,275,218
Ensembl chr15:103,252,713...103,275,190 		JBrowse link
G Itga6 integrin alpha 6 decreases expression EXP lead acetate results in decreased expression of ITGA6 mRNA CTD PMID:20542052 NCBI chr 2:71,617,236...71,688,761
Ensembl chr 2:71,575,960...71,688,760 		JBrowse link
G Itgae integrin alpha E, epithelial-associated multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of ITGAE protein CTD PMID:38072110 NCBI chr11:72,981,396...73,038,272
Ensembl chr11:72,981,409...73,038,272 		JBrowse link
G Itgal integrin alpha L decreases expression EXP lead acetate results in decreased expression of ITGAL mRNA CTD PMID:22609695 NCBI chr 7:126,895,404...126,934,309
Ensembl chr 7:126,895,432...126,934,310 		JBrowse link
G Itgax integrin alpha X increases expression EXP lead acetate results in increased expression of ITGAX mRNA CTD PMID:21829687 NCBI chr 7:127,728,697...127,749,829
Ensembl chr 7:127,728,719...127,749,829 		JBrowse link
G Itgb1 integrin beta 1 (fibronectin receptor beta) increases expression EXP lead acetate results in increased expression of ITGB1 mRNA CTD PMID:22609695 NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681 		JBrowse link
G Itgb3bp integrin beta 3 binding protein (beta3-endonexin) increases expression EXP lead acetate results in increased expression of ITGB3BP mRNA CTD PMID:22609695 NCBI chr 4:99,655,643...99,717,403
Ensembl chr 4:99,653,639...99,787,010 		JBrowse link
G Itgb4 integrin beta 4 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of ITGB4 mRNA CTD PMID:12634122 NCBI chr11:115,865,556...115,899,238
Ensembl chr11:115,865,535...115,899,238 		JBrowse link
G Itgb5 integrin beta 5 increases expression EXP lead acetate results in increased expression of ITGB5 mRNA CTD PMID:22609695 NCBI chr16:33,650,021...33,769,708
Ensembl chr16:33,650,035...33,769,708 		JBrowse link
G Itgbl1 integrin, beta-like 1 decreases expression ISO lead acetate results in decreased expression of ITGBL1 mRNA CTD PMID:11578147 NCBI chr14:123,897,331...124,215,173
Ensembl chr14:123,897,383...124,213,030 		JBrowse link
G Itih4 inter alpha-trypsin inhibitor, heavy chain 4 increases expression EXP lead acetate results in increased expression of ITIH4 mRNA CTD PMID:22609695 NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310 		JBrowse link
G Itih5 inter-alpha-trypsin inhibitor, heavy chain 5 increases expression EXP lead acetate results in increased expression of ITIH5 mRNA CTD PMID:21829687 NCBI chr 2:10,158,354...10,261,340
Ensembl chr 2:10,158,382...10,261,340 		JBrowse link
G Itm2b integral membrane protein 2B multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of ITM2B protein CTD PMID:38072110 NCBI chr14:73,599,666...73,622,729
Ensembl chr14:73,599,666...73,622,729 		JBrowse link
G Itm2c integral membrane protein 2C increases expression ISO lead acetate results in increased expression of ITM2C mRNA CTD PMID:38568856 NCBI chr 1:85,822,231...85,836,419
Ensembl chr 1:85,822,002...85,836,396 		JBrowse link
G Itpkc inositol 1,4,5-trisphosphate 3-kinase C decreases expression EXP lead acetate results in decreased expression of ITPKC mRNA CTD PMID:20542052 NCBI chr 7:26,906,595...26,928,042
Ensembl chr 7:26,906,597...26,928,086 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor 1 increases expression EXP lead acetate results in increased expression of ITPR1 mRNA CTD PMID:21829687 NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070 		JBrowse link
G Ivd isovaleryl coenzyme A dehydrogenase increases expression EXP lead acetate results in increased expression of IVD protein CTD PMID:20797405 NCBI chr 2:118,692,475...118,713,388
Ensembl chr 2:118,692,435...118,713,390 		JBrowse link
G Jak1 Janus kinase 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of JAK1 protein CTD PMID:32428222 NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479 		JBrowse link
G Jhy junctional cadherin complex regulator affects expression ISO lead acetate affects the expression of JHY mRNA CTD PMID:22641619 NCBI chr 9:40,806,147...40,877,560
Ensembl chr 9:40,806,145...40,875,414 		JBrowse link
G Jkamp JNK1/MAPK8-associated membrane protein decreases expression EXP lead acetate results in decreased expression of JKAMP mRNA CTD PMID:21829687 NCBI chr12:72,132,348...72,148,301
Ensembl chr12:72,132,363...72,148,235 		JBrowse link
G Jmjd6 jumonji domain containing 6 decreases expression EXP lead acetate results in decreased expression of JMJD6 mRNA CTD PMID:21829687 NCBI chr11:116,728,258...116,734,593
Ensembl chr11:116,728,258...116,734,275 		JBrowse link
G Jpt2 Jupiter microtubule associated homolog 2 decreases expression EXP lead acetate results in decreased expression of JPT2 mRNA CTD PMID:22613225 NCBI chr17:25,161,444...25,179,597
Ensembl chr17:25,156,393...25,179,663 		JBrowse link
G Jun jun proto-oncogene increases expression ISO lead acetate results in increased expression of JUN mRNA; lead acetate results in increased expression of JUN protein CTD PMID:23765435 PMID:38568856 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459 		JBrowse link
G Junb jun B proto-oncogene multiple interactions
decreases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of JUNB mRNA
lead acetate results in decreased expression of JUNB mRNA 		CTD PMID:12634122 PMID:22641619 NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347 		JBrowse link
G Jup junction plakoglobin decreases expression ISO lead acetate results in decreased expression of JUP mRNA CTD PMID:38568856 NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589 		JBrowse link
G Kalrn kalirin, RhoGEF kinase increases expression
decreases expression 		EXP lead acetate results in increased expression of KALRN mRNA
lead acetate results in decreased expression of KALRN mRNA 		CTD PMID:20542052 PMID:22609695 NCBI chr16:33,789,443...34,393,647
Ensembl chr16:33,789,443...34,393,902 		JBrowse link
G Kank1 KN motif and ankyrin repeat domains 1 decreases expression
multiple interactions 		EXP lead acetate results in decreased expression of KANK1 mRNA
[lead acetate results in increased abundance of Lead] which results in increased methylation of KANK1 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of KANK1 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of KANK1 promoter 		CTD PMID:22613225 PMID:33445541 NCBI chr19:25,214,146...25,411,861
Ensembl chr19:25,214,339...25,411,860 		JBrowse link
G Kap kidney androgen regulated protein increases expression EXP lead acetate results in increased expression of KAP mRNA CTD PMID:22609695 NCBI chr 6:133,826,818...133,830,630
Ensembl chr 6:133,826,814...133,830,725 		JBrowse link
G Kat6a K(lysine) acetyltransferase 6A increases expression EXP lead acetate results in increased expression of KAT6A mRNA CTD PMID:20542052 NCBI chr 8:23,349,458...23,433,275
Ensembl chr 8:23,349,551...23,433,275 		JBrowse link
G Katnal1 katanin p60 subunit A-like 1 increases expression ISO lead acetate results in increased expression of KATNAL1 mRNA CTD PMID:38568856 NCBI chr 5:148,808,394...148,865,978
Ensembl chr 5:148,808,394...148,931,957 		JBrowse link
G Kcnab1 potassium voltage-gated channel, shaker-related subfamily, beta member 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCNAB1 mRNA CTD PMID:22839698 NCBI chr 3:64,856,636...65,285,643
Ensembl chr 3:64,856,617...65,285,644 		JBrowse link
G Kcnb1 potassium voltage gated channel, Shab-related subfamily, member 1 decreases expression ISO lead acetate results in decreased expression of KCNB1 mRNA CTD PMID:38568856 NCBI chr 2:166,937,889...167,032,088
Ensembl chr 2:166,937,889...167,032,075 		JBrowse link
G Kcnip2 Kv channel-interacting protein 2 increases expression EXP lead acetate results in increased expression of KCNIP2 mRNA CTD PMID:22609695 NCBI chr19:45,780,785...45,804,948
Ensembl chr19:45,780,278...45,804,500 		JBrowse link
G Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 decreases expression ISO lead acetate results in decreased expression of KCNJ16 mRNA CTD PMID:22641619 NCBI chr11:110,858,859...110,918,794
Ensembl chr11:110,858,859...110,918,794 		JBrowse link
G Kcnj5 potassium inwardly-rectifying channel, subfamily J, member 5 decreases expression EXP lead acetate results in decreased expression of KCNJ5 mRNA CTD PMID:21829687 PMID:22609695 NCBI chr 9:32,226,002...32,255,640
Ensembl chr 9:32,226,003...32,255,646 		JBrowse link
G Kcnk2 potassium channel, subfamily K, member 2 decreases expression ISO lead acetate results in decreased expression of KCNK2 mRNA CTD PMID:38568856 NCBI chr 1:188,940,127...189,134,951
Ensembl chr 1:188,940,127...189,134,470 		JBrowse link
G Kcnn4 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 multiple interactions
increases activity 		EXP [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of KCNN4 protein]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of KCNN4 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of KCNN4 protein] CTD PMID:22033380 NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115 		JBrowse link
G Kctd1 potassium channel tetramerisation domain containing 1 increases expression EXP lead acetate results in increased expression of KCTD1 mRNA CTD PMID:21829687 NCBI chr18:15,101,742...15,284,503
Ensembl chr18:15,101,742...15,284,503 		JBrowse link
G Kctd20 potassium channel tetramerisation domain containing 20 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCTD20 mRNA CTD PMID:22839698 NCBI chr17:29,171,420...29,188,523
Ensembl chr17:29,170,924...29,188,523 		JBrowse link
G Kdelr3 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3 increases expression ISO lead acetate results in increased expression of KDELR3 mRNA CTD PMID:38568856 NCBI chr15:79,400,609...79,411,940
Ensembl chr15:79,400,612...79,411,940 		JBrowse link
G Kdm3a lysine (K)-specific demethylase 3A decreases expression ISO lead acetate results in decreased expression of KDM3A mRNA CTD PMID:38568856 NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974 		JBrowse link
G Kdm3b KDM3B lysine (K)-specific demethylase 3B multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of KDM3B protein CTD PMID:38072110 NCBI chr18:34,910,061...34,972,423
Ensembl chr18:34,910,100...34,971,713 		JBrowse link
G Kdr kinase insert domain protein receptor decreases expression EXP lead acetate results in decreased expression of KDR mRNA CTD PMID:20542052 NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118 		JBrowse link
G Keap1 kelch-like ECH-associated protein 1 multiple interactions
decreases expression 		ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein]
[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 mRNA
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 mRNA; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of KEAP1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 mRNA]; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of KEAP1 protein]
lead acetate results in decreased expression of KEAP1 mRNA 		CTD PMID:31610155 PMID:33862172 PMID:38180308 PMID:39276841 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657 		JBrowse link
G Khk ketohexokinase decreases expression ISO lead acetate results in decreased expression of KHK mRNA CTD PMID:38568856 NCBI chr 5:31,078,780...31,088,592
Ensembl chr 5:31,078,775...31,088,592 		JBrowse link
G Kidins220 kinase D-interacting substrate 220 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of KIDINS220 mRNA CTD PMID:22839698 NCBI chr12:25,024,909...25,113,151
Ensembl chr12:25,024,924...25,113,151 		JBrowse link
G Kif11 kinesin family member 11 decreases expression
increases expression 		EXP lead acetate results in decreased expression of KIF11 mRNA
lead acetate results in increased expression of KIF11 mRNA 		CTD PMID:20542052 PMID:22609695 NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307 		JBrowse link
G Kif13b kinesin family member 13B increases expression EXP lead acetate results in increased expression of KIF13B mRNA CTD PMID:22613225 NCBI chr14:64,889,633...65,047,067
Ensembl chr14:64,884,714...65,047,066 		JBrowse link
G Kif17 kinesin family member 17 decreases expression EXP lead acetate results in decreased expression of KIF17 mRNA CTD PMID:22609695 NCBI chr 4:137,989,562...138,029,284
Ensembl chr 4:137,977,746...138,029,278 		JBrowse link
G Kif19a kinesin family member 19A decreases expression ISO lead acetate results in decreased expression of KIF19A mRNA CTD PMID:22641619 NCBI chr11:114,656,227...114,681,565
Ensembl chr11:114,656,214...114,681,565 		JBrowse link
G Kif1b kinesin family member 1B decreases expression EXP lead acetate results in decreased expression of KIF1B mRNA CTD PMID:21829687 NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150 		JBrowse link
G Kif1c kinesin family member 1C increases expression ISO lead acetate results in increased expression of KIF1C mRNA CTD PMID:38568856 NCBI chr11:70,591,170...70,622,796
Ensembl chr11:70,591,374...70,622,790 		JBrowse link
G Kif23 kinesin family member 23 increases expression EXP lead acetate results in increased expression of KIF23 mRNA CTD PMID:22609695 NCBI chr 9:61,824,559...61,854,078
Ensembl chr 9:61,823,187...61,854,056 		JBrowse link
G Kif3b kinesin family member 3B decreases methylation ISO lead acetate results in decreased methylation of KIF3B gene CTD PMID:29571894 NCBI chr 2:153,132,028...153,175,310
Ensembl chr 2:153,133,333...153,175,310 		JBrowse link
G Kif5a kinesin family member 5A increases expression
multiple interactions 		EXP lead acetate results in increased expression of KIF5A mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of KIF5A mRNA; [lead acetate results in increased abundance of Lead] which results in increased methylation of KIF5A intron 		CTD PMID:22609695 PMID:32458983 PMID:33445541 NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217 		JBrowse link
G Kirrel3 kirre like nephrin family adhesion molecule 3 increases expression EXP lead acetate results in increased expression of KIRREL3 mRNA CTD PMID:20542052 NCBI chr 9:34,396,850...34,952,103
Ensembl chr 9:34,397,190...34,948,012 		JBrowse link
G Kitl kit ligand increases expression
multiple interactions 		ISO lead acetate results in increased expression of KITLG mRNA
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KITLG mRNA 		CTD PMID:22839698 NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278 		JBrowse link
G Kl klotho affects expression
decreases expression
multiple interactions 		ISO
EXP 		lead acetate affects the expression of KL mRNA
lead acetate results in decreased expression of KL mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of KL protein 		CTD PMID:21864555 PMID:22609695 PMID:39150886 NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282 		JBrowse link
G Klc2 kinesin light chain 2 increases expression ISO lead acetate results in increased expression of KLC2 mRNA CTD PMID:38568856 NCBI chr19:5,157,774...5,168,326
Ensembl chr19:5,157,774...5,168,588 		JBrowse link
G Klf16 Kruppel-like transcription factor 16 increases expression ISO lead acetate results in increased expression of KLF16 mRNA CTD PMID:38568856 NCBI chr10:80,402,955...80,413,130
Ensembl chr10:80,402,958...80,413,155 		JBrowse link
G Klf6 Kruppel-like transcription factor 6 increases methylation
increases expression 		ISO
EXP 		lead acetate results in increased methylation of KLF6 gene
lead acetate results in increased expression of KLF6 mRNA 		CTD PMID:25270620 PMID:29571894 NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393 		JBrowse link
G Klf9 Kruppel-like transcription factor 9 decreases expression ISO lead acetate results in decreased expression of KLF9 mRNA CTD PMID:22641619 NCBI chr19:23,118,590...23,145,493
Ensembl chr19:23,118,590...23,145,498 		JBrowse link
G Klhdc2 kelch domain containing 2 decreases expression EXP lead acetate results in decreased expression of KLHDC2 mRNA CTD PMID:21829687 NCBI chr12:69,343,455...69,357,461
Ensembl chr12:69,343,455...69,357,461 		JBrowse link
G Klhl1 kelch-like 1 decreases expression
increases methylation 		EXP
ISO 		lead acetate results in decreased expression of KLHL1 mRNA
lead acetate results in increased methylation of KLHL1 gene 		CTD PMID:22613225 PMID:29571894 NCBI chr14:96,342,695...96,756,525
Ensembl chr14:96,340,172...96,756,538 		JBrowse link
G Klk1b24 kallikrein 1-related peptidase b24 decreases expression EXP lead acetate results in decreased expression of KLK1B24 mRNA CTD PMID:21829687 NCBI chr 7:43,837,658...43,841,879
Ensembl chr 7:43,837,660...43,841,879 		JBrowse link
G Klk1b27 kallikrein 1-related peptidase b27 decreases expression EXP lead acetate results in decreased expression of KLK1B27 mRNA CTD PMID:22613225 NCBI chr 7:43,701,714...43,706,136
Ensembl chr 7:43,701,714...43,706,136 		JBrowse link
G Klk6 kallikrein related-peptidase 6 increases expression ISO lead acetate results in increased expression of KLK6 mRNA CTD PMID:22641619 NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454 		JBrowse link
G Klra16 killer cell lectin-like receptor, subfamily A, member 16 decreases expression EXP lead acetate results in decreased expression of KLRA16 mRNA CTD PMID:22609695
G Klra7 killer cell lectin-like receptor, subfamily A, member 7 decreases expression EXP lead acetate results in decreased expression of KLRA7 mRNA CTD PMID:22609695 NCBI chr 6:130,195,568...130,210,285
Ensembl chr 6:130,195,568...130,210,285 		JBrowse link
G Klrb1f killer cell lectin-like receptor subfamily B member 1F increases expression EXP lead acetate results in increased expression of KLRB1F mRNA CTD PMID:22609695 NCBI chr 6:129,022,800...129,036,687
Ensembl chr 6:129,022,864...129,034,427 		JBrowse link
G Kng1 kininogen 1 increases expression ISO lead acetate results in increased expression of KNG1 mRNA CTD PMID:22641619 NCBI chr16:22,876,970...22,900,828
Ensembl chr16:22,876,615...22,900,828 		JBrowse link
G Kpna2 karyopherin subunit alpha 2 decreases expression ISO lead acetate results in decreased expression of KPNA2 mRNA CTD PMID:11578147 NCBI chr11:106,879,455...106,890,351
Ensembl chr11:106,879,455...106,890,367 		JBrowse link
G Kpna4 karyopherin subunit alpha 4 increases expression ISO lead acetate results in increased expression of KPNA4 mRNA CTD PMID:38568856 NCBI chr 3:68,979,554...69,034,425
Ensembl chr 3:68,974,482...69,034,446 		JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog decreases expression
multiple interactions
increases expression 		EXP
ISO 		lead acetate results in decreased expression of KRAS mRNA
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA
lead acetate results in increased expression of KRAS mRNA 		CTD PMID:21829687 PMID:22839698 PMID:25270620 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965 		JBrowse link
G Krt15 keratin 15 decreases expression ISO lead acetate results in decreased expression of KRT15 mRNA CTD PMID:38568856 NCBI chr11:100,022,585...100,026,775
Ensembl chr11:100,022,584...100,026,754 		JBrowse link
G Krt17 keratin 17 increases expression ISO lead acetate results in increased expression of KRT17 mRNA CTD PMID:38568856 NCBI chr11:100,147,041...100,151,855
Ensembl chr11:100,147,043...100,151,855 		JBrowse link
G Krt18 keratin 18 affects expression ISO lead acetate affects the expression of KRT18 protein CTD PMID:36539177 NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462 		JBrowse link
G Krt80 keratin 80 decreases expression ISO lead acetate results in decreased expression of KRT80 mRNA CTD PMID:38568856 NCBI chr15:101,246,196...101,268,043
Ensembl chr15:101,245,325...101,268,043 		JBrowse link
G Ky kyphoscoliosis peptidase increases expression EXP lead acetate results in increased expression of KY mRNA CTD PMID:20542052 NCBI chr 9:102,382,954...102,423,443
Ensembl chr 9:102,382,949...102,423,438 		JBrowse link
G L3mbtl1 L3MBTL1 histone methyl-lysine binding protein increases expression ISO lead acetate results in increased expression of L3MBTL1 mRNA CTD PMID:22641619 NCBI chr 2:162,784,260...162,819,726
Ensembl chr 2:162,785,392...162,816,442 		JBrowse link
G Lacc1 laccase domain containing 1 increases expression ISO lead acetate results in increased expression of LACC1 mRNA CTD PMID:22641619 NCBI chr14:77,261,640...77,274,344
Ensembl chr14:77,261,640...77,274,344 		JBrowse link
G Lair1 leukocyte-associated Ig-like receptor 1 decreases expression EXP lead acetate results in decreased expression of LAIR1 mRNA CTD PMID:21829687 NCBI chr 7:4,010,072...4,076,566
Ensembl chr 7:4,006,401...4,066,178 		JBrowse link
G Lama1 laminin, alpha 1 increases expression EXP lead acetate results in increased expression of LAMA1 mRNA CTD PMID:22609695 NCBI chr17:68,004,129...68,129,640
Ensembl chr17:68,004,254...68,129,642 		JBrowse link
G Lama2 laminin, alpha 2 increases expression EXP lead acetate results in increased expression of LAMA2 mRNA CTD PMID:22609695 NCBI chr10:26,857,281...27,493,021
Ensembl chr10:26,856,032...27,495,754 		JBrowse link
G Lama3 laminin, alpha 3 affects expression
decreases expression 		ISO
EXP 		lead acetate affects the expression of LAMA3 mRNA
lead acetate results in decreased expression of LAMA3 mRNA 		CTD PMID:21864555 PMID:22609695 NCBI chr18:12,466,806...12,716,070
Ensembl chr18:12,466,876...12,716,070 		JBrowse link
G Lama5 laminin, alpha 5 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of LAMA5 mRNA
lead acetate results in decreased expression of LAMA5 mRNA 		CTD PMID:22609695 PMID:38568856 NCBI chr 2:179,818,166...179,867,652
Ensembl chr 2:179,818,166...179,867,652 		JBrowse link
G Lamb1 laminin B1 decreases expression ISO lead acetate results in decreased expression of LAMB1 mRNA CTD PMID:38568856 NCBI chr12:31,315,230...31,379,643
Ensembl chr12:31,315,233...31,379,643 		JBrowse link
G Lamb3 laminin, beta 3 increases expression ISO lead acetate results in increased expression of LAMB3 mRNA CTD PMID:38568856 NCBI chr 1:192,976,661...193,026,186
Ensembl chr 1:192,890,007...193,026,186 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 decreases expression
increases expression
multiple interactions 		ISO lead acetate results in decreased expression of LAMP1 protein
lead acetate results in increased expression of LAMP1 mRNA
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [lead acetate results in decreased expression of LAMP1 protein] 		CTD PMID:34842334 PMID:38568856 NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 multiple interactions EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in increased expression of LAMP2 mRNA CTD PMID:33445541 PMID:39276841 NCBI chr  X:37,488,524...37,545,337
Ensembl chr  X:37,490,234...37,545,331 		JBrowse link
G Laptm5 lysosomal-associated protein transmembrane 5 decreases expression ISO lead acetate results in decreased expression of LAPTM5 mRNA CTD PMID:38568856 NCBI chr 4:130,640,627...130,663,459
Ensembl chr 4:130,640,436...130,663,452 		JBrowse link
G Larp1 La ribonucleoprotein 1, translational regulator increases expression ISO lead acetate results in increased expression of LARP1 mRNA CTD PMID:11578147 NCBI chr11:57,899,711...57,952,860
Ensembl chr11:57,899,890...57,952,860 		JBrowse link
G Larp1b La ribonucleoprotein 1B increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of LARP1B mRNA
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LARP1B mRNA 		CTD PMID:21829687 PMID:22839698 NCBI chr 3:40,904,198...40,994,642
Ensembl chr 3:40,904,263...40,994,669 		JBrowse link
G Lat linker for activation of T cells decreases expression EXP lead acetate results in decreased expression of LAT mRNA CTD PMID:21829687 NCBI chr 7:125,962,999...125,968,877
Ensembl chr 7:125,962,996...125,968,742 		JBrowse link
G Lat2 linker for activation of T cells family, member 2 increases expression EXP lead acetate results in increased expression of LAT2 mRNA CTD PMID:20542052 NCBI chr 5:134,628,957...134,648,637
Ensembl chr 5:134,628,876...134,643,879 		JBrowse link
G Lbh limb-bud and heart decreases expression EXP lead acetate results in decreased expression of LBH mRNA CTD PMID:21829687 NCBI chr17:73,225,300...73,248,941
Ensembl chr17:73,225,300...73,248,942 		JBrowse link
G Lbp lipopolysaccharide binding protein increases expression EXP lead acetate results in increased expression of LBP mRNA CTD PMID:21829687 NCBI chr 2:158,148,413...158,174,772
Ensembl chr 2:158,148,413...158,174,772 		JBrowse link
G Lce1a1 late cornified envelope 1A1 decreases expression EXP lead acetate results in decreased expression of LCE1A1 mRNA CTD PMID:22609695 NCBI chr 3:92,553,839...92,555,614
Ensembl chr 3:92,553,842...92,555,614 		JBrowse link
G Lce1b late cornified envelope 1B increases expression EXP lead acetate results in increased expression of LCE1B mRNA CTD PMID:22609695 NCBI chr 3:92,562,957...92,564,233
Ensembl chr 3:92,562,957...92,564,233 		JBrowse link
G Lck lymphocyte protein tyrosine kinase increases expression EXP lead acetate results in increased expression of LCK mRNA CTD PMID:21829687 NCBI chr 4:129,442,142...129,467,415
Ensembl chr 4:129,442,137...129,467,434 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions
increases expression
decreases expression 		EXP
ISO 		pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of LCN2 mRNA]
lead acetate results in decreased expression of LCN2 mRNA 		CTD PMID:22641619 PMID:36539177 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264 		JBrowse link
G Lcn5 lipocalin 5 increases expression EXP lead acetate results in increased expression of LCN5 mRNA CTD PMID:22609695 NCBI chr 2:25,547,944...25,552,242
Ensembl chr 2:25,547,964...25,551,989 		JBrowse link
G Lcp1 lymphocyte cytosolic protein 1 increases expression EXP lead acetate results in increased expression of LCP1 mRNA CTD PMID:20542052 NCBI chr14:75,368,570...75,468,282
Ensembl chr14:75,368,541...75,468,282 		JBrowse link
G Ldah lipid droplet associated hydrolase decreases expression ISO lead acetate results in decreased expression of LDAH mRNA CTD PMID:22641619 NCBI chr12:8,258,095...8,350,811
Ensembl chr12:8,258,107...8,335,759 		JBrowse link
G Ldb1 LIM domain binding 1 decreases expression EXP lead acetate results in decreased expression of LDB1 mRNA CTD PMID:20542052 NCBI chr19:46,019,963...46,036,584
Ensembl chr19:46,020,009...46,033,653 		JBrowse link
G Ldb3 LIM domain binding 3 decreases expression EXP lead acetate results in decreased expression of LDB3 mRNA CTD PMID:22609695 NCBI chr14:34,248,656...34,312,276
Ensembl chr14:34,248,560...34,310,639 		JBrowse link
G Ldha lactate dehydrogenase A affects expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate affects the expression of LDHA mRNA
[lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LDHA mRNA]; [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LDHA protein]
lead acetate results in decreased expression of LDHA mRNA 		CTD PMID:21864555 PMID:25270620 PMID:30615929 PMID:38157908 NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051 		JBrowse link
G Ldlr low density lipoprotein receptor decreases expression EXP
ISO 		lead acetate results in decreased expression of LDLR mRNA
lead acetate results in decreased expression of LDLR mRNA; lead acetate results in decreased expression of LDLR protein 		CTD PMID:25270620 PMID:29908845 NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215 		JBrowse link
G Ldlrad3 low density lipoprotein receptor class A domain containing 3 increases expression EXP lead acetate results in increased expression of LDLRAD3 mRNA CTD PMID:21829687 NCBI chr 2:101,780,546...102,016,805
Ensembl chr 2:101,780,548...102,016,730 		JBrowse link
G Ldlrad4 low density lipoprotein receptor class A domain containing 4 increases expression EXP lead acetate results in increased expression of LDLRAD4 mRNA CTD PMID:22609695 NCBI chr18:68,065,345...68,393,621
Ensembl chr18:68,066,328...68,401,701 		JBrowse link
G Leap2 liver-expressed antimicrobial peptide 2 decreases expression EXP lead acetate results in decreased expression of LEAP2 mRNA CTD PMID:25270620 NCBI chr11:53,313,008...53,313,963
Ensembl chr11:53,313,008...53,313,997 		JBrowse link
G Lepr leptin receptor decreases expression ISO lead acetate results in decreased expression of LEPR mRNA CTD PMID:38568856 NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549 		JBrowse link
G Letmd1 LETM1 domain containing 1 decreases expression ISO lead acetate results in decreased expression of LETMD1 mRNA CTD PMID:38568856 NCBI chr15:100,360,302...100,377,133
Ensembl chr15:100,366,904...100,377,045 		JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase increases expression ISO lead acetate results in increased expression of LFNG mRNA CTD PMID:22641619 NCBI chr 5:140,593,096...140,601,300
Ensembl chr 5:140,593,075...140,601,300 		JBrowse link
G Lgr5 leucine rich repeat containing G protein coupled receptor 5 decreases expression EXP lead acetate results in decreased expression of LGR5 mRNA CTD PMID:22613225 NCBI chr10:115,286,219...115,423,685
Ensembl chr10:115,286,216...115,423,685 		JBrowse link
G Lhb luteinizing hormone beta decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of LHB protein
naringenin inhibits the reaction [lead acetate results in decreased expression of LHB protein] 		CTD PMID:36807407 NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321 		JBrowse link
G Lhfpl3 lipoma HMGIC fusion partner-like 3 decreases expression EXP lead acetate results in decreased expression of LHFPL3 mRNA CTD PMID:22613225 NCBI chr 5:22,951,052...23,480,595
Ensembl chr 5:22,951,057...23,480,595 		JBrowse link
G Lhfpl4 lipoma HMGIC fusion partner-like protein 4 decreases expression EXP lead acetate results in decreased expression of LHFPL4 mRNA CTD PMID:20542052 NCBI chr 6:113,145,048...113,172,345
Ensembl chr 6:113,145,051...113,172,345 		JBrowse link
G Lhx4 LIM homeobox protein 4 decreases expression ISO lead acetate results in decreased expression of LHX4 mRNA CTD PMID:22641619 NCBI chr 1:155,573,777...155,627,481
Ensembl chr 1:155,573,777...155,627,430 		JBrowse link
G Lif leukemia inhibitory factor increases methylation
increases expression 		ISO lead acetate results in increased methylation of LIF gene
lead acetate results in increased expression of LIF mRNA 		CTD PMID:29571894 PMID:38568856 NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514 		JBrowse link
G Lig4 ligase IV, DNA, ATP-dependent decreases expression ISO lead acetate results in decreased expression of LIG4 mRNA CTD PMID:22641619 NCBI chr 8:10,020,020...10,027,680
Ensembl chr 8:10,019,049...10,027,686 		JBrowse link
G Limk1 LIM domain kinase 1 increases expression ISO lead acetate results in increased expression of LIMK1 mRNA CTD PMID:38568856 NCBI chr 5:134,684,893...134,718,713
Ensembl chr 5:134,684,893...134,717,452 		JBrowse link
G Lims1 LIM and senescent cell antigen-like domains 1 increases expression ISO lead acetate results in increased expression of LIMS1 mRNA CTD PMID:38568856 NCBI chr10:58,159,164...58,260,513
Ensembl chr10:58,159,288...58,260,513 		JBrowse link
G Lims2 LIM and senescent cell antigen like domains 2 increases expression ISO lead acetate results in increased expression of LIMS2 mRNA CTD PMID:22641619 NCBI chr18:32,055,346...32,091,673
Ensembl chr18:32,055,343...32,091,672 		JBrowse link
G Lin28a lin-28 homolog A increases methylation ISO lead acetate results in increased methylation of LIN28A gene CTD PMID:29571894 NCBI chr 4:133,730,641...133,746,504
Ensembl chr 4:133,730,641...133,746,152 		JBrowse link
G Lipa lysosomal acid lipase A increases expression EXP lead acetate results in increased expression of LIPA mRNA CTD PMID:21829687 NCBI chr19:34,469,716...34,504,874
Ensembl chr19:34,469,718...34,504,874 		JBrowse link
G Lman2l lectin, mannose-binding 2-like increases expression EXP lead acetate results in increased expression of LMAN2L mRNA CTD PMID:21829687 NCBI chr 1:36,458,274...36,484,352
Ensembl chr 1:36,458,952...36,484,352 		JBrowse link
G Lmo4 LIM domain only 4 increases expression ISO lead acetate results in increased expression of LMO4 mRNA CTD PMID:38568856 NCBI chr 3:143,894,291...143,911,016
Ensembl chr 3:143,894,291...143,910,981 		JBrowse link
G Lnx1 ligand of numb-protein X 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LNX1 mRNA CTD PMID:22839698 NCBI chr 5:74,753,108...74,865,203
Ensembl chr 5:74,753,108...74,863,573 		JBrowse link
G Lonp1 lon peptidase 1, mitochondrial multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 protein; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 protein] CTD PMID:39547369 NCBI chr17:56,921,297...56,933,903
Ensembl chr17:56,921,297...56,933,887 		JBrowse link
G Lonrf3 LON peptidase N-terminal domain and ring finger 3 increases expression EXP lead acetate results in increased expression of LONRF3 mRNA CTD PMID:25270620 NCBI chr  X:35,592,011...35,630,510
Ensembl chr  X:35,592,006...35,625,994 		JBrowse link
G Lox lysyl oxidase decreases expression ISO lead acetate results in decreased expression of LOX mRNA CTD PMID:38568856 NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939 		JBrowse link
G Loxl3 lysyl oxidase-like 3 decreases expression EXP lead acetate results in decreased expression of LOXL3 mRNA CTD PMID:22609695 NCBI chr 6:83,011,186...83,029,547
Ensembl chr 6:83,011,154...83,029,543 		JBrowse link
G Lpar6 lysophosphatidic acid receptor 6 decreases expression EXP lead acetate results in decreased expression of LPAR6 mRNA CTD PMID:21829687 NCBI chr14:73,475,331...73,477,798
Ensembl chr14:73,475,335...73,480,734 		JBrowse link
G Lpin1 lipin 1 decreases expression ISO lead acetate results in decreased expression of LPIN1 mRNA CTD PMID:38568856 NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967 		JBrowse link
G Lpl lipoprotein lipase increases expression EXP lead acetate results in increased expression of LPL mRNA CTD PMID:21829687 NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100 		JBrowse link
G Lpxn leupaxin increases expression ISO lead acetate results in increased expression of LPXN mRNA CTD PMID:38568856 NCBI chr19:12,773,251...12,811,177
Ensembl chr19:12,773,557...12,811,171 		JBrowse link
G Lrch1 leucine-rich repeats and calponin homology (CH) domain containing 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of LRCH1 intron CTD PMID:33445541 NCBI chr14:74,992,113...75,185,447
Ensembl chr14:74,992,115...75,185,316 		JBrowse link
G Lrg1 leucine-rich alpha-2-glycoprotein 1 decreases expression ISO lead acetate results in decreased expression of LRG1 mRNA CTD PMID:38568856 NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001 		JBrowse link
G Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 decreases expression EXP lead acetate results in decreased expression of LRIG1 mRNA CTD PMID:22613225 NCBI chr 6:94,581,510...94,677,205
Ensembl chr 6:94,581,510...94,677,139 		JBrowse link
G Lrit3 leucine-rich repeat, immunoglobulin-like and transmembrane domains 3 decreases expression ISO lead acetate results in decreased expression of LRIT3 mRNA CTD PMID:22641619 NCBI chr 3:129,577,590...129,597,785
Ensembl chr 3:129,581,530...129,597,679 		JBrowse link
G Lrp1 low density lipoprotein receptor-related protein 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of LRP1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of LRP1 protein CTD PMID:31730887 NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017 		JBrowse link
G Lrp4 low density lipoprotein receptor-related protein 4 increases expression EXP lead acetate results in increased expression of LRP4 mRNA CTD PMID:20542052 NCBI chr 2:91,287,794...91,344,246
Ensembl chr 2:91,287,856...91,344,124 		JBrowse link
G Lrp8 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor increases expression ISO lead acetate results in increased expression of LRP8 mRNA CTD PMID:38568856 NCBI chr 4:107,659,337...107,734,037
Ensembl chr 4:107,659,066...107,734,037 		JBrowse link
G Lrpap1 low density lipoprotein receptor-related protein associated protein 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of LRPAP1 mRNA CTD PMID:12634122 NCBI chr 5:35,248,834...35,263,043
Ensembl chr 5:35,248,845...35,263,110 		JBrowse link
G Lrrc23 leucine rich repeat containing 23 increases expression ISO lead acetate results in increased expression of LRRC23 mRNA CTD PMID:11578147 NCBI chr 6:124,746,832...124,757,411
Ensembl chr 6:124,746,826...124,756,690 		JBrowse link
G Lrrc43 leucine rich repeat containing 43 increases expression ISO lead acetate results in increased expression of LRRC43 mRNA CTD PMID:22641619 NCBI chr 5:123,627,349...123,646,268
Ensembl chr 5:123,627,368...123,646,268 		JBrowse link
G Lrrc59 leucine rich repeat containing 59 increases expression ISO lead acetate results in increased expression of LRRC59 mRNA CTD PMID:38568856 NCBI chr11:94,520,603...94,536,049
Ensembl chr11:94,520,593...94,536,042 		JBrowse link
G Lrrcc1 leucine rich repeat and coiled-coil domain containing 1 decreases expression ISO lead acetate results in decreased expression of LRRCC1 mRNA CTD PMID:22641619 NCBI chr 3:14,595,512...14,637,718
Ensembl chr 3:14,598,848...14,637,718 		JBrowse link
G Lrriq4 leucine-rich repeats and IQ motif containing 4 increases expression EXP lead acetate results in increased expression of LRRIQ4 mRNA CTD PMID:22609695 NCBI chr 3:30,698,636...30,726,583
Ensembl chr 3:30,698,656...30,726,580 		JBrowse link
G Lrrk1 leucine-rich repeat kinase 1 decreases expression EXP lead acetate results in decreased expression of LRRK1 mRNA CTD PMID:22609695 NCBI chr 7:65,908,493...66,038,089
Ensembl chr 7:65,876,660...66,038,098 		JBrowse link
G Ltbp2 latent transforming growth factor beta binding protein 2 increases expression ISO lead acetate results in increased expression of LTBP2 mRNA CTD PMID:37939567 NCBI chr12:84,829,986...84,923,581
Ensembl chr12:84,829,986...84,923,306 		JBrowse link
G Ltf lactotransferrin decreases expression ISO lead acetate results in decreased expression of LTF mRNA CTD PMID:38568856 NCBI chr 9:110,848,360...110,871,834
Ensembl chr 9:110,848,339...110,871,835 		JBrowse link
G Lum lumican decreases expression ISO lead acetate results in decreased expression of LUM mRNA CTD PMID:11578147 NCBI chr10:97,401,363...97,408,565
Ensembl chr10:97,400,990...97,408,565 		JBrowse link
G Ly6g6c lymphocyte antigen 6 family member G6C increases expression EXP lead acetate results in increased expression of LY6G6C mRNA CTD PMID:21829687 NCBI chr17:35,286,301...35,289,024
Ensembl chr17:35,284,364...35,289,026 		JBrowse link
G Ly6k lymphocyte antigen 6 family member K increases expression ISO lead acetate results in increased expression of LY6K mRNA CTD PMID:38568856 NCBI chr15:74,668,723...74,671,817
Ensembl chr15:74,668,723...74,671,835 		JBrowse link
G Ly96 lymphocyte antigen 96 increases expression EXP lead acetate results in increased expression of LY96 mRNA CTD PMID:20542052 NCBI chr 1:16,758,680...16,779,829
Ensembl chr 1:16,758,275...16,779,835 		JBrowse link
G Lypd3 Ly6/Plaur domain containing 3 decreases expression EXP lead acetate results in decreased expression of LYPD3 mRNA CTD PMID:22613225 NCBI chr 7:24,335,995...24,340,543
Ensembl chr 7:24,335,975...24,340,543 		JBrowse link
G Lyrm1 LYR motif containing 1 increases expression ISO lead acetate results in increased expression of LYRM1 mRNA CTD PMID:22641619 NCBI chr 7:119,495,038...119,515,979
Ensembl chr 7:119,495,084...119,556,186 		JBrowse link
G Lyrm7 LYR motif containing 7 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LYRM7 mRNA CTD PMID:22839698 NCBI chr11:54,717,692...54,751,738
Ensembl chr11:54,717,692...54,751,742 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 increases expression ISO lead acetate results in increased expression of LYVE1 mRNA CTD PMID:22641619 NCBI chr 7:110,449,814...110,462,160
Ensembl chr 7:110,449,814...110,462,446 		JBrowse link
G Mab21l1 mab-21-like 1 decreases expression ISO lead acetate results in decreased expression of MAB21L1 mRNA CTD PMID:22641619 NCBI chr 3:55,689,931...55,692,708
Ensembl chr 3:55,689,931...55,692,422 		JBrowse link
G Macf1 microtubule-actin crosslinking factor 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of MACF1 mRNA CTD PMID:22839698 NCBI chr 4:123,243,386...123,581,594
Ensembl chr 4:123,243,426...123,581,331 		JBrowse link
G Maea macrophage erythroblast attacher decreases expression EXP lead acetate results in decreased expression of MAEA mRNA CTD PMID:22609695 NCBI chr 5:33,492,916...33,530,638
Ensembl chr 5:33,492,853...33,530,640 		JBrowse link
G Mafb MAF bZIP transcription factor B decreases expression ISO lead acetate results in decreased expression of MAFB mRNA CTD PMID:38568856 NCBI chr 2:160,205,597...160,208,985
Ensembl chr 2:160,205,623...160,208,985 		JBrowse link
G Mafg v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) increases expression ISO lead acetate results in increased expression of MAFG mRNA CTD PMID:38568856 NCBI chr11:120,515,943...120,525,771
Ensembl chr11:120,515,943...120,524,426 		JBrowse link
G Mag myelin-associated glycoprotein increases expression
multiple interactions 		ISO lead acetate results in increased expression of MAG mRNA
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] affects the expression of MAG protein 		CTD PMID:11578147 PMID:23680456 NCBI chr 7:30,598,600...30,614,347
Ensembl chr 7:30,598,601...30,614,298 		JBrowse link
G Mageb1 MAGE family member B1 decreases expression ISO lead acetate results in decreased expression of MAGEB1 mRNA CTD PMID:22641619 NCBI chr  X:91,058,797...91,059,939
Ensembl chr  X:91,058,797...91,059,939 		JBrowse link
G Magoh mago homolog, exon junction complex core component decreases expression EXP lead acetate results in decreased expression of MAGOH mRNA CTD PMID:21829687 NCBI chr 4:107,736,952...107,744,621
Ensembl chr 4:107,736,952...107,744,621 		JBrowse link
G Mak male germ cell-associated kinase decreases expression ISO lead acetate results in decreased expression of MAK mRNA CTD PMID:22641619 NCBI chr13:41,178,483...41,233,182
Ensembl chr13:41,178,484...41,233,182 		JBrowse link
G Mal2 mal, T cell differentiation protein 2 decreases expression ISO lead acetate results in decreased expression of MAL2 mRNA CTD PMID:38568856 NCBI chr15:54,434,762...54,466,242
Ensembl chr15:54,434,588...54,466,243 		JBrowse link
G Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) increases expression EXP lead acetate results in increased expression of MALAT1 mRNA CTD PMID:21829687 NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,853,602 		JBrowse link
G Mamdc2 MAM domain containing 2 increases expression ISO lead acetate results in increased expression of MAMDC2 mRNA CTD PMID:22641619 NCBI chr19:23,279,973...23,425,855
Ensembl chr19:23,279,973...23,425,806 		JBrowse link
G Man1b1 mannosidase, alpha, class 1B, member 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of MAN1B1 protein CTD PMID:38072110 NCBI chr 2:25,222,742...25,242,225
Ensembl chr 2:25,222,350...25,242,224 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor increases expression ISO lead acetate results in increased expression of MANF mRNA CTD PMID:38568856 NCBI chr 9:106,765,952...106,769,137
Ensembl chr 9:106,715,511...106,769,178 		JBrowse link
G Map1a microtubule-associated protein 1 A increases expression ISO lead acetate results in increased expression of MAP1A mRNA CTD PMID:37939567 NCBI chr 2:121,119,608...121,141,313
Ensembl chr 2:121,120,081...121,141,313 		JBrowse link
G Map1b microtubule-associated protein 1B increases expression ISO lead acetate results in increased expression of MAP1B mRNA CTD PMID:38568856 NCBI chr13:99,557,972...99,653,110
Ensembl chr13:99,557,954...99,653,048 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B protein; [lead acetate results in increased abundance of Lead] which results in increased lipidation of MAP1LC3B protein CTD PMID:36652739 PMID:36840722 NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499 		JBrowse link
G Map2 microtubule-associated protein 2 decreases expression
multiple interactions
increases expression 		EXP
ISO 		lead acetate results in decreased expression of MAP2 mRNA
PANX2 protein inhibits the reaction [lead acetate results in increased expression of MAP2 mRNA] 		CTD PMID:22013134 PMID:37939567 NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742 		JBrowse link
G Map2k1 mitogen-activated protein kinase kinase 1 multiple interactions ISO bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein]; lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein; Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K1 protein] CTD PMID:11861786 NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913 		JBrowse link
G Map2k2 mitogen-activated protein kinase kinase 2 multiple interactions ISO bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K2 protein]; lead acetate results in increased phosphorylation of and results in increased activity of MAP2K2 protein; Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAP2K2 protein] CTD PMID:11861786 NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809 		JBrowse link
G Map2k6 mitogen-activated protein kinase kinase 6 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAP2K6 mRNA CTD PMID:12634122 NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of MAP3K5 mRNA CTD PMID:36642386 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 increases expression EXP
ISO 		lead acetate results in increased expression of MAP4K4 mRNA CTD PMID:21829687 PMID:38568856 NCBI chr 1:39,939,806...40,065,470
Ensembl chr 1:39,940,073...40,065,470 		JBrowse link
G Map4k5 mitogen-activated protein kinase kinase kinase kinase 5 increases expression EXP lead acetate results in increased expression of MAP4K5 mRNA CTD PMID:21322097 NCBI chr12:69,850,531...69,939,937
Ensembl chr12:69,850,524...69,939,974 		JBrowse link
G Map6d1 MAP6 domain containing 1 increases expression EXP lead acetate results in increased expression of MAP6D1 mRNA CTD PMID:20542052 NCBI chr16:20,052,059...20,060,108
Ensembl chr16:20,052,053...20,060,108 		JBrowse link
G Map7d1 MAP7 domain containing 1 increases expression ISO lead acetate results in increased expression of MAP7D1 mRNA CTD PMID:38568856 NCBI chr 4:126,125,960...126,150,112
Ensembl chr 4:126,125,960...126,150,136 		JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions
increases expression
increases phosphorylation
affects expression
decreases phosphorylation
increases oxidation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; [E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK1 protein modified form]] which results in decreased phosphorylation of MAPK1 protein modified form; [lead acetate results in decreased expression of PRKCA protein] inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; E 3330 inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK1 protein modified form]; E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK1 protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK1 protein]; lead acetate promotes the reaction [MAPK1 protein modified form binds to APEX1 protein]; lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein; RTKI cpd inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; SU 6656 inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; U 0126 inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]
lead acetate results in increased expression of MAPK1 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of MAPK1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of MAPK1 protein; Ascorbic Acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; Genistein inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; lead acetate results in decreased phosphorylation of and results in decreased activity of MAPK1 protein; lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein; Quercetin inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]
lead acetate affects the expression of MAPK1
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]; Quercetin inhibits the reaction [lead acetate results in increased phosphorylation of MAPK1 protein]
lead acetate results in decreased phosphorylation of MAPK1 protein
lead acetate results in increased oxidation of MAPK1 protein; lead acetate results in increased oxidation of MAPK1 protein modified form 		CTD PMID:11233754 PMID:11861786 PMID:15302094 PMID:17298174 PMID:19133285 More... NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317 		JBrowse link
G Mapk10 mitogen-activated protein kinase 10 affects expression ISO lead acetate affects the expression of MAPK10 CTD PMID:24293362 NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200 		JBrowse link
G Mapk11 mitogen-activated protein kinase 11 affects expression
increases expression 		ISO
EXP 		lead acetate affects the expression of MAPK11
lead acetate results in increased expression of MAPK11 mRNA 		CTD PMID:21322097 PMID:24293362 NCBI chr15:89,026,685...89,033,809
Ensembl chr15:89,026,689...89,033,831 		JBrowse link
G Mapk14 mitogen-activated protein kinase 14 affects expression
increases expression
multiple interactions 		ISO lead acetate affects the expression of MAPK14
lead acetate results in increased expression of MAPK14 mRNA
sinapinic acid inhibits the reaction [lead acetate results in increased expression of MAPK14 mRNA] 		CTD PMID:24293362 PMID:37471654 NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380 		JBrowse link
G Mapk15 mitogen-activated protein kinase 15 multiple interactions
increases expression 		ISO sinapinic acid inhibits the reaction [lead acetate results in increased expression of MAPK15 mRNA] CTD PMID:37471654 NCBI chr15:75,865,581...75,871,002
Ensembl chr15:75,865,618...75,871,003 		JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation
affects expression
decreases phosphorylation
increases oxidation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; [E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK3 protein modified form]] which results in decreased phosphorylation of MAPK3 protein modified form; [lead acetate results in decreased expression of PRKCA protein] inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; APEX1 protein promotes the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; bisindolylmaleimide I inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; E 3330 inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK3 protein modified form]; E 3330 promotes the reaction [lead acetate results in increased oxidation of MAPK3 protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; lead acetate promotes the reaction [APEX1 protein results in increased phosphorylation of MAPK3 protein]; lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein; RTKI cpd inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; SU 6656 inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; Tetradecanoylphorbol Acetate inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; U 0126 inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK3 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of MAPK3 mRNA; [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of MAPK3 protein; Ascorbic Acid inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; Genistein inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]; lead acetate results in decreased phosphorylation of and results in decreased activity of MAPK3 protein; lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein; Quercetin inhibits the reaction [lead acetate results in increased phosphorylation of MAPK3 protein]
lead acetate affects the expression of MAPK3
lead acetate results in decreased phosphorylation of MAPK3 protein
lead acetate results in increased oxidation of MAPK3 protein; lead acetate results in increased oxidation of MAPK3 protein modified form 		CTD PMID:11233754 PMID:11861786 PMID:15302094 PMID:17298174 PMID:19133285 More... NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991 		JBrowse link
G Mapk4 mitogen-activated protein kinase 4 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK4 mRNA CTD PMID:12634122 NCBI chr18:74,061,557...74,198,643
Ensembl chr18:74,061,557...74,198,430 		JBrowse link
G Mapk6 mitogen-activated protein kinase 6 increases expression EXP lead acetate results in increased expression of MAPK6 mRNA CTD PMID:21322097 NCBI chr 9:75,294,064...75,317,303
Ensembl chr 9:75,276,344...75,317,287 		JBrowse link
G Mapk7 mitogen-activated protein kinase 7 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of MAPK7 protein CTD PMID:39947421 NCBI chr11:61,379,638...61,385,101
Ensembl chr11:61,379,638...61,385,232 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases expression
multiple interactions
affects expression
increases phosphorylation 		ISO lead acetate results in increased expression of MAPK8 mRNA
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK8 protein]; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK8 protein; [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of MAPK8 protein; Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of MAPK8 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of MAPK8 mRNA]
lead acetate affects the expression of MAPK8 		CTD PMID:20829427 PMID:24293362 PMID:25088297 PMID:35307918 PMID:37471654 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions
increases phosphorylation 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MAPK9 mRNA
lead acetate results in increased phosphorylation of MAPK9 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein]; [Cadmium Chloride co-treated with sodium arsenite co-treated with lead acetate] results in increased phosphorylation of MAPK9 protein; Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of MAPK9 protein] 		CTD PMID:12634122 PMID:20829427 PMID:25088297 NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248 		JBrowse link
G Mapkapk2 MAP kinase-activated protein kinase 2 increases expression EXP lead acetate results in increased expression of MAPKAPK2 mRNA CTD PMID:21322097 NCBI chr 1:130,981,437...131,025,580
Ensembl chr 1:130,981,437...131,025,563 		JBrowse link
G Mapre2 microtubule-associated protein, RP/EB family, member 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of MAPRE2 protein CTD PMID:38072110 NCBI chr18:23,885,390...24,026,918
Ensembl chr18:23,885,390...24,026,918 		JBrowse link
G Mapt microtubule-associated protein tau increases expression
multiple interactions
increases phosphorylation 		EXP
ISO 		lead acetate results in increased expression of MAPT mRNA
lead acetate results in increased expression of and results in increased phosphorylation of MAPT protein
lead acetate results in decreased expression of and results in increased phosphorylation of MAPT protein; lead acetate results in increased expression of and results in increased phosphorylation of MAPT protein; Proanthocyanidins inhibits the reaction [lead acetate results in increased phosphorylation of MAPT protein]
[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of MAPT protein; lead acetate affects the reaction [MAPT protein affects the abundance of CDK5R1 protein modified form]; lead acetate results in increased expression of and results in increased phosphorylation of MAPT protein 		CTD PMID:22811615 PMID:23134599 PMID:24954411 PMID:25088297 PMID:27012722 More... NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916 		JBrowse link
G Marchf7 membrane associated ring-CH-type finger 7 increases expression EXP lead acetate results in increased expression of MARCHF7 mRNA CTD PMID:21829687 NCBI chr 2:60,040,086...60,079,555
Ensembl chr 2:60,040,231...60,081,020 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO lead acetate results in decreased expression of MARCKS mRNA; lead acetate results in decreased expression of MARCKS protein CTD PMID:11578147 NCBI chr10:37,009,239...37,014,922
Ensembl chr10:37,009,371...37,014,916 		JBrowse link
G Marcksl1 MARCKS-like 1 decreases expression EXP lead acetate results in decreased expression of MARCKSL1 mRNA CTD PMID:25270620 NCBI chr 4:129,407,374...129,409,774
Ensembl chr 4:129,407,374...129,409,778 		JBrowse link
G Mark2 MAP/microtubule affinity regulating kinase 2 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of MARK2 mRNA CTD PMID:22839698 NCBI chr19:7,252,761...7,319,222
Ensembl chr19:7,252,761...7,319,225 		JBrowse link
G Mars1 methionine-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of MARS1 mRNA CTD PMID:11578147 NCBI chr10:127,132,090...127,147,655
Ensembl chr10:127,132,090...127,147,655 		JBrowse link
G Masp1 MBL associated serine protease 1 decreases expression EXP lead acetate results in decreased expression of MASP1 mRNA CTD PMID:22609695 NCBI chr16:23,261,778...23,340,127
Ensembl chr16:23,268,167...23,339,565 		JBrowse link
G Mast2 microtubule associated serine/threonine kinase 2 increases expression EXP lead acetate results in increased expression of MAST2 mRNA CTD PMID:21829687 NCBI chr 4:116,163,957...116,321,420
Ensembl chr 4:116,163,959...116,321,471 		JBrowse link
G Mastl microtubule associated serine/threonine kinase-like increases expression EXP lead acetate results in increased expression of MASTL mRNA CTD PMID:22609695 NCBI chr 2:23,006,549...23,046,036
Ensembl chr 2:23,005,618...23,046,036 		JBrowse link
G Mat2a methionine adenosyltransferase 2A decreases expression EXP lead acetate results in decreased expression of MAT2A mRNA CTD PMID:21829687 NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541 		JBrowse link
G Matk megakaryocyte-associated tyrosine kinase multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MATK mRNA CTD PMID:12634122 NCBI chr10:81,088,769...81,098,819
Ensembl chr10:81,088,769...81,099,199 		JBrowse link
G Mb myoglobin decreases expression EXP lead acetate results in decreased expression of MB mRNA CTD PMID:22609695 PMID:29746905 NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870 		JBrowse link
G Mbd3 methyl-CpG binding domain protein 3 increases expression ISO lead acetate results in increased expression of MBD3 mRNA CTD PMID:38568856 NCBI chr10:80,228,373...80,235,365
Ensembl chr10:80,228,373...80,235,384 		JBrowse link
G Mbd3l2 methyl-CpG binding domain protein 3-like 2 increases expression EXP lead acetate results in increased expression of MBD3L2 mRNA CTD PMID:22609695 NCBI chr 9:18,341,911...18,357,612
Ensembl chr 9:18,341,950...18,357,612 		JBrowse link
G Mbd4 methyl-CpG binding domain protein 4 decreases expression ISO lead acetate results in decreased expression of MBD4 mRNA CTD PMID:38568856 NCBI chr 6:115,817,658...115,830,361
Ensembl chr 6:115,817,658...115,830,332 		JBrowse link
G Mbp myelin basic protein decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of MBP mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of MBP mRNA
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of MBP protein
lead acetate results in decreased expression of MBP protein 		CTD PMID:21829687 PMID:23680456 PMID:32458983 NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762 		JBrowse link
G Mbtd1 mbt domain containing 1 decreases expression EXP lead acetate results in decreased expression of MBTD1 mRNA CTD PMID:21829687 NCBI chr11:93,776,635...93,837,815
Ensembl chr11:93,776,678...93,837,811 		JBrowse link
G Mc4r melanocortin 4 receptor increases expression ISO lead acetate results in increased expression of MC4R mRNA CTD PMID:22641619 NCBI chr18:66,990,776...66,993,558
Ensembl chr18:66,990,775...66,993,577 		JBrowse link
G Mcc mutated in colorectal cancers multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCC mRNA CTD PMID:12634122 NCBI chr18:44,558,127...44,945,573
Ensembl chr18:44,558,127...44,945,249 		JBrowse link
G Mcf2 mcf.2 transforming sequence multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MCF2 mRNA CTD PMID:12634122 NCBI chr  X:59,101,316...59,224,546
Ensembl chr  X:59,101,316...59,224,449 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 decreases expression EXP lead acetate results in decreased expression of MCM2 mRNA CTD PMID:21829687 NCBI chr 6:88,860,456...88,875,762
Ensembl chr 6:88,860,456...88,875,762 		JBrowse link
G Mcm8 minichromosome maintenance 8 homologous recombination repair factor increases expression ISO lead acetate results in increased expression of MCM8 mRNA CTD PMID:38568856 NCBI chr 2:132,658,061...132,686,117
Ensembl chr 2:132,658,061...132,686,117 		JBrowse link
G Mdfic MyoD family inhibitor domain containing decreases expression ISO lead acetate results in decreased expression of MDFIC mRNA CTD PMID:22641619 NCBI chr 6:15,720,660...15,802,168
Ensembl chr 6:15,720,660...15,802,168 		JBrowse link
G Mdh2 malate dehydrogenase 2, NAD (mitochondrial) multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of MDH2 protein CTD PMID:38072110 NCBI chr 5:135,807,503...135,819,240
Ensembl chr 5:135,807,334...135,819,252 		JBrowse link
G Mdk midkine decreases expression ISO lead acetate results in decreased expression of MDK mRNA CTD PMID:21864555 NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642 		JBrowse link
G Mdp1 magnesium-dependent phosphatase 1 decreases expression EXP lead acetate results in decreased expression of MDP1 mRNA CTD PMID:21829687 NCBI chr14:55,895,346...55,897,908
Ensembl chr14:55,895,336...55,897,965 		JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic increases expression ISO lead acetate results in increased expression of ME1 mRNA CTD PMID:22839698 PMID:37939567 PMID:38568856 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006 		JBrowse link
G Me2 malic enzyme 2, NAD(+)-dependent, mitochondrial multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ME2 intron CTD PMID:33445541 NCBI chr18:73,898,025...73,949,326
Ensembl chr18:73,902,974...73,948,520 		JBrowse link
G Mecp2 methyl CpG binding protein 2 decreases expression
affects expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of MECP2 protein
lead acetate affects the expression of MECP2 mRNA
[lead acetate results in increased abundance of Lead] which affects the expression of MECP2 protein 		CTD PMID:22160880 PMID:23246732 PMID:29481626 NCBI chr  X:73,070,198...73,129,296
Ensembl chr  X:73,070,198...73,129,296 		JBrowse link
G Med10 mediator complex subunit 10 increases expression ISO lead acetate results in increased expression of MED10 mRNA CTD PMID:38568856 NCBI chr13:69,950,467...69,964,221
Ensembl chr13:69,950,514...69,964,223 		JBrowse link
G Med13l mediator complex subunit 13-like increases expression EXP lead acetate results in increased expression of MED13L mRNA CTD PMID:20542052 NCBI chr 5:118,698,363...118,903,503
Ensembl chr 5:118,698,744...118,903,503 		JBrowse link
G Mef2a myocyte enhancer factor 2A affects expression EXP lead acetate affects the expression of MEF2A mRNA CTD PMID:21829687 NCBI chr 7:66,880,911...67,026,435
Ensembl chr 7:66,880,911...67,022,606 		JBrowse link
G Mef2c myocyte enhancer factor 2C multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of MEF2C protein CTD PMID:39947421 NCBI chr13:83,652,136...83,815,197
Ensembl chr13:83,652,153...83,815,199 		JBrowse link
G Megf9 multiple EGF-like-domains 9 increases expression ISO lead acetate results in increased expression of MEGF9 mRNA CTD PMID:37939567 NCBI chr 4:70,350,164...70,453,165
Ensembl chr 4:70,345,302...70,453,232 		JBrowse link
G Meig1 meiosis expressed gene 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of MEIG1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of MEIG1 protein CTD PMID:32142724 NCBI chr 2:3,410,080...3,423,685
Ensembl chr 2:3,410,080...3,423,685 		JBrowse link
G Mepe matrix extracellular phosphoglycoprotein with ASARM motif (bone) increases expression EXP lead acetate results in increased expression of MEPE mRNA CTD PMID:22609695 NCBI chr 5:104,473,195...104,486,477
Ensembl chr 5:104,473,195...104,486,477 		JBrowse link
G Mertk MER proto-oncogene tyrosine kinase increases expression ISO lead acetate results in increased expression of MERTK mRNA CTD PMID:22641619 NCBI chr 2:128,540,836...128,645,082
Ensembl chr 2:128,540,876...128,644,814 		JBrowse link
G Mest mesoderm specific transcript increases expression
decreases methylation 		ISO lead acetate results in increased expression of MEST mRNA
lead acetate results in decreased methylation of MEST gene 		CTD PMID:25596546 NCBI chr 6:30,733,505...30,783,580
Ensembl chr 6:30,723,546...30,748,464 		JBrowse link
G Met met proto-oncogene decreases expression ISO lead acetate results in decreased expression of MET protein CTD PMID:17298174 NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979 		JBrowse link
G Mettl17 methyltransferase like 17 increases methylation ISO lead acetate results in increased methylation of METTL17 gene CTD PMID:29571894 NCBI chr14:52,122,375...52,129,325
Ensembl chr14:52,122,299...52,130,496 		JBrowse link
G Mettl4 methyltransferase 4, N6-adenosine decreases expression EXP lead acetate results in decreased expression of METTL4 mRNA CTD PMID:22613225 NCBI chr17:95,030,018...95,057,579
Ensembl chr17:95,030,018...95,057,447 		JBrowse link
G Mfrp membrane frizzled-related protein affects expression ISO lead acetate affects the expression of MFRP mRNA CTD PMID:21864555 NCBI chr 9:44,013,067...44,020,484
Ensembl chr 9:44,013,026...44,020,484 		JBrowse link
G Mfsd11 major facilitator superfamily domain containing 11 increases expression EXP lead acetate results in increased expression of MFSD11 mRNA CTD PMID:21829687 NCBI chr11:116,743,037...116,766,486
Ensembl chr11:116,743,266...116,766,461 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 increases expression ISO lead acetate results in increased expression of MGST1 mRNA CTD PMID:11578147 PMID:22641619 PMID:37939567 PMID:38568856 NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753 		JBrowse link
G Mia2 MIA SH3 domain ER export factor 2 decreases expression EXP lead acetate results in decreased expression of MIA2 mRNA CTD PMID:21829687 NCBI chr12:59,142,368...59,237,006
Ensembl chr12:59,142,585...59,238,369 		JBrowse link
G Mid1 midline 1 increases expression EXP lead acetate results in increased expression of MID1 mRNA CTD PMID:20542052 NCBI chr  X:168,468,178...168,773,692
Ensembl chr  X:168,468,195...168,773,794 		JBrowse link
G Mid1ip1 Mid1 interacting protein 1 (gastrulation specific G12-like (zebrafish)) increases expression ISO lead acetate results in increased expression of MID1IP1 mRNA CTD PMID:38568856 NCBI chr  X:10,583,604...10,585,941
Ensembl chr  X:10,581,252...10,585,929 		JBrowse link
G Miga2 mitoguardin 2 increases expression EXP lead acetate results in increased expression of MIGA2 mRNA CTD PMID:21829687 NCBI chr 2:30,254,232...30,275,532
Ensembl chr 2:30,254,245...30,275,533 		JBrowse link
G Mink1 misshapen-like kinase 1 (zebrafish) increases expression EXP lead acetate results in increased expression of MINK1 mRNA CTD PMID:21322097 NCBI chr11:70,452,272...70,505,309
Ensembl chr11:70,453,707...70,505,309 		JBrowse link
G Mios meiosis regulator for oocyte development increases expression EXP lead acetate results in increased expression of MIOS mRNA CTD PMID:20542052 NCBI chr 6:8,209,111...8,240,573
Ensembl chr 6:8,209,222...8,236,274 		JBrowse link
G Miox myo-inositol oxygenase decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of MIOX mRNA
lead acetate results in increased expression of MIOX mRNA 		CTD PMID:22609695 PMID:22641619 NCBI chr15:89,218,676...89,221,210
Ensembl chr15:89,218,601...89,221,218 		JBrowse link
G Mir100 microRNA 100 decreases expression EXP lead acetate results in decreased expression of MIR100 mRNA CTD PMID:36183778 NCBI chr 9:41,442,721...41,442,800
Ensembl chr 9:41,442,721...41,442,800 		JBrowse link
G Mir106b microRNA 106b multiple interactions ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in increased expression of MIR106B mRNA; MIR106B mRNA affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of XIAP protein] CTD PMID:32344020 NCBI chr 5:138,163,999...138,164,080
Ensembl chr 5:138,163,999...138,164,080 		JBrowse link
G Mir1247 microRNA 1247 increases expression EXP lead acetate results in increased expression of MIR1247 mRNA CTD PMID:36183778 NCBI chr12:110,244,482...110,244,563
Ensembl chr12:110,244,482...110,244,563 		JBrowse link
G Mir1306 microRNA 1306 increases expression EXP lead acetate results in increased expression of MIR1306 mRNA CTD PMID:36183778 NCBI chr16:18,102,103...18,102,181
Ensembl chr16:18,102,103...18,102,181 		JBrowse link
G Mir149 microRNA 149 increases expression EXP lead acetate results in increased expression of MIR149 mRNA CTD PMID:36183778 NCBI chr 1:92,778,100...92,778,165
Ensembl chr 1:92,778,100...92,778,165 		JBrowse link
G Mir154 microRNA 154 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR154 mRNA CTD PMID:24080485 NCBI chr12:109,704,867...109,704,932
Ensembl chr12:109,704,867...109,704,932 		JBrowse link
G Mir194-1 microRNA 194-1 decreases expression EXP lead acetate results in decreased expression of MIR194-1 mRNA CTD PMID:36183778 NCBI chr 1:185,045,516...185,045,582
Ensembl chr 1:185,045,516...185,045,582 		JBrowse link
G Mir194-2 microRNA 194-2 increases expression EXP lead acetate results in increased expression of MIR194-2 mRNA CTD PMID:36183778 NCBI chr19:6,314,673...6,314,758
Ensembl chr19:6,314,673...6,314,758 		JBrowse link
G Mir1b microRNA 1b increases expression EXP lead acetate results in increased expression of MIR1B mRNA CTD PMID:36183778 NCBI chr18:10,785,446...10,785,567
Ensembl chr18:10,785,446...10,785,567 		JBrowse link
G Mir202 microRNA 202 increases expression EXP lead acetate results in increased expression of MIR202 mRNA CTD PMID:36183778 NCBI chr 7:139,537,602...139,537,673
Ensembl chr 7:139,537,602...139,537,673 		JBrowse link
G Mir204 microRNA 204 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR204 mRNA CTD PMID:24080485 NCBI chr19:22,727,969...22,728,036
Ensembl chr19:22,727,969...22,728,036 		JBrowse link
G Mir205 microRNA 205 decreases expression EXP lead acetate results in decreased expression of MIR205 mRNA CTD PMID:36183778 NCBI chr 1:193,189,771...193,189,838
Ensembl chr 1:193,189,771...193,189,838 		JBrowse link
G Mir206 microRNA 206 decreases expression EXP lead acetate results in decreased expression of MIR206 mRNA CTD PMID:36183778 NCBI chr 1:20,749,234...20,749,306
Ensembl chr 1:20,749,234...20,749,306 		JBrowse link
G Mir216a microRNA 216a decreases expression EXP lead acetate results in decreased expression of MIR216A mRNA CTD PMID:36183778 NCBI chr11:28,707,012...28,707,083
Ensembl chr11:28,707,012...28,707,083 		JBrowse link
G Mir221 microRNA 221 decreases expression EXP lead acetate results in decreased expression of MIR221 mRNA CTD PMID:36183778 NCBI chr  X:19,012,533...19,012,627
Ensembl chr  X:19,012,533...19,012,627 		JBrowse link
G Mir222 microRNA 222 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR222 mRNA CTD PMID:24080485 NCBI chr  X:19,013,132...19,013,210
Ensembl chr  X:19,013,132...19,013,210 		JBrowse link
G Mir27b microRNA 27b multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR27B mRNA CTD PMID:24080485 NCBI chr13:63,448,526...63,448,598
Ensembl chr13:63,448,526...63,448,598 		JBrowse link
G Mir3065 microRNA 3065 increases expression EXP lead acetate results in increased expression of MIR3065 mRNA CTD PMID:36183778 NCBI chr11:119,905,593...119,905,679
Ensembl chr11:119,905,593...119,905,679 		JBrowse link
G Mir30c-1 microRNA 30c-1 increases expression EXP lead acetate results in increased expression of MIR30C-1 mRNA CTD PMID:36183778 NCBI chr 4:120,626,731...120,626,819
Ensembl chr 4:120,626,731...120,626,819 		JBrowse link
G Mir3107 microRNA 3107 decreases expression EXP lead acetate results in decreased expression of MIR3107 mRNA CTD PMID:36183778 NCBI chr 8:23,632,589...23,632,678
Ensembl chr 8:23,632,589...23,632,678 		JBrowse link
G Mir330 microRNA 330 increases expression EXP lead acetate results in increased expression of MIR330 mRNA CTD PMID:36183778 NCBI chr 7:18,915,390...18,915,487
Ensembl chr 7:18,915,390...18,915,487 		JBrowse link
G Mir338 microRNA 338 increases expression EXP lead acetate results in increased expression of MIR338 mRNA CTD PMID:36183778 NCBI chr11:119,905,591...119,905,688
Ensembl chr11:119,905,591...119,905,688 		JBrowse link
G Mir339 microRNA 339 increases expression EXP lead acetate results in increased expression of MIR339 mRNA CTD PMID:36183778 NCBI chr 5:139,355,405...139,355,500
Ensembl chr 5:139,355,405...139,355,500 		JBrowse link
G Mir34b microRNA 34b multiple interactions EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in increased expression of MIR34B mRNA
[[lead acetate results in increased abundance of Lead] which results in increased expression of MIR34B mRNA] which results in decreased expression of VAMP2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of MIR34B mRNA 		CTD PMID:35367965 NCBI chr 9:51,014,862...51,014,945
Ensembl chr 9:51,014,862...51,014,945 		JBrowse link
G Mir34c microRNA 34c increases expression EXP lead acetate results in increased expression of MIR34C mRNA CTD PMID:27293183 NCBI chr 9:51,014,334...51,014,410
Ensembl chr 9:51,014,334...51,014,410 		JBrowse link
G Mir363 microRNA 363 decreases expression EXP lead acetate results in decreased expression of MIR363 mRNA CTD PMID:36183778 NCBI chr  X:51,830,570...51,830,644
Ensembl chr  X:51,830,570...51,830,644 		JBrowse link
G Mir375 microRNA 375 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR375 mRNA CTD PMID:24080485 NCBI chr 1:74,939,817...74,939,880
Ensembl chr 1:74,939,817...74,939,880 		JBrowse link
G Mir376c microRNA 376c multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR376C mRNA CTD PMID:24080485 NCBI chr12:109,689,152...109,689,237
Ensembl chr12:109,689,152...109,689,237 		JBrowse link
G Mir379 microRNA 379 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of MIR379 mRNA CTD PMID:24080485 NCBI chr12:109,675,494...109,675,559
Ensembl chr12:109,675,494...109,675,559 		JBrowse link
G Mir382 microRNA 382 increases expression EXP lead acetate results in increased expression of MIR382 mRNA CTD PMID:36183778 NCBI chr12:109,700,205...109,700,280
Ensembl chr12:109,700,205...109,700,280 		JBrowse link
G Mir451a microRNA 451a decreases expression EXP lead acetate results in decreased expression of MIR451A mRNA CTD PMID:36183778 NCBI chr11:77,963,996...77,964,067
Ensembl chr11:77,963,996...77,964,067 		JBrowse link
G Mir466h microRNA 466h increases expression EXP lead acetate results in increased expression of MIR466H mRNA CTD PMID:36183778 NCBI chr 2:10,519,702...10,519,782
Ensembl chr 2:10,519,702...10,519,782 		JBrowse link
G Mir466i microRNA 466i increases expression EXP lead acetate results in increased expression of MIR466I mRNA CTD PMID:36183778 NCBI chr13:17,922,058...17,922,178
Ensembl chr13:17,922,058...17,922,178 		JBrowse link
G Mir467c microRNA 467c increases expression EXP lead acetate results in increased expression of MIR467C mRNA CTD PMID:36183778 NCBI chr 2:10,478,742...10,478,838
Ensembl chr 2:10,478,742...10,478,838 		JBrowse link
G Mir467d microRNA 467d increases expression EXP lead acetate results in increased expression of MIR467D mRNA CTD PMID:36183778 NCBI chr 2:10,512,441...10,512,525
Ensembl chr 2:10,512,441...10,512,525 		JBrowse link
G Mir485 microRNA 485 increases expression EXP lead acetate results in increased expression of MIR485 mRNA CTD PMID:36183778 NCBI chr12:109,701,336...109,701,408
Ensembl chr12:109,701,336...109,701,408 		JBrowse link
G Mir486 microRNA 486 decreases expression EXP lead acetate results in decreased expression of MIR486 mRNA CTD PMID:36183778 NCBI chr 8:23,632,571...23,632,698
Ensembl chr 8:23,632,571...23,632,698 		JBrowse link
G Mir488 microRNA 488 decreases expression EXP lead acetate results in decreased expression of MIR488 mRNA CTD PMID:36183778 NCBI chr 1:158,333,195...158,333,303
Ensembl chr 1:158,333,195...158,333,303 		JBrowse link
G Mir543 microRNA 543 increases expression EXP lead acetate results in increased expression of MIR543 mRNA CTD PMID:36183778 NCBI chr12:109,683,692...109,683,767
Ensembl chr12:109,683,692...109,683,767 		JBrowse link
G Mir574 microRNA 574 increases expression EXP lead acetate results in increased expression of MIR574 mRNA CTD PMID:36183778 NCBI chr 5:65,127,661...65,127,738
Ensembl chr 5:65,127,661...65,127,738 		JBrowse link
G Mir664 microRNA 664 increases expression EXP lead acetate results in increased expression of MIR664 mRNA CTD PMID:36183778 NCBI chr 1:184,975,172...184,975,240
Ensembl chr 1:184,975,172...184,975,240 		JBrowse link
G Mir671 microRNA 671 decreases expression
multiple interactions 		EXP lead acetate results in decreased expression of MIR671 mRNA
MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP3 protein]; MIR671 mRNA inhibits the reaction [lead acetate results in increased expression of CASP9 protein] 		CTD PMID:27604105 NCBI chr 5:24,797,112...24,797,209
Ensembl chr 5:24,797,112...24,797,209 		JBrowse link
G Mir674 microRNA 674 increases expression EXP lead acetate results in increased expression of MIR674 mRNA CTD PMID:36183778 NCBI chr 2:117,015,608...117,015,707
Ensembl chr 2:117,015,608...117,015,707 		JBrowse link
G Mir704 microRNA 704 increases expression EXP lead acetate results in increased expression of MIR704 mRNA CTD PMID:36183778 NCBI chr 6:47,780,510...47,780,586
Ensembl chr 6:47,780,510...47,780,586 		JBrowse link
G Mir7213 microRNA 7213 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of MIR7213 promoter CTD PMID:33445541 NCBI chr15:79,883,171...79,883,227
Ensembl chr15:79,883,171...79,883,227 		JBrowse link
G Mir7b microRNA 7b decreases expression EXP lead acetate results in decreased expression of MIR7B mRNA CTD PMID:36183778 NCBI chr17:56,549,988...56,550,098
Ensembl chr17:56,549,988...56,550,098 		JBrowse link
G Mir883b microRNA 883b increases expression EXP lead acetate results in increased expression of MIR883B mRNA CTD PMID:36183778 NCBI chr  X:65,833,496...65,833,573
Ensembl chr  X:65,833,496...65,833,573 		JBrowse link
G Mirlet7c-1 microRNA let7c-1 decreases expression EXP lead acetate results in decreased expression of MIRLET7C-1 mRNA CTD PMID:36183778 NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638 		JBrowse link
G Mis18a MIS18 kinetochore protein A affects expression ISO lead acetate affects the expression of MIS18A mRNA CTD PMID:22641619 NCBI chr16:90,516,200...90,524,259
Ensembl chr16:90,516,200...90,524,292 		JBrowse link
G Mitf melanogenesis associated transcription factor increases expression EXP lead acetate results in increased expression of MITF mRNA CTD PMID:20542052 NCBI chr 6:97,783,966...97,998,321
Ensembl chr 6:97,784,013...97,998,310 		JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein] CTD PMID:33978298 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090 		JBrowse link
G Mknk2 MAP kinase-interacting serine/threonine kinase 2 decreases expression EXP lead acetate results in decreased expression of MKNK2 mRNA CTD PMID:25270620 NCBI chr10:80,501,152...80,512,264
Ensembl chr10:80,501,161...80,513,946 		JBrowse link
G Mlec malectin increases expression EXP lead acetate results in increased expression of MLEC mRNA CTD PMID:21829687 NCBI chr 5:115,281,040...115,296,235
Ensembl chr 5:115,281,040...115,296,238 		JBrowse link
G Mlf1 myeloid leukemia factor 1 decreases expression EXP lead acetate results in decreased expression of MLF1 mRNA CTD PMID:22609695 NCBI chr 3:67,281,430...67,307,333
Ensembl chr 3:67,281,430...67,307,336 		JBrowse link
G Mllt1 myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1 increases expression ISO lead acetate results in increased expression of MLLT1 mRNA CTD PMID:38568856 NCBI chr17:57,199,611...57,242,497
Ensembl chr17:57,198,385...57,242,415 		JBrowse link
G Mllt11 myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 increases expression ISO lead acetate results in increased expression of MLLT11 mRNA CTD PMID:38568856 NCBI chr 3:95,125,852...95,139,486
Ensembl chr 3:95,126,446...95,139,482 		JBrowse link
G Mllt3 myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of MLLT3 mRNA
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of MLLT3 mRNA 		CTD PMID:21829687 PMID:22839698 NCBI chr 4:87,688,162...87,951,652
Ensembl chr 4:87,688,162...87,951,601 		JBrowse link
G Mlph melanophilin increases expression ISO lead acetate results in increased expression of MLPH mRNA CTD PMID:38568856 NCBI chr 1:90,842,750...90,878,864
Ensembl chr 1:90,842,807...90,878,864 		JBrowse link
G Mlxip MLX interacting protein decreases expression ISO lead acetate results in decreased expression of MLXIP mRNA CTD PMID:22641619 NCBI chr 5:123,532,438...123,595,998
Ensembl chr 5:123,532,861...123,595,995 		JBrowse link
G Mmp14 matrix metallopeptidase 14 (membrane-inserted) decreases expression
increases expression 		ISO lead acetate results in decreased expression of MMP14 mRNA
lead acetate results in increased expression of MMP14 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821 		JBrowse link
G Mmp19 matrix metallopeptidase 19 increases expression EXP lead acetate results in increased expression of MMP19 mRNA CTD PMID:22609695 NCBI chr10:128,626,779...128,636,696
Ensembl chr10:128,626,779...128,636,693 		JBrowse link
G Mmp2 matrix metallopeptidase 2 affects expression ISO lead acetate affects the expression of MMP2 mRNA CTD PMID:21864555 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048 		JBrowse link
G Mmp25 matrix metallopeptidase 25 increases expression EXP lead acetate results in increased expression of MMP25 mRNA CTD PMID:20542052 NCBI chr17:23,847,289...23,864,006
Ensembl chr17:23,847,285...23,864,251 		JBrowse link
G Mmp28 matrix metallopeptidase 28 (epilysin) decreases expression ISO lead acetate results in decreased expression of MMP28 mRNA CTD PMID:38568856 NCBI chr11:83,331,594...83,353,890
Ensembl chr11:83,331,594...83,353,897 		JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of MMP3 protein CTD PMID:38072110 NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression EXP lead acetate results in increased expression of MMP9 mRNA CTD PMID:20542052 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770 		JBrowse link
G Mocos molybdenum cofactor sulfurase increases expression EXP lead acetate results in increased expression of MOCOS mRNA CTD PMID:22609695 NCBI chr18:24,786,538...24,834,634
Ensembl chr18:24,786,748...24,834,632 		JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 increases expression EXP lead acetate results in increased expression of MOGAT2 mRNA CTD PMID:20542052 NCBI chr 7:98,868,291...98,887,818
Ensembl chr 7:98,868,291...98,887,826 		JBrowse link
G Morf4l2 mortality factor 4 like 2 decreases expression EXP lead acetate results in decreased expression of MORF4L2 mRNA CTD PMID:21829687 NCBI chr  X:135,633,691...135,644,435
Ensembl chr  X:135,633,691...135,644,439 		JBrowse link
G Mos Moloney sarcoma oncogene decreases expression EXP lead acetate results in decreased expression of MOS mRNA CTD PMID:22609695 NCBI chr 4:3,870,658...3,872,105
Ensembl chr 4:3,870,657...3,872,105 		JBrowse link
G Mospd1 motile sperm domain containing 1 decreases expression ISO lead acetate results in decreased expression of MOSPD1 mRNA CTD PMID:22641619 NCBI chr  X:52,433,471...52,459,567
Ensembl chr  X:52,433,475...52,459,379 		JBrowse link
G Mov10 Mov10 RISC complex RNA helicase decreases expression EXP lead acetate results in decreased expression of MOV10 mRNA CTD PMID:36183778 NCBI chr 3:104,702,144...104,725,935
Ensembl chr 3:104,702,152...104,725,879 		JBrowse link
G Mpeg1 macrophage expressed gene 1 increases expression EXP lead acetate results in increased expression of MPEG1 mRNA CTD PMID:21829687 NCBI chr19:12,438,134...12,442,649
Ensembl chr19:12,438,143...12,442,649 		JBrowse link
G Mphosph6 M phase phosphoprotein 6 increases expression ISO lead acetate results in increased expression of MPHOSPH6 mRNA CTD PMID:38568856 NCBI chr 8:118,518,376...118,528,713
Ensembl chr 8:118,518,384...118,528,682 		JBrowse link
G Mpo myeloperoxidase increases expression
multiple interactions 		ISO lead acetate results in increased expression of MPO protein
3-methyladenine inhibits the reaction [lead acetate results in increased expression of MPO protein] 		CTD PMID:32879255 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239 		JBrowse link
G Mprip myosin phosphatase Rho interacting protein increases expression ISO lead acetate results in increased expression of MPRIP mRNA CTD PMID:38568856 NCBI chr11:59,552,973...59,671,686
Ensembl chr11:59,552,131...59,671,686 		JBrowse link
G Mrc1 mannose receptor, C type 1 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of MRC1 mRNA
[lead acetate results in increased abundance of Lead] promotes the reaction [[IL4 protein co-treated with IFNG protein] results in increased expression of MRC1 protein] 		CTD PMID:22641619 PMID:34352350 NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868 		JBrowse link
G Mrc2 mannose receptor, C type 2 decreases expression EXP lead acetate results in decreased expression of MRC2 mRNA CTD PMID:22609695 NCBI chr11:105,183,440...105,241,971
Ensembl chr11:105,183,469...105,241,965 		JBrowse link
G Mrpl11 mitochondrial ribosomal protein L11 increases expression EXP lead acetate results in increased expression of MRPL11 mRNA CTD PMID:22609695 NCBI chr19:5,012,180...5,017,023
Ensembl chr19:5,012,175...5,017,027 		JBrowse link
G Mrpl19 mitochondrial ribosomal protein L19 increases expression EXP lead acetate results in increased expression of MRPL19 mRNA CTD PMID:21829687 NCBI chr 6:81,934,807...81,942,930
Ensembl chr 6:81,934,832...81,942,939 		JBrowse link
G Mrpl21 mitochondrial ribosomal protein L21 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of MRPL21 protein CTD PMID:38072110 NCBI chr19:3,332,997...3,342,837
Ensembl chr19:3,332,901...3,342,837 		JBrowse link
G Mrpl3 mitochondrial ribosomal protein L3 increases expression EXP lead acetate results in increased expression of MRPL3 mRNA CTD PMID:22609695 NCBI chr 9:104,930,394...104,954,665
Ensembl chr 9:104,930,438...104,957,087 		JBrowse link
G Mrpl41 mitochondrial ribosomal protein L41 increases expression ISO lead acetate results in increased expression of MRPL41 mRNA CTD PMID:38568856 NCBI chr 2:24,862,482...24,865,110
Ensembl chr 2:24,864,129...24,865,110 		JBrowse link
G Mrps12 mitochondrial ribosomal protein S12 decreases expression EXP lead acetate results in decreased expression of MRPS12 mRNA CTD PMID:25270620 NCBI chr 7:28,439,066...28,441,246
Ensembl chr 7:28,439,066...28,441,245 		JBrowse link
G Mrps27 mitochondrial ribosomal protein S27 decreases expression ISO lead acetate results in decreased expression of MRPS27 mRNA CTD PMID:38568856 NCBI chr13:99,481,275...99,552,070
Ensembl chr13:99,481,294...99,552,070 		JBrowse link
G Mrps33 mitochondrial ribosomal protein S33 decreases expression ISO lead acetate results in decreased expression of MRPS33 mRNA CTD PMID:22641619 NCBI chr 6:39,778,738...39,787,870
Ensembl chr 6:39,778,738...39,787,922 		JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 decreases expression EXP lead acetate results in decreased expression of MRPS6 mRNA CTD PMID:21829687 NCBI chr16:91,855,224...91,909,115
Ensembl chr16:91,855,158...91,909,115 		JBrowse link
G Msgn1 mesogenin 1 decreases expression EXP lead acetate results in decreased expression of MSGN1 mRNA CTD PMID:22609695 NCBI chr12:11,258,383...11,258,949
Ensembl chr12:11,258,361...11,258,973 		JBrowse link
G Msh2 mutS homolog 2 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MSH2 mRNA CTD PMID:12634122 NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141 		JBrowse link
G Msh5 mutS homolog 5 decreases expression EXP lead acetate results in decreased expression of MSH5 mRNA CTD PMID:22609695 PMID:22613225 NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721 		JBrowse link
G Msi2 musashi RNA-binding protein 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of MSI2 intron CTD PMID:33445541 NCBI chr11:88,230,208...88,609,197
Ensembl chr11:88,230,208...88,609,339 		JBrowse link
G Msln mesothelin decreases expression ISO lead acetate results in decreased expression of MSLN mRNA CTD PMID:38568856 NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352 		JBrowse link
G Msmo1 methylsterol monoxygenase 1 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of MSMO1 mRNA
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MSMO1 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MSMO1 protein 		CTD PMID:38157908 PMID:38568856 NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826 		JBrowse link
G Msx2 msh homeobox 2 decreases expression EXP lead acetate results in decreased expression of MSX2 mRNA CTD PMID:22609695 NCBI chr13:53,620,917...53,626,816
Ensembl chr13:53,620,920...53,627,110 		JBrowse link
G mt-Atp8 ATP synthase 8, mitochondrial decreases expression ISO lead acetate results in decreased expression of ATP8 mRNA CTD PMID:37939567 NCBI chr MT:7,766...7,969
Ensembl chr MT:7,766...7,969 		JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of COX1 mRNA CTD PMID:39276841 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872 		JBrowse link
G Mt1 metallothionein 1 increases expression
multiple interactions
affects expression
decreases response to substance 		EXP
ISO 		lead acetate results in increased expression of MT1 mRNA
[lead acetate co-treated with Cadmium Chloride] results in increased expression of MT1A mRNA; lead acetate promotes the reaction [Cadmium Chloride results in increased expression of MT1A mRNA]; Melatonin promotes the reaction [lead acetate results in increased expression of MT1A mRNA]
lead acetate results in increased expression of MT1 mRNA; lead acetate results in increased expression of MT1A mRNA
lead acetate affects the expression of MT1 mRNA
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of MT1X mRNA
lead acetate results in increased expression of MT1X mRNA
MT1 results in decreased susceptibility to lead acetate 		CTD PMID:12634122 PMID:19096765 PMID:20600549 PMID:21335049 PMID:22839698 More... NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955 		JBrowse link
G Mt2 metallothionein 2 decreases response to substance
increases expression
multiple interactions
decreases expression 		EXP
ISO 		MT2 results in decreased susceptibility to lead acetate
lead acetate results in increased expression of MT2A mRNA
[lead acetate co-treated with Cadmium Chloride] results in increased expression of MT2A mRNA; lead acetate promotes the reaction [Cadmium Chloride results in increased expression of MT2A mRNA]; Melatonin promotes the reaction [lead acetate results in increased expression of MT2A mRNA]
lead acetate results in increased expression of MT2 mRNA
lead acetate results in decreased expression of MT2A mRNA
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased expression of MT2 mRNA 		CTD PMID:19096765 PMID:20600549 PMID:21335049 PMID:22641619 PMID:22839698 More... NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196 		JBrowse link
G Mt3 metallothionein 3 multiple interactions
decreases expression
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of MT3 mRNA
coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of MT3 mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of MT3 protein]
lead acetate results in decreased expression of MT3 mRNA; lead acetate results in decreased expression of MT3 protein
lead acetate results in increased expression of MT3 mRNA; lead acetate results in increased expression of MT3 protein 		CTD PMID:12634122 PMID:29452138 PMID:33856607 NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774 		JBrowse link
G Mta1 metastasis associated 1 increases expression ISO lead acetate results in increased expression of MTA1 mRNA CTD PMID:38568856 NCBI chr12:113,061,830...113,100,826
Ensembl chr12:113,061,898...113,100,826 		JBrowse link
G Mtf1 metal response element binding transcription factor 1 affects phosphorylation ISO lead acetate affects the phosphorylation of MTF1 protein CTD PMID:24962574 NCBI chr 4:124,696,342...124,743,593
Ensembl chr 4:124,695,897...124,743,593 		JBrowse link
G Mtfr1l mitochondrial fission regulator 1-like increases expression EXP lead acetate results in increased expression of MTFR1L mRNA CTD PMID:21829687 NCBI chr 4:134,252,866...134,262,698
Ensembl chr 4:134,252,861...134,262,698 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase increases expression ISO lead acetate results in increased expression of MTHFD2 mRNA CTD PMID:11578147 NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890 		JBrowse link
G Mtmr10 myotubularin related protein 10 decreases expression EXP lead acetate results in decreased expression of MTMR10 mRNA CTD PMID:21829687 NCBI chr 7:63,937,443...63,990,556
Ensembl chr 7:63,937,401...63,990,554 		JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation
multiple interactions
increases phosphorylation
decreases expression 		ISO lead acetate results in decreased phosphorylation of MTOR protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of MTOR mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of MTOR protein; naringenin inhibits the reaction [lead acetate results in decreased expression of MTOR protein]
lead acetate results in increased phosphorylation of MTOR protein
SRT1720 inhibits the reaction [lead acetate results in increased phosphorylation of MTOR protein]
lead acetate results in decreased expression of MTOR mRNA; lead acetate results in decreased expression of MTOR protein 		CTD PMID:22811615 PMID:30980912 PMID:32879255 PMID:34842334 PMID:36652739 More... NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140 		JBrowse link
G Mtus1 mitochondrial tumor suppressor 1 decreases expression ISO lead acetate results in decreased expression of MTUS1 mRNA CTD PMID:38568856 NCBI chr 8:41,443,949...41,587,318
Ensembl chr 8:41,443,951...41,586,763 		JBrowse link
G Mtx1 metaxin 1 increases expression EXP lead acetate results in increased expression of MTX1 mRNA CTD PMID:21829687 NCBI chr 3:89,116,388...89,121,214
Ensembl chr 3:89,116,388...89,134,395 		JBrowse link
G Muc1 mucin 1, transmembrane decreases expression ISO lead acetate results in decreased expression of MUC1 mRNA CTD PMID:38568856 NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688 		JBrowse link
G Muc5ac mucin 5, subtypes A and C, tracheobronchial/gastric increases expression EXP lead acetate results in increased expression of MUC5AC mRNA CTD PMID:22609695 NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968 		JBrowse link
G Mug1 murinoglobulin 1 decreases expression ISO lead acetate results in decreased expression of MUG1 mRNA CTD PMID:22641619 NCBI chr 6:121,815,455...121,866,016
Ensembl chr 6:121,815,500...121,866,016 		JBrowse link
G Mup4 major urinary protein 4 increases expression ISO lead acetate results in increased expression of MUP4 mRNA CTD PMID:22641619 NCBI chr 4:59,956,804...59,960,667
Ensembl chr 4:59,956,804...59,960,710 		JBrowse link
G Mustn1 musculoskeletal, embryonic nuclear protein 1 increases expression ISO lead acetate results in increased expression of MUSTN1 mRNA CTD PMID:22641619 NCBI chr14:30,601,214...30,603,567
Ensembl chr14:30,601,157...30,603,567 		JBrowse link
G Mutyh mutY DNA glycosylase increases expression EXP lead acetate results in increased expression of MUTYH mRNA CTD PMID:21335049 NCBI chr 4:116,664,846...116,676,641
Ensembl chr 4:116,664,920...116,676,637 		JBrowse link
G Mvd mevalonate (diphospho) decarboxylase decreases expression EXP lead acetate results in decreased expression of MVD mRNA CTD PMID:22613225 NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161 		JBrowse link
G Mvk mevalonate kinase multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MVK mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of MVK protein CTD PMID:38157908 NCBI chr 5:114,582,324...114,598,652
Ensembl chr 5:114,582,330...114,598,652 		JBrowse link
G Mx2 MX dynamin-like GTPase 2 decreases expression EXP lead acetate results in decreased expression of MX2 mRNA CTD PMID:22613225 NCBI chr16:97,337,281...97,362,101
Ensembl chr16:97,336,508...97,362,100 		JBrowse link
G Mxd4 Max dimerization protein 4 decreases expression ISO lead acetate results in decreased expression of MXD4 mRNA CTD PMID:38568856 NCBI chr 5:34,331,231...34,345,076
Ensembl chr 5:34,331,227...34,345,064 		JBrowse link
G Myadm myeloid-associated differentiation marker increases expression ISO lead acetate results in increased expression of MYADM mRNA CTD PMID:38568856 NCBI chr 7:3,337,563...3,347,871
Ensembl chr 7:3,337,605...3,348,958 		JBrowse link
G Mybl1 myeloblastosis oncogene-like 1 decreases expression EXP lead acetate results in decreased expression of MYBL1 mRNA CTD PMID:22609695 NCBI chr 1:9,737,632...9,770,664
Ensembl chr 1:9,737,640...9,770,434 		JBrowse link
G Mybpc1 myosin binding protein C, slow-type decreases expression ISO lead acetate results in decreased expression of MYBPC1 mRNA CTD PMID:38568856 NCBI chr10:88,354,141...88,441,051
Ensembl chr10:88,354,141...88,441,014 		JBrowse link
G Mybph myosin binding protein H decreases expression EXP lead acetate results in decreased expression of MYBPH mRNA CTD PMID:22609695 NCBI chr 1:134,121,159...134,128,975
Ensembl chr 1:134,121,186...134,128,970 		JBrowse link
G Mycn v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA CTD PMID:12634122 NCBI chr12:12,986,094...12,991,837
Ensembl chr12:12,986,094...12,991,915 		JBrowse link
G Myd88 myeloid differentiation primary response gene 88 multiple interactions
increases expression 		EXP 3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of MYD88 protein] CTD PMID:37385299 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477 		JBrowse link
G Myh4 myosin, heavy polypeptide 4, skeletal muscle decreases expression
multiple interactions 		EXP lead acetate results in decreased expression of MYH4 mRNA; lead acetate results in decreased expression of MYH4 protein
HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 protein] 		CTD PMID:37797690 NCBI chr11:67,128,638...67,151,273
Ensembl chr11:67,128,855...67,151,272 		JBrowse link
G Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha decreases expression EXP lead acetate results in decreased expression of MYH6 mRNA CTD PMID:22609695 NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384 		JBrowse link
G Myl3 myosin, light polypeptide 3 affects expression EXP lead acetate affects the expression of MYL3 mRNA CTD PMID:22609695 NCBI chr 9:110,592,746...110,598,870
Ensembl chr 9:110,570,929...110,598,866 		JBrowse link
G Myl9 myosin, light polypeptide 9, regulatory increases expression ISO lead acetate results in increased expression of MYL9 mRNA CTD PMID:38568856 NCBI chr 2:156,617,373...156,623,578
Ensembl chr 2:156,617,340...156,623,578 		JBrowse link
G Myo5a myosin VA increases expression ISO lead acetate results in increased expression of MYO5A mRNA CTD PMID:38568856 NCBI chr 9:74,975,183...75,130,970
Ensembl chr 9:74,978,297...75,130,970 		JBrowse link
G Myo6 myosin VI decreases expression EXP lead acetate results in decreased expression of MYO6 mRNA CTD PMID:21829687 NCBI chr 9:80,072,262...80,219,011
Ensembl chr 9:80,072,313...80,219,011 		JBrowse link
G Myod1 myogenic differentiation 1 multiple interactions
decreases expression 		EXP HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 protein]
lead acetate results in decreased expression of MYOD1 mRNA; lead acetate results in decreased expression of MYOD1 protein 		CTD PMID:37797690 NCBI chr 7:46,025,898...46,028,516
Ensembl chr 7:46,025,898...46,028,523 		JBrowse link
G Myog myogenin decreases expression
multiple interactions
increases expression 		EXP lead acetate results in decreased expression of MYOG mRNA; lead acetate results in decreased expression of MYOG protein
HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG protein]
lead acetate results in increased expression of MYOG mRNA 		CTD PMID:22613225 PMID:37797690 NCBI chr 1:134,217,742...134,220,286
Ensembl chr 1:134,217,727...134,220,286 		JBrowse link
G Myoz1 myozenin 1 increases expression EXP lead acetate results in increased expression of MYOZ1 mRNA CTD PMID:22609695 NCBI chr14:20,699,170...20,706,608
Ensembl chr14:20,699,175...20,706,608 		JBrowse link
G Myoz3 myozenin 3 decreases expression EXP lead acetate results in decreased expression of MYOZ3 mRNA CTD PMID:22609695 NCBI chr18:60,706,789...60,724,931
Ensembl chr18:60,706,822...60,724,860 		JBrowse link
G N4bp2l2 NEDD4 binding protein 2-like 2 decreases expression EXP lead acetate results in decreased expression of N4BP2L2 mRNA CTD PMID:21829687 NCBI chr 5:150,515,310...150,589,213
Ensembl chr 5:150,531,472...150,589,648 		JBrowse link
G Naa20 N(alpha)-acetyltransferase 20, NatB catalytic subunit increases expression EXP lead acetate results in increased expression of NAA20 mRNA CTD PMID:21829687 NCBI chr 2:145,743,454...145,758,345
Ensembl chr 2:145,744,019...145,758,345 		JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression EXP lead acetate results in increased expression of NAAA mRNA CTD PMID:22609695 NCBI chr 5:92,405,519...92,426,040
Ensembl chr 5:92,405,518...92,426,029 		JBrowse link
G Nacc1 nucleus accumbens associated 1, BEN and BTB (POZ) domain containing increases expression ISO lead acetate results in increased expression of NACC1 mRNA CTD PMID:38568856 NCBI chr 8:85,397,106...85,414,528
Ensembl chr 8:85,397,108...85,414,531 		JBrowse link
G Naga N-acetyl galactosaminidase, alpha increases expression EXP lead acetate results in increased expression of NAGA mRNA CTD PMID:21829687 NCBI chr15:82,213,746...82,222,983
Ensembl chr15:82,213,733...82,223,126 		JBrowse link
G Naip5 NLR family, apoptosis inhibitory protein 5 decreases expression
increases expression 		EXP lead acetate results in decreased expression of NAIP5 mRNA
lead acetate results in increased expression of NAIP5 mRNA 		CTD PMID:21829687 PMID:22609695 NCBI chr13:100,348,243...100,387,437
Ensembl chr13:100,348,247...100,382,831 		JBrowse link
G Nanog Nanog homeobox decreases expression
increases expression 		EXP lead acetate results in decreased expression of NANOG mRNA
lead acetate results in increased expression of NANOG mRNA 		CTD PMID:25270620 PMID:31715224 NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592 		JBrowse link
G Naprt nicotinate phosphoribosyltransferase decreases expression ISO lead acetate results in decreased expression of NAPRT mRNA CTD PMID:38568856 NCBI chr15:75,762,812...75,766,330
Ensembl chr15:75,762,805...75,766,330 		JBrowse link
G Narf nuclear prelamin A recognition factor increases expression EXP lead acetate results in increased expression of NARF mRNA CTD PMID:22609695 NCBI chr11:121,128,062...121,146,682
Ensembl chr11:121,128,079...121,146,682 		JBrowse link
G Nars1 asparaginyl-tRNA synthetase 1 increases expression ISO
EXP 		lead acetate results in increased expression of NARS1 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr18:64,632,726...64,649,586
Ensembl chr18:64,632,718...64,649,723 		JBrowse link
G Nat1 N-acetyl transferase 1 increases expression EXP lead acetate results in increased expression of NAT1 mRNA CTD PMID:22609695 NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756 		JBrowse link
G Nav3 neuron navigator 3 increases expression ISO lead acetate results in increased expression of NAV3 mRNA CTD PMID:38568856 NCBI chr10:109,517,121...110,292,148
Ensembl chr10:109,517,120...110,292,065 		JBrowse link
G Nbl1 NBL1, DAN family BMP antagonist increases expression ISO lead acetate results in increased expression of NBL1 mRNA CTD PMID:38568856 NCBI chr 4:138,809,602...138,820,437
Ensembl chr 4:138,809,595...138,820,304 		JBrowse link
G Ncam2 neural cell adhesion molecule 2 decreases expression EXP lead acetate results in decreased expression of NCAM2 mRNA CTD PMID:22609695 NCBI chr16:80,997,501...81,425,549
Ensembl chr16:80,997,585...81,423,716 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 increases expression EXP lead acetate results in increased expression of NCF1 mRNA CTD PMID:21829687 NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of NCOA2 mRNA
lead acetate promotes the reaction [VDR protein binds to NCOA2 protein] 		CTD PMID:21229763 PMID:22641619 NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307 		JBrowse link
G Ncoa4 nuclear receptor coactivator 4 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 protein; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 mRNA]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NCOA4 protein] CTD PMID:39276841 NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812 		JBrowse link
G Ncoa7 nuclear receptor coactivator 7 decreases expression ISO lead acetate results in decreased expression of NCOA7 mRNA CTD PMID:38568856 NCBI chr10:30,521,578...30,683,401
Ensembl chr10:30,504,995...30,679,322 		JBrowse link
G Ncor2 nuclear receptor co-repressor 2 increases expression ISO lead acetate results in increased expression of NCOR2 mRNA CTD PMID:38568856 NCBI chr 5:125,094,217...125,256,302
Ensembl chr 5:125,094,217...125,256,283 		JBrowse link
G Ncs1 neuronal calcium sensor 1 increases expression ISO lead acetate results in increased expression of NCS1 mRNA CTD PMID:38568856 NCBI chr 2:31,135,766...31,186,001
Ensembl chr 2:31,135,835...31,186,001 		JBrowse link
G Ncstn nicastrin increases expression EXP lead acetate results in increased expression of NCSTN mRNA CTD PMID:20542052 NCBI chr 1:171,893,580...171,910,356
Ensembl chr 1:171,893,580...171,910,362 		JBrowse link
G Ndrg1 N-myc downstream regulated gene 1 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of NDRG1 mRNA
lead acetate results in decreased expression of NDRG1 mRNA 		CTD PMID:20542052 PMID:38568856 NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489 		JBrowse link
G Ndufa7 NADH:ubiquinone oxidoreductase subunit A7 decreases expression EXP lead acetate results in decreased expression of NDUFA7 mRNA CTD PMID:21829687 NCBI chr17:34,043,546...34,057,290
Ensembl chr17:34,043,546...34,057,291 		JBrowse link
G Ndufa9 NADH:ubiquinone oxidoreductase subunit A9 decreases expression EXP lead acetate results in decreased expression of NDUFA9 mRNA CTD PMID:21829687 NCBI chr 6:126,798,826...126,826,107
Ensembl chr 6:126,798,684...126,826,099 		JBrowse link
G Ndufab1 NADH:ubiquinone oxidoreductase subunit AB1 decreases expression EXP lead acetate results in decreased expression of NDUFAB1 mRNA CTD PMID:21829687 NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109 		JBrowse link
G Ndufb8 NADH:ubiquinone oxidoreductase subunit B8 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of NDUFB8 protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of NDUFB8 protein] CTD PMID:36096218 NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879 		JBrowse link
G Ndufc1 NADH:ubiquinone oxidoreductase subunit C1 increases expression EXP lead acetate results in increased expression of NDUFC1 mRNA CTD PMID:21829687 NCBI chr 3:51,312,876...51,323,167
Ensembl chr 3:51,312,098...51,316,409 		JBrowse link
G Ndufs1 NADH:ubiquinone oxidoreductase core subunit S1 increases expression EXP lead acetate results in increased expression of NDUFS1 protein CTD PMID:20797405 NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992 		JBrowse link
G Nefh neurofilament, heavy polypeptide increases expression EXP lead acetate results in increased expression of NEFH protein CTD PMID:20797405 NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064 		JBrowse link
G Nefl neurofilament, light polypeptide increases expression EXP lead acetate results in increased expression of NEFL protein CTD PMID:20797405 NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544 		JBrowse link
G Nefm neurofilament, medium polypeptide affects expression
multiple interactions 		EXP
ISO 		lead acetate affects the expression of NEFM protein
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of NEFM protein 		CTD PMID:20797405 PMID:23680456 NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295 		JBrowse link
G Nelfa negative elongation factor complex member A, Whsc2 increases expression EXP lead acetate results in increased expression of NELFA mRNA CTD PMID:21829687 NCBI chr 5:34,055,263...34,093,615
Ensembl chr 5:34,055,260...34,093,757 		JBrowse link
G Nemf nuclear export mediator factor decreases expression EXP lead acetate results in decreased expression of NEMF mRNA CTD PMID:22609695 NCBI chr12:69,358,315...69,403,975
Ensembl chr12:69,357,296...69,403,939 		JBrowse link
G Nes nestin increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of NES mRNA
F2RL2 protein inhibits the reaction [lead acetate results in increased expression of NES mRNA]
lead acetate results in decreased expression of NES protein 		CTD PMID:24260418 PMID:25496477 PMID:37939567 PMID:38072110 NCBI chr 3:87,878,400...87,887,758
Ensembl chr 3:87,878,385...87,887,758 		JBrowse link
G Net1 neuroepithelial cell transforming gene 1 increases expression ISO lead acetate results in increased expression of NET1 mRNA CTD PMID:22641619 NCBI chr13:3,932,018...3,968,220
Ensembl chr13:3,932,018...3,968,220 		JBrowse link
G Neurl4 neuralized E3 ubiquitin protein ligase 4 increases expression EXP lead acetate results in increased expression of NEURL4 mRNA CTD PMID:20542052 NCBI chr11:69,792,545...69,804,648
Ensembl chr11:69,791,898...69,804,646 		JBrowse link
G Neurod1 neurogenic differentiation 1 decreases expression EXP lead acetate results in decreased expression of NEUROD1 mRNA CTD PMID:24260418 NCBI chr 2:79,282,981...79,286,980
Ensembl chr 2:79,282,865...79,287,095 		JBrowse link
G Neurod4 neurogenic differentiation 4 decreases expression ISO lead acetate results in decreased expression of NEUROD4 mRNA CTD PMID:22641619 NCBI chr10:130,104,021...130,116,123
Ensembl chr10:130,104,021...130,116,109 		JBrowse link
G Neurog1 neurogenin 1 increases expression EXP lead acetate results in increased expression of NEUROG1 mRNA CTD PMID:24260418 NCBI chr13:56,398,291...56,399,993
Ensembl chr13:56,398,291...56,399,976 		JBrowse link
G Nf1 neurofibromin 1 decreases expression EXP lead acetate results in decreased expression of NF1 mRNA CTD PMID:33932463 NCBI chr11:79,223,541...79,472,435
Ensembl chr11:79,230,519...79,472,438 		JBrowse link
G Nfasc neurofascin increases expression EXP lead acetate results in increased expression of NFASC mRNA CTD PMID:20542052 NCBI chr 1:132,492,428...132,669,567
Ensembl chr 1:132,492,428...132,669,535 		JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 affects localization
increases expression
multiple interactions
increases activity
decreases expression 		ISO
EXP 		lead acetate affects the localization of NFE2L2 protein
lead acetate results in increased expression of NFE2L2 mRNA
[[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of NFE2L2 protein; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of NFE2L2 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of NFE2L2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]; Fatty Acids, Omega-3 inhibits the reaction [lead acetate results in decreased expression of and affects the localization of NFE2L2 protein]; lead acetate results in decreased expression of and affects the localization of NFE2L2 protein
lead acetate results in increased activity of NFE2L2 protein
[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] affects the localization of NFE2L2 protein; [lead acetate results in increased abundance of Lead] inhibits the reaction [Ascorbic Acid results in increased expression of NFE2L2 protein]; [lead acetate results in increased abundance of Lead] inhibits the reaction [Rosmarinic Acid results in increased expression of NFE2L2 protein]; [lead acetate results in increased abundance of Lead] which affects the localization of NFE2L2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA; Ascorbic Acid promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]; lead acetate results in increased activity of and affects the localization of NFE2L2 protein; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased activity of and affects the localization of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLM mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GSTA1 mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of NQO1 mRNA]; NFE2L2 protein affects the reaction [[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 mRNA]; NFE2L2 protein affects the reaction [[[lead acetate results in increased abundance of Lead] which co-treated with Rutin] results in increased expression of IL10 protein]; NFE2L2 protein affects the reaction [lead acetate results in increased expression of SPP1 mRNA]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B mRNA]]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of IL1B protein]]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF mRNA]]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF protein]]; NFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]; NFE2L2 protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; NFE2L2 protein inhibits the reaction [lead acetate results in increased expression of BAX protein]; Rosmarinic Acid affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]
lead acetate results in decreased expression of NFE2L2 mRNA; lead acetate results in decreased expression of NFE2L2 protein
2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of NFE2L2 mRNA]; [lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein; Cholecalciferol promotes the reaction [lead acetate results in increased expression of NFE2L2 mRNA]; coenzyme Q10 inhibits the reaction [lead acetate affects the localization of NFE2L2 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of NFE2L2 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 protein]; ferrostatin-1 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NFE2L2 mRNA]; Genistein inhibits the reaction [lead acetate results in decreased expression of NFE2L2 protein]; lead acetate promotes the reaction [Zinc Oxide results in increased expression of and affects the localization of NFE2L2 protein]; lead acetate results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 protein]; NFE2L2 protein results in decreased susceptibility to [lead acetate results in increased abundance of Lead]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of NFE2L2 mRNA]; Zinc Oxide promotes the reaction [lead acetate results in increased expression of and affects the localization of NFE2L2 protein] 		CTD PMID:23274417 PMID:26498409 PMID:26797587 PMID:27562236 PMID:30114225 More... NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985 		JBrowse link
G Nfia nuclear factor I/A increases expression EXP lead acetate results in increased expression of NFIA mRNA CTD PMID:22609695 NCBI chr 4:97,469,534...98,007,113
Ensembl chr 4:97,660,971...98,007,111 		JBrowse link
G Nfil3 nuclear factor, interleukin 3, regulated decreases expression ISO lead acetate results in decreased expression of NFIL3 mRNA CTD PMID:38568856 NCBI chr13:53,121,245...53,136,914
Ensembl chr13:53,121,245...53,135,109 		JBrowse link
G Nfix nuclear factor I/X multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA CTD PMID:12634122 NCBI chr 8:85,431,341...85,527,086
Ensembl chr 8:85,426,505...85,526,973 		JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions
increases expression
decreases expression 		ISO sinapinic acid inhibits the reaction [lead acetate results in increased expression of NFKB1 mRNA]
lead acetate results in decreased expression of NFKB1 protein 		CTD PMID:16547843 PMID:37471654 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308 		JBrowse link
G Nfkb2 nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 increases expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of NFKB2 mRNA
Cholecalciferol inhibits the reaction [lead acetate results in increased expression of NFKB2 mRNA]
lead acetate results in decreased expression of NFKB2 mRNA 		CTD PMID:24260418 PMID:34051273 NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha decreases expression EXP lead acetate results in decreased expression of NFKBIA mRNA CTD PMID:21829687 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nfya nuclear transcription factor-Y alpha increases expression EXP lead acetate results in increased expression of NFYA mRNA CTD PMID:21829687 NCBI chr17:48,693,917...48,716,782
Ensembl chr17:48,693,913...48,716,934 		JBrowse link
G Ngb neuroglobin multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of NGB mRNA CTD PMID:36642386 NCBI chr12:87,144,305...87,149,313
Ensembl chr12:87,144,305...87,149,313 		JBrowse link
G Ngf nerve growth factor multiple interactions
affects expression
increases activity 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased activity of NGF protein]
lead acetate affects the expression of NGF mRNA
lead acetate results in decreased expression of and affects the localization of NGF protein 		CTD PMID:11233754 PMID:24260418 PMID:28427492 NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329 		JBrowse link
G Niban2 niban apoptosis regulator 2 increases expression ISO lead acetate results in increased expression of NIBAN2 mRNA CTD PMID:38568856 NCBI chr 2:32,766,146...32,815,265
Ensembl chr 2:32,766,126...32,815,266 		JBrowse link
G Nid1 nidogen 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of NID1 protein CTD PMID:38072110 NCBI chr13:13,612,252...13,686,849
Ensembl chr13:13,612,136...13,686,854 		JBrowse link
G Nif3l1 Ngg1 interacting factor 3-like 1 (S. pombe) increases expression EXP lead acetate results in increased expression of NIF3L1 mRNA CTD PMID:21829687 NCBI chr 1:58,484,310...58,501,435
Ensembl chr 1:58,484,310...58,520,975 		JBrowse link
G Nin ninein decreases expression EXP lead acetate results in decreased expression of NIN mRNA CTD PMID:21829687 NCBI chr12:70,058,209...70,160,575
Ensembl chr12:70,058,209...70,160,491 		JBrowse link
G Nkx2-2 NK2 homeobox 2 decreases expression EXP lead acetate results in decreased expression of NKX2-2 mRNA CTD PMID:22613225 NCBI chr 2:146,967,909...147,037,270
Ensembl chr 2:147,019,466...147,036,163 		JBrowse link
G Nkx6-2 NK6 homeobox 2 increases expression ISO lead acetate results in increased expression of NKX6-2 mRNA CTD PMID:22641619 NCBI chr 7:139,159,292...139,162,726
Ensembl chr 7:139,159,292...139,162,713 		JBrowse link
G Nlgn1 neuroligin 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of NLGN1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of NLGN1 protein CTD PMID:29476096 NCBI chr 3:25,475,972...26,387,504
Ensembl chr 3:25,480,379...26,386,609 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions
increases expression 		EXP
ISO 		1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NLRP3 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of NLRP3 protein; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL1B protein]; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of IL6 protein]; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]; NLRP3 gene mutant form results in decreased susceptibility to [lead acetate results in increased abundance of Lead]
lead acetate results in increased expression of NLRP3 mRNA
sinapinic acid inhibits the reaction [lead acetate results in increased expression of NLRP3 mRNA] 		CTD PMID:36308466 PMID:37471654 NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782 		JBrowse link
G Nlrp5 NLR family, pyrin domain containing 5 increases expression EXP lead acetate results in increased expression of NLRP5 mRNA CTD PMID:22613225 NCBI chr 7:23,085,314...23,141,348
Ensembl chr 7:23,085,314...23,141,347 		JBrowse link
G Nmbr neuromedin B receptor increases expression
affects expression 		EXP
ISO 		lead acetate results in increased expression of NMBR mRNA
lead acetate affects the expression of NMBR mRNA 		CTD PMID:20542052 PMID:22641619 NCBI chr10:14,634,894...14,647,202
Ensembl chr10:14,581,335...14,646,594 		JBrowse link
G Nme4 NME/NM23 nucleoside diphosphate kinase 4 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of NME4 protein CTD PMID:38072110 NCBI chr17:26,310,708...26,314,650
Ensembl chr17:26,310,708...26,314,576 		JBrowse link
G Nmur2 neuromedin U receptor 2 increases expression ISO lead acetate results in increased expression of NMUR2 mRNA CTD PMID:22641619 NCBI chr11:55,915,816...55,931,813
Ensembl chr11:55,915,813...55,931,836 		JBrowse link
G Nod1 nucleotide-binding oligomerization domain containing 1 decreases expression EXP lead acetate results in decreased expression of NOD1 mRNA CTD PMID:25270620 NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597 		JBrowse link
G Nod2 nucleotide-binding oligomerization domain containing 2 increases expression EXP lead acetate results in increased expression of NOD2 mRNA CTD PMID:20542052 NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102 		JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of NOLC1 promoter CTD PMID:33445541 NCBI chr19:46,064,286...46,073,982
Ensembl chr19:46,064,302...46,073,969 		JBrowse link
G Nop10 NOP10 ribonucleoprotein increases expression ISO lead acetate results in increased expression of NOP10 mRNA CTD PMID:38568856 NCBI chr 2:112,092,271...112,093,243
Ensembl chr 2:112,092,271...112,093,614 		JBrowse link
G Nos1 nitric oxide synthase 1, neuronal multiple interactions
increases expression
decreases expression 		ISO
EXP 		tempol inhibits the reaction [lead acetate results in increased expression of NOS1 protein]
[lead acetate results in increased abundance of Lead] which results in decreased expression of NOS1 protein; puerarin inhibits the reaction [lead acetate results in decreased expression of NOS1 protein]; Quercetin inhibits the reaction [lead acetate results in decreased expression of NOS1 protein] 		CTD PMID:11454931 PMID:21195594 PMID:23501611 PMID:23855546 PMID:26660114 NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905 		JBrowse link
G Nos2 nitric oxide synthase 2, inducible increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of NOS2 mRNA
lead acetate results in increased expression of NOS2 mRNA; lead acetate results in increased expression of NOS2 protein
5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of NOS2 mRNA]; [lead acetate results in increased abundance of Lead] which results in increased expression of NOS2 mRNA; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of NOS2 mRNA]; Minocycline inhibits the reaction [lead acetate results in increased expression of NOS2 protein]; sodium bisulfide inhibits the reaction [lead acetate results in increased expression of NOS2 protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in increased expression of NOS2 protein]; tempol inhibits the reaction [lead acetate results in increased expression of NOS2 protein]
[lead acetate results in increased abundance of Lead] which results in increased expression of NOS2 protein; MitoTEMPO inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NOS2 protein] 		CTD PMID:11454931 PMID:22609695 PMID:22952811 PMID:30980911 PMID:32116774 More... NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080 		JBrowse link
G Nos3 nitric oxide synthase 3, endothelial cell increases expression
decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of NOS3 protein
lead acetate results in decreased expression of NOS3 protein
puerarin inhibits the reaction [lead acetate results in decreased expression of NOS3 protein]; Quercetin inhibits the reaction [lead acetate results in decreased expression of NOS3 protein]
Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein]; sodium bisulfide inhibits the reaction [lead acetate results in decreased expression of NOS3 protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in decreased expression of NOS3 protein]; tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein]
tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein]; U 74389F inhibits the reaction [lead acetate results in increased expression of NOS3 protein] 		CTD PMID:11230275 PMID:11454931 PMID:11729227 PMID:23501611 PMID:23855546 More... NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472 		JBrowse link
G Notch2 notch 2 increases expression EXP lead acetate results in increased expression of NOTCH2 mRNA CTD PMID:20542052 NCBI chr 3:97,920,854...98,057,683
Ensembl chr 3:97,920,843...98,057,677 		JBrowse link
G Notch4 notch 4 increases expression EXP lead acetate results in increased expression of NOTCH4 mRNA CTD PMID:22609695 NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477 		JBrowse link
G Nox1 NADPH oxidase 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of NOX1 mRNA CTD PMID:39276841 NCBI chr  X:132,987,170...133,038,455
Ensembl chr  X:132,987,170...133,122,705 		JBrowse link
G Nox4 NADPH oxidase 4 decreases expression EXP lead acetate results in decreased expression of NOX4 mRNA CTD PMID:29746905 NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918 		JBrowse link
G Npas4 neuronal PAS domain protein 4 decreases expression ISO lead acetate results in decreased expression of NPAS4 mRNA CTD PMID:22641619 NCBI chr19:5,034,381...5,053,467
Ensembl chr19:5,034,383...5,040,344 		JBrowse link
G Npepl1 aminopeptidase-like 1 increases expression EXP lead acetate results in increased expression of NPEPL1 mRNA CTD PMID:21829687 NCBI chr 2:173,951,904...173,964,495
Ensembl chr 2:173,952,142...173,964,863 		JBrowse link
G Npffr2 neuropeptide FF receptor 2 decreases expression EXP lead acetate results in decreased expression of NPFFR2 mRNA CTD PMID:22609695 NCBI chr 5:89,674,805...89,731,473
Ensembl chr 5:89,675,288...89,731,599 		JBrowse link
G Npm1 nucleophosmin 1 increases expression ISO lead acetate results in increased expression of NPM1 mRNA CTD PMID:22641619 NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206 		JBrowse link
G Npnt nephronectin decreases expression EXP lead acetate results in decreased expression of NPNT mRNA CTD PMID:22613225 NCBI chr 3:132,587,506...132,656,052
Ensembl chr 3:132,587,506...132,656,052 		JBrowse link
G Npr1 natriuretic peptide receptor 1 increases expression ISO lead acetate results in increased expression of NPR1 mRNA CTD PMID:11578147 NCBI chr 3:90,357,898...90,373,235
Ensembl chr 3:90,357,898...90,373,173 		JBrowse link
G Npr3 natriuretic peptide receptor 3 decreases expression ISO lead acetate results in decreased expression of NPR3 mRNA CTD PMID:22641619 NCBI chr15:11,839,982...11,907,287
Ensembl chr15:11,839,982...11,907,373 		JBrowse link
G Nprl2 NPR2 like, GATOR1 complex subunit decreases expression ISO lead acetate results in decreased expression of NPRL2 mRNA CTD PMID:38568856 NCBI chr 9:107,419,405...107,422,905
Ensembl chr 9:107,419,425...107,422,905 		JBrowse link
G Npsr1 neuropeptide S receptor 1 increases expression ISO lead acetate results in increased expression of NPSR1 mRNA CTD PMID:22641619 NCBI chr 9:24,009,212...24,229,151
Ensembl chr 9:24,009,292...24,227,694 		JBrowse link
G Nptx1 neuronal pentraxin 1 decreases expression ISO lead acetate results in decreased expression of NPTX1 mRNA CTD PMID:37939567 NCBI chr11:119,429,545...119,438,646
Ensembl chr11:119,429,545...119,438,579 		JBrowse link
G Npy1r neuropeptide Y receptor Y1 increases expression ISO lead acetate results in increased expression of NPY1R mRNA CTD PMID:11578147 NCBI chr 8:67,149,595...67,159,452
Ensembl chr 8:67,149,844...67,159,444 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of NQO1 mRNA
2-tert-butylhydroquinone promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 protein; NFE2L2 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 protein]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of NQO1 mRNA]
[lead acetate results in increased abundance of Lead] which results in decreased expression of NQO1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of NQO1 mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of NQO1 mRNA]; Rutin promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of NQO1 mRNA] 		CTD PMID:25270620 PMID:26498409 PMID:27562236 PMID:30476502 PMID:31610155 More... NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Nqo2 N-ribosyldihydronicotinamide quinone reductase 2 decreases expression ISO lead acetate results in decreased expression of NQO2 mRNA CTD PMID:22641619 NCBI chr13:34,148,642...34,172,448
Ensembl chr13:34,148,670...34,172,426 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 increases expression ISO lead acetate results in increased expression of NR1H3 mRNA; lead acetate results in increased expression of NR1H3 protein CTD PMID:29908845 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179 		JBrowse link
G Nr2e3 nuclear receptor subfamily 2, group E, member 3 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of NR2E3 mRNA CTD PMID:28050121 NCBI chr 9:59,850,054...59,868,117
Ensembl chr 9:59,850,054...59,867,942 		JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 decreases expression EXP lead acetate results in decreased expression of NR2F2 mRNA CTD PMID:21829687 NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483 		JBrowse link
G Nr2f6 nuclear receptor subfamily 2, group F, member 6 decreases expression EXP lead acetate results in decreased expression of NR2F6 mRNA CTD PMID:25270620 NCBI chr 8:71,826,762...71,834,593
Ensembl chr 8:71,826,767...71,834,604 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which affects the expression of NR3C1 protein; [lead acetate results in increased abundance of Lead] which results in decreased methylation of NR3C1 exon CTD PMID:29481626 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474 		JBrowse link
G Nr4a1 nuclear receptor subfamily 4, group A, member 1 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of NR4A1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of NR4A1 protein 		CTD PMID:22641619 PMID:39947421 NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676 		JBrowse link
G Nrcam neuronal cell adhesion molecule increases expression ISO lead acetate results in increased expression of NRCAM mRNA CTD PMID:38568856 NCBI chr12:44,375,568...44,651,977
Ensembl chr12:44,375,668...44,648,747 		JBrowse link
G Nrep neuronal regeneration related protein decreases expression ISO lead acetate results in decreased expression of NREP mRNA CTD PMID:11578147 NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082 		JBrowse link
G Nrgn neurogranin increases expression ISO lead acetate results in increased expression of NRGN mRNA CTD PMID:38568856 NCBI chr 9:37,455,789...37,464,041
Ensembl chr 9:37,455,788...37,464,200 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 affects expression EXP lead acetate affects the expression of NRIP1 mRNA CTD PMID:21829687 NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715 		JBrowse link
G Nrk Nik related kinase multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of NRK intron CTD PMID:33445541 NCBI chr  X:137,814,980...137,911,281
Ensembl chr  X:137,815,179...137,911,281 		JBrowse link
G Nrl neural retina leucine zipper gene multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of NRL mRNA CTD PMID:28050121 NCBI chr14:55,756,973...55,762,438
Ensembl chr14:55,756,435...55,762,438 		JBrowse link
G Nsa2 NSA2 ribosome biogenesis homolog decreases expression EXP lead acetate results in decreased expression of NSA2 mRNA CTD PMID:22609695 NCBI chr13:97,265,935...97,274,434
Ensembl chr13:97,265,932...97,274,445 		JBrowse link
G Nsdhl NAD(P) dependent steroid dehydrogenase-like decreases expression EXP lead acetate results in decreased expression of NSDHL mRNA CTD PMID:22613225 NCBI chr  X:71,962,127...72,002,134
Ensembl chr  X:71,962,163...72,002,120 		JBrowse link
G Nsg1 neuron specific gene family member 1 decreases expression ISO lead acetate results in decreased expression of NSG1 mRNA CTD PMID:11578147 NCBI chr 5:38,294,537...38,317,087
Ensembl chr 5:38,294,536...38,317,251 		JBrowse link
G Nsmce1 NSE1 homolog, SMC5-SMC6 complex component decreases expression EXP lead acetate results in decreased expression of NSMCE1 mRNA CTD PMID:21829687 NCBI chr 7:125,066,816...125,090,615
Ensembl chr 7:125,066,812...125,090,768 		JBrowse link
G Nsun2 NOL1/NOP2/Sun domain family member 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of NSUN2 protein CTD PMID:38072110 NCBI chr13:69,760,135...69,783,899
Ensembl chr13:69,681,865...69,783,899 		JBrowse link
G Nsun3 NOL1/NOP2/Sun domain family member 3 increases expression EXP lead acetate results in increased expression of NSUN3 mRNA CTD PMID:21829687 NCBI chr16:62,552,807...62,607,238
Ensembl chr16:62,552,807...62,607,181 		JBrowse link
G Nt5c1b 5'-nucleotidase, cytosolic IB increases expression EXP lead acetate results in increased expression of NT5C1B mRNA CTD PMID:22609695 NCBI chr12:10,419,971...10,440,174
Ensembl chr12:10,419,973...10,440,175 		JBrowse link
G Nt5e 5' nucleotidase, ecto increases expression ISO lead acetate results in increased expression of NT5E mRNA CTD PMID:38568856 NCBI chr 9:88,209,662...88,254,142
Ensembl chr 9:88,209,250...88,254,145 		JBrowse link
G Ntf3 neurotrophin 3 decreases expression ISO lead acetate results in decreased expression of NTF3 mRNA CTD PMID:22160880 NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873 		JBrowse link
G Ntf5 neurotrophin 5 increases expression EXP lead acetate results in increased expression of NTF4 mRNA CTD PMID:24260418 NCBI chr 7:45,063,119...45,066,603
Ensembl chr 7:45,063,119...45,066,603 		JBrowse link
G Nthl1 nth (endonuclease III)-like 1 (E.coli) multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NTHL1 mRNA CTD PMID:12634122 NCBI chr17:24,851,656...24,857,812
Ensembl chr17:24,851,654...24,857,811 		JBrowse link
G Ntmt2 N-terminal Xaa-Pro-Lys N-methyltransferase 2 increases expression ISO lead acetate results in increased expression of NTMT2 mRNA CTD PMID:22641619 NCBI chr 1:163,529,415...163,552,801
Ensembl chr 1:163,529,825...163,552,801 		JBrowse link
G Ntng1 netrin G1 increases methylation ISO lead acetate results in increased methylation of NTNG1 gene CTD PMID:29571894 NCBI chr 3:109,687,366...110,057,291
Ensembl chr 3:109,687,356...110,051,327 		JBrowse link
G Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 decreases expression
increases expression 		ISO lead acetate results in decreased expression of NTRK2 protein
lead acetate results in increased expression of NTRK2 mRNA 		CTD PMID:27492863 PMID:33862172 NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784 		JBrowse link
G Nuak2 NUAK family, SNF1-like kinase, 2 increases expression EXP lead acetate results in increased expression of NUAK2 mRNA CTD PMID:21829687 NCBI chr 1:132,243,827...132,261,233
Ensembl chr 1:132,243,864...132,261,226 		JBrowse link
G Nudcd3 NudC domain containing 3 decreases expression EXP lead acetate results in decreased expression of NUDCD3 mRNA CTD PMID:20542052 NCBI chr11:6,055,705...6,150,190
Ensembl chr11:6,055,691...6,150,415 		JBrowse link
G Nup210 nucleoporin 210 decreases expression ISO lead acetate results in decreased expression of NUP210 mRNA CTD PMID:38568856 NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811 		JBrowse link
G Nupr1 nuclear protein transcription regulator 1 increases expression EXP
ISO 		lead acetate results in increased expression of NUPR1 mRNA CTD PMID:22641619 PMID:25270620 NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033 		JBrowse link
G Nxpe4 neurexophilin and PC-esterase domain family, member 4 increases expression ISO lead acetate results in increased expression of NXPE4 mRNA CTD PMID:22641619 NCBI chr 9:48,073,302...48,311,325
Ensembl chr 9:48,073,321...48,311,325 		JBrowse link
G Oas1g 2'-5' oligoadenylate synthetase 1G decreases expression ISO lead acetate results in decreased expression of OAS1A mRNA CTD PMID:22641619 NCBI chr 5:121,014,205...121,025,676
Ensembl chr 5:121,014,205...121,025,676 		JBrowse link
G Ocln occludin multiple interactions
decreases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of OCLN protein] CTD PMID:24200059 NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226 		JBrowse link
G Ogfr opioid growth factor receptor increases expression ISO lead acetate results in increased expression of OGFR mRNA CTD PMID:38568856 NCBI chr 2:180,231,200...180,237,630
Ensembl chr 2:180,231,038...180,237,629 		JBrowse link
G Olfml3 olfactomedin-like 3 increases expression EXP lead acetate results in increased expression of OLFML3 mRNA CTD PMID:20542052 NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317 		JBrowse link
G Olig1 oligodendrocyte transcription factor 1 decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of OLIG1 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of OLIG1 mRNA 		CTD PMID:25270620 PMID:32458983 NCBI chr16:91,066,657...91,068,827
Ensembl chr16:91,066,660...91,068,821 		JBrowse link
G Olig2 oligodendrocyte transcription factor 2 multiple interactions
increases expression 		ISO [lead acetate results in increased abundance of Lead] which results in increased expression of OLIG2 mRNA; F2RL2 protein promotes the reaction [lead acetate results in increased expression of OLIG2 mRNA]; PANX2 protein promotes the reaction [lead acetate results in increased expression of OLIG2 mRNA]; TRIM16L protein promotes the reaction [lead acetate results in increased expression of OLIG2 mRNA] CTD PMID:32458983 PMID:37939567 NCBI chr16:91,016,745...91,025,567
Ensembl chr16:91,022,345...91,025,565 		JBrowse link
G Omd osteomodulin increases expression ISO lead acetate results in increased expression of OMD mRNA CTD PMID:22641619 NCBI chr13:49,735,938...49,746,088
Ensembl chr13:49,735,938...49,746,298 		JBrowse link
G Omt2b oocyte maturation, beta decreases expression EXP lead acetate results in decreased expression of OMT2B mRNA CTD PMID:22609695 NCBI chr 9:78,235,312...78,236,902
Ensembl chr 9:78,234,871...78,236,902 		JBrowse link
G Onecut1 one cut domain, family member 1 increases expression EXP lead acetate results in increased expression of ONECUT1 mRNA CTD PMID:22609695 NCBI chr 9:74,769,203...74,796,930
Ensembl chr 9:74,769,203...74,799,063 		JBrowse link
G Oog1 oogenesin 1 increases expression EXP lead acetate results in increased expression of OOG1 mRNA CTD PMID:22609695 NCBI chr12:87,649,435...87,655,615
Ensembl chr12:87,649,458...87,655,620 		JBrowse link
G Opn3 opsin 3 decreases expression ISO lead acetate results in decreased expression of OPN3 mRNA CTD PMID:38568856 NCBI chr 1:175,489,993...175,520,198
Ensembl chr 1:175,489,987...175,520,342 		JBrowse link
G Oprm1 opioid receptor, mu 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] promotes the reaction [Enkephalin, Ala(2)-MePhe(4)-Gly(5)- binds to OPRM1 protein] CTD PMID:33248188 NCBI chr10:6,708,593...6,988,209
Ensembl chr10:6,708,506...6,988,198 		JBrowse link
G Or11i1 olfactory receptor family 11 subfamily I member 1 decreases expression EXP lead acetate results in decreased expression of OR11I1 mRNA CTD PMID:20542052 NCBI chr 3:106,728,923...106,729,873
Ensembl chr 3:106,727,801...106,733,603 		JBrowse link
G Or13g1 olfactory receptor family 13 subfamily G member 1 decreases expression EXP lead acetate results in decreased expression of OR13G1 mRNA CTD PMID:22613225 NCBI chr 7:85,955,393...85,956,319
Ensembl chr 7:85,953,682...85,962,916 		JBrowse link
G Or14j5 olfactory receptor family 14 subfamily J member 5 decreases expression EXP lead acetate results in decreased expression of OR14J5 mRNA CTD PMID:22613225 NCBI chr17:38,161,485...38,162,444
Ensembl chr17:38,158,374...38,162,948 		JBrowse link
G Or14j6 olfactory receptor family 14 subfamily J member 6 decreases expression EXP lead acetate results in decreased expression of OR14J6 mRNA CTD PMID:22613225 NCBI chr17:38,214,439...38,215,410
Ensembl chr17:38,211,328...38,217,686 		JBrowse link
G Or1e1f olfactory receptor family 1 subfamily E member 1F increases expression EXP lead acetate results in increased expression of OR1E1F mRNA CTD PMID:20542052 NCBI chr11:73,855,436...73,856,383
Ensembl chr11:73,851,643...73,858,638 		JBrowse link
G Or2y13 olfactory receptor family 2 subfamily Y member 14 decreases expression EXP lead acetate results in decreased expression of OR2Y13 mRNA CTD PMID:22613225 NCBI chr11:49,414,552...49,415,487
Ensembl chr11:49,410,475...49,418,026 		JBrowse link
G Or4c102 olfactory receptor family 4 subfamily C member 102 increases expression EXP lead acetate results in increased expression of OR4C102 mRNA CTD PMID:20542052 NCBI chr 2:88,422,150...88,423,070
Ensembl chr 2:88,416,798...88,423,106 		JBrowse link
G Or4c118 olfactory receptor family 4 subfamily C member 118 increases expression EXP lead acetate results in increased expression of OR4C118 mRNA CTD PMID:20542052 NCBI chr 2:88,974,430...88,981,680
Ensembl chr 2:88,973,852...88,981,904 		JBrowse link
G Or4c120 olfactory receptor family 4 subfamily C member 120 increases expression EXP lead acetate results in increased expression of OR4C120 mRNA CTD PMID:20542052 NCBI chr 2:89,000,563...89,001,589
Ensembl chr 2:88,998,724...89,005,013 		JBrowse link
G Or4c15b olfactory receptor family 4 subfamily C member 15B decreases expression EXP lead acetate results in decreased expression of OR4C15B mRNA CTD PMID:22613225 NCBI chr 2:89,112,540...89,113,475
Ensembl chr 2:89,110,820...89,118,358 		JBrowse link
G Or4d10b olfactory receptor family 4 subfamily D member 10B increases expression EXP lead acetate results in increased expression of OR4D10B mRNA CTD PMID:20542052 NCBI chr19:12,036,173...12,037,114
Ensembl chr19:12,035,988...12,040,046 		JBrowse link
G Or4d2 olfactory receptor family 4 subfamily D member 2 decreases expression EXP lead acetate results in decreased expression of OR4D2 mRNA CTD PMID:22613225 NCBI chr11:87,783,813...87,784,748
Ensembl chr11:87,783,444...87,788,213 		JBrowse link
G Or4k1 olfactory receptor family 4 subfamily K member 1 decreases expression EXP lead acetate results in decreased expression of OR4K1 mRNA CTD PMID:22613225 NCBI chr14:50,377,159...50,378,094
Ensembl chr14:50,371,215...50,380,137 		JBrowse link
G Or4k2 olfactory receptor family 4 subfamily K member 2 decreases expression EXP lead acetate results in decreased expression of OR4K2 mRNA CTD PMID:22613225 NCBI chr14:50,423,719...50,424,675
Ensembl chr14:50,420,753...50,425,655 		JBrowse link
G Or4k37 olfactory receptor family 4 subfamily K member 37 decreases expression EXP lead acetate results in decreased expression of OR4K37 mRNA CTD PMID:22613225 NCBI chr 2:111,158,766...111,159,683
Ensembl chr 2:111,156,865...111,163,197 		JBrowse link
G Or4k42 olfactory receptor family 4 subfamily K member 42 decreases expression EXP lead acetate results in decreased expression of OR4K42 mRNA CTD PMID:22613225 NCBI chr 2:111,319,563...111,324,160
Ensembl chr 2:111,317,873...111,324,174 		JBrowse link
G Or51a42 olfactory receptor family 51 subfamily A member 42 increases expression EXP lead acetate results in increased expression of OR51A42 mRNA CTD PMID:20542052 NCBI chr 7:103,707,863...103,708,807
Ensembl chr 7:103,702,807...103,710,652 		JBrowse link
G Or51e2 olfactory receptor family 51 subfamily E member 2 decreases expression ISO lead acetate results in decreased expression of OLR59 mRNA CTD PMID:22641619 NCBI chr 7:102,389,928...102,408,678
Ensembl chr 7:102,387,718...102,408,678 		JBrowse link
G Or51l1 olfactory receptor family 51 subfamily L member 1 decreases expression ISO lead acetate results in decreased expression of OR51L1 mRNA CTD PMID:22641619 NCBI chr 7:102,783,583...102,784,530
Ensembl chr 7:102,783,583...102,784,530 		JBrowse link
G Or52e7 olfactory receptor family 52 subfamily E member 7 increases expression EXP lead acetate results in increased expression of OR52E7 mRNA CTD PMID:20542052 NCBI chr 7:104,680,774...104,685,360
Ensembl chr 7:104,681,905...104,686,957 		JBrowse link
G Or55b4 olfactory receptor family 55 subfamily B member 4 increases expression EXP lead acetate results in increased expression of OR55B4 mRNA CTD PMID:20542052 NCBI chr 7:102,133,321...102,137,514
Ensembl chr 7:102,131,238...102,137,520 		JBrowse link
G Or5ac21 olfactory receptor family 5 subfamily AC member 21 decreases expression EXP lead acetate results in decreased expression of OR5AC21 mRNA CTD PMID:22613225 NCBI chr16:59,123,518...59,124,438
Ensembl chr16:59,119,244...59,124,776 		JBrowse link
G Or5g23 olfactory receptor family 5 subfamily G member 23 decreases expression EXP lead acetate results in decreased expression of OR5G23 mRNA CTD PMID:22613225 NCBI chr 2:85,438,308...85,439,252
Ensembl chr 2:85,437,381...85,442,247 		JBrowse link
G Or5h26 olfactory receptor family 5 subfamily H member 26 decreases expression EXP lead acetate results in decreased expression of OR5H26 mRNA CTD PMID:22613225 NCBI chr16:58,987,575...58,992,475
Ensembl chr16:58,987,010...58,990,817 		JBrowse link
G Or5p50 olfactory receptor family 5 subfamily P member 50 decreases expression EXP lead acetate results in decreased expression of OR5P50 mRNA CTD PMID:22613225 NCBI chr 7:107,421,730...107,422,674
Ensembl chr 7:107,419,773...107,424,748 		JBrowse link
G Or5p61 olfactory receptor family 5 subfamily P member 61 decreases expression EXP lead acetate results in decreased expression of OR5P61 mRNA CTD PMID:22613225 NCBI chr 7:107,758,125...107,759,078
Ensembl chr 7:107,758,125...107,759,078 		JBrowse link
G Or6c205 olfactory receptor family 6 subfamily C member 205 decreases expression EXP lead acetate results in decreased expression of OR6C205 mRNA CTD PMID:22613225 NCBI chr10:129,086,405...129,087,343
Ensembl chr10:129,084,281...129,089,793 		JBrowse link
G Or6c206 olfactory receptor family 6 subfamily C member 206 decreases expression EXP lead acetate results in decreased expression of OR6C206 mRNA CTD PMID:22613225 NCBI chr10:129,096,832...129,097,770
Ensembl chr10:129,094,996...129,100,167 		JBrowse link
G Or7e165 olfactory receptor family 7 subfamily E member 165 decreases expression EXP lead acetate results in decreased expression of OR7E165 mRNA CTD PMID:22613225 NCBI chr 9:19,691,579...19,695,360
Ensembl chr 9:19,691,579...19,696,629 		JBrowse link
G Or8c10 olfactory receptor family 8 subfamily C member 10 decreases expression EXP lead acetate results in decreased expression of OR8C10 mRNA CTD PMID:22613225 NCBI chr 9:38,278,844...38,279,839
Ensembl chr 9:38,278,192...38,282,651 		JBrowse link
G Or8j3 olfactory receptor family 8 subfamily J member 3 increases expression EXP lead acetate results in increased expression of OR8J3 mRNA CTD PMID:20542052 NCBI chr 2:86,028,147...86,029,094
Ensembl chr 2:86,026,254...86,033,353 		JBrowse link
G Orai1 ORAI calcium release-activated calcium modulator 1 multiple interactions EXP
ISO 		lead acetate inhibits the reaction [STIM1 protein binds to ORAI1 protein] CTD PMID:38281554 NCBI chr 5:123,153,078...123,168,515
Ensembl chr 5:123,153,137...123,168,519 		JBrowse link
G Osgin1 oxidative stress induced growth inhibitor 1 increases expression ISO lead acetate results in increased expression of OSGIN1 mRNA CTD PMID:27562236 PMID:37939567 PMID:38568856 NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995 		JBrowse link
G Osm oncostatin M increases expression EXP lead acetate results in increased expression of OSM mRNA CTD PMID:20542052 NCBI chr11:4,186,831...4,191,027
Ensembl chr11:4,186,420...4,191,026 		JBrowse link
G Osmr oncostatin M receptor increases expression EXP lead acetate results in increased expression of OSMR mRNA CTD PMID:21829687 NCBI chr15:6,843,049...6,904,434
Ensembl chr15:6,843,058...6,904,450 		JBrowse link
G Ost4 oligosaccharyltransferase complex subunit 4 (non-catalytic) increases expression ISO lead acetate results in increased expression of OST4 mRNA CTD PMID:38568856 NCBI chr 5:31,063,860...31,065,155
Ensembl chr 5:31,063,229...31,065,132 		JBrowse link
G Ostc oligosaccharyltransferase complex subunit (non-catalytic) decreases expression EXP lead acetate results in decreased expression of OSTC mRNA CTD PMID:21829687 NCBI chr 3:130,489,566...130,503,093
Ensembl chr 3:130,489,561...130,503,093 		JBrowse link
G Otc ornithine transcarbamylase decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of OTC mRNA
lead acetate results in increased expression of OTC mRNA 		CTD PMID:11578147 PMID:22609695 NCBI chr  X:10,118,584...10,187,275
Ensembl chr  X:10,118,544...10,187,263 		JBrowse link
G Otop3 otopetrin 3 decreases expression ISO lead acetate results in decreased expression of OTOP3 mRNA CTD PMID:22641619 NCBI chr11:115,225,557...115,237,753
Ensembl chr11:115,225,557...115,237,753 		JBrowse link
G Otub1 OTU domain, ubiquitin aldehyde binding 1 increases expression EXP lead acetate results in increased expression of OTUB1 mRNA CTD PMID:21829687 NCBI chr19:7,175,571...7,183,649
Ensembl chr19:7,175,567...7,183,681 		JBrowse link
G Otud5 OTU domain containing 5 increases expression EXP lead acetate results in increased expression of OTUD5 mRNA CTD PMID:22609695 NCBI chr  X:7,705,852...7,742,861
Ensembl chr  X:7,707,603...7,742,865 		JBrowse link
G Otulin OTU deubiquitinase with linear linkage specificity multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of OTULIN intron CTD PMID:33445541 NCBI chr15:27,606,005...27,630,793
Ensembl chr15:27,542,721...27,630,779 		JBrowse link
G Otx2 orthodenticle homeobox 2 decreases expression
multiple interactions
affects expression 		ISO
EXP 		lead acetate results in decreased expression of OTX2 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of OTX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of OTX2 mRNA
lead acetate affects the expression of OTX2 mRNA 		CTD PMID:21864555 PMID:22641619 PMID:28050121 PMID:39150886 NCBI chr14:48,894,238...48,905,101
Ensembl chr14:48,895,134...48,911,276 		JBrowse link
G Oxct2a 3-oxoacid CoA transferase 2A decreases expression EXP lead acetate results in decreased expression of OXCT2A mRNA CTD PMID:20542052 NCBI chr 4:123,215,668...123,217,472
Ensembl chr 4:123,215,668...123,217,427 		JBrowse link
G P2rx4 purinergic receptor P2X, ligand-gated ion channel 4 increases expression ISO lead acetate results in increased expression of P2RX4 mRNA; lead acetate results in increased expression of P2RX4 protein CTD PMID:26478469 PMID:29457680 NCBI chr 5:122,845,581...122,867,802
Ensembl chr 5:122,845,607...122,867,801 		JBrowse link
G P2rx7 purinergic receptor P2X, ligand-gated ion channel, 7 increases expression ISO lead acetate results in increased expression of P2RX7 mRNA; lead acetate results in increased expression of P2RX7 protein CTD PMID:20932874 PMID:22641619 PMID:26478469 NCBI chr 5:122,781,990...122,830,399
Ensembl chr 5:122,781,974...122,829,495 		JBrowse link
G P2ry1 purinergic receptor P2Y, G-protein coupled 1 increases expression EXP lead acetate results in increased expression of P2RY1 mRNA CTD PMID:22609695 NCBI chr 3:60,910,206...60,916,403
Ensembl chr 3:60,910,216...60,916,403 		JBrowse link
G P2ry6 pyrimidinergic receptor P2Y, G-protein coupled, 6 increases expression EXP lead acetate results in increased expression of P2RY6 mRNA CTD PMID:21829687 NCBI chr 7:100,586,837...100,628,528
Ensembl chr 7:100,586,837...100,623,856 		JBrowse link
G P4ha2 procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of P4HA2 protein CTD PMID:38072110 NCBI chr11:53,991,750...54,022,494
Ensembl chr11:53,990,921...54,022,491 		JBrowse link
G P4htm prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of P4HTM protein CTD PMID:38072110 NCBI chr 9:108,456,025...108,475,482
Ensembl chr 9:108,456,061...108,474,866 		JBrowse link
G Pa2g4 proliferation-associated 2G4 decreases expression EXP lead acetate results in decreased expression of PA2G4 mRNA CTD PMID:21335049 NCBI chr10:128,393,635...128,401,803
Ensembl chr10:128,393,635...128,401,856 		JBrowse link
G Pabpc6 poly(A) binding protein, cytoplasmic 6 decreases expression ISO lead acetate results in decreased expression of PABPC3 mRNA CTD PMID:37939567 NCBI chr17:9,885,426...9,888,633
Ensembl chr17:9,885,424...9,888,646 		JBrowse link
G Pabpn1 poly(A) binding protein, nuclear 1 decreases expression EXP lead acetate results in decreased expression of PABPN1 mRNA CTD PMID:21829687 NCBI chr14:55,131,600...55,136,384
Ensembl chr14:55,129,957...55,135,626 		JBrowse link
G Pacc1 proton activated chloride channel 1 increases expression ISO lead acetate results in increased expression of PACC1 mRNA CTD PMID:38568856 NCBI chr 1:191,058,099...191,083,481
Ensembl chr 1:191,058,109...191,083,111 		JBrowse link
G Pak4 p21 (RAC1) activated kinase 4 increases expression ISO lead acetate results in increased expression of PAK4 mRNA CTD PMID:38568856 NCBI chr 7:28,258,244...28,297,609
Ensembl chr 7:28,258,244...28,297,610 		JBrowse link
G Pals2 protein associated with LIN7 2, MAGUK family member decreases expression ISO lead acetate results in decreased expression of PALS2 mRNA CTD PMID:11578147 NCBI chr 6:50,087,206...50,176,134
Ensembl chr 6:50,087,221...50,175,919 		JBrowse link
G Pantr1 POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of PANTR1 intron CTD PMID:33445541 NCBI chr 1:42,687,360...42,733,985
Ensembl chr 1:42,629,754...42,734,584 		JBrowse link
G Panx2 pannexin 2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of PANX2 mRNA; lead acetate results in increased expression of PANX2 protein
PANX2 protein inhibits the reaction [lead acetate results in increased expression of GFAP mRNA]; PANX2 protein inhibits the reaction [lead acetate results in increased expression of MAP2 mRNA]; PANX2 protein inhibits the reaction [lead acetate results in increased expression of TUBB3 mRNA]; PANX2 protein promotes the reaction [lead acetate results in increased expression of OLIG2 mRNA] 		CTD PMID:37939567 PMID:38568856 NCBI chr15:88,941,797...88,957,769
Ensembl chr15:88,943,937...88,957,770 		JBrowse link
G Papss2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 decreases expression ISO lead acetate results in decreased expression of PAPSS2 mRNA CTD PMID:22641619 NCBI chr19:32,573,072...32,644,587
Ensembl chr19:32,573,190...32,644,587 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 increases expression
increases cleavage
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of PARP1 mRNA
lead acetate results in increased cleavage of PARP1 protein
2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [lead acetate results in increased cleavage of PARP1 protein]; 3-aminobenzamide inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased cleavage of PARP1 protein]; [lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein; [lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 mRNA; [lead acetate co-treated with sodium arsenite] results in increased expression of and results in increased cleavage of PARP1 protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of PARP1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of PARP1 mRNA; Cadmium Chloride inhibits the reaction [lead acetate results in increased cleavage of PARP1 protein]; CR8 compound analog inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PARP1 protein]; lead acetate results in increased expression of and results in increased cleavage of PARP1 protein; PPARG protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]; PPARG protein affects the reaction [lead acetate results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PARP1 protein]
lead acetate results in decreased expression of PARP1 mRNA 		CTD PMID:21829687 PMID:28283887 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819 		JBrowse link
G Parp4 poly (ADP-ribose) polymerase family, member 4 decreases expression ISO lead acetate results in decreased expression of PARP4 mRNA CTD PMID:38568856 NCBI chr14:56,812,982...56,897,256
Ensembl chr14:56,813,076...56,897,251 		JBrowse link
G Pax6 paired box 6 increases expression EXP lead acetate results in increased expression of PAX6 mRNA CTD PMID:22609695 NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709 		JBrowse link
G Pbld1 phenazine biosynthesis-like protein domain containing 1 increases expression EXP
ISO 		lead acetate results in increased expression of PBLD1 mRNA
lead acetate results in increased expression of PBLD mRNA 		CTD PMID:22609695 PMID:22641619 NCBI chr10:62,896,404...62,913,743
Ensembl chr10:62,895,941...62,913,741 		JBrowse link
G Pbx3 pre B cell leukemia homeobox 3 decreases expression EXP lead acetate results in decreased expression of PBX3 mRNA CTD PMID:22613225 NCBI chr 2:34,061,469...34,264,168
Ensembl chr 2:34,061,469...34,263,154 		JBrowse link
G Pbx4 pre B cell leukemia homeobox 4 decreases expression EXP lead acetate results in decreased expression of PBX4 mRNA CTD PMID:22609695 NCBI chr 8:70,285,127...70,324,942
Ensembl chr 8:70,285,141...70,324,942 		JBrowse link
G Pbxip1 pre B cell leukemia transcription factor interacting protein 1 affects expression ISO lead acetate affects the expression of PBXIP1 mRNA CTD PMID:21864555 NCBI chr 3:89,343,982...89,358,259
Ensembl chr 3:89,344,013...89,358,259 		JBrowse link
G Pcbp2 poly(rC) binding protein 2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of PCBP2 mRNA CTD PMID:39276841 NCBI chr15:102,378,974...102,408,503
Ensembl chr15:102,378,974...102,408,496 		JBrowse link
G Pcdh18 protocadherin 18 decreases expression EXP lead acetate results in decreased expression of PCDH18 mRNA CTD PMID:22613225 NCBI chr 3:49,697,745...49,711,723
Ensembl chr 3:49,697,745...49,711,774 		JBrowse link
G Pcdh7 protocadherin 7 increases expression EXP lead acetate results in increased expression of PCDH7 mRNA CTD PMID:22609695 NCBI chr 5:57,873,487...58,290,578
Ensembl chr 5:57,875,309...58,290,572 		JBrowse link
G Pcdha1 protocadherin alpha 1 increases methylation ISO lead acetate results in increased methylation of PCDHA1 gene CTD PMID:29571894 NCBI chr18:37,063,338...37,320,710
Ensembl chr18:37,063,237...37,320,714 		JBrowse link
G Pcdhb2 protocadherin beta 2 increases expression EXP lead acetate results in increased expression of PCDHB2 mRNA CTD PMID:22613225 NCBI chr18:37,427,893...37,430,667
Ensembl chr18:37,427,865...37,430,677 		JBrowse link
G Pcdhb20 protocadherin beta 20 increases expression
increases methylation 		EXP
ISO 		lead acetate results in increased expression of PCDHB14 mRNA
lead acetate results in increased methylation of PCDHB20 gene 		CTD PMID:22609695 PMID:29571894 NCBI chr18:37,637,332...37,640,713
Ensembl chr18:37,637,317...37,640,875 		JBrowse link
G Pcdhb9 protocadherin beta 9 decreases expression EXP lead acetate results in decreased expression of PCDHB9 mRNA CTD PMID:21829687 NCBI chr18:37,533,908...37,536,962
Ensembl chr18:37,533,908...37,536,962 		JBrowse link
G Pck2 phosphoenolpyruvate carboxykinase 2 (mitochondrial) increases expression EXP lead acetate results in increased expression of PCK2 mRNA CTD PMID:25270620 NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO lead acetate results in decreased expression of PCNA mRNA CTD PMID:33862172 NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234 		JBrowse link
G Pcx pyruvate carboxylase decreases expression ISO lead acetate results in decreased expression of PC mRNA CTD PMID:38568856 NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780 		JBrowse link
G Pcyox1 prenylcysteine oxidase 1 decreases expression EXP lead acetate results in decreased expression of PCYOX1 mRNA CTD PMID:21829687 NCBI chr 6:86,362,988...86,374,132
Ensembl chr 6:86,362,988...86,374,136 		JBrowse link
G Pcyt1b phosphate cytidylyltransferase 1, choline, beta isoform multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of PCYT1B intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PCYT1B promoter CTD PMID:33445541 NCBI chr  X:92,698,469...92,793,557
Ensembl chr  X:92,698,469...92,793,557 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein (myomegalin) multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of PDE4DIP mRNA CTD PMID:22839698 NCBI chr 3:97,597,144...97,796,023
Ensembl chr 3:97,597,140...97,796,023 		JBrowse link
G Pde5a phosphodiesterase 5A, cGMP-specific decreases methylation ISO lead acetate results in decreased methylation of PDE5A gene CTD PMID:29571894 NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023 		JBrowse link
G Pdf peptide deformylase (mitochondrial) decreases expression ISO lead acetate results in decreased expression of PDF mRNA CTD PMID:37939567 NCBI chr 8:107,772,921...107,775,246
Ensembl chr 8:107,771,330...107,775,246 		JBrowse link
G Pdgfb platelet derived growth factor, B polypeptide multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of PDGFB exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PDGFB intron CTD PMID:33445541 NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178 		JBrowse link
G Pdgfc platelet-derived growth factor, C polypeptide increases expression EXP lead acetate results in increased expression of PDGFC mRNA CTD PMID:22609695 NCBI chr 3:80,943,723...81,121,347
Ensembl chr 3:80,943,723...81,121,347 		JBrowse link
G Pdgfd platelet-derived growth factor, D polypeptide decreases expression EXP lead acetate results in decreased expression of PDGFD mRNA CTD PMID:22609695 NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850 		JBrowse link
G Pdgfra platelet derived growth factor receptor, alpha polypeptide multiple interactions ISO CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]; FYN protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein]; lead acetate results in decreased expression of and results in decreased phosphorylation of and results in decreased activity of PDGFRA protein
[lead acetate results in increased abundance of Lead] which results in increased expression of PDGFRA mRNA 		CTD PMID:17298174 PMID:32458983 NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876 		JBrowse link
G Pdia3 protein disulfide isomerase associated 3 increases expression EXP lead acetate results in increased expression of PDIA3 protein CTD PMID:20797405 NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168 		JBrowse link
G Pdk1 pyruvate dehydrogenase kinase, isoenzyme 1 decreases expression ISO lead acetate results in decreased expression of PDK1 mRNA CTD PMID:38568856 NCBI chr 2:71,703,398...71,734,202
Ensembl chr 2:71,703,568...71,734,202 		JBrowse link
G Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 increases expression
decreases expression 		ISO lead acetate results in increased expression of PDK4 mRNA
lead acetate results in decreased expression of PDK4 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309 		JBrowse link
G Pdlim1 PDZ and LIM domain 1 (elfin) decreases expression EXP lead acetate results in decreased expression of PDLIM1 mRNA CTD PMID:22609695 NCBI chr19:40,210,683...40,260,060
Ensembl chr19:40,209,617...40,260,286 		JBrowse link
G Pdlim2 PDZ and LIM domain 2 decreases expression ISO lead acetate results in decreased expression of PDLIM2 mRNA CTD PMID:38568856 NCBI chr14:70,401,667...70,415,140
Ensembl chr14:70,401,667...70,415,130 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 increases expression ISO lead acetate results in increased expression of PDLIM7 mRNA CTD PMID:38568856 NCBI chr13:55,645,300...55,661,281
Ensembl chr13:55,643,608...55,661,489 		JBrowse link
G Pdpk1 3-phosphoinositide dependent protein kinase 1 decreases expression EXP lead acetate results in decreased expression of PDPK1 mRNA CTD PMID:20542052 NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898 		JBrowse link
G Pdxp pyridoxal (pyridoxine, vitamin B6) phosphatase decreases expression ISO lead acetate results in decreased expression of PDXP mRNA CTD PMID:37939567 NCBI chr15:78,796,342...78,803,717
Ensembl chr15:78,798,119...78,803,717 		JBrowse link
G Pdyn prodynorphin decreases expression ISO lead acetate results in decreased expression of PDYN mRNA CTD PMID:11578147 NCBI chr 2:129,528,469...129,541,858
Ensembl chr 2:129,528,485...129,541,764 		JBrowse link
G Pdzk1ip1 PDZK1 interacting protein 1 decreases expression ISO lead acetate results in decreased expression of PDZK1IP1 mRNA CTD PMID:38568856 NCBI chr 4:114,945,905...114,951,091
Ensembl chr 4:114,945,905...114,951,096 		JBrowse link
G Pdzrn3 PDZ domain containing RING finger 3 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of PDZRN3 intron CTD PMID:33445541 NCBI chr 6:101,126,568...101,354,858
Ensembl chr 6:101,126,570...101,354,858 		JBrowse link
G Pea15a proliferation and apoptosis adaptor protein 15A increases expression ISO lead acetate results in increased expression of PEA15 mRNA CTD PMID:38568856 NCBI chr 1:172,024,295...172,034,298
Ensembl chr 1:172,024,295...172,034,371 		JBrowse link
G Peli2 pellino 2 increases expression EXP lead acetate results in increased expression of PELI2 mRNA CTD PMID:20542052 NCBI chr14:48,358,096...48,519,035
Ensembl chr14:48,358,280...48,519,032 		JBrowse link
G Pelp1 proline, glutamic acid and leucine rich protein 1 increases expression ISO lead acetate results in increased expression of PELP1 mRNA CTD PMID:38568856 NCBI chr11:70,283,709...70,300,862
Ensembl chr11:70,283,709...70,300,857 		JBrowse link
G Per1 period circadian clock 1 decreases expression EXP lead acetate results in decreased expression of PER1 mRNA CTD PMID:21829687 NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786 		JBrowse link
G Per2 period circadian clock 2 decreases expression ISO lead acetate results in decreased expression of PER2 mRNA CTD PMID:38568856 NCBI chr 1:91,343,699...91,387,028
Ensembl chr 1:91,343,704...91,387,046 		JBrowse link
G Pex2 peroxisomal biogenesis factor 2 decreases expression EXP lead acetate results in decreased expression of PEX2 mRNA CTD PMID:21829687 NCBI chr 3:5,625,248...5,643,655
Ensembl chr 3:5,625,248...5,641,299 		JBrowse link
G Pex6 peroxisomal biogenesis factor 6 increases expression EXP lead acetate results in increased expression of PEX6 mRNA CTD PMID:21829687 NCBI chr17:47,022,402...47,036,469
Ensembl chr17:47,022,389...47,036,467 		JBrowse link
G Pfdn5 prefoldin 5 decreases expression EXP lead acetate results in decreased expression of PFDN5 mRNA CTD PMID:22609695 NCBI chr15:102,234,551...102,239,925
Ensembl chr15:102,234,551...102,240,308 		JBrowse link
G Pfkl phosphofructokinase, liver, B-type multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PFKL mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PFKL protein CTD PMID:38157908 NCBI chr10:77,822,781...77,845,641
Ensembl chr10:77,822,781...77,845,917 		JBrowse link
G Pfkm phosphofructokinase, muscle multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PFKM mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PFKM protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of PFKM protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PFKM protein] CTD PMID:34508822 PMID:38157908 NCBI chr15:97,990,470...98,030,328
Ensembl chr15:97,990,470...98,030,332 		JBrowse link
G Pfn3 profilin 3 increases expression EXP lead acetate results in increased expression of PFN3 mRNA CTD PMID:22609695 NCBI chr13:55,562,501...55,563,045
Ensembl chr13:55,562,501...55,563,045 		JBrowse link
G Pgd phosphogluconate dehydrogenase increases expression
decreases activity 		ISO lead acetate results in increased expression of PGD mRNA
lead acetate results in decreased activity of PGD protein 		CTD PMID:22641619 PMID:25228019 PMID:38568856 NCBI chr 4:149,234,448...149,251,162
Ensembl chr 4:149,234,448...149,251,228 		JBrowse link
G Pgf placental growth factor multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of PGF mRNA CTD PMID:22839698 NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PGK1 mRNA]; [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PGK1 protein] CTD PMID:38157908 NCBI chr  X:105,230,706...105,247,305
Ensembl chr  X:105,230,706...105,247,305 		JBrowse link
G Pgm1 phosphoglucomutase 1 multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PGM1 mRNA; [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of PGM1 protein CTD PMID:38157908 NCBI chr 4:99,786,648...99,844,491
Ensembl chr 4:99,786,611...99,844,491 		JBrowse link
G Pgrmc2 progesterone receptor membrane component 2 increases expression ISO lead acetate results in increased expression of PGRMC2 mRNA CTD PMID:38568856 NCBI chr 3:41,020,772...41,037,443
Ensembl chr 3:41,020,761...41,037,481 		JBrowse link
G Phactr2 phosphatase and actin regulator 2 decreases expression EXP lead acetate results in decreased expression of PHACTR2 mRNA CTD PMID:22609695 NCBI chr10:13,083,461...13,350,266
Ensembl chr10:13,083,461...13,350,156 		JBrowse link
G Phf10 PHD finger protein 10 increases expression
increases methylation 		EXP
ISO 		lead acetate results in increased expression of PHF10 mRNA
lead acetate results in increased methylation of PHF10 gene 		CTD PMID:25270620 PMID:29571894 NCBI chr17:15,165,269...15,181,550
Ensembl chr17:15,165,271...15,181,535 		JBrowse link
G Phf8 PHD finger protein 8 decreases expression EXP lead acetate results in decreased expression of PHF8 mRNA CTD PMID:21829687 NCBI chr  X:150,303,621...150,416,855
Ensembl chr  X:150,303,668...150,416,855 		JBrowse link
G Phka2 phosphorylase kinase alpha 2 decreases expression EXP lead acetate results in decreased expression of PHKA2 mRNA CTD PMID:21829687 NCBI chr  X:159,284,900...159,384,772
Ensembl chr  X:159,285,162...159,381,874 		JBrowse link
G Phkb phosphorylase kinase beta increases expression ISO lead acetate results in increased expression of PHKB mRNA; lead acetate results in increased expression of PHKB protein CTD PMID:28916327 NCBI chr 8:86,567,489...86,790,883
Ensembl chr 8:86,567,588...86,788,005 		JBrowse link
G Phlda1 pleckstrin homology like domain, family A, member 1 increases expression ISO lead acetate results in increased expression of PHLDA1 mRNA CTD PMID:38568856 NCBI chr10:111,342,147...111,344,510
Ensembl chr10:111,342,147...111,344,506 		JBrowse link
G Phlda2 pleckstrin homology like domain, family A, member 2 increases expression ISO lead acetate results in increased expression of PHLDA2 mRNA CTD PMID:38568856 NCBI chr 7:143,055,282...143,056,882
Ensembl chr 7:143,055,282...143,056,887 		JBrowse link
G Phrf1 PHD and ring finger domains 1 increases expression ISO lead acetate results in increased expression of PHRF1 mRNA CTD PMID:38568856 NCBI chr 7:140,808,373...140,842,664
Ensembl chr 7:140,808,697...140,842,663 		JBrowse link
G Pi16 peptidase inhibitor 16 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 5' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 promoter CTD PMID:33445541 NCBI chr17:29,537,770...29,547,876
Ensembl chr17:29,536,654...29,549,567 		JBrowse link
G Pibf1 progesterone immunomodulatory binding factor 1 decreases expression ISO lead acetate results in decreased expression of PIBF1 mRNA CTD PMID:22641619 NCBI chr14:99,336,892...99,492,335
Ensembl chr14:99,336,860...99,491,929 		JBrowse link
G Pidd1 p53 induced death domain protein 1 decreases expression EXP lead acetate results in decreased expression of PIDD1 mRNA CTD PMID:22609695 NCBI chr 7:141,018,026...141,027,477
Ensembl chr 7:141,018,026...141,023,938 		JBrowse link
G Pigk phosphatidylinositol glycan anchor biosynthesis, class K increases expression ISO lead acetate results in increased expression of PIGK mRNA CTD PMID:22641619 NCBI chr 3:152,419,718...152,548,705
Ensembl chr 3:152,419,737...152,686,045 		JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha decreases phosphorylation
multiple interactions 		EXP lead acetate results in decreased phosphorylation of PIK3CA protein
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased phosphorylation of PIK3CA protein] 		CTD PMID:37385299 NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635 		JBrowse link
G Pik3cd phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta decreases expression EXP lead acetate results in decreased expression of PIK3CD mRNA CTD PMID:33932463 NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028 		JBrowse link
G Pik3cg phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG protein CTD PMID:36652739 NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 decreases expression ISO lead acetate results in decreased expression of PIK3R1 mRNA CTD PMID:30980912 NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725 		JBrowse link
G Pim1 proviral integration site 1 increases expression ISO lead acetate results in increased expression of PIM1 mRNA CTD PMID:38568856 NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086 		JBrowse link
G Pink1 PTEN induced putative kinase 1 multiple interactions ISO [[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; [amyloid beta-protein (25-35) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; lead acetate promotes the reaction [PINK1 protein binds to ATM protein]; lead acetate results in increased expression of and results in increased phosphorylation of PINK1 protein CTD PMID:29660402 PMID:35300571 NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618 		JBrowse link
G Pip prolactin induced protein decreases expression EXP lead acetate results in decreased expression of PIP mRNA CTD PMID:22609695 NCBI chr 6:41,824,483...41,828,999
Ensembl chr 6:41,824,469...41,828,999 		JBrowse link
G Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type 1 beta multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PIP5K1B mRNA CTD PMID:12634122 NCBI chr19:24,272,158...24,533,236
Ensembl chr19:24,272,158...24,533,236 		JBrowse link
G Pir pirin increases expression ISO lead acetate results in increased expression of PIR mRNA CTD PMID:22839698 PMID:27562236 PMID:37939567 PMID:38568856 NCBI chr  X:163,052,427...163,156,009
Ensembl chr  X:163,052,367...163,156,007 		JBrowse link
G Pitpnc1 phosphatidylinositol transfer protein, cytoplasmic 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of PITPNC1 intron CTD PMID:33445541 NCBI chr11:107,098,718...107,361,546
Ensembl chr11:107,098,718...107,361,525 		JBrowse link
G Pkd1l3 polycystic kidney disease 1 like 3 increases expression EXP lead acetate results in increased expression of PKD1L3 mRNA CTD PMID:20542052 NCBI chr 8:110,340,828...110,399,305
Ensembl chr 8:110,341,149...110,401,018 		JBrowse link
G Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 increases expression ISO lead acetate results in increased expression of PKMYT1 mRNA CTD PMID:38568856 NCBI chr17:23,945,385...23,955,709
Ensembl chr17:23,945,310...23,955,709 		JBrowse link
G Pkp1 plakophilin 1 increases methylation ISO lead acetate results in increased methylation of PKP1 gene CTD PMID:29571894 NCBI chr 1:135,799,132...135,846,945
Ensembl chr 1:135,799,133...135,846,945 		JBrowse link
G Pkp2 plakophilin 2 decreases expression ISO lead acetate results in decreased expression of PKP2 mRNA CTD PMID:38568856 NCBI chr16:16,031,209...16,090,576
Ensembl chr16:16,031,182...16,090,576 		JBrowse link
G Pla2g1b phospholipase A2, group IB, pancreas increases expression ISO
EXP 		lead acetate results in increased expression of PLA2G1B mRNA CTD PMID:11578147 PMID:20542052 NCBI chr 5:115,604,201...115,612,781
Ensembl chr 5:115,604,321...115,612,781 		JBrowse link
G Pla2g2a phospholipase A2, group IIA (platelets, synovial fluid) increases expression ISO lead acetate results in increased expression of PLA2G2A mRNA CTD PMID:11578147 NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497 		JBrowse link
G Pla2g2d phospholipase A2, group IID decreases expression EXP lead acetate results in decreased expression of PLA2G2D mRNA CTD PMID:22613225 NCBI chr 4:138,503,046...138,509,363
Ensembl chr 4:138,503,046...138,509,357 		JBrowse link
G Pla2g5 phospholipase A2, group V affects expression
decreases expression 		ISO lead acetate affects the expression of PLA2G5 mRNA
lead acetate results in decreased expression of PLA2G5 mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr 4:138,526,558...138,590,784
Ensembl chr 4:138,526,555...138,590,793 		JBrowse link
G Pla2r1 phospholipase A2 receptor 1 decreases expression ISO lead acetate results in decreased expression of PLA2R1 mRNA CTD PMID:22641619 NCBI chr 2:60,247,887...60,383,669
Ensembl chr 2:60,247,887...60,383,652 		JBrowse link
G Plac8 placenta-specific 8 decreases expression EXP lead acetate results in decreased expression of PLAC8 mRNA CTD PMID:21829687 NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111 		JBrowse link
G Plagl1 pleiomorphic adenoma gene-like 1 decreases expression ISO lead acetate results in decreased expression of PLAGL1 mRNA CTD PMID:22641619 NCBI chr10:12,966,576...13,007,438
Ensembl chr10:12,936,248...13,007,438 		JBrowse link
G Plat plasminogen activator, tissue affects activity ISO lead acetate affects the activity of PLAT protein CTD PMID:2143947 NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860 		JBrowse link
G Plce1 phospholipase C, epsilon 1 increases expression EXP lead acetate results in increased expression of PLCE1 mRNA CTD PMID:20542052 NCBI chr19:38,469,438...38,773,549
Ensembl chr19:38,469,557...38,773,474 		JBrowse link
G Pld2 phospholipase D2 decreases expression ISO lead acetate results in decreased expression of PLD2 mRNA CTD PMID:38568856 NCBI chr11:70,430,318...70,448,936
Ensembl chr11:70,430,890...70,448,936 		JBrowse link
G Pld4 phospholipase D family member 4 increases expression EXP lead acetate results in increased expression of PLD4 mRNA CTD PMID:21829687 NCBI chr12:112,727,089...112,735,420
Ensembl chr12:112,727,089...112,735,424 		JBrowse link
G Pld5 phospholipase D family member 5 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of PLD5 mRNA
lead acetate results in increased expression of PLD5 mRNA 		CTD PMID:22613225 PMID:38568856 NCBI chr 1:175,789,867...176,109,078
Ensembl chr 1:175,789,872...176,102,878 		JBrowse link
G Plec plectin increases expression ISO lead acetate results in increased expression of PLEC mRNA CTD PMID:38568856 NCBI chr15:76,055,174...76,115,578
Ensembl chr15:76,055,174...76,116,774 		JBrowse link
G Plekho1 pleckstrin homology domain containing, family O member 1 increases expression ISO lead acetate results in increased expression of PLEKHO1 mRNA CTD PMID:38568856 NCBI chr 3:95,896,110...95,903,258
Ensembl chr 3:95,895,741...95,903,313 		JBrowse link
G Plg plasminogen affects activity ISO lead acetate affects the activity of PLG protein modified form CTD PMID:2143947 NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272 		JBrowse link
G Plin2 perilipin 2 increases expression EXP lead acetate results in increased expression of PLIN2 mRNA CTD PMID:21829687 NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297 		JBrowse link
G Plin5 perilipin 5 decreases expression EXP lead acetate results in decreased expression of PLIN5 mRNA CTD PMID:25270620 NCBI chr17:56,418,601...56,424,606
Ensembl chr17:56,418,601...56,424,596 		JBrowse link
G Plk4 polo like kinase 4 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of PLK4 mRNA
lead acetate results in increased expression of PLK4 mRNA 		CTD PMID:21829687 PMID:22641619 NCBI chr 3:40,754,463...40,771,318
Ensembl chr 3:40,754,454...40,771,318 		JBrowse link
G Pln phospholamban increases expression ISO lead acetate results in increased expression of PLN mRNA CTD PMID:22641619 NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083 		JBrowse link
G Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of PLOD2 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of PLOD2 protein 		CTD PMID:22641619 PMID:38072110 NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481 		JBrowse link
G Plp1 proteolipid protein (myelin) 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] affects the expression of PLP1 protein CTD PMID:23680456 NCBI chr  X:135,720,897...135,739,331
Ensembl chr  X:135,723,420...135,740,482 		JBrowse link
G Plpp1 phospholipid phosphatase 1 increases expression ISO lead acetate results in increased expression of PLPP1 mRNA CTD PMID:38568856 NCBI chr13:112,937,311...113,004,428
Ensembl chr13:112,937,326...113,004,428 		JBrowse link
G Plpp3 phospholipid phosphatase 3 increases expression EXP lead acetate results in increased expression of PLPP3 mRNA CTD PMID:20542052 NCBI chr 4:105,014,544...105,089,964
Ensembl chr 4:105,014,544...105,089,961 		JBrowse link
G Plpp4 phospholipid phosphatase 4 decreases expression ISO lead acetate results in decreased expression of PLPP4 mRNA CTD PMID:22641619 NCBI chr 7:128,858,114...128,993,138
Ensembl chr 7:128,858,755...128,993,136 		JBrowse link
G Plxna1 plexin A1 decreases expression EXP
ISO 		lead acetate results in decreased expression of PLXNA1 mRNA CTD PMID:20542052 PMID:22641619 NCBI chr 6:89,293,295...89,339,595
Ensembl chr 6:89,293,296...89,339,602 		JBrowse link
G Plxna2 plexin A2 increases expression ISO lead acetate results in increased expression of PLXNA2 mRNA CTD PMID:38568856 NCBI chr 1:194,302,020...194,499,177
Ensembl chr 1:194,300,526...194,499,177 		JBrowse link
G Pm20d2 peptidase M20 domain containing 2 decreases expression ISO lead acetate results in decreased expression of PM20D2 mRNA CTD PMID:38568856 NCBI chr 4:33,170,309...33,189,732
Ensembl chr 4:33,174,230...33,189,737 		JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 increases expression ISO lead acetate results in increased expression of PMAIP1 mRNA CTD PMID:38568856 NCBI chr18:66,591,675...66,598,629
Ensembl chr18:66,591,604...66,598,636 		JBrowse link
G Pmel premelanosome protein decreases expression EXP lead acetate results in decreased expression of PMEL mRNA CTD PMID:22609695 NCBI chr10:128,531,757...128,555,993
Ensembl chr10:128,540,064...128,556,107 		JBrowse link
G Pmepa1 prostate transmembrane protein, androgen induced 1 increases expression
affects methylation 		ISO lead acetate results in increased expression of PMEPA1 mRNA
lead acetate affects the methylation of PMEPA1 gene 		CTD PMID:29571894 PMID:37939567 NCBI chr 2:173,066,251...173,118,329
Ensembl chr 2:173,066,251...173,118,326 		JBrowse link
G Pmm2 phosphomannomutase 2 increases expression EXP lead acetate results in increased expression of PMM2 mRNA CTD PMID:20542052 NCBI chr16:8,455,467...8,475,472
Ensembl chr16:8,455,538...8,480,331 		JBrowse link
G Pnlip pancreatic lipase increases expression EXP
ISO 		lead acetate results in increased expression of PNLIP mRNA CTD PMID:20542052 PMID:22641619 NCBI chr19:58,658,797...58,670,231
Ensembl chr19:58,640,930...58,670,220 		JBrowse link
G Pnmt phenylethanolamine-N-methyltransferase increases expression EXP lead acetate results in increased expression of PNMT mRNA CTD PMID:22609695 NCBI chr11:98,277,449...98,279,006
Ensembl chr11:98,277,276...98,279,007 		JBrowse link
G Pnpla1 patatin-like phospholipase domain containing 1 decreases expression ISO lead acetate results in decreased expression of PNPLA1 mRNA CTD PMID:22641619 NCBI chr17:29,077,262...29,109,282
Ensembl chr17:29,077,385...29,109,283 		JBrowse link
G Pnrc1 proline-rich nuclear receptor coactivator 1 decreases expression ISO lead acetate results in decreased expression of PNRC1 mRNA CTD PMID:38568856 NCBI chr 4:33,245,423...33,248,787
Ensembl chr 4:33,245,423...33,290,163 		JBrowse link
G Pnrc2 proline-rich nuclear receptor coactivator 2 decreases expression ISO lead acetate results in decreased expression of PNRC2 mRNA CTD PMID:38568856 NCBI chr 4:135,598,229...135,601,157
Ensembl chr 4:135,598,229...135,601,161 		JBrowse link
G Pold1 polymerase (DNA directed), delta 1, catalytic subunit multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with lead acetate] results in decreased expression of POLD1 protein
lead acetate results in increased expression of POLD1 mRNA 		CTD PMID:21829687 PMID:38072110 NCBI chr 7:44,182,168...44,198,239
Ensembl chr 7:44,182,170...44,198,273 		JBrowse link
G Pole polymerase (DNA directed), epsilon increases expression EXP lead acetate results in increased expression of POLE mRNA CTD PMID:22609695 NCBI chr 5:110,434,185...110,485,319
Ensembl chr 5:110,434,172...110,485,340 		JBrowse link
G Pole4 polymerase (DNA-directed), epsilon 4 (p12 subunit) decreases expression EXP lead acetate results in decreased expression of POLE4 mRNA CTD PMID:21829687 NCBI chr 6:82,593,513...82,629,985
Ensembl chr 6:82,595,973...82,682,346 		JBrowse link
G Polq polymerase (DNA directed), theta increases expression ISO lead acetate results in increased expression of POLQ mRNA CTD PMID:22641619 NCBI chr16:36,832,104...36,922,321
Ensembl chr16:36,832,148...36,915,779 		JBrowse link
G Polr1h RNA polymerase I subunit H increases expression ISO lead acetate results in increased expression of ZNRD1 mRNA CTD PMID:38568856 NCBI chr17:37,265,250...37,269,417
Ensembl chr17:37,265,248...37,269,451 		JBrowse link
G Polr3k polymerase (RNA) III (DNA directed) polypeptide K decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of POLR3K mRNA
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of POLR3K mRNA 		CTD PMID:22641619 PMID:22839698 NCBI chr 2:181,506,153...181,512,623
Ensembl chr 2:181,506,130...181,512,623 		JBrowse link
G Pomp proteasome maturation protein multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of POMP protein CTD PMID:38072110 NCBI chr 5:147,797,438...147,812,594
Ensembl chr 5:147,797,271...147,813,266 		JBrowse link
G Pon1 paraoxonase 1 affects expression ISO lead acetate affects the expression of PON1 mRNA CTD PMID:21864555 NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946 		JBrowse link
G Pon2 paraoxonase 2 increases expression
multiple interactions
decreases activity 		ISO lead acetate results in increased expression of PON2 mRNA
Calcium inhibits the reaction [lead acetate results in decreased activity of PON2 protein] 		CTD PMID:22271317 NCBI chr 6:5,264,620...5,298,408
Ensembl chr 6:5,264,147...5,298,455 		JBrowse link
G Pop5 processing of precursor 5, ribonuclease P/MRP family (S. cerevisiae) increases expression EXP lead acetate results in increased expression of POP5 mRNA CTD PMID:21829687 NCBI chr 5:115,373,505...115,379,031
Ensembl chr 5:115,373,895...115,383,410 		JBrowse link
G Popdc3 popeye domain containing 3 increases expression ISO lead acetate results in increased expression of POPDC3 mRNA CTD PMID:38568856 NCBI chr10:45,165,401...45,194,546
Ensembl chr10:45,054,194...45,194,548 		JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of POR mRNA CTD PMID:39276841 NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180 		JBrowse link
G Porcn porcupine O-acyltransferase multiple interactions EXP [[lead acetate results in increased abundance of Lead] which results in decreased expression of PORCN protein] which results in decreased localization of WNT3A protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of PORCN mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PORCN protein CTD PMID:37436718 NCBI chr  X:8,060,085...8,072,794
Ensembl chr  X:8,060,087...8,072,764 		JBrowse link
G Postn periostin, osteoblast specific factor increases expression ISO lead acetate results in increased expression of POSTN mRNA CTD PMID:38568856 NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458 		JBrowse link
G Pou2f2 POU domain, class 2, transcription factor 2 increases activity
increases expression 		ISO lead acetate results in increased activity of POU2F2 protein
lead acetate results in increased expression of POU2F2 mRNA; lead acetate results in increased expression of POU2F2 protein 		CTD PMID:17093203 NCBI chr 7:24,790,111...24,879,292
Ensembl chr 7:24,786,769...24,879,151 		JBrowse link
G Pou4f1 POU domain, class 4, transcription factor 1 decreases expression ISO lead acetate results in decreased expression of POU4F1 mRNA; lead acetate results in decreased expression of POU4F1 protein CTD PMID:16384672 NCBI chr14:104,699,111...104,705,554
Ensembl chr14:104,699,112...104,705,435 		JBrowse link
G Pou4f2 POU domain, class 4, transcription factor 2 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of POU4F2 mRNA
[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of POU4F2 protein 		CTD PMID:20542052 PMID:23680456 NCBI chr 8:79,159,638...79,163,276
Ensembl chr 8:79,159,639...79,163,274 		JBrowse link
G Pou5f1 POU domain, class 5, transcription factor 1 increases expression EXP lead acetate results in increased expression of POU5F1 mRNA CTD PMID:31715224 NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha increases expression EXP lead acetate results in increased expression of PPARA mRNA CTD PMID:22609695 NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020 		JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions
increases expression 		ISO [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein; [lead acetate co-treated with Cadmium Chloride] results in increased expression of PPARG protein; [lead acetate co-treated with sodium arsenite co-treated with Cadmium Chloride] results in increased expression of PPARG protein; [lead acetate co-treated with sodium arsenite] results in increased expression of PPARG protein; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]; [sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein; CR8 compound analog inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]; CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]; PPARG protein affects the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased expression of and results in increased cleavage of PARP1 protein]; PPARG protein affects the reaction [lead acetate results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of PPARG protein]; T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]; T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]
lead acetate results in increased expression of PPARG protein 		CTD PMID:24481447 PMID:28283887 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360 		JBrowse link
G Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha increases expression
multiple interactions 		EXP lead acetate results in increased expression of PPARGC1A protein
PPARGC1A protein affects the reaction [lead acetate results in increased expression of SIRT3 protein]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP3 protein]; PPARGC1A protein inhibits the reaction [lead acetate results in increased activity of CASP9 protein] 		CTD PMID:27236077 NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068 		JBrowse link
G Ppcdc phosphopantothenoylcysteine decarboxylase increases expression EXP lead acetate results in increased expression of PPCDC mRNA CTD PMID:21829687 NCBI chr 9:57,292,378...57,347,440
Ensembl chr 9:57,292,378...57,347,407 		JBrowse link
G Ppcs phosphopantothenoylcysteine synthetase decreases expression EXP lead acetate results in decreased expression of PPCS mRNA CTD PMID:21829687 NCBI chr 4:119,275,724...119,279,673
Ensembl chr 4:119,275,727...119,279,617 		JBrowse link
G Ppdpf pancreatic progenitor cell differentiation and proliferation factor increases expression ISO lead acetate results in increased expression of PPDPF mRNA CTD PMID:38568856 NCBI chr 2:180,828,615...180,830,297
Ensembl chr 2:180,829,040...180,830,564 		JBrowse link
G Ppef1 protein phosphatase with EF hand calcium-binding domain 1 increases expression ISO lead acetate results in increased expression of PPEF1 mRNA CTD PMID:11578147 NCBI chr  X:159,404,997...159,534,286
Ensembl chr  X:159,406,090...159,518,761 		JBrowse link
G Ppef2 protein phosphatase, EF hand calcium-binding domain 2 decreases expression ISO lead acetate results in decreased expression of PPEF2 mRNA CTD PMID:22641619 NCBI chr 5:92,374,109...92,404,759
Ensembl chr 5:92,374,538...92,404,137 		JBrowse link
G Ppif peptidylprolyl isomerase F (cyclophilin F) multiple interactions ISO PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of RPTOR protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of H2AX protein] CTD PMID:31874198 NCBI chr14:25,693,998...25,700,892
Ensembl chr14:25,694,578...25,700,892 		JBrowse link
G Ppil1 peptidylprolyl isomerase (cyclophilin)-like 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of PPIL1 mRNA CTD PMID:22839698 NCBI chr17:29,469,809...29,482,945
Ensembl chr17:29,469,777...29,483,160 		JBrowse link
G Ppl periplakin decreases expression ISO lead acetate results in decreased expression of PPL mRNA CTD PMID:38568856 NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285 		JBrowse link
G Ppm1g protein phosphatase 1G (formerly 2C), magnesium-dependent, gamma isoform decreases expression EXP lead acetate results in decreased expression of PPM1G mRNA CTD PMID:21829687 NCBI chr 5:31,360,012...31,377,889
Ensembl chr 5:31,360,008...31,378,031 		JBrowse link
G Ppp1ca protein phosphatase 1 catalytic subunit alpha increases methylation ISO lead acetate results in increased methylation of PPP1CA gene CTD PMID:29571894 NCBI chr19:4,242,173...4,245,418
Ensembl chr19:4,242,064...4,245,419 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta increases expression
decreases methylation 		EXP
ISO 		lead acetate results in increased expression of PPP1CB mRNA
lead acetate results in decreased methylation of PPP1CB gene 		CTD PMID:22609695 PMID:29571894 NCBI chr 5:32,616,192...32,651,057
Ensembl chr 5:32,616,187...32,674,777 		JBrowse link
G Ppp1r12a protein phosphatase 1, regulatory subunit 12A multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of PPP1R12A mRNA; PPP1R12A protein affects the reaction [[lead acetate results in increased abundance of Lead] which affects the localization of HDAC4 protein] CTD PMID:33080273 NCBI chr10:107,997,913...108,115,846
Ensembl chr10:107,998,054...108,120,336 		JBrowse link
G Ppp1r18 protein phosphatase 1, regulatory subunit 18 increases expression ISO lead acetate results in increased expression of PPP1R18 mRNA CTD PMID:38568856 NCBI chr17:36,176,483...36,186,488
Ensembl chr17:36,176,485...36,186,488 		JBrowse link
G Ppp1r9b protein phosphatase 1, regulatory subunit 9B decreases expression ISO lead acetate results in decreased expression of PPP1R9B mRNA CTD PMID:22160880 NCBI chr11:94,882,038...94,897,724
Ensembl chr11:94,881,861...94,897,725 		JBrowse link
G Ppp2ca protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of PPP2CA mRNA CTD PMID:33080273 NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605 		JBrowse link
G Ppp3r1 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) increases expression ISO lead acetate results in increased expression of PPP3R1 mRNA CTD PMID:11578147 NCBI chr11:17,109,298...17,150,380
Ensembl chr11:17,109,263...17,150,375 		JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit increases expression ISO lead acetate results in increased expression of PPP5C protein CTD PMID:23134599 NCBI chr 7:16,738,575...16,761,812
Ensembl chr 7:16,738,565...16,761,849 		JBrowse link
G Ppp6r3 protein phosphatase 6, regulatory subunit 3 decreases expression EXP lead acetate results in decreased expression of PPP6R3 mRNA CTD PMID:21829687 NCBI chr19:3,504,928...3,626,191
Ensembl chr19:3,504,928...3,625,749 		JBrowse link
G Prdm14 PR domain containing 14 decreases expression EXP lead acetate results in decreased expression of PRDM14 mRNA CTD PMID:25270620 NCBI chr 1:13,183,649...13,197,467
Ensembl chr 1:13,183,681...13,197,387 		JBrowse link
G Prdx1 peroxiredoxin 1 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of PRDX1 mRNA
lead acetate results in increased expression of PRDX1 mRNA 		CTD PMID:21829687 PMID:33862172 NCBI chr 4:116,542,796...116,557,196
Ensembl chr 4:116,542,741...116,558,019 		JBrowse link
G Prdx2 peroxiredoxin 2 multiple interactions
affects localization 		EXP
ISO 		[S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate affects the localization of PRDX2 protein]; [S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate promotes the reaction [PRDX2 protein binds to PRDX2 protein]]; Clotrimazole inhibits the reaction [lead acetate promotes the reaction [PRDX2 protein binds to PRDX2 protein]]; lead acetate promotes the reaction [PRDX2 protein binds to PRDX2 protein]; S-allylcysteine inhibits the reaction [lead acetate affects the localization of PRDX2 protein]; S-allylcysteine inhibits the reaction [lead acetate promotes the reaction [PRDX2 protein binds to PRDX2 protein]]
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PRDX2 mRNA 		CTD PMID:22033380 PMID:22839698 NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463 		JBrowse link
G Prdx4 peroxiredoxin 4 decreases expression EXP lead acetate results in decreased expression of PRDX4 mRNA CTD PMID:29746905 NCBI chr  X:154,106,914...154,125,268
Ensembl chr  X:154,106,914...154,123,750 		JBrowse link
G Prelp proline arginine-rich end leucine-rich repeat increases expression EXP lead acetate results in increased expression of PRELP mRNA CTD PMID:21829687 NCBI chr 1:133,838,042...133,857,820
Ensembl chr 1:133,838,042...133,849,152 		JBrowse link
G Prickle3 prickle planar cell polarity protein 3 increases expression EXP lead acetate results in increased expression of PRICKLE3 mRNA CTD PMID:21829687 NCBI chr  X:7,523,616...7,535,086
Ensembl chr  X:7,523,499...7,534,425 		JBrowse link
G Prkaa2 protein kinase, AMP-activated, alpha 2 catalytic subunit multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of PRKAA2 mRNA CTD PMID:39276841 NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087 		JBrowse link
G Prkaca protein kinase, cAMP dependent, catalytic, alpha decreases expression ISO lead acetate results in decreased expression of PRKACA protein CTD PMID:25981801 NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072 		JBrowse link
G Prkar1a protein kinase, cAMP dependent regulatory, type I, alpha increases expression EXP lead acetate results in increased expression of PRKAR1A mRNA CTD PMID:21829687 NCBI chr11:109,539,849...109,560,489
Ensembl chr11:109,540,231...109,560,482 		JBrowse link
G Prkca protein kinase C, alpha decreases expression
increases phosphorylation
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased expression of PRKCA protein
lead acetate results in increased phosphorylation of PRKCA protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of PRKCA mRNA; Genistein inhibits the reaction [lead acetate results in increased phosphorylation of PRKCA protein]; Nimodipine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein]; Ro 31-8220 promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein]; Tetradecanoylphorbol Acetate inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of and results in decreased phosphorylation of PRKCA protein]
lead acetate results in increased expression of PRKCA mRNA
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased activity of PRKCA protein]; [lead acetate results in decreased expression of PRKCA protein] inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [lead acetate results in decreased expression of PRKCA protein] inhibits the reaction [lead acetate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased activity of PRKCA protein]; lead acetate results in increased activity of and affects the localization of PRKCA protein; PRKCA mutant form inhibits the reaction [lead acetate results in increased activity of HRAS protein]; SU 6656 inhibits the reaction [lead acetate results in increased activity of PRKCA protein] 		CTD PMID:11861786 PMID:16547843 PMID:19133285 PMID:22609695 PMID:25981801 More... NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754 		JBrowse link
G Prkcb protein kinase C, beta decreases expression ISO lead acetate results in decreased expression of PRKCB protein CTD PMID:16547843 NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625 		JBrowse link
G Prkce protein kinase C, epsilon decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of PRKCE protein
[lead acetate results in increased abundance of Lead] which results in increased methylation of PRKCE intron 		CTD PMID:16547843 PMID:33445541 NCBI chr17:86,472,631...86,965,347
Ensembl chr17:86,475,213...86,965,347 		JBrowse link
G Prkcg protein kinase C, gamma decreases expression ISO lead acetate results in decreased expression of PRKCG protein CTD PMID:16547843 NCBI chr 7:3,352,038...3,379,615
Ensembl chr 7:3,337,704...3,379,615 		JBrowse link
G Prkch protein kinase C, eta increases expression EXP lead acetate results in increased expression of PRKCH mRNA CTD PMID:20542052 NCBI chr12:73,631,570...73,824,959
Ensembl chr12:73,631,570...73,824,959 		JBrowse link
G Prkci protein kinase C, iota decreases expression ISO lead acetate results in decreased expression of PRKCI protein CTD PMID:16547843 NCBI chr 3:31,049,893...31,106,889
Ensembl chr 3:31,049,896...31,107,108 		JBrowse link
G Prkcq protein kinase C, theta decreases expression EXP lead acetate results in decreased expression of PRKCQ mRNA CTD PMID:22613225 NCBI chr 2:11,176,922...11,306,033
Ensembl chr 2:11,176,919...11,306,033 		JBrowse link
G Prkdc protein kinase, DNA activated, catalytic polypeptide increases expression EXP lead acetate results in increased expression of PRKDC mRNA CTD PMID:20542052 NCBI chr16:15,455,698...15,660,103
Ensembl chr16:15,455,730...15,660,099 		JBrowse link
G Prkg1 protein kinase, cGMP-dependent, type I increases methylation ISO lead acetate results in increased methylation of PRKG1 gene CTD PMID:29571894 NCBI chr19:30,541,887...31,742,675
Ensembl chr19:30,541,889...31,742,433 		JBrowse link
G Prkn parkin RBR E3 ubiquitin protein ligase multiple interactions
affects localization 		EXP
ISO 		lead acetate results in increased phosphorylation of and affects the localization of PRKN protein
[[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PRKN protein; [[lead acetate results in increased abundance of Lead] co-treated with [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)]] results in decreased expression of PRKN mRNA; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (1-40)] results in decreased expression of PRKN mRNA; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (1-40)] results in decreased expression of PRKN protein; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (25-35)] results in decreased expression of PRKN mRNA; [[lead acetate results in increased abundance of Lead] which co-treated with amyloid beta-protein (25-35)] results in decreased expression of PRKN protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of PRKN mRNA
lead acetate affects the localization of PRKN protein 		CTD PMID:29660402 PMID:35300571 NCBI chr17:11,059,227...12,282,257
Ensembl chr17:11,059,271...12,282,248 		JBrowse link
G Prkra protein kinase, interferon inducible double stranded RNA dependent activator multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of PRKRA protein CTD PMID:38072110 NCBI chr 2:76,436,385...76,478,614
Ensembl chr 2:76,460,242...76,478,359 		JBrowse link
G Prl2c2 prolactin family 2, subfamily c, member 2 decreases expression EXP lead acetate results in decreased expression of PRL2C2 mRNA CTD PMID:22613225 NCBI chr13:13,170,705...13,179,978
Ensembl chr13:13,170,710...13,179,968 		JBrowse link
G Prl2c5 prolactin family 2, subfamily c, member 5 decreases expression EXP lead acetate results in decreased expression of PRL2C5 mRNA CTD PMID:22613225 NCBI chr13:13,357,288...13,366,515
Ensembl chr13:13,357,300...13,366,508 		JBrowse link
G Prl7c1 prolactin family 7, subfamily c, member 1 decreases expression EXP lead acetate results in decreased expression of PRL7C1 mRNA CTD PMID:22613225 NCBI chr13:27,957,583...27,964,829
Ensembl chr13:27,957,478...27,964,787 		JBrowse link
G Prlr prolactin receptor decreases expression ISO lead acetate results in decreased expression of PRLR mRNA CTD PMID:21864555 NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266 		JBrowse link
G Prnp prion protein increases expression EXP lead acetate results in increased expression of PRNP mRNA CTD PMID:29746905 NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349 		JBrowse link
G Procr protein C receptor, endothelial increases expression EXP lead acetate results in increased expression of PROCR mRNA CTD PMID:20542052 NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391 		JBrowse link
G Prokr2 prokineticin receptor 2 decreases expression ISO lead acetate results in decreased expression of PROKR2 mRNA CTD PMID:22641619 NCBI chr 2:132,211,625...132,227,413
Ensembl chr 2:132,179,653...132,227,367 		JBrowse link
G Prol1 proline rich, lacrimal 1 increases expression EXP lead acetate results in increased expression of PROL1 mRNA CTD PMID:22609695 NCBI chr 5:88,465,171...88,476,676
Ensembl chr 5:88,465,171...88,476,673 		JBrowse link
G Prom1 prominin 1 decreases expression EXP lead acetate results in decreased expression of PROM1 mRNA CTD PMID:22613225 NCBI chr 5:44,150,963...44,260,850
Ensembl chr 5:44,150,962...44,259,374 		JBrowse link
G Prpf19 pre-mRNA processing factor 19 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of PRPF19 intron CTD PMID:33445541 NCBI chr19:10,872,595...10,886,923
Ensembl chr19:10,872,595...10,886,923 		JBrowse link
G Prph2 peripherin 2 decreases expression ISO lead acetate results in decreased expression of PRPH2 mRNA CTD PMID:22641619 NCBI chr17:47,221,404...47,235,859
Ensembl chr17:47,221,385...47,235,859 		JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 affects expression ISO lead acetate affects the expression of PRPS1 mRNA CTD PMID:22641619 NCBI chr  X:139,357,352...139,376,889
Ensembl chr  X:139,357,362...139,376,889 		JBrowse link
G Prpsap2 phosphoribosyl pyrophosphate synthetase-associated protein 2 increases expression EXP lead acetate results in increased expression of PRPSAP2 mRNA CTD PMID:21829687 NCBI chr11:61,620,476...61,652,924
Ensembl chr11:61,620,476...61,652,914 		JBrowse link
G Prr11 proline rich 11 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of PRR11 mRNA CTD PMID:22839698 NCBI chr11:86,979,982...86,999,540
Ensembl chr11:86,979,979...86,999,534 		JBrowse link
G Prr15l proline rich 15-like decreases expression ISO lead acetate results in decreased expression of PRR15L mRNA CTD PMID:38568856 NCBI chr11:96,816,987...96,826,474
Ensembl chr11:96,818,930...96,828,656 		JBrowse link
G Prr5 proline rich 5 (renal) increases expression ISO lead acetate results in increased expression of PRR5 mRNA CTD PMID:22641619 NCBI chr15:84,547,407...84,590,610
Ensembl chr15:84,553,821...84,587,874 		JBrowse link
G Prrg2 proline-rich Gla (G-carboxyglutamic acid) polypeptide 2 increases expression EXP lead acetate results in increased expression of PRRG2 mRNA CTD PMID:22609695 NCBI chr 7:44,703,008...44,711,828
Ensembl chr 7:44,703,008...44,712,101 		JBrowse link
G Prrt1 proline-rich transmembrane protein 1 affects expression ISO lead acetate affects the expression of PRRT1 protein CTD PMID:36539177 NCBI chr17:34,848,396...34,852,108
Ensembl chr17:34,848,507...34,852,100 		JBrowse link
G Prss12 serine protease 12 neurotrypsin (motopsin) increases expression ISO lead acetate results in increased expression of PRSS12 mRNA CTD PMID:22641619 NCBI chr 3:123,240,562...123,300,251
Ensembl chr 3:123,240,562...123,300,246 		JBrowse link
G Prss2 serine protease 2 increases expression EXP lead acetate results in increased expression of PRSS2 mRNA CTD PMID:20542052 NCBI chr 6:41,498,710...41,502,013
Ensembl chr 6:41,498,721...41,502,013 		JBrowse link
G Prss8 serine protease 8 (prostasin) decreases expression ISO lead acetate results in decreased expression of PRSS8 mRNA CTD PMID:38568856 NCBI chr 7:127,524,889...127,529,266
Ensembl chr 7:127,524,888...127,529,276 		JBrowse link
G Psma8 proteasome subunit alpha 8 increases expression EXP lead acetate results in increased expression of PSMA8 mRNA CTD PMID:22609695 NCBI chr18:14,839,192...14,895,358
Ensembl chr18:14,839,208...14,895,358 		JBrowse link
G Psmb7 proteasome (prosome, macropain) subunit, beta type 7 decreases expression EXP lead acetate results in decreased expression of PSMB7 mRNA CTD PMID:21829687 NCBI chr 2:38,478,058...38,533,964
Ensembl chr 2:38,478,048...38,534,099 		JBrowse link
G Psmb9 proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) decreases expression EXP lead acetate results in decreased expression of PSMB9 mRNA CTD PMID:22609695 NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738 		JBrowse link
G Psmc6 proteasome (prosome, macropain) 26S subunit, ATPase, 6 increases expression EXP lead acetate results in increased expression of PSMC6 mRNA CTD PMID:21829687 NCBI chr14:45,567,285...45,587,150
Ensembl chr14:45,567,245...45,587,162 		JBrowse link
G Psmd4 proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 increases expression EXP lead acetate results in increased expression of PSMD4 mRNA CTD PMID:22609695 NCBI chr 3:94,939,999...94,949,880
Ensembl chr 3:94,940,005...94,949,925 		JBrowse link
G Psme2 proteasome (prosome, macropain) activator subunit 2 (PA28 beta) increases expression EXP lead acetate results in increased expression of PSME2 mRNA CTD PMID:21829687 NCBI chr14:55,824,897...55,828,558
Ensembl chr14:55,824,898...55,828,570 		JBrowse link
G Psors1c2 psoriasis susceptibility 1 candidate 2 (human) decreases expression EXP lead acetate results in decreased expression of PSORS1C2 mRNA CTD PMID:22609695 NCBI chr17:35,842,462...35,845,544
Ensembl chr17:35,844,098...35,845,544 		JBrowse link
G Psph phosphoserine phosphatase decreases expression ISO lead acetate results in decreased expression of PSPH mRNA CTD PMID:11578147 NCBI chr 5:129,842,622...129,864,318
Ensembl chr 5:129,842,622...129,864,513
Ensembl chr 5:129,842,622...129,864,513 		JBrowse link
G Ptbp3 polypyrimidine tract binding protein 3 increases expression EXP lead acetate results in increased expression of PTBP3 mRNA CTD PMID:22609695 NCBI chr 4:59,471,868...59,549,288
Ensembl chr 4:59,471,868...59,549,364 		JBrowse link
G Ptchd3 patched domain containing 3 decreases expression EXP lead acetate results in decreased expression of PTCHD3 mRNA CTD PMID:22613225 NCBI chr11:121,721,050...121,734,259
Ensembl chr11:121,721,073...121,734,249 		JBrowse link
G Ptges3 prostaglandin E synthase 3 decreases expression EXP lead acetate results in decreased expression of PTGES3 mRNA CTD PMID:21829687 NCBI chr10:127,894,851...127,913,123
Ensembl chr10:127,894,823...127,913,141 		JBrowse link
G Ptgfr prostaglandin F receptor increases expression EXP lead acetate results in increased expression of PTGFR mRNA CTD PMID:22609695 NCBI chr 3:151,504,247...151,543,165
Ensembl chr 3:151,502,139...151,543,267 		JBrowse link
G Ptgr1 prostaglandin reductase 1 increases expression ISO lead acetate results in increased expression of PTGR1 mRNA CTD PMID:22839698 PMID:38568856 NCBI chr 4:58,965,590...58,987,131
Ensembl chr 4:58,965,439...58,987,119 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of PTGS2 mRNA
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; U 0126 inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]
lead acetate results in decreased expression of PTGS2 mRNA
lead acetate results in increased expression of PTGS2 mRNA; lead acetate results in increased expression of PTGS2 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; SB 203580 inhibits the reaction [lead acetate results in increased expression of PTGS2 protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of PTGS2 mRNA] 		CTD PMID:16395254 PMID:22728154 PMID:24530660 PMID:25088297 PMID:25270620 More... NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978 		JBrowse link
G Pth parathyroid hormone multiple interactions ISO [Ethanol co-treated with lead acetate] results in increased expression of PTH protein CTD PMID:23376407 NCBI chr 7:112,984,783...112,987,879
Ensembl chr 7:112,984,787...112,987,777 		JBrowse link
G Pthlh parathyroid hormone-like peptide multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of PTHLH protein CTD PMID:23604592 NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681 		JBrowse link
G Ptms parathymosin increases expression ISO lead acetate results in increased expression of PTMS mRNA CTD PMID:38568856 NCBI chr 6:124,890,638...124,894,909
Ensembl chr 6:124,890,644...124,897,066 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4a1 multiple interactions
decreases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PTP4A1 mRNA
lead acetate results in decreased expression of PTP4A1 mRNA 		CTD PMID:12634122 PMID:21829687 NCBI chr 1:30,979,384...30,988,838
Ensembl chr 1:30,979,383...30,988,390
Ensembl chr 1:30,979,383...30,988,390 		JBrowse link
G Ptp4a3 protein tyrosine phosphatase 4a3 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of PTP4A3 intron CTD PMID:33445541 NCBI chr15:73,594,991...73,629,075
Ensembl chr15:73,594,994...73,630,615 		JBrowse link
G Ptpn12 protein tyrosine phosphatase, non-receptor type 12 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of PTPN12 mRNA CTD PMID:22839698 NCBI chr 5:21,191,643...21,261,009
Ensembl chr 5:21,191,643...21,260,909 		JBrowse link
G Ptpn14 protein tyrosine phosphatase, non-receptor type 14 increases expression EXP lead acetate results in increased expression of PTPN14 mRNA CTD PMID:25270620 NCBI chr 1:189,460,417...189,608,892
Ensembl chr 1:189,460,465...189,608,892 		JBrowse link
G Ptpn2 protein tyrosine phosphatase, non-receptor type 2 decreases expression EXP lead acetate results in decreased expression of PTPN2 mRNA CTD PMID:21829687 NCBI chr18:67,798,571...67,857,697
Ensembl chr18:67,798,581...67,857,665 		JBrowse link
G Ptpn21 protein tyrosine phosphatase, non-receptor type 21 decreases expression EXP lead acetate results in decreased expression of PTPN21 mRNA CTD PMID:22609695 NCBI chr12:98,643,000...98,703,664
Ensembl chr12:98,643,000...98,703,664 		JBrowse link
G Ptpn23 protein tyrosine phosphatase, non-receptor type 23 increases expression ISO lead acetate results in increased expression of PTPN23 mRNA CTD PMID:38568856 NCBI chr 9:110,214,152...110,237,278
Ensembl chr 9:110,214,150...110,237,281 		JBrowse link
G Ptpn6 protein tyrosine phosphatase, non-receptor type 6 decreases expression EXP lead acetate results in decreased expression of PTPN6 mRNA CTD PMID:22609695 NCBI chr 6:124,697,670...124,715,672
Ensembl chr 6:124,697,670...124,715,677 		JBrowse link
G Ptprcap protein tyrosine phosphatase receptor type C polypeptide-associated protein increases expression EXP lead acetate results in increased expression of PTPRCAP mRNA CTD PMID:21829687 NCBI chr19:4,204,645...4,206,709
Ensembl chr19:4,203,603...4,206,750 		JBrowse link
G Ptprn protein tyrosine phosphatase receptor type N increases expression ISO lead acetate results in increased expression of PTPRN mRNA CTD PMID:11578147 NCBI chr 1:75,223,679...75,241,437
Ensembl chr 1:75,223,671...75,241,146 		JBrowse link
G Ptpro protein tyrosine phosphatase receptor type O decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of PTPRO mRNA
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PTPRO mRNA 		CTD PMID:21829687 PMID:22839698 NCBI chr 6:137,229,189...137,440,251
Ensembl chr 6:137,229,317...137,440,231 		JBrowse link
G Pvalb parvalbumin multiple interactions
decreases expression 		ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of PVALB protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PVALB protein]
lead acetate results in decreased expression of PVALB mRNA 		CTD PMID:31708536 PMID:33862172 NCBI chr15:78,075,312...78,090,600
Ensembl chr15:78,075,314...78,090,600 		JBrowse link
G Pxdc1 PX domain containing 1 increases expression ISO lead acetate results in increased expression of PXDC1 mRNA CTD PMID:38568856 NCBI chr13:34,811,823...34,836,664
Ensembl chr13:34,811,817...34,837,469 		JBrowse link
G Pxylp1 2-phosphoxylose phosphatase 1 increases expression EXP lead acetate results in increased expression of PXYLP1 mRNA CTD PMID:21829687 NCBI chr 9:96,705,396...96,774,732
Ensembl chr 9:96,705,389...96,774,722 		JBrowse link
G Pygb brain glycogen phosphorylase decreases expression ISO lead acetate results in decreased expression of PYGB mRNA; lead acetate results in decreased expression of PYGB protein CTD PMID:28916327 NCBI chr 2:150,628,716...150,673,668
Ensembl chr 2:150,628,655...150,673,678 		JBrowse link
G Pygm muscle glycogen phosphorylase decreases expression ISO lead acetate results in decreased expression of PYGM protein CTD PMID:28916327 NCBI chr19:6,434,438...6,448,494
Ensembl chr19:6,434,429...6,448,489 		JBrowse link
G Pyroxd2 pyridine nucleotide-disulphide oxidoreductase domain 2 increases expression ISO lead acetate results in increased expression of PYROXD2 mRNA CTD PMID:22641619 NCBI chr19:42,714,296...42,741,261
Ensembl chr19:42,714,297...42,741,214 		JBrowse link
G Qars1 glutaminyl-tRNA synthetase 1 decreases expression ISO lead acetate results in decreased expression of QARS1 mRNA CTD PMID:11578147 NCBI chr 9:108,385,204...108,393,140
Ensembl chr 9:108,384,905...108,393,140 		JBrowse link
G Qtrt2 queuine tRNA-ribosyltransferase accessory subunit 2 decreases expression EXP lead acetate results in decreased expression of QTRT2 mRNA CTD PMID:22609695 NCBI chr16:43,681,879...43,710,063
Ensembl chr16:43,681,770...43,747,172 		JBrowse link
G Rab11fip2 RAB11 family interacting protein 2 (class I) decreases expression EXP lead acetate results in decreased expression of RAB11FIP2 mRNA CTD PMID:20542052 NCBI chr19:59,881,934...59,933,086
Ensembl chr19:59,891,316...59,932,086 		JBrowse link
G Rab14 RAB14, member RAS oncogene family decreases expression EXP lead acetate results in decreased expression of RAB14 mRNA CTD PMID:21829687 NCBI chr 2:35,070,217...35,091,132
Ensembl chr 2:35,070,217...35,091,132 		JBrowse link
G Rab17 RAB17, member RAS oncogene family decreases expression ISO lead acetate results in decreased expression of RAB17 mRNA CTD PMID:38568856 NCBI chr 1:90,885,855...90,897,395
Ensembl chr 1:90,885,855...90,897,383 		JBrowse link
G Rab2b RAB2B, member RAS oncogene family decreases expression EXP lead acetate results in decreased expression of RAB2B mRNA CTD PMID:22609695 NCBI chr14:52,499,216...52,516,852
Ensembl chr14:52,499,216...52,517,002 		JBrowse link
G Rab34 RAB34, member RAS oncogene family decreases expression EXP lead acetate results in decreased expression of RAB34 mRNA CTD PMID:20542052 NCBI chr11:78,079,253...78,083,019
Ensembl chr11:78,079,256...78,083,019 		JBrowse link
G Rab5if RAB5 interacting factor increases expression ISO lead acetate results in increased expression of RAB5IF mRNA CTD PMID:38568856 NCBI chr 2:156,705,042...156,715,483
Ensembl chr 2:156,705,048...156,715,483 		JBrowse link
G Rab7b RAB7B, member RAS oncogene family increases expression ISO lead acetate results in increased expression of RAB7B mRNA CTD PMID:22641619 NCBI chr 1:131,616,412...131,646,288
Ensembl chr 1:131,616,433...131,643,177 		JBrowse link
G Rabl6 RAB, member RAS oncogene family-like 6 increases expression ISO lead acetate results in increased expression of RABL6 mRNA CTD PMID:38568856 NCBI chr 2:25,473,029...25,498,493
Ensembl chr 2:25,473,030...25,498,533 		JBrowse link
G Rac1 Rac family small GTPase 1 increases expression ISO lead acetate results in increased expression of RAC1 mRNA CTD PMID:11578147 NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791 		JBrowse link
G Rad17 RAD17 checkpoint clamp loader component multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of RAD17 protein CTD PMID:38072110 NCBI chr13:100,753,672...100,787,569
Ensembl chr13:100,753,672...100,787,559 		JBrowse link
G Rad51b RAD51 paralog B decreases expression EXP lead acetate results in decreased expression of RAD51B mRNA CTD PMID:22609695 NCBI chr12:79,344,032...79,895,034
Ensembl chr12:79,344,056...79,861,464 		JBrowse link
G Raf1 v-raf-leukemia viral oncogene 1 increases phosphorylation
multiple interactions 		ISO lead acetate results in increased phosphorylation of RAF1 protein
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of RAF1 protein]; HRAS mutant form inhibits the reaction [lead acetate results in increased phosphorylation of RAF1 protein]; SU 6656 inhibits the reaction [lead acetate results in increased phosphorylation of RAF1 protein] 		CTD PMID:19133285 NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596 		JBrowse link
G Rag1 recombination activating 1 decreases expression EXP lead acetate results in decreased expression of RAG1 mRNA CTD PMID:22609695 NCBI chr 2:101,468,597...101,479,877
Ensembl chr 2:101,468,627...101,479,846 		JBrowse link
G Rag2 recombination activating gene 2 increases expression EXP lead acetate results in increased expression of RAG2 mRNA CTD PMID:20542052 NCBI chr 2:101,455,057...101,462,873
Ensembl chr 2:101,455,063...101,462,874 		JBrowse link
G Ralgapa1 Ral GTPase activating protein, alpha subunit 1 increases expression EXP lead acetate results in increased expression of RALGAPA1 mRNA CTD PMID:20542052 NCBI chr12:55,649,673...55,868,522
Ensembl chr12:55,649,681...55,867,952 		JBrowse link
G Rap2a RAS related protein 2a decreases methylation ISO lead acetate results in decreased methylation of RAP2A gene CTD PMID:29571894 NCBI chr14:120,715,873...120,744,606
Ensembl chr14:120,715,856...120,744,606 		JBrowse link
G Rap2c RAP2C, member of RAS oncogene family multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RAP2C mRNA CTD PMID:22839698 NCBI chr  X:50,093,163...50,108,966
Ensembl chr  X:50,092,789...50,106,895 		JBrowse link
G Rapgefl1 Rap guanine nucleotide exchange factor (GEF)-like 1 increases expression EXP lead acetate results in increased expression of RAPGEFL1 mRNA CTD PMID:21829687 NCBI chr11:98,727,611...98,744,519
Ensembl chr11:98,727,611...98,744,523 		JBrowse link
G Raph1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 increases expression ISO lead acetate results in increased expression of RAPH1 mRNA CTD PMID:38568856 NCBI chr 1:60,509,997...60,606,233
Ensembl chr 1:60,521,451...60,606,263 		JBrowse link
G Rara retinoic acid receptor, alpha decreases expression EXP lead acetate results in decreased expression of RARA mRNA CTD PMID:22609695 NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768 		JBrowse link
G Rars1 arginyl-tRNA synthetase 1 decreases expression ISO lead acetate results in decreased expression of RARS1 mRNA CTD PMID:11578147 NCBI chr11:35,699,207...35,725,355
Ensembl chr11:35,699,208...35,725,333 		JBrowse link
G Rasl11b RAS-like, family 11, member B increases expression ISO lead acetate results in increased expression of RASL11B mRNA CTD PMID:37939567 NCBI chr 5:74,355,987...74,360,138
Ensembl chr 5:74,355,947...74,360,142 		JBrowse link
G Rax retina and anterior neural fold homeobox increases expression EXP lead acetate results in increased expression of RAX mRNA CTD PMID:22609695 NCBI chr18:66,067,710...66,072,160
Ensembl chr18:66,061,348...66,072,858 		JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RB1 protein]; [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RB1 protein; Wortmannin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RB1 protein] CTD PMID:18353414 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262 		JBrowse link
G Rbbp4 retinoblastoma binding protein 4, chromatin remodeling factor multiple interactions
decreases expression 		ISO pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in decreased expression of RBBP4 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in decreased expression of RBBP4 protein]; RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 mRNA]; RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 protein]
lead acetate results in decreased expression of RBBP4 mRNA; lead acetate results in decreased expression of RBBP4 protein 		CTD PMID:37866543 NCBI chr 4:129,200,893...129,229,163
Ensembl chr 4:129,200,893...129,229,163 		JBrowse link
G Rbfox1 RNA binding protein, fox-1 homolog (C. elegans) 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which affects the methylation of RBFOX1 intron CTD PMID:33445541 NCBI chr16:5,702,566...7,230,344
Ensembl chr16:5,124,665...7,229,391 		JBrowse link
G Rbfox3 RNA binding protein, fox-1 homolog (C. elegans) 3 increases expression
decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of RBFOX3 mRNA
lead acetate results in decreased expression of RBFOX3 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of RBFOX3 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of RBFOX3 protein] 		CTD PMID:25496477 PMID:33862172 PMID:33978298 NCBI chr11:118,380,586...118,802,423
Ensembl chr11:118,380,588...118,802,423 		JBrowse link
G Rbm24 RNA binding motif protein 24 increases expression EXP lead acetate results in increased expression of RBM24 mRNA CTD PMID:20542052 NCBI chr13:46,571,664...46,584,575
Ensembl chr13:46,571,910...46,584,571 		JBrowse link
G Rbm3 RNA binding motif (RNP1, RRM) protein 3 increases expression EXP lead acetate results in increased expression of RBM3 mRNA CTD PMID:21829687 NCBI chr  X:8,005,214...8,012,119
Ensembl chr  X:8,005,214...8,012,119 		JBrowse link
G Rbm4 RNA binding motif protein 4 increases expression EXP lead acetate results in increased expression of RBM4 mRNA CTD PMID:21829687 NCBI chr19:4,834,321...4,844,037
Ensembl chr19:4,834,321...4,843,929 		JBrowse link
G Rbp3 retinol binding protein 3, interstitial decreases expression ISO lead acetate results in decreased expression of RBP3 mRNA CTD PMID:22641619 NCBI chr14:33,675,960...33,686,176
Ensembl chr14:33,675,960...33,686,173 		JBrowse link
G Rbpj recombination signal binding protein for immunoglobulin kappa J region increases methylation ISO lead acetate results in increased methylation of RBPJ gene CTD PMID:29571894 NCBI chr 5:53,713,121...53,814,787
Ensembl chr 5:53,623,494...53,814,704 		JBrowse link
G Rbsn rabenosyn, RAB effector decreases expression EXP lead acetate results in decreased expression of RBSN mRNA CTD PMID:21829687 NCBI chr 6:92,163,693...92,191,874
Ensembl chr 6:92,163,693...92,191,906 		JBrowse link
G Rcor2 REST corepressor 2 decreases expression EXP lead acetate results in decreased expression of RCOR2 mRNA CTD PMID:25270620 NCBI chr19:7,244,759...7,252,590
Ensembl chr19:7,244,690...7,252,590 		JBrowse link
G Rcvrn recoverin increases expression EXP lead acetate results in increased expression of RCVRN mRNA CTD PMID:21829687 NCBI chr11:67,586,152...67,594,181
Ensembl chr11:67,586,152...67,594,159 		JBrowse link
G Rdh13 retinol dehydrogenase 13 (all-trans and 9-cis) increases methylation ISO lead acetate results in increased methylation of RDH13 gene CTD PMID:29571894 NCBI chr 7:4,428,664...4,474,279
Ensembl chr 7:4,427,769...4,448,648 		JBrowse link
G Rdh9 retinol dehydrogenase 9 increases expression EXP lead acetate results in increased expression of RDH9 mRNA CTD PMID:21829687 NCBI chr10:127,612,274...127,628,566
Ensembl chr10:127,612,255...127,628,566 		JBrowse link
G Recql4 RecQ protein-like 4 increases expression ISO lead acetate results in increased expression of RECQL4 mRNA CTD PMID:38568856 NCBI chr15:76,587,753...76,594,820
Ensembl chr15:76,587,753...76,594,748 		JBrowse link
G Reg1 regenerating islet-derived 1 decreases expression EXP lead acetate results in decreased expression of REG1 mRNA CTD PMID:22609695 NCBI chr 6:78,402,966...78,405,651
Ensembl chr 6:78,399,694...78,405,650 		JBrowse link
G Reg2 regenerating islet-derived 2 increases expression EXP lead acetate results in increased expression of REG2 mRNA CTD PMID:22609695 NCBI chr 6:78,382,138...78,385,082
Ensembl chr 6:78,372,606...78,385,089 		JBrowse link
G Rel reticuloendotheliosis oncogene increases expression EXP lead acetate results in increased expression of REL mRNA CTD PMID:24260418 NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970 		JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases expression
affects localization
decreases expression 		EXP
ISO 		2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of RELA protein]; 3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of RELA protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased expression of RELA protein]; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased phosphorylation of RELA protein; [lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RELA protein; [Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased phosphorylation of RELA protein]; lead acetate results in increased phosphorylation of and results in increased expression of RELA protein; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of RELA protein]; U 0126 inhibits the reaction [lead acetate results in increased expression of RELA protein]
lead acetate results in increased expression of RELA mRNA; lead acetate results in increased expression of RELA protein
lead acetate affects the localization of RELA protein
Ascorbic Acid inhibits the reaction [lead acetate affects the localization of RELA protein]; Proanthocyanidins inhibits the reaction [lead acetate affects the localization of RELA protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of RELA protein]; Quercetin inhibits the reaction [lead acetate affects the localization of RELA protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of RELA protein]
lead acetate results in decreased expression of RELA mRNA 		CTD PMID:22728154 PMID:24260418 PMID:24530660 PMID:25088297 PMID:36539177 More... NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158 		JBrowse link
G Relb avian reticuloendotheliosis viral (v-rel) oncogene related B affects expression EXP lead acetate affects the expression of RELB mRNA CTD PMID:24260418 NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363 		JBrowse link
G Reln reelin increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of RELN mRNA
lead acetate results in decreased expression of RELN mRNA 		CTD PMID:24260418 PMID:33862172 NCBI chr 5:22,089,452...22,549,703
Ensembl chr 5:22,089,452...22,549,700 		JBrowse link
G Rerg RAS-like, estrogen-regulated, growth-inhibitor decreases expression ISO lead acetate results in decreased expression of RERG mRNA CTD PMID:38568856 NCBI chr 6:137,031,822...137,147,494
Ensembl chr 6:137,031,823...137,147,495 		JBrowse link
G Rest RE1-silencing transcription factor increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of REST mRNA; lead acetate results in increased expression of REST protein
[lead acetate results in increased abundance of Lead] which results in increased expression of REST protein; REST protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 mRNA]; REST protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of HAP1 protein]
REST protein promotes the reaction [lead acetate results in decreased expression of SV2C mRNA]; REST protein promotes the reaction [lead acetate results in decreased expression of SV2C protein] 		CTD PMID:29505838 PMID:30742882 NCBI chr 5:77,413,273...77,434,279
Ensembl chr 5:77,413,338...77,434,279 		JBrowse link
G Ret ret proto-oncogene multiple interactions
increases expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of RET mRNA
lead acetate results in increased expression of RET mRNA 		CTD PMID:12634122 PMID:22641619 NCBI chr 6:118,128,709...118,174,705
Ensembl chr 6:118,128,706...118,174,679 		JBrowse link
G Retnlb resistin like beta decreases expression EXP lead acetate results in decreased expression of RETNLB mRNA CTD PMID:22609695 NCBI chr16:48,637,219...48,639,255
Ensembl chr16:48,637,219...48,639,255 		JBrowse link
G Retreg1 reticulophagy regulator 1 increases expression ISO lead acetate results in increased expression of RETREG1 mRNA CTD PMID:22641619 NCBI chr15:25,840,795...25,973,782
Ensembl chr15:25,843,266...25,973,773 		JBrowse link
G Retsat retinol saturase (all trans retinol 13,14 reductase) increases expression ISO lead acetate results in increased expression of RETSAT mRNA CTD PMID:22641619 NCBI chr 6:72,575,585...72,584,471
Ensembl chr 6:72,575,458...72,585,408 		JBrowse link
G Rfx1 regulatory factor X, 1 (influences HLA class II expression) increases expression EXP lead acetate results in increased expression of RFX1 mRNA CTD PMID:22609695 NCBI chr 8:84,789,787...84,823,630
Ensembl chr 8:84,793,463...84,823,621 		JBrowse link
G Rgcc regulator of cell cycle multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RGCC mRNA CTD PMID:22839698 NCBI chr14:79,526,190...79,539,075
Ensembl chr14:79,526,196...79,539,085 		JBrowse link
G Rgs13 regulator of G-protein signaling 13 affects expression ISO lead acetate affects the expression of RGS13 mRNA CTD PMID:22641619 NCBI chr 1:144,013,083...144,053,240
Ensembl chr 1:144,014,392...144,053,110 		JBrowse link
G Rgs16 regulator of G-protein signaling 16 increases expression ISO lead acetate results in increased expression of RGS16 mRNA CTD PMID:37939567 NCBI chr 1:153,616,099...153,621,212
Ensembl chr 1:153,616,095...153,621,214 		JBrowse link
G Rgs18 regulator of G-protein signaling 18 affects expression ISO lead acetate affects the expression of RGS18 mRNA CTD PMID:21864555 NCBI chr 1:144,628,430...144,651,165
Ensembl chr 1:144,628,421...144,651,173 		JBrowse link
G Rgs19 regulator of G-protein signaling 19 decreases expression EXP lead acetate results in decreased expression of RGS19 mRNA CTD PMID:21829687 NCBI chr 2:181,330,212...181,336,330
Ensembl chr 2:181,330,212...181,335,770 		JBrowse link
G Rgs22 regulator of G-protein signalling 22 affects expression
increases expression 		ISO lead acetate affects the expression of RGS22 mRNA
lead acetate results in increased expression of RGS22 mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr15:35,960,664...36,140,718
Ensembl chr15:36,009,625...36,140,546 		JBrowse link
G Rhbdd2 rhomboid domain containing 2 decreases expression EXP lead acetate results in decreased expression of RHBDD2 mRNA CTD PMID:22609695 NCBI chr 5:135,661,508...135,675,230
Ensembl chr 5:135,661,472...135,675,302 		JBrowse link
G Rhebl1 Ras homolog enriched in brain like 1 increases expression EXP lead acetate results in increased expression of RHEBL1 mRNA CTD PMID:21829687 NCBI chr15:98,775,659...98,779,424
Ensembl chr15:98,775,659...98,792,421 		JBrowse link
G Rho rhodopsin multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of RHO mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of RHO protein CTD PMID:28050121 NCBI chr 6:115,903,741...115,916,999
Ensembl chr 6:115,908,709...115,916,997 		JBrowse link
G Rhov ras homolog family member V decreases expression ISO lead acetate results in decreased expression of RHOV mRNA CTD PMID:38568856 NCBI chr 2:119,099,682...119,108,489
Ensembl chr 2:119,099,682...119,101,753 		JBrowse link
G Rhox9 reproductive homeobox 9 increases expression EXP lead acetate results in increased expression of RHOX9 mRNA CTD PMID:22609695 NCBI chr  X:36,987,974...36,990,647
Ensembl chr  X:36,987,974...36,990,647 		JBrowse link
G Rims1 regulating synaptic membrane exocytosis 1 decreases expression ISO lead acetate results in decreased expression of RIMS1 mRNA CTD PMID:22160880 NCBI chr 1:22,356,196...22,845,239
Ensembl chr 1:22,356,475...22,845,203 		JBrowse link
G Ring1 ring finger protein 1 increases expression ISO lead acetate results in increased expression of RING1 mRNA CTD PMID:38568856 NCBI chr17:34,239,766...34,243,654
Ensembl chr17:34,239,766...34,243,654 		JBrowse link
G Riok3 RIO kinase 3 increases expression EXP lead acetate results in increased expression of RIOK3 mRNA CTD PMID:25270620 NCBI chr18:12,259,114...12,290,424
Ensembl chr18:12,261,798...12,290,444 		JBrowse link
G Ripk4 receptor-interacting serine-threonine kinase 4 decreases expression ISO lead acetate results in decreased expression of RIPK4 mRNA CTD PMID:38568856 NCBI chr16:97,543,133...97,564,979
Ensembl chr16:97,543,133...97,564,987 		JBrowse link
G Ripor1 RHO family interacting cell polarization regulator 1 increases expression ISO lead acetate results in increased expression of RIPOR1 mRNA CTD PMID:38568856 NCBI chr 8:106,320,588...106,348,851
Ensembl chr 8:106,331,887...106,348,851 		JBrowse link
G Ripor2 RHO family interacting cell polarization regulator 2 decreases expression ISO lead acetate results in decreased expression of RIPOR2 mRNA CTD PMID:38568856 NCBI chr13:24,685,513...24,917,789
Ensembl chr13:24,685,508...24,917,799 		JBrowse link
G Rit1 Ras-like without CAAX 1 increases expression EXP lead acetate results in increased expression of RIT1 mRNA CTD PMID:21829687 NCBI chr 3:88,624,154...88,638,354
Ensembl chr 3:88,624,145...88,638,356 		JBrowse link
G Rnase1 ribonuclease, RNase A family, 1 (pancreatic) increases expression EXP lead acetate results in increased expression of RNASE1 mRNA CTD PMID:20542052 NCBI chr14:51,382,459...51,384,224
Ensembl chr14:51,382,455...51,384,242 		JBrowse link
G Rnase4 ribonuclease, RNase A family 4 increases expression EXP lead acetate results in increased expression of RNASE4 mRNA CTD PMID:21829687 NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608 		JBrowse link
G Rnaseh2c ribonuclease H2, subunit C decreases expression EXP lead acetate results in decreased expression of RNASEH2C mRNA CTD PMID:21829687 PMID:25270620 NCBI chr19:5,651,901...5,652,987
Ensembl chr19:5,651,901...5,657,047 		JBrowse link
G Rnasel ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) increases expression ISO lead acetate results in increased expression of RNASEL mRNA CTD PMID:22641619 NCBI chr 1:153,625,089...153,644,441
Ensembl chr 1:153,625,172...153,639,967 		JBrowse link
G Rnf115 ring finger protein 115 increases expression EXP lead acetate results in increased expression of RNF115 mRNA CTD PMID:25270620 NCBI chr 3:96,634,869...96,698,471
Ensembl chr 3:96,634,980...96,698,954 		JBrowse link
G Rnf13 ring finger protein 13 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of RNF13 protein CTD PMID:38072110 NCBI chr 3:57,643,468...57,742,846
Ensembl chr 3:57,643,483...57,742,654 		JBrowse link
G Rnf138 ring finger protein 138 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of RNF138 mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of RNF138 protein 		CTD PMID:20542052 PMID:38072110 NCBI chr18:21,134,202...21,161,281
Ensembl chr18:21,134,398...21,161,281 		JBrowse link
G Rnf145 ring finger protein 145 decreases expression EXP lead acetate results in decreased expression of RNF145 mRNA CTD PMID:25270620 NCBI chr11:44,409,486...44,456,347
Ensembl chr11:44,409,791...44,456,347 		JBrowse link
G Rnf38 ring finger protein 38 decreases expression EXP lead acetate results in decreased expression of RNF38 mRNA CTD PMID:20542052 NCBI chr 4:44,126,210...44,233,929
Ensembl chr 4:44,126,210...44,233,789 		JBrowse link
G Rnh1 ribonuclease/angiogenin inhibitor 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of RNH1 protein CTD PMID:38072110 NCBI chr 7:140,740,239...140,752,764
Ensembl chr 7:140,740,239...140,752,770 		JBrowse link
G Robo2 roundabout guidance receptor 2 affects expression ISO lead acetate affects the expression of ROBO2 protein CTD PMID:36539177 NCBI chr16:73,688,725...75,244,331
Ensembl chr16:73,688,727...75,244,270 		JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 decreases expression EXP lead acetate results in decreased expression of ROCK1 mRNA CTD PMID:22609695 NCBI chr18:10,064,401...10,182,225
Ensembl chr18:10,064,401...10,182,045 		JBrowse link
G Romo1 reactive oxygen species modulator 1 increases expression ISO lead acetate results in increased expression of ROMO1 mRNA CTD PMID:38568856 NCBI chr 2:155,986,073...155,987,714
Ensembl chr 2:155,985,959...155,987,717 		JBrowse link
G Ropn1l ropporin 1-like increases expression EXP lead acetate results in increased expression of ROPN1L mRNA CTD PMID:22609695 NCBI chr15:31,441,356...31,453,835
Ensembl chr15:31,441,357...31,453,883 		JBrowse link
G Rorc RAR-related orphan receptor gamma decreases expression ISO lead acetate results in decreased expression of RORC mRNA CTD PMID:38568856 NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583 		JBrowse link
G Rpa3 replication protein A3 increases expression ISO lead acetate results in increased expression of RPA3 mRNA CTD PMID:22641619 NCBI chr 6:8,255,936...8,259,141
Ensembl chr 6:8,255,936...8,259,173 		JBrowse link
G Rpe65 retinal pigment epithelium 65 increases expression ISO lead acetate results in increased expression of RPE65 mRNA CTD PMID:22641619 NCBI chr 3:159,304,712...159,330,944
Ensembl chr 3:159,304,812...159,330,958 		JBrowse link
G Rpgr retinitis pigmentosa GTPase regulator increases expression ISO lead acetate results in increased expression of RPGR mRNA CTD PMID:22641619 NCBI chr  X:10,024,455...10,083,034
Ensembl chr  X:9,939,860...10,083,159 		JBrowse link
G Rpl10l ribosomal protein L10-like increases expression ISO lead acetate results in increased expression of RPL10L mRNA CTD PMID:22641619 NCBI chr12:66,330,153...66,331,175
Ensembl chr12:66,330,153...66,331,175 		JBrowse link
G Rpl17 ribosomal protein L17 affects expression ISO lead acetate affects the expression of RPL17 protein CTD PMID:36539177 NCBI chr18:75,132,049...75,136,455
Ensembl chr18:75,131,629...75,136,452 		JBrowse link
G Rpl22 ribosomal protein L22 decreases expression EXP lead acetate results in decreased expression of RPL22 mRNA CTD PMID:21829687 NCBI chr 4:152,408,893...152,418,539
Ensembl chr 4:152,410,199...152,418,528 		JBrowse link
G Rpl22l1 ribosomal protein L22 like 1 decreases expression
increases expression 		ISO lead acetate results in decreased expression of RPL22L1 mRNA
lead acetate results in increased expression of RPL22L1 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 3:28,859,660...28,861,573
Ensembl chr 3:28,859,585...28,861,573 		JBrowse link
G Rpl39l ribosomal protein L39-like decreases expression EXP lead acetate results in decreased expression of RPL39L mRNA CTD PMID:22609695 NCBI chr16:9,988,061...9,992,775
Ensembl chr16:9,988,090...9,992,775 		JBrowse link
G Rpl7a ribosomal protein L7A affects expression ISO lead acetate affects the expression of RPL7A protein CTD PMID:36539177 NCBI chr 2:26,800,697...26,803,330
Ensembl chr 2:26,800,776...26,803,330 		JBrowse link
G Rpn1 ribophorin I decreases expression EXP lead acetate results in decreased expression of RPN1 mRNA CTD PMID:21829687 NCBI chr 6:88,061,455...88,082,286
Ensembl chr 6:88,061,464...88,082,286 		JBrowse link
G Rpp30 ribonuclease P/MRP 30 subunit increases expression EXP lead acetate results in increased expression of RPP30 mRNA CTD PMID:21829687 NCBI chr19:36,061,118...36,082,173
Ensembl chr19:36,061,116...36,082,177 		JBrowse link
G Rpp40 ribonuclease P 40 subunit increases expression EXP lead acetate results in increased expression of RPP40 mRNA CTD PMID:21829687 NCBI chr13:36,080,685...36,095,548
Ensembl chr13:36,077,455...36,090,342 		JBrowse link
G Rps10 ribosomal protein S10 increases expression EXP lead acetate results in increased expression of RPS10 mRNA CTD PMID:21829687 NCBI chr17:27,849,389...27,854,218
Ensembl chr17:27,849,392...27,855,643 		JBrowse link
G Rps18 ribosomal protein S18 decreases expression EXP lead acetate results in decreased expression of RPS18 mRNA CTD PMID:22609695 NCBI chr17:34,170,972...34,174,639
Ensembl chr17:34,170,973...34,174,975 		JBrowse link
G Rps19 ribosomal protein S19 increases expression EXP lead acetate results in increased expression of RPS19 mRNA CTD PMID:22613225 NCBI chr 7:24,584,013...24,589,236
Ensembl chr 7:24,583,796...24,589,231 		JBrowse link
G Rps6ka4 ribosomal protein S6 kinase, polypeptide 4 increases expression ISO lead acetate results in increased expression of RPS6KA4 mRNA CTD PMID:38568856 NCBI chr19:6,806,573...6,819,513
Ensembl chr19:6,806,578...6,818,004 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 decreases phosphorylation ISO lead acetate results in decreased phosphorylation of RPS6KB1 protein CTD PMID:22811615 PMID:32879255 NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631 		JBrowse link
G Rptor regulatory associated protein of MTOR, complex 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of RPTOR protein; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of RPTOR protein] CTD PMID:31874198 NCBI chr11:119,493,731...119,790,417
Ensembl chr11:119,493,731...119,790,402 		JBrowse link
G Rrad Ras-related associated with diabetes decreases expression EXP lead acetate results in decreased expression of RRAD mRNA CTD PMID:22609695 NCBI chr 8:105,354,702...105,357,921
Ensembl chr 8:105,354,702...105,357,959 		JBrowse link
G Rrs1 ribosome biogenesis regulator 1 increases expression ISO lead acetate results in increased expression of RRS1 mRNA CTD PMID:38568856 NCBI chr 1:9,615,633...9,617,680
Ensembl chr 1:9,615,633...9,617,680 		JBrowse link
G Rs1 retinoschisis (X-linked, juvenile) 1 (human) decreases expression ISO lead acetate results in decreased expression of RS1 mRNA CTD PMID:22641619 NCBI chr  X:159,548,815...159,584,800
Ensembl chr  X:159,551,009...159,582,659 		JBrowse link
G Rsph10b radial spoke head 10 homolog B (Chlamydomonas) multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RSPH10B2 mRNA CTD PMID:22839698 Ensembl chr 5:143,869,853...143,922,537 JBrowse link
G Rsph4a radial spoke head 4 homolog A (Chlamydomonas) affects expression ISO lead acetate affects the expression of RSPH4A mRNA CTD PMID:22641619 NCBI chr10:33,781,107...33,792,017
Ensembl chr10:33,781,107...33,792,017 		JBrowse link
G Rspo3 R-spondin 3 decreases expression ISO lead acetate results in decreased expression of RSPO3 mRNA CTD PMID:22641619 NCBI chr10:29,329,102...29,411,863
Ensembl chr10:29,328,412...29,411,863 		JBrowse link
G Rsrp1 arginine/serine rich protein 1 decreases expression ISO lead acetate results in decreased expression of RSRP1 mRNA CTD PMID:38568856 NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982 		JBrowse link
G Rtl6 retrotransposon Gag like 6 increases expression EXP lead acetate results in increased expression of RTL6 mRNA CTD PMID:21829687 NCBI chr15:84,437,599...84,442,024
Ensembl chr15:84,437,599...84,442,024 		JBrowse link
G Rtn4 reticulon 4 affects expression
increases expression 		ISO lead acetate affects the expression of RTN4 mRNA
lead acetate results in increased expression of RTN4 mRNA 		CTD PMID:21864555 PMID:38568856 NCBI chr11:29,642,898...29,694,414
Ensembl chr11:29,642,947...29,694,331 		JBrowse link
G Rundc3b RUN domain containing 3B decreases expression EXP lead acetate results in decreased expression of RUNDC3B mRNA CTD PMID:21829687 NCBI chr 5:8,540,336...8,673,079
Ensembl chr 5:8,540,334...8,672,952 		JBrowse link
G Runx1 runt related transcription factor 1 increases expression EXP lead acetate results in increased expression of RUNX1 mRNA CTD PMID:20542052 PMID:21829687 NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037 		JBrowse link
G Rusc2 RUN and SH3 domain containing 2 increases expression ISO lead acetate results in increased expression of RUSC2 mRNA CTD PMID:38568856 NCBI chr 4:43,377,202...43,427,088
Ensembl chr 4:43,381,979...43,427,088 		JBrowse link
G Rwdd4a RWD domain containing 4A decreases expression ISO lead acetate results in decreased expression of RWDD4A mRNA CTD PMID:22641619 NCBI chr 8:47,986,680...48,005,872
Ensembl chr 8:47,986,699...48,005,990 		JBrowse link
G Rxrg retinoid X receptor gamma decreases expression ISO lead acetate results in decreased expression of RXRG mRNA CTD PMID:22641619 NCBI chr 1:167,425,902...167,467,191
Ensembl chr 1:167,425,953...167,467,192 		JBrowse link
G Ryr3 ryanodine receptor 3 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of RYR3 protein CTD PMID:30905827 NCBI chr 2:112,461,699...113,047,755
Ensembl chr 2:112,461,700...113,047,441 		JBrowse link
G S100a10 S100 calcium binding protein A10 (calpactin) increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of S100A10 mRNA
lead acetate results in decreased expression of S100A10 mRNA 		CTD PMID:20542052 PMID:36539177 NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950 		JBrowse link
G S100a11 S100 calcium binding protein A11 increases expression ISO lead acetate results in increased expression of S100A11 mRNA CTD PMID:38568856 NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594 		JBrowse link
G S100a2 S100 calcium binding protein A2 increases expression ISO lead acetate results in increased expression of S100A2 mRNA CTD PMID:38568856 NCBI chr 3:90,497,554...90,498,815
Ensembl chr 3:90,467,670...90,498,838 		JBrowse link
G S100a4 S100 calcium binding protein A4 decreases expression ISO lead acetate results in decreased expression of S100A4 mRNA CTD PMID:38568856 NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352 		JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) decreases expression ISO lead acetate results in decreased expression of S100A8 mRNA CTD PMID:38568856 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342 		JBrowse link
G S100a9 S100 calcium binding protein A9 (calgranulin B) decreases expression ISO lead acetate results in decreased expression of S100A9 mRNA CTD PMID:38568856 NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028 		JBrowse link
G S100b S100 protein, beta polypeptide, neural decreases expression
increases expression 		ISO lead acetate results in decreased expression of S100B protein
lead acetate results in increased expression of S100B protein 		CTD PMID:17047031 PMID:38072110 NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993 		JBrowse link
G S1pr1 sphingosine-1-phosphate receptor 1 increases expression EXP lead acetate results in increased expression of S1PR1 mRNA CTD PMID:21829687 NCBI chr 3:115,504,082...115,508,704
Ensembl chr 3:115,504,082...115,508,721 		JBrowse link
G Saa1 serum amyloid A 1 decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of SAA1 mRNA
lead acetate results in increased expression of SAA1 mRNA 		CTD PMID:22609695 PMID:38568856 NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404 		JBrowse link
G Saa2 serum amyloid A 2 decreases expression ISO lead acetate results in decreased expression of SAA2 mRNA CTD PMID:38568856 NCBI chr 7:46,401,257...46,403,737
Ensembl chr 7:46,401,214...46,403,737 		JBrowse link
G Sall4 spalt like transcription factor 4 increases expression EXP lead acetate results in increased expression of SALL4 mRNA CTD PMID:22609695 NCBI chr 2:168,590,252...168,609,121
Ensembl chr 2:168,590,252...168,609,863 		JBrowse link
G Sapcd2 suppressor APC domain containing 2 increases expression ISO lead acetate results in increased expression of SAPCD2 mRNA CTD PMID:38568856 NCBI chr 2:25,261,974...25,268,225
Ensembl chr 2:25,262,333...25,268,225 		JBrowse link
G Sart1 squamous cell carcinoma antigen recognized by T cells 1 affects expression
increases expression 		ISO lead acetate affects the expression of SART1 protein
lead acetate results in increased expression of SART1 mRNA 		CTD PMID:36539177 PMID:38568856 NCBI chr19:5,427,551...5,438,731
Ensembl chr19:5,427,551...5,438,731 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 increases expression ISO lead acetate results in increased expression of SAT1 mRNA CTD PMID:11578147 PMID:38568856 NCBI chr  X:153,996,128...153,999,345
Ensembl chr  X:153,996,128...153,999,445 		JBrowse link
G Sbk1 SH3-binding kinase 1 increases expression ISO lead acetate results in increased expression of SBK1 mRNA CTD PMID:22641619 NCBI chr 7:125,847,524...125,894,188
Ensembl chr 7:125,848,034...125,894,188 		JBrowse link
G Sbno2 strawberry notch 2 increases expression EXP lead acetate results in increased expression of SBNO2 mRNA CTD PMID:20542052 NCBI chr10:79,892,826...79,941,942
Ensembl chr10:79,892,826...79,941,405 		JBrowse link
G Sbsn suprabasin decreases expression EXP lead acetate results in decreased expression of SBSN mRNA CTD PMID:21829687 NCBI chr 7:30,432,099...30,455,559
Ensembl chr 7:30,450,896...30,455,559 		JBrowse link
G Scaf1 SR-related CTD-associated factor 1 increases expression ISO lead acetate results in increased expression of SCAF1 mRNA CTD PMID:38568856 NCBI chr 7:44,652,372...44,665,537
Ensembl chr 7:44,652,372...44,665,787 		JBrowse link
G Scaf11 SR-related CTD-associated factor 11 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of SCAF11 mRNA CTD PMID:22839698 NCBI chr15:96,309,580...96,358,695
Ensembl chr15:96,309,580...96,358,724 		JBrowse link
G Scamp1 secretory carrier membrane protein 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SCAMP1 mRNA CTD PMID:22839698 NCBI chr13:94,337,818...94,422,339
Ensembl chr13:94,337,818...94,422,365 		JBrowse link
G Scand1 SCAN domain-containing 1 decreases expression ISO lead acetate results in decreased expression of SCAND1 mRNA CTD PMID:22641619 NCBI chr 2:156,153,766...156,154,624
Ensembl chr 2:156,153,766...156,154,667 		JBrowse link
G Scarb1 scavenger receptor class B, member 1 increases expression EXP lead acetate results in increased expression of SCARB1 mRNA CTD PMID:21829687 NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158 		JBrowse link
G Scarf2 scavenger receptor class F, member 2 decreases expression ISO lead acetate results in decreased expression of SCARF2 mRNA CTD PMID:37939567 NCBI chr16:17,615,146...17,626,158
Ensembl chr16:17,615,146...17,626,157 		JBrowse link
G Scd1 stearoyl-Coenzyme A desaturase 1 increases expression EXP lead acetate results in increased expression of SCD1 mRNA CTD PMID:30623991 NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318 		JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of SCD protein CTD PMID:38072110 NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303 		JBrowse link
G Scgb1c1 secretoglobin, family 1C, member 1 decreases expression ISO lead acetate results in decreased expression of SCGB1C1 mRNA CTD PMID:22641619 NCBI chr 7:140,425,478...140,426,682
Ensembl chr 7:140,425,460...140,426,682 		JBrowse link
G Scgb2b27 secretoglobin, family 2B, member 27 increases expression EXP lead acetate results in increased expression of SCGB2B27 mRNA CTD PMID:22609695 NCBI chr 7:33,711,344...33,713,367
Ensembl chr 7:33,711,346...33,713,367 		JBrowse link
G Schip1 schwannomin interacting protein 1 increases expression EXP lead acetate results in increased expression of SCHIP1 mRNA CTD PMID:21829687 NCBI chr 3:67,972,135...68,533,815
Ensembl chr 3:67,972,135...68,533,814 		JBrowse link
G Scn7a sodium channel, voltage-gated, type VII, alpha increases expression ISO lead acetate results in increased expression of SCN7A mRNA CTD PMID:22641619 NCBI chr 2:66,503,770...66,615,254
Ensembl chr 2:66,503,769...66,615,258 		JBrowse link
G Scnn1a sodium channel, nonvoltage-gated 1 alpha decreases expression ISO lead acetate results in decreased expression of SCNN1A mRNA CTD PMID:38568856 NCBI chr 6:125,286,657...125,321,906
Ensembl chr 6:125,297,622...125,321,906 		JBrowse link
G Scnn1b sodium channel, nonvoltage-gated 1 beta decreases expression ISO lead acetate results in decreased expression of SCNN1B mRNA CTD PMID:38568856 NCBI chr 7:121,464,261...121,517,951
Ensembl chr 7:121,464,261...121,517,737 		JBrowse link
G Scnn1g sodium channel, nonvoltage-gated 1 gamma decreases expression ISO lead acetate results in decreased expression of SCNN1G mRNA CTD PMID:38568856 NCBI chr 7:121,333,643...121,367,705
Ensembl chr 7:121,333,702...121,367,698 		JBrowse link
G Scrn3 secernin 3 increases expression ISO lead acetate results in increased expression of SCRN3 mRNA CTD PMID:22641619 NCBI chr 2:73,142,980...73,168,158
Ensembl chr 2:73,142,945...73,168,162 		JBrowse link
G Sct secretin decreases expression EXP lead acetate results in decreased expression of SCT mRNA CTD PMID:22609695 NCBI chr 7:140,858,243...140,859,082
Ensembl chr 7:140,858,243...140,859,046 		JBrowse link
G Sdc1 syndecan 1 increases expression ISO lead acetate results in increased expression of SDC1 mRNA CTD PMID:38568856 NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715 		JBrowse link
G Sdcbp2 syndecan binding protein (syntenin) 2 increases expression ISO lead acetate results in increased expression of SDCBP2 mRNA CTD PMID:38568856 NCBI chr 2:151,414,203...151,431,925
Ensembl chr 2:151,414,542...151,431,925 		JBrowse link
G Sdccag8 serologically defined colon cancer antigen 8 increases expression EXP lead acetate results in increased expression of SDCCAG8 mRNA CTD PMID:20542052 NCBI chr 1:176,642,226...176,848,004
Ensembl chr 1:176,642,226...176,848,003 		JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of SDF2L1 mRNA
lead acetate results in increased expression of SDF2L1 mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247 		JBrowse link
G Sdhb succinate dehydrogenase complex, subunit B, iron sulfur (Ip) multiple interactions
decreases expression 		ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in decreased expression of SDHB protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SDHB protein]
lead acetate results in decreased expression of SDHB mRNA 		CTD PMID:21829687 PMID:36096218 NCBI chr 4:140,688,582...140,706,509
Ensembl chr 4:140,688,514...140,706,504 		JBrowse link
G Sdr16c5 short chain dehydrogenase/reductase family 16C, member 5 decreases expression EXP lead acetate results in decreased expression of SDR16C5 mRNA CTD PMID:21829687 NCBI chr 4:3,995,942...4,019,663
Ensembl chr 4:3,995,936...4,019,663 		JBrowse link
G Sec14l5 SEC14-like lipid binding 5 increases expression EXP lead acetate results in increased expression of SEC14L5 mRNA CTD PMID:21829687 NCBI chr16:4,964,758...5,005,135
Ensembl chr16:4,964,973...5,005,135 		JBrowse link
G Sec23b SEC23 homolog B, COPII coat complex component multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SEC23B mRNA CTD PMID:22839698 NCBI chr 2:144,398,165...144,432,673
Ensembl chr 2:144,398,149...144,432,669 		JBrowse link
G Sec24d SEC24 homolog D, COPII coat complex component increases expression ISO lead acetate results in increased expression of SEC24D mRNA CTD PMID:38568856 NCBI chr 3:123,058,451...123,159,290
Ensembl chr 3:123,061,104...123,159,290 		JBrowse link
G Sec61g SEC61 translocon subunit gamma increases expression ISO lead acetate results in increased expression of SEC61G mRNA CTD PMID:38568856 NCBI chr11:16,451,638...16,458,484
Ensembl chr11:16,450,530...16,458,484 		JBrowse link
G Sel1l sel-1 suppressor of lin-12-like (C. elegans) multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SEL1L mRNA CTD PMID:22839698 NCBI chr12:91,772,817...91,815,931
Ensembl chr12:91,772,817...91,815,931 		JBrowse link
G Sel1l3 sel-1 suppressor of lin-12-like 3 (C. elegans) increases expression ISO lead acetate results in increased expression of SEL1L3 mRNA CTD PMID:38568856 NCBI chr 5:53,264,425...53,370,794
Ensembl chr 5:53,264,425...53,371,269 		JBrowse link
G Selenbp1 selenium binding protein 1 decreases expression ISO lead acetate results in decreased expression of SELENBP1 mRNA CTD PMID:38568856 NCBI chr 3:94,840,394...94,852,069
Ensembl chr 3:94,840,367...94,852,069 		JBrowse link
G Selenop selenoprotein P increases expression ISO lead acetate results in increased expression of SELENOP protein CTD PMID:25975991 NCBI chr15:3,300,249...3,309,992
Ensembl chr15:3,298,029...3,309,990 		JBrowse link
G Selp selectin, platelet increases expression EXP lead acetate results in increased expression of SELP mRNA CTD PMID:20542052 NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595 		JBrowse link
G Sema3e sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E increases expression EXP lead acetate results in increased expression of SEMA3E mRNA CTD PMID:25270620 NCBI chr 5:14,075,290...14,306,703
Ensembl chr 5:14,075,290...14,306,703 		JBrowse link
G Sema6a sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A decreases expression EXP lead acetate results in decreased expression of SEMA6A mRNA CTD PMID:22613225 NCBI chr18:47,378,321...47,504,267
Ensembl chr18:47,368,665...47,501,937 		JBrowse link
G Senp6 SUMO/sentrin specific peptidase 6 increases expression ISO lead acetate results in increased expression of SENP6 mRNA CTD PMID:22641619 NCBI chr 9:79,973,862...80,052,064
Ensembl chr 9:79,974,185...80,052,235 		JBrowse link
G Septin12 septin 12 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of SEPTIN12 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of SEPTIN12 protein CTD PMID:32142724 NCBI chr16:4,804,722...4,815,716
Ensembl chr16:4,804,722...4,815,716 		JBrowse link
G Septin9 septin 9 increases expression ISO lead acetate results in increased expression of SEPTIN9 mRNA CTD PMID:38568856 NCBI chr11:117,090,487...117,253,151
Ensembl chr11:117,090,487...117,253,151 		JBrowse link
G Serpinb1b serine (or cysteine) peptidase inhibitor, clade B, member 1b decreases expression EXP lead acetate results in decreased expression of SERPINB1B mRNA CTD PMID:29746905 NCBI chr13:33,262,478...33,278,363
Ensembl chr13:33,262,558...33,278,363 		JBrowse link
G Serpinb2 serine (or cysteine) peptidase inhibitor, clade B, member 2 increases expression ISO lead acetate results in increased expression of SERPINB2 mRNA CTD PMID:38568856 NCBI chr 1:107,439,153...107,453,330
Ensembl chr 1:107,439,153...107,463,208 		JBrowse link
G Serpinb3a serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A decreases expression ISO lead acetate results in decreased expression of SERPINB4 mRNA CTD PMID:38568856 NCBI chr 1:106,973,317...106,980,033
Ensembl chr 1:106,973,317...106,980,033 		JBrowse link
G Serpinb3b serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3B increases expression EXP lead acetate results in increased expression of SERPINB3B mRNA CTD PMID:20542052 NCBI chr 1:107,081,691...107,088,844
Ensembl chr 1:107,081,670...107,206,091 		JBrowse link
G Serpinb3d serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3D decreases expression ISO lead acetate results in decreased expression of SERPINB3 mRNA CTD PMID:38568856 NCBI chr 1:107,005,893...107,011,210
Ensembl chr 1:107,005,897...107,011,236 		JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 increases expression ISO lead acetate results in increased expression of SERPINE1 mRNA CTD PMID:27562236 PMID:37939567 PMID:38568856 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122 		JBrowse link
G Serping1 serine (or cysteine) peptidase inhibitor, clade G, member 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of SERPING1 protein CTD PMID:38072110 NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788 		JBrowse link
G Serpinh1 serine (or cysteine) peptidase inhibitor, clade H, member 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of SERPINH1 protein CTD PMID:38072110 NCBI chr 7:98,994,583...99,002,321
Ensembl chr 7:98,994,583...99,002,446 		JBrowse link
G Setd7 SET domain containing (lysine methyltransferase) 7 increases methylation ISO lead acetate results in increased methylation of SETD7 gene CTD PMID:29571894 NCBI chr 3:51,422,740...51,468,519
Ensembl chr 3:51,422,740...51,468,300 		JBrowse link
G Sf3a2 splicing factor 3a, subunit 2 increases expression ISO lead acetate results in increased expression of SF3A2 mRNA CTD PMID:38568856 NCBI chr10:80,634,569...80,640,756
Ensembl chr10:80,634,032...80,640,758 		JBrowse link
G Sfn stratifin decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of SFN mRNA
lead acetate results in increased expression of SFN mRNA 		CTD PMID:20680508 PMID:37939567 PMID:38568856 NCBI chr 4:133,327,867...133,329,163
Ensembl chr 4:133,327,867...133,329,479 		JBrowse link
G Sfpq splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) increases expression EXP lead acetate results in increased expression of SFPQ mRNA CTD PMID:21829687 NCBI chr 4:126,914,504...126,944,894
Ensembl chr 4:126,915,117...126,930,806 		JBrowse link
G Sfrp1 secreted frizzled-related protein 1 affects expression ISO lead acetate affects the expression of SFRP1 mRNA CTD PMID:21864555 NCBI chr 8:23,901,401...23,939,648
Ensembl chr 8:23,901,518...23,939,648 		JBrowse link
G Sfrp2 secreted frizzled-related protein 2 decreases expression EXP lead acetate results in decreased expression of SFRP2 mRNA CTD PMID:22613225 NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623 		JBrowse link
G Sftpb surfactant associated protein B decreases expression ISO lead acetate results in decreased expression of SFTPB mRNA CTD PMID:38568856 NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354 		JBrowse link
G Sftpc surfactant associated protein C decreases expression EXP lead acetate results in decreased expression of SFTPC mRNA CTD PMID:21829687 NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521 		JBrowse link
G Sgk1 serum/glucocorticoid regulated kinase 1 increases expression
multiple interactions
decreases expression 		ISO
EXP 		lead acetate results in increased expression of SGK1 mRNA
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SGK1 mRNA
lead acetate results in decreased expression of SGK1 mRNA 		CTD PMID:12634122 PMID:22641619 PMID:25270620 PMID:38568856 NCBI chr10:21,758,083...21,875,802
Ensembl chr10:21,758,083...21,875,802 		JBrowse link
G Sgpp2 sphingosine-1-phosphate phosphatase 2 decreases expression ISO lead acetate results in decreased expression of SGPP2 mRNA CTD PMID:38568856 NCBI chr 1:78,286,186...78,396,926
Ensembl chr 1:78,286,982...78,396,926 		JBrowse link
G Sh2d2a SH2 domain containing 2A increases expression ISO lead acetate results in increased expression of SH2D2A mRNA CTD PMID:38568856 NCBI chr 3:87,754,070...87,763,116
Ensembl chr 3:87,754,062...87,763,029 		JBrowse link
G Sh3bgrl3 SH3 domain binding glutamic acid-rich protein-like 3 increases expression ISO lead acetate results in increased expression of SH3BGRL3 mRNA CTD PMID:38568856 NCBI chr 4:133,854,717...133,856,044
Ensembl chr 4:133,854,717...133,856,100 		JBrowse link
G Sh3rf2 SH3 domain containing ring finger 2 decreases expression ISO lead acetate results in decreased expression of SH3RF2 mRNA CTD PMID:38568856 NCBI chr18:42,185,531...42,291,760
Ensembl chr18:42,186,732...42,292,025 		JBrowse link
G Shisa4 shisa family member 4 increases expression ISO lead acetate results in increased expression of SHISA4 mRNA CTD PMID:38568856 NCBI chr 1:135,298,578...135,302,812
Ensembl chr 1:135,298,795...135,302,975 		JBrowse link
G Shmt2 serine hydroxymethyltransferase 2 (mitochondrial) increases expression ISO
EXP 		lead acetate results in increased expression of SHMT2 mRNA CTD PMID:11578147 PMID:25270620 NCBI chr10:127,352,992...127,358,313
Ensembl chr10:127,352,992...127,358,313 		JBrowse link
G Shroom1 shroom family member 1 increases expression ISO lead acetate results in increased expression of SHROOM1 mRNA CTD PMID:38568856 NCBI chr11:53,347,904...53,358,593
Ensembl chr11:53,348,032...53,358,593 		JBrowse link
G Shroom3 shroom family member 3 increases expression EXP lead acetate results in increased expression of SHROOM3 mRNA CTD PMID:22609695 NCBI chr 5:92,831,294...93,113,618
Ensembl chr 5:92,831,294...93,113,177 		JBrowse link
G Siae sialic acid acetylesterase increases expression EXP lead acetate results in increased expression of SIAE mRNA CTD PMID:21829687 NCBI chr 9:37,525,117...37,559,554
Ensembl chr 9:37,466,994...37,560,951 		JBrowse link
G Sidt1 SID1 transmembrane family, member 1 increases expression EXP lead acetate results in increased expression of SIDT1 mRNA CTD PMID:22609695 NCBI chr16:44,060,540...44,153,575
Ensembl chr16:44,060,543...44,153,559 		JBrowse link
G Sik1 salt inducible kinase 1 decreases expression ISO lead acetate results in decreased expression of SIK1 mRNA CTD PMID:22641619 NCBI chr17:32,063,222...32,074,808
Ensembl chr17:32,063,224...32,074,778 		JBrowse link
G Sin3a transcriptional regulator, SIN3A (yeast) decreases expression ISO lead acetate results in decreased expression of SIN3A mRNA CTD PMID:38568856 NCBI chr 9:56,979,271...57,035,652
Ensembl chr 9:56,979,324...57,035,650 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions
decreases expression 		ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of SIRT1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SIRT1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of SIRT1 mRNA; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SIRT1 mRNA]; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SIRT1 protein]
lead acetate results in decreased expression of SIRT1 protein
SRT1720 inhibits the reaction [lead acetate results in decreased expression of SIRT1 protein] 		CTD PMID:33978298 PMID:34842334 PMID:39276841 NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483 		JBrowse link
G Sirt3 sirtuin 3 increases expression
multiple interactions 		EXP lead acetate results in increased expression of SIRT3 protein
PPARGC1A protein affects the reaction [lead acetate results in increased expression of SIRT3 protein] 		CTD PMID:27236077 NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222 		JBrowse link
G Skil SKI-like increases expression ISO lead acetate results in increased expression of SKIL mRNA CTD PMID:37939567 NCBI chr 3:31,149,259...31,176,741
Ensembl chr 3:31,149,207...31,176,726 		JBrowse link
G Slamf1 signaling lymphocytic activation molecule family member 1 decreases expression EXP lead acetate results in decreased expression of SLAMF1 mRNA CTD PMID:22609695 NCBI chr 1:171,594,700...171,628,752
Ensembl chr 1:171,594,695...171,628,752 		JBrowse link
G Slc10a1 solute carrier family 10 (sodium/bile acid cotransporter family), member 1 decreases expression EXP lead acetate results in decreased expression of SLC10A1 mRNA CTD PMID:22609695 NCBI chr12:80,999,959...81,015,479
Ensembl chr12:80,999,957...81,015,479 		JBrowse link
G Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 decreases expression
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased expression of SLC11A2 mRNA; lead acetate results in decreased expression of SLC11A2 protein
[lead acetate results in increased abundance of Lead] which affects the expression of SLC11A2 protein
lead acetate results in increased expression of SLC11A2 mRNA; lead acetate results in increased expression of SLC11A2 mRNA alternative form
lead acetate results in increased expression of SLC11A2 mRNA; lead acetate results in increased expression of SLC11A2 protein 		CTD PMID:23219683 PMID:30312686 PMID:34350654 NCBI chr15:100,285,779...100,322,090
Ensembl chr15:100,285,779...100,322,953 		JBrowse link
G Slc12a2 solute carrier family 12, member 2 decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased expression of SLC12A2 mRNA
lead acetate results in increased expression of SLC12A2 mRNA 		CTD PMID:11578147 PMID:21829687 NCBI chr18:58,011,505...58,079,893
Ensembl chr18:58,011,750...58,079,893 		JBrowse link
G Slc12a8 solute carrier family 12 (potassium/chloride transporters), member 8 increases expression ISO lead acetate results in increased expression of SLC12A8 mRNA CTD PMID:22839698 NCBI chr16:33,337,440...33,484,508
Ensembl chr16:33,337,698...33,484,505 		JBrowse link
G Slc13a3 solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 increases expression ISO lead acetate results in increased expression of SLC13A3 mRNA CTD PMID:22641619 NCBI chr 2:165,247,215...165,315,117
Ensembl chr 2:165,246,948...165,315,150 		JBrowse link
G Slc16a3 solute carrier family 16 (monocarboxylic acid transporters), member 3 multiple interactions
increases expression 		EXP [lead acetate results in increased abundance of Lead] which results in increased expression of SLC16A3 protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of SLC16A3 protein]; lead acetate results in decreased expression of and affects the localization of SLC16A3 protein
lead acetate results in increased expression of SLC16A3 mRNA 		CTD PMID:30615929 PMID:34508822 NCBI chr11:120,839,310...120,849,826
Ensembl chr11:120,839,306...120,851,694 		JBrowse link
G Slc16a5 solute carrier family 16 (monocarboxylic acid transporters), member 5 decreases expression EXP
ISO 		lead acetate results in decreased expression of SLC16A5 mRNA CTD PMID:21829687 PMID:38568856 NCBI chr11:115,353,231...115,365,224
Ensembl chr11:115,353,300...115,365,224 		JBrowse link
G Slc17a3 solute carrier family 17 (sodium phosphate), member 3 increases expression EXP lead acetate results in increased expression of SLC17A3 mRNA CTD PMID:20542052 NCBI chr13:24,020,905...24,044,701
Ensembl chr13:24,023,417...24,044,699 		JBrowse link
G Slc17a6 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 decreases expression EXP lead acetate results in decreased expression of SLC17A6 mRNA CTD PMID:22613225 NCBI chr 7:51,271,578...51,320,874
Ensembl chr 7:51,271,754...51,320,867 		JBrowse link
G Slc17a7 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 decreases expression
increases expression 		EXP lead acetate results in decreased expression of SLC17A7 mRNA
lead acetate results in increased expression of SLC17A7 mRNA 		CTD PMID:24260418 NCBI chr 7:44,813,345...44,825,563
Ensembl chr 7:44,813,373...44,825,566 		JBrowse link
G Slc18a1 solute carrier family 18 (vesicular monoamine), member 1 decreases expression
increases methylation 		ISO lead acetate results in decreased expression of SLC18A1 mRNA
lead acetate results in increased methylation of SLC18A1 gene 		CTD PMID:22641619 PMID:29571894 NCBI chr 8:69,490,360...69,547,951
Ensembl chr 8:69,490,363...69,541,887 		JBrowse link
G Slc18a2 solute carrier family 18 (vesicular monoamine), member 2 decreases expression EXP lead acetate results in decreased expression of SLC18A2 mRNA CTD PMID:22613225 NCBI chr19:59,249,310...59,284,444
Ensembl chr19:59,249,328...59,284,444 		JBrowse link
G Slc18a3 solute carrier family 18 (vesicular monoamine), member 3 decreases expression ISO lead acetate results in decreased expression of SLC18A3 protein CTD PMID:27492863 NCBI chr14:32,184,394...32,186,807
Ensembl chr14:32,184,395...32,186,807 		JBrowse link
G Slc19a3 solute carrier family 19, member 3 increases expression ISO lead acetate results in increased expression of SLC19A3 mRNA CTD PMID:22641619 NCBI chr 1:82,990,242...83,016,541
Ensembl chr 1:82,990,244...83,016,169 		JBrowse link
G Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 increases expression ISO lead acetate results in increased expression of SLC1A1 mRNA; lead acetate results in increased expression of SLC1A1 protein CTD PMID:15985313 NCBI chr19:28,812,535...28,891,360
Ensembl chr19:28,812,449...28,891,360 		JBrowse link
G Slc1a2 solute carrier family 1 (glial high affinity glutamate transporter), member 2 decreases expression ISO lead acetate results in decreased expression of SLC1A2 mRNA CTD PMID:15985313 NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129 		JBrowse link
G Slc1a3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 affects expression
increases expression 		ISO lead acetate affects the expression of SLC1A3 mRNA
lead acetate results in increased expression of SLC1A3 mRNA 		CTD PMID:11578147 PMID:15985313 NCBI chr15:8,663,608...8,742,648
Ensembl chr15:8,663,608...8,740,248 		JBrowse link
G Slc1a4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 increases expression EXP lead acetate results in increased expression of SLC1A4 mRNA CTD PMID:25270620 NCBI chr11:20,252,180...20,282,713
Ensembl chr11:20,252,180...20,282,713 		JBrowse link
G Slc22a14 solute carrier family 22 (organic cation transporter), member 14 increases expression ISO lead acetate results in increased expression of SLC22A14 mRNA CTD PMID:37939567 NCBI chr 9:118,998,521...119,019,496
Ensembl chr 9:118,998,523...119,019,473 		JBrowse link
G Slc22a3 solute carrier family 22 (organic cation transporter), member 3 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of SLC22A3 mRNA CTD PMID:22839698 NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591 		JBrowse link
G Slc22a4 solute carrier family 22 (organic cation transporter), member 4 increases expression ISO lead acetate results in increased expression of SLC22A4 mRNA CTD PMID:38568856 NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916 		JBrowse link
G Slc25a16 solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16 increases expression ISO lead acetate results in increased expression of SLC25A16 mRNA CTD PMID:11578147 NCBI chr10:62,756,454...62,782,278
Ensembl chr10:62,756,412...62,782,277 		JBrowse link
G Slc25a23 solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 decreases expression ISO lead acetate results in decreased expression of SLC25A23 mRNA CTD PMID:38568856 NCBI chr17:57,350,711...57,366,863
Ensembl chr17:57,350,711...57,366,863 		JBrowse link
G Slc25a28 solute carrier family 25, member 28 increases expression EXP lead acetate results in increased expression of SLC25A28 mRNA CTD PMID:21829687 NCBI chr19:43,652,240...43,663,320
Ensembl chr19:43,652,240...43,663,320 		JBrowse link
G Slc26a2 solute carrier family 26 (sulfate transporter), member 2 decreases expression ISO lead acetate results in decreased expression of SLC26A2 mRNA CTD PMID:38568856 NCBI chr18:61,329,926...61,344,668
Ensembl chr18:61,325,991...61,344,684 		JBrowse link
G Slc26a7 solute carrier family 26, member 7 decreases expression ISO lead acetate results in decreased expression of SLC26A7 mRNA CTD PMID:22641619 NCBI chr 4:14,502,430...14,621,946
Ensembl chr 4:14,502,430...14,621,805 		JBrowse link
G Slc27a2 solute carrier family 27 (fatty acid transporter), member 2 decreases expression ISO lead acetate results in decreased expression of SLC27A2 mRNA CTD PMID:38568856 NCBI chr 2:126,394,944...126,430,163
Ensembl chr 2:126,394,327...126,430,163 		JBrowse link
G Slc27a4 solute carrier family 27 (fatty acid transporter), member 4 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of SLC27A4 protein CTD PMID:38072110 NCBI chr 2:29,692,646...29,707,534
Ensembl chr 2:29,692,646...29,707,534 		JBrowse link
G Slc27a5 solute carrier family 27 (fatty acid transporter), member 5 decreases expression EXP lead acetate results in decreased expression of SLC27A5 mRNA CTD PMID:22613225 NCBI chr 7:12,722,273...12,732,119
Ensembl chr 7:12,722,273...12,732,119 		JBrowse link
G Slc29a2 solute carrier family 29 (nucleoside transporters), member 2 decreases expression ISO lead acetate results in decreased expression of SLC29A2 mRNA CTD PMID:38568856 NCBI chr19:5,069,085...5,082,000
Ensembl chr19:5,073,888...5,082,000 		JBrowse link
G Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of SLC2A1 mRNA; lead acetate results in increased expression of SLC2A1 protein
[[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of SLC2A1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein]
[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein; [sodium arsenite co-treated with lead acetate] results in decreased expression of SLC2A1 protein; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 mRNA]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A1 protein] 		CTD PMID:30980912 PMID:31874198 PMID:34508822 PMID:38072110 PMID:38157908 NCBI chr 4:118,966,001...118,994,527
Ensembl chr 4:118,965,908...118,995,180 		JBrowse link
G Slc2a10 solute carrier family 2 (facilitated glucose transporter), member 10 increases expression ISO lead acetate results in increased expression of SLC2A10 mRNA CTD PMID:22641619 NCBI chr 2:165,345,817...165,361,837
Ensembl chr 2:165,345,707...165,361,837 		JBrowse link
G Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 increases methylation
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in increased methylation of SLC2A3 gene
[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein
lead acetate results in increased expression of SLC2A3 mRNA; lead acetate results in increased expression of SLC2A3 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SLC2A3 mRNA; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 mRNA]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC2A3 protein] 		CTD PMID:12634122 PMID:29571894 PMID:30980912 PMID:31874198 PMID:34508822 NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599 		JBrowse link
G Slc2a5 solute carrier family 2 (facilitated glucose transporter), member 5 decreases expression ISO lead acetate results in decreased expression of SLC2A5 mRNA CTD PMID:22641619 NCBI chr 4:150,203,801...150,228,625
Ensembl chr 4:150,203,740...150,228,626 		JBrowse link
G Slc30a1 solute carrier family 30 (zinc transporter), member 1 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of SLC30A1 mRNA
[sodium arsenite co-treated with lead acetate] results in increased expression of SLC30A1 protein 		CTD PMID:25270620 PMID:38072110 NCBI chr 1:191,638,810...191,645,359
Ensembl chr 1:191,638,879...191,645,359 		JBrowse link
G Slc30a2 solute carrier family 30 (zinc transporter), member 2 increases expression ISO lead acetate results in increased expression of SLC30A2 protein CTD PMID:24311739 NCBI chr 4:134,070,357...134,081,795
Ensembl chr 4:134,070,492...134,081,795 		JBrowse link
G Slc30a5 solute carrier family 30 (zinc transporter), member 5 increases expression EXP lead acetate results in increased expression of SLC30A5 mRNA; lead acetate results in increased expression of SLC30A5 protein CTD PMID:30623991 NCBI chr13:100,939,153...100,969,988
Ensembl chr13:100,939,156...100,969,935 		JBrowse link
G Slc30a6 solute carrier family 30 (zinc transporter), member 6 increases expression EXP lead acetate results in increased expression of SLC30A6 mRNA CTD PMID:30623991 NCBI chr17:74,702,573...74,731,225
Ensembl chr17:74,702,603...74,731,216 		JBrowse link
G Slc31a1 solute carrier family 31, member 1 multiple interactions
increases expression 		ISO
EXP 		lead acetate promotes the reaction [SLC31A1 protein results in increased uptake of Copper]; lead acetate results in increased expression of and affects the localization of SLC31A1 protein
[[lead acetate results in increased abundance of Lead] co-treated with [cupric chloride results in increased abundance of Copper]] results in increased expression of SLC31A1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of SLC31A1 protein
lead acetate results in increased expression of SLC31A1 mRNA; lead acetate results in increased expression of SLC31A1 protein 		CTD PMID:24316150 PMID:25579025 PMID:30623991 PMID:40010429 NCBI chr 4:62,278,821...62,310,006
Ensembl chr 4:62,278,964...62,310,006 		JBrowse link
G Slc32a1 solute carrier family 32 (GABA vesicular transporter), member 1 decreases expression ISO lead acetate results in decreased expression of SLC32A1 protein CTD PMID:20375082 NCBI chr 2:158,449,158...158,457,667
Ensembl chr 2:158,452,687...158,457,668 		JBrowse link
G Slc35a5 solute carrier family 35, member A5 decreases expression EXP lead acetate results in decreased expression of SLC35A5 mRNA CTD PMID:22609695 NCBI chr16:44,959,936...44,979,036
Ensembl chr16:44,959,936...44,979,069 		JBrowse link
G Slc35e1 solute carrier family 35, member E1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of SLC35E1 mRNA CTD PMID:22839698 NCBI chr 8:73,231,839...73,246,473
Ensembl chr 8:73,234,485...73,246,458 		JBrowse link
G Slc35f2 solute carrier family 35, member F2 decreases expression ISO lead acetate results in decreased expression of SLC35F2 mRNA CTD PMID:22641619 NCBI chr 9:53,678,733...53,725,445
Ensembl chr 9:53,678,822...53,725,438 		JBrowse link
G Slc37a2 solute carrier family 37 (glycerol-3-phosphate transporter), member 2 increases expression ISO lead acetate results in increased expression of SLC37A2 mRNA CTD PMID:38568856 NCBI chr 9:37,140,445...37,166,709
Ensembl chr 9:37,138,881...37,167,034 		JBrowse link
G Slc38a2 solute carrier family 38, member 2 decreases expression EXP lead acetate results in decreased expression of SLC38A2 mRNA CTD PMID:21829687 NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611 		JBrowse link
G Slc39a10 solute carrier family 39 (zinc transporter), member 10 decreases expression EXP lead acetate results in decreased expression of SLC39A10 mRNA CTD PMID:25270620 NCBI chr 1:46,846,704...46,964,952
Ensembl chr 1:46,846,704...46,932,012 		JBrowse link
G Slc39a12 solute carrier family 39 (zinc transporter), member 12 decreases expression ISO lead acetate results in decreased expression of SLC39A12 mRNA CTD PMID:22641619 NCBI chr 2:14,345,476...14,499,787
Ensembl chr 2:14,393,127...14,499,788 		JBrowse link
G Slc39a14 solute carrier family 39 (zinc transporter), member 14 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of SLC39A14 mRNA CTD PMID:39276841 NCBI chr14:70,540,916...70,588,873
Ensembl chr14:70,540,918...70,588,874 		JBrowse link
G Slc39a4 solute carrier family 39 (zinc transporter), member 4 decreases expression ISO lead acetate results in decreased expression of SLC39A4 mRNA CTD PMID:22641619 NCBI chr15:76,496,583...76,501,579
Ensembl chr15:76,496,583...76,501,584 		JBrowse link
G Slc39a5 solute carrier family 39 (metal ion transporter), member 5 increases expression EXP lead acetate results in increased expression of SLC39A5 mRNA CTD PMID:20542052 NCBI chr10:128,231,796...128,237,145
Ensembl chr10:128,231,800...128,237,098 		JBrowse link
G Slc39a8 solute carrier family 39 (metal ion transporter), member 8 decreases expression ISO
EXP 		lead acetate results in decreased expression of SLC39A8 mRNA CTD PMID:22613225 PMID:22641619 PMID:38568856 NCBI chr 3:135,522,644...135,594,333
Ensembl chr 3:135,531,040...135,594,333 		JBrowse link
G Slc3a2 solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of SLC3A2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of SLC3A2 mRNA 		CTD PMID:25270620 PMID:38568856 PMID:39276841 NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733 		JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 decreases expression
multiple interactions
increases expression 		ISO
EXP 		lead acetate results in decreased expression of SLC40A1 mRNA; lead acetate results in decreased expression of SLC40A1 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC40A1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC40A1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of SLC40A1 mRNA
lead acetate results in increased expression of SLC40A1 mRNA 		CTD PMID:22613225 PMID:23219683 PMID:30623991 PMID:36642386 PMID:39276841 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683 		JBrowse link
G Slc48a1 solute carrier family 48 (heme transporter), member 1 increases expression ISO lead acetate results in increased expression of SLC48A1 mRNA CTD PMID:38568856 NCBI chr15:97,682,246...97,690,573
Ensembl chr15:97,676,401...97,690,573 		JBrowse link
G Slc4a1 solute carrier family 4 (anion exchanger), member 1 increases expression ISO lead acetate results in increased expression of SLC4A1 mRNA CTD PMID:22641619 NCBI chr11:102,239,646...102,256,107
Ensembl chr11:102,239,650...102,257,029 		JBrowse link
G Slc4a11 solute carrier family 4, sodium bicarbonate transporter-like, member 11 decreases expression ISO lead acetate results in decreased expression of SLC4A11 mRNA CTD PMID:38568856 NCBI chr 2:130,526,027...130,539,439
Ensembl chr 2:130,526,033...130,539,439 		JBrowse link
G Slc4a5 solute carrier family 4, sodium bicarbonate cotransporter, member 5 affects expression ISO lead acetate affects the expression of SLC4A5 mRNA CTD PMID:21864555 NCBI chr 6:83,184,561...83,281,927
Ensembl chr 6:83,196,810...83,281,927 		JBrowse link
G Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 increases expression
decreases expression 		ISO lead acetate results in increased expression of SLC4A7 mRNA
lead acetate results in decreased expression of SLC4A7 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr14:7,669,819...7,766,808
Ensembl chr14:7,669,823...7,767,484 		JBrowse link
G Slc5a11 solute carrier family 5 (sodium/glucose cotransporter), member 11 decreases expression EXP lead acetate results in decreased expression of SLC5A11 mRNA CTD PMID:22613225 NCBI chr 7:122,813,817...122,873,612
Ensembl chr 7:122,814,003...122,872,476 		JBrowse link
G Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5 affects expression ISO lead acetate affects the expression of SLC5A5 mRNA CTD PMID:21864555 NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401 		JBrowse link
G Slc5a7 solute carrier family 5 (choline transporter), member 7 affects expression ISO lead acetate affects the expression of SLC5A7 mRNA CTD PMID:22641619 NCBI chr17:54,580,618...54,606,071
Ensembl chr17:54,580,618...54,606,062 		JBrowse link
G Slc5a8 solute carrier family 5 (iodide transporter), member 8 decreases expression EXP lead acetate results in decreased expression of SLC5A8 mRNA CTD PMID:21829687 NCBI chr10:88,721,854...88,765,377
Ensembl chr10:88,721,854...88,765,377 		JBrowse link
G Slc6a1 solute carrier family 6 (neurotransmitter transporter, GABA), member 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC6A1 protein; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC6A1 protein] CTD PMID:31708536 NCBI chr 6:114,259,735...114,294,491
Ensembl chr 6:114,259,596...114,294,493 		JBrowse link
G Slc6a11 solute carrier family 6 (neurotransmitter transporter, GABA), member 11 decreases expression EXP lead acetate results in decreased expression of SLC6A11 mRNA CTD PMID:22613225 NCBI chr 6:114,108,202...114,226,847
Ensembl chr 6:114,108,202...114,226,913 		JBrowse link
G Slc6a2 solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 affects expression ISO lead acetate affects the expression of SLC6A2 mRNA CTD PMID:21864555 NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295 		JBrowse link
G Slc6a5 solute carrier family 6 (neurotransmitter transporter, glycine), member 5 increases methylation ISO lead acetate results in increased methylation of SLC6A5 gene CTD PMID:29571894 NCBI chr 7:49,556,733...49,613,612
Ensembl chr 7:49,559,894...49,613,604 		JBrowse link
G Slc6a6 solute carrier family 6 (neurotransmitter transporter, taurine), member 6 decreases expression
increases expression 		ISO lead acetate results in decreased expression of SLC6A6 mRNA
lead acetate results in increased expression of SLC6A6 mRNA 		CTD PMID:11578147 PMID:38568856 NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047 		JBrowse link
G Slc6a8 solute carrier family 6 (neurotransmitter transporter, creatine), member 8 increases expression ISO lead acetate results in increased expression of SLC6A8 mRNA CTD PMID:11578147 NCBI chr  X:72,716,739...72,726,108
Ensembl chr  X:72,716,756...72,726,108 		JBrowse link
G Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 increases expression ISO lead acetate results in increased expression of SLC6A9 mRNA CTD PMID:11578147 NCBI chr 4:117,692,240...117,726,502
Ensembl chr 4:117,691,703...117,732,395 		JBrowse link
G Slc7a1 solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 increases expression EXP lead acetate results in increased expression of SLC7A1 mRNA CTD PMID:25270620 NCBI chr 5:148,264,220...148,336,714
Ensembl chr 5:148,264,220...148,336,714 		JBrowse link
G Slc7a10 solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 increases expression EXP lead acetate results in increased expression of SLC7A10 protein CTD PMID:25242007 NCBI chr 7:34,885,520...34,900,539
Ensembl chr 7:34,885,810...34,900,539 		JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 increases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of SLC7A11 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of SLC7A11 mRNA; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 protein]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of SLC7A11 mRNA]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of SLC7A11 mRNA]
[sodium arsenite co-treated with lead acetate] results in increased expression of SLC7A11 protein 		CTD PMID:22839698 PMID:25270620 PMID:27562236 PMID:36642386 PMID:37939567 More... NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063 		JBrowse link
G Slc7a8 solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 increases expression ISO lead acetate results in increased expression of SLC7A8 mRNA CTD PMID:27562236 NCBI chr14:54,959,672...55,019,343
Ensembl chr14:54,959,666...55,019,403 		JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 increases expression EXP lead acetate results in increased expression of SLCO1A1 mRNA CTD PMID:22609695 NCBI chr 6:141,853,007...141,892,688
Ensembl chr 6:141,853,008...141,892,688 		JBrowse link
G Slco1a5 solute carrier organic anion transporter family, member 1a5 decreases expression
affects expression 		ISO lead acetate results in decreased expression of SLCO1A5 mRNA
lead acetate affects the expression of SLCO1A5 mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr 6:142,179,953...142,268,707
Ensembl chr 6:142,179,953...142,268,707 		JBrowse link
G Slco1b2 solute carrier organic anion transporter family, member 1b2 decreases expression EXP lead acetate results in decreased expression of SLCO1B2 mRNA CTD PMID:22609695 NCBI chr 6:141,575,178...141,632,372
Ensembl chr 6:141,575,244...141,632,372 		JBrowse link
G Slco2a1 solute carrier organic anion transporter family, member 2a1 increases expression
decreases expression 		ISO lead acetate results in increased expression of SLCO2A1 mRNA
lead acetate results in decreased expression of SLCO2A1 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 9:102,885,686...102,973,201
Ensembl chr 9:102,865,911...102,973,201 		JBrowse link
G Slco4a1 solute carrier organic anion transporter family, member 4a1 decreases expression ISO lead acetate results in decreased expression of SLCO4A1 mRNA CTD PMID:38568856 NCBI chr 2:180,098,019...180,116,646
Ensembl chr 2:180,098,038...180,116,660 		JBrowse link
G Slfn5 schlafen 5 decreases expression ISO lead acetate results in decreased expression of SLFN5 mRNA CTD PMID:22641619 PMID:38568856 NCBI chr11:82,842,175...82,855,681
Ensembl chr11:82,842,175...82,855,666 		JBrowse link
G Slitrk6 SLIT and NTRK-like family, member 6 increases expression ISO lead acetate results in increased expression of SLITRK6 mRNA CTD PMID:22641619 NCBI chr14:110,984,770...110,992,640
Ensembl chr14:110,986,012...110,992,581 		JBrowse link
G Smad1 SMAD family member 1 multiple interactions EXP lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD1 protein] CTD PMID:17805416 NCBI chr 8:80,065,024...80,126,057
Ensembl chr 8:80,065,024...80,126,147 		JBrowse link
G Smad3 SMAD family member 3 increases methylation ISO lead acetate results in increased methylation of SMAD3 gene CTD PMID:29571894 NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276 		JBrowse link
G Smad5 SMAD family member 5 multiple interactions
increases methylation 		EXP
ISO 		lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD5 protein]
lead acetate results in increased methylation of SMAD5 gene 		CTD PMID:17805416 PMID:29571894 NCBI chr13:56,850,804...56,890,191
Ensembl chr13:56,850,823...56,890,190 		JBrowse link
G Smad9 SMAD family member 9 multiple interactions EXP lead acetate inhibits the reaction [BMP2 protein results in increased phosphorylation of SMAD9 protein] CTD PMID:17805416 NCBI chr 3:54,662,873...54,709,162
Ensembl chr 3:54,663,003...54,708,678 		JBrowse link
G Smarca2 SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 increases expression ISO lead acetate results in increased expression of SMARCA2 protein CTD PMID:38072110 NCBI chr19:26,582,578...26,755,721
Ensembl chr19:26,582,450...26,755,722 		JBrowse link
G Smarca4 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 increases expression ISO lead acetate results in increased expression of SMARCA4 protein CTD PMID:38072110 NCBI chr 9:21,527,377...21,615,526
Ensembl chr 9:21,527,465...21,615,526 		JBrowse link
G Smarcad1 SNF2 related chromatin remodeling ATPase with DExD box 1 increases methylation ISO lead acetate results in increased methylation of SMARCAD1 gene CTD PMID:29571894 NCBI chr 6:65,019,577...65,093,045
Ensembl chr 6:65,019,567...65,093,045 		JBrowse link
G Smarcd2 SWI/SNF related BAF chromatin remodeling complex subunit D2 decreases expression EXP lead acetate results in decreased expression of SMARCD2 mRNA CTD PMID:22609695 NCBI chr11:106,153,997...106,163,810
Ensembl chr11:106,154,005...106,163,798 		JBrowse link
G Smc1b structural maintenance of chromosomes 1B decreases expression EXP lead acetate results in decreased expression of SMC1B mRNA CTD PMID:22609695 NCBI chr15:84,948,890...85,016,158
Ensembl chr15:84,948,890...85,016,165 		JBrowse link
G Smc3 structural maintenance of chromosomes 3 affects expression ISO lead acetate affects the expression of SMC3 protein CTD PMID:36539177 NCBI chr19:53,588,827...53,634,262
Ensembl chr19:53,588,829...53,634,264 		JBrowse link
G Smcr8 Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SMCR8 mRNA CTD PMID:22839698 NCBI chr11:60,668,351...60,679,113
Ensembl chr11:60,668,350...60,679,113 		JBrowse link
G Smim11 small integral membrane protein 11 decreases expression EXP lead acetate results in decreased expression of SMIM11 mRNA CTD PMID:21829687 NCBI chr16:92,098,131...92,109,929
Ensembl chr16:92,098,174...92,109,929 		JBrowse link
G Smox spermine oxidase decreases expression ISO lead acetate results in decreased expression of SMOX mRNA CTD PMID:38568856 NCBI chr 2:131,333,624...131,367,103
Ensembl chr 2:131,333,416...131,367,842 		JBrowse link
G Smpd1 sphingomyelin phosphodiesterase 1, acid lysosomal increases activity
multiple interactions 		EXP lead acetate results in increased activity of SMPD1 protein
[S-allylcysteine co-treated with Clotrimazole] inhibits the reaction [lead acetate results in increased activity of SMPD1 protein]; Clotrimazole inhibits the reaction [lead acetate results in increased activity of SMPD1 protein]; S-allylcysteine inhibits the reaction [lead acetate results in increased activity of SMPD1 protein] 		CTD PMID:22033380 NCBI chr 7:105,203,567...105,207,596
Ensembl chr 7:105,203,567...105,207,596 		JBrowse link
G Smpdl3a sphingomyelin phosphodiesterase, acid-like 3A decreases expression EXP lead acetate results in decreased expression of SMPDL3A mRNA CTD PMID:21829687 NCBI chr10:57,670,640...57,687,926
Ensembl chr10:57,670,431...57,687,926 		JBrowse link
G Smpdl3b sphingomyelin phosphodiesterase, acid-like 3B decreases expression EXP lead acetate results in decreased expression of SMPDL3B mRNA CTD PMID:21829687 NCBI chr 4:132,460,277...132,484,558
Ensembl chr 4:132,460,277...132,484,563 		JBrowse link
G Smtn smoothelin decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of SMTN mRNA
lead acetate results in increased expression of SMTN mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr11:3,467,522...3,489,337
Ensembl chr11:3,467,521...3,490,612 		JBrowse link
G Smtnl2 smoothelin-like 2 decreases expression EXP lead acetate results in decreased expression of SMTNL2 mRNA CTD PMID:25270620 NCBI chr11:72,279,989...72,302,539
Ensembl chr11:72,279,990...72,302,539 		JBrowse link
G Smyd5 SET and MYND domain containing 5 increases methylation ISO lead acetate results in increased methylation of SMYD5 gene CTD PMID:29571894 NCBI chr 6:85,408,958...85,423,411
Ensembl chr 6:85,408,971...85,423,417 		JBrowse link
G Snai1 snail family zinc finger 1 multiple interactions ISO CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of SNAI1 protein] CTD PMID:39722890 NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734 		JBrowse link
G Snai2 snail family zinc finger 2 increases expression ISO lead acetate results in increased expression of SNAI2 mRNA CTD PMID:38568856 NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249 		JBrowse link
G Snap25 synaptosomal-associated protein 25 decreases expression EXP
ISO 		lead acetate results in decreased expression of SNAP25 mRNA; lead acetate results in decreased expression of SNAP25 protein CTD PMID:21126476 PMID:27492863 PMID:27984133 NCBI chr 2:136,555,359...136,624,348
Ensembl chr 2:136,555,373...136,624,348 		JBrowse link
G Snap29 synaptosomal-associated protein 29 increases methylation ISO lead acetate results in increased methylation of SNAP29 gene CTD PMID:29571894 NCBI chr16:17,223,864...17,248,690
Ensembl chr16:17,223,850...17,248,691 		JBrowse link
G Snca synuclein, alpha increases expression ISO lead acetate results in increased expression of SNCA protein CTD PMID:22811615 NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839 		JBrowse link
G Sncaip synuclein, alpha interacting protein (synphilin) decreases expression ISO lead acetate results in decreased expression of SNCAIP mRNA CTD PMID:38568856 NCBI chr18:52,900,872...53,049,007
Ensembl chr18:52,900,781...53,049,007 		JBrowse link
G Snd1 staphylococcal nuclease and tudor domain containing 1 increases expression EXP lead acetate results in increased expression of SND1 mRNA CTD PMID:22609695 NCBI chr 6:28,480,332...28,935,161
Ensembl chr 6:28,475,138...28,935,161 		JBrowse link
G Snhg7 small nucleolar RNA host gene 7 decreases expression ISO lead acetate results in decreased expression of SNHG7 mRNA CTD PMID:38568856 NCBI chr 2:26,527,188...26,530,256
Ensembl chr 2:26,526,613...26,530,577 		JBrowse link
G Snrnp70 small nuclear ribonucleoprotein 70 (U1) increases expression ISO lead acetate results in increased expression of SNRNP70 mRNA CTD PMID:38568856 NCBI chr 7:45,025,878...45,045,177
Ensembl chr 7:45,025,877...45,045,166 		JBrowse link
G Snrpf small nuclear ribonucleoprotein polypeptide F decreases expression ISO lead acetate results in decreased expression of SNRPF mRNA CTD PMID:22641619 NCBI chr10:93,418,891...93,425,520
Ensembl chr10:93,418,891...93,425,568 		JBrowse link
G Sntb2 syntrophin, basic 2 increases expression EXP lead acetate results in increased expression of SNTB2 mRNA CTD PMID:22613225 NCBI chr 8:107,662,372...107,740,864
Ensembl chr 8:107,662,382...107,746,346 		JBrowse link
G Sntg2 syntrophin, gamma 2 increases expression EXP lead acetate results in increased expression of SNTG2 mRNA CTD PMID:22613225 NCBI chr12:30,224,481...30,423,424
Ensembl chr12:30,224,481...30,423,374 		JBrowse link
G Snx10 sorting nexin 10 decreases expression ISO lead acetate results in decreased expression of SNX10 mRNA CTD PMID:22641619 NCBI chr 6:51,500,882...51,567,659
Ensembl chr 6:51,500,881...51,567,659 		JBrowse link
G Snx4 sorting nexin 4 increases expression EXP lead acetate results in increased expression of SNX4 mRNA CTD PMID:21829687 NCBI chr16:33,071,826...33,119,932
Ensembl chr16:33,071,812...33,120,639 		JBrowse link
G Snx6 sorting nexin 6 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 protein CTD PMID:30738087 NCBI chr12:54,793,124...54,842,464
Ensembl chr12:54,793,134...54,842,488 		JBrowse link
G Sod1 superoxide dismutase 1, soluble multiple interactions
decreases activity
decreases expression
increases expression
increases activity 		ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in decreased expression of SOD1 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of SOD1 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SOD1 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SOD1 mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SOD1 mRNA]
lead acetate results in decreased activity of SOD1 protein
3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in decreased activity of SOD1 protein]; [cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD1 protein]; [lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD1 protein]; [lead acetate results in increased abundance of Lead] which results in decreased activity of SOD1 protein; [lead acetate results in increased abundance of Lead] which results in increased activity of SOD1 protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of SOD1 protein]; Acetylcysteine inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD1 protein]]; Acetylcysteine inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD1 protein]]; mitoquinone inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD1 protein]]; mitoquinone inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD1 protein]]; tetrathiomolybdate inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD1 protein]]; tetrathiomolybdate inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD1 protein]]
lead acetate results in decreased expression of SOD1 mRNA
[Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of SOD1 protein]; lead acetate promotes the reaction [sodium arsenite results in decreased activity of SOD1 protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in decreased activity of SOD1 protein]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in decreased activity of SOD1 protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in decreased activity of SOD1 protein]]; sinapinic acid inhibits the reaction [lead acetate results in decreased expression of SOD1 protein]; sodium arsenite promotes the reaction [lead acetate results in decreased activity of SOD1 protein]
lead acetate results in increased expression of SOD1 mRNA; lead acetate results in increased expression of SOD1 protein
lead acetate results in decreased expression of SOD1 mRNA; lead acetate results in decreased expression of SOD1 protein
lead acetate results in increased activity of SOD1 protein 		CTD PMID:12634122 PMID:15014207 PMID:15569323 PMID:20680508 PMID:22534743 More... NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217 		JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial decreases activity
multiple interactions
decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased activity of SOD2 protein
[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD2 protein]; [lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD2 protein]; [lead acetate results in increased abundance of Lead] which results in increased activity of SOD2 protein; Acetylcysteine inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD2 protein]]; Acetylcysteine inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD2 protein]]; mitoquinone inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD2 protein]]; mitoquinone inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD2 protein]]; tetrathiomolybdate inhibits the reaction [[cupric chloride results in increased abundance of Copper] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased activity of SOD2 protein]]; tetrathiomolybdate inhibits the reaction [[lead acetate results in increased abundance of Lead] inhibits the reaction [[cupric chloride results in increased abundance of Copper] which results in increased activity of SOD2 protein]]
lead acetate results in decreased expression of SOD2 mRNA
lead acetate results in increased expression of SOD2 mRNA
lead acetate results in decreased expression of SOD2 mRNA; lead acetate results in decreased expression of SOD2 protein
5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in decreased expression of SOD2 mRNA]; [Zinc co-treated with Iron co-treated with Calcium] inhibits the reaction [lead acetate results in decreased expression of SOD2 protein]; coenzyme Q10 inhibits the reaction [lead acetate results in decreased expression of SOD2 mRNA]; Genistein inhibits the reaction [lead acetate results in decreased expression of SOD2 protein]; lead acetate promotes the reaction [sodium arsenite results in decreased activity of SOD2 protein]; lead acetate results in decreased expression of and results in decreased activity of SOD2 protein; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate promotes the reaction [sodium arsenite results in decreased activity of SOD2 protein]]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [lead acetate results in decreased activity of SOD2 protein]; monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite promotes the reaction [lead acetate results in decreased activity of SOD2 protein]]; sodium arsenite promotes the reaction [lead acetate results in decreased activity of SOD2 protein]
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SOD2 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SOD2 mRNA; Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SOD2 mRNA]; Rosmarinic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SOD2 mRNA] 		CTD PMID:22197700 PMID:22534743 PMID:22839698 PMID:23906897 PMID:26797587 More... NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950 		JBrowse link
G Sod3 superoxide dismutase 3, extracellular affects expression
increases expression 		ISO
EXP 		lead acetate affects the expression of SOD3 mRNA
lead acetate results in increased expression of SOD3 mRNA 		CTD PMID:21864555 PMID:29746905 NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760 		JBrowse link
G Sorcs2 sortilin-related VPS10 domain containing receptor 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of SORCS2 intron CTD PMID:33445541 NCBI chr 5:36,174,524...36,555,541
Ensembl chr 5:36,174,524...36,555,483 		JBrowse link
G Sord sorbitol dehydrogenase increases expression ISO lead acetate results in increased expression of SORD mRNA CTD PMID:11578147 NCBI chr 2:122,065,320...122,095,818
Ensembl chr 2:122,065,230...122,095,821 		JBrowse link
G Sostdc1 sclerostin domain containing 1 decreases expression EXP lead acetate results in decreased expression of SOSTDC1 mRNA CTD PMID:22609695 NCBI chr12:36,364,168...36,368,451
Ensembl chr12:36,364,138...36,368,451 		JBrowse link
G Sowahc sosondowah ankyrin repeat domain family member C increases expression EXP lead acetate results in increased expression of SOWAHC mRNA CTD PMID:21829687 NCBI chr10:59,057,744...59,062,256
Ensembl chr10:59,057,775...59,062,256 		JBrowse link
G Sox18 SRY (sex determining region Y)-box 18 decreases expression ISO lead acetate results in decreased expression of SOX18 mRNA CTD PMID:22641619 NCBI chr 2:181,311,630...181,313,433
Ensembl chr 2:181,311,629...181,313,433 		JBrowse link
G Sox2 SRY (sex determining region Y)-box 2 increases expression
decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of SOX2 mRNA
lead acetate results in decreased expression of SOX2 mRNA
sodium arsenite promotes the reaction [lead acetate results in decreased expression of SOX2 mRNA] 		CTD PMID:31715224 PMID:38072110 NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610 		JBrowse link
G Sox3 SRY (sex determining region Y)-box 3 affects expression EXP lead acetate affects the expression of SOX3 mRNA CTD PMID:24260418 NCBI chr  X:59,934,972...59,937,045
Ensembl chr  X:59,934,972...59,937,036 		JBrowse link
G Sox4 SRY (sex determining region Y)-box 4 decreases expression EXP lead acetate results in decreased expression of SOX4 mRNA CTD PMID:22613225 NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696 		JBrowse link
G Sox9 SRY (sex determining region Y)-box 9 multiple interactions
increases expression 		EXP BMP2 promotes the reaction [lead acetate results in increased expression of SOX9 mRNA]; lead acetate promotes the reaction [BMP2 results in increased expression of SOX9 mRNA] CTD PMID:17805416 NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586 		JBrowse link
G Sp1 trans-acting transcription factor 1 multiple interactions
increases expression 		ISO
EXP 		tolfenamic acid inhibits the reaction [lead acetate results in increased expression of SP1 protein]
lead acetate results in increased expression of SP1 mRNA; lead acetate results in increased expression of SP1 protein 		CTD PMID:23867794 PMID:24260418 PMID:24462621 NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839 		JBrowse link
G Sp100 nuclear antigen Sp100 decreases expression ISO lead acetate results in decreased expression of SP100 mRNA CTD PMID:22641619 NCBI chr 1:85,577,683...85,637,719
Ensembl chr 1:85,577,709...85,637,719 		JBrowse link
G Sp110 Sp110 nuclear body protein increases expression EXP lead acetate results in increased expression of SP110 mRNA CTD PMID:20542052 NCBI chr 1:85,498,462...85,538,571
Ensembl chr 1:85,504,620...85,526,538 		JBrowse link
G Sp2 Sp2 transcription factor increases expression EXP lead acetate results in increased expression of SP2 mRNA CTD PMID:20542052 NCBI chr11:96,844,158...96,873,785
Ensembl chr11:96,844,167...96,873,785 		JBrowse link
G Sp7 Sp7 transcription factor 7 decreases expression EXP lead acetate results in decreased expression of SP7 mRNA CTD PMID:22613225 NCBI chr15:102,265,038...102,275,498
Ensembl chr15:102,265,041...102,275,617 		JBrowse link
G Spa17 sperm autoantigenic protein 17 affects expression ISO lead acetate affects the expression of SPA17 mRNA CTD PMID:21864555 NCBI chr 9:37,514,590...37,525,018
Ensembl chr 9:37,514,586...37,525,018 		JBrowse link
G Spaca3 sperm acrosome associated 3 increases expression EXP lead acetate results in increased expression of SPACA3 mRNA CTD PMID:20542052 NCBI chr11:80,749,189...80,758,640
Ensembl chr11:80,749,191...80,758,640 		JBrowse link
G Spag16 sperm associated antigen 16 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of SPAG16 intron CTD PMID:33445541 NCBI chr 1:69,866,031...70,764,291
Ensembl chr 1:69,866,129...70,764,291 		JBrowse link
G Spag17 sperm associated antigen 17 increases expression EXP lead acetate results in increased expression of SPAG17 mRNA CTD PMID:20542052 NCBI chr 3:99,792,653...100,050,638
Ensembl chr 3:99,792,722...100,050,638 		JBrowse link
G Sparcl1 SPARC-like 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of SPARCL1 protein CTD PMID:38072110 NCBI chr 5:104,226,974...104,261,954
Ensembl chr 5:104,226,977...104,261,599 		JBrowse link
G Spata6 spermatogenesis associated 6 decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of SPATA6 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of SPATA6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SPATA6 protein 		CTD PMID:22641619 PMID:32142724 NCBI chr 4:111,577,151...111,686,339
Ensembl chr 4:111,577,181...111,686,381 		JBrowse link
G Spatc1l spermatogenesis and centriole associated 1 like multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of SPATC1L mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SPATC1L protein CTD PMID:32142724 NCBI chr10:76,394,180...76,406,035
Ensembl chr10:76,398,106...76,406,035 		JBrowse link
G Spcs1 signal peptidase complex subunit 1 homolog (S. cerevisiae) affects expression EXP lead acetate affects the expression of SPCS1 mRNA CTD PMID:21829687 NCBI chr14:30,721,783...30,723,330
Ensembl chr14:30,721,783...30,723,629 		JBrowse link
G Spcs2 signal peptidase complex subunit 2 homolog (S. cerevisiae) decreases expression EXP lead acetate results in decreased expression of SPCS2 mRNA CTD PMID:21829687 NCBI chr 7:99,486,775...99,512,576
Ensembl chr 7:99,486,776...99,512,669 		JBrowse link
G Spdl1 spindle apparatus coiled-coil protein 1 increases expression EXP lead acetate results in increased expression of SPDL1 mRNA CTD PMID:22609695 NCBI chr11:34,700,012...34,724,492
Ensembl chr11:34,700,017...34,724,468 		JBrowse link
G Spesp1 sperm equatorial segment protein 1 decreases expression EXP lead acetate results in decreased expression of SPESP1 mRNA CTD PMID:22609695 NCBI chr 9:62,178,011...62,189,461
Ensembl chr 9:62,178,011...62,189,490 		JBrowse link
G Spg21 SPG21, maspardin increases expression EXP lead acetate results in increased expression of SPG21 mRNA CTD PMID:20542052 NCBI chr 9:65,360,571...65,395,753
Ensembl chr 9:65,368,229...65,395,752 		JBrowse link
G Sphk1 sphingosine kinase 1 increases expression ISO lead acetate results in increased expression of SPHK1 mRNA CTD PMID:38568856 NCBI chr11:116,421,662...116,427,502
Ensembl chr11:116,421,751...116,427,501 		JBrowse link
G Spink1 serine peptidase inhibitor, Kazal type 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SPINK1 mRNA CTD PMID:12634122 NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622 		JBrowse link
G Spink2 serine peptidase inhibitor, Kazal type 2 increases expression EXP lead acetate results in increased expression of SPINK2 mRNA CTD PMID:20542052 NCBI chr 5:77,352,953...77,364,106
Ensembl chr 5:77,352,954...77,359,318 		JBrowse link
G Spink4 serine peptidase inhibitor, Kazal type 4 decreases expression ISO lead acetate results in decreased expression of SPINK4 mRNA CTD PMID:22641619 NCBI chr 4:40,920,056...40,931,395
Ensembl chr 4:40,920,052...40,931,395 		JBrowse link
G Spocd1 SPOC domain containing 1 increases expression ISO lead acetate results in increased expression of SPOCD1 mRNA CTD PMID:38568856 NCBI chr 4:129,822,560...129,850,908
Ensembl chr 4:129,823,042...129,850,908 		JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression
multiple interactions 		ISO
EXP 		lead acetate results in increased expression of SPP1 mRNA
lead acetate results in increased expression of and results in increased secretion of SPP1 protein; NFE2L2 protein affects the reaction [lead acetate results in increased expression of SPP1 mRNA] 		CTD PMID:27562236 PMID:30312686 PMID:37939567 PMID:38568856 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916 		JBrowse link
G Sprn shadow of prion protein decreases expression ISO lead acetate results in decreased expression of SPRN mRNA CTD PMID:22641619 NCBI chr 7:139,730,541...139,734,572
Ensembl chr 7:139,730,541...139,734,790 		JBrowse link
G Sprr1b small proline-rich protein 1B increases expression EXP lead acetate results in increased expression of SPRR1B mRNA CTD PMID:22609695 NCBI chr 3:92,344,115...92,346,124
Ensembl chr 3:92,344,116...92,346,096 		JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 decreases expression EXP lead acetate results in decreased expression of SPRY2 mRNA CTD PMID:22609695 NCBI chr14:106,129,381...106,134,559
Ensembl chr14:106,129,381...106,134,253 		JBrowse link
G Spry4 sprouty RTK signaling antagonist 4 increases expression ISO lead acetate results in increased expression of SPRY4 mRNA CTD PMID:38568856 NCBI chr18:38,719,300...38,734,400
Ensembl chr18:38,719,300...38,734,468 		JBrowse link
G Spryd7 SPRY domain containing 7 increases expression ISO lead acetate results in increased expression of SPRYD7 mRNA CTD PMID:38568856 NCBI chr14:61,769,300...61,794,335
Ensembl chr14:61,769,442...61,794,335 		JBrowse link
G Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 decreases expression EXP lead acetate results in decreased expression of SPSB1 mRNA CTD PMID:21829687 NCBI chr 4:149,980,740...150,039,494
Ensembl chr 4:149,980,740...150,039,500 		JBrowse link
G Sptbn1 spectrin beta, non-erythrocytic 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SPTBN1 mRNA CTD PMID:22839698 NCBI chr11:30,049,395...30,218,384
Ensembl chr11:30,049,395...30,218,175 		JBrowse link
G Sptbn2 spectrin beta, non-erythrocytic 2 decreases expression EXP lead acetate results in decreased expression of SPTBN2 mRNA CTD PMID:21829687 NCBI chr19:4,761,236...4,804,006
Ensembl chr19:4,761,195...4,802,388 		JBrowse link
G Sptssa serine palmitoyltransferase, small subunit A decreases expression ISO lead acetate results in decreased expression of SPTSSA mRNA CTD PMID:38568856 NCBI chr12:54,692,159...54,703,357
Ensembl chr12:54,692,177...54,703,358 		JBrowse link
G Spz1 spermatogenic leucine zipper 1 increases expression EXP lead acetate results in increased expression of SPZ1 mRNA CTD PMID:22609695 NCBI chr13:92,711,139...92,712,740
Ensembl chr13:92,711,144...92,712,680 		JBrowse link
G Sqstm1 sequestosome 1 increases expression
multiple interactions
decreases expression 		EXP
ISO 		lead acetate results in increased expression of SQSTM1 mRNA
[lead acetate results in increased abundance of Lead] which results in decreased expression of SQSTM1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SQSTM1 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of SQSTM1 mRNA
lead acetate results in increased expression of SQSTM1 mRNA; lead acetate results in increased expression of SQSTM1 protein
(1E,4E)-1,5-bis(2-methoxyphenyl)penta-1,4-dien-3-one inhibits the reaction [lead acetate results in increased expression of SQSTM1 protein]; [sodium arsenite co-treated with lead acetate] results in increased expression of SQSTM1 protein; Chloroquine promotes the reaction [lead acetate results in increased expression of SQSTM1 protein]; Sirolimus inhibits the reaction [lead acetate results in increased expression of SQSTM1 protein]; SRT1720 inhibits the reaction [lead acetate results in increased expression of SQSTM1 protein]
lead acetate results in decreased expression of SQSTM1 protein 		CTD PMID:29746905 PMID:32879255 PMID:34842334 PMID:36652739 PMID:36840722 More... NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654 		JBrowse link
G Src Rous sarcoma oncogene multiple interactions
increases phosphorylation 		ISO 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead acetate results in increased phosphorylation of SRC protein]; EGFR mutant form inhibits the reaction [lead acetate results in increased phosphorylation of SRC protein] CTD PMID:19133285 PMID:26926986 NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782 		JBrowse link
G Srcin1 SRC kinase signaling inhibitor 1 decreases expression EXP lead acetate results in decreased expression of SRCIN1 mRNA CTD PMID:36183778 NCBI chr11:97,400,166...97,466,059
Ensembl chr11:97,400,166...97,467,012 		JBrowse link
G Srebf1 sterol regulatory element binding transcription factor 1 increases expression
multiple interactions 		ISO lead acetate results in increased expression of SREBF1 protein
SRT1720 inhibits the reaction [lead acetate results in increased expression of SREBF1 protein] 		CTD PMID:34842334 NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407 		JBrowse link
G Srebf2 sterol regulatory element binding factor 2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of SREBF2 mRNA; lead acetate results in increased expression of SREBF2 protein
SRT1720 inhibits the reaction [lead acetate results in increased expression of SREBF2 protein] 		CTD PMID:29908845 PMID:34842334 NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580 		JBrowse link
G Sri sorcin increases expression ISO lead acetate results in increased expression of SRI mRNA CTD PMID:11578147 NCBI chr 5:8,096,078...8,119,314
Ensembl chr 5:8,096,078...8,119,379 		JBrowse link
G Srr serine racemase decreases expression EXP lead acetate results in decreased expression of SRR mRNA; lead acetate results in decreased expression of SRR protein CTD PMID:25242007 NCBI chr11:74,794,853...74,818,427
Ensembl chr11:74,797,185...74,816,774 		JBrowse link
G Srsf10 serine and arginine-rich splicing factor 10 decreases expression EXP lead acetate results in decreased expression of SRSF10 mRNA CTD PMID:21829687 NCBI chr 4:135,582,454...135,597,219
Ensembl chr 4:135,583,058...135,597,219 		JBrowse link
G Srsf2 serine and arginine-rich splicing factor 2 decreases expression EXP lead acetate results in decreased expression of SRSF2 mRNA CTD PMID:21829687 NCBI chr11:116,740,723...116,744,511
Ensembl chr11:116,740,727...116,743,920 		JBrowse link
G Srsf5 serine and arginine-rich splicing factor 5 decreases expression EXP lead acetate results in decreased expression of SRSF5 mRNA CTD PMID:21335049 NCBI chr12:80,992,308...80,997,277
Ensembl chr12:80,992,278...80,997,281 		JBrowse link
G Srsf6 serine and arginine-rich splicing factor 6 decreases expression EXP lead acetate results in decreased expression of SRSF6 mRNA CTD PMID:21829687 NCBI chr 2:162,773,428...162,779,041
Ensembl chr 2:162,773,448...162,779,041 		JBrowse link
G Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) increases expression EXP
ISO 		lead acetate results in increased expression of SRXN1 mRNA CTD PMID:25270620 PMID:38568856 NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296 		JBrowse link
G Ssbp1 single-stranded DNA binding protein 1 decreases expression EXP lead acetate results in decreased expression of SSBP1 mRNA CTD PMID:21829687 NCBI chr 6:40,448,302...40,458,757
Ensembl chr 6:40,448,286...40,461,634 		JBrowse link
G Ssbp3 single-stranded DNA binding protein 3 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of SSBP3 mRNA CTD PMID:22839698 NCBI chr 4:106,768,667...106,906,891
Ensembl chr 4:106,767,898...106,906,891 		JBrowse link
G Ssh3 slingshot protein phosphatase 3 decreases expression ISO lead acetate results in decreased expression of SSH3 mRNA CTD PMID:38568856 NCBI chr19:4,311,696...4,319,261
Ensembl chr19:4,311,696...4,319,208 		JBrowse link
G Sspn sarcospan multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of SSPN mRNA CTD PMID:12634122 NCBI chr 6:145,860,423...145,910,951
Ensembl chr 6:145,877,367...145,910,949
Ensembl chr 6:145,877,367...145,910,949 		JBrowse link
G Ssr3 signal sequence receptor, gamma increases expression ISO lead acetate results in increased expression of SSR3 mRNA CTD PMID:38568856 NCBI chr 3:65,287,078...65,299,974
Ensembl chr 3:65,287,076...65,300,044 		JBrowse link
G Sstr4 somatostatin receptor 4 decreases expression EXP lead acetate results in decreased expression of SSTR4 mRNA CTD PMID:21829687 NCBI chr 2:148,237,297...148,238,684
Ensembl chr 2:148,237,264...148,238,687 		JBrowse link
G St13 suppression of tumorigenicity 13 affects expression EXP lead acetate affects the expression of ST13 mRNA CTD PMID:21829687 NCBI chr15:81,247,869...81,284,278
Ensembl chr15:81,247,870...81,284,278 		JBrowse link
G St3gal1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ST3GAL1 mRNA CTD PMID:22839698 NCBI chr15:66,974,724...67,048,575
Ensembl chr15:66,974,724...67,048,679 		JBrowse link
G St6galnac1 ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 increases expression EXP lead acetate results in increased expression of ST6GALNAC1 mRNA CTD PMID:20542052 NCBI chr11:116,655,851...116,666,333
Ensembl chr11:116,655,851...116,666,333 		JBrowse link
G Stac src homology three (SH3) and cysteine rich domain increases expression ISO lead acetate results in increased expression of STAC mRNA CTD PMID:38568856 NCBI chr 9:111,386,476...111,519,673
Ensembl chr 9:111,390,505...111,519,416 		JBrowse link
G Stac2 SH3 and cysteine rich domain 2 decreases expression ISO lead acetate results in decreased expression of STAC2 mRNA CTD PMID:38568856 NCBI chr11:97,927,449...97,944,288
Ensembl chr11:97,927,449...97,944,288 		JBrowse link
G Stambpl1 STAM binding protein like 1 decreases expression EXP lead acetate results in decreased expression of STAMBPL1 mRNA CTD PMID:21829687 NCBI chr19:34,169,629...34,217,733
Ensembl chr19:34,169,629...34,217,733 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of STAR mRNA; lead acetate results in decreased expression of STAR protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of STAR mRNA; Glycine inhibits the reaction [lead acetate results in decreased expression of STAR mRNA]; lead acetate inhibits the reaction [Bucladesine results in increased expression of STAR protein]; Taurine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of STAR mRNA] 		CTD PMID:11213355 PMID:12647776 PMID:22806249 PMID:25981801 PMID:26558472 More... NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010 		JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of STAT1 protein; baricitinib inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased phosphorylation of STAT1 protein] CTD PMID:32428222 NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 increases phosphorylation
decreases expression 		ISO lead acetate results in increased phosphorylation of STAT3 protein
lead acetate results in decreased expression of STAT3 mRNA 		CTD PMID:26542248 PMID:38568856 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366 		JBrowse link
G Stat5b signal transducer and activator of transcription 5B multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of STAT5B intron CTD PMID:33445541 NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550 		JBrowse link
G Stc1 stanniocalcin 1 decreases expression ISO lead acetate results in decreased expression of STC1 mRNA CTD PMID:38568856 NCBI chr14:69,266,738...69,278,850
Ensembl chr14:69,266,687...69,279,253 		JBrowse link
G Stc2 stanniocalcin 2 increases expression EXP lead acetate results in increased expression of STC2 mRNA CTD PMID:25270620 NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074 		JBrowse link
G Steap1 six transmembrane epithelial antigen of the prostate 1 affects expression ISO lead acetate affects the expression of STEAP1 mRNA CTD PMID:21864555 NCBI chr 5:5,786,322...5,799,317
Ensembl chr 5:5,786,317...5,799,326 		JBrowse link
G Steap3 STEAP family member 3 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of STEAP3 mRNA CTD PMID:39276841 NCBI chr 1:120,154,137...120,198,810
Ensembl chr 1:120,118,487...120,200,435 		JBrowse link
G Steap4 STEAP family member 4 increases expression EXP
ISO 		lead acetate results in increased expression of STEAP4 mRNA CTD PMID:22609695 PMID:36539177 NCBI chr 5:8,010,472...8,032,213
Ensembl chr 5:8,010,457...8,032,213 		JBrowse link
G Stim1 stromal interaction molecule 1 multiple interactions ISO
EXP 		lead acetate inhibits the reaction [STIM1 protein binds to ORAI1 protein] CTD PMID:38281554 NCBI chr 7:101,909,279...102,086,525
Ensembl chr 7:101,917,013...102,086,526 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 decreases expression EXP lead acetate results in decreased expression of STIP1 mRNA CTD PMID:21829687 NCBI chr19:6,998,064...7,017,394
Ensembl chr19:6,998,070...7,017,335 		JBrowse link
G Stk10 serine/threonine kinase 10 increases expression EXP lead acetate results in increased expression of STK10 mRNA CTD PMID:25270620 NCBI chr11:32,483,266...32,574,595
Ensembl chr11:32,483,305...32,574,587 		JBrowse link
G Stk32c serine/threonine kinase 32C affects expression ISO lead acetate affects the expression of STK32C protein CTD PMID:36539177 NCBI chr 7:138,683,554...138,793,223
Ensembl chr 7:138,683,554...138,793,223 		JBrowse link
G Stmn1 stathmin 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of STMN1 mRNA CTD PMID:36642386 NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154 		JBrowse link
G Stom stomatin multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA
lead acetate results in increased expression of STOM mRNA 		CTD PMID:12634122 PMID:22609695 NCBI chr 2:35,204,002...35,227,021
Ensembl chr 2:35,203,998...35,226,988 		JBrowse link
G Stpg1 sperm tail PG rich repeat containing 1 decreases expression ISO lead acetate results in decreased expression of STPG1 mRNA CTD PMID:22641619 NCBI chr 4:135,221,971...135,265,015
Ensembl chr 4:135,222,101...135,265,114 		JBrowse link
G Stra6 stimulated by retinoic acid gene 6 affects expression ISO lead acetate affects the expression of STRA6 mRNA CTD PMID:21864555 NCBI chr 9:57,971,076...58,061,287
Ensembl chr 9:57,971,071...58,061,279 		JBrowse link
G Strip2 striatin interacting protein 2 increases expression EXP lead acetate results in increased expression of STRIP2 mRNA CTD PMID:20542052 NCBI chr 6:29,916,975...29,959,680
Ensembl chr 6:29,917,011...29,959,680 		JBrowse link
G Stx1a syntaxin 1A (brain) increases expression
decreases expression 		ISO lead acetate results in increased expression of STX1A mRNA; lead acetate results in increased expression of STX1A protein
lead acetate results in decreased expression of STX1A mRNA 		CTD PMID:11578147 PMID:27984133 NCBI chr 5:135,051,473...135,079,954
Ensembl chr 5:135,052,336...135,079,954 		JBrowse link
G Stx1b syntaxin 1B decreases expression ISO lead acetate results in decreased expression of STX1B mRNA CTD PMID:27984133 NCBI chr 7:127,403,072...127,423,703
Ensembl chr 7:127,403,072...127,423,721 		JBrowse link
G Suclg1 succinate-CoA ligase, GDP-forming, alpha subunit decreases expression EXP lead acetate results in decreased expression of SUCLG1 mRNA CTD PMID:21829687 NCBI chr 6:73,225,488...73,253,890
Ensembl chr 6:73,225,365...73,253,894 		JBrowse link
G Sucnr1 succinate receptor 1 increases expression ISO lead acetate results in increased expression of SUCNR1 mRNA CTD PMID:22641619 NCBI chr 3:59,989,290...59,994,987
Ensembl chr 3:59,989,290...59,994,987 		JBrowse link
G Sulf1 sulfatase 1 affects expression ISO lead acetate affects the expression of SULF1 mRNA CTD PMID:22641619 NCBI chr 1:12,762,421...12,946,090
Ensembl chr 1:12,762,501...12,931,416 		JBrowse link
G Sult1c2 sulfotransferase family, cytosolic, 1C, member 2 decreases expression EXP lead acetate results in decreased expression of SULT1C2 mRNA CTD PMID:22609695 NCBI chr17:54,136,665...54,152,986
Ensembl chr17:54,136,665...54,153,367 		JBrowse link
G Sult1e1 sulfotransferase family 1E, member 1 decreases expression ISO lead acetate results in decreased expression of SULT1E1 mRNA CTD PMID:38568856 NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453 		JBrowse link
G Sumo2 small ubiquitin-like modifier 2 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of SUMO2 protein CTD PMID:38072110 NCBI chr11:115,413,935...115,427,056
Ensembl chr11:115,413,928...115,427,102 		JBrowse link
G Sumo3 small ubiquitin-like modifier 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of SUMO3 protein CTD PMID:38072110 NCBI chr10:77,441,931...77,454,165
Ensembl chr10:77,441,931...77,454,165 		JBrowse link
G Sun2 Sad1 and UNC84 domain containing 2 increases expression ISO lead acetate results in increased expression of SUN2 mRNA CTD PMID:38568856 NCBI chr15:79,608,269...79,626,757
Ensembl chr15:79,608,271...79,626,737 		JBrowse link
G Sun5 Sad1 and UNC84 domain containing 5 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of SUN5 promoter CTD PMID:33445541 NCBI chr 2:153,698,108...153,713,281
Ensembl chr 2:153,698,108...153,713,004 		JBrowse link
G Susd2 sushi domain containing 2 decreases expression ISO lead acetate results in decreased expression of SUSD2 mRNA CTD PMID:38568856 NCBI chr10:75,472,453...75,479,842
Ensembl chr10:75,472,540...75,479,842 		JBrowse link
G Suv39h1 suppressor of variegation 3-9 1 increases methylation ISO lead acetate results in increased methylation of SUV39H1 gene CTD PMID:29571894 NCBI chr  X:7,927,401...7,940,994
Ensembl chr  X:7,927,410...7,940,999 		JBrowse link
G Sv2c synaptic vesicle glycoprotein 2c decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of SV2C mRNA; lead acetate results in decreased expression of SV2C protein
REST protein promotes the reaction [lead acetate results in decreased expression of SV2C mRNA]; REST protein promotes the reaction [lead acetate results in decreased expression of SV2C protein] 		CTD PMID:29505838 NCBI chr13:96,091,102...96,270,837
Ensembl chr13:96,091,102...96,269,085 		JBrowse link
G Sval2 seminal vesicle antigen-like 2 decreases expression EXP lead acetate results in decreased expression of SVAL2 mRNA CTD PMID:22609695 NCBI chr 6:41,837,241...41,841,347
Ensembl chr 6:41,829,923...41,841,347 		JBrowse link
G Sycn syncollin increases expression
decreases expression 		EXP lead acetate results in increased expression of SYCN mRNA
lead acetate results in decreased expression of SYCN mRNA 		CTD PMID:20542052 PMID:22609695 NCBI chr 7:28,240,310...28,241,635
Ensembl chr 7:28,240,310...28,241,634 		JBrowse link
G Syn1 synapsin I decreases phosphorylation
multiple interactions
decreases expression
increases expression 		ISO
EXP 		lead acetate results in decreased phosphorylation of SYN1 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of SYN1 protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SYN1 protein]; Hemin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of SYN1 protein]
lead acetate results in decreased expression of SYN1 protein
lead acetate results in increased expression of SYN1 mRNA 		CTD PMID:17047031 PMID:24260418 PMID:30121340 PMID:36096218 NCBI chr  X:20,726,750...20,787,157
Ensembl chr  X:20,726,750...20,787,243 		JBrowse link
G Syn3 synapsin III increases expression EXP lead acetate results in increased expression of SYN3 mRNA CTD PMID:22609695 NCBI chr10:85,884,610...86,336,730
Ensembl chr10:85,890,989...86,334,760 		JBrowse link
G Syngap1 synaptic Ras GTPase activating protein 1 homolog (rat) multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of SYNGAP1 protein CTD PMID:39947421 NCBI chr17:27,160,186...27,191,408
Ensembl chr17:27,160,227...27,191,408 		JBrowse link
G Syp synaptophysin multiple interactions
decreases expression
increases expression 		ISO
EXP 		BDNF protein inhibits the reaction [lead acetate results in decreased expression of SYP protein]
[lead acetate results in increased abundance of Lead] which results in decreased expression of SYP mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SYP protein
[[lead acetate results in increased abundance of Lead] which co-treated with APP protein modified form] results in decreased expression of SYP protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] which results in decreased expression of SYP protein
lead acetate results in increased expression of SYP protein 		CTD PMID:17047031 PMID:20375082 PMID:26660114 PMID:27771255 PMID:27984133 More... NCBI chr  X:7,504,819...7,519,495
Ensembl chr  X:7,504,710...7,519,495 		JBrowse link
G Syt1 synaptotagmin I decreases expression ISO lead acetate results in decreased expression of SYT1 protein CTD PMID:27984133 NCBI chr10:108,333,511...108,846,852
Ensembl chr10:108,333,511...108,846,843 		JBrowse link
G Syt2 synaptotagmin II increases methylation ISO lead acetate results in increased methylation of SYT2 gene CTD PMID:29571894 NCBI chr 1:134,574,319...134,680,887
Ensembl chr 1:134,574,415...134,690,331 		JBrowse link
G Syt8 synaptotagmin VIII decreases expression ISO lead acetate results in decreased expression of SYT8 mRNA CTD PMID:38568856 NCBI chr 7:141,988,195...141,994,136
Ensembl chr 7:141,988,587...141,994,133 		JBrowse link
G Sytl1 synaptotagmin-like 1 decreases expression ISO lead acetate results in decreased expression of SYTL1 mRNA CTD PMID:38568856 NCBI chr 4:132,980,401...132,990,398
Ensembl chr 4:132,980,401...132,990,424 		JBrowse link
G Sytl3 synaptotagmin-like 3 decreases expression
increases expression 		EXP lead acetate results in decreased expression of SYTL3 mRNA
lead acetate results in increased expression of SYTL3 mRNA 		CTD PMID:21829687 PMID:22609695 NCBI chr17:6,925,633...7,005,449
Ensembl chr17:6,926,492...7,005,443 		JBrowse link
G T brachyury, T-box transcription factor T increases expression EXP lead acetate results in increased expression of T mRNA CTD PMID:22609695 NCBI chr17:8,653,255...8,661,328
Ensembl chr17:8,653,255...8,661,328 		JBrowse link
G Tacc2 transforming, acidic coiled-coil containing protein 2 decreases expression ISO lead acetate results in decreased expression of TACC2 mRNA CTD PMID:38568856 NCBI chr 7:130,154,735...130,369,435
Ensembl chr 7:130,179,168...130,366,515 		JBrowse link
G Tacr3 tachykinin receptor 3 decreases expression ISO lead acetate results in decreased expression of TACR3 mRNA CTD PMID:22641619 NCBI chr 3:134,534,768...134,640,342
Ensembl chr 3:134,534,768...134,640,340 		JBrowse link
G Tagln transgelin increases expression ISO lead acetate results in increased expression of TAGLN mRNA CTD PMID:22641619 PMID:38568856 NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356 		JBrowse link
G Tal2 T cell acute lymphocytic leukemia 2 increases expression EXP lead acetate results in increased expression of TAL2 mRNA CTD PMID:22609695 NCBI chr 4:53,779,701...53,788,712
Ensembl chr 4:53,779,705...53,788,712 		JBrowse link
G Taldo1 transaldolase 1 increases expression ISO lead acetate results in increased expression of TALDO1 mRNA CTD PMID:38568856 NCBI chr 7:140,972,073...140,982,889
Ensembl chr 7:140,972,112...140,982,881 		JBrowse link
G Tars1 threonyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of TARS1 mRNA CTD PMID:11578147 NCBI chr15:11,383,749...11,399,744
Ensembl chr15:11,382,387...11,399,751 		JBrowse link
G Tas2r119 taste receptor, type 2, member 119 increases expression EXP lead acetate results in increased expression of TAS2R119 mRNA CTD PMID:22609695 NCBI chr15:32,177,435...32,178,440
Ensembl chr15:32,177,435...32,178,440 		JBrowse link
G Tat tyrosine aminotransferase decreases expression ISO
EXP 		lead acetate results in decreased expression of TAT mRNA CTD PMID:11578147 PMID:22609695 PMID:25270620 NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435 		JBrowse link
G Tbc1d14 TBC1 domain family, member 14 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of TBC1D14 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of TBC1D14 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of TBC1D14 promoter CTD PMID:33445541 NCBI chr 5:36,647,948...36,743,611
Ensembl chr 5:36,647,948...36,750,620 		JBrowse link
G Tbc1d16 TBC1 domain family, member 16 affects expression EXP lead acetate affects the expression of TBC1D16 mRNA CTD PMID:21829687 NCBI chr11:119,033,869...119,119,354
Ensembl chr11:119,033,871...119,119,325 		JBrowse link
G Tbcb tubulin folding cofactor B decreases expression ISO lead acetate results in decreased expression of TBCB mRNA CTD PMID:22641619 NCBI chr 7:29,923,554...29,931,622
Ensembl chr 7:29,923,556...29,931,697 		JBrowse link
G Tbcd tubulin-specific chaperone d decreases expression EXP lead acetate results in decreased expression of TBCD mRNA CTD PMID:21829687 NCBI chr11:121,342,817...121,507,996
Ensembl chr11:121,342,775...121,507,990 		JBrowse link
G Tbl1xr1 transducin (beta)-like 1X-linked receptor 1 decreases expression EXP lead acetate results in decreased expression of TBL1XR1 mRNA CTD PMID:25270620 NCBI chr 3:22,130,756...22,270,758
Ensembl chr 3:22,130,816...22,270,758 		JBrowse link
G Tbrg1 transforming growth factor beta regulated gene 1 increases expression EXP lead acetate results in increased expression of TBRG1 mRNA CTD PMID:20542052 NCBI chr 9:37,560,478...37,568,608
Ensembl chr 9:37,560,059...37,568,608 		JBrowse link
G Tbx18 T-box18 increases expression ISO lead acetate results in increased expression of TBX18 mRNA CTD PMID:22641619 NCBI chr 9:87,584,853...87,613,313
Ensembl chr 9:87,584,853...87,613,313 		JBrowse link
G Tbx3os2 T-box 3, opposite strand 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of TBX3OS2 intron CTD PMID:33445541 NCBI chr 5:119,823,153...119,829,283
Ensembl chr 5:119,822,760...119,848,430 		JBrowse link
G Tc2n tandem C2 domains, nuclear decreases expression ISO lead acetate results in decreased expression of TC2N mRNA CTD PMID:22641619 NCBI chr12:101,611,705...101,685,178
Ensembl chr12:101,611,702...101,684,782 		JBrowse link
G Tceal7 transcription elongation factor A (SII)-like 7 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in increased expression of TCEAL7 protein CTD PMID:38072110 NCBI chr  X:135,124,790...135,126,849
Ensembl chr  X:135,115,528...135,126,849 		JBrowse link
G Tceanc transcription elongation factor A (SII) N-terminal and central domain containing increases methylation ISO lead acetate results in increased methylation of TCEANC gene CTD PMID:29571894 NCBI chr  X:165,282,806...165,301,594
Ensembl chr  X:165,282,808...165,301,563 		JBrowse link
G Tcf7 transcription factor 7, T cell specific increases expression ISO lead acetate results in increased expression of TCF7 mRNA CTD PMID:37939567 NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158 		JBrowse link
G Tcf7l1 transcription factor 7 like 1 (T cell specific, HMG box) increases expression EXP lead acetate results in increased expression of TCF7L1 mRNA CTD PMID:22609695 NCBI chr 6:72,603,354...72,766,028
Ensembl chr 6:72,603,361...72,766,237 		JBrowse link
G Tcf7l2 transcription factor 7 like 2, T cell specific, HMG box increases expression EXP lead acetate results in increased expression of TCF7L2 mRNA CTD PMID:36183778 NCBI chr19:55,730,227...55,922,091
Ensembl chr19:55,730,252...55,922,086 		JBrowse link
G Tcstv6a Tcstv family member 6A increases expression EXP lead acetate results in increased expression of TCSTV6A mRNA CTD PMID:22609695 NCBI chr13:120,306,880...120,308,226
Ensembl chr13:120,297,542...120,308,106 		JBrowse link
G Tctn2 tectonic family member 2 affects methylation ISO lead acetate affects the methylation of TCTN2 gene CTD PMID:29571894 NCBI chr 5:124,736,812...124,765,803
Ensembl chr 5:124,736,812...124,765,803 		JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase increases expression ISO lead acetate results in increased expression of TDO2 mRNA CTD PMID:22839698 NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509 		JBrowse link
G Tdp2 tyrosyl-DNA phosphodiesterase 2 increases expression ISO lead acetate results in increased expression of TDP2 mRNA CTD PMID:38568856 NCBI chr13:25,015,642...25,026,136
Ensembl chr13:25,015,662...25,026,136 		JBrowse link
G Tec tec protein tyrosine kinase decreases expression ISO lead acetate results in decreased expression of TEC mRNA CTD PMID:22641619 NCBI chr 5:72,913,061...73,025,997
Ensembl chr 5:72,913,059...73,025,826 		JBrowse link
G Tef thyrotroph embryonic factor increases methylation ISO lead acetate results in increased methylation of TEF gene CTD PMID:29571894 NCBI chr15:81,686,874...81,711,064
Ensembl chr15:81,686,622...81,711,064 		JBrowse link
G Telo2 telomere maintenance 2 increases expression EXP
ISO 		lead acetate results in increased expression of TELO2 mRNA CTD PMID:22609695 PMID:38568856 NCBI chr17:25,318,543...25,334,951
Ensembl chr17:25,318,544...25,334,941 		JBrowse link
G Tenm3 teneurin transmembrane protein 3 decreases expression EXP lead acetate results in decreased expression of TENM3 mRNA CTD PMID:25270620 NCBI chr 8:48,678,700...51,370,255
Ensembl chr 8:48,680,717...49,296,986 		JBrowse link
G Tespa1 thymocyte expressed, positive selection associated 1 increases expression EXP lead acetate results in increased expression of TESPA1 mRNA CTD PMID:21829687 NCBI chr10:130,158,696...130,199,338
Ensembl chr10:130,158,739...130,199,980 		JBrowse link
G Tet1 tet methylcytosine dioxygenase 1 increases methylation ISO lead acetate results in increased methylation of TET1 gene CTD PMID:29571894 NCBI chr10:62,640,349...62,723,242
Ensembl chr10:62,640,349...62,744,775 		JBrowse link
G Tex101 testis expressed gene 101 decreases expression EXP lead acetate results in decreased expression of TEX101 mRNA CTD PMID:21829687 NCBI chr 7:24,367,437...24,371,475
Ensembl chr 7:24,367,432...24,376,100 		JBrowse link
G Tex15 testis expressed gene 15 meiosis and synapsis associated increases expression ISO lead acetate results in increased expression of TEX15 mRNA CTD PMID:22641619 NCBI chr 8:34,006,712...34,082,531
Ensembl chr 8:34,006,766...34,075,610 		JBrowse link
G Tfap2d transcription factor AP-2, delta increases methylation ISO lead acetate results in increased methylation of TFAP2D gene CTD PMID:29571894 NCBI chr 1:19,173,246...19,244,172
Ensembl chr 1:19,173,246...19,236,570 		JBrowse link
G Tfcp2l1 transcription factor CP2-like 1 increases expression
decreases expression 		ISO lead acetate results in increased expression of TFCP2L1 mRNA
lead acetate results in decreased expression of TFCP2L1 mRNA 		CTD PMID:22641619 PMID:38568856 NCBI chr 1:118,555,646...118,612,898
Ensembl chr 1:118,555,675...118,612,898 		JBrowse link
G Tff2 trefoil factor 2 (spasmolytic protein 1) increases expression EXP lead acetate results in increased expression of TFF2 mRNA CTD PMID:20542052 NCBI chr17:31,360,036...31,363,256
Ensembl chr17:31,360,023...31,363,256 		JBrowse link
G Tfpi2 tissue factor pathway inhibitor 2 increases expression ISO lead acetate results in increased expression of TFPI2 mRNA CTD PMID:38568856 NCBI chr 6:3,962,589...3,988,977
Ensembl chr 6:3,962,595...3,988,919 		JBrowse link
G Tfrc transferrin receptor multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of TFRC mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of TFRC protein; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TFRC mRNA]; Deferoxamine inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TFRC protein]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TFRC mRNA]; ferrostatin-1 inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TFRC protein] CTD PMID:36642386 PMID:39276841 NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression
multiple interactions
affects expression 		EXP
ISO 		lead acetate results in increased expression of TGFB1 mRNA
naringenin inhibits the reaction [lead acetate results in increased expression of TGFB1 protein]
[[lead acetate results in increased abundance of Lead] co-treated with [IL4 protein co-treated with IL13 protein]] results in increased expression of TGFB1 protein
lead acetate affects the expression of TGFB1 protein 		CTD PMID:21322097 PMID:34352350 PMID:36807407 PMID:38568856 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502 		JBrowse link
G Tgfb2 transforming growth factor, beta 2 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TGFB2 mRNA CTD PMID:12634122 NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186 		JBrowse link
G Tgfbi transforming growth factor, beta induced increases expression ISO lead acetate results in increased expression of TGFBI mRNA CTD PMID:38568856 NCBI chr13:56,757,399...56,787,172
Ensembl chr13:56,757,336...56,787,375 		JBrowse link
G Tgfbr3 transforming growth factor, beta receptor III increases expression ISO lead acetate results in increased expression of TGFBR3 mRNA CTD PMID:22641619 NCBI chr 5:107,254,433...107,437,495
Ensembl chr 5:107,254,436...107,437,495 		JBrowse link
G Tgm1 transglutaminase 1, K polypeptide decreases expression ISO lead acetate results in decreased expression of TGM1 mRNA CTD PMID:38568856 NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383 		JBrowse link
G Tgoln1 trans-golgi network protein decreases expression
increases expression 		EXP lead acetate results in decreased expression of TGOLN1 mRNA
lead acetate results in increased expression of TGOLN1 mRNA 		CTD PMID:21829687 PMID:25270620 NCBI chr 6:72,585,403...72,593,983
Ensembl chr 6:72,585,415...72,593,983 		JBrowse link
G Thap6 THAP domain containing 6 decreases expression EXP lead acetate results in decreased expression of THAP6 mRNA CTD PMID:21829687 NCBI chr 5:92,110,741...92,119,996
Ensembl chr 5:92,110,248...92,170,798
Ensembl chr 5:92,110,248...92,170,798 		JBrowse link
G Thbd thrombomodulin increases expression EXP
ISO 		lead acetate results in increased expression of THBD mRNA CTD PMID:21829687 PMID:38568856 NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108 		JBrowse link
G Thbs1 thrombospondin 1 increases expression EXP
ISO 		lead acetate results in increased expression of THBS1 mRNA CTD PMID:22609695 PMID:37939567 NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614 		JBrowse link
G Thbs2 thrombospondin 2 decreases expression ISO lead acetate results in decreased expression of THBS2 mRNA CTD PMID:11578147 NCBI chr17:14,885,762...14,914,524
Ensembl chr17:14,885,762...14,914,497 		JBrowse link
G Thoc5 THO complex 5 decreases expression EXP lead acetate results in decreased expression of THOC5 mRNA CTD PMID:20542052 NCBI chr11:4,845,339...4,878,867
Ensembl chr11:4,845,320...4,878,867 		JBrowse link
G Thsd1 thrombospondin, type I, domain 1 decreases expression EXP lead acetate results in decreased expression of THSD1 mRNA CTD PMID:22609695 NCBI chr 8:22,711,623...22,752,973
Ensembl chr 8:22,717,329...22,751,350 		JBrowse link
G Thumpd3 THUMP domain containing 3 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of THUMPD3 protein CTD PMID:38072110 NCBI chr 6:113,023,292...113,045,239
Ensembl chr 6:113,023,186...113,045,234 		JBrowse link
G Tigd5 tigger transposable element derived 5 increases expression ISO lead acetate results in increased expression of TIGD5 mRNA CTD PMID:38568856 NCBI chr15:75,781,584...75,786,384
Ensembl chr15:75,781,584...75,786,384 		JBrowse link
G Timd2 T cell immunoglobulin and mucin domain containing 2 increases expression EXP lead acetate results in increased expression of TIMD2 mRNA CTD PMID:22609695 NCBI chr11:46,559,787...46,597,934
Ensembl chr11:46,559,787...46,597,888 		JBrowse link
G Timp1 tissue inhibitor of metalloproteinase 1 increases expression ISO lead acetate results in increased expression of TIMP1 mRNA CTD PMID:38568856 NCBI chr  X:20,736,524...20,740,972
Ensembl chr  X:20,736,405...20,740,974 		JBrowse link
G Tinagl1 tubulointerstitial nephritis antigen-like 1 increases expression EXP lead acetate results in increased expression of TINAGL1 mRNA CTD PMID:22613225 NCBI chr 4:130,059,393...130,068,915
Ensembl chr 4:130,058,247...130,068,915 		JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase increases expression ISO lead acetate results in increased expression of TIPARP mRNA CTD PMID:38568856 NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions
decreases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of TJP1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of TJP1 protein]
[lead acetate results in increased abundance of Lead] which results in decreased expression of TJP1 protein 		CTD PMID:24200059 PMID:31730887 NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529 		JBrowse link
G Tjp3 tight junction protein 3 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of TJP3 mRNA
lead acetate results in decreased expression of TJP3 mRNA 		CTD PMID:20542052 PMID:38568856 NCBI chr10:81,109,022...81,127,415
Ensembl chr10:81,109,041...81,127,415 		JBrowse link
G Tk1 thymidine kinase 1 increases expression EXP lead acetate results in increased expression of TK1 mRNA CTD PMID:22609695 NCBI chr11:117,706,345...117,716,913
Ensembl chr11:117,706,352...117,716,918 		JBrowse link
G Tktl1 transketolase-like 1 increases expression
decreases methylation 		ISO lead acetate results in increased expression of TKTL1 mRNA
lead acetate results in decreased methylation of TKTL1 gene 		CTD PMID:22641619 PMID:29571894 NCBI chr  X:73,220,865...73,252,104
Ensembl chr  X:73,220,865...73,252,106 		JBrowse link
G Tln2 talin 2 decreases expression EXP lead acetate results in decreased expression of TLN2 mRNA CTD PMID:21829687 NCBI chr 9:67,124,371...67,541,357
Ensembl chr 9:67,124,369...67,466,985 		JBrowse link
G Tlnrd1 talin rod domain containing 1 increases expression ISO lead acetate results in increased expression of TLNRD1 mRNA CTD PMID:38568856 NCBI chr 7:83,529,703...83,533,549
Ensembl chr 7:83,529,081...83,533,513 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions
increases expression 		EXP 3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of TLR4 protein] CTD PMID:37385299 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521 		JBrowse link
G Tlr5 toll-like receptor 5 decreases expression EXP lead acetate results in decreased expression of TLR5 mRNA CTD PMID:22609695 NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010 		JBrowse link
G Tlr6 toll-like receptor 6 decreases expression ISO lead acetate results in decreased expression of TLR6 mRNA CTD PMID:22641619 NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440 		JBrowse link
G Tlr8 toll-like receptor 8 increases expression EXP lead acetate results in increased expression of TLR8 mRNA CTD PMID:20542052 NCBI chr  X:166,024,119...166,047,325
Ensembl chr  X:166,025,692...166,047,325 		JBrowse link
G Tlr9 toll-like receptor 9 increases expression EXP lead acetate results in increased expression of TLR9 mRNA CTD PMID:20542052 NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082 		JBrowse link
G Tlx1 T cell leukemia, homeobox 1 increases expression EXP lead acetate results in increased expression of TLX1 mRNA CTD PMID:20542052 NCBI chr19:45,138,531...45,145,382
Ensembl chr19:45,139,119...45,145,382 		JBrowse link
G Tm4sf1 transmembrane 4 superfamily member 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TM4SF1 mRNA CTD PMID:12634122 NCBI chr 3:57,193,038...57,295,150
Ensembl chr 3:57,193,032...57,209,409
Ensembl chr 3:57,193,032...57,209,409 		JBrowse link
G Tm4sf19 transmembrane 4 L six family member 19 decreases expression ISO lead acetate results in decreased expression of TM4SF19 mRNA CTD PMID:22641619 NCBI chr16:32,218,823...32,227,397
Ensembl chr16:32,219,324...32,227,045 		JBrowse link
G Tm4sf20 transmembrane 4 L six family member 20 decreases expression EXP lead acetate results in decreased expression of TM4SF20 mRNA CTD PMID:22609695 NCBI chr 1:82,734,368...82,746,182
Ensembl chr 1:82,734,370...82,746,182 		JBrowse link
G Tm4sf5 transmembrane 4 superfamily member 5 decreases expression EXP lead acetate results in decreased expression of TM4SF5 mRNA CTD PMID:22609695 NCBI chr11:70,396,100...70,402,009
Ensembl chr11:70,396,070...70,402,004 		JBrowse link
G Tmbim6 transmembrane BAX inhibitor motif containing 6 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of TMBIM6 protein CTD PMID:38072110 NCBI chr15:99,290,828...99,307,930
Ensembl chr15:99,290,763...99,307,930 		JBrowse link
G Tmed4 transmembrane p24 trafficking protein 4 increases expression EXP lead acetate results in increased expression of TMED4 mRNA CTD PMID:21829687 NCBI chr11:6,220,714...6,224,837
Ensembl chr11:6,220,369...6,224,870 		JBrowse link
G Tmed9 transmembrane p24 trafficking protein 9 increases expression ISO lead acetate results in increased expression of TMED9 mRNA CTD PMID:38568856 NCBI chr13:55,740,948...55,745,510
Ensembl chr13:55,721,545...55,745,510 		JBrowse link
G Tmem144 transmembrane protein 144 increases expression ISO lead acetate results in increased expression of TMEM144 mRNA CTD PMID:22641619 NCBI chr 3:79,719,871...79,760,093
Ensembl chr 3:79,719,871...79,760,080 		JBrowse link
G Tmem158 transmembrane protein 158 increases expression ISO lead acetate results in increased expression of TMEM158 mRNA CTD PMID:22839698 NCBI chr 9:123,088,122...123,089,854
Ensembl chr 9:123,088,118...123,089,829 		JBrowse link
G Tmem176a transmembrane protein 176A increases expression EXP lead acetate results in increased expression of TMEM176A mRNA CTD PMID:21829687 NCBI chr 6:48,818,417...48,822,298
Ensembl chr 6:48,817,853...48,824,005 		JBrowse link
G Tmem204 transmembrane protein 204 increases expression EXP lead acetate results in increased expression of TMEM204 mRNA CTD PMID:20542052 NCBI chr17:25,276,676...25,300,088
Ensembl chr17:25,276,676...25,302,565 		JBrowse link
G Tmem219 transmembrane protein 219 decreases expression EXP lead acetate results in decreased expression of TMEM219 mRNA CTD PMID:21829687 NCBI chr 7:126,485,391...126,527,993
Ensembl chr 7:126,485,343...126,522,089 		JBrowse link
G Tmem254 transmembrane protein 254 decreases expression EXP lead acetate results in decreased expression of TMEM254 mRNA CTD PMID:25270620 NCBI chr14:25,923,722...25,928,096
Ensembl chr14:25,923,724...25,928,096 		JBrowse link
G Tmem255a transmembrane protein 255A increases expression ISO lead acetate results in increased expression of TMEM255A mRNA CTD PMID:22839698 NCBI chr  X:37,285,450...37,341,373
Ensembl chr  X:37,285,450...37,341,316 		JBrowse link
G Tmem40 transmembrane protein 40 decreases expression EXP lead acetate results in decreased expression of TMEM40 mRNA CTD PMID:25270620 NCBI chr 6:115,706,092...115,739,427
Ensembl chr 6:115,706,092...115,739,371 		JBrowse link
G Tmem54 transmembrane protein 54 increases expression ISO lead acetate results in increased expression of TMEM54 mRNA CTD PMID:38568856 NCBI chr 4:128,999,321...129,005,419
Ensembl chr 4:128,999,341...129,005,419 		JBrowse link
G Tmem63a transmembrane protein 63a increases expression ISO lead acetate results in increased expression of TMEM63A mRNA CTD PMID:22641619 NCBI chr 1:180,769,899...180,802,671
Ensembl chr 1:180,769,909...180,802,677 		JBrowse link
G Tmprss4 transmembrane protease, serine 4 increases expression EXP lead acetate results in increased expression of TMPRSS4 mRNA CTD PMID:22609695 NCBI chr 9:45,084,024...45,115,417
Ensembl chr 9:45,084,024...45,115,390 		JBrowse link
G Tmsb10 thymosin beta 10 increases expression EXP lead acetate results in increased expression of TMSB10 mRNA CTD PMID:21829687 NCBI chr 6:72,934,330...72,935,731
Ensembl chr 6:72,934,330...72,935,731 		JBrowse link
G Tmt1a thiol methyltransferase 1A1 decreases expression ISO lead acetate results in decreased expression of METTL7A mRNA CTD PMID:38568856 NCBI chr15:100,201,969...100,227,882
Ensembl chr15:100,202,021...100,226,543 		JBrowse link
G Tmtc4 transmembrane and tetratricopeptide repeat containing 4 increases expression EXP lead acetate results in increased expression of TMTC4 mRNA CTD PMID:21829687 NCBI chr14:123,156,383...123,220,697
Ensembl chr14:123,156,383...123,221,447 		JBrowse link
G Tnc tenascin C decreases expression
affects expression 		ISO
EXP 		lead acetate results in decreased expression of TNC mRNA
lead acetate affects the expression of TNC protein 		CTD PMID:11578147 PMID:22613225 PMID:36539177 NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
increases secretion
decreases expression 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased expression of TNF mRNA]; [lead acetate results in increased abundance of Lead] which results in increased expression of TNF mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of TNF protein; lead acetate promotes the reaction [Hemagglutinins results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF mRNA]]; NFE2L2 protein affects the reaction [Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF protein]]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF mRNA]; Rutin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of TNF protein]
lead acetate results in increased expression of TNF mRNA; lead acetate results in increased expression of TNF protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead acetate results in increased expression of TNF protein]; 3-methyladenine inhibits the reaction [lead acetate results in increased expression of TNF protein]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of TNF mRNA]; 5,7,3',4'-tetramethylluteolin inhibits the reaction [lead acetate results in increased expression of TNF protein]; Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of TNF protein]; Cholecalciferol inhibits the reaction [lead acetate results in increased expression of TNF protein]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of TNF mRNA]; coenzyme Q10 inhibits the reaction [lead acetate results in increased expression of TNF protein]; lead acetate promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; lead acetate promotes the reaction [Zinc Oxide results in increased expression of TNF protein]; lead acetate results in increased expression of and results in increased secretion of TNF protein; Minocycline inhibits the reaction [lead acetate results in increased secretion of TNF protein]; naringenin inhibits the reaction [lead acetate results in increased expression of TNF protein]; Plant Oils inhibits the reaction [lead acetate results in increased expression of TNF protein]; Proanthocyanidins inhibits the reaction [lead acetate results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [lead acetate results in increased expression of TNF protein]; Quercetin inhibits the reaction [lead acetate results in increased expression of TNF protein]; SB 203580 inhibits the reaction [lead acetate results in increased expression of TNF protein]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of TNF mRNA]; sinapinic acid inhibits the reaction [lead acetate results in increased expression of TNF protein]; sodium bisulfide inhibits the reaction [lead acetate results in increased expression of TNF protein]; sodium boranocarbonate inhibits the reaction [lead acetate results in increased expression of TNF protein]; Zinc Oxide promotes the reaction [lead acetate results in increased expression of TNF protein]
1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in increased secretion of TNF protein]; 3,4-di-O-caffeoylquinic acid inhibits the reaction [lead acetate results in increased expression of TNF protein]; [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with U 0126] inhibits the reaction [lead acetate results in increased secretion of TNF protein]; [[Microplastics results in increased abundance of [Polyvinyl Chloride co-treated with Polyethylene]] co-treated with [lead acetate results in increased abundance of Lead]] results in increased expression of TNF protein; [lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein; [lead acetate results in increased abundance of Lead] which results in increased expression of TNF mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of TNF protein; [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of TNF protein; Celecoxib inhibits the reaction [lead acetate results in increased secretion of TNF protein]; chelerythrine inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; chelerythrine inhibits the reaction [lead acetate results in increased expression of TNF protein]; gadolinium chloride inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Minocycline inhibits the reaction [lead acetate results in increased secretion of TNF protein]; MitoTEMPO inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]; NLRP3 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of and results in increased secretion of TNF protein]; Pentoxifylline inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; U 0126 inhibits the reaction [lead acetate promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]; U 0126 inhibits the reaction [lead acetate results in increased secretion of TNF protein]
lead acetate results in decreased expression of TNF protein 		CTD PMID:10936489 PMID:15302094 PMID:15843504 PMID:16581537 PMID:17047031 More... NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983 		JBrowse link
G Tnfrsf11a tumor necrosis factor receptor superfamily, member 11a, NFKB activator increases expression ISO lead acetate results in increased expression of TNFRSF11A mRNA CTD PMID:22641619 NCBI chr 1:105,708,443...105,777,172
Ensembl chr 1:105,708,443...105,775,709 		JBrowse link
G Tnfrsf11b tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) decreases expression
multiple interactions 		ISO
EXP 		lead acetate results in decreased expression of TNFRSF11B mRNA; lead acetate results in decreased expression of TNFRSF11B protein
Ethanol promotes the reaction [lead acetate results in decreased expression of TNFRSF11B protein] 		CTD PMID:22641619 PMID:23376407 PMID:30312686 NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880 		JBrowse link
G Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a increases expression ISO lead acetate results in increased expression of TNFRSF12A mRNA CTD PMID:38568856 NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442 		JBrowse link
G Tnfrsf19 tumor necrosis factor receptor superfamily, member 19 increases expression ISO lead acetate results in increased expression of TNFRSF19 mRNA CTD PMID:37939567 NCBI chr14:61,201,283...61,284,304
Ensembl chr14:61,201,324...61,283,939 		JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFRSF1B mRNA
lead acetate results in increased expression of TNFRSF1B mRNA 		CTD PMID:12634122 PMID:21829687 NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440 		JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 multiple interactions
increases expression 		ISO
EXP 		[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFSF10 mRNA
lead acetate results in increased expression of TNFSF10 mRNA 		CTD PMID:12634122 PMID:20542052 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576 		JBrowse link
G Tnfsf11 tumor necrosis factor (ligand) superfamily, member 11 increases expression
multiple interactions 		ISO lead acetate results in increased expression of TNFSF11 protein
Ethanol promotes the reaction [lead acetate results in increased expression of TNFSF11 protein] 		CTD PMID:23376407 NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483 		JBrowse link
G Tnfsf13b tumor necrosis factor (ligand) superfamily, member 13b increases expression EXP lead acetate results in increased expression of TNFSF13B mRNA CTD PMID:20542052 NCBI chr 8:10,056,637...10,086,000
Ensembl chr 8:10,056,467...10,089,072 		JBrowse link
G Tnfsf14 tumor necrosis factor (ligand) superfamily, member 14 decreases expression ISO lead acetate results in decreased expression of TNFSF14 mRNA CTD PMID:38568856 NCBI chr17:57,496,437...57,501,182
Ensembl chr17:57,496,492...57,501,177 		JBrowse link
G Tnfsf9 tumor necrosis factor (ligand) superfamily, member 9 increases expression ISO lead acetate results in increased expression of TNFSF9 mRNA CTD PMID:38568856 NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757 		JBrowse link
G Tnik TRAF2 and NCK interacting kinase decreases expression ISO lead acetate results in decreased expression of TNIK mRNA CTD PMID:22641619 NCBI chr 3:28,317,362...28,724,734
Ensembl chr 3:28,317,363...28,730,007 		JBrowse link
G Tnk1 tyrosine kinase, non-receptor, 1 increases expression EXP lead acetate results in increased expression of TNK1 mRNA CTD PMID:22609695 NCBI chr11:69,741,389...69,749,556
Ensembl chr11:69,741,831...69,749,556 		JBrowse link
G Tnni2 troponin I, skeletal, fast 2 decreases expression ISO lead acetate results in decreased expression of TNNI2 mRNA CTD PMID:38568856 NCBI chr 7:141,995,553...141,998,147
Ensembl chr 7:141,995,545...141,998,147 		JBrowse link
G Tnnt1 troponin T1, skeletal, slow decreases expression ISO lead acetate results in decreased expression of TNNT1 mRNA CTD PMID:22641619 NCBI chr 7:4,507,568...4,518,974
Ensembl chr 7:4,507,569...4,519,381 		JBrowse link
G Tnp2 transition protein 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased expression of TNP2 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of TNP2 protein CTD PMID:32142724 NCBI chr16:10,605,799...10,606,519
Ensembl chr16:10,605,800...10,606,524 		JBrowse link
G Tnrc6a trinucleotide repeat containing 6a multiple interactions ISO
EXP 		[lead acetate co-treated with zinc protoporphyrin] results in increased expression of TNRC6A mRNA
[lead acetate results in increased abundance of Lead] which results in increased methylation of TNRC6A exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of TNRC6A intron 		CTD PMID:22839698 PMID:33445541 NCBI chr 7:122,630,324...122,794,519
Ensembl chr 7:122,723,108...122,794,519 		JBrowse link
G Tns1 tensin 1 decreases expression EXP lead acetate results in decreased expression of TNS1 mRNA CTD PMID:25270620 NCBI chr 1:73,949,391...74,163,707
Ensembl chr 1:73,949,390...74,163,608 		JBrowse link
G Tns2 tensin 2 decreases expression ISO lead acetate results in decreased expression of TNS2 mRNA CTD PMID:38568856 NCBI chr15:102,006,910...102,024,836
Ensembl chr15:102,008,848...102,024,836 		JBrowse link
G Top2a topoisomerase (DNA) II alpha decreases expression EXP lead acetate results in decreased expression of TOP2A mRNA CTD PMID:22613225 NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015 		JBrowse link
G Tor4a torsin family 4, member A increases expression ISO lead acetate results in increased expression of TOR4A mRNA CTD PMID:38568856 NCBI chr 2:25,082,732...25,086,825
Ensembl chr 2:25,082,978...25,086,898 		JBrowse link
G Tpcn2 two pore segment channel 2 decreases expression EXP lead acetate results in decreased expression of TPCN2 mRNA CTD PMID:22609695 NCBI chr 7:144,735,370...144,837,743
Ensembl chr 7:144,740,261...144,837,748 		JBrowse link
G Tpsb2 tryptase beta 2 decreases expression EXP lead acetate results in decreased expression of TPSB2 mRNA CTD PMID:22609695 NCBI chr17:25,585,282...25,587,070
Ensembl chr17:25,585,170...25,588,079 		JBrowse link
G Tpst1 protein-tyrosine sulfotransferase 1 increases expression ISO lead acetate results in increased expression of TPST1 mRNA CTD PMID:38568856 NCBI chr 5:130,102,167...130,164,575
Ensembl chr 5:130,102,167...130,164,570 		JBrowse link
G Traf1 TNF receptor-associated factor 1 decreases expression EXP lead acetate results in decreased expression of TRAF1 mRNA CTD PMID:22609695 NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784 		JBrowse link
G Traf2 TNF receptor-associated factor 2 increases expression EXP lead acetate results in increased expression of TRAF2 mRNA CTD PMID:20542052 NCBI chr 2:25,407,994...25,436,952
Ensembl chr 2:25,407,994...25,436,952 		JBrowse link
G Trat1 T cell receptor associated transmembrane adaptor 1 increases expression EXP lead acetate results in increased expression of TRAT1 mRNA CTD PMID:21829687 NCBI chr16:48,551,137...48,630,883
Ensembl chr16:48,551,137...48,592,384
Ensembl chr16:48,551,137...48,592,384 		JBrowse link
G Trbv13-2 T cell receptor beta, variable 13-2 decreases expression EXP lead acetate results in decreased expression of TRBV13-2 mRNA CTD PMID:21829687 NCBI chr 6:41,098,330...41,098,766
Ensembl chr 6:41,098,330...41,098,766 		JBrowse link
G Treml4 triggering receptor expressed on myeloid cells-like 4 increases expression EXP lead acetate results in increased expression of TREML4 mRNA CTD PMID:21829687 NCBI chr17:48,571,229...48,582,635
Ensembl chr17:48,571,323...48,582,388 		JBrowse link
G Trex2 three prime repair exonuclease 2 increases expression EXP lead acetate results in increased expression of TREX2 mRNA CTD PMID:22609695 NCBI chr  X:72,477,311...72,478,949
Ensembl chr  X:72,477,311...72,478,950 		JBrowse link
G Trf transferrin increases expression ISO lead acetate results in increased expression of TF protein CTD PMID:21549428 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643 		JBrowse link
G Trhde TRH-degrading enzyme increases expression
affects methylation 		ISO lead acetate results in increased expression of TRHDE mRNA
lead acetate affects the methylation of TRHDE gene 		CTD PMID:29571894 NCBI chr10:114,234,725...114,638,207
Ensembl chr10:114,234,726...114,638,212 		JBrowse link
G Trhr thyrotropin releasing hormone receptor decreases expression ISO lead acetate results in decreased expression of TRHR mRNA CTD PMID:22641619 NCBI chr15:44,059,314...44,099,308
Ensembl chr15:44,059,531...44,099,308 		JBrowse link
G Trib1 tribbles pseudokinase 1 increases expression ISO lead acetate results in increased expression of IFIT1 mRNA CTD PMID:22641619 NCBI chr15:59,520,503...59,528,948
Ensembl chr15:59,520,199...59,528,948 		JBrowse link
G Trib2 tribbles pseudokinase 2 increases expression EXP lead acetate results in increased expression of TRIB2 mRNA CTD PMID:21829687 NCBI chr12:15,841,726...15,866,963
Ensembl chr12:15,841,728...15,866,923 		JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression EXP lead acetate results in increased expression of TRIB3 mRNA CTD PMID:25270620 NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952 		JBrowse link
G Trim16 tripartite motif-containing 16 increases expression ISO lead acetate results in increased expression of TRIM16 mRNA CTD PMID:37939567 PMID:38568856 NCBI chr11:62,711,034...62,733,774
Ensembl chr11:62,711,057...62,741,634 		JBrowse link
G Trim25 tripartite motif-containing 25 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of TRIM25 protein CTD PMID:38072110 NCBI chr11:88,890,194...88,911,119
Ensembl chr11:88,890,202...88,911,119 		JBrowse link
G Trim28 tripartite motif-containing 28 increases expression ISO lead acetate results in increased expression of TRIM28 mRNA CTD PMID:38568856 NCBI chr 7:12,758,079...12,764,959
Ensembl chr 7:12,733,041...12,764,962 		JBrowse link
G Trim29 tripartite motif-containing 29 decreases expression ISO lead acetate results in decreased expression of TRIM29 mRNA CTD PMID:38568856 NCBI chr 9:43,222,012...43,247,422
Ensembl chr 9:43,222,145...43,247,412 		JBrowse link
G Trim35 tripartite motif-containing 35 increases expression EXP lead acetate results in increased expression of TRIM35 mRNA CTD PMID:25270620 NCBI chr14:66,534,474...66,548,873
Ensembl chr14:66,534,480...66,548,873 		JBrowse link
G Trim42 tripartite motif-containing 42 increases expression EXP lead acetate results in increased expression of TRIM42 mRNA CTD PMID:20542052 NCBI chr 9:97,231,615...97,252,011
Ensembl chr 9:97,231,615...97,252,011 		JBrowse link
G Trim59 tripartite motif-containing 59 increases expression EXP lead acetate results in increased expression of TRIM59 mRNA CTD PMID:20542052 NCBI chr 3:68,942,625...68,952,075
Ensembl chr 3:68,942,621...68,952,088 		JBrowse link
G Trim65 tripartite motif-containing 65 decreases expression EXP lead acetate results in decreased expression of TRIM65 mRNA CTD PMID:21829687 NCBI chr11:116,008,015...116,022,239
Ensembl chr11:116,012,672...116,021,954 		JBrowse link
G Trim67 tripartite motif-containing 67 decreases expression EXP lead acetate results in decreased expression of TRIM67 mRNA CTD PMID:22613225 NCBI chr 8:125,519,758...125,561,443
Ensembl chr 8:125,519,831...125,561,452 		JBrowse link
G Trnt1 tRNA nucleotidyl transferase, CCA-adding, 1 decreases expression ISO lead acetate results in decreased expression of TRNT1 mRNA CTD PMID:22641619 NCBI chr 6:106,746,099...106,759,435
Ensembl chr 6:106,746,081...106,759,435 		JBrowse link
G Trp53 transformation related protein 53 decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of TP53 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of TP53 mRNA 		CTD PMID:38568856 PMID:39276841 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699 		JBrowse link
G Trp63 transformation related protein 63 increases expression EXP lead acetate results in increased expression of TRP63 mRNA CTD PMID:22609695 NCBI chr16:25,502,513...25,710,842
Ensembl chr16:25,502,513...25,710,852 		JBrowse link
G Trpc1 transient receptor potential cation channel, subfamily C, member 1 increases expression EXP
ISO 		lead acetate results in increased expression of TRPC1 mRNA
lead acetate results in increased expression of TRPC1 mRNA; lead acetate results in increased expression of TRPC1 protein 		CTD PMID:21829687 PMID:22674931 NCBI chr 9:95,587,125...95,632,438
Ensembl chr 9:95,587,135...95,632,428 		JBrowse link
G Trpc4 transient receptor potential cation channel, subfamily C, member 4 increases expression ISO lead acetate results in increased expression of TRPC4 mRNA; lead acetate results in increased expression of TRPC4 protein CTD PMID:22674931 NCBI chr 3:54,063,441...54,225,892
Ensembl chr 3:54,063,456...54,225,892 		JBrowse link
G Trpc6 transient receptor potential cation channel, subfamily C, member 6 increases expression EXP lead acetate results in increased expression of TRPC6 mRNA CTD PMID:22613225 NCBI chr 9:8,543,868...8,680,753
Ensembl chr 9:8,544,143...8,680,742 		JBrowse link
G Trpm1 transient receptor potential cation channel, subfamily M, member 1 decreases expression ISO lead acetate results in decreased expression of TRPM1 mRNA CTD PMID:22641619 NCBI chr 7:63,803,583...63,923,630
Ensembl chr 7:63,803,583...63,919,523 		JBrowse link
G Trpv4 transient receptor potential cation channel, subfamily V, member 4 affects expression
decreases expression 		ISO lead acetate affects the expression of TRPV4 mRNA
lead acetate results in decreased expression of TRPV4 mRNA 		CTD PMID:21864555 PMID:22641619 NCBI chr 5:114,760,213...114,796,497
Ensembl chr 5:114,760,213...114,796,482 		JBrowse link
G Trpv5 transient receptor potential cation channel, subfamily V, member 5 multiple interactions ISO [lead acetate results in increased abundance of Lead] which affects the expression of TRPV5 protein CTD PMID:34350654 NCBI chr 6:41,628,595...41,658,158
Ensembl chr 6:41,629,107...41,657,703 		JBrowse link
G Try4 trypsin 4 increases expression EXP lead acetate results in increased expression of PRSS3 mRNA; lead acetate results in increased expression of TRY4 mRNA CTD PMID:20542052 NCBI chr 6:41,279,206...41,282,467
Ensembl chr 6:41,279,203...41,282,466 		JBrowse link
G Try5 trypsin 5 increases expression EXP lead acetate results in increased expression of TRY5 mRNA CTD PMID:20542052 NCBI chr 6:41,288,166...41,291,644
Ensembl chr 6:41,288,167...41,293,775 		JBrowse link
G Tsc1 TSC complex subunit 1 increases expression EXP lead acetate results in increased expression of TSC1 mRNA CTD PMID:22609695 NCBI chr 2:28,531,005...28,581,183
Ensembl chr 2:28,531,240...28,581,179 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 increases expression EXP lead acetate results in increased expression of TSC22D1 mRNA CTD PMID:21829687 NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 affects expression
decreases expression
increases expression 		EXP
ISO 		lead acetate affects the expression of TSC22D3 mRNA
lead acetate results in decreased expression of TSC22D3 mRNA
lead acetate results in increased expression of TSC22D3 mRNA 		CTD PMID:21829687 PMID:22641619 PMID:38568856 NCBI chr  X:139,440,277...139,501,257
Ensembl chr  X:139,440,277...139,501,408 		JBrowse link
G Tsg101 tumor susceptibility gene 101 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of TSG101 protein CTD PMID:36840722 NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717 		JBrowse link
G Tshb thyroid stimulating hormone, beta subunit multiple interactions
decreases secretion
decreases expression 		ISO lead acetate promotes the reaction [Zinc Oxide results in decreased secretion of TSHB protein]; Thyroxine inhibits the reaction [lead acetate results in decreased expression of TSHB protein]; Zinc Oxide promotes the reaction [lead acetate results in decreased secretion of TSHB protein] CTD PMID:21871911 PMID:34553816 NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034 		JBrowse link
G Tspan1 tetraspanin 1 decreases expression EXP
ISO 		lead acetate results in decreased expression of TSPAN1 mRNA CTD PMID:22609695 PMID:38568856 NCBI chr 4:116,019,078...116,024,818
Ensembl chr 4:116,019,066...116,024,798 		JBrowse link
G Tspan13 tetraspanin 13 increases expression EXP lead acetate results in increased expression of TSPAN13 mRNA CTD PMID:21829687 NCBI chr12:36,064,554...36,092,477
Ensembl chr12:36,064,556...36,092,499 		JBrowse link
G Tspan2 tetraspanin 2 affects expression ISO lead acetate affects the expression of TSPAN2 protein CTD PMID:36539177 NCBI chr 3:102,642,086...102,679,626
Ensembl chr 3:102,641,845...102,708,829 		JBrowse link
G Tspan32 tetraspanin 32 decreases expression EXP lead acetate results in decreased expression of TSPAN32 mRNA CTD PMID:21829687 NCBI chr 7:142,558,644...142,573,223
Ensembl chr 7:142,558,783...142,573,381 		JBrowse link
G Tspan7 tetraspanin 7 increases expression ISO lead acetate results in increased expression of TSPAN7 mRNA CTD PMID:38568856 NCBI chr  X:10,351,355...10,462,843
Ensembl chr  X:10,351,397...10,462,844 		JBrowse link
G Tsr2 TSR2 20S rRNA accumulation increases expression EXP lead acetate results in increased expression of TSR2 mRNA CTD PMID:20542052 NCBI chr  X:149,870,090...149,879,539
Ensembl chr  X:149,870,090...149,879,539 		JBrowse link
G Tst thiosulfate sulfurtransferase, mitochondrial decreases expression ISO lead acetate results in decreased expression of TST mRNA CTD PMID:38568856 NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107 		JBrowse link
G Ttc13 tetratricopeptide repeat domain 13 decreases expression ISO lead acetate results in decreased expression of TTC13 mRNA CTD PMID:38568856 NCBI chr 8:125,398,066...125,448,748
Ensembl chr 8:125,398,071...125,448,722 		JBrowse link
G Ttc39d tetratricopeptide repeat domain 39D decreases expression EXP lead acetate results in decreased expression of TTC39D mRNA CTD PMID:22609695 NCBI chr17:80,523,343...80,525,365
Ensembl chr17:80,514,889...80,525,365 		JBrowse link
G Ttc8 tetratricopeptide repeat domain 8 increases expression EXP lead acetate results in increased expression of TTC8 mRNA CTD PMID:20542052 NCBI chr12:98,886,796...98,949,509
Ensembl chr12:98,886,833...98,949,497 		JBrowse link
G Tti1 TELO2 interacting protein 1 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of TTI1 protein CTD PMID:38072110 NCBI chr 2:157,823,723...157,870,382
Ensembl chr 2:157,823,723...157,870,353 		JBrowse link
G Ttr transthyretin affects expression ISO lead acetate affects the expression of TTR protein CTD PMID:36539177 NCBI chr18:20,797,266...20,807,383
Ensembl chr18:20,798,337...20,807,378 		JBrowse link
G Tuba1a tubulin, alpha 1A increases expression ISO lead acetate results in increased expression of TUBA1A mRNA CTD PMID:38568856 NCBI chr15:98,847,728...98,851,382
Ensembl chr15:98,847,718...98,851,584 		JBrowse link
G Tuba4a tubulin, alpha 4A increases expression ISO lead acetate results in increased expression of TUBA4A mRNA CTD PMID:37939567 PMID:38568856 NCBI chr 1:75,190,867...75,197,905
Ensembl chr 1:75,190,872...75,196,509 		JBrowse link
G Tubb2a tubulin, beta 2A class IIA increases expression ISO lead acetate results in increased expression of TUBB2A mRNA CTD PMID:38568856 NCBI chr13:34,258,261...34,261,991
Ensembl chr13:34,258,257...34,261,990 		JBrowse link
G Tubb3 tubulin, beta 3 class III increases expression
multiple interactions 		ISO lead acetate results in increased expression of TUBB3 mRNA
PANX2 protein inhibits the reaction [lead acetate results in increased expression of TUBB3 mRNA] 		CTD PMID:33862172 PMID:37939567 NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754 		JBrowse link
G Tubb6 tubulin, beta 6 class V increases expression EXP lead acetate results in increased expression of TUBB6 mRNA CTD PMID:21829687 NCBI chr18:67,523,801...67,535,819
Ensembl chr18:67,523,787...67,535,819 		JBrowse link
G Tulp1 TUB like protein 1 decreases expression ISO lead acetate results in decreased expression of TULP1 mRNA CTD PMID:22641619 NCBI chr17:28,570,489...28,584,190
Ensembl chr17:28,570,489...28,584,196 		JBrowse link
G Tulp2 TUB like protein 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of TULP2 exon CTD PMID:33445541 NCBI chr 7:45,131,450...45,173,070
Ensembl chr 7:45,131,301...45,173,056 		JBrowse link
G Txn1 thioredoxin 1 increases expression ISO lead acetate results in increased expression of TXN mRNA CTD PMID:38568856 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411 		JBrowse link
G Txndc8 thioredoxin domain containing 8 increases expression EXP lead acetate results in increased expression of TXNDC8 mRNA CTD PMID:22609695 NCBI chr 4:57,984,029...58,009,126
Ensembl chr 4:57,984,027...58,009,124 		JBrowse link
G Txnip thioredoxin interacting protein decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of TXNIP mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of TXNIP protein 		CTD PMID:22641619 PMID:38072110 PMID:38568856 NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199 		JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO lead acetate results in increased expression of TXNRD1 mRNA; lead acetate results in increased expression of TXNRD1 protein CTD PMID:24345272 PMID:27562236 PMID:37939567 PMID:38568856 NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546 		JBrowse link
G Uba2 ubiquitin-like modifier activating enzyme 2 decreases expression EXP lead acetate results in decreased expression of UBA2 mRNA CTD PMID:21829687 NCBI chr 7:33,840,121...33,868,014
Ensembl chr 7:33,840,113...33,869,024 		JBrowse link
G Uba7 ubiquitin-like modifier activating enzyme 7 decreases expression
increases expression 		EXP lead acetate results in decreased expression of UBA7 mRNA
lead acetate results in increased expression of UBA7 mRNA 		CTD PMID:22609695 PMID:22613225 NCBI chr 9:107,852,766...107,861,255
Ensembl chr 9:107,852,704...107,861,259 		JBrowse link
G Ubap1 ubiquitin-associated protein 1 increases expression EXP lead acetate results in increased expression of UBAP1 mRNA CTD PMID:25270620 NCBI chr 4:41,348,996...41,389,766
Ensembl chr 4:41,348,996...41,390,525 		JBrowse link
G Ubash3b ubiquitin associated and SH3 domain containing, B decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of UBASH3B mRNA
lead acetate results in increased expression of UBASH3B mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr 9:40,922,056...41,069,358
Ensembl chr 9:40,922,394...41,072,993 		JBrowse link
G Ubc ubiquitin C decreases expression
increases expression 		EXP
ISO 		lead acetate results in decreased expression of UBC mRNA
lead acetate results in increased expression of UBC mRNA 		CTD PMID:21829687 PMID:38568856 NCBI chr 5:125,463,029...125,467,081
Ensembl chr 5:125,463,029...125,467,266 		JBrowse link
G Ube2k ubiquitin-conjugating enzyme E2K affects expression ISO lead acetate affects the expression of UBE2K protein CTD PMID:36539177 NCBI chr 5:65,694,588...65,756,332
Ensembl chr 5:65,694,576...65,756,331 		JBrowse link
G Ube2r2 ubiquitin-conjugating enzyme E2R 2 increases expression ISO lead acetate results in increased expression of UBE2R2 mRNA CTD PMID:38568856 NCBI chr 4:41,136,021...41,193,370
Ensembl chr 4:41,135,743...41,193,380 		JBrowse link
G Ube3d ubiquitin protein ligase E3D increases expression EXP lead acetate results in increased expression of UBE3D mRNA CTD PMID:20542052 NCBI chr 9:86,189,364...86,347,003
Ensembl chr 9:86,189,359...86,347,003 		JBrowse link
G Ubfd1 ubiquitin family domain containing 1 increases expression EXP lead acetate results in increased expression of UBFD1 mRNA CTD PMID:21829687 NCBI chr 7:121,666,318...121,681,422
Ensembl chr 7:121,666,398...121,681,417 		JBrowse link
G Ubp1 upstream binding protein 1 decreases expression EXP lead acetate results in decreased expression of UBP1 mRNA CTD PMID:21829687 NCBI chr 9:113,760,002...113,807,095
Ensembl chr 9:113,760,002...113,806,270 		JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 (putative) multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of UBR7 protein CTD PMID:38072110 NCBI chr12:102,724,234...102,743,960
Ensembl chr12:102,724,226...102,743,966 		JBrowse link
G Ubxn1 UBX domain protein 1 decreases expression ISO lead acetate results in decreased expression of UBXN1 mRNA CTD PMID:38568856 NCBI chr19:8,848,912...8,853,030
Ensembl chr19:8,848,860...8,853,227 		JBrowse link
G Ubxn2a UBX domain protein 2A multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of UBXN2A mRNA CTD PMID:22839698 NCBI chr12:4,926,814...4,957,749
Ensembl chr12:4,929,032...4,957,705 		JBrowse link
G Ubxn2b UBX domain protein 2B decreases expression
multiple interactions 		ISO lead acetate results in decreased expression of UBXN2B mRNA
[sodium arsenite co-treated with lead acetate] results in decreased expression of UBXN2B protein 		CTD PMID:38072110 PMID:38568856 NCBI chr 4:6,191,105...6,219,788
Ensembl chr 4:6,191,098...6,221,688 		JBrowse link
G Ubxn6 UBX domain protein 6 multiple interactions ISO [sodium arsenite co-treated with lead acetate] results in decreased expression of UBXN6 protein CTD PMID:38072110 NCBI chr17:56,374,045...56,386,333
Ensembl chr17:56,374,045...56,382,028 		JBrowse link
G Uevld UEV and lactate/malate dehyrogenase domains increases expression EXP lead acetate results in increased expression of UEVLD mRNA CTD PMID:22609695 NCBI chr 7:46,572,964...46,608,275
Ensembl chr 7:46,572,964...46,608,275 		JBrowse link
G Ugdh UDP-glucose dehydrogenase increases expression ISO lead acetate results in increased expression of UGDH mRNA CTD PMID:38568856 NCBI chr 5:65,570,550...65,593,185
Ensembl chr 5:65,570,564...65,593,292 		JBrowse link
G Ugt2a1 UDP glucuronosyltransferase 2 family, polypeptide A1 decreases expression EXP lead acetate results in decreased expression of UGT2A1 mRNA CTD PMID:22609695 NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730 		JBrowse link
G Ugt8a UDP galactosyltransferase 8A increases expression ISO lead acetate results in increased expression of UGT8 mRNA CTD PMID:22641619 NCBI chr 3:125,655,071...125,732,301
Ensembl chr 3:125,658,920...125,732,268 		JBrowse link
G Uhmk1 U2AF homology motif (UHM) kinase 1 decreases expression EXP lead acetate results in decreased expression of UHMK1 mRNA CTD PMID:21829687 NCBI chr 1:170,020,989...170,043,466
Ensembl chr 1:170,020,989...170,042,966 		JBrowse link
G Unc5cl unc-5 family C-terminal like multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased methylation of UNC5CL 3' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of UNC5CL exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of UNC5CL intron CTD PMID:33445541 NCBI chr17:48,761,155...48,846,737
Ensembl chr17:48,761,929...48,846,742 		JBrowse link
G Unc93b1 unc-93 homolog B1, TLR signaling regulator increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of UNC93B1 mRNA
lead acetate results in decreased expression of UNC93B1 mRNA 		CTD PMID:20542052 PMID:38568856 NCBI chr19:3,985,222...3,999,340
Ensembl chr19:3,985,186...3,999,340 		JBrowse link
G Unkl unkempt family like zinc finger increases expression ISO lead acetate results in increased expression of UNKL mRNA CTD PMID:38568856 NCBI chr17:25,407,336...25,453,417
Ensembl chr17:25,407,371...25,453,417 		JBrowse link
G Uqcrc1 ubiquinol-cytochrome c reductase core protein 1 increases expression EXP lead acetate results in increased expression of UQCRC1 protein CTD PMID:20797405 NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691 		JBrowse link
G Uqcrc2 ubiquinol cytochrome c reductase core protein 2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of UQCRC2 protein; BACH1 gene mutant form inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of UQCRC2 protein] CTD PMID:36096218 NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747 		JBrowse link
G Uqcrq ubiquinol-cytochrome c reductase, complex III subunit VII increases expression ISO lead acetate results in increased expression of UQCRQ mRNA CTD PMID:11578147 NCBI chr11:53,318,749...53,321,658
Ensembl chr11:53,318,749...53,321,658 		JBrowse link
G Uros uroporphyrinogen III synthase increases expression ISO lead acetate results in increased expression of UROS mRNA CTD PMID:22641619 NCBI chr 7:133,287,871...133,312,176
Ensembl chr 7:133,287,972...133,311,801 		JBrowse link
G Usf1 upstream transcription factor 1 decreases expression EXP lead acetate results in decreased expression of USF1 mRNA CTD PMID:21829687 NCBI chr 1:171,238,881...171,246,327
Ensembl chr 1:171,238,881...171,246,710 		JBrowse link
G Usf2 upstream transcription factor 2 increases expression EXP lead acetate results in increased expression of USF2 mRNA CTD PMID:21829687 NCBI chr 7:30,645,421...30,656,288
Ensembl chr 7:30,644,673...30,656,228 		JBrowse link
G Usp13 ubiquitin specific peptidase 13 (isopeptidase T-3) multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP13 mRNA CTD PMID:22839698 NCBI chr 3:32,870,432...32,992,224
Ensembl chr 3:32,871,695...32,992,220 		JBrowse link
G Usp18 ubiquitin specific peptidase 18 decreases expression ISO lead acetate results in decreased expression of USP18 mRNA CTD PMID:22641619 NCBI chr 6:121,222,865...121,247,876
Ensembl chr 6:121,222,865...121,247,876 		JBrowse link
G Usp31 ubiquitin specific peptidase 31 increases methylation ISO lead acetate results in increased methylation of USP31 gene CTD PMID:29571894 NCBI chr 7:121,241,244...121,306,683
Ensembl chr 7:121,241,244...121,306,476 		JBrowse link
G Usp34 ubiquitin specific peptidase 34 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP34 mRNA CTD PMID:22839698 NCBI chr11:23,256,433...23,440,560
Ensembl chr11:23,256,895...23,440,560 		JBrowse link
G Usp40 ubiquitin specific peptidase 40 increases expression EXP lead acetate results in increased expression of USP40 mRNA CTD PMID:20542052 NCBI chr 1:87,872,841...87,936,308
Ensembl chr 1:87,872,841...87,936,273 		JBrowse link
G Usp42 ubiquitin specific peptidase 42 increases expression EXP lead acetate results in increased expression of USP42 mRNA CTD PMID:20542052 NCBI chr 5:143,696,077...143,741,600
Ensembl chr 5:143,696,080...143,718,035 		JBrowse link
G Usp6nl USP6 N-terminal like decreases expression EXP lead acetate results in decreased expression of USP6NL mRNA CTD PMID:22613225 NCBI chr 2:6,327,444...6,453,107
Ensembl chr 2:6,327,478...6,451,201 		JBrowse link
G Uspl1 ubiquitin specific peptidase like 1 decreases expression EXP lead acetate results in decreased expression of USPL1 mRNA CTD PMID:21829687 NCBI chr 5:149,121,338...149,152,246
Ensembl chr 5:149,121,160...149,152,244 		JBrowse link
G Uxs1 UDP-glucuronate decarboxylase 1 decreases expression EXP lead acetate results in decreased expression of UXS1 mRNA CTD PMID:20542052 NCBI chr 1:43,786,121...43,866,999
Ensembl chr 1:43,786,126...43,866,960 		JBrowse link
G V1rd19 vomeronasal 1 receptor, D19 decreases expression EXP lead acetate results in decreased expression of V1RD19 mRNA CTD PMID:22613225 NCBI chr 7:23,702,536...23,703,453
Ensembl chr 7:23,701,116...23,704,482 		JBrowse link
G Vamp1 vesicle-associated membrane protein 1 increases expression
decreases expression 		EXP
ISO 		lead acetate results in increased expression of VAMP1 mRNA
lead acetate results in decreased expression of VAMP1 mRNA 		CTD PMID:24260418 PMID:27984133 NCBI chr 6:125,192,544...125,199,269
Ensembl chr 6:125,192,514...125,222,927 		JBrowse link
G Vamp2 vesicle-associated membrane protein 2 multiple interactions
affects expression
affects localization
decreases expression 		ISO
EXP 		2,2'-(hydroxynitrosohydrazono)bis-ethanamine inhibits the reaction [lead acetate affects the localization of VAMP2 protein]; [[lead acetate results in increased abundance of Lead] which results in increased expression of MIR34B mRNA] which results in decreased expression of VAMP2 protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of VAMP2 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of VAMP2 protein; BDNF protein inhibits the reaction [lead acetate results in decreased expression of VAMP2 protein]
lead acetate affects the expression of VAMP2 mRNA 		CTD PMID:20375082 PMID:22265330 PMID:27984133 PMID:35367965 NCBI chr11:68,979,354...68,983,207
Ensembl chr11:68,979,316...68,983,210 		JBrowse link
G Vamp5 vesicle-associated membrane protein 5 increases expression ISO lead acetate results in increased expression of VAMP5 mRNA CTD PMID:22641619 NCBI chr 6:72,345,032...72,357,451
Ensembl chr 6:72,345,777...72,357,451 		JBrowse link
G Vapa vesicle-associated membrane protein, associated protein A decreases expression
multiple interactions 		EXP
ISO 		lead acetate results in decreased expression of VAPA mRNA
lead acetate results in decreased expression of VAPA protein
sodium arsenite promotes the reaction [lead acetate results in decreased expression of VAPA protein] 		CTD PMID:21829687 PMID:38072110 NCBI chr17:65,887,048...65,925,441
Ensembl chr17:65,885,322...65,920,550 		JBrowse link
G Vasp vasodilator-stimulated phosphoprotein decreases expression EXP lead acetate results in decreased expression of VASP mRNA CTD PMID:21829687 NCBI chr 7:18,990,854...19,005,779
Ensembl chr 7:18,990,854...19,005,742 		JBrowse link
G Vat1l vesicle amine transport protein 1 like decreases expression ISO lead acetate results in decreased expression of VAT1L mRNA CTD PMID:38568856 NCBI chr 8:114,932,307...115,100,814
Ensembl chr 8:114,932,352...115,100,811 		JBrowse link
G Vav3 vav 3 oncogene decreases expression ISO lead acetate results in decreased expression of VAV3 mRNA CTD PMID:38568856 NCBI chr 3:109,247,757...109,593,010
Ensembl chr 3:109,247,969...109,593,014 		JBrowse link
G Vdac1 voltage-dependent anion channel 1 decreases expression ISO
EXP 		lead acetate results in decreased expression of VDAC1 protein
lead acetate results in decreased expression of VDAC1 mRNA; lead acetate results in decreased expression of VDAC1 protein 		CTD PMID:19822599 PMID:20797405 NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224 		JBrowse link
G Vdr vitamin D (1,25-dihydroxyvitamin D3) receptor multiple interactions ISO lead acetate promotes the reaction [VDR protein binds to NCOA2 protein] CTD PMID:21229763 NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511 		JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO lead acetate results in increased expression of VEGFA mRNA CTD PMID:11578147 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295 		JBrowse link
G Vegfc vascular endothelial growth factor C increases expression ISO lead acetate results in increased expression of VEGFC mRNA CTD PMID:38568856 NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131 		JBrowse link
G Vgf VGF nerve growth factor inducible increases expression
multiple interactions 		ISO lead acetate results in increased expression of VGF mRNA
[sodium arsenite co-treated with lead acetate] results in increased expression of VGF protein 		CTD PMID:27562236 PMID:38072110 NCBI chr 5:137,054,156...137,062,205
Ensembl chr 5:137,055,246...137,062,205 		JBrowse link
G Vgll3 vestigial like family member 3 decreases expression ISO lead acetate results in decreased expression of VGLL3 mRNA CTD PMID:22641619 NCBI chr16:65,612,075...65,663,254
Ensembl chr16:65,612,143...65,663,254 		JBrowse link
G Vim vimentin multiple interactions
affects expression 		ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of VIM mRNA
lead acetate affects the expression of VIM protein
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of VIM protein] 		CTD PMID:12634122 PMID:36539177 PMID:39722890 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637 		JBrowse link
G Vldlr very low density lipoprotein receptor increases expression EXP lead acetate results in increased expression of VLDLR mRNA CTD PMID:25270620 NCBI chr19:27,190,070...27,231,631
Ensembl chr19:27,193,884...27,231,631 		JBrowse link
G Vmn1r43 vomeronasal 1 receptor 43 increases expression EXP lead acetate results in increased expression of VMN1R43 mRNA CTD PMID:22609695 NCBI chr 6:89,846,443...89,847,511
Ensembl chr 6:89,835,916...89,853,395 		JBrowse link
G Vmn1r55 vomeronasal 1 receptor 55 decreases expression EXP lead acetate results in decreased expression of VMN1R55 mRNA CTD PMID:22613225 NCBI chr 7:5,149,489...5,150,421
Ensembl chr 7:5,132,290...5,152,669 		JBrowse link
G Vmn1r80 vomeronasal 1 receptor 80 increases expression EXP lead acetate results in increased expression of VMN1R80 mRNA CTD PMID:20542052 NCBI chr 7:11,926,892...11,927,818
Ensembl chr 7:11,923,213...11,937,240 		JBrowse link
G Vmn2r104 vomeronasal 2, receptor 104 decreases expression EXP lead acetate results in decreased expression of VMN2R104 mRNA CTD PMID:22613225 NCBI chr17:20,249,687...20,268,467
Ensembl chr17:20,248,680...20,268,598 		JBrowse link
G Vmn2r122 vomeronasal 2, receptor, 122 decreases expression EXP lead acetate results in decreased expression of VMN2R122 mRNA CTD PMID:22609695 NCBI chr 4:156,554,341...156,562,726 JBrowse link
G Vps33a VPS33A CORVET/HOPS core subunit increases expression
affects expression
multiple interactions 		EXP
ISO 		lead acetate results in increased expression of VPS33A mRNA
lead acetate affects the expression of VPS33A protein
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of VPS33A mRNA 		CTD PMID:20542052 PMID:22839698 PMID:36539177 NCBI chr 5:123,666,820...123,711,104
Ensembl chr 5:123,666,722...123,711,101 		JBrowse link
G Vps36 vacuolar protein sorting 36 decreases expression EXP lead acetate results in decreased expression of VPS36 mRNA CTD PMID:21829687 NCBI chr 8:22,682,849...22,710,969
Ensembl chr 8:22,682,825...22,710,859 		JBrowse link
G Vstm2l V-set and transmembrane domain containing 2-like increases expression ISO lead acetate results in increased expression of VSTM2L mRNA CTD PMID:38568856 NCBI chr 2:157,756,573...157,786,639
Ensembl chr 2:157,756,573...157,786,639 		JBrowse link
G Vsx2 visual system homeobox 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which affects the expression of VSX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of VSX2 mRNA CTD PMID:28050121 NCBI chr12:84,616,602...84,642,231
Ensembl chr12:84,616,536...84,642,231 		JBrowse link
G Vwa3b von Willebrand factor A domain containing 3B affects expression ISO lead acetate affects the expression of VWA3B mRNA CTD PMID:21864555 NCBI chr 1:37,068,372...37,226,689
Ensembl chr 1:37,065,677...37,226,694 		JBrowse link
G Vwc2l von Willebrand factor C domain-containing protein 2-like decreases expression ISO lead acetate results in decreased expression of VWC2L mRNA CTD PMID:22641619 NCBI chr 1:70,764,471...70,928,097
Ensembl chr 1:70,764,874...70,924,556 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase1 increases expression ISO lead acetate results in increased expression of WARS1 mRNA CTD PMID:11578147 NCBI chr12:108,825,956...108,860,095
Ensembl chr12:108,825,956...108,860,100 		JBrowse link
G Wasf2 WASP family, member 2 decreases expression EXP lead acetate results in decreased expression of WASF2 mRNA CTD PMID:21829687 NCBI chr 4:132,857,843...132,927,067
Ensembl chr 4:132,857,816...132,927,067 		JBrowse link
G Wdr35 WD repeat domain 35 increases expression EXP lead acetate results in increased expression of WDR35 mRNA CTD PMID:20542052 NCBI chr12:9,023,897...9,078,848
Ensembl chr12:9,023,892...9,078,847 		JBrowse link
G Wdr86 WD repeat domain 86 decreases expression ISO lead acetate results in decreased expression of WDR86 mRNA CTD PMID:37939567 NCBI chr 5:24,901,898...24,935,696
Ensembl chr 5:24,916,736...24,935,725 		JBrowse link
G Wfdc18 WAP four-disulfide core domain 18 increases expression EXP lead acetate results in increased expression of WFDC18 mRNA CTD PMID:20542052 NCBI chr11:83,599,830...83,602,186
Ensembl chr11:83,599,841...83,602,174 		JBrowse link
G Wipi1 WD repeat domain, phosphoinositide interacting 1 decreases expression EXP lead acetate results in decreased expression of WIPI1 mRNA CTD PMID:22609695 NCBI chr11:109,464,347...109,502,215
Ensembl chr11:109,464,157...109,502,793 		JBrowse link
G Wnt1 wingless-type MMTV integration site family, member 1 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT1 mRNA CTD PMID:12634122 NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718 		JBrowse link
G Wnt11 wingless-type MMTV integration site family, member 11 multiple interactions EXP [lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT11 mRNA]; [lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT11 protein] CTD PMID:38157908 NCBI chr 7:98,484,293...98,503,954
Ensembl chr 7:98,484,319...98,504,402 		JBrowse link
G Wnt2 wingless-type MMTV integration site family, member 2 multiple interactions ISO [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 NCBI chr 6:17,988,939...18,032,771
Ensembl chr 6:17,988,939...18,030,584 		JBrowse link
G Wnt3a wingless-type MMTV integration site family, member 3A multiple interactions EXP [[lead acetate results in increased abundance of Lead] which results in decreased expression of PORCN protein] which results in decreased localization of WNT3A protein; [lead acetate results in increased abundance of Lead] which results in decreased localization of WNT3A protein; [lead acetate results in increased abundance of Lead] which results in increased expression of WNT3A mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of WNT3A protein CTD PMID:37436718 NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578 		JBrowse link
G Wnt5a wingless-type MMTV integration site family, member 5A increases expression ISO lead acetate results in increased expression of WNT5A mRNA CTD PMID:38568856 NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405 		JBrowse link
G Wnt7a wingless-type MMTV integration site family, member 7A multiple interactions
increases expression
decreases expression 		ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of WNT7A mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of WNT7A protein; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of WNT7A mRNA]; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of WNT7A protein]
lead acetate results in increased expression of WNT7A mRNA
WNT7A protein inhibits the reaction [lead acetate results in increased phosphorylation of CTNNB1 protein]
lead acetate results in decreased expression of WNT7A protein 		CTD PMID:11578147 PMID:24999626 PMID:27936013 NCBI chr 6:91,340,963...91,388,335
Ensembl chr 6:91,340,963...91,388,345 		JBrowse link
G Wnt8a wingless-type MMTV integration site family, member 8A multiple interactions EXP [lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA] CTD PMID:38157908 NCBI chr18:34,675,380...34,681,114
Ensembl chr18:34,675,366...34,681,326 		JBrowse link
G Wnt9a wingless-type MMTV integration site family, member 9A decreases expression EXP lead acetate results in decreased expression of WNT9A mRNA CTD PMID:22609695 NCBI chr11:59,197,675...59,224,378
Ensembl chr11:59,197,754...59,224,378 		JBrowse link
G Wsb2 WD repeat and SOCS box-containing 2 increases expression
multiple interactions 		ISO lead acetate results in increased expression of WSB2 mRNA
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of WSB2 mRNA 		CTD PMID:22839698 PMID:38568856 NCBI chr 5:117,495,370...117,516,666
Ensembl chr 5:117,495,369...117,516,666 		JBrowse link
G Wwp1 WW domain containing E3 ubiquitin protein ligase 1 increases expression EXP lead acetate results in increased expression of WWP1 mRNA CTD PMID:20542052 NCBI chr 4:19,608,296...19,709,004
Ensembl chr 4:19,608,303...19,708,993 		JBrowse link
G Xaf1 XIAP associated factor 1 increases expression EXP lead acetate results in increased expression of XAF1 mRNA CTD PMID:22613225 NCBI chr11:72,192,229...72,204,560
Ensembl chr11:72,192,455...72,204,559 		JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions
increases expression 		ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of XBP1 mRNA
lead acetate results in increased expression of XBP1 mRNA 		CTD PMID:36642386 PMID:38568856 NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893 		JBrowse link
G Xiap X-linked inhibitor of apoptosis multiple interactions ISO
EXP 		[lead acetate results in increased abundance of Lead] which results in decreased expression of XIAP mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of XIAP protein; MIR106B mRNA affects the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of XIAP protein] CTD PMID:32344020 NCBI chr  X:41,148,483...41,198,541
Ensembl chr  X:41,148,556...41,198,533 		JBrowse link
G Xpa xeroderma pigmentosum, complementation group A increases expression EXP lead acetate results in increased expression of XPA mRNA CTD PMID:22609695 NCBI chr 4:46,175,222...46,196,317
Ensembl chr 4:46,155,347...46,196,311 		JBrowse link
G Xpot exportin, tRNA (nuclear export receptor for tRNAs) increases expression ISO lead acetate results in increased expression of XPOT mRNA CTD PMID:11578147 NCBI chr10:121,423,285...121,462,411
Ensembl chr10:121,423,285...121,462,237 		JBrowse link
G Yap1 yes-associated protein 1 affects expression ISO lead acetate affects the expression of YAP1 mRNA CTD PMID:21864555 NCBI chr 9:7,932,000...8,004,890
Ensembl chr 9:7,932,000...8,004,597 		JBrowse link
G Yars1 tyrosyl-tRNA synthetase 1 increases expression ISO lead acetate results in increased expression of YARS1 mRNA CTD PMID:11578147 NCBI chr 4:129,083,595...129,113,033
Ensembl chr 4:129,083,553...129,113,400 		JBrowse link
G Yif1a Yip1 interacting factor homolog A (S. cerevisiae) decreases expression EXP lead acetate results in decreased expression of YIF1A mRNA CTD PMID:21829687 NCBI chr19:5,138,566...5,142,907
Ensembl chr19:5,138,566...5,142,909 		JBrowse link
G Yipf5 Yip1 domain family, member 5 increases expression ISO lead acetate results in increased expression of YIPF5 mRNA CTD PMID:38568856 NCBI chr18:40,337,918...40,352,452
Ensembl chr18:40,336,949...40,352,482 		JBrowse link
G Ypel3 yippee like 3 decreases expression ISO lead acetate results in decreased expression of YPEL3 mRNA CTD PMID:38568856 NCBI chr 7:126,376,135...126,379,682
Ensembl chr 7:126,376,127...126,379,686 		JBrowse link
G Yy1 YY1 transcription factor decreases methylation ISO lead acetate results in decreased methylation of YY1 gene CTD PMID:29571894 NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074 		JBrowse link
G Zap70 zeta-chain (TCR) associated protein kinase decreases expression EXP lead acetate results in decreased expression of ZAP70 mRNA CTD PMID:20542052 NCBI chr 1:36,800,912...36,821,899
Ensembl chr 1:36,800,879...36,821,899 		JBrowse link
G Zbtb32 zinc finger and BTB domain containing 32 increases expression EXP lead acetate results in increased expression of ZBTB32 mRNA CTD PMID:20542052 NCBI chr 7:30,289,105...30,302,244
Ensembl chr 7:30,289,106...30,298,334 		JBrowse link
G Zc3h3 zinc finger CCCH type containing 3 increases expression EXP lead acetate results in increased expression of ZC3H3 mRNA CTD PMID:22609695 NCBI chr15:75,626,279...75,713,772
Ensembl chr15:75,626,279...75,713,764 		JBrowse link
G Zcchc2 zinc finger, CCHC domain containing 2 increases expression EXP lead acetate results in increased expression of ZCCHC2 mRNA CTD PMID:21829687 NCBI chr 1:105,916,929...105,961,807
Ensembl chr 1:105,918,136...105,961,804 		JBrowse link
G Zcchc8 zinc finger, CCHC domain containing 8 decreases expression EXP lead acetate results in decreased expression of ZCCHC8 mRNA CTD PMID:21829687 NCBI chr 5:123,836,365...123,859,107
Ensembl chr 5:123,836,357...123,859,163 		JBrowse link
G Zcrb1 zinc finger CCHC-type and RNA binding motif 1 increases expression ISO lead acetate results in increased expression of ZCRB1 mRNA CTD PMID:38568856 NCBI chr15:93,283,987...93,296,218
Ensembl chr15:93,283,978...93,296,215 		JBrowse link
G Zdhhc14 zinc finger, DHHC domain containing 14 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ZDHHC14 intron CTD PMID:33445541 NCBI chr17:5,542,220...5,810,517
Ensembl chr17:5,542,832...5,804,086 		JBrowse link
G Zdhhc9 zinc finger, DHHC domain containing 9 decreases expression EXP lead acetate results in decreased expression of ZDHHC9 mRNA CTD PMID:22613225 NCBI chr  X:47,260,844...47,297,792
Ensembl chr  X:47,260,846...47,297,755 		JBrowse link
G Zeb1 zinc finger E-box binding homeobox 1 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ZEB1 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein] CTD PMID:39276841 PMID:39722890 NCBI chr18:5,591,330...5,775,468
Ensembl chr18:5,591,860...5,775,467 		JBrowse link
G Zfand6 zinc finger, AN1-type domain 6 increases expression EXP lead acetate results in increased expression of ZFAND6 mRNA CTD PMID:20542052 NCBI chr 7:84,264,253...84,339,224
Ensembl chr 7:84,262,974...84,339,167 		JBrowse link
G Zfp185 zinc finger protein 185 decreases expression EXP lead acetate results in decreased expression of ZFP185 mRNA CTD PMID:22609695 NCBI chr  X:72,030,860...72,075,149
Ensembl chr  X:72,030,945...72,075,149 		JBrowse link
G Zfp263 zinc finger protein 263 increases expression EXP lead acetate results in increased expression of ZFP263 mRNA CTD PMID:21829687 NCBI chr16:3,561,883...3,568,654
Ensembl chr16:3,561,957...3,568,654 		JBrowse link
G Zfp330 zinc finger protein 330 increases expression EXP
ISO 		lead acetate results in increased expression of ZFP330 mRNA
lead acetate results in increased expression of ZNF330 mRNA 		CTD PMID:25270620 PMID:38568856 NCBI chr 8:83,490,247...83,500,774
Ensembl chr 8:83,490,236...83,500,789 		JBrowse link
G Zfp352 zinc finger protein 352 increases expression EXP lead acetate results in increased expression of ZFP352 mRNA CTD PMID:22609695 NCBI chr 4:90,107,057...90,113,924
Ensembl chr 4:90,107,057...90,113,939 		JBrowse link
G Zfp36 zinc finger protein 36 increases expression EXP lead acetate results in increased expression of ZFP36 mRNA CTD PMID:20542052 NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678 		JBrowse link
G Zfp36l1 zinc finger protein 36, C3H type-like 1 increases expression ISO lead acetate results in increased expression of ZFP36L1 mRNA CTD PMID:38568856 NCBI chr12:80,154,534...80,159,787
Ensembl chr12:80,154,528...80,159,787 		JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 increases expression EXP lead acetate results in increased expression of ZFP36L2 mRNA CTD PMID:21829687 NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375 		JBrowse link
G Zfp42 zinc finger protein 42 increases expression EXP lead acetate results in increased expression of ZFP42 mRNA CTD PMID:31715224 NCBI chr 8:43,748,100...43,760,041
Ensembl chr 8:43,748,100...43,760,017 		JBrowse link
G Zfp426 zinc finger protein 426 increases expression EXP lead acetate results in increased expression of ZFP426 mRNA CTD PMID:21829687 NCBI chr 9:20,379,845...20,404,042
Ensembl chr 9:20,379,845...20,404,042 		JBrowse link
G Zfp467 zinc finger protein 467 decreases expression ISO lead acetate results in decreased expression of ZNF467 mRNA CTD PMID:38568856 NCBI chr 6:48,404,626...48,422,926
Ensembl chr 6:48,404,631...48,422,759 		JBrowse link
G Zfp507 zinc finger protein 507 increases expression EXP lead acetate results in increased expression of ZFP507 mRNA CTD PMID:21829687 NCBI chr 7:35,471,768...35,502,749
Ensembl chr 7:35,471,768...35,502,428 		JBrowse link
G Zfp560 zinc finger protein 560 decreases expression EXP lead acetate results in decreased expression of ZFP560 mRNA CTD PMID:21829687 NCBI chr 9:20,256,432...20,296,479
Ensembl chr 9:20,256,432...20,296,473 		JBrowse link
G Zfp59 zinc finger protein 59 increases expression EXP lead acetate results in increased expression of ZFP59 mRNA CTD PMID:21829687 NCBI chr 7:27,535,471...27,556,218
Ensembl chr 7:27,538,032...27,555,863 		JBrowse link
G Zfp598 zinc finger protein 598 increases expression ISO lead acetate results in increased expression of ZNF598 mRNA CTD PMID:38568856 NCBI chr17:24,888,661...24,900,997
Ensembl chr17:24,888,661...24,900,990 		JBrowse link
G Zfp655 zinc finger protein 655 increases expression EXP lead acetate results in increased expression of ZFP655 mRNA CTD PMID:25270620 NCBI chr 5:145,168,503...145,184,116
Ensembl chr 5:145,168,525...145,213,723 		JBrowse link
G Zfp692 zinc finger protein 692 decreases expression ISO lead acetate results in decreased expression of ZNF692 mRNA CTD PMID:38568856 NCBI chr11:58,197,883...58,205,971
Ensembl chr11:58,197,895...58,205,453 		JBrowse link
G Zfp746 zinc finger protein 746 increases expression ISO lead acetate results in increased expression of ZNF746 mRNA CTD PMID:38568856 NCBI chr 6:48,039,325...48,064,275
Ensembl chr 6:48,039,329...48,063,527 		JBrowse link
G Zfp768 zinc finger protein 768 increases expression ISO lead acetate results in increased expression of ZNF768 mRNA CTD PMID:38568856 NCBI chr 7:126,941,967...126,944,486
Ensembl chr 7:126,941,967...126,944,761 		JBrowse link
G Zfp771 zinc finger protein 771 increases expression EXP lead acetate results in increased expression of ZFP771 mRNA CTD PMID:22609695 NCBI chr 7:126,842,168...126,854,044
Ensembl chr 7:126,843,446...126,853,975 		JBrowse link
G Zfp787 zinc finger protein 787 increases expression ISO lead acetate results in increased expression of ZNF787 mRNA CTD PMID:38568856 NCBI chr 7:6,134,488...6,162,382
Ensembl chr 7:6,134,490...6,158,996 		JBrowse link
G Zfp827 zinc finger protein 827 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in increased expression of ZNF827 mRNA CTD PMID:22839698 NCBI chr 8:79,753,754...79,920,397
Ensembl chr 8:79,755,066...79,920,395 		JBrowse link
G Zfp930 zinc finger protein 930 decreases expression EXP lead acetate results in decreased expression of ZFP930 mRNA CTD PMID:20542052 NCBI chr 8:69,661,701...69,683,188
Ensembl chr 8:69,661,690...69,683,188 		JBrowse link
G Zfyve16 zinc finger, FYVE domain containing 16 multiple interactions ISO [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of ZFYVE16 mRNA CTD PMID:22839698 NCBI chr13:92,624,257...92,667,318
Ensembl chr13:92,623,616...92,667,376 		JBrowse link
G Zic4 zinc finger protein of the cerebellum 4 increases expression EXP lead acetate results in increased expression of ZIC4 mRNA CTD PMID:22609695 NCBI chr 9:91,247,636...91,271,404
Ensembl chr 9:91,244,466...91,271,401 		JBrowse link
G Zim1 zinc finger, imprinted 1 decreases expression EXP lead acetate results in decreased expression of ZIM1 mRNA CTD PMID:22609695 NCBI chr 7:6,677,443...6,699,521
Ensembl chr 7:6,674,268...6,699,449 		JBrowse link
G Zmynd10 zinc finger, MYND domain containing 10 affects expression ISO lead acetate affects the expression of ZMYND10 mRNA CTD PMID:21864555 NCBI chr 9:107,424,067...107,428,520
Ensembl chr 9:107,424,497...107,428,518 		JBrowse link
G Znrd2 zinc ribbon domain containing 2 decreases expression EXP lead acetate results in decreased expression of ZNRD2 mRNA CTD PMID:25270620 NCBI chr19:5,780,334...5,781,760
Ensembl chr19:5,780,331...5,781,760
Ensembl chr19:5,780,331...5,781,760 		JBrowse link
G Zup1 zinc finger containing ubiquitin peptidase 1 increases expression ISO lead acetate results in increased expression of ZUP1 mRNA CTD PMID:22641619 NCBI chr10:33,795,138...33,827,316
Ensembl chr10:33,795,138...33,827,265 		JBrowse link
G Zyg11a zyg-11 family member A, cell cycle regulator increases expression ISO lead acetate results in increased expression of EIF3CL mRNA CTD PMID:11578147 NCBI chr 4:108,037,442...108,075,285
Ensembl chr 4:108,038,935...108,075,245 		JBrowse link
G Zyx zyxin increases expression ISO lead acetate results in increased expression of ZYX mRNA CTD PMID:38568856 NCBI chr 6:42,326,507...42,337,158
Ensembl chr 6:42,326,564...42,337,147 		JBrowse link
lead ion term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hmbs hydroxymethylbilane synthase decreases activity ISO Lead ion decreases activity of purified Hmbs protein RGD PMID:6732900 RGD:25394584 NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525 		JBrowse link
lead nitrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aco1 aconitase 1 decreases expression
multiple interactions 		ISO lead nitrate results in decreased expression of ACO1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in decreased expression of ACO1 protein] 		CTD PMID:22502979 NCBI chr 4:40,143,429...40,199,011
Ensembl chr 4:40,143,081...40,198,338 		JBrowse link
G Acta1 actin alpha 1, skeletal muscle increases expression EXP lead nitrate results in increased expression of ACTA1 protein CTD PMID:20435106 NCBI chr 8:124,618,497...124,621,514
Ensembl chr 8:124,618,508...124,621,490 		JBrowse link
G Ahr aryl-hydrocarbon receptor increases expression
multiple interactions 		ISO lead nitrate results in increased expression of AHR mRNA; lead nitrate results in increased expression of AHR protein
AHR promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] 		CTD PMID:31682781 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of AHSG mRNA CTD PMID:32949613 NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199 		JBrowse link
G Akap3 A kinase anchor protein 3 decreases expression ISO lead nitrate results in decreased expression of AKAP3 mRNA CTD PMID:21628963 NCBI chr 6:126,830,061...126,851,271
Ensembl chr 6:126,830,061...126,851,271 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase decreases activity
multiple interactions 		ISO lead nitrate results in decreased activity of ALAD protein
lead nitrate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]] 		CTD PMID:2061546 NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Alb albumin multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in decreased expression of ALB protein CTD PMID:39414706 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461 		JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of ALPL protein CTD PMID:39414706 NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 decreases expression
multiple interactions 		EXP lead nitrate results in decreased expression of APAF1 protein
mangiferin inhibits the reaction [lead nitrate results in decreased expression of APAF1 protein] 		CTD PMID:23451106 NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632 		JBrowse link
G Arhgdib Rho, GDP dissociation inhibitor beta increases expression EXP lead nitrate results in increased expression of ARHGDIB protein CTD PMID:20435106 NCBI chr 6:136,900,653...136,918,895
Ensembl chr 6:136,900,653...136,918,897 		JBrowse link
G Arrdc5 arrestin domain containing 5 decreases expression ISO lead nitrate results in decreased expression of ARRDC5 mRNA CTD PMID:21628963 NCBI chr17:56,601,111...56,607,262
Ensembl chr17:56,601,111...56,607,286 		JBrowse link
G Azin2 antizyme inhibitor 2 decreases expression ISO lead nitrate results in decreased expression of AZIN2 mRNA CTD PMID:21628963 NCBI chr 4:128,824,026...128,856,250
Ensembl chr 4:128,824,026...128,856,235 		JBrowse link
G Bax BCL2-associated X protein multiple interactions
increases expression 		EXP
ISO 		mangiferin inhibits the reaction [lead nitrate results in increased expression of BAX protein]
[lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of BAX mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of BAX mRNA] 		CTD PMID:23451106 PMID:30738203 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 decreases expression
multiple interactions 		EXP
ISO 		lead nitrate results in decreased expression of BCL2 protein
[lead nitrate results in increased abundance of Lead] which results in decreased expression of BCL2 mRNA
mangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein] 		CTD PMID:23451106 PMID:30738203 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Cadm3 cell adhesion molecule 3 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CADM3 mRNA CTD PMID:32949613 NCBI chr 1:173,161,825...173,195,214
Ensembl chr 1:173,160,825...173,195,261 		JBrowse link
G Car9 carbonic anhydrase 9 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA CTD PMID:32949613 NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729 		JBrowse link
G Casp14 caspase 14 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CASP14 mRNA CTD PMID:32949613 NCBI chr10:78,547,829...78,554,181
Ensembl chr10:78,547,825...78,554,128 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases expression
increases activity 		ISO
EXP 		[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP3 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP3 mRNA]
lead nitrate results in increased expression of CASP3 protein
puerarin inhibits the reaction [lead nitrate results in increased activity of CASP3 protein]
[sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP3 protein; mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP3 protein] 		CTD PMID:23451106 PMID:24505050 PMID:30738203 PMID:39414706 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp6 caspase 6 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP6 protein CTD PMID:39414706 NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752 		JBrowse link
G Casp7 caspase 7 multiple interactions
decreases expression 		EXP lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA]
lead nitrate results in decreased expression of CASP7 mRNA 		CTD PMID:11891201 NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776 		JBrowse link
G Casp8 caspase 8 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of CASP8 protein CTD PMID:39414706 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression 		EXP
ISO 		mangiferin inhibits the reaction [lead nitrate results in increased expression of CASP9 protein]
[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein; [lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased activity of CASP9 protein]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of CASP9 mRNA] 		CTD PMID:23451106 PMID:30738203 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287 		JBrowse link
G Cat catalase decreases activity
multiple interactions 		EXP
ISO 		lead nitrate results in decreased activity of CAT protein
[lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased activity of CAT protein]
Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of CAT protein]; puerarin inhibits the reaction [lead nitrate results in decreased activity of CAT protein]
mangiferin inhibits the reaction [lead nitrate results in decreased activity of CAT protein] 		CTD PMID:23315276 PMID:23451106 PMID:24987671 PMID:30738203 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CCL20 mRNA CTD PMID:32949613 NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888 		JBrowse link
G Ccng1 cyclin G1 multiple interactions EXP lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138 		JBrowse link
G Cd86 CD86 antigen increases expression EXP lead nitrate results in increased expression of CD86 protein CTD PMID:23376802 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443 		JBrowse link
G Cdyl chromodomain protein, Y chromosome-like decreases expression ISO lead nitrate results in decreased expression of CDYL mRNA CTD PMID:21628963 NCBI chr13:35,843,801...36,058,047
Ensembl chr13:35,843,816...36,058,046 		JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase increases phosphorylation
multiple interactions 		EXP lead nitrate results in increased phosphorylation of CHUK protein
mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of CHUK protein] 		CTD PMID:23451106 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919 		JBrowse link
G Cox8c cytochrome c oxidase subunit 8C decreases expression ISO lead nitrate results in decreased expression of COX8C mRNA CTD PMID:21628963 NCBI chr12:102,865,565...102,866,793
Ensembl chr12:102,865,575...102,866,785 		JBrowse link
G Cps1 carbamoyl-phosphate synthetase 1 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CPS1 mRNA CTD PMID:32949613 NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418 		JBrowse link
G Crisp2 cysteine-rich secretory protein 2 decreases expression ISO lead nitrate results in decreased expression of CRISP2 mRNA CTD PMID:21628963 NCBI chr17:41,075,625...41,105,037
Ensembl chr17:41,074,911...41,117,894 		JBrowse link
G Crp C-reactive protein, pentraxin-related multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CRP mRNA CTD PMID:32949613 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598 		JBrowse link
G Cryaa crystallin, alpha A affects metabolic processing ISO lead nitrate affects the metabolism of CRYAA protein CTD PMID:21139692 NCBI chr17:31,896,905...31,900,704
Ensembl chr17:31,896,781...31,900,707 		JBrowse link
G Cryab crystallin, alpha B affects metabolic processing ISO lead nitrate affects the metabolism of CRYAB protein CTD PMID:21139692 NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936 		JBrowse link
G Cst8 cystatin 8 (cystatin-related epididymal spermatogenic) decreases expression ISO lead nitrate results in decreased expression of CST8 mRNA CTD PMID:21628963 NCBI chr 2:148,640,759...148,647,516
Ensembl chr 2:148,640,705...148,647,515 		JBrowse link
G Ctnna1 catenin alpha 1 multiple interactions EXP lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr18:35,251,955...35,387,829
Ensembl chr18:35,251,912...35,387,832 		JBrowse link
G Ctnnb1 catenin beta 1 multiple interactions EXP
ISO 		[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein; [lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA]
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of CTNNB1 mRNA] 		CTD PMID:30731080 PMID:35738543 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573 		JBrowse link
G Cux2 cut-like homeobox 2 multiple interactions EXP lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 5:121,996,025...122,188,522
Ensembl chr 5:121,994,429...122,188,165 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CXCL13 mRNA CTD PMID:32949613 NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927 		JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 increases expression
multiple interactions 		ISO lead nitrate results in increased expression of CXCL8 protein
[lead nitrate results in increased abundance of Lead] which results in increased secretion of CXCL8 protein 		CTD PMID:34189835 PMID:39579145 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression 		ISO lead nitrate inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benz(a)anthracene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(b)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased activity of CYP1A1 protein]; lead nitrate inhibits the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; lead nitrate promotes the reaction [benzo(k)fluoranthene results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA]
lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein]; Resveratrol inhibits the reaction [lead nitrate results in increased expression of CYP1A1 mRNA]
lead nitrate results in increased expression of CYP1A1 mRNA; lead nitrate results in increased expression of CYP1A1 protein 		CTD PMID:8902619 PMID:11162773 PMID:11408366 PMID:17889500 PMID:23391631 More... NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
multiple interactions 		ISO lead nitrate results in decreased activity of CYP1A2 protein
lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 mRNA]; lead nitrate inhibits the reaction [2-methoxy-4-aminoazobenzene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [beta-Naphthoflavone results in increased expression of CYP1A2 protein]; lead nitrate inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A2 protein]; lead nitrate results in decreased expression of and results in decreased activity of CYP1A2 protein 		CTD PMID:8902619 PMID:11162773 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986 		JBrowse link
G Cyp2a5 cytochrome P450, family 2, subfamily a, polypeptide 5 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of CYP2A6 mRNA CTD PMID:32949613 NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973 		JBrowse link
G Cyp2c52-ps cytochrome P450, family 2, subfamily c, polypeptide 52, pseudogene increases expression ISO lead nitrate results in increased expression of CYP2C11 mRNA CTD PMID:23391631 NCBI chr19:38,965,106...38,992,071
Ensembl chr19:38,965,091...38,991,733
Ensembl chr19:38,965,091...38,991,733 		JBrowse link
G Cyp4a12b cytochrome P450, family 4, subfamily a, polypeptide 12B increases expression ISO lead nitrate results in increased expression of CYP4A1 mRNA CTD PMID:23391631 NCBI chr 4:115,268,821...115,296,231
Ensembl chr 4:115,268,821...115,296,231 		JBrowse link
G Cyp51 cytochrome P450, family 51 increases expression
multiple interactions 		EXP
ISO 		lead nitrate results in increased expression of CYP51 mRNA
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA] 		CTD PMID:15475176 PMID:22293356 NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746 		JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 decreases expression
multiple interactions 		EXP
ISO 		lead nitrate results in decreased expression of CYP7A1 mRNA
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] 		CTD PMID:15475176 PMID:16049268 PMID:22293356 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression ISO lead nitrate results in increased expression of DDIT3 mRNA CTD PMID:14971657 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions EXP
ISO 		[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA; [lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein]
[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of DKK1 mRNA 		CTD PMID:30731080 PMID:32949613 NCBI chr19:30,523,276...30,526,896
Ensembl chr19:30,523,263...30,527,065 		JBrowse link
G Dmp1 dentin matrix protein 1 multiple interactions ISO lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DMP1 mRNA] CTD PMID:35738543 NCBI chr 5:104,345,441...104,361,968
Ensembl chr 5:104,350,479...104,361,968 		JBrowse link
G Dnase1 deoxyribonuclease I multiple interactions EXP lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr16:3,855,007...3,857,888
Ensembl chr16:3,854,806...3,857,888 		JBrowse link
G Dnmt3a DNA methyltransferase 3A multiple interactions
decreases expression 		ISO 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]
lead nitrate results in decreased expression of DNMT3A mRNA; lead nitrate results in decreased expression of DNMT3A protein 		CTD PMID:24639330 NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443 		JBrowse link
G Dpt dermatopontin multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of DPT mRNA CTD PMID:32949613 NCBI chr 1:164,624,232...164,651,843
Ensembl chr 1:164,624,213...164,651,835 		JBrowse link
G Dspp dentin sialophosphoprotein multiple interactions ISO lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of DSPP mRNA] CTD PMID:35738543 NCBI chr 5:104,318,569...104,327,993
Ensembl chr 5:104,318,578...104,327,993 		JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions ISO E2F1 protein inhibits the reaction [lead nitrate results in decreased expression of DNMT3A mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA] CTD PMID:24639330 NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812 		JBrowse link
G Egfl8 EGF-like domain 8 increases expression ISO lead nitrate results in increased expression of EGFL8 protein CTD PMID:19332663 NCBI chr17:34,832,174...34,835,536
Ensembl chr17:34,832,323...34,834,945 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions
increases phosphorylation 		ISO EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR mutant form affects the reaction [lead nitrate results in increased secretion of Dinoprostone]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of EGFR protein] CTD PMID:20850495 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158 		JBrowse link
G Eif2ak1 eukaryotic translation initiation factor 2 alpha kinase 1 increases response to substance
multiple interactions 		EXP EIF2AK1 gene mutant form results in increased susceptibility to lead nitrate
[lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Bilirubin; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased abundance of Malondialdehyde; [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA 		CTD PMID:25411909 NCBI chr 5:143,803,586...143,839,535
Ensembl chr 5:143,803,543...143,841,069 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 increases phosphorylation
multiple interactions 		ISO lead nitrate results in increased phosphorylation of EIF4EBP1 protein
puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of EIF4EBP1 protein] 		CTD PMID:27762461 NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702 		JBrowse link
G Ercc1 excision repair cross-complementing rodent repair deficiency, complementation group 1 multiple interactions EXP lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449 		JBrowse link
G Ercc3 excision repair cross-complementing rodent repair deficiency, complementation group 3 multiple interactions EXP lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204 		JBrowse link
G Ezr ezrin multiple interactions EXP lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183 		JBrowse link
G Fabp9 fatty acid binding protein 9, testis decreases expression ISO lead nitrate results in decreased expression of FABP9 mRNA CTD PMID:21628963 NCBI chr 3:10,258,683...10,262,343
Ensembl chr 3:10,258,681...10,262,343 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 increases expression ISO lead nitrate results in increased expression of FDFT1 mRNA CTD PMID:15475176 NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027 		JBrowse link
G Fdps farnesyl diphosphate synthetase increases expression ISO lead nitrate results in increased expression of FDPS mRNA CTD PMID:15475176 NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266 		JBrowse link
G Fhl1 four and a half LIM domains 1 decreases expression ISO lead nitrate results in decreased expression of FHL1 mRNA CTD PMID:21628963 NCBI chr  X:55,776,569...55,838,704
Ensembl chr  X:55,777,147...55,838,706 		JBrowse link
G Fos FBJ osteosarcoma oncogene increases expression ISO lead nitrate results in increased expression of FOS mRNA CTD PMID:14971657 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047 		JBrowse link
G Foxa2 forkhead box A2 multiple interactions EXP lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889 		JBrowse link
G Ftl1 ferritin light polypeptide 1 increases expression ISO lead nitrate results in increased expression of FTL protein CTD PMID:19332663 NCBI chr 7:45,107,368...45,109,310
Ensembl chr 7:45,107,368...45,109,308 		JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked decreases activity ISO lead nitrate results in decreased activity of G6PD protein CTD PMID:28557068 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha increases expression ISO lead nitrate results in increased expression of GADD45A mRNA CTD PMID:14971657 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441 		JBrowse link
G Garin1b golgi associated RAB2 interactor 1B decreases expression ISO lead nitrate results in decreased expression of GARIN1B mRNA CTD PMID:21628963 NCBI chr 6:29,313,468...29,336,021
Ensembl chr 6:29,319,139...29,336,018 		JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions
increases expression 		ISO Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of GFAP protein]
lead nitrate results in increased expression of GFAP mRNA; lead nitrate results in increased expression of GFAP protein 		CTD PMID:24987671 NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738 		JBrowse link
G Ggnbp1 gametogenetin binding protein 1 decreases expression ISO lead nitrate results in decreased expression of GGNBP1 mRNA CTD PMID:21628963 NCBI chr17:27,237,009...27,255,352
Ensembl chr17:27,236,961...27,256,598 		JBrowse link
G Gh growth hormone multiple interactions
decreases secretion 		ISO lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein]
lead nitrate results in decreased secretion of GH1 protein 		CTD PMID:12022635 NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691 		JBrowse link
G Ghrh growth hormone releasing hormone multiple interactions ISO lead nitrate inhibits the reaction [GHRH protein results in increased expression of GH1 protein] CTD PMID:12022635 NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426 		JBrowse link
G Gja5 gap junction protein, alpha 5 multiple interactions
increases expression 		EXP lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA]
lead nitrate results in increased expression of GJA5 mRNA 		CTD PMID:11891201 NCBI chr 3:96,939,718...96,960,950
Ensembl chr 3:96,812,009...96,984,732 		JBrowse link
G Gjb2 gap junction protein, beta 2 multiple interactions EXP lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159 		JBrowse link
G Gm128 predicted gene 128 decreases expression ISO lead nitrate results in decreased expression of C2H1ORF56 mRNA CTD PMID:21628963 NCBI chr 3:95,144,230...95,148,946
Ensembl chr 3:95,144,231...95,148,909 		JBrowse link
G Gm22711 predicted gene, 22711 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA50C mRNA CTD PMID:32949613 NCBI chr11:106,392,071...106,392,203
Ensembl chr11:106,392,071...106,392,203
Ensembl chr11:106,392,071...106,392,203 		JBrowse link
G Gm24523 predicted gene, 24523 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA72 mRNA CTD PMID:32949613 NCBI chr15:34,440,937...34,441,068
Ensembl chr15:34,440,937...34,441,068 		JBrowse link
G Gm25636 predicted gene, 25636 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA13 mRNA CTD PMID:32949613 NCBI chr 7:109,622,417...109,622,549
Ensembl chr 7:109,622,417...109,622,549 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of GOT1 protein CTD PMID:39414706 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044 		JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of GPT protein CTD PMID:39414706 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886 		JBrowse link
G Grin2a glutamate receptor, ionotropic, NMDA2A (epsilon 1) multiple interactions EXP lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424 		JBrowse link
G Grin2c glutamate receptor, ionotropic, NMDA2C (epsilon 3) increases expression ISO lead nitrate results in increased expression of GRIN2C mRNA CTD PMID:23358146 NCBI chr11:115,139,995...115,158,123
Ensembl chr11:115,139,995...115,158,069 		JBrowse link
G Gsg1 germ cell associated 1 decreases expression ISO lead nitrate results in decreased expression of GSG1 mRNA CTD PMID:21628963 NCBI chr 6:135,214,327...135,231,334
Ensembl chr 6:135,214,324...135,231,349
Ensembl chr 6:135,214,324...135,231,349 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions EXP [lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein] CTD PMID:30731080 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446 		JBrowse link
G Gsr glutathione reductase multiple interactions
decreases activity 		EXP mangiferin inhibits the reaction [lead nitrate results in decreased activity of GSR protein] CTD PMID:23451106 NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191 		JBrowse link
G Gstt1 glutathione S-transferase, theta 1 multiple interactions EXP lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418 		JBrowse link
G Hamp hepcidin antimicrobial peptide multiple interactions EXP [lead nitrate co-treated with EIF2AK1 gene mutant form] results in increased expression of HAMP mRNA CTD PMID:25411909 NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457 		JBrowse link
G Hmgb4 high-mobility group box 4 decreases expression ISO lead nitrate results in decreased expression of HMGB4 mRNA CTD PMID:21628963 NCBI chr 4:128,154,005...128,154,688
Ensembl chr 4:128,154,005...128,154,750 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase increases expression
multiple interactions 		EXP
ISO 		lead nitrate results in increased expression of HMGCR mRNA
[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA] 		CTD PMID:15475176 PMID:16705668 PMID:22293356 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression ISO lead nitrate results in increased expression of HMOX1 mRNA CTD PMID:23391631 PMID:34189835 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Hnf4a hepatic nuclear factor 4, alpha decreases expression EXP lead nitrate results in decreased expression of HNF4A mRNA CTD PMID:16049268 NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha (cytosolic), class B member 1 multiple interactions EXP lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197 		JBrowse link
G Hspa2 heat shock protein 2 multiple interactions
decreases expression
increases expression 		ISO Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA2 mRNA]
lead nitrate results in decreased expression of HSPA2 mRNA 		CTD PMID:21628963 PMID:24987671 NCBI chr12:76,450,688...76,453,712
Ensembl chr12:76,450,950...76,453,712 		JBrowse link
G Hspa5 heat shock protein 5 increases expression EXP
ISO 		lead nitrate results in increased expression of HSPA5 protein
lead nitrate results in increased expression of HSPA5 mRNA 		CTD PMID:14971657 PMID:20435106 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559 		JBrowse link
G Hspa9 heat shock protein 9 multiple interactions
increases expression 		ISO Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in increased expression of HSPA9 protein]
lead nitrate results in increased expression of HSPA9 mRNA; lead nitrate results in increased expression of HSPA9 protein 		CTD PMID:24987671 NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410 		JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions EXP lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of IGFBP1 mRNA CTD PMID:32949613 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 multiple interactions EXP lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions
increases expression 		EXP [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate
lead nitrate results in increased expression of IL1A mRNA 		CTD PMID:22293356 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892 		JBrowse link
G Il1b interleukin 1 beta multiple interactions
increases expression 		EXP
ISO 		[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of CYP51 mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of HMGCR mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [IL1A gene mutant form co-treated with IL1B gene mutant form] results in decreased susceptibility to lead nitrate
lead nitrate results in increased expression of IL1B mRNA
lead nitrate results in increased expression of IL1B mRNA; lead nitrate results in increased expression of IL1B protein 		CTD PMID:15475176 PMID:16049268 PMID:22293356 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il2 interleukin 2 decreases secretion ISO lead nitrate results in decreased secretion of IL2 protein CTD PMID:27714827 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108 		JBrowse link
G Il6 interleukin 6 multiple interactions EXP [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of IL6 protein CTD PMID:39414706 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979 		JBrowse link
G Il6ra interleukin 6 receptor, alpha multiple interactions EXP lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503 		JBrowse link
G Ins1 insulin I multiple interactions EXP [lead nitrate results in increased abundance of Lead] inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:33038468 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Iqcf1 IQ motif containing F1 decreases expression ISO lead nitrate results in decreased expression of IQCF1 mRNA CTD PMID:21628963 NCBI chr 9:106,377,166...106,379,449
Ensembl chr 9:106,377,166...106,379,453 		JBrowse link
G Iqcf5 IQ motif containing F5 decreases expression ISO lead nitrate results in decreased expression of IQCF5 mRNA CTD PMID:21628963 NCBI chr 9:106,391,772...106,393,202
Ensembl chr 9:106,391,772...106,393,209 		JBrowse link
G Itga6 integrin alpha 6 multiple interactions EXP lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 2:71,617,236...71,688,761
Ensembl chr 2:71,575,960...71,688,760 		JBrowse link
G Itgam integrin alpha M multiple interactions EXP lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663 		JBrowse link
G Krt14 keratin 14 increases expression EXP lead nitrate results in increased expression of KRT14 protein CTD PMID:20435106 NCBI chr11:100,093,988...100,098,336
Ensembl chr11:100,093,988...100,098,374 		JBrowse link
G Lamp1 lysosomal-associated membrane protein 1 increases expression EXP lead nitrate results in increased expression of LAMP1 protein CTD PMID:23376802 NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338 		JBrowse link
G Lamp2 lysosomal-associated membrane protein 2 increases expression EXP lead nitrate results in increased expression of LAMP2 protein CTD PMID:23376802 NCBI chr  X:37,488,524...37,545,337
Ensembl chr  X:37,490,234...37,545,331 		JBrowse link
G Ldhc lactate dehydrogenase C decreases expression ISO lead nitrate results in decreased expression of LDHC mRNA CTD PMID:21628963 NCBI chr 7:46,510,687...46,527,571
Ensembl chr 7:46,510,627...46,527,566 		JBrowse link
G Lrrc46 leucine rich repeat containing 46 decreases expression ISO lead nitrate results in decreased expression of LRRC46 mRNA CTD PMID:21628963 NCBI chr11:96,925,428...96,932,195
Ensembl chr11:96,925,428...96,932,233 		JBrowse link
G Lta lymphotoxin A multiple interactions EXP lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327 		JBrowse link
G Lum lumican multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of LUM mRNA CTD PMID:32949613 NCBI chr10:97,401,363...97,408,565
Ensembl chr10:97,400,990...97,408,565 		JBrowse link
G Lypd4 Ly6/Plaur domain containing 4 decreases expression ISO lead nitrate results in decreased expression of LYPD4 mRNA CTD PMID:21628963 NCBI chr 7:24,564,044...24,569,180
Ensembl chr 7:24,564,045...24,569,366 		JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO [lead nitrate results in increased abundance of Lead] which results in increased expression of MAP1LC3B protein CTD PMID:39579145 NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499 		JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions
increases phosphorylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein]
mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK1 protein] 		CTD PMID:20850495 PMID:22502979 PMID:23451106 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317 		JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions
increases phosphorylation 		ISO
EXP 		2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]; RTKI cpd inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein]
mangiferin inhibits the reaction [lead nitrate results in increased phosphorylation of MAPK3 protein] 		CTD PMID:20850495 PMID:22502979 PMID:23451106 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991 		JBrowse link
G Marchf11 membrane associated ring-CH-type finger 11 decreases expression ISO lead nitrate results in decreased expression of MARCHF11 mRNA CTD PMID:21628963 NCBI chr15:26,309,134...26,409,672
Ensembl chr15:26,309,134...26,409,662 		JBrowse link
G Mcl1 myeloid cell leukemia sequence 1 multiple interactions EXP lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487 		JBrowse link
G Met met proto-oncogene multiple interactions EXP lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions EXP lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753 		JBrowse link
G Mir139 microRNA 139 increases expression ISO lead nitrate results in increased expression of MIR139 mRNA CTD PMID:35738543 NCBI chr 7:101,124,583...101,124,650
Ensembl chr 7:101,124,583...101,124,650 		JBrowse link
G Mir142 microRNA 142 increases expression ISO lead nitrate results in increased expression of MIR142 mRNA CTD PMID:35738543 NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753 		JBrowse link
G Mir675 microRNA 675 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of MIR675 mRNA CTD PMID:32949613 NCBI chr 7:142,130,801...142,130,884
Ensembl chr 7:142,130,801...142,130,884 		JBrowse link
G Mroh2b maestro heat-like repeat family member 2B decreases expression ISO lead nitrate results in decreased expression of MROH2B mRNA CTD PMID:21628963 NCBI chr15:4,927,697...4,991,689
Ensembl chr15:4,928,219...4,991,687 		JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial multiple interactions
decreases expression 		ISO puerarin inhibits the reaction [lead nitrate results in decreased expression of COX1 mRNA] CTD PMID:23315276 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872 		JBrowse link
G mt-Co2 cytochrome c oxidase II, mitochondrial multiple interactions
decreases expression 		ISO puerarin inhibits the reaction [lead nitrate results in decreased expression of COX2 mRNA] CTD PMID:23315276 NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696 		JBrowse link
G mt-Co3 cytochrome c oxidase III, mitochondrial multiple interactions
decreases expression 		ISO puerarin inhibits the reaction [lead nitrate results in decreased expression of COX3 mRNA] CTD PMID:23315276 NCBI chr MT:8,607...9,390
Ensembl chr MT:8,607...9,390 		JBrowse link
G Mt1 metallothionein 1 affects localization
decreases response to substance
increases expression
multiple interactions 		EXP lead nitrate affects the localization of MT1 protein
MT1 results in decreased susceptibility to lead nitrate
lead nitrate results in increased expression of MT1 mRNA
lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT1 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT1 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] 		CTD PMID:11891201 PMID:19542206 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955 		JBrowse link
G Mt2 metallothionein 2 multiple interactions
decreases response to substance 		EXP lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CCNG1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CTNNA1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [DNASE1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ERCC3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [EZR affects the expression of MT2 mRNA]; lead nitrate affects the reaction [FOXA2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJA5 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GJB2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GRIN2A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [GSTT1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [HSP90AB1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGF2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IGFBP6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [IL6RA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGA6 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ITGAM affects the expression of MT2 mRNA]; lead nitrate affects the reaction [LTA affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MCL1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MET affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MGST1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RAD23 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA]
MT2 results in decreased susceptibility to lead nitrate 		CTD PMID:11891201 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions
increases phosphorylation 		ISO puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of MTOR protein] CTD PMID:27762461 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140 		JBrowse link
G Myc myelocytomatosis oncogene multiple interactions EXP lead nitrate affects the reaction [MYC affects the expression of MT1 mRNA]; lead nitrate affects the reaction [MYC affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223 		JBrowse link
G Myh6 myosin, heavy polypeptide 6, cardiac muscle, alpha decreases expression ISO lead nitrate results in decreased expression of MYH6 protein CTD PMID:23391631 NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384 		JBrowse link
G Myh7 myosin, heavy polypeptide 7, cardiac muscle, beta increases expression
multiple interactions 		ISO lead nitrate results in increased expression of MYH7 mRNA; lead nitrate results in increased expression of MYH7 protein
resveratrol inhibits the reaction [lead nitrate results in increased expression of MYH7 mRNA] 		CTD PMID:23391631 NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083 		JBrowse link
G Ncam1 neural cell adhesion molecule 1 multiple interactions
decreases expression 		ISO Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 mRNA]; Ashwagandha inhibits the reaction [lead nitrate results in decreased expression of NCAM1 protein]
lead nitrate results in decreased expression of NCAM1 mRNA; lead nitrate results in decreased expression of NCAM1 protein 		CTD PMID:24987671 NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225 		JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 (non-protein coding) multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of NEAT1 mRNA CTD PMID:32949613 NCBI chr19:5,874,736...5,895,508
Ensembl chr19:5,874,736...5,897,132 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha decreases expression
multiple interactions 		EXP lead nitrate results in decreased expression of NFKBIA protein
mangiferin inhibits the reaction [lead nitrate results in decreased expression of NFKBIA protein] 		CTD PMID:23451106 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nfkbib nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta multiple interactions EXP lead nitrate affects the reaction [NFKBIB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NFKBIB affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937 		JBrowse link
G Nppb natriuretic peptide type B increases expression ISO lead nitrate results in increased expression of NPPB mRNA CTD PMID:23391631 NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 increases expression ISO lead nitrate results in increased expression of NQO1 mRNA CTD PMID:23391631 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 decreases expression EXP
ISO 		lead nitrate results in decreased expression of NR0B2 mRNA CTD PMID:15475176 PMID:16049268 NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847 		JBrowse link
G Nr1h3 nuclear receptor subfamily 1, group H, member 3 decreases expression ISO lead nitrate results in decreased expression of NR1H3 mRNA CTD PMID:15475176 NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 increases expression EXP lead nitrate results in increased expression of NR5A2 mRNA CTD PMID:16049268 NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186 		JBrowse link
G Numb NUMB endocytic adaptor protein multiple interactions EXP lead nitrate affects the reaction [NUMB affects the expression of MT1 mRNA]; lead nitrate affects the reaction [NUMB affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr12:83,840,808...83,968,708
Ensembl chr12:83,840,808...83,968,708 		JBrowse link
G Odf1 outer dense fiber of sperm tails 1 decreases expression ISO lead nitrate results in decreased expression of ODF1 mRNA CTD PMID:21628963 NCBI chr15:38,219,447...38,226,979
Ensembl chr15:38,219,447...38,226,979 		JBrowse link
G Omd osteomodulin multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of OMD mRNA CTD PMID:32949613 NCBI chr13:49,735,938...49,746,088
Ensembl chr13:49,735,938...49,746,298 		JBrowse link
G Oxct2a 3-oxoacid CoA transferase 2A decreases expression ISO lead nitrate results in decreased expression of OXCT2A mRNA CTD PMID:21628963 NCBI chr 4:123,215,668...123,217,472
Ensembl chr 4:123,215,668...123,217,427 		JBrowse link
G Paqr5 progestin and adipoQ receptor family member V decreases expression ISO lead nitrate results in decreased expression of PAQR5 mRNA CTD PMID:21628963 NCBI chr 9:61,861,020...61,934,085
Ensembl chr 9:61,860,763...61,934,138 		JBrowse link
G Pias2 protein inhibitor of activated STAT 2 multiple interactions EXP lead nitrate affects the reaction [PIAS2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [PIAS2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr18:77,152,883...77,243,406
Ensembl chr18:77,152,904...77,241,496 		JBrowse link
G Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) multiple interactions
increases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 2-aminoethoxydiphenyl borate inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; [lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone; EGFR mutant form affects the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; EGFR mutant form affects the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; EGFR promotes the reaction [lead nitrate results in increased expression of PLA2G4A mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PLA2G4A mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PLA2G4A mRNA] CTD PMID:20850495 NCBI chr 1:149,705,369...149,837,041
Ensembl chr 1:149,705,369...149,837,041 		JBrowse link
G Plac8 placenta-specific 8 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of PLAC8 mRNA CTD PMID:32949613 NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111 		JBrowse link
G Pold1 polymerase (DNA directed), delta 1, catalytic subunit multiple interactions EXP lead nitrate affects the reaction [POLD1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POLD1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:44,182,168...44,198,239
Ensembl chr 7:44,182,170...44,198,273 		JBrowse link
G Pou3f3 POU domain, class 3, transcription factor 3 multiple interactions EXP lead nitrate affects the reaction [POU3F3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [POU3F3 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 1:42,734,928...42,739,370
Ensembl chr 1:42,734,085...42,742,336 		JBrowse link
G Prm1 protamine 1 decreases expression ISO lead nitrate results in decreased expression of PRM1 mRNA CTD PMID:21628963 NCBI chr16:10,614,196...10,614,687
Ensembl chr16:10,614,190...10,623,703 		JBrowse link
G Prm3 protamine 3 decreases expression ISO lead nitrate results in decreased expression of PRM3 mRNA CTD PMID:21628963 NCBI chr16:10,608,372...10,608,778
Ensembl chr16:10,608,369...10,608,778 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression 		ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein]; [lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone; Decitabine promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; E2F1 protein inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; lead nitrate inhibits the reaction [E2F1 protein results in decreased expression of PTGS2 mRNA]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [[lead nitrate results in increased expression of PTGS2 mRNA] which results in increased secretion of Dinoprostone]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of PTGS2 protein]
lead nitrate results in increased expression of PTGS2 mRNA; lead nitrate results in increased expression of PTGS2 protein 		CTD PMID:20850495 PMID:21435385 PMID:24639330 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978 		JBrowse link
G Rb1 RB transcriptional corepressor 1 multiple interactions
increases expression 		ISO 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [lead nitrate results in increased expression of RB1 protein]; lead nitrate promotes the reaction [RB1 protein results in increased expression of PTGS2 mRNA]; RB1 protein promotes the reaction [lead nitrate results in increased expression of PTGS2 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 mRNA]; RTKI cpd inhibits the reaction [lead nitrate results in increased expression of RB1 protein] CTD PMID:24639330 NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262 		JBrowse link
G Rbl2 RB transcriptional corepressor like 2 multiple interactions EXP lead nitrate affects the reaction [RBL2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RBL2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472 		JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases expression 		EXP
ISO 		mangiferin inhibits the reaction [lead nitrate results in increased expression of RELA protein]
lead nitrate results in increased expression of RELA mRNA; lead nitrate results in increased expression of RELA protein
RELA promotes the reaction [lead nitrate results in decreased expression of GSTA1 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA] 		CTD PMID:23451106 PMID:31682781 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158 		JBrowse link
G Ribc2 RIB43A domain with coiled-coils 2 decreases expression ISO lead nitrate results in decreased expression of RIBC2 mRNA CTD PMID:21628963 NCBI chr15:85,016,261...85,028,771
Ensembl chr15:85,016,279...85,028,771 		JBrowse link
G Rps2 ribosomal protein S2 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of RPS2 mRNA CTD PMID:32949613 NCBI chr17:24,939,037...24,940,901
Ensembl chr17:24,937,090...24,940,903 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions
increases phosphorylation 		ISO puerarin inhibits the reaction [lead nitrate results in increased phosphorylation of RPS6KB1 protein] CTD PMID:27762461 NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631 		JBrowse link
G Runx1 runt related transcription factor 1 multiple interactions EXP lead nitrate affects the reaction [RUNX1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [RUNX1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr16:92,398,354...92,622,962
Ensembl chr16:92,398,354...92,623,037 		JBrowse link
G Runx2 runt related transcription factor 2 multiple interactions EXP
ISO 		[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein]
lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of RUNX2 mRNA] 		CTD PMID:30731080 PMID:35738543 NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684 		JBrowse link
G Scgn secretagogin, EF-hand calcium binding protein multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SCGN mRNA CTD PMID:32949613 NCBI chr13:24,137,439...24,175,310
Ensembl chr13:24,137,439...24,175,197 		JBrowse link
G Serpina1b serine (or cysteine) preptidase inhibitor, clade A, member 1B multiple interactions EXP lead nitrate affects the reaction [SERPINA1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SERPINA1B affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr12:103,694,415...103,704,448
Ensembl chr12:103,694,415...103,796,632 		JBrowse link
G Smcp sperm mitochondria-associated cysteine-rich protein decreases expression ISO lead nitrate results in decreased expression of SMCP mRNA CTD PMID:21628963 NCBI chr 3:92,491,173...92,496,380
Ensembl chr 3:92,491,174...92,496,304 		JBrowse link
G Snca synuclein, alpha affects localization
multiple interactions
increases expression 		EXP lead nitrate affects the localization of SNCA protein
MT1 protein promotes the reaction [lead nitrate results in increased expression of SNCA mRNA] 		CTD PMID:19542206 NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839 		JBrowse link
G Snora64 small nucleolar RNA, H/ACA box 64 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA64 mRNA CTD PMID:32949613 NCBI chr17:24,939,763...24,939,879
Ensembl chr17:24,939,746...24,939,879 		JBrowse link
G Snora65 small nucleolar RNA, H/ACA box 65 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNORA65 mRNA CTD PMID:32949613 NCBI chr 2:32,853,313...32,853,430
Ensembl chr 2:32,853,303...32,853,432 		JBrowse link
G Socs1 suppressor of cytokine signaling 1 multiple interactions EXP lead nitrate affects the reaction [SOCS1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SOCS1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400 		JBrowse link
G Sod1 superoxide dismutase 1, soluble multiple interactions
decreases activity 		ISO Ashwagandha inhibits the reaction [lead nitrate results in decreased activity of SOD1 protein] CTD PMID:24987671 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217 		JBrowse link
G Sp3 trans-acting transcription factor 3 multiple interactions
decreases expression 		EXP lead nitrate affects the reaction [SP3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SP3 affects the expression of MT2 mRNA]
lead nitrate results in decreased expression of SP3 mRNA 		CTD PMID:11891201 NCBI chr 2:72,766,774...72,810,790
Ensembl chr 2:72,766,771...72,810,790 		JBrowse link
G Spata18 spermatogenesis associated 18 decreases expression ISO lead nitrate results in decreased expression of SPATA18 mRNA CTD PMID:21628963 NCBI chr 5:73,808,723...73,836,927
Ensembl chr 5:73,808,722...73,836,855 		JBrowse link
G Spata20 spermatogenesis associated 20 decreases expression ISO lead nitrate results in decreased expression of SPATA20 mRNA CTD PMID:21628963 NCBI chr11:94,369,730...94,376,136
Ensembl chr11:94,369,730...94,377,005 		JBrowse link
G Spata21 spermatogenesis associated 21 decreases expression ISO lead nitrate results in decreased expression of SPATA21 mRNA CTD PMID:21628963 NCBI chr 4:140,815,631...140,840,071
Ensembl chr 4:140,815,644...140,840,071 		JBrowse link
G Spata6 spermatogenesis associated 6 decreases expression ISO lead nitrate results in decreased expression of SPATA6 mRNA CTD PMID:21628963 NCBI chr 4:111,577,151...111,686,339
Ensembl chr 4:111,577,181...111,686,381 		JBrowse link
G Spp2 secreted phosphoprotein 2 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of SPP2 mRNA CTD PMID:32949613 NCBI chr 1:88,334,688...88,356,022
Ensembl chr 1:88,334,683...88,354,160 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
increases expression 		EXP
ISO 		lead nitrate affects the reaction [SQSTM1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SQSTM1 affects the expression of MT2 mRNA]
puerarin inhibits the reaction [lead nitrate results in increased expression of SQSTM1 protein] 		CTD PMID:11891201 PMID:27762461 NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654 		JBrowse link
G Srebf2 sterol regulatory element binding factor 2 increases expression ISO lead nitrate results in increased expression of SREBF2 mRNA CTD PMID:15475176 PMID:16705668 NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580 		JBrowse link
G Sumo1 small ubiquitin-like modifier 1 multiple interactions EXP lead nitrate affects the reaction [SUMO1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [SUMO1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 1:59,678,593...59,709,993
Ensembl chr 1:59,625,717...59,709,993 		JBrowse link
G Susd2 sushi domain containing 2 multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of SUSD2 mRNA CTD PMID:32949613 NCBI chr10:75,472,453...75,479,842
Ensembl chr10:75,472,540...75,479,842 		JBrowse link
G Tbx2 T-box 2 multiple interactions EXP lead nitrate affects the reaction [TBX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TBX2 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr11:85,723,441...85,732,774
Ensembl chr11:85,723,377...85,732,774 		JBrowse link
G Tekt2 tektin 2 decreases expression ISO lead nitrate results in decreased expression of TEKT2 mRNA CTD PMID:21628963 NCBI chr 4:126,215,914...126,219,481
Ensembl chr 4:126,215,914...126,219,481 		JBrowse link
G Tekt4 tektin 4 decreases expression ISO lead nitrate results in decreased expression of TEKT4 mRNA CTD PMID:21628963 NCBI chr17:25,673,511...25,695,576
Ensembl chr17:25,673,515...25,695,576 		JBrowse link
G Tmod1 tropomodulin 1 decreases expression ISO lead nitrate results in decreased expression of TMOD1 mRNA CTD PMID:21628963 NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression 		EXP
ISO 		[IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in increased expression of TNF mRNA]; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead nitrate co-treated with Mercuric Chloride co-treated with chromium trioxide co-treated with chromium trioxide co-treated with manganese chloride co-treated with ferric chloride] results in increased expression of TNF protein
[lead nitrate results in increased abundance of Lead] which results in increased secretion of TNF protein
Lead nitrate increases expression of Tnf mRNA in liver 		CTD
RGD		 PMID:15475176 PMID:16049268 PMID:22293356 PMID:39414706 PMID:39579145 More... RGD:14995487, RGD:14995476 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983 		JBrowse link
G Tnfrsf1a tumor necrosis factor receptor superfamily, member 1a multiple interactions EXP lead nitrate affects the reaction [TNFRSF1A affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1A affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447 		JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b multiple interactions EXP lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440 		JBrowse link
G Tnp1 transition protein 1 decreases expression ISO lead nitrate results in decreased expression of TNP1 mRNA CTD PMID:21628963 NCBI chr 1:73,054,233...73,055,058
Ensembl chr 1:73,054,233...73,055,068 		JBrowse link
G Tnp2 transition protein 2 decreases expression ISO lead nitrate results in decreased expression of TNP2 mRNA CTD PMID:21628963 NCBI chr16:10,605,799...10,606,519
Ensembl chr16:10,605,800...10,606,524 		JBrowse link
G Tppp2 tubulin polymerization-promoting protein family member 2 decreases expression ISO lead nitrate results in decreased expression of TPPP2 mRNA CTD PMID:21628963 NCBI chr14:52,155,887...52,158,161
Ensembl chr14:52,155,882...52,158,157 		JBrowse link
G Trim27 tripartite motif-containing 27 multiple interactions EXP lead nitrate affects the reaction [TRIM27 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TRIM27 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr13:21,363,570...21,378,893
Ensembl chr13:21,363,615...21,378,894 		JBrowse link
G Trp53 transformation related protein 53 increases expression
multiple interactions 		ISO lead nitrate results in increased expression of TP53 mRNA
[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA; AHR promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; RELA promotes the reaction [lead nitrate results in increased expression of TP53 mRNA]; titanium dioxide inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of TP53 mRNA] 		CTD PMID:30738203 PMID:31682781 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699 		JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions ISO lead nitrate inhibits the reaction [Adenosine Diphosphate Ribose results in increased activity of TRPM2 protein] CTD PMID:22750002 NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions EXP [lead nitrate results in increased abundance of Lead] inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] CTD PMID:29957541 NCBI chr  X:139,440,277...139,501,257
Ensembl chr  X:139,440,277...139,501,408 		JBrowse link
G Tsg101 tumor susceptibility gene 101 multiple interactions EXP lead nitrate affects the reaction [TSG101 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TSG101 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 7:46,538,693...46,569,716
Ensembl chr 7:46,538,697...46,569,717 		JBrowse link
G Tssk2 testis-specific serine kinase 2 decreases expression ISO lead nitrate results in decreased expression of TSSK2 mRNA CTD PMID:21628963 NCBI chr16:17,716,501...17,717,888
Ensembl chr16:17,716,501...17,717,888 		JBrowse link
G Tssk3 testis-specific serine kinase 3 decreases expression ISO lead nitrate results in decreased expression of TSSK3 mRNA CTD PMID:21628963 NCBI chr 4:129,382,801...129,385,523
Ensembl chr 4:129,382,807...129,384,815 		JBrowse link
G Ttf1 transcription termination factor, RNA polymerase I multiple interactions EXP lead nitrate affects the reaction [TTF1 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TTF1 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 2:28,950,211...28,977,668
Ensembl chr 2:28,950,274...28,977,668 		JBrowse link
G Tuba8 tubulin, alpha 8 decreases expression ISO lead nitrate results in decreased expression of TUBA8 mRNA CTD PMID:21628963 NCBI chr 6:121,187,666...121,209,304
Ensembl chr 6:121,187,655...121,203,813 		JBrowse link
G Tulp2 TUB like protein 2 decreases expression ISO lead nitrate results in decreased expression of TULP2 mRNA CTD PMID:21628963 NCBI chr 7:45,131,450...45,173,070
Ensembl chr 7:45,131,301...45,173,056 		JBrowse link
G Wnt1 wingless-type MMTV integration site family, member 1 multiple interactions ISO lead nitrate inhibits the reaction [[Dexamethasone co-treated with beta-glycerophosphoric acid co-treated with ascorbate-2-phosphate] results in increased expression of WNT1 mRNA] CTD PMID:35738543 NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718 		JBrowse link
G Wnt3a wingless-type MMTV integration site family, member 3A multiple interactions EXP [lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA; [lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein] CTD PMID:30731080 NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578 		JBrowse link
G Wnt4 wingless-type MMTV integration site family, member 4 multiple interactions EXP lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037 		JBrowse link
G Zfhx3 zinc finger homeobox 3 multiple interactions EXP lead nitrate affects the reaction [ZFHX3 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [ZFHX3 affects the expression of MT2 mRNA] CTD PMID:11891201 NCBI chr 8:109,005,975...109,688,272
Ensembl chr 8:108,669,276...109,688,262 		JBrowse link
G Znrf4 zinc and ring finger 4 decreases expression ISO lead nitrate results in decreased expression of ZNRF4 mRNA CTD PMID:21628963 NCBI chr17:56,818,248...56,819,483
Ensembl chr17:56,818,248...56,819,431 		JBrowse link
G Zp3r zona pellucida 3 receptor multiple interactions ISO [Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of C4BPA mRNA CTD PMID:32949613 NCBI chr 1:130,474,847...130,557,371
Ensembl chr 1:130,504,450...130,557,358 		JBrowse link
lead oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alb albumin multiple interactions ISO [cupric oxide co-treated with lead oxide co-treated with Zinc Oxide] results in decreased expression of ALB protein CTD PMID:28212817 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions
increases activity 		ISO [cupric oxide co-treated with lead oxide co-treated with Zinc Oxide] results in increased activity of GGT1 protein; [cupric oxide co-treated with lead oxide] results in increased activity of GGT1 protein; [lead oxide co-treated with Zinc Oxide] results in increased activity of GGT1 protein
lead oxide results in increased activity of GGT1 protein 		CTD PMID:28212817 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034 		JBrowse link
G Lhb luteinizing hormone beta decreases expression ISO lead oxide results in decreased expression of LHB protein CTD PMID:28212817 NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321 		JBrowse link
G Prl prolactin multiple interactions ISO [cupric oxide co-treated with lead oxide] results in increased expression of PRL protein CTD PMID:28212817 NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188 		JBrowse link
lead tetraacetate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G App amyloid beta precursor protein decreases expression EXP lead tetraacetate results in decreased expression of APP mRNA CTD PMID:20865013 NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654 		JBrowse link
G Mapt microtubule-associated protein tau decreases expression EXP lead tetraacetate results in decreased expression of MAPT mRNA CTD PMID:20865013 NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916 		JBrowse link
G Nrxn1 neurexin I decreases expression EXP lead tetraacetate results in decreased expression of NRXN1 mRNA CTD PMID:20865013 NCBI chr17:90,341,072...91,400,587
Ensembl chr17:90,341,059...91,400,499 		JBrowse link
G Prnp prion protein decreases expression EXP lead tetraacetate results in decreased expression of PRNP mRNA CTD PMID:20865013 NCBI chr 2:131,751,848...131,780,356
Ensembl chr 2:131,751,848...131,780,349 		JBrowse link
G Syp synaptophysin decreases expression EXP lead tetraacetate results in decreased expression of SYP mRNA CTD PMID:20865013 NCBI chr  X:7,504,819...7,519,495
Ensembl chr  X:7,504,710...7,519,495 		JBrowse link
G Tubb3 tubulin, beta 3 class III decreases expression EXP lead tetraacetate results in decreased expression of TUBB3 mRNA CTD PMID:20865013 NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754 		JBrowse link
lead(0) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G 1110004F10Rik RIKEN cDNA 1110004F10 gene affects expression ISO Lead affects the expression of C11ORF58 mRNA CTD PMID:28903495 NCBI chr 7:115,680,596...115,704,445
Ensembl chr 7:115,638,632...115,704,445 		JBrowse link
G 1700123O20Rik RIKEN cDNA 1700123O20 gene affects expression ISO Lead affects the expression of C14ORF119 mRNA CTD PMID:28903495 NCBI chr14:54,923,628...54,928,201
Ensembl chr14:54,923,673...54,928,198 		JBrowse link
G 1810055G02Rik RIKEN cDNA 1810055G02 gene decreases expression ISO Lead results in decreased expression of C11ORF24 mRNA CTD PMID:19921347 NCBI chr19:3,758,343...3,767,882
Ensembl chr19:3,758,293...3,767,881 		JBrowse link
G 2010003K11Rik RIKEN cDNA 2010003K11 gene affects methylation ISO Lead affects the methylation of C11ORF86 gene CTD PMID:31636367 NCBI chr19:4,546,816...4,548,611
Ensembl chr19:4,546,816...4,548,611 		JBrowse link
G 2210016L21Rik RIKEN cDNA 2210016L21 gene affects splicing ISO Lead affects the splicing of C12ORF43 mRNA CTD PMID:28903495 NCBI chr 5:115,080,213...115,086,610
Ensembl chr 5:115,080,217...115,087,842 		JBrowse link
G 2610524H06Rik RIKEN cDNA 2610524H06 gene increases expression ISO Lead results in increased expression of C12ORF76 mRNA CTD PMID:19921347 NCBI chr 5:114,959,998...114,961,529
Ensembl chr 5:114,946,257...114,961,529 		JBrowse link
G 2700049A03Rik RIKEN cDNA 2700049A03 gene affects expression ISO Lead affects the expression of KIAA0586 mRNA CTD PMID:28903495 NCBI chr12:71,183,627...71,356,273
Ensembl chr12:71,183,622...71,290,077 		JBrowse link
G 4833439L19Rik RIKEN cDNA 4833439L19 gene affects splicing ISO Lead affects the splicing of KIAA1191 mRNA CTD PMID:28903495 NCBI chr13:54,699,031...54,713,195
Ensembl chr13:54,699,031...54,713,248 		JBrowse link
G 4930469K13Rik RIKEN cDNA 4930469K13 gene increases expression ISO Lead results in increased expression of C5ORF58 mRNA CTD PMID:19921347 NCBI chr11:33,923,961...34,048,554
Ensembl chr11:33,923,961...34,053,738 		JBrowse link
G 4930579G24Rik RIKEN cDNA 4930579G24 gene affects expression ISO Lead affects the expression of C4ORF46 mRNA CTD PMID:28903495 NCBI chr 3:79,536,386...79,540,127
Ensembl chr 3:79,536,386...79,540,127 		JBrowse link
G 9930012K11Rik RIKEN cDNA 9930012K11 gene increases expression ISO Lead results in increased expression of C8ORF58 mRNA CTD PMID:19921347 NCBI chr14:70,391,854...70,396,951
Ensembl chr14:70,391,854...70,396,951 		JBrowse link
G A130010J15Rik RIKEN cDNA A130010J15 gene affects methylation ISO Lead affects the methylation of C1ORF74 gene CTD PMID:31636367 NCBI chr 1:192,855,777...192,860,145
Ensembl chr 1:192,850,354...192,860,140 		JBrowse link
G A2m alpha-2-macroglobulin affects binding ISO A2M protein binds to Lead CTD PMID:23896426 NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186 		JBrowse link
G A930009A15Rik RIKEN cDNA A930009A15 gene affects binding ISO DCD protein binds to Lead CTD PMID:23896426 NCBI chr10:115,399,555...115,418,359
Ensembl chr10:115,405,891...115,418,353 		JBrowse link
G Aagab alpha- and gamma-adaptin binding protein affects expression ISO Lead affects the expression of AAGAB mRNA CTD PMID:28903495 NCBI chr 9:63,509,897...63,551,872
Ensembl chr 9:63,509,942...63,551,870 		JBrowse link
G Abca2 ATP-binding cassette, sub-family A member 2 affects expression ISO Lead affects the expression of ABCA2 mRNA CTD PMID:28903495 NCBI chr 2:25,318,611...25,338,556
Ensembl chr 2:25,318,715...25,338,552 		JBrowse link
G Abca3 ATP-binding cassette, sub-family A member 3 affects expression ISO Lead affects the expression of ABCA3 mRNA CTD PMID:28903495 NCBI chr17:24,570,997...24,629,178
Ensembl chr17:24,570,924...24,629,175 		JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A affects abundance ISO ABCB1 gene polymorphism affects the abundance of Lead CTD PMID:25728017 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575 		JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 increases expression ISO Lead results in increased expression of ABCC3 mRNA CTD PMID:19921347 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823 		JBrowse link
G Abcf1 ATP-binding cassette, sub-family F member 1 decreases expression ISO Lead results in decreased expression of ABCF1 mRNA CTD PMID:19921347 NCBI chr17:36,267,711...36,280,642
Ensembl chr17:36,267,711...36,280,653 		JBrowse link
G Abcg4 ATP binding cassette subfamily G member 4 affects expression ISO Lead affects the expression of ABCG4 mRNA CTD PMID:28903495 NCBI chr 9:44,184,485...44,199,953
Ensembl chr 9:44,184,485...44,199,912 		JBrowse link
G Abhd12 abhydrolase domain containing 12 decreases expression ISO Lead results in decreased expression of ABHD12 mRNA CTD PMID:19921347 NCBI chr 2:150,674,413...150,746,705
Ensembl chr 2:150,674,413...150,746,661 		JBrowse link
G Abhd2 abhydrolase domain containing 2 affects expression ISO Lead affects the expression of ABHD2 mRNA CTD PMID:28903495 NCBI chr 7:78,923,002...79,015,257
Ensembl chr 7:78,922,947...79,015,256 		JBrowse link
G Abhd8 abhydrolase domain containing 8 affects expression ISO Lead affects the expression of ABHD8 mRNA CTD PMID:28903495 NCBI chr 8:71,909,344...71,917,351
Ensembl chr 8:71,909,349...71,916,299
Ensembl chr 8:71,909,349...71,916,299 		JBrowse link
G Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase decreases expression ISO Lead results in decreased expression of ABL2 mRNA CTD PMID:19921347 NCBI chr 1:156,386,160...156,477,189
Ensembl chr 1:156,386,356...156,477,138 		JBrowse link
G Ablim1 actin-binding LIM protein 1 affects splicing
affects expression 		ISO Lead affects the splicing of ABLIM1 mRNA
Lead affects the expression of ABLIM1 mRNA 		CTD PMID:28903495 NCBI chr19:57,021,165...57,303,776
Ensembl chr19:57,021,165...57,303,351 		JBrowse link
G Ablim2 actin-binding LIM protein 2 affects expression ISO Lead affects the expression of ABLIM2 mRNA CTD PMID:28903495 NCBI chr 5:35,915,200...36,042,323
Ensembl chr 5:35,915,224...36,042,317 		JBrowse link
G Ablim3 actin binding LIM protein family, member 3 affects methylation ISO Lead affects the methylation of ABLIM3 gene CTD PMID:31636367 NCBI chr18:61,932,463...62,044,956
Ensembl chr18:61,932,463...62,044,895 		JBrowse link
G Abr active BCR-related gene affects methylation ISO Lead affects the methylation of ABR gene CTD PMID:31636367 NCBI chr11:76,307,560...76,468,515
Ensembl chr11:76,307,560...76,514,384 		JBrowse link
G Abt1 activator of basal transcription 1 affects expression ISO Lead affects the expression of ABT1 mRNA CTD PMID:28903495 NCBI chr13:23,602,531...23,608,036
Ensembl chr13:23,602,531...23,608,036 		JBrowse link
G Acaca acetyl-Coenzyme A carboxylase alpha increases expression EXP Lead results in increased expression of ACACA mRNA CTD PMID:29529432 NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477 		JBrowse link
G Acacb acetyl-Coenzyme A carboxylase beta decreases expression
affects methylation 		ISO Lead results in decreased expression of ACACB mRNA
Lead affects the methylation of ACACB gene 		CTD PMID:19921347 PMID:31636367 NCBI chr 5:114,284,748...114,388,822
Ensembl chr 5:114,284,596...114,388,822 		JBrowse link
G Acadl acyl-Coenzyme A dehydrogenase, long-chain decreases expression ISO Lead results in decreased expression of ACADL mRNA CTD PMID:19921347 NCBI chr 1:66,869,998...66,902,468
Ensembl chr 1:66,869,998...66,902,436 		JBrowse link
G Acadm acyl-Coenzyme A dehydrogenase, medium chain affects expression ISO Lead affects the expression of ACADM mRNA CTD PMID:28903495 NCBI chr 3:153,627,990...153,650,280
Ensembl chr 3:153,627,994...153,650,269 		JBrowse link
G Acbd4 acyl-Coenzyme A binding domain containing 4 affects expression ISO Lead affects the expression of ACBD4 mRNA CTD PMID:28903495 NCBI chr11:102,992,524...103,003,026
Ensembl chr11:102,992,508...103,005,229 		JBrowse link
G Acbd5 acyl-Coenzyme A binding domain containing 5 affects expression ISO Lead affects the expression of ACBD5 mRNA CTD PMID:28903495 NCBI chr 2:22,958,189...23,004,525
Ensembl chr 2:22,958,179...23,005,570 		JBrowse link
G Acd adrenocortical dysplasia decreases expression ISO Lead results in decreased expression of ACD mRNA CTD PMID:19921347 NCBI chr 8:106,424,789...106,427,748
Ensembl chr 8:106,422,492...106,427,734 		JBrowse link
G Ace angiotensin I converting enzyme increases activity ISO Lead results in increased activity of ACE protein CTD PMID:21364929 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790 		JBrowse link
G Ache acetylcholinesterase decreases activity
affects expression
multiple interactions 		ISO Lead results in decreased activity of ACHE protein
Lead affects the expression of ACHE mRNA
[Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium co-treated with Zinc] results in increased activity of ACHE protein; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese co-treated with Selenium] results in increased activity of ACHE protein; [Aluminum co-treated with Lead co-treated with Mercury co-treated with Manganese] results in increased activity of ACHE protein; [lead acetate results in increased abundance of Lead] which results in decreased activity of ACHE protein; [lead acetate results in increased abundance of Lead] which results in increased activity of ACHE protein; Aluminum promotes the reaction [Lead results in decreased activity of ACHE protein] 		CTD PMID:15266904 PMID:15452883 PMID:28903495 PMID:35307918 PMID:35398025 More... NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728 		JBrowse link
G Ackr2 atypical chemokine receptor 2 increases expression ISO Lead results in increased expression of ACKR2 mRNA CTD PMID:19921347 NCBI chr 9:121,727,421...121,740,177
Ensembl chr 9:121,727,421...121,740,140 		JBrowse link
G Acox1 acyl-Coenzyme A oxidase 1, palmitoyl increases expression EXP Lead results in increased expression of ACOX1 mRNA CTD PMID:29529432 NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871 		JBrowse link
G Acp1 acid phosphatase 1, soluble affects splicing ISO Lead affects the splicing of ACP1 mRNA CTD PMID:28903495 NCBI chr12:30,943,325...30,961,616
Ensembl chr12:30,943,325...30,961,588 		JBrowse link
G Acrv1 acrosomal vesicle protein 1 decreases expression ISO Lead results in decreased expression of ACRV1 mRNA CTD PMID:19921347 NCBI chr 9:36,604,550...36,610,139
Ensembl chr 9:36,604,516...36,610,139 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 decreases expression ISO Lead results in decreased expression of ACSBG1 mRNA CTD PMID:19921347 NCBI chr 9:54,512,163...54,569,169
Ensembl chr 9:54,512,161...54,569,154 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ACSL4 mRNA CTD PMID:39276841 NCBI chr  X:141,100,989...141,173,792
Ensembl chr  X:141,100,989...141,173,531 		JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 decreases expression ISO Lead results in decreased expression of ACSM1 mRNA CTD PMID:33194959 NCBI chr 7:119,217,035...119,261,738
Ensembl chr 7:119,206,249...119,261,738 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 increases expression ISO Lead results in increased expression of ACSM3 mRNA CTD PMID:37386098 NCBI chr 7:119,360,106...119,384,119
Ensembl chr 7:119,360,146...119,386,736 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 decreases expression ISO Lead results in decreased expression of ACSS1 mRNA CTD PMID:19921347 NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420 		JBrowse link
G Acss3 acyl-CoA synthetase short-chain family member 3 affects expression ISO Lead affects the expression of ACSS3 mRNA CTD PMID:28903495 NCBI chr10:106,769,375...106,959,622
Ensembl chr10:106,769,378...106,959,529 		JBrowse link
G Actb actin, beta affects expression ISO Lead affects the expression of ACTB mRNA CTD PMID:28903495 NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509 		JBrowse link
G Actl6a actin-like 6A affects expression ISO Lead affects the expression of ACTL6A mRNA CTD PMID:28903495 NCBI chr 3:32,762,695...32,781,122
Ensembl chr 3:32,760,447...32,781,122 		JBrowse link
G Actn1 actinin, alpha 1 affects methylation ISO
EXP 		Lead affects the methylation of ACTN1 gene CTD PMID:31636367 PMID:38833407 NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145 		JBrowse link
G Actn2 actinin alpha 2 affects expression ISO Lead affects the expression of ACTN2 mRNA CTD PMID:28903495 NCBI chr13:12,284,312...12,355,613
Ensembl chr13:12,284,312...12,355,641 		JBrowse link
G Actn4 actinin alpha 4 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ACTN4 intron CTD PMID:33445541 NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765 		JBrowse link
G Acvr1 activin A receptor, type 1 affects expression ISO Lead affects the expression of ACVR1 mRNA CTD PMID:28903495 NCBI chr 2:58,336,450...58,456,840
Ensembl chr 2:58,278,656...58,457,169 		JBrowse link
G Acvr1c activin A receptor, type IC increases expression ISO Lead results in increased expression of ACVR1C mRNA CTD PMID:19921347 NCBI chr 2:58,157,465...58,247,909
Ensembl chr 2:58,157,465...58,247,907 		JBrowse link
G Acyp1 acylphosphatase 1 affects expression ISO Lead affects the expression of ACYP1 mRNA CTD PMID:28903495 NCBI chr12:85,319,172...85,335,257
Ensembl chr12:85,319,172...85,335,212 		JBrowse link
G Adam23 a disintegrin and metallopeptidase domain 23 increases methylation EXP Lead results in increased methylation of ADAM23 gene CTD PMID:38833407 NCBI chr 1:63,484,880...63,635,263
Ensembl chr 1:63,485,050...63,635,435 		JBrowse link
G Adam9 ADAM metallopeptidase domain 9 decreases expression
affects expression 		ISO Lead results in decreased expression of ADAM9 mRNA
Lead affects the expression of ADAM9 mRNA 		CTD PMID:22313790 PMID:28903495 NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif 1 affects expression ISO Lead affects the expression of ADAMTS1 mRNA CTD PMID:28903495 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001 		JBrowse link
G Adamts12 ADAM metallopeptidase with thrombospondin type 1 motif 12 affects methylation ISO Lead affects the methylation of ADAMTS12 gene CTD PMID:31636367 NCBI chr15:11,064,781...11,349,321
Ensembl chr15:11,064,876...11,349,317 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif 2 affects expression ISO Lead affects the expression of ADAMTS2 mRNA CTD PMID:28903495 NCBI chr11:50,492,912...50,698,400
Ensembl chr11:50,492,911...50,698,400 		JBrowse link
G Adamts3 ADAM metallopeptidase with thrombospondin type 1 motif 3 affects expression ISO Lead affects the expression of ADAMTS3 mRNA CTD PMID:28903495 NCBI chr 5:89,821,700...90,031,521
Ensembl chr 5:89,824,946...90,031,193 		JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif 5 affects expression ISO Lead affects the expression of ADAMTS5 mRNA CTD PMID:28903495 NCBI chr16:85,655,045...85,698,013
Ensembl chr16:85,653,061...85,698,716 		JBrowse link
G Adap1 ArfGAP with dual PH domains 1 affects expression ISO Lead affects the expression of ADAP1 mRNA CTD PMID:28903495 NCBI chr 5:139,257,631...139,311,516
Ensembl chr 5:139,257,631...139,311,377 		JBrowse link
G Adck2 aarF domain containing kinase 2 affects expression ISO Lead affects the expression of ADCK2 mRNA CTD PMID:28903495 NCBI chr 6:39,550,778...39,565,703
Ensembl chr 6:39,550,807...39,565,703 		JBrowse link
G Adcy2 adenylate cyclase 2 affects expression ISO Lead affects the expression of ADCY2 mRNA CTD PMID:28903495 NCBI chr13:68,768,162...69,147,719
Ensembl chr13:68,768,162...69,147,660 		JBrowse link
G Adcy8 adenylate cyclase 8 affects expression ISO Lead affects the expression of ADCY8 mRNA CTD PMID:28903495 NCBI chr15:64,570,884...64,794,145
Ensembl chr15:64,568,933...64,794,145 		JBrowse link
G Adcy9 adenylate cyclase 9 affects expression ISO Lead affects the expression of ADCY9 mRNA CTD PMID:28903495 NCBI chr16:4,102,750...4,255,094
Ensembl chr16:4,105,393...4,238,362 		JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 affects expression ISO Lead affects the expression of ADCYAP1 mRNA CTD PMID:28903495 NCBI chr17:93,506,448...93,513,967
Ensembl chr17:93,506,445...93,513,965 		JBrowse link
G Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 affects splicing ISO Lead affects the splicing of ADCYAP1R1 mRNA CTD PMID:28903495 NCBI chr 6:55,428,486...55,478,440
Ensembl chr 6:55,428,963...55,478,436 		JBrowse link
G Add1 adducin 1 decreases expression
affects splicing 		ISO Lead results in decreased expression of ADD1 mRNA
Lead affects the splicing of ADD1 mRNA 		CTD PMID:19921347 PMID:28903495 NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652 		JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 affects expression ISO Lead affects the expression of ADGRB1 mRNA CTD PMID:28903495 NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314 		JBrowse link
G Adgrb2 adhesion G protein-coupled receptor B2 affects splicing
affects expression 		ISO Lead affects the splicing of ADGRB2 mRNA
Lead affects the expression of ADGRB2 mRNA 		CTD PMID:28903495 NCBI chr 4:129,878,566...129,916,426
Ensembl chr 4:129,878,663...129,916,426 		JBrowse link
G Adgrl1 adhesion G protein-coupled receptor L1 affects expression
affects splicing 		ISO Lead affects the expression of ADGRL1 mRNA
Lead affects the splicing of ADGRL1 mRNA 		CTD PMID:28903495 NCBI chr 8:84,626,598...84,668,583
Ensembl chr 8:84,626,734...84,668,583 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide increases expression ISO Lead results in increased expression of ADH4 mRNA CTD PMID:19921347 NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653 		JBrowse link
G Adipor1 adiponectin receptor 1 affects expression ISO Lead affects the expression of ADIPOR1 mRNA CTD PMID:28903495 NCBI chr 1:134,343,116...134,361,089
Ensembl chr 1:134,343,116...134,361,089 		JBrowse link
G Adora1 adenosine A1 receptor decreases expression ISO Lead results in decreased expression of ADORA1 mRNA CTD PMID:19921347 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169 		JBrowse link
G Adora2b adenosine A2b receptor affects expression ISO Lead affects the expression of ADORA2B mRNA CTD PMID:28903495 NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279 		JBrowse link
G Adra2a adrenergic receptor, alpha 2a affects expression ISO Lead affects the expression of ADRA2A mRNA CTD PMID:28903495 NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413 		JBrowse link
G Adsl adenylosuccinate lyase affects expression ISO Lead affects the expression of ADSL mRNA CTD PMID:28903495 NCBI chr15:80,832,691...80,855,148
Ensembl chr15:80,832,691...80,855,147 		JBrowse link
G Aff4 AF4/FMR2 family, member 4 affects splicing ISO Lead affects the splicing of AFF4 mRNA CTD PMID:28903495 NCBI chr11:53,240,807...53,312,657
Ensembl chr11:53,241,660...53,312,657 		JBrowse link
G Aftph aftiphilin decreases expression ISO Lead results in decreased expression of AFTPH mRNA CTD PMID:19921347 NCBI chr11:20,635,084...20,691,599
Ensembl chr11:20,635,084...20,691,589 		JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 affects expression ISO Lead affects the expression of AGAP1 mRNA CTD PMID:28903495 NCBI chr 1:89,382,533...89,823,004
Ensembl chr 1:89,382,528...89,825,339 		JBrowse link
G Agap2 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 affects expression ISO Lead affects the expression of AGAP2 mRNA CTD PMID:28903495 NCBI chr10:126,911,154...126,929,039
Ensembl chr10:126,911,153...126,929,038 		JBrowse link
G Agbl4 ATP/GTP binding protein-like 4 decreases expression ISO Lead results in decreased expression of AGBL4 mRNA CTD PMID:19921347 NCBI chr 4:110,254,823...111,521,521
Ensembl chr 4:110,254,858...111,514,707 		JBrowse link
G Ago1 argonaute RISC catalytic subunit 1 affects expression ISO Lead affects the expression of AGO1 mRNA CTD PMID:28903495 NCBI chr 4:126,328,805...126,362,500
Ensembl chr 4:126,328,805...126,362,376 		JBrowse link
G Agpat5 1-acylglycerol-3-phosphate O-acyltransferase 5 affects splicing ISO Lead affects the splicing of AGPAT5 mRNA CTD PMID:28903495 NCBI chr 8:18,896,295...18,934,429
Ensembl chr 8:18,896,293...18,941,377 		JBrowse link
G Agt angiotensinogen decreases activity
affects binding 		ISO Lead results in decreased activity of AGT protein
AGT protein binds to Lead 		CTD PMID:11369112 PMID:23896426 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445 		JBrowse link
G Agtpbp1 ATP/GTP binding protein 1 affects splicing ISO Lead affects the splicing of AGTPBP1 mRNA CTD PMID:28903495 NCBI chr13:59,597,348...59,705,184
Ensembl chr13:59,593,556...59,733,041 		JBrowse link
G Ahr aryl-hydrocarbon receptor multiple interactions
affects expression 		EXP
ISO 		AHR protein promotes the reaction [Lead results in increased activity of CRYZ protein]; AHR protein promotes the reaction [Lead results in increased activity of GSTA2 protein]; Lead results in increased activity of [AHR protein binds to ARNT protein]
Lead affects the expression of AHR mRNA 		CTD PMID:15297030 PMID:16093525 PMID:23631153 NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037 		JBrowse link
G Ahsg alpha-2-HS-glycoprotein affects methylation ISO Lead affects the methylation of AHSG gene CTD PMID:31636367 NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199 		JBrowse link
G AI593442 expressed sequence AI593442 affects expression ISO Lead affects the expression of C11ORF87 mRNA CTD PMID:28903495 NCBI chr 9:52,584,332...52,593,434
Ensembl chr 9:52,584,342...52,591,080 		JBrowse link
G Aifm1 apoptosis-inducing factor, mitochondrion-associated 1 multiple interactions
decreases expression 		ISO [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; [lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]; PPIF protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of AIFM1 protein]
Lead results in decreased expression of AIFM1 mRNA 		CTD PMID:19921347 PMID:31874198 PMID:35300571 NCBI chr  X:47,563,821...47,602,440
Ensembl chr  X:47,563,821...47,602,440 		JBrowse link
G Aifm2 apoptosis-inducing factor, mitochondrion-associated 2 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA CTD PMID:39276841 NCBI chr10:61,551,042...61,575,474
Ensembl chr10:61,551,042...61,575,039 		JBrowse link
G Aire autoimmune regulator affects methylation ISO Lead affects the methylation of AIRE gene CTD PMID:31636367 NCBI chr10:77,865,856...77,879,444
Ensembl chr10:77,865,856...77,879,444 		JBrowse link
G Airn antisense Igf2r RNA decreases methylation EXP Lead results in decreased methylation of AIRN gene CTD PMID:38833407 NCBI chr17:12,960,198...13,078,771
Ensembl chr17:12,960,198...13,079,299 		JBrowse link
G Ajuba ajuba LIM protein affects expression ISO Lead affects the expression of AJUBA mRNA CTD PMID:28903495 NCBI chr14:54,804,926...54,815,118
Ensembl chr14:54,804,929...54,815,015 		JBrowse link
G Ak3 adenylate kinase 3 affects methylation ISO Lead affects the methylation of AK3 gene CTD PMID:31636367 NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361 		JBrowse link
G Ak5 adenylate kinase 5 affects expression ISO Lead affects the expression of AK5 mRNA CTD PMID:28903495 NCBI chr 3:152,168,461...152,373,992
Ensembl chr 3:152,168,452...152,373,997 		JBrowse link
G Akap1 A kinase anchor protein 1 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in increased expression of AKAP1 mRNA CTD PMID:33445541 NCBI chr11:88,721,618...88,755,426
Ensembl chr11:88,721,618...88,755,412 		JBrowse link
G Akap10 A kinase anchor protein 10 affects expression ISO Lead affects the expression of AKAP10 mRNA CTD PMID:28903495 NCBI chr11:61,756,029...61,821,134
Ensembl chr11:61,762,133...61,821,078 		JBrowse link
G Akap6 A kinase anchor protein 6 affects expression ISO Lead affects the expression of AKAP6 mRNA CTD PMID:28903495 NCBI chr12:52,745,371...53,202,351
Ensembl chr12:52,746,166...53,202,382 		JBrowse link
G Akr1c20 aldo-keto reductase family 1, member C20 affects splicing ISO Lead affects the splicing of AKR1C1 mRNA CTD PMID:28903495 NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344 		JBrowse link
G Akr1c21 aldo-keto reductase family 1, member C21 affects splicing
multiple interactions 		ISO Lead affects the splicing of AKR1C2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of AKR1C2 mRNA 		CTD PMID:28903495 PMID:39276841 NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540 		JBrowse link
G Akr1c6 aldo-keto reductase family 1, member C6 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of AKR1C1 mRNA CTD PMID:39276841 NCBI chr13:4,484,354...4,507,529
Ensembl chr13:4,484,305...4,507,876 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 decreases phosphorylation
increases phosphorylation
multiple interactions 		ISO Lead results in decreased phosphorylation of AKT1 protein
Lead results in increased phosphorylation of AKT1 protein
[lead acetate results in increased abundance of Lead] which results in decreased expression of AKT1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of AKT1 protein; Plant Extracts inhibits the reaction [Lead results in increased phosphorylation of AKT1 protein] 		CTD PMID:22129743 PMID:32976933 PMID:36652739 PMID:37269892 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Akt2 thymoma viral proto-oncogene 2 decreases expression ISO Lead results in decreased expression of AKT2 mRNA CTD PMID:19921347 NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251 		JBrowse link
G Akt3 thymoma viral proto-oncogene 3 increases expression ISO Lead results in increased expression of AKT3 mRNA CTD PMID:19921347 NCBI chr 1:176,847,642...177,091,688
Ensembl chr 1:176,847,639...177,085,769 		JBrowse link
G Aktip AKT interacting protein increases expression ISO Lead results in increased expression of AKTIP mRNA CTD PMID:19921347 NCBI chr 8:91,834,267...91,862,122
Ensembl chr 8:91,838,412...91,926,604 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase affects abundance
decreases activity
affects response to substance
multiple interactions
increases methylation
decreases expression
increases response to substance 		ISO ALAD gene SNP affects the abundance of Lead
Lead results in decreased activity of ALAD protein
ALAD gene polymorphism affects the susceptibility to Lead; ALAD gene SNP affects the susceptibility to Lead; ALAD polymorphism affects the susceptibility to Lead; ALAD protein affects the susceptibility to Lead
[Arsenic co-treated with Lead co-treated with Cadmium] results in decreased activity of ALAD protein; [Arsenic co-treated with Lead] results in decreased activity of ALAD protein; [Disulfiram co-treated with Lead] results in decreased activity of ALAD protein; [Lead co-treated with Cadmium] results in decreased activity of ALAD protein; Gallic Acid inhibits the reaction [Lead results in decreased activity of ALAD protein]
Lead results in increased methylation of ALAD promoter
Lead results in decreased expression of ALAD mRNA; Lead results in decreased expression of ALAD protein
[ALAD gene SNP affects the susceptibility to [Opium co-treated with Lead]] which affects the abundance of Lead; [VDR gene polymorphism co-treated with ALAD gene polymorphism] affects the abundance of Lead; [Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]; ALAD gene polymorphism affects the abundance of and affects the susceptibility to Lead; ALAD gene polymorphism affects the susceptibility to and affects the abundance of Lead; ALAD gene SNP affects the susceptibility to [Opium co-treated with Lead]; Cadmium affects the reaction [[Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]]; Uric Acid affects the reaction [ALAD polymorphism affects the susceptibility to Lead]
ALAD gene polymorphism results in increased susceptibility to Lead; ALAD gene SNP results in increased susceptibility to Lead; ALAD protein results in increased susceptibility to Lead 		CTD PMID:2748540 PMID:11049814 PMID:15452883 PMID:16140629 PMID:16263504 More... NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Alas1 aminolevulinic acid synthase 1 increases expression ISO Lead results in increased expression of ALAS1 mRNA CTD PMID:37386098 NCBI chr 9:106,110,654...106,125,153
Ensembl chr 9:106,110,654...106,125,853 		JBrowse link
G Alb albumin affects binding
multiple interactions 		ISO ALB protein binds to Lead
[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein; [Selenium co-treated with Zinc] inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; [Zinc co-treated with Copper co-treated with Manganese co-treated with Potassium Dichromate co-treated with Nickel co-treated with Cadmium co-treated with Lead co-treated with Mercury] affects the expression of ALB protein; Selenium inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein]; Zinc inhibits the reaction [[Lead co-treated with Cadmium co-treated with Mercury co-treated with Arsenic] results in decreased expression of ALB protein] 		CTD PMID:23896426 PMID:30090589 PMID:37676925 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule affects splicing ISO Lead affects the splicing of ALCAM mRNA CTD PMID:28903495 NCBI chr16:52,069,359...52,273,444
Ensembl chr16:52,069,359...52,274,437 		JBrowse link
G Aldh16a1 aldehyde dehydrogenase 16 family, member A1 affects expression ISO Lead affects the expression of ALDH16A1 mRNA CTD PMID:28903495 NCBI chr 7:44,791,257...44,804,008
Ensembl chr 7:44,790,108...44,804,008 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 decreases expression ISO Lead results in decreased expression of ALDH1B1 mRNA CTD PMID:19921347 NCBI chr 4:45,799,022...45,804,608
Ensembl chr 4:45,799,022...45,804,604 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial multiple interactions
affects abundance 		ISO [Ethanol co-treated with Lead] results in decreased expression of and results in decreased activity of ALDH2 protein; Calcium affects the reaction [ALDH2 gene SNP affects the abundance of Lead]; Lead results in decreased expression of and results in decreased activity of ALDH2 protein; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [[Ethanol co-treated with Lead] results in decreased expression of and results in decreased activity of ALDH2 protein]; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Lead results in decreased expression of and results in decreased activity of ALDH2 protein]; NAD inhibits the reaction [[Ethanol co-treated with Lead] results in decreased expression of and results in decreased activity of ALDH2 protein]
[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]; [lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] affects the reaction [Ethanol affects the expression of ALDH2 protein]]; Cyanamide affects the reaction [[lead acetate results in increased abundance of Lead] which affects the expression of ALDH2 protein] 		CTD PMID:28212632 PMID:31550440 PMID:37142061 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase family 3, subfamily A2 decreases expression ISO Lead results in decreased expression of ALDH3A2 mRNA CTD PMID:19921347 NCBI chr11:61,114,240...61,158,267
Ensembl chr11:61,114,243...61,158,290 		JBrowse link
G Aldh5a1 aldhehyde dehydrogenase family 5, subfamily A1 affects expression ISO Lead affects the expression of ALDH5A1 mRNA CTD PMID:28903495 NCBI chr13:25,091,562...25,121,740
Ensembl chr13:25,091,562...25,121,644 		JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9, subfamily A1 decreases expression ISO Lead results in decreased expression of ALDH9A1 mRNA CTD PMID:19921347 NCBI chr 1:167,177,560...167,196,100
Ensembl chr 1:167,177,560...167,196,101 		JBrowse link
G Aldoc aldolase C, fructose-bisphosphate multiple interactions EXP [[lead acetate results in increased abundance of Lead] co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in decreased expression of ALDOC mRNA; [lead acetate results in increased abundance of Lead] promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALDOC mRNA] CTD PMID:38157908 NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607 		JBrowse link
G Alg8 ALG8 alpha-1,3-glucosyltransferase decreases expression ISO Lead results in decreased expression of ALG8 mRNA CTD PMID:19921347 NCBI chr 7:97,020,774...97,041,366
Ensembl chr 7:97,020,813...97,041,392 		JBrowse link
G Alkbh7 alkB homolog 7 increases expression ISO Lead results in increased expression of ALKBH7 mRNA CTD PMID:19921347 NCBI chr17:57,304,339...57,306,340
Ensembl chr17:57,304,339...57,306,322 		JBrowse link
G Alox15 arachidonate 15-lipoxygenase multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ALOX15 mRNA CTD PMID:39276841 NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ALOX5 mRNA CTD PMID:39276841 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139 		JBrowse link
G Alpi alkaline phosphatase, intestinal multiple interactions ISO [Cadmium co-treated with Lead] results in increased expression of ALPI protein CTD PMID:23806787 NCBI chr 1:87,025,724...87,029,328
Ensembl chr 1:87,025,724...87,029,328 		JBrowse link
G Alpl alkaline phosphatase, liver/bone/kidney decreases expression EXP Lead results in decreased expression of ALPL mRNA CTD PMID:23086611 NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695 		JBrowse link
G Amfr autocrine motility factor receptor affects expression ISO Lead affects the expression of AMFR mRNA CTD PMID:28903495 NCBI chr 8:94,698,216...94,739,301
Ensembl chr 8:94,698,216...94,739,470 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 multiple interactions
increases expression 		EXP Dietary Fats promotes the reaction [Lead results in increased expression of AMIGO2 mRNA]; Lead promotes the reaction [Dietary Fats results in increased expression of AMIGO2 mRNA] CTD PMID:34742682 NCBI chr15:97,141,955...97,145,168
Ensembl chr15:97,142,006...97,145,168 		JBrowse link
G Amn amnionless decreases expression ISO Lead results in decreased expression of AMN mRNA CTD PMID:19921347 NCBI chr12:111,237,530...111,242,860
Ensembl chr12:111,237,529...111,242,860 		JBrowse link
G Amn1 antagonist of mitotic exit network 1 affects splicing ISO Lead affects the splicing of AMN1 mRNA CTD PMID:28903495 NCBI chr 6:149,059,075...149,090,210
Ensembl chr 6:149,058,645...149,090,210 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 increases methylation EXP Lead results in increased methylation of AMPD3 gene CTD PMID:38833407 NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612 		JBrowse link
G Anapc2 anaphase promoting complex subunit 2 decreases expression ISO Lead results in decreased expression of ANAPC2 mRNA CTD PMID:19921347 NCBI chr 2:25,162,469...25,175,928
Ensembl chr 2:25,162,490...25,175,927 		JBrowse link
G Anapc5 anaphase-promoting complex subunit 5 decreases expression ISO Lead results in decreased expression of ANAPC5 mRNA CTD PMID:19921347 NCBI chr 5:122,925,522...122,960,402
Ensembl chr 5:122,925,522...122,959,402 		JBrowse link
G Ank1 ankyrin 1, erythroid affects expression
affects methylation 		ISO Lead affects the expression of ANK1 mRNA
Lead affects the methylation of ANK1 gene 		CTD PMID:28903495 PMID:31636367 NCBI chr 8:23,464,852...23,640,517
Ensembl chr 8:23,464,860...23,640,513 		JBrowse link
G Ank2 ankyrin 2, brain affects splicing
multiple interactions 		ISO
EXP 		Lead affects the splicing of ANK2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ANK2 mRNA 		CTD PMID:28903495 PMID:33445541 NCBI chr 3:126,715,256...127,293,996
Ensembl chr 3:126,715,261...127,292,999 		JBrowse link
G Ank3 ankyrin 3, epithelial affects splicing ISO Lead affects the splicing of ANK3 mRNA CTD PMID:28903495 NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268 		JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A affects expression ISO Lead affects the expression of ANKDD1A mRNA CTD PMID:28903495 NCBI chr 9:65,395,746...65,427,691
Ensembl chr 9:65,395,752...65,427,475 		JBrowse link
G Ankfn1 ankyrin-repeat and fibronectin type III domain containing 1 affects expression ISO Lead affects the expression of ANKFN1 mRNA CTD PMID:28903495 NCBI chr11:89,280,918...89,668,727
Ensembl chr11:89,281,049...89,732,092 		JBrowse link
G Ankhd1 ankyrin repeat and KH domain containing 1 decreases expression ISO Lead results in decreased expression of ANKHD1 mRNA CTD PMID:19921347 NCBI chr18:36,693,656...36,791,961
Ensembl chr18:36,693,040...36,791,966 		JBrowse link
G Ankra2 ankyrin repeat family A member 2 affects expression ISO Lead affects the expression of ANKRA2 mRNA CTD PMID:28903495 NCBI chr13:98,399,584...98,411,262
Ensembl chr13:98,399,582...98,411,262 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 affects expression
affects splicing 		ISO Lead affects the expression of ANKRD12 mRNA
Lead affects the splicing of ANKRD12 mRNA 		CTD PMID:28903495 NCBI chr17:66,272,698...66,386,242
Ensembl chr17:66,272,693...66,384,084 		JBrowse link
G Ankrd13a ankyrin repeat domain 13a affects expression ISO Lead affects the expression of ANKRD13A mRNA CTD PMID:28903495 NCBI chr 5:114,913,009...114,943,882
Ensembl chr 5:114,912,738...114,944,261 		JBrowse link
G Ankrd13c ankyrin repeat domain 13c affects expression ISO Lead affects the expression of ANKRD13C mRNA CTD PMID:28903495 NCBI chr 3:157,650,886...157,713,671
Ensembl chr 3:157,652,876...157,713,671 		JBrowse link
G Ankrd16 ankyrin repeat domain 16 decreases expression ISO Lead results in decreased expression of ANKRD16 mRNA CTD PMID:19921347 NCBI chr 2:11,781,902...11,795,138
Ensembl chr 2:11,782,687...11,795,140 		JBrowse link
G Ankrd46 ankyrin repeat domain 46 affects expression ISO Lead affects the expression of ANKRD46 mRNA CTD PMID:28903495 NCBI chr15:36,477,814...36,496,937
Ensembl chr15:36,477,814...36,496,966 		JBrowse link
G Ankrd6 ankyrin repeat domain 6 decreases expression ISO Lead results in decreased expression of ANKRD6 mRNA CTD PMID:37386098 NCBI chr 4:32,804,027...32,950,884
Ensembl chr 4:32,804,035...32,950,841 		JBrowse link
G Ano1 anoctamin 1, calcium activated chloride channel affects methylation ISO Lead affects the methylation of ANO1 gene CTD PMID:31636367 NCBI chr 7:144,142,286...144,305,762
Ensembl chr 7:144,142,286...144,305,711 		JBrowse link
G Ano2 anoctamin 2 multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 intron; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANO2 promoter CTD PMID:33445541 NCBI chr 6:125,667,382...126,017,115
Ensembl chr 6:125,667,382...126,017,089 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A multiple interactions EXP [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A exon; [lead acetate results in increased abundance of Lead] which results in decreased methylation of ANP32A intron CTD PMID:33445541 NCBI chr 9:62,248,637...62,286,084
Ensembl chr 9:62,248,575...62,286,094 		JBrowse link
G Anxa1 annexin A1 affects activity
multiple interactions 		ISO Lead affects the activity of ANXA1 protein
Lead affects the reaction [[Magnesium co-treated with Adenosine Triphosphate] affects the activity of ANXA1 protein] 		CTD PMID:20655937 NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308 		JBrowse link
G Anxa2 annexin A2 decreases expression
affects binding 		ISO Lead results in decreased expression of ANXA2 mRNA
ANXA2 protein binds to Lead 		CTD PMID:19921347 PMID:23896426 NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077 		JBrowse link
G Anxa4 annexin A4 decreases expression ISO Lead results in decreased expression of ANXA4 mRNA CTD PMID:19921347 NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566 		JBrowse link
G Anxa5 annexin A5 affects expression ISO Lead affects the expression of ANXA5 mRNA CTD PMID:28903495 NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043 		JBrowse link
G Ap2a1 adaptor-related protein complex 2, alpha 1 subunit affects splicing ISO Lead affects the splicing of AP2A1 mRNA CTD PMID:28903495 NCBI chr 7:44,549,797...44,578,914
Ensembl chr 7:44,549,797...44,578,920 		JBrowse link
G Ap2b1 adaptor-related protein complex 2, beta 1 subunit affects expression
affects splicing 		ISO Lead affects the expression of AP2B1 mRNA
Lead affects the splicing of AP2B1 mRNA 		CTD PMID:28903495 NCBI chr11:83,189,545...83,295,861
Ensembl chr11:83,189,850...83,295,861 		JBrowse link
G Ap2m1 adaptor-related protein complex 2, mu 1 subunit decreases expression ISO Lead results in decreased expression of AP2M1 mRNA CTD PMID:19921347 NCBI chr16:20,354,230...20,363,659
Ensembl chr16:20,354,228...20,363,659 		JBrowse link
G Ap3m1 adaptor-related protein complex 3, mu 1 subunit affects expression ISO Lead affects the expression of AP3M1 mRNA CTD PMID:28903495 NCBI chr14:21,083,810...21,102,603
Ensembl chr14:21,081,510...21,102,576 		JBrowse link
G Ap4e1 adaptor-related protein complex AP-4, epsilon 1 affects expression ISO Lead affects the expression of AP4E1 mRNA CTD PMID:28903495 NCBI chr 2:126,850,600...126,911,734
Ensembl chr 2:126,850,637...126,909,829 		JBrowse link
G Apba1 amyloid beta precursor protein binding family A member 1 affects expression ISO Lead affects the expression of APBA1 mRNA CTD PMID:28903495 NCBI chr19:23,736,170...23,926,961
Ensembl chr19:23,736,251...23,926,960 		JBrowse link
G Apba2 amyloid beta precursor protein binding family A member 2 affects splicing ISO Lead affects the splicing of APBA2 mRNA CTD PMID:28903495 NCBI chr 7:64,151,444...64,403,620
Ensembl chr 7:64,151,454...64,403,626 		JBrowse link
G Apcs amyloid P component, serum affects binding ISO APCS protein binds to Lead CTD PMID:23896426 NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608 		JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 multiple interactions
affects expression
affects response to substance 		ISO APEX1 protein inhibits the reaction [Lead results in decreased activity of APEX1 protein]
Lead affects the expression of APEX1 mRNA
APEX1 gene polymorphism affects the susceptibility to Lead 		CTD PMID:17013835 PMID:22466227 PMID:28903495 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596 		JBrowse link
G Aph1a aph1 homolog A, gamma secretase subunit increases expression ISO Lead results in increased expression of APH1A mRNA CTD PMID:19921347 NCBI chr 3:95,801,233...95,805,904
Ensembl chr 3:95,801,281...95,805,600 		JBrowse link
G Aplp2 amyloid beta precursor-like protein 2 decreases expression
affects expression
affects splicing 		ISO Lead results in decreased expression of APLP2 mRNA
Lead affects the expression of APLP2 mRNA
Lead affects the splicing of APLP2 mRNA 		CTD PMID:19921347 PMID:28903495 NCBI chr 9:31,060,853...31,123,144
Ensembl chr 9:31,060,853...31,123,111 		JBrowse link
G Apoa1 apolipoprotein A-I affects binding ISO APOA1 protein binds to Lead CTD PMID:23896426 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764 		JBrowse link
G Apoa2 apolipoprotein A-II affects binding ISO APOA2 protein binds to Lead CTD PMID:23896426 NCBI chr 1:171,049,133...171,053,948
Ensembl chr 1:171,052,623...171,053,948 		JBrowse link
G Apoe apolipoprotein E affects expression ISO Lead affects the expression of APOE protein CTD PMID:20681587 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113 		JBrowse link
G Apol9a apolipoprotein L 9a decreases expression
affects expression 		ISO Lead results in decreased expression of APOL4 mRNA
Lead affects the expression of APOL4 mRNA 		CTD PMID:19921347 PMID:28903495 NCBI chr15:77,287,989...77,295,280
Ensembl chr15:77,287,989...77,295,335 		JBrowse link
G App amyloid beta precursor protein decreases expression
increases expression
multiple interactions
affects expression
affects splicing
increases secretion
increases localization
affects abundance 		ISO
EXP 		Lead results in decreased expression of APP protein modified form
Lead results in increased expression of APP protein
[lead acetate results in increased abundance of Lead] which results in increased expression of APP mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of APP protein; fisetin inhibits the reaction [Lead results in increased expression of APP protein]
Lead affects the expression of APP mRNA
Lead affects the splicing of APP mRNA
Lead results in increased expression of APP mRNA; Lead results in increased expression of APP protein
[[lead acetate results in increased abundance of Lead] which co-treated with APP protein modified form] results in decreased expression of SYP protein; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [[APP protein co-treated with APP protein modified form] results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein binds to APP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form binds to APP protein modified form]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein modified form results in increased expression of BACE1 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of GAP43 protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in decreased expression of SYP protein]; [lead acetate results in increased abundance of Lead] promotes the reaction [APP protein results in increased expression of BACE1 protein]; [Lead co-treated with APP protein co-treated with APP protein modified form] results in increased expression of BACE1 protein; [Lead co-treated with APP protein modified form] results in increased abundance of 8-epi-prostaglandin F2alpha; [Lead co-treated with APP protein modified form] results in increased expression of PTGS2 protein; [Lead co-treated with APP protein modified form] results in increased expression of TP53 protein
Lead results in increased secretion of APP protein alternative form
Lead results in increased expression of APP protein alternative form
Lead results in increased localization of APP protein
Lead affects the abundance of APP mRNA; Lead affects the abundance of APP protein
[Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [BACE1 protein results in increased metabolism of APP protein]; [Arsenic co-treated with Cadmium co-treated with Lead] promotes the reaction [PSEN1 protein results in increased metabolism of APP protein]; [Arsenic co-treated with Cadmium co-treated with Lead] results in increased expression of APP protein alternative form; Arsenic promotes the reaction [Lead results in increased expression of APP protein alternative form]; Lead affects the reaction [APP protein binds to APP protein]; PRKCD protein promotes the reaction [Lead results in increased localization of APP protein]; rottlerin inhibits the reaction [PRKCD protein promotes the reaction [Lead results in increased localization of APP protein]] 		CTD PMID:16230335 PMID:19921347 PMID:20488202 PMID:21315759 PMID:22272629 More... NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654 		JBrowse link
G Aqp1 aquaporin 1 affects expression ISO Lead affects the expression of AQP1 mRNA CTD PMID:28903495 NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540 		JBrowse link
G Aqp4 aquaporin 4 affects expression ISO Lead affects the expression of AQP4 mRNA CTD PMID:28903495 NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039 		JBrowse link
G Aqr aquarius affects expression ISO Lead affects the expression of AQR mRNA CTD PMID:28903495 NCBI chr 2:113,931,642...114,005,788
Ensembl chr 2:113,931,651...114,017,505 		JBrowse link
G Araf Araf proto-oncogene, serine/threonine kinase decreases expression ISO Lead results in decreased expression of ARAF mRNA CTD PMID:19921347 NCBI chr  X:20,663,946...20,726,760
Ensembl chr  X:20,664,053...20,726,758 		JBrowse link
G Arc activity regulated cytoskeletal-associated protein multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in decreased expression of ARC mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of ARC protein; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of ARC mRNA]; asarone inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of ARC protein] CTD PMID:27936013 PMID:39947421 NCBI chr15:74,540,930...74,544,419
Ensembl chr15:74,540,932...74,544,419 		JBrowse link
G Arf3 ARF GTPase 3 decreases expression ISO Lead results in decreased expression of ARF3 mRNA CTD PMID:19921347 NCBI chr15:98,635,505...98,660,999
Ensembl chr15:98,634,515...98,661,095 		JBrowse link
G Arg1 arginase, liver decreases expression
multiple interactions 		ISO Lead results in decreased expression of ARG1 mRNA
[Lead co-treated with amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] results in decreased expression of ARG1 mRNA; [Lead co-treated with amyloid beta-protein (1-40)] results in decreased expression of ARG1 mRNA; [Lead co-treated with amyloid beta-protein (1-40)] results in decreased expression of ARG1 protein; [Lead co-treated with amyloid beta-protein (25-35)] results in decreased expression of ARG1 mRNA 		CTD PMID:38700421 NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382 		JBrowse link
G Arhgap1 Rho GTPase activating protein 1 affects splicing ISO Lead affects the splicing of ARHGAP1 mRNA CTD PMID:28903495 NCBI chr 2:91,480,463...91,502,670
Ensembl chr 2:91,480,205...91,502,671 		JBrowse link
G Arhgap20 Rho GTPase activating protein 20 affects expression ISO Lead affects the expression of ARHGAP20 mRNA CTD PMID:28903495 NCBI chr 9:51,676,651...51,765,158
Ensembl chr 9:51,676,637...51,765,156 		JBrowse link
G Arhgap22 Rho GTPase activating protein 22 increases expression ISO Lead results in increased expression of ARHGAP22 mRNA CTD PMID:19921347 NCBI chr14:32,935,952...33,091,893
Ensembl chr14:32,935,983...33,091,891 		JBrowse link
G Arhgap29 Rho GTPase activating protein 29 affects expression ISO Lead affects the expression of ARHGAP29 mRNA CTD PMID:28903495 NCBI chr 3:121,746,752...121,810,326
Ensembl chr 3:121,746,190...121,810,402 		JBrowse link
G Arhgap30 Rho GTPase activating protein 30 decreases expression ISO Lead results in decreased expression of ARHGAP30 mRNA CTD PMID:19921347 NCBI chr 1:171,216,528...171,237,808
Ensembl chr 1:171,216,522...171,237,866 		JBrowse link
G Arhgap31 Rho GTPase activating protein 31 increases expression ISO Lead results in increased expression of ARHGAP31 mRNA CTD PMID:19921347 NCBI chr16:38,418,705...38,533,397
Ensembl chr16:38,418,702...38,533,636 		JBrowse link
G Arhgap42 Rho GTPase activating protein 42 affects expression ISO Lead affects the expression of ARHGAP42 mRNA CTD PMID:28903495 NCBI chr 9:8,992,508...9,239,032
Ensembl chr 9:8,994,330...9,239,106 		JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha decreases expression ISO Lead results in decreased expression of ARHGDIA mRNA CTD PMID:19921347 NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450 		JBrowse link
G Arhgdig Rho GDP dissociation inhibitor gamma affects expression ISO Lead affects the expression of ARHGDIG mRNA CTD PMID:28903495 NCBI chr17:26,418,157...26,420,324
Ensembl chr17:26,418,157...26,426,760 		JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 affects splicing ISO Lead affects the splicing of ARHGEF12 mRNA CTD PMID:28903495 NCBI chr 9:42,875,138...43,017,069
Ensembl chr 9:42,875,138...43,018,534 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 affects methylation ISO Lead affects the methylation of ARHGEF2 gene CTD PMID:31636367 NCBI chr 3:88,500,427...88,556,839
Ensembl chr 3:88,513,273...88,555,359 		JBrowse link
G Arhgef3 Rho guanine nucleotide exchange factor 3 affects expression ISO Lead affects the expression of ARHGEF3 mRNA CTD PMID:28903495 NCBI chr14:26,836,418...27,125,873
Ensembl chr14:26,836,856...27,125,868 		JBrowse link
G Arhgef4 Rho guanine nucleotide exchange factor 4 affects expression
affects methylation 		ISO Lead affects the expression of ARHGEF4 mRNA
Lead affects the methylation of ARHGEF4 gene 		CTD PMID:28903495 PMID:31636367 NCBI chr 1:34,717,263...34,851,819
Ensembl chr 1:34,717,269...34,852,390 		JBrowse link
G Ark2n arkadia (RNF111) N-terminal like PKA signaling regulator 2N decreases expression ISO Lead results in decreased expression of ARK2N mRNA CTD PMID:19921347 NCBI chr18:77,719,184...77,802,190
Ensembl chr18:77,719,193...77,802,186 		JBrowse link
G Arl1 ADP-ribosylation factor-like 1 affects splicing ISO Lead affects the splicing of ARL1 mRNA CTD PMID:28903495 NCBI chr10:88,566,720...88,579,956
Ensembl chr10:88,566,720...88,579,956 		JBrowse link
G Arl5a ADP-ribosylation factor-like 5A affects splicing ISO Lead affects the splicing of ARL5A mRNA CTD PMID:28903495 NCBI chr 2:52,287,961...52,314,886
Ensembl chr 2:52,287,963...52,314,913 		JBrowse link
G Arl8a ADP-ribosylation factor-like 8A affects expression ISO Lead affects the expression of ARL8A mRNA CTD PMID:28903495 NCBI chr 1:135,074,572...135,084,007
Ensembl chr 1:135,074,562...135,084,007 		JBrowse link
G Arln allregulin increases expression ISO Lead results in increased expression of ARLN mRNA CTD PMID:19921347 NCBI chr 3:122,718,046...122,719,843
Ensembl chr 3:122,717,852...122,719,833 		JBrowse link
G Armc8 armadillo repeat containing 8 affects splicing ISO Lead affects the splicing of ARMC8 mRNA CTD PMID:28903495 NCBI chr 9:99,360,438...99,451,471
Ensembl chr 9:99,360,425...99,450,952 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases expression 		EXP
ISO 		Lead results in increased activity of [AHR protein binds to ARNT protein]
Lead results in increased expression of ARNT mRNA 		CTD PMID:16093525 PMID:19921347 NCBI chr 3:95,341,674...95,404,551
Ensembl chr 3:95,341,699...95,404,551 		JBrowse link
G Arpc1a actin related protein 2/3 complex, subunit 1A affects expression ISO Lead affects the expression of ARPC1A mRNA CTD PMID:28903495 NCBI chr 5:145,020,679...145,045,566
Ensembl chr 5:145,020,640...145,045,571 		JBrowse link
G Arpc2 actin related protein 2/3 complex, subunit 2 increases expression ISO Lead results in increased expression of ARPC2 mRNA CTD PMID:37386098 NCBI chr 1:74,275,656...74,307,368
Ensembl chr 1:74,275,243...74,307,368 		JBrowse link
G Arrdc1 arrestin domain containing 1 decreases expression ISO Lead results in decreased expression of ARRDC1 mRNA CTD PMID:19921347 NCBI chr 2:24,815,364...24,825,347
Ensembl chr 2:24,815,364...24,825,264 		JBrowse link
G Arrdc2 arrestin domain containing 2 affects expression ISO Lead affects the expression of ARRDC2 mRNA CTD PMID:28903495 NCBI chr 8:71,287,773...71,293,173
Ensembl chr 8:71,287,773...71,292,364 		JBrowse link
G Artn artemin decreases expression ISO Lead results in decreased expression of ARTN mRNA CTD PMID:19921347 NCBI chr 4:117,783,105...117,787,993
Ensembl chr 4:117,783,359...117,786,960 		JBrowse link
G Asah1 N-acylsphingosine amidohydrolase 1 affects expression ISO Lead affects the expression of ASAH1 mRNA CTD PMID:28903495 NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810 		JBrowse link
G Asb2 ankyrin repeat and SOCS box-containing 2 decreases expression ISO Lead results in decreased expression of ASB2 mRNA CTD PMID:19921347 NCBI chr12:103,287,401...103,322,260
Ensembl chr12:103,287,401...103,322,260 		JBrowse link
G Ascc2 activating signal cointegrator 1 complex subunit 2 affects expression ISO Lead affects the expression of ASCC2 mRNA CTD PMID:28903495 NCBI chr11:4,587,698...4,635,699
Ensembl chr11:4,587,747...4,635,699 		JBrowse link
G Asns asparagine synthetase increases expression ISO Lead results in increased expression of ASNS mRNA CTD PMID:37386098 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254 		JBrowse link
G Asph aspartate-beta-hydroxylase affects expression ISO Lead affects the expression of ASPH mRNA CTD PMID:22313790 NCBI chr 4:9,449,085...9,669,344
Ensembl chr 4:9,448,069...9,669,344 		JBrowse link
G Asphd1 aspartate beta-hydroxylase domain containing 1 affects expression ISO Lead affects the expression of ASPHD1 mRNA CTD PMID:22313790 NCBI chr 7:126,545,159...126,548,754
Ensembl chr 7:126,544,739...126,548,754 		JBrowse link
G Asphd2 aspartate beta-hydroxylase domain containing 2 affects expression ISO Lead affects the expression of ASPHD2 mRNA CTD PMID:22313790 NCBI chr 5:112,532,220...112,543,236
Ensembl chr 5:112,532,220...112,542,732 		JBrowse link
G Aspscr1 ASPSCR1 tether for SLC2A4, UBX domain containing decreases expression ISO Lead results in decreased expression of ASPSCR1 mRNA CTD PMID:19921347 NCBI chr11:120,563,878...120,600,273
Ensembl chr11:120,563,799...120,600,273 		JBrowse link
G Atad2b ATPase family, AAA domain containing 2B affects expression ISO Lead affects the expression of ATAD2B mRNA CTD PMID:28903495 NCBI chr12:4,964,404...5,097,396
Ensembl chr12:4,967,353...5,097,394 		JBrowse link
G Atad5 ATPase family, AAA domain containing 5 increases expression
affects expression 		ISO Lead results in increased expression of ATAD5 mRNA
Lead affects the expression of ATAD5 mRNA 		CTD PMID:19921347 PMID:28903495 NCBI chr11:79,980,205...80,026,623
Ensembl chr11:79,980,226...80,026,620 		JBrowse link
G Atf2 activating transcription factor 2 affects splicing ISO Lead affects the splicing of ATF2 mRNA CTD PMID:28903495 NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983 		JBrowse link
G Atf4 activating transcription factor 4 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATF4 mRNA CTD PMID:39547369 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742 		JBrowse link
G Atf5 activating transcription factor 5 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATF5 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of ATF5 protein; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of CLPP mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of HSPD1 mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 mRNA]; ATF5 protein affects the reaction [[lead acetate results in increased abundance of Lead] which results in increased expression of LONP1 protein]; ATF5 protein affects the susceptibility to [lead acetate results in increased abundance of Lead]; ATF5 protein results in decreased susceptibility to [lead acetate results in increased abundance of Lead] CTD PMID:39547369 NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082 		JBrowse link
G Atg5 autophagy related 5 multiple interactions EXP
ISO 		[lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 mRNA; [lead acetate results in increased abundance of Lead] which results in increased expression of ATG5 protein 		CTD PMID:33445541 PMID:36652739 NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287 		JBrowse link
G Atg7 autophagy related 7 multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA CTD PMID:39276841 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575 		JBrowse link
G Atl1 atlastin GTPase 1 affects expression ISO Lead affects the expression of ATL1 mRNA CTD PMID:28903495 NCBI chr12:69,939,879...70,010,859
Ensembl chr12:69,939,388...70,013,191 		JBrowse link
G Atm ataxia telangiectasia mutated multiple interactions ISO [lead acetate results in increased abundance of Lead] which results in increased expression of ATM mRNA CTD PMID:39276841 NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040 		JBrowse link
G Atp10b ATPase, class V, type 10B affects expression ISO Lead affects the expression of ATP10B mRNA CTD PMID:28903495 NCBI chr11:42,902,991...43,153,112
Ensembl chr11:43,040,704...43,153,112 		JBrowse link
G Atp11c ATPase, class VI, type 11C affects expression ISO Lead affects the expression of ATP11C mRNA CTD PMID:28903495 NCBI chr  X:59,268,643...59,450,041
Ensembl chr  X:59,268,650...59,636,304 		JBrowse link
G Atp13a2 ATPase type 13A2 affects expression ISO Lead affects the expression of ATP13A2 mRNA CTD PMID:28903495 NCBI chr 4:140,711,812...140,734,641
Ensembl chr 4:140,714,184...140,734,641 		JBrowse link
G Atp1a1 ATPase, Na+/K+ transporting, alpha 1 polypeptide affects expression
increases expression 		ISO Lead affects the expression of ATP1A1 mRNA
Lead results in increased expression of ATP1A1 protein 		CTD PMID:21364929 PMID:28903495 NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000 		JBrowse link
G Atp1a3 ATPase, Na+/K+ transporting, alpha 3 polypeptide affects expression ISO Lead affects the expression of ATP1A3 mRNA CTD PMID:28903495 NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383 		JBrowse link
G Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide affects expression ISO Lead affects the expression of ATP1B1 mRNA CTD PMID:28903495 NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924 		JBrowse link
G Atp1b2 ATPase, Na+/K+ transporting, beta 2 polypeptide affects expression ISO Lead affects the expression of ATP1B2 mRNA CTD PMID:28903495 NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768 		JBrowse link
G Atp2b3 ATPase, Ca++ transporting, plasma membrane 3 affects expression ISO Lead affects the expression of ATP2B3 mRNA CTD PMID:28903495 NCBI chr  X:72,546,356...72,632,267
Ensembl chr  X:72,546,692...72,614,611 		JBrowse link
G Atp2b4 ATPase, Ca++ transporting, plasma membrane 4 affects splicing ISO Lead affects the splicing of ATP2B4 mRNA CTD PMID:28903495 NCBI chr 1:133,630,416...133,728,755
Ensembl chr 1:133,627,195...133,728,779 		JBrowse link
G Atp2c1 ATPase, Ca++-sequestering affects expression ISO Lead affects the expression of ATP2C1 mRNA CTD PMID:28903495 NCBI chr 9:105,288,561...105,398,456
Ensembl chr 9:105,280,738...105,404,518 		JBrowse link
G Atp5f1b ATP synthase F1 subunit beta decreases expression ISO Lead results in decreased expression of ATP5F1B mRNA CTD PMID:19921347 NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260 		JBrowse link
G Atp5f1c ATP synthase F1 subunit gamma affects splicing ISO Lead affects the splicing of ATP5F1C mRNA CTD PMID:28903495 NCBI chr 2:10,060,841...10,085,321
Ensembl chr 2:10,060,827...10,085,321 		JBrowse link
G Atp5mc2 ATP synthase membrane subunit c locus 2 affects expression ISO Lead affects the expression of ATP5MC2 mRNA CTD PMID:28903495 NCBI chr15:102,571,303...102,579,482
Ensembl chr15:102,571,299...102,580,787 		JBrowse link
G Atp5po ATP synthase peripheral stalk subunit OSCP affects expression ISO Lead affects the expression of ATP5PO mRNA CTD PMID:28903495 NCBI chr16:91,722,111...91,728,518
Ensembl chr16:91,722,102...91,728,575
Ensembl chr16:91,722,102...91,728,575 		JBrowse link
G Atp6ap2 ATPase, H+ transporting, lysosomal accessory protein 2 decreases expression
affects expression 		ISO Lead results in decreased expression of ATP6AP2 mRNA
Lead affects the expression of ATP6AP2 mRNA 		CTD PMID:19921347 PMID:28903495 NCBI chr  X:12,453,998...12,483,290
Ensembl chr  X:12,454,040...12,483,288 		JBrowse link
G Atp6v0a1 ATPase, H+ transporting, lysosomal V0 subunit A1 affects expression ISO Lead affects the expression of ATP6V0A1 mRNA CTD PMID:28903495 NCBI chr11:100,899,262...100,954,545
Ensembl chr11:100,900,278...100,954,545 		JBrowse link
G Atp6v0a2 ATPase, H+ transporting, lysosomal V0 subunit A2 affects expression ISO Lead affects the expression of ATP6V0A2 mRNA CTD PMID:28903495 NCBI chr 5:124,767,117...124,801,519
Ensembl chr 5:124,766,641...124,801,519 		JBrowse link
G Atp6v1g2 ATPase, H+ transporting, lysosomal V1 subunit G2 affects expression
multiple interactions 		ISO Lead affects the expression of ATP6V1G2 mRNA
[lead acetate results in increased abundance of Lead] which results in increased expression of ATP6V1G2 mRNA 		CTD PMID:28903495 PMID:36642386 NCBI chr17:35,453,910...35,457,743
Ensembl chr17:35,452,636...35,457,743 		JBrowse link
G Atp7a ATPase, copper transporting, alpha polypeptide multiple interactions EXP [[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7A protein CTD PMID:40010429 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532 		JBrowse link
G Atp7b ATPase, copper transporting, beta polypeptide multiple interactions
affects expression 		EXP
ISO 		[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7B protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7B protein
Lead affects the expression of ATP7B mRNA 		CTD PMID:28903495 PMID:40010429 NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321 		JBrowse link
G Atp8b1 ATPase, class I, type 8B, member 1 decreases expression ISO Lead results in decreased expression of ATP8B1 mRNA CTD PMID:19921347 NCBI chr18:64,662,050...64,794,342
Ensembl chr18:64,662,038...64,794,338 		JBrowse link
G Atp9a ATPase, class II, type 9A affects expression ISO Lead affects the expression of ATP9A mRNA CTD PMID:28903495 NCBI chr 2:168,476,358...168,584,290
Ensembl chr 2:168,476,358...168,584,329 		JBrowse link
G Atxn1 ataxin 1 affects expression ISO Lead affects the expression of ATXN1 mRNA CTD PMID:28903495 NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484 		JBrowse link
G Atxn2 ataxin 2 affects splicing ISO Lead affects the splicing of ATXN2 mRNA CTD PMID:28903495 NCBI chr 5:121,849,794...121,954,372
Ensembl chr 5:121,849,400...121,954,556 		JBrowse link
G Auts2 autism susceptibility candidate 2 affects splicing ISO Lead affects the splicing of AUTS2 mRNA CTD PMID:28903495 NCBI chr 5:131,466,171...132,572,059
Ensembl chr 5:131,466,171...132,572,183 		JBrowse link
G Aven apoptosis, caspase activation inhibitor affects expression ISO Lead affects the expression of AVEN mRNA CTD PMID:28903495 NCBI chr 2:112,323,231...112,461,598
Ensembl chr 2:112,323,309...112,464,918 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc affects binding ISO AZGP1 protein binds to Lead CTD PMID:23896426 NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495 		JBrowse link
G B2m beta-2 microglobulin affects expression
multiple interactions 		ISO Lead affects the expression of B2M mRNA
[Metals, Heavy results in increased abundance of Lead] which results in increased secretion of B2M protein 		CTD PMID:28903495 PMID:39357351 NCBI chr 2:121,978,168...121,983,563
Ensembl chr 2:121,978,167...121,983,564 		JBrowse link
G B3galnt1 UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 affects splicing ISO Lead affects the splicing of B3GALNT1 mRNA CTD PMID:28903495 NCBI chr 3:69,481,252...69,506,305
Ensembl chr 3:69,481,491...69,506,293